Citrus Sinensis ID: 005846
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 674 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | yes | no | 0.936 | 0.943 | 0.602 | 0.0 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.976 | 0.974 | 0.563 | 0.0 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.939 | 0.936 | 0.536 | 0.0 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.884 | 0.950 | 0.579 | 0.0 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.945 | 0.945 | 0.529 | 0.0 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.937 | 0.959 | 0.525 | 0.0 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.919 | 0.940 | 0.537 | 0.0 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.930 | 0.927 | 0.530 | 0.0 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.933 | 0.944 | 0.517 | 0.0 | |
| O65482 | 830 | Putative cysteine-rich re | no | no | 0.948 | 0.769 | 0.507 | 0.0 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 773 bits (1997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/654 (60%), Positives = 491/654 (75%), Gaps = 23/654 (3%)
Query: 26 AVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRV 85
A D Y H C TAN+T NSTY NL LL+S+ +SR +S+GF NAT GQ P+RV
Sbjct: 34 AQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASL---SSRNASYSTGFQNATVGQAPDRV 90
Query: 86 YGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSP 145
GLF CRGD +T C+ CV+FA D L CP KE L+Y EC+LRYS+Q+I ST+ T+
Sbjct: 91 TGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTG 150
Query: 146 TVSLLNTQNVTDQ--GRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCT 203
V L+NT+NVT L++LV ++Q T A++++K+F TRK NFT Q+ Y L QCT
Sbjct: 151 GVILVNTRNVTSNQLDLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCT 210
Query: 204 PDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVL 263
PDL+ DC+ CL+ + ++P+ + G R++ PSC RYE+Y FY ESA PP P P +
Sbjct: 211 PDLTRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSI 267
Query: 264 LSP---PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPE 320
+P PP S GK G S +IAIV PI V +LFI G+CFL R+A+K Y P
Sbjct: 268 STPPVSAPPRS-----GKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSY-YTPS 321
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA 380
+ A +D+TT +SLQ D+ TI+ AT+ F NK+G+GGFGEVYKG L G E+AVKRLSK+
Sbjct: 322 AFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKS 381
Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
SGQG EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++LVYE+VPNKSLDYFL+DP K+GQ
Sbjct: 382 SGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQ 441
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
LDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMARIFG+D
Sbjct: 442 LDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLD 501
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560
QT+ NTSRIVGTYGYM+PEYAMHGQ+S+KSDVYSFGVLVLEII+GKKNS+FYQTDGA DL
Sbjct: 502 QTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDL 561
Query: 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
+SYAW W +G PL+L+D + ++ RNEV+RC+ +GLLCVQEDPAERP+++TIVLML S
Sbjct: 562 VSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTS 621
Query: 621 YSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
+VTLP P+QP F SR +D +TSKS+ SVD+ASIT+++PR
Sbjct: 622 NTVTLPVPRQPGLFFQSRIGKD------PLDTDTTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/674 (56%), Positives = 481/674 (71%), Gaps = 16/674 (2%)
Query: 8 MFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGN 67
+FS+FL +L TV D Y H+C T ++RNS+Y NL +LSS+ +S
Sbjct: 11 LFSVFLFMILK-----TVTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSL---SSPNA 62
Query: 68 GFSSGFFNATAGQ--DPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWY 125
++S F NA AG+ D NRVYG+FLCRGD + C+DCV FAA + LQ CP K ++WY
Sbjct: 63 AYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWY 122
Query: 126 AECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQ--GRLNELVGTQMSQVVTQAVSNTKRF 183
EC++RYS+QSI M P V L N QN+T+ R NE + + V +A ++++F
Sbjct: 123 DECMVRYSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKF 182
Query: 184 ATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRY 243
AT KANFT FQT+YSL QCTPDL++ DC +CLR + LP CC GGRV+ PSC+ RY
Sbjct: 183 ATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRY 242
Query: 244 ELYPFYNESATAPPAPAPVLLS-PPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFIL 302
ELYPFYNE+ A P P + PP ++ + +GK + + AI P++V VL +
Sbjct: 243 ELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSV-CVLLLG 301
Query: 303 GFCF-LRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEV 361
C+ L R+ K +A E ++ +T+ E+LQF F IE ATNKFS NKLG GGFGEV
Sbjct: 302 AMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEV 361
Query: 362 YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421
YKG L +G+ +A+KRLS+ S QGAEEFKNEV +VAKLQHRNL +LLG+CL+GEEKILVYE
Sbjct: 362 YKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYE 421
Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481
FVPNKSLDYFL+D EK+ LDW RRYKII GIARGILYLH DSRL IIHRDLKASNILLD
Sbjct: 422 FVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLD 481
Query: 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 541
A+M+PKISDFGMARIFGVDQTQ NT RIVGTYGYM+PEYA+HG++SVKSDVYSFGVLVLE
Sbjct: 482 ADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLE 541
Query: 542 IITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCV 601
+ITGKKNS+FY+ DG DL++Y WK W + +PL+L+D + ++ NEVIRCI + LLCV
Sbjct: 542 LITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCV 601
Query: 602 QEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKS-TSKSIP 660
QED +ERPSM I++M+NS++VTLP P++ F + + + P SD S TSKS+P
Sbjct: 602 QEDSSERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSRDPRSGGSASDHSATSKSLP 661
Query: 661 WSVDEASITEVYPR 674
SVD++SIT VYPR
Sbjct: 662 LSVDDSSITIVYPR 675
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 707 bits (1826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/649 (53%), Positives = 461/649 (71%), Gaps = 16/649 (2%)
Query: 31 YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFL 90
Y H C ++ NSTY NL LLSS ASR +S+GF N AGQ P+RV GLFL
Sbjct: 39 YLNHDCPNRTTYSSNSTYSTNLKTLLSSF---ASRNASYSTGFQNIRAGQTPDRVTGLFL 95
Query: 91 CRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLL 150
CRGD + C +CV F+ + L CP +E + +Y EC+LRYS ++ ST+ + +
Sbjct: 96 CRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMR 155
Query: 151 NTQNVT----DQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDL 206
N N++ + + +LV + M+Q +A +++++F+T K T+ QTLY L QCTPDL
Sbjct: 156 NPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDL 215
Query: 207 SSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSP 266
+ DC +CL ++ R+ + G R +PSCN RYELY FYNE+A P+P P+
Sbjct: 216 ARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGS 273
Query: 267 PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNADND 326
PP + + GKSG +S+ ++ + +AV + ++G+CFL ++ KK ++ S +D
Sbjct: 274 TPPLTSPSIPGKSG-NSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASEVGDD 332
Query: 327 LTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE 386
+ T +SLQ D+ TI+ ATN F+ NK+G GGFGEVYKG +G+E+AVKRLSK S QG
Sbjct: 333 MATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEA 392
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD L+DP KQ QLDW +R
Sbjct: 393 EFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQR 452
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
Y IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+DFGMARIFG+DQTQ NT
Sbjct: 453 YNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNT 512
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566
SRIVGTYGYMAPEYAMHGQFS+KSDVYSFGVLVLEII+G+KNS+F ++DGA DLL++ W+
Sbjct: 513 SRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWR 572
Query: 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626
W + T L L+D + ++ +EV+RCI +GLLCVQEDPA+RP+++T+ +ML S +VTLP
Sbjct: 573 LWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTLP 632
Query: 627 SPQQPAFFIGSRTERDLPTKEFECSDKS-TSKSIPWSVDEASITEVYPR 674
P+QP FFI S P K+ SD+S T+KS P S+D+ IT++YPR
Sbjct: 633 VPRQPGFFIQSS-----PVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/613 (57%), Positives = 448/613 (73%), Gaps = 17/613 (2%)
Query: 31 YATHVCSTTANFTRNSTYEKNLNLLLSSIPT-NASRGNGFSSGFFNATAGQDPNRVYGLF 89
Y H+C T ++RNS Y NL LLSS+ NAS +S+GF +A AGQ P+RV GLF
Sbjct: 26 YIKHICPNTTTYSRNSPYLTNLRTLLSSLSAPNAS----YSTGFQSARAGQAPDRVTGLF 81
Query: 90 LCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSL 149
LCRGD + + C++CV F+ D L CP ++++ +Y EC+LRYSDQ+I ST+A
Sbjct: 82 LCRGDVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIR 141
Query: 150 LNTQNVTDQGRLN---ELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDL 206
+N DQ ++N + V + M+Q +A S+ ++F T KA +T QTLY L QCTPDL
Sbjct: 142 MNGNISIDQNQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDL 201
Query: 207 SSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSP 266
+ DC +CL ++ +P K GGR L+ SCN RYEL+ FYNE+ T AP L P
Sbjct: 202 TRQDCFSCLESSIKLMPLY---KTGGRTLYSSCNSRYELFAFYNET-TVRTQQAPPPLPP 257
Query: 267 PPPGSVTTSR--GKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNAD 324
VT+ GKS S+ ++AIV I V A+L I G+CF +R NA P + D
Sbjct: 258 SSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNA-PAFDGD 316
Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG 384
D+TT ESLQ D+ I ATNKFS +NK+G+GGFGEVYKG +G E+AVKRLSK+SGQG
Sbjct: 317 -DITT-ESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQG 374
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
EFKNEVV+VAKLQHRNLVRLLGF + G E+ILVYE++PNKSLDYFL+DP KQ QLDW+
Sbjct: 375 DTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWT 434
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
RRYK+IGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPK++DFG+ARIFG+DQTQ
Sbjct: 435 RRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQE 494
Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYA 564
NTSRIVGT+GYMAPEYA+HGQFSVKSDVYSFGVLVLEII+GKKN++FY+TDGA DL+++A
Sbjct: 495 NTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTHA 554
Query: 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624
W+ W +GT L L+D + D+ ++EV+RCI + LLCVQEDPAERP ++TI +ML S +VT
Sbjct: 555 WRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTVT 614
Query: 625 LPSPQQPAFFIGS 637
LP P QP F + S
Sbjct: 615 LPVPLQPGFPVQS 627
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 684 bits (1764), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/663 (52%), Positives = 465/663 (70%), Gaps = 26/663 (3%)
Query: 26 AVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPT-NASRGNGFSSGFFNATAGQDPNR 84
A D Y H C T ++ NSTY NL LLSS+ + NAS +S+GF NATAG+ P+R
Sbjct: 24 AQDPFYLNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNAS----YSTGFQNATAGKAPDR 79
Query: 85 VYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATS 144
V GLFLCRGD + C++CV F+ L LCP +E + +Y +C+LRYS ++I ST T+
Sbjct: 80 VTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTAITN 139
Query: 145 PTVSLLNTQNVT--DQGRLN---ELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSL 199
+L+ N +Q +++ V + MS+ +A +++++ T T +Q LY L
Sbjct: 140 EGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYGL 199
Query: 200 AQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAP 259
QCTPDL+ +DC +CL+ ++ + + G R+ +PSC RYELYPFYNESA P
Sbjct: 200 LQCTPDLTRADCLSCLQSSINGM---ALSRIGARLYWPSCTARYELYPFYNESAIETPPL 256
Query: 260 APVL--------LSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKA 311
P L PP S ++ GKSG +S+ ++ V +AV + ++G+CFL +K
Sbjct: 257 PPPPPPPPPRESLVSTPPISSSSLPGKSG-NSTVLVVAVVVLAVLLFIALVGYCFLAKKK 315
Query: 312 KKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQE 371
KK ++ S +D+ T +SLQ D+ TI+ ATN F+ NK+G GGFGEVYKG +G+E
Sbjct: 316 KKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKE 375
Query: 372 IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
+AVKRLSK S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD
Sbjct: 376 VAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCL 435
Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
L+DP KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+DF
Sbjct: 436 LFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADF 495
Query: 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
GMARIFG+DQTQ NTSRIVGTYGYMAPEYAMHGQFS+KSDVYSFGVLVLEII+G+KNS+F
Sbjct: 496 GMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSF 555
Query: 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611
++DGA DLL++AW+ W + L L+D + ++ +EV+RCI +GLLCVQEDPA+RP++
Sbjct: 556 GESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAI 615
Query: 612 ATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEV 671
+T+ +ML S +VTLP P+QP FFI R +D + +T+KS P S+D+ SIT++
Sbjct: 616 STVFMMLTSNTVTLPVPRQPGFFIQCRAVKD----PLDSDQSTTTKSFPASIDDESITDL 671
Query: 672 YPR 674
YPR
Sbjct: 672 YPR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/654 (52%), Positives = 455/654 (69%), Gaps = 22/654 (3%)
Query: 26 AVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRV 85
A D + + C ++ NSTY NL + + + +SR +S+GF NAT GQ +RV
Sbjct: 23 AQDPRFLAYYCPNATTYSSNSTYLTNLK---TLLSSLSSRNASYSTGFQNATVGQALDRV 79
Query: 86 YGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSP 145
GLFLCRGD + C++CVTFA + CP +E + +Y EC+LRYS ++I ST T+
Sbjct: 80 TGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKNILSTAITNE 139
Query: 146 TVSLLNTQNVTD--QGRLNE---LVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLA 200
+L N Q ++N+ LV + M+Q+ +A N ++F+T K T QT Y L
Sbjct: 140 GEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLV 199
Query: 201 QCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPA 260
QCTPDLS +C CL ++ R+P + G R +PSCN RYELY FYNE+A P P
Sbjct: 200 QCTPDLSRQNCMNCLTSSINRMPF---SRIGARQFWPSCNSRYELYDFYNETAIGTPPPP 256
Query: 261 PVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPE 320
L+ + KSG S+ ++A+V PI V ++FI G+CF ++AKK Y P
Sbjct: 257 LPPLA------SPSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPA 310
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA 380
+ D D TT+ESLQ D+ I+ ATN FS +NK+G GGFG+VYKG +G E+AVKRLSK
Sbjct: 311 LDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKT 369
Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
S QG EFKNEVV+VA L+H+NLVR+LGF +E EE+ILVYE+V NKSLD FL+DP K+GQ
Sbjct: 370 SEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQ 429
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
L W++RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMARIFG+D
Sbjct: 430 LYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMD 489
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560
QTQ NTSRIVGTYGYM+PEYAM GQFS+KSDVYSFGVLVLEII+G+KN++F +TD A DL
Sbjct: 490 QTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDL 549
Query: 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
+++AW+ WR+GT L L+D + DS ++EV+RC +GLLCVQEDP +RP+M+TI +ML S
Sbjct: 550 VTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTS 609
Query: 621 YSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
++ LP+PQQP FF+ SR T + +T+KS+ S+D+ S++++ PR
Sbjct: 610 NTMALPAPQQPGFFVRSRP----GTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 664 bits (1713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/659 (53%), Positives = 453/659 (68%), Gaps = 39/659 (5%)
Query: 28 DREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYG 87
D Y HVC T +RNS Y NL LL+S+ +N + FS G + T GQ+ + V+G
Sbjct: 28 DPTYVGHVC--TNRISRNSIYFSNLQTLLTSLSSNNAY---FSLGSHSLTKGQNSDMVFG 82
Query: 88 LFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTV 147
L+LC+GD + C++CV FAA+D CP KE ++ Y EC+L YSD++IF T+ T+
Sbjct: 83 LYLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNIFMDTVTTTTI 142
Query: 148 SLLNTQNVT-DQG-RLNELVGTQMSQVVTQAVSNT-KRFATRKANFTTFQTLYSLAQCTP 204
NTQ VT DQ R N+ V + M + +A ++T K+FA +K++F++ Q+LY+ QC P
Sbjct: 143 ITWNTQKVTADQSDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIP 202
Query: 205 DLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVL- 263
DL+S DC CL+ ++ L K GGR L PSCN RYE+YPFY E+ P PV
Sbjct: 203 DLTSEDCVMCLQQSIKEL---YFNKVGGRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSA 259
Query: 264 -----LSPP--PPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYN 316
+S P PPG +GK+ I + I+V + + F ++AKK Y+
Sbjct: 260 PPLPLVSTPSFPPG-----KGKNSTVIIIAIVVPVAISVLICVAVFSF-HASKRAKKTYD 313
Query: 317 AVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR 376
PE ++D+TT SLQFDF+ IE AT+KFS NKLG+GGFG+VYKG LP+G ++AVKR
Sbjct: 314 -TPE---EDDITTAGSLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKR 369
Query: 377 LSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE 436
LSK SGQG +EFKNEVV+VAKLQHRNLV+LLGFCLE EEKILVYEFV NKSLDYFL+D
Sbjct: 370 LSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSR 429
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
Q QLDW+ RYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMARI
Sbjct: 430 MQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARI 489
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556
F +DQT+ +T R+VGTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+G+KNS+ YQ D
Sbjct: 490 FEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDA 549
Query: 557 A-ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
+ +L++Y W+ W DG+PL L+D++ DSY RNE+IRCI + LLCVQED RP+M+ IV
Sbjct: 550 SFGNLVTYTWRLWSDGSPLDLVDSSFRDSYQRNEIIRCIHIALLCVQEDTENRPTMSAIV 609
Query: 616 LMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
ML + S+ L PQ P FF S E+ P S KS S+D ASIT + PR
Sbjct: 610 QMLTTSSIALAVPQPPGFFFRSNHEQAGP---------SMDKSSLCSIDAASITILAPR 659
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 662 bits (1707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/663 (53%), Positives = 457/663 (68%), Gaps = 36/663 (5%)
Query: 31 YATHVC-STTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLF 89
+ H C S+ ++RNSTY NL + + + +SR +S+GF ATAGQ P+RV GLF
Sbjct: 31 HLNHSCPSSILTYSRNSTYFTNLK---TLLSSLSSRNASYSTGFQTATAGQAPDRVTGLF 87
Query: 90 LCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSL 149
LCRGD + C++CV F+ ++ L CP +KE +L+Y EC+LRYS ++I ST+ + L
Sbjct: 88 LCRGDVSQEVCRNCVAFSVKETLYWCPYNKEVVLYYDECMLRYSHRNILSTVTYDGSAIL 147
Query: 150 LNTQNVT--DQGRLNE---LVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTP 204
LN N++ +Q +++E LV + ++ +A +++K+F TRK T Q LY L QCTP
Sbjct: 148 LNGANISSSNQNQVDEFRDLVSSTLNLAAVEAANSSKKFYTRKV--ITPQPLYLLVQCTP 205
Query: 205 DLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPA---- 260
DL+ DC CL+ ++ + + GGR +PSCN RYE Y FYNE+AT +P
Sbjct: 206 DLTRQDCLRCLQKSIKGMSLY---RIGGRFFYPSCNSRYENYSFYNETATRSSSPPSLPP 262
Query: 261 ------PVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKK 314
+ L+PPP + + RGK G +SS II +V PI +LF+ F +K +
Sbjct: 263 RSTPQQQLKLAPPP---LISERGK-GRNSSVIIVVVVPIIALLLLFVAFFSLRAKKTRTN 318
Query: 315 YNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAV 374
Y P + +D+TT SLQFDF+ IE ATNKF NKLG+GGFGEVYKG+ PSG ++AV
Sbjct: 319 YEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAV 378
Query: 375 KRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434
KRLSK SGQG EF NEV++VAKLQHRNLVRLLGFCLE +E+ILVYEFVPNKSLDYF++D
Sbjct: 379 KRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFD 438
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
Q LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILL +MN KI+DFGMA
Sbjct: 439 STMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMA 498
Query: 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554
RIFG+DQT+ NT RIVGTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+GKKNSN YQ
Sbjct: 499 RIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQM 558
Query: 555 DG--AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612
DG A +L++Y W+ W +G+PL+L+D + D+Y NEV RCI + LLCVQE+ +RP+M+
Sbjct: 559 DGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMS 618
Query: 613 TIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDK-STSKSIPWSVDEASITEV 671
IV ML + S+ L PQ+P FF R ++ D+ S + S SVD+ASIT V
Sbjct: 619 AIVQMLTTSSIALAVPQRPGFFF-----RSSKHEQVGLVDRLSINTSALCSVDDASITNV 673
Query: 672 YPR 674
PR
Sbjct: 674 TPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 659 bits (1699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/673 (51%), Positives = 448/673 (66%), Gaps = 44/673 (6%)
Query: 22 SFTVAVDRE-YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQ 80
SFT + Y H CS T ++ NSTY NL + + + +SR +S+GF NATAGQ
Sbjct: 18 SFTASAQNPFYLYHNCSITTTYSSNSTYSTNLK---TLLSSLSSRNASYSTGFQNATAGQ 74
Query: 81 DPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFST 140
P+ V GLFLCRG+ + C+ C+ + + L CP +E + +Y +C+LRYS+++I ST
Sbjct: 75 APDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILST 134
Query: 141 MATSPTVSLLNTQN--VTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYS 198
+ T V + N +N Q R +LV M+ +A + KRFA K + Q+LY
Sbjct: 135 LNTDGGVFMQNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYG 194
Query: 199 LAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPA 258
+ QCTPDL+ DC CL+ ++ ++ K GGR PSC RY+ Y FYNE P
Sbjct: 195 MVQCTPDLTEQDCLDCLQQSINQV---TYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTPQ 251
Query: 259 PAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAV 318
+ SP P GK G SS +IA+V PI V +LF+ F R K KK A+
Sbjct: 252 DS----SPRP--------GKGGNSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAI 299
Query: 319 P----------------ESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVY 362
P E+ +D+TT SLQFDF+ I AT+ F NKLG+GGFGEVY
Sbjct: 300 PLFKVKRKETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVY 359
Query: 363 KGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422
KG PSG ++AVKRLSK SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKILVYEF
Sbjct: 360 KGTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEF 419
Query: 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
VPNKSLDYFL+DP QGQLDWSRRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA
Sbjct: 420 VPNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDA 479
Query: 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
+MNPK++DFGMARIFG+DQT+ NT R+VGTYGYMAPEYAM+G+FS+KSDVYSFGVLVLEI
Sbjct: 480 DMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEI 539
Query: 543 ITGKKNSNFYQTDGA-ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCV 601
++G KNS+ Q DG+ ++L++Y W+ W +G+P +L+D + D+Y +E+ RCI + LLCV
Sbjct: 540 VSGMKNSSLDQMDGSISNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCV 599
Query: 602 QEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPW 661
QED +RP+M+ IV ML + S+ L P+ P FF+ S+ E+ E C TS +
Sbjct: 600 QEDANDRPTMSAIVQMLTTSSIALAVPRPPGFFLRSKQEQ----AERACPSMDTSDL--F 653
Query: 662 SVDEASITEVYPR 674
S+DEASIT V PR
Sbjct: 654 SIDEASITSVAPR 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/709 (50%), Positives = 461/709 (65%), Gaps = 70/709 (9%)
Query: 24 TVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPN 83
T A+D Y HVC + A F R+STY NL LLS++ +S +S+GF NATAG+ P+
Sbjct: 134 TSALDPTYVYHVCPSWATFPRSSTYMTNLITLLSTL---SSPSASYSTGFQNATAGKHPD 190
Query: 84 RVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMAT 143
RV GLF CRGD + C+ CV+FA + CP+ KE L+Y +C LRYS+++I ST T
Sbjct: 191 RVTGLFNCRGDVSPEVCRRCVSFAVNETSTRCPIEKEVTLYYDQCTLRYSNRNILSTSNT 250
Query: 144 SPTVSLLNTQNVT--DQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQ 201
+ + L N+QN+T +Q R +LV T M+Q A +++KRF R ANFTT +LY+L Q
Sbjct: 251 NGGIILANSQNMTSNEQARFKDLVLTTMNQATIAAANSSKRFDARSANFTTLHSLYTLVQ 310
Query: 202 CTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPA- 260
CT DL+ DC +CL+ + +LP+ K GG+ + PSC+ R+EL FYN+SA P P
Sbjct: 311 CTHDLTRQDCLSCLQQIINQLPT---EKIGGQFIVPSCSSRFELCLFYNQSAVTTPQPQQ 367
Query: 261 ----------------------PVL--LSPP---------PPG-------SVTTSRGKSG 280
P++ LS PG V+ + GK G
Sbjct: 368 NSAPPPPPTSIPSPRPGLNSRFPLITCLSAVSFEKFKDLLKPGFICILIKIVSENTGKGG 427
Query: 281 ISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESN------------ADN--D 326
SS IIA+V I +LF+ F ++ KK A+P N A+N
Sbjct: 428 NSSVIIIAVVVSITALLLLFVAVFSVRTKRRKKMIGAIPLLNVKRKDTEVTEPLAENGDS 487
Query: 327 LTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE 386
+TT SLQFDF+ I ATN F NKLG+GGFGEVYKG PSG ++AVKRLSK SGQG
Sbjct: 488 ITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGER 547
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLDYFL+D + QLDW+RR
Sbjct: 548 EFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRR 607
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
YKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMARIFG+DQT+ NT
Sbjct: 608 YKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANT 667
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA-ADLLSYAW 565
R+VGTYGYMAPEYAM+GQFS+KSDVYSFGVLV EII+G KNS+ YQ D + ++L++Y W
Sbjct: 668 RRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTW 727
Query: 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625
+ W +G+ L L+D + D+Y +++ RCI + LLCVQED +RP+M+ IV ML + S+ L
Sbjct: 728 RLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIVL 787
Query: 626 PSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
P+QP FF R E + S + S+D+ASIT V PR
Sbjct: 788 AVPKQPGFFFRGRHE------QVGEVGSSVDRLALCSIDDASITSVAPR 830
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 674 | ||||||
| 255555035 | 671 | ATP binding protein, putative [Ricinus c | 0.976 | 0.980 | 0.641 | 0.0 | |
| 255555031 | 674 | ATP binding protein, putative [Ricinus c | 0.948 | 0.948 | 0.647 | 0.0 | |
| 224113935 | 674 | predicted protein [Populus trichocarpa] | 0.961 | 0.961 | 0.659 | 0.0 | |
| 359474717 | 663 | PREDICTED: cysteine-rich receptor-like p | 0.937 | 0.953 | 0.638 | 0.0 | |
| 359474715 | 684 | PREDICTED: cysteine-rich receptor-like p | 0.980 | 0.966 | 0.624 | 0.0 | |
| 359496581 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.934 | 0.945 | 0.626 | 0.0 | |
| 224076504 | 671 | predicted protein [Populus trichocarpa] | 0.986 | 0.991 | 0.645 | 0.0 | |
| 224076444 | 673 | predicted protein [Populus trichocarpa] | 0.989 | 0.991 | 0.645 | 0.0 | |
| 296088180 | 699 | unnamed protein product [Vitis vinifera] | 0.934 | 0.901 | 0.594 | 0.0 | |
| 351721533 | 667 | cysteine-rich protein precursor [Glycine | 0.936 | 0.946 | 0.626 | 0.0 |
| >gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/673 (64%), Positives = 519/673 (77%), Gaps = 15/673 (2%)
Query: 9 FSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNG 68
F + L++LL A EY H CS T FT NSTY+ NLN + ++ S
Sbjct: 7 FPIILLFLLRLAI-IVKAESPEYRYHFCSNTTTFTPNSTYQTNLN----QVLSSLSNNAN 61
Query: 69 FSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAEC 128
S GFFN +GQ P+ VYG FLCRGD +T CQDCVTFA +D+++ CP+ K I+WY +C
Sbjct: 62 NSIGFFNIPSGQQPDDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDQC 121
Query: 129 LLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQA---VSNTKRFAT 185
LLRY +QS STM +P V L NTQ+++D R + L+ T M + T A S K+FA
Sbjct: 122 LLRYENQSFISTMDQTPGVFLSNTQDISDPDRFDNLLATTMENLATDASSAASGEKKFAA 181
Query: 186 RKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYEL 245
NFT FQ LYSL QCTPDLS+ C CLRGA++ LPSCC GK+G VL+PSCNVRYE+
Sbjct: 182 TDDNFTAFQKLYSLVQCTPDLSNPGCRQCLRGAISNLPSCCGGKRGANVLYPSCNVRYEV 241
Query: 246 YPFYNESATAPPAPAPVLLSPPP----PGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFI 301
YPF+N +A PP P+P PPP G+ + G+SGIS+ I+AIVAP+A+ VLF
Sbjct: 242 YPFFNATAVEPPPPSPSPAVPPPPPTGSGTRPETEGQSGISTVIIVAIVAPVAIAIVLFS 301
Query: 302 LGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEV 361
L +C+LRR+ +KKY+AV E N++TT+ESLQ D T+E ATNKFS DNKLGEGGFGEV
Sbjct: 302 LAYCYLRRRPRKKYDAVQEDG--NEITTVESLQIDLNTVEAATNKFSADNKLGEGGFGEV 359
Query: 362 YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421
YKG+LP+GQEIAVK+LS++SGQGA+EFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYE
Sbjct: 360 YKGILPNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYE 419
Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481
FV NKSLDYFL+DPEKQ QLDWS RYKI+GGIARGILYLHEDS+LRI+HRDLK SNILLD
Sbjct: 420 FVSNKSLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVSNILLD 479
Query: 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 541
MNPKISDFG ARIFGVDQ+QGNT RIVGTYGYM+PEYAMHGQFSVKSD+YSFGVL+LE
Sbjct: 480 RNMNPKISDFGTARIFGVDQSQGNTKRIVGTYGYMSPEYAMHGQFSVKSDMYSFGVLILE 539
Query: 542 IITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCV 601
II GKKNS+FY+ DGA DL+SY WK WRDGTP++++D + DSYSRNEV+RCIQ+GLLCV
Sbjct: 540 IICGKKNSSFYEIDGAGDLVSYVWKHWRDGTPMEVMDPVIKDSYSRNEVLRCIQIGLLCV 599
Query: 602 QEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPW 661
QEDPA+R +MAT+VLMLNS+SVTLP PQQPAF I SR++ +P K E DKST KS+
Sbjct: 600 QEDPADRLTMATVVLMLNSFSVTLPVPQQPAFLIHSRSQPTMPMKGLEL-DKSTPKSMQL 658
Query: 662 SVDEASITEVYPR 674
SVD+ IT++YPR
Sbjct: 659 SVDQEPITQIYPR 671
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555031|ref|XP_002518553.1| ATP binding protein, putative [Ricinus communis] gi|223542398|gb|EEF43940.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 871 bits (2250), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/650 (64%), Positives = 519/650 (79%), Gaps = 11/650 (1%)
Query: 31 YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFL 90
Y HVCS T F NSTY+ NLN L S+ NA+ S GF+N ++GQDP+ +YGLFL
Sbjct: 30 YLYHVCSNTTTFAPNSTYQTNLNQLFPSLSNNANN----SIGFYNRSSGQDPDDIYGLFL 85
Query: 91 CRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLL 150
CRGD +T CQDCVTFA++D+++ CP+ K I+WY ECLL Y+++S++S MA P V LL
Sbjct: 86 CRGDVSTDVCQDCVTFASQDIVKRCPIEKVAIVWYDECLLHYANRSLYSIMAQEPGVFLL 145
Query: 151 NTQNVTDQGRLNELVGTQMSQVVTQAVS---NTKRFATRKANFTTFQTLYSLAQCTPDLS 207
N QN+ DQ R N L+ T M ++ T+A S K+FA + NFT F+ LYSL QCTPDLS
Sbjct: 146 NVQNIADQDRFNNLLATTMGKLATEAASAASGEKKFAVKIDNFTAFEKLYSLVQCTPDLS 205
Query: 208 SSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESA---TAPPAPAPVLL 264
+ DC CL+ A++ LP+CC GK+GGRVL+PSCN+RYE+YPF+N +A P V
Sbjct: 206 NLDCGRCLQAAISNLPTCCDGKRGGRVLYPSCNIRYEVYPFFNVTALEPPPPSPSPVVPP 265
Query: 265 SPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNAD 324
P G+ ++GKSG+S+ TI+AIVAP+AV V F LG C+LRR+A+KKY+A E +A
Sbjct: 266 PPTSSGTRPETKGKSGLSTVTIVAIVAPVAVAIVFFFLGCCYLRRRARKKYDAGQEDDAG 325
Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG 384
N++TT+ESLQ D TIE AT+KFS NKLGEGGFG+VYKG LP+GQEIAVK+LS++S QG
Sbjct: 326 NEITTVESLQIDLNTIEAATDKFSAANKLGEGGFGKVYKGTLPNGQEIAVKKLSRSSVQG 385
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
A+EFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL+D +KQGQLDW
Sbjct: 386 AQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDAKKQGQLDWQ 445
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
RYKI+GGIARGI+YLHEDS+L+IIHRDLK SNILLD +MNPKISDFGMARIFGVDQTQG
Sbjct: 446 TRYKIVGGIARGIIYLHEDSQLKIIHRDLKVSNILLDKDMNPKISDFGMARIFGVDQTQG 505
Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYA 564
NT+RIVGTYGYM+PEYAMHG FSVKSD+YSFGVLVLEII GKKNS+FY+ GA+DL+SY
Sbjct: 506 NTNRIVGTYGYMSPEYAMHGHFSVKSDIYSFGVLVLEIICGKKNSSFYEIHGASDLVSYV 565
Query: 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624
W W+DGTP++++D L DSYSRNEV+RCIQ+GLLCVQED +RP+MATI+LMLNS+SVT
Sbjct: 566 WTHWKDGTPMEVVDPVLKDSYSRNEVLRCIQIGLLCVQEDATDRPTMATIMLMLNSFSVT 625
Query: 625 LPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
LP P+QPAFF+ S +E +P + + SDKST+KS+ W +E SIT+VYPR
Sbjct: 626 LPVPRQPAFFLHSSSEPTMPMEGLQ-SDKSTTKSMQWYGNEESITQVYPR 674
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113935|ref|XP_002316618.1| predicted protein [Populus trichocarpa] gi|222859683|gb|EEE97230.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2240), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/658 (65%), Positives = 530/658 (80%), Gaps = 10/658 (1%)
Query: 24 TVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPN 83
T A D + C T FTRNSTY+ NLNLLLSS+ +NA+R N +GF+N +AGQDP+
Sbjct: 20 TQAQDPTFLYPYCPNTTTFTRNSTYQANLNLLLSSLSSNATRNN--INGFYNVSAGQDPD 77
Query: 84 RVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMAT 143
VYG+FLCRGD + S C++CV FAA+DVL+ CP+ K ++W+ EC LRYS+++IFST+
Sbjct: 78 AVYGMFLCRGDVSNSVCRNCVNFAAKDVLERCPIEKVAMIWFDECELRYSNRNIFSTVDQ 137
Query: 144 SPTVSLLNTQNVTDQ-GRLNELVGTQMSQVVTQAVS---NTKRFATRKANFTTFQTLYSL 199
T+ +++ NVT Q R N+LV T ++ + +A S K+FA ++ N+T Q LY+L
Sbjct: 138 DFTLFMMSPNNVTVQPDRFNQLVETTINDIAARAASAPSGAKKFAVQQVNYTGIQKLYTL 197
Query: 200 AQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAP 259
QCTPDLS+ DC+ CL+GA+++L +CC+ KQGGRVLF SCN RYELY FYN +A A AP
Sbjct: 198 VQCTPDLSTPDCSRCLQGAISKLGNCCNRKQGGRVLFASCNFRYELYEFYNATAAAEAAP 257
Query: 260 APVLLSPPPPGSV--TTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNA 317
P ++ PP + T +GK G+S+ IIAI+ P+ V+ VLF LGFCFL R+AK N+
Sbjct: 258 PPPPVALSPPPTSGPETRKGKGGVSTVLIIAILIPVTVSLVLFCLGFCFLSRRAKSNKNS 317
Query: 318 VPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL 377
E++ N++T +ESLQFD +I+ ATN FS DNKLGEGGFGEVYKG LP+GQ IAVKRL
Sbjct: 318 AQENDVGNEITNVESLQFDLSSIQDATNHFSADNKLGEGGFGEVYKGTLPNGQAIAVKRL 377
Query: 378 SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK 437
SK SGQGA EFKNEV+LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF++DPEK
Sbjct: 378 SKGSGQGAAEFKNEVILVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFVFDPEK 437
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
QG LDWS+RYKIIGGIARGILYLHEDSRLR+IHRDLKASNILLD +MN K+SDFGMARIF
Sbjct: 438 QGLLDWSKRYKIIGGIARGILYLHEDSRLRVIHRDLKASNILLDGDMNAKVSDFGMARIF 497
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557
GVDQTQG T+RIVGTYGYM+PEYAMHGQFSVKSD YSFGVL+LEII+GKKNS+FYQT GA
Sbjct: 498 GVDQTQGCTNRIVGTYGYMSPEYAMHGQFSVKSDAYSFGVLILEIISGKKNSSFYQTGGA 557
Query: 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617
ADL SYAWK WRDGTPL+++D L D+YSRNEV+RCI +GLLCVQEDPA RP+MAT+VL+
Sbjct: 558 ADLASYAWKHWRDGTPLEVMDPTLADTYSRNEVMRCIHIGLLCVQEDPASRPTMATVVLL 617
Query: 618 LNSYSVTLPSPQQPAFFIGSRTER-DLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
LNSYS+TLP PQ+PAFF+ SRT++ +P+KEF +DKS S S+P+S DE SITEVYPR
Sbjct: 618 LNSYSITLPLPQEPAFFLHSRTDQGSIPSKEF-FADKSKSNSVPYSGDEGSITEVYPR 674
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/652 (63%), Positives = 502/652 (76%), Gaps = 20/652 (3%)
Query: 31 YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRV-YGLF 89
Y H+C T F NS+YE NLN LSS+ +NA+R +GF+N TAG+ P V YGLF
Sbjct: 24 YLYHICPNTTTFNPNSSYETNLNFALSSLSSNATR----DTGFYNVTAGRTPPDVAYGLF 79
Query: 90 LCRGDQTTSDCQDCVTFAARD-VLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVS 148
LCRGD T+ CQDCV A + V Q C K+ I+WY EC+LRYS++S FS ++ SP VS
Sbjct: 80 LCRGDVTSQVCQDCVATAVNETVRQRCRGFKQAIIWYDECMLRYSNESFFSQVSESPRVS 139
Query: 149 LLNTQNVTDQGRLNELVGTQMSQVVTQAVSNT--KRFATRKANFTTFQTLYSLAQCTPDL 206
+ NTQN+T+ + N+++G + + TQAV++ K+FAT++ NFT FQ +YSL QCTPDL
Sbjct: 140 MWNTQNITEPDQFNQVLGDTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSLVQCTPDL 199
Query: 207 SSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSP 266
S C+ CL G +A LP CC GKQG RVLFPSCNVRYELYPFY A P P
Sbjct: 200 SPDQCDRCLIGTIAILPDCCGGKQGARVLFPSCNVRYELYPFYQSVAAPPSPPPARP--- 256
Query: 267 PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLF-ILGFCFLRRKAKKKYNAVPESNADN 325
S ++ GK GISS TI+ IV P V+ V+F IL +CF+RR AKK+Y+ + N +
Sbjct: 257 ----SEPSTEGKGGISSKTIVIIVVPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENVEF 312
Query: 326 DLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA 385
++TT +SLQFD TI+ ATN FS NK+GEGGFG VYKG L SGQEIA+KRLSK+SGQGA
Sbjct: 313 NITTEQSLQFDLATIQAATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGA 372
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY---DPEKQGQLD 442
EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLDYFL+ P K+GQLD
Sbjct: 373 VEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQPTKRGQLD 432
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
WSRRYKIIGGIARGILYLHEDSRLR+IHRDLKASN+LLD +MNPKISDFGMARIFGVDQT
Sbjct: 433 WSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQT 492
Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS 562
QGNT+R+VGTYGYM+PEYAMHG+FSVKSDVYSFGVLVLEII+GK+++ F+++D A DLLS
Sbjct: 493 QGNTNRVVGTYGYMSPEYAMHGRFSVKSDVYSFGVLVLEIISGKRSNCFHESDQAEDLLS 552
Query: 563 YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622
YAWK WR+ TPL+ + +S+S+NEVIRCI +GLLCVQEDP +RPSMA++VLML+SYS
Sbjct: 553 YAWKLWRNDTPLEFMGPTTRNSFSKNEVIRCIHMGLLCVQEDPDDRPSMASVVLMLSSYS 612
Query: 623 VTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
VTLP PQQPA F + D P E SD+S SKS+ WSV+EASIT++YPR
Sbjct: 613 VTLPLPQQPASFSRTGALSDFPIMALE-SDQSASKSMTWSVNEASITDLYPR 663
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474715|ref|XP_003631522.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2163), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/685 (62%), Positives = 517/685 (75%), Gaps = 24/685 (3%)
Query: 9 FSLFLIYLLSFQFSFT---VAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASR 65
FS L++L + + + + +Y HVCS T NSTY+ NLN LLSS+ +NA+R
Sbjct: 5 FSRNLLFLCALGLAISCLAIQAAPDYIHHVCSNTTTIQPNSTYQTNLNSLLSSLSSNATR 64
Query: 66 GNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWY 125
NGF +NATAGQ P+ YGLFLCRGD DC+DCV A+ ++LQ C K+ I+WY
Sbjct: 65 ANGF----YNATAGQSPDVAYGLFLCRGDVAIDDCRDCVANASAEILQQCSGVKKAIIWY 120
Query: 126 AECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNT--KRF 183
+C+L YS++SIFS + +P + L N QNVTD G N+LV M+ T A ++ K+F
Sbjct: 121 DQCMLHYSNRSIFSRVEENPMLQLYNLQNVTDPGPFNQLVVDTMNATATLAANDESGKKF 180
Query: 184 ATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRY 243
AT++ NFT QTLYSL QCTPDLS +DC+ CL GA+ L CCSGKQG R L PSCN RY
Sbjct: 181 ATKEENFTGSQTLYSLVQCTPDLSIADCSKCLEGAIGALSLCCSGKQGARTLTPSCNARY 240
Query: 244 ELYPFYNESA-------TAPPAPAPVLLSPPPPGSVT------TSRGKSGISSSTIIAIV 290
ELYPFY A P A VLL PPP S ++ GK GISS TI+ IV
Sbjct: 241 ELYPFYQLEAGPLAPALAPAPTSATVLLPPPPAPSSKSSATEPSTEGKGGISSKTIVIIV 300
Query: 291 APIAVTAVLF-ILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFST 349
P V+ V+F IL +CF+RR AKK+Y+ + N + ++TT +SLQFD TI+ ATN FS
Sbjct: 301 VPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENVEFNITTEQSLQFDLATIQAATNNFSD 360
Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
NK+GEGGFG VYKG L SGQEIA+KRLSK+SGQGA EFKNEVVLVAKLQHRNLVRLLGF
Sbjct: 361 HNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLLGF 420
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
CLEGEEKILVYE+VPNKSLDYFL+DP+K+GQLDWSRRYKIIGGIARGILYLHEDSRLR+I
Sbjct: 421 CLEGEEKILVYEYVPNKSLDYFLFDPDKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVI 480
Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
HRDLKASN+LLD +MNPKISDFGMARIFGVDQTQGNT+R+VGTYGYM+PEYAMHG+FSVK
Sbjct: 481 HRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQGNTNRVVGTYGYMSPEYAMHGRFSVK 540
Query: 530 SDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNE 589
SDVYSFGVLVLEII+GK+++ F+++D A DLLSYAWK WR+ TPL+ + +S+S+NE
Sbjct: 541 SDVYSFGVLVLEIISGKRSNCFHESDQAEDLLSYAWKLWRNDTPLEFMGPTTRNSFSKNE 600
Query: 590 VIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFE 649
VIRCI +GLLCVQEDP +RPSMA++VLML+SYSVTLP PQQPA F + D P E
Sbjct: 601 VIRCIHMGLLCVQEDPDDRPSMASVVLMLSSYSVTLPLPQQPASFSRTGALSDFPIMALE 660
Query: 650 CSDKSTSKSIPWSVDEASITEVYPR 674
SD+S SKS+ WSV+EASIT++YPR
Sbjct: 661 -SDQSASKSMTWSVNEASITDLYPR 684
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 836 bits (2160), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/643 (62%), Positives = 500/643 (77%), Gaps = 13/643 (2%)
Query: 36 CSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQ 95
C+ +N+ NSTY+ +LN+LL+S+ ++A+ NG F N TAGQ P+ VYGL+LCRGD
Sbjct: 33 CTENSNYVPNSTYQSSLNVLLTSLSSDATILNG--RKFHNTTAGQAPDMVYGLYLCRGDV 90
Query: 96 TTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNV 155
T + CQDCV A++++L CP KE + WY +C+LRYS++SIFS M P +++ N+ ++
Sbjct: 91 TDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSLDM 150
Query: 156 TDQGRLNELVGTQMSQVVTQAVSNTKR---FATRKANFTTFQTLYSLAQCTPDLSSSDCN 212
D R +++V M ++ +A N+ F T +ANF +Y L QCTPDLS S+C+
Sbjct: 151 DDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSNCS 210
Query: 213 TCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSV 272
TCL +R+ +CC GKQG R+L PSCN RYELYPFY + A A P S+
Sbjct: 211 TCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPL-----SL 265
Query: 273 TTSRGKSGISSSTIIAIVAPIAVTAVLF-ILGFCFLRRKAKKKYNAVPESNADNDLTTLE 331
+ GK G SS +IAI+ P+AV+ V+F IL +CF+ RKAKKKY++ E +ND+TT++
Sbjct: 266 LSPPGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAKKKYSSTEEEKVENDITTVQ 325
Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
SLQFDF T+E ATN FS DNK+GEGGFG+VYKG L SG+EIA+KRLS++S QGA EFKNE
Sbjct: 326 SLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIAIKRLSRSSAQGAVEFKNE 385
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
VVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLD FL+DP+KQGQLDWSRRYKIIG
Sbjct: 386 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLFDPDKQGQLDWSRRYKIIG 445
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
GIARGILYLHEDS+L++IHRDLKASN+LLD +MNPKISDFGMARIFG DQT+G+T R+VG
Sbjct: 446 GIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGMARIFGGDQTRGSTKRVVG 505
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571
TYGYM+PEYAM G FS KSDVYSFGVLVLEII+GKK S+FY++D DLL YAWK WRDG
Sbjct: 506 TYGYMSPEYAMRGHFSAKSDVYSFGVLVLEIISGKKISHFYESDQTEDLLGYAWKLWRDG 565
Query: 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQP 631
TPL+L+D + DSY+RNEVIRCI +GLLCVQEDP +RPSMA++VLML+SYSVTLP PQQP
Sbjct: 566 TPLELMDPIMRDSYARNEVIRCIHMGLLCVQEDPDDRPSMASVVLMLSSYSVTLPLPQQP 625
Query: 632 AFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
AFFIGS T+ P K SD+STSKS PWSV+E SI+E+YPR
Sbjct: 626 AFFIGSGTQSGFPIKAE--SDQSTSKSTPWSVNETSISELYPR 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076504|ref|XP_002304953.1| predicted protein [Populus trichocarpa] gi|222847917|gb|EEE85464.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2135), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/680 (64%), Positives = 521/680 (76%), Gaps = 15/680 (2%)
Query: 1 MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIP 60
M LKF++ L+ LL+ D Y H C T NSTY NLNLLLSS+
Sbjct: 1 MNSLKFYVI---LLSLLTLAIITLAQDDANYLNHNCQNATTSTINSTYRVNLNLLLSSLA 57
Query: 61 TNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKE 120
+NA+R N ++GF+N + GQ+ ++VYGLF+CRGD + S CQ+CVTFA +D++Q CP+
Sbjct: 58 SNATRNN--TNGFYNTSFGQNTDQVYGLFICRGDVSNSVCQNCVTFATKDIVQRCPIGIA 115
Query: 121 TILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQ-GRLNELVGTQMSQVVTQAVS- 178
+I++Y C+LRYS+ + FS + SP SLLNTQN+T + R N LVG ++ + +A S
Sbjct: 116 SIVYYDACILRYSNVNFFSKVDQSPGFSLLNTQNITTEPQRFNNLVGAAVNDLAARAASA 175
Query: 179 --NTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLF 236
K+FA K +F FQ +YSLAQCTPDLSSSDCN CL A+A LP+CCS K GGRVLF
Sbjct: 176 PPGAKKFAVNKTSFNAFQNIYSLAQCTPDLSSSDCNRCLSAAIAGLPNCCSSKIGGRVLF 235
Query: 237 PSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVT 296
PSC + YE+ FY+ ATA A +P PP K G+S+ IIAIV PIAV+
Sbjct: 236 PSCYIHYEITEFYD--ATAVAAESPPPPPPPVALPSPPPPQKGGVSTVLIIAIVIPIAVS 293
Query: 297 AVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
LF + FCFLRR A+K + VPE++ +++TT ESLQFD TIE ATN FS DNKLGEG
Sbjct: 294 IALFSMCFCFLRR-ARKTRDYVPENDVGDEITTEESLQFDLSTIEAATNNFSADNKLGEG 352
Query: 357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
GFGEVYKG LP+GQ+IAVKRLS+ SGQGA EFKNEVVLVAKLQHRNLVR+ GFCLE EEK
Sbjct: 353 GFGEVYKGTLPNGQQIAVKRLSRNSGQGAAEFKNEVVLVAKLQHRNLVRVQGFCLEREEK 412
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
ILVYEFV NKSLDYFL+DPE+QG LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS
Sbjct: 413 ILVYEFVSNKSLDYFLFDPERQGLLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 472
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
NILLD +MNPKISDFG+ARIF VDQTQ +T RIVGTYGYM+PEYAMHG+FSVKSDVYSFG
Sbjct: 473 NILLDGDMNPKISDFGLARIFVVDQTQASTIRIVGTYGYMSPEYAMHGRFSVKSDVYSFG 532
Query: 537 VLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQL 596
VL+LEIITGKKNS+FYQT GA DL+SY WK WRDGTPL++LD LTD+YSRNEVIRCI +
Sbjct: 533 VLILEIITGKKNSSFYQTGGAVDLVSYVWKHWRDGTPLEVLDPTLTDTYSRNEVIRCIHI 592
Query: 597 GLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRT--ERDLPTKEFECSDKS 654
GLLCVQEDPA RP+MATI+L LNSYSVTLPSPQ+PAFF S E ++ +KEF ++S
Sbjct: 593 GLLCVQEDPAIRPAMATIILTLNSYSVTLPSPQEPAFFFHSTITDEVNISSKEF-LLEQS 651
Query: 655 TSKSIPWSVDEASITEVYPR 674
SKS+ +SVDE SITEVYPR
Sbjct: 652 KSKSVAYSVDEDSITEVYPR 671
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076444|ref|XP_002304944.1| predicted protein [Populus trichocarpa] gi|222847908|gb|EEE85455.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2123), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/680 (64%), Positives = 518/680 (76%), Gaps = 13/680 (1%)
Query: 1 MPPLKFFMFSLFLIYLLSFQFSFTVAVDREYATHVCSTTANFTRNSTYEKNLNLLLSSIP 60
M LKF++ L L+ L + A D Y H C T NSTY NLNLLLSS+
Sbjct: 1 MNSLKFYVILLSLLTLAIITLAQEDA-DANYLNHFCQNATTSTINSTYRVNLNLLLSSLA 59
Query: 61 TNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKE 120
+NA+R N ++GF+N + GQ+ ++VYGLF+CRGD + + CQ+CVTFA +D++Q CPV
Sbjct: 60 SNATRNN--TNGFYNTSFGQNTDQVYGLFICRGDVSNTVCQNCVTFATKDIVQRCPVGIA 117
Query: 121 TILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNVTDQ-GRLNELVGTQMSQVVTQAVS- 178
+I++Y C+LRYS+ + FS + SP SLLNTQN+T + R N LVG ++ + +A S
Sbjct: 118 SIVYYDACILRYSNVNFFSKVDQSPGFSLLNTQNITTEPQRFNNLVGAAVNDLAARAASA 177
Query: 179 --NTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLF 236
K+FA K +F FQ +YSLAQCTPDLSSSDCN CL A+A LP+CCS K GGRVLF
Sbjct: 178 PPGAKKFAVNKTSFNAFQNIYSLAQCTPDLSSSDCNRCLSAAIAGLPNCCSSKIGGRVLF 237
Query: 237 PSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVT 296
PSC + YE+ FY+ ATA A +P PP K +S+ IIAIV PIAV+
Sbjct: 238 PSCYIHYEITEFYD--ATAVAAESPPPPPPPVVIPSPPPPQKGSVSTVLIIAIVIPIAVS 295
Query: 297 AVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
LF + FCFLRR A+K + VPE++ +++TT ESLQFD TIE ATN S DNKLGEG
Sbjct: 296 IALFCMCFCFLRR-ARKTRDYVPENDVGDEITTEESLQFDLSTIEAATNNCSPDNKLGEG 354
Query: 357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
GFGEVYKG LP+GQ+IAVKRLS+ SGQGA EFKNEVVLVAKLQHRNLVRL GFCLE EEK
Sbjct: 355 GFGEVYKGTLPNGQQIAVKRLSRNSGQGAAEFKNEVVLVAKLQHRNLVRLQGFCLEREEK 414
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
ILVYEFV NKSLDYFL+DPE+QG LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS
Sbjct: 415 ILVYEFVSNKSLDYFLFDPERQGLLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 474
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
NILLD +MNPKISDFG+ARIF VDQTQ +T+RIVGTYGYM+PEYAMHG+FSVKSDVYSFG
Sbjct: 475 NILLDGDMNPKISDFGLARIFVVDQTQASTNRIVGTYGYMSPEYAMHGRFSVKSDVYSFG 534
Query: 537 VLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQL 596
VL+LEIITGKKNS+FYQT GA DL+SY W WRDGTPL++LD LTD+YSRNEVIRCI +
Sbjct: 535 VLILEIITGKKNSSFYQTGGAPDLVSYVWNHWRDGTPLEVLDPTLTDTYSRNEVIRCIHI 594
Query: 597 GLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRT--ERDLPTKEFECSDKS 654
GLLCVQEDPA RP+MATIVL LNSY VTLPSPQ+PAFF S E ++ +KEF D+S
Sbjct: 595 GLLCVQEDPAIRPAMATIVLTLNSYLVTLPSPQEPAFFFRSTITDEVNISSKEF-LLDQS 653
Query: 655 TSKSIPWSVDEASITEVYPR 674
KSI +SVDE SITEVYPR
Sbjct: 654 KRKSIAYSVDEVSITEVYPR 673
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088180|emb|CBI35672.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/676 (59%), Positives = 500/676 (73%), Gaps = 46/676 (6%)
Query: 36 CSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQ 95
C+ +N+ NSTY+ +LN+LL+S+ ++A+ NG F N TAGQ P+ VYGL+LCRGD
Sbjct: 33 CTENSNYVPNSTYQSSLNVLLTSLSSDATILNG--RKFHNTTAGQAPDMVYGLYLCRGDV 90
Query: 96 TTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTVSLLNTQNV 155
T + CQDCV A++++L CP KE + WY +C+LRYS++SIFS M P +++ N+ ++
Sbjct: 91 TDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSLDM 150
Query: 156 TDQGRLNELVGTQMSQVVTQAVSNTKR---FATRKANFTTFQTLYSLAQCTPDLSSSDCN 212
D R +++V M ++ +A N+ F T +ANF +Y L QCTPDLS S+C+
Sbjct: 151 DDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSNCS 210
Query: 213 TCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLLSPPPPGSV 272
TCL +R+ +CC GKQG R+L PSCN RYELYPFY + A A P S+
Sbjct: 211 TCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPL-----SL 265
Query: 273 TTSRGKSGISSSTIIAIVAPIA---------------------------------VTAVL 299
+ GK G SS +IAI+ P+A ++ V+
Sbjct: 266 LSPPGKKGNSSQLLIAIIVPVAGTLIISGFLCYCWLNRKRWNIFTNNYHHSYSNNLSVVI 325
Query: 300 F-ILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
F IL +CF+ RKAKKKY++ E +ND+TT++SLQFDF T+E ATN FS DNK+GEGGF
Sbjct: 326 FSILCYCFICRKAKKKYSSTEEEKVENDITTVQSLQFDFGTLEAATNNFSDDNKIGEGGF 385
Query: 359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
G+VYKG L SG+EIA+KRLS++S QGA EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL
Sbjct: 386 GDVYKGTLSSGKEIAIKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 445
Query: 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
VYE+VPNKSLD FL+DP+KQGQLDWSRRYKIIGGIARGILYLHEDS+L++IHRDLKASN+
Sbjct: 446 VYEYVPNKSLDCFLFDPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNV 505
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
LLD +MNPKISDFGMARIFG DQT+G+T R+VGTYGYM+PEYAM G FS KSDVYSFGVL
Sbjct: 506 LLDGDMNPKISDFGMARIFGGDQTRGSTKRVVGTYGYMSPEYAMRGHFSAKSDVYSFGVL 565
Query: 539 VLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGL 598
VLEII+GKK S+FY++D DLL YAWK WRDGTPL+L+D + DSY+RNEVIRCI +GL
Sbjct: 566 VLEIISGKKISHFYESDQTEDLLGYAWKLWRDGTPLELMDPIMRDSYARNEVIRCIHMGL 625
Query: 599 LCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKS 658
LCVQEDP +RPSMA++VLML+SYSVTLP PQQPAFFIGS T+ P K SD+STSKS
Sbjct: 626 LCVQEDPDDRPSMASVVLMLSSYSVTLPLPQQPAFFIGSGTQSGFPIKAE--SDQSTSKS 683
Query: 659 IPWSVDEASITEVYPR 674
PWSV+E SI+E+YPR
Sbjct: 684 TPWSVNETSISELYPR 699
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/651 (62%), Positives = 498/651 (76%), Gaps = 20/651 (3%)
Query: 31 YATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAG---QDPNRVYG 87
Y H CS N T NS Y+ NL LL+S+ +NA+ ++ F N T G +RVYG
Sbjct: 30 YLYHNCSG-GNTTANSAYQLNLRTLLTSLSSNAT-----TTEFSNNTVGLGTSPSDRVYG 83
Query: 88 LFLCRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSDQSIFSTMATSPTV 147
LF+CRGD ++ CQ CV A + C ++K+ ++WY EC +RYS++S FST+ T P V
Sbjct: 84 LFMCRGDVPSALCQQCVVNATGRLRSQCSLAKQAVIWYDECTVRYSNRSFFSTVDTRPRV 143
Query: 148 SLLNTQNVTDQGRLNELVGTQMSQVVTQAVS---NTKRFATRKANFTTFQTLYSLAQCTP 204
LLNT N+++Q L+ +++ +A + K++A +AN + FQ+LY LAQCTP
Sbjct: 144 GLLNTANISNQDSFMRLLFQTINRTADEAANFSVGLKKYAVNQANISGFQSLYCLAQCTP 203
Query: 205 DLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPFYNESATAPPAPAPVLL 264
DLS +C +CL G + LP CC GKQGGRVL+PSCNVRYELYPFY +A+ P +
Sbjct: 204 DLSQENCRSCLSGVIGDLPWCCQGKQGGRVLYPSCNVRYELYPFYRVTASPPSSSPSPPT 263
Query: 265 SPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYN-AVPESNA 323
PPP + S G SGIS+ TI+AIV PI V ++FI+G CFL R+A+KK +V E
Sbjct: 264 LLPPP-TSPISPGSSGISAGTIVAIVVPITVAVLIFIVGICFLSRRARKKQQGSVKEGKT 322
Query: 324 DNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ 383
D+ T++SLQFDF TIE ATNKFS DNKLGEGGFGEVYKG L SGQ +AVKRLSK+SGQ
Sbjct: 323 AYDIPTVDSLQFDFSTIEAATNKFSADNKLGEGGFGEVYKGTLSSGQVVAVKRLSKSSGQ 382
Query: 384 GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
G EEFKNEVV+VAKLQHRNLVRLLGFCL+GEEKILVYE+VPNKSLDY L+DPEKQ +LDW
Sbjct: 383 GGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILVYEYVPNKSLDYILFDPEKQRELDW 442
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
RRYKIIGGIARGI YLHEDSRLRIIHRDLKASNILLD +MNPKISDFGMARIFGVDQTQ
Sbjct: 443 GRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNILLDGDMNPKISDFGMARIFGVDQTQ 502
Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563
GNTSRIVGTYGYMAPEYAMHG+FSVKSDVYSFGVL++EI++GKKNS+FYQTDGA DLLSY
Sbjct: 503 GNTSRIVGTYGYMAPEYAMHGEFSVKSDVYSFGVLLMEILSGKKNSSFYQTDGAEDLLSY 562
Query: 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623
AW+ W+DGTPL+L+D L +SY++NEVIR I +GLLCVQEDPA+RP+MATIVLML+S +V
Sbjct: 563 AWQLWKDGTPLELMDPILRESYNQNEVIRSIHIGLLCVQEDPADRPTMATIVLMLDSNTV 622
Query: 624 TLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASITEVYPR 674
TLP+P QPAFF+ S T+ ++P KE +SIP SV++ SI+E+ PR
Sbjct: 623 TLPTPTQPAFFVHSGTDPNMP-KEL-----PFDQSIPMSVNDMSISEMDPR 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 674 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.547 | 0.551 | 0.704 | 5e-203 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.556 | 0.555 | 0.657 | 6.1e-194 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.550 | 0.548 | 0.649 | 9.1e-180 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.550 | 0.562 | 0.630 | 3.9e-179 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.551 | 0.550 | 0.629 | 6e-172 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.529 | 0.430 | 0.633 | 4.2e-171 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.534 | 0.538 | 0.672 | 2.6e-169 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.544 | 0.568 | 0.621 | 1.7e-167 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.532 | 0.538 | 0.656 | 2.2e-163 | |
| TAIR|locus:2123126 | 666 | CRK31 "cysteine-rich RLK (RECE | 0.551 | 0.558 | 0.615 | 4.4e-154 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1396 (496.5 bits), Expect = 5.0e-203, Sum P(2) = 5.0e-203
Identities = 265/376 (70%), Positives = 320/376 (85%)
Query: 299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
LFI G+CFL R+A+K Y P + A +D+TT +SLQ D+ TI+ AT+ F NK+G+GGF
Sbjct: 301 LFIAGYCFLTRRARKSYYT-PSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGF 359
Query: 359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
GEVYKG L G E+AVKRLSK+SGQG EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++L
Sbjct: 360 GEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVL 419
Query: 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
VYE+VPNKSLDYFL+DP K+GQLDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNI
Sbjct: 420 VYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNI 479
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
LLDA+MNPKI+DFGMARIFG+DQT+ NTSRIVGTYGYM+PEYAMHGQ+S+KSDVYSFGVL
Sbjct: 480 LLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVL 539
Query: 539 VLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGL 598
VLEII+GKKNS+FYQTDGA DL+SYAW W +G PL+L+D + ++ RNEV+RC+ +GL
Sbjct: 540 VLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGL 599
Query: 599 LCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKS 658
LCVQEDPAERP+++TIVLML S +VTLP P+QP F SR +D P +D +TSKS
Sbjct: 600 LCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKD-PLD----TD-TTSKS 653
Query: 659 IPWSVDEASITEVYPR 674
+ SVD+ASIT+++PR
Sbjct: 654 LLGSVDDASITDIHPR 669
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1280 (455.6 bits), Expect = 6.1e-194, Sum P(2) = 6.1e-194
Identities = 250/380 (65%), Positives = 304/380 (80%)
Query: 299 LFILG-FCFL-RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
+ +LG C+L R+ K +A E ++ +T+ E+LQF F IE ATNKFS NKLG G
Sbjct: 297 VLLLGAMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHG 356
Query: 357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
GFGEVYKG L +G+ +A+KRLS+ S QGAEEFKNEV +VAKLQHRNL +LLG+CL+GEEK
Sbjct: 357 GFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEK 416
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
ILVYEFVPNKSLDYFL+D EK+ LDW RRYKII GIARGILYLH DSRL IIHRDLKAS
Sbjct: 417 ILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKAS 476
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
NILLDA+M+PKISDFGMARIFGVDQTQ NT RIVGTYGYM+PEYA+HG++SVKSDVYSFG
Sbjct: 477 NILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFG 536
Query: 537 VLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQL 596
VLVLE+ITGKKNS+FY+ DG DL++Y WK W + +PL+L+D + ++ NEVIRCI +
Sbjct: 537 VLVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHI 596
Query: 597 GLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGS-RTERDLPTKEFECSDKS- 654
LLCVQED +ERPSM I++M+NS++VTLP P++ F + + + RD P SD S
Sbjct: 597 ALLCVQEDSSERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSRD-PRSGGSASDHSA 655
Query: 655 TSKSIPWSVDEASITEVYPR 674
TSKS+P SVD++SIT VYPR
Sbjct: 656 TSKSLPLSVDDSSITIVYPR 675
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 9.1e-180, Sum P(2) = 9.1e-180
Identities = 246/379 (64%), Positives = 306/379 (80%)
Query: 299 LFI--LGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
LFI +G+CFL ++ KK ++ S +D+ T +SLQ D+ TI+ ATN F+ NK+G G
Sbjct: 303 LFIALVGYCFLAQRTKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRG 362
Query: 357 GFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416
GFGEVYKG +G+E+AVKRLSK S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+
Sbjct: 363 GFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEER 422
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
ILVYE++PNKSLD L+DP KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKAS
Sbjct: 423 ILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKAS 482
Query: 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
NILLDA++NPKI+DFGMARIFG+DQTQ NTSRIVGTYGYMAPEYAMHGQFS+KSDVYSFG
Sbjct: 483 NILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFG 542
Query: 537 VLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQL 596
VLVLEII+G+KNS+F ++DGA DLL++ W+ W + T L L+D + ++ +EV+RCI +
Sbjct: 543 VLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHI 602
Query: 597 GLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTS 656
GLLCVQEDPA+RP+++T+ +ML S +VTLP P+QP FFI S +D PT SD+ST+
Sbjct: 603 GLLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFIQSSPVKD-PTD----SDQSTT 657
Query: 657 -KSIPWSVDEASITEVYPR 674
KS P S+D+ IT++YPR
Sbjct: 658 TKSTPASIDDELITDLYPR 676
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 3.9e-179, Sum P(2) = 3.9e-179
Identities = 237/376 (63%), Positives = 301/376 (80%)
Query: 299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
+FI G+CF ++AKK Y P + D D TT+ESLQ D+ I+ ATN FS +NK+G GGF
Sbjct: 289 IFIAGYCFFAKRAKKTYGTTPALDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGF 347
Query: 359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
G+VYKG +G E+AVKRLSK S QG EFKNEVV+VA L+H+NLVR+LGF +E EE+IL
Sbjct: 348 GDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERIL 407
Query: 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
VYE+V NKSLD FL+DP K+GQL W++RY IIGGIARGILYLH+DSRL IIHRDLKASNI
Sbjct: 408 VYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNI 467
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
LLDA+MNPKI+DFGMARIFG+DQTQ NTSRIVGTYGYM+PEYAM GQFS+KSDVYSFGVL
Sbjct: 468 LLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVL 527
Query: 539 VLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGL 598
VLEII+G+KN++F +TD A DL+++AW+ WR+GT L L+D + DS ++EV+RC +GL
Sbjct: 528 VLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGL 587
Query: 599 LCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKS 658
LCVQEDP +RP+M+TI +ML S ++ LP+PQQP FF+ SR T + +T+KS
Sbjct: 588 LCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFFVRSRPG----TNRLDSDQSTTNKS 643
Query: 659 IPWSVDEASITEVYPR 674
+ S+D+ S++++ PR
Sbjct: 644 VTVSIDDKSMSDLDPR 659
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 6.0e-172, Sum P(2) = 6.0e-172
Identities = 238/378 (62%), Positives = 287/378 (75%)
Query: 299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
LF+ F +K + Y P + +D+TT SLQFDF+ IE ATNKF NKLG+GGF
Sbjct: 303 LFVAFFSLRAKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGF 362
Query: 359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
GEVYKG+ PSG ++AVKRLSK SGQG EF NEV++VAKLQHRNLVRLLGFCLE +E+IL
Sbjct: 363 GEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERIL 422
Query: 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
VYEFVPNKSLDYF++D Q LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NI
Sbjct: 423 VYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNI 482
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
LL +MN KI+DFGMARIFG+DQT+ NT RIVGTYGYM+PEYAM+GQFS+KSDVYSFGVL
Sbjct: 483 LLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVL 542
Query: 539 VLEIITGKKNSNFYQTDG--AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQL 596
VLEII+GKKNSN YQ DG A +L++Y W+ W +G+PL+L+D + D+Y NEV RCI +
Sbjct: 543 VLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHI 602
Query: 597 GLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTS 656
LLCVQE+ +RP+M+ IV ML + S+ L PQ+P FF S + + S +
Sbjct: 603 ALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVD----RLSIN 658
Query: 657 KSIPWSVDEASITEVYPR 674
S SVD+ASIT V PR
Sbjct: 659 TSALCSVDDASITNVTPR 676
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1175 (418.7 bits), Expect = 4.2e-171, Sum P(2) = 4.2e-171
Identities = 232/366 (63%), Positives = 281/366 (76%)
Query: 312 KKKYNAVPESNADN--DLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
K+K V E A+N +TT SLQFDF+ I ATN F NKLG+GGFGEVYKG PSG
Sbjct: 471 KRKDTEVTEPLAENGDSITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSG 530
Query: 370 QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
++AVKRLSK SGQG EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLD
Sbjct: 531 VQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLD 590
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
YFL+D + QLDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++
Sbjct: 591 YFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVA 650
Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 549
DFGMARIFG+DQT+ NT R+VGTYGYMAPEYAM+GQFS+KSDVYSFGVLV EII+G KNS
Sbjct: 651 DFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNS 710
Query: 550 NFYQTDGA-ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER 608
+ YQ D + ++L++Y W+ W +G+ L L+D + D+Y +++ RCI + LLCVQED +R
Sbjct: 711 SLYQMDDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDR 770
Query: 609 PSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASI 668
P+M+ IV ML + S+ L P+QP FF R E+ E S + S+D+ASI
Sbjct: 771 PNMSAIVQMLTTSSIVLAVPKQPGFFFRGRHEQ---VGEV---GSSVDRLALCSIDDASI 824
Query: 669 TEVYPR 674
T V PR
Sbjct: 825 TSVAPR 830
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.6e-169, Sum P(2) = 2.6e-169
Identities = 246/366 (67%), Positives = 297/366 (81%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
+ KK Y E A +++TT SLQF F+TIE AT+KFS N +G GGFGEVY+G L SG
Sbjct: 309 RRKKSYKTT-EVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSG 367
Query: 370 QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
E+AVKRLSK SGQGAEEFKNE VLV+KLQH+NLVRLLGFCLEGEEKILVYEFVPNKSLD
Sbjct: 368 PEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLD 427
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
YFL+DP KQG+LDW+RRY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+
Sbjct: 428 YFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIA 487
Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 549
DFGMARIFGVDQ+Q NT RI GT+GYM+PEYAM G FS+KSDVYSFGVLVLEII+GKKNS
Sbjct: 488 DFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNS 547
Query: 550 NFYQTDGA-ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER 608
+FY D + ++L+++AW+ WR+G+PL+L+D + +SY +E RCI + LLCVQEDPA+R
Sbjct: 548 SFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADR 607
Query: 609 PSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIPWSVDEASI 668
P + I++ML S + TL P+ P F + R DL E ++ STS+SIP S+++ASI
Sbjct: 608 PLLPAIIMMLTSSTTTLHVPRAPGFCLSGR---DLEQDGVEYTE-STSRSIPGSINDASI 663
Query: 669 TEVYPR 674
TE YPR
Sbjct: 664 TEFYPR 669
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1183 (421.5 bits), Expect = 1.7e-167, Sum P(2) = 1.7e-167
Identities = 235/378 (62%), Positives = 289/378 (76%)
Query: 299 LFILGFCFLRRKAKKKYNAV-PESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGG 357
L ++ +R K K+ N P + ND+TT SLQFDF+ IE ATN F NKLG+GG
Sbjct: 277 LLLVAVFSVRAKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGG 336
Query: 358 FGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417
FGEVYKG L SG ++AVKRLSK SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKI
Sbjct: 337 FGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKI 396
Query: 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477
LVYEFVPNKSLD+FL+D + +LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA N
Sbjct: 397 LVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGN 456
Query: 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
ILLD +MNPKI+DFGMARIFG+DQT+ T R+VGTYGYM+PEYAM+GQFS+KSDVYSFGV
Sbjct: 457 ILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGV 516
Query: 538 LVLEIITGKKNSNFYQTD-GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQL 596
LVLEII+G KNS+ YQ D +L++Y W+ W +G+P +L+D + D+Y +E+ RCI +
Sbjct: 517 LVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHI 576
Query: 597 GLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTS 656
LLCVQED +RP+M++IV ML + + L P+ P FF S+ E+ P+ D ST
Sbjct: 577 ALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRSKQEQAGPS-----IDSSTH 631
Query: 657 KSIPWSVDEASITEVYPR 674
SVDEASIT V PR
Sbjct: 632 ----CSVDEASITRVTPR 645
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 2.2e-163, Sum P(2) = 2.2e-163
Identities = 241/367 (65%), Positives = 296/367 (80%)
Query: 299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
L +LGF RR+ K Y ++ +++D++T +SL +DF+TIE ATNKFST NKLGEGGF
Sbjct: 305 LLVLGFVLFRRR--KSYQRT-KTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGF 361
Query: 359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
G VYKG L +G ++AVKRLSK SGQG EF+NE VLV KLQHRNLVRLLGFCLE EE+IL
Sbjct: 362 GAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQIL 421
Query: 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
+YEFV NKSLDYFL+DPEKQ QLDW+RRYKIIGGIARGILYLH+DSRL+IIHRDLKASNI
Sbjct: 422 IYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNI 481
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
LLDA+MNPKI+DFG+A IFGV+QTQGNT+RI GTY YM+PEYAMHGQ+S+KSD+YSFGVL
Sbjct: 482 LLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVL 541
Query: 539 VLEIITGKKNSNFYQTDG---AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQ 595
VLEII+GKKNS YQ D A +L++YA + WR+ +PL+L+D +Y NEV RCI
Sbjct: 542 VLEIISGKKNSGVYQMDETSTAGNLVTYASRLWRNKSPLELVDPTFGRNYQSNEVTRCIH 601
Query: 596 LGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKST 655
+ LLCVQE+P +RP ++TI+LML S ++TLP P+ P FF SR + L ++ E SD+ T
Sbjct: 602 IALLCVQENPEDRPMLSTIILMLTSNTITLPVPRLPGFFPRSR-QLKLVSEGSE-SDQYT 659
Query: 656 SKSIPWS 662
SKS +S
Sbjct: 660 SKSSSFS 666
|
|
| TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1218 (433.8 bits), Expect = 4.4e-154, Sum P(2) = 4.4e-154
Identities = 232/377 (61%), Positives = 294/377 (77%)
Query: 299 LFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGF 358
L LG +R+ + Y + + + D+D+T+ +SLQFDF TIEVAT+ FS +NKLG+GGF
Sbjct: 294 LVALGLVIWKRR--QSYKTL-KYHTDDDMTSPQSLQFDFTTIEVATDNFSRNNKLGQGGF 350
Query: 359 GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418
GEVYKG+LP+ EIAVKRLS SGQG +EFKNEVV+VAKLQH+NLVRLLGFC+E +E+IL
Sbjct: 351 GEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQIL 410
Query: 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
VYEFV NKSLDYFL+DP+ + QLDW RRY IIGG+ RG+LYLH+DSRL IIHRD+KASNI
Sbjct: 411 VYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNI 470
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
LLDA+MNPKI+DFGMAR F VDQT+ T R+VGT+GYM PEY HGQFS KSDVYSFGVL
Sbjct: 471 LLDADMNPKIADFGMARNFRVDQTEDQTGRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVL 530
Query: 539 VLEIITGKKNSNFYQTDGAA-DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG 597
+LEI+ GKKNS+F+Q D + +L+++ W+ W + +PL L+D + +SY +EVIRCI +G
Sbjct: 531 ILEIVCGKKNSSFFQMDDSGGNLVTHVWRLWNNDSPLDLIDPAIKESYDNDEVIRCIHIG 590
Query: 598 LLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSK 657
+LCVQE PA+RP M+TI ML + S+TLP P+ P FF +R D T E +S+S
Sbjct: 591 ILCVQETPADRPEMSTIFQMLTNSSITLPVPRPPGFFFRNRPNLDPLTYGSE-QGQSSSM 649
Query: 658 SIPWSVDEASITEVYPR 674
S+P+S+D ASIT PR
Sbjct: 650 SVPFSIDSASITRATPR 666
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GYA4 | CRK10_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6024 | 0.9362 | 0.9431 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.2 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 674 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-57 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-57 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-44 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-40 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-37 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-37 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-35 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-35 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-32 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-31 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-29 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-28 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-28 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-25 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-25 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-24 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-57
Identities = 101/277 (36%), Positives = 140/277 (50%), Gaps = 30/277 (10%)
Query: 350 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNL 403
KLGEG FGEVYKG L E+AVK L + AS Q EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
V+LLG C E E ++V E++P L +L + L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGYMAPEYAM 522
IHRDL A N L+ + KISDFG++R ++ D + ++ +MAPE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177
Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
G+F+ KSDV+SFGVL+ EI T G++ Y A++L Y + G L
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYL----KKGYRLPKPPNCP 230
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
+ Y +L L C EDP +RP+ + +V +L
Sbjct: 231 PELY---------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 3e-57
Identities = 99/276 (35%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 350 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNL 403
KLGEG FGEVYKG L E+AVK L + AS Q EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
V+LLG C E E +V E++ L +L + + +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
IHRDL A N L+ + KISDFG++R D + +MAPE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKE 177
Query: 524 GQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582
G+F+ KSDV+SFGVL+ EI T G++ Y ++L Y ++G L
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEYL----KNGYRLPQPPNCPP 230
Query: 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
+ Y L L C EDP +RP+ + +V +L
Sbjct: 231 ELY---------DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 2e-54
Identities = 97/286 (33%), Positives = 133/286 (46%), Gaps = 52/286 (18%)
Query: 352 KLGEGGFGEVYKGVL-----PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVR 405
KLGEG FGEVYKG L + ++AVK L AS + EEF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
LLG C +GE +V E++P L FL + +L ++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGY-----MAPE 519
+HRDL A N L+ + KISDFG++R I+ D + G MAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLPIKWMAPE 174
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQTDGAADLLSYAWKQWRDGT 572
G+F+ KSDV+SFGVL+ EI T G N + DG
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL-------------ELLEDGY 221
Query: 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
L + + Y +L L C DP +RP+ + +V L
Sbjct: 222 RLPRPENCPDELY---------ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 6e-54
Identities = 75/194 (38%), Positives = 109/194 (56%), Gaps = 11/194 (5%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
LGEGGFG VY +G+++A+K + K S EE E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
+ LV E+ SL L E +G+L +I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 471 RDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSV 528
RDLK NILLD+ K++DFG++++ D++ T IVGT YMAPE + G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 529 KSDVYSFGVLVLEI 542
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 4e-52
Identities = 84/270 (31%), Positives = 120/270 (44%), Gaps = 26/270 (9%)
Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
KLG G FG VYK G+ +AVK L K + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
+ + LV E+ L +L + G L KI I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-YAMHGQFS 527
IHRDLK NILLD KI+DFG+A+ + + + VGT YMAPE +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 528 VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSR 587
K DV+S GV++ E++TGK F + L R P +
Sbjct: 178 PKVDVWSLGVILYELLTGK--PPFSGENILDQLQLIR----RILGP----PLEFDEPKWS 227
Query: 588 NEVIRCIQL--GLLCVQEDPAERPSMATIV 615
+ L L DP++RP+ I+
Sbjct: 228 SGSEEAKDLIKKCLNK--DPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 6e-52
Identities = 95/287 (33%), Positives = 134/287 (46%), Gaps = 45/287 (15%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
KLGEG FGEVYKG L G+ AVK L + AS + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL------YDPEKQGQLDWSRRYKIIGGIARGILY 459
LLG C E E LV E++ L +L + ++ L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGYMAP 518
L + +HRDL A N L+ ++ KISDFG++R ++ D + T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQTDGAADLLSYAWKQWRDG 571
E G F+ KSDV+SFGVL+ EI T G N + R G
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-------------YLRKG 223
Query: 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
L + + Y +L L C Q DP +RP+ + +V L
Sbjct: 224 YRLPKPEYCPDELY---------ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 4e-51
Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 28/272 (10%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLV 404
+ KLGEG FG+VY +G+ +A+K + K + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
RL + ++ LV E+ L L +K+G+L D +R Y + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFY--LRQILSALEYLHS 115
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
I+HRDLK NILLD + + K++DFG+AR + VGT YMAPE +
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLL 169
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582
+ D++S GV++ E++TGK + D D L +K+ P
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK---PPFPGD---DQLLELFKKIGKPKPPFPPPEWDI 223
Query: 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+++ + + + DP +R +
Sbjct: 224 SPEAKDLIRKLLVK-------DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 79/269 (29%), Positives = 135/269 (50%), Gaps = 33/269 (12%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
LG G FG VY + +G+ +AVK LS S + E + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 408 GFCLEGEEK-ILVY-EFVPNKSLDYFLYDPEKQGQLDWS--RRYKIIGGIARGILYLHED 463
G + E+ + ++ E+V SL L +K G+L R+Y I G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKY--TRQILEGLAYLH-- 118
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
I+HRD+K +NIL+D++ K++DFG A+ G +T T + GT +MAPE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 524 GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL--LDTNL 581
++ +D++S G V+E+ TGK + + L ++ G+ + + +L
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP--PWSELGNPMAAL------YKIGSSGEPPEIPEHL 229
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
++ + +R C++ DP +RP+
Sbjct: 230 SEEA--KDFLRK------CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 73/198 (36%), Positives = 111/198 (56%), Gaps = 6/198 (3%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
F+ + KLG G FGEV++G+ + +A+K L ++F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
C GE ++ E + SL FL PE Q L + + +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
IHRDL A NIL+ ++ K++DFG+AR+ D + +I Y + APE A HG F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 527 SVKSDVYSFGVLVLEIIT 544
S KSDV+SFG+L+ E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 93/288 (32%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + KLG G FGEV+ G ++AVK L K E F E ++ KL+H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L C E E +V E++ SL FL E + +L + + IA G+ YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYL 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMA 517
IHRDL A NIL+ + KI+DFG+AR+ D+ +G I T A
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----A 172
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
PE A +G+F++KSDV+SFG+L+ EI+T Y ++L + +R P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT--YGRVPYPGMTNREVLEQVERGYRMPRPPNCP 230
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
+L D L L C +DP ERP+ + L Y
Sbjct: 231 EELYD-----------------LMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 71/206 (34%), Positives = 116/206 (56%), Gaps = 21/206 (10%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKGV +P G+ +A+K L + + A +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHE 462
LG CL + L+ + +P L ++ + + Q L+W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
R++HRDL A N+L+ + KI+DFG+A++ VD+ + + +MA E +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKK 547
H ++ KSDV+S+GV V E++T G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 86/304 (28%), Positives = 135/304 (44%), Gaps = 74/304 (24%)
Query: 353 LGEGGFGEVYKGVLPSGQE------IAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVR 405
LGEG FG+V+ G + +AVK L + + A + F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPE---------KQGQLDWSRRYKIIGGIA 454
G C EG+ I+V+E++ + L+ FL + P+ G+L S+ +I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTY 513
G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + ++
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGT 572
+M PE M+ +F+ +SDV+SFGV++ EI T GK+ W
Sbjct: 190 -WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ----------------PWYG----- 227
Query: 573 PLQLLDTNLTDSYSRNEVIRCIQLGLL-----------------CVQEDPAERPSMATIV 615
S EVI CI G L C + DP +R ++ I
Sbjct: 228 ------------LSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
Query: 616 LMLN 619
L
Sbjct: 276 ERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 139 bits (349), Expect = 7e-36
Identities = 90/337 (26%), Positives = 136/337 (40%), Gaps = 24/337 (7%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH-R 401
+ KLGEG FGEVY + +A+K L+K + E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N+V+L F + LV E+V SL+ L ++G L S I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQT----QGNTSRIVGTYGYM 516
IIHRD+K NILLD + K+ DFG+A++ + S VGT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 517 APEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573
APE + S SD++S G+ + E++TG + A TP
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII--LELPTP 233
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL--MLNSYSVTLPSPQQP 631
+ ++ ++ + LL DP R S ++ + +L +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAK--DPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 632 AFFIGSRTER-DLPTKEFECSDKSTSKSIPWSVDEAS 667
S R LP S +I S +
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 346 KFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
F K+G+GGFGEVYK +G+E+A+K + S + E+ NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGIL- 458
+ G L+ +E +V EF SL E Q I + + +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----------IAYVCKELLK 109
Query: 459 ---YLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
YLH IIHRD+KA+NILL D E+ K+ DFG++ + +VGT
Sbjct: 110 GLEYLHS---NGIIHRDIKAANILLTSDGEV--KLIDFGLSAQL---SDTKARNTMVGTP 161
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+MAPE + K+D++S G+ +E+ GK
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 42/284 (14%)
Query: 351 NKLGEGGFGEVYKGV--LPSGQEI--AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LG G FG V KGV + SG+E+ AVK L + G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 406 LLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ--LDWSRRYKIIGGIARGILYLHE 462
L+G C GE +LV E P L Y E + + + +A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAPEY 520
+HRDL A N+LL KISDFGM+R G + G + + APE
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPEC 169
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP---LQLL 577
+G+FS KSDV+S+GV + E SY K + + + +L
Sbjct: 170 INYGKFSSKSDVWSYGVTLWE------------------AFSYGAKPYGEMKGAEVIAML 211
Query: 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
++ + L C + P +RP+ + +
Sbjct: 212 ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 85/285 (29%), Positives = 140/285 (49%), Gaps = 41/285 (14%)
Query: 350 DNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLV 404
+ +G G FGEV +G L P +EI A+K L + +S + +F E ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
RL G + +++ E++ N SLD FL E G+ + ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIF----GVDQTQGNTSRIVGTYGYMAPEY 520
+ +HRDL A NIL+++ + K+SDFG++R T+G I T APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
+ +F+ SDV+SFG+++ E+ +SY + + D + ++
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEV------------------MSYGERPYWDMSNQDVIKA- 220
Query: 581 LTDSYSRNEVIRC----IQLGLLCVQEDPAERPSMATIVLMLNSY 621
+ D Y + C QL L C Q+D ERP+ + IV L+
Sbjct: 221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 29/284 (10%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAE--EFKNEVVLVAKLQHRNL 403
+LGEG FG+V +G+++AVK L SG+ +F+ E+ ++ L H N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 404 VRLLGFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V+ G C + + L+ E++P+ SL +L + Q++ R I +G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT--QGNTSRIVGTYGYMAPE 519
R IHRDL A NIL+++E KISDFG+A++ D+ + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578
+FS SDV+SFGV + E+ T G + + A+ L +LL+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQS-----PPAEFLRMIGIAQGQMIVTRLLE 237
Query: 579 TNLTDSYSRNEVIRC----IQLGLLCVQEDPAERPSMATIVLML 618
L + C L LC + +P +RPS A ++L++
Sbjct: 238 L-LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQHRN 402
+ + +G G FG VYKG+ L +G +A+K++S K + + E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ +G + ++ E+ N SL + +K G S + + +G+ YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+IHRD+KA+NIL + K++DFG+A + +VGT +MAPE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172
Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
S SD++S G V+E++TG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 48/279 (17%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G GQ++AVK L K A+ F E ++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 413 GEEKILVYEFVPNKSLDYFLYDP-----EKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G +V E++ SL +L QL ++ + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAPEYAMHGQ 525
+HRDL A N+L+ ++ K+SDFG+A+ + +QG S G + APE +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEALREKK 175
Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DGTPLQLLDTNL 581
FS KSDV+SFG+L+ EI + + Y D++ + K +R +G P ++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHVEKGYRMEAPEGCPPEVY---- 229
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
++ C + DPA+RP+ + L
Sbjct: 230 -------------KVMKDCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 84/277 (30%), Positives = 132/277 (47%), Gaps = 35/277 (12%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
KLG G FGEV++G+ + +AVK L K ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
E +V E + SL +L L + + +A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFSV 528
DL A N+L+ K++DFG+AR+ D +R G + APE A++ +FS+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIY---EAR-EGAKFPIKWTAPEAALYNRFSI 183
Query: 529 KSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DGTPLQLLDTNLTDS 584
KSDV+SFG+L+ EI+T + Y A++L + +R G P +L D
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP--YPGMTNAEVLQQVDQGYRMPCPPGCPKELYD------ 235
Query: 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
+ L C +EDP +RP+ T+ L +
Sbjct: 236 -----------IMLDCWKEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 74/213 (34%), Positives = 114/213 (53%), Gaps = 29/213 (13%)
Query: 353 LGEGGFGEVYKG--VLPSGQE----IAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
LGEG FG+VYKG P+ + +A+K L + A + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLDWSRRYKIIGG 452
LLG C + + +++E++ + L FL D + LD S I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSRI 509
IA G+ YL S +HRDL A N L+ + KISDFG++R I+ D + Q +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
V +M PE ++G+F+ +SD++SFGV++ EI
Sbjct: 190 V---RWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 37/274 (13%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
++G+G FG+VY G+ +K LS S + E+ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-------LDWSRRYKIIGGIARGILYL 460
E + +V E+ L + +K+G+ LDW + + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H +I+HRD+K NI L + K+ DFG++++ T +VGT Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
+ ++ KSD++S G ++ E+ T K F +LL A K G
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH--PFE----GENLLELALKI-LKGQY-----PP 222
Query: 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+ YS +R + LL Q+DP ERPS+A I
Sbjct: 223 IPSQYSSE--LRNLVSSLL--QKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 24/204 (11%)
Query: 353 LGEGGFGEVY----KGVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVR 405
LG+G FG+V K +G+ A+K L K + E E +++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
L + + EEK+ LV E+ P L L K+G+ + +R Y I + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFY--AAEIVLALEYLH- 110
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
L II+RDLK NILLDA+ + K++DFG+A+ + ++ NT GT Y+APE +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166
Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
+ D +S GVL+ E++TGK
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 45/104 (43%), Positives = 62/104 (59%), Gaps = 5/104 (4%)
Query: 34 HVCSTTAN---FTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFL 90
H+CS+ + T NST+E NLN LLSS+ +NA+ +G GF T+G P+ VYGL
Sbjct: 2 HLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSG--KGFAAGTSGAAPDTVYGLAQ 59
Query: 91 CRGDQTTSDCQDCVTFAARDVLQLCPVSKETILWYAECLLRYSD 134
CRGD + SDC+ C+ A ++ + CP K +WY C LRY
Sbjct: 60 CRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYES 103
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 74/278 (26%), Positives = 123/278 (44%), Gaps = 55/278 (19%)
Query: 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLVRLLG 408
LG+G G VYK P+G+ A+K++ G ++ E+ + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 409 -FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHED 463
F EGE I V E++ SL L K ++ IAR IL YLH
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGK-----IPEP--VLAYIARQILKGLDYLH-- 116
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
++ IIHRD+K SN+L++++ KI+DFG++++ ++ T + VGT YM+PE
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQG 174
Query: 524 GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT-NLT 582
+S +D++S G+ +LE GK + + + +L+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK----------------FPFLPPGQPSFFELMQAICDG 218
Query: 583 DSYS----------RNEVIRCIQLGLLCVQEDPAERPS 610
S R+ + C+Q DP +RPS
Sbjct: 219 PPPSLPAEEFSPEFRDFISACLQK-------DPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 48/300 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLSKASGQGAE-EFKNEVV 393
E+ K + +LG+G FG VY+G+ + G+ +A+K +++ + EF NE
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PE-----KQGQLDWSRR 446
++ + ++VRLLG G+ ++V E + L +L PE G +
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
++ IA G+ YL + +HRDL A N ++ ++ KI DFGM R I+ D +
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQTDGAA 558
++ +MAPE G F+ KSDV+SFGV++ E+ T G N +
Sbjct: 179 GKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237
Query: 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
L + P +LL+ L +C Q +P RP+ IV L
Sbjct: 238 GHLDLP-----ENCPDKLLE-----------------LMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 94/286 (32%), Positives = 139/286 (48%), Gaps = 39/286 (13%)
Query: 353 LGEGGFGEVYKG----VLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLV 404
LG G FGEVY+G +L G +AVK L K A+ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ----LDWSRRYKIIGGIARGILYL 460
+LLG CL E + ++ E + L +L D + L I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 461 HEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG 514
++ IHRDL A N L+ DA+ KI DFG+AR I+ D + ++
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTP 573
+MAPE + G+F+ +SDV+SFGVL+ EI+T G++ Y ++L + G
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPALNNQEVLQHV----TAGGR 231
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
LQ + Y QL C +DP+ERP+ I +L
Sbjct: 232 LQKPENCPDKIY---------QLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 89/271 (32%), Positives = 131/271 (48%), Gaps = 39/271 (14%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKAS----GQGA-EEFKNEVVLVAKLQHRNLVRL 406
LG G FG VY+G+ L G AVK +S A GQ A ++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHE 462
LG E + + E VP SL L +K G +I R IL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFP----EPVIRLYTRQILLGLEYLHD 120
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+HRD+K +NIL+D K++DFGMA+ G+ +MAPE
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 523 H-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
G + + +D++S G VLE+ TGK + Q +G A + +K R L + +L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAV----FKIGRSKE-LPPIPDHL 227
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612
+D + I C+Q DP+ RP+ A
Sbjct: 228 SDEAK--DFIL------KCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 92/292 (31%), Positives = 141/292 (48%), Gaps = 44/292 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
EV KLG G FGEV+ G ++A+K L + S E F E L+ +LQH
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LVRL + + +E I ++ E++ N SL FL PE +L ++ + IA G+ +
Sbjct: 61 PRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAF 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
+ R IHRDL+A+NIL+ + KI+DFG+AR+ ++ T+R + + A
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTA 171
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQTDGAADLLSYAWKQWR- 569
PE +G F++KSDV+SFG+L+ EI+T G N Q L ++ R
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN------LERGYRMPRP 225
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
D P +L + L LC +E P ERP+ + +L +
Sbjct: 226 DNCPEELYE-----------------LMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 75/221 (33%), Positives = 121/221 (54%), Gaps = 24/221 (10%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ +LP + +AVK L +AS ++F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQ----------GQLDWSRRYKIIGGI 453
G C EG ++V+E++ + L+ FL + P+ + GQL + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGT 512
A G++YL + L +HRDL N L+ + KI DFGM+R I+ D + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 187
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
+M PE ++ +F+ +SD++SFGV++ EI T K +YQ
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-WYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 87/300 (29%), Positives = 130/300 (43%), Gaps = 54/300 (18%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
EV + + LG G FGEVY+G+ ++AVK L S Q +F E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKI 449
+++K H+N+VRL+G E + ++ E + L FL + PE+ L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAR-IFGVDQTQG 504
+A+G YL E+ IHRD+ A N LL + P KI+DFGMAR I+ +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRK 177
Query: 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII-------TGKKNSNFYQ--TD 555
R + +M PE + G F+ K+DV+SFGVL+ EI G+ N + T
Sbjct: 178 G-GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236
Query: 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
G R P + ++ C Q P +RP+ ATI+
Sbjct: 237 GG-----------RLDPP-------------KGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/195 (30%), Positives = 108/195 (55%), Gaps = 9/195 (4%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG GEVYK +G+E+A+K++ + Q E NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L G+E +V E++ SL + + +++ + + + +G+ YLH +IH
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
RD+K+ NILL + + K++DFG A ++++ N+ +VGT +MAPE + K
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKV 197
Query: 531 DVYSFGVLVLEIITG 545
D++S G++ +E+ G
Sbjct: 198 DIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-29
Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 36/288 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ KLG G FGEV+ G ++AVK L K E F E ++ KL+H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LV+L + + EE I +V E++ SL FL D E + L + +A G+ Y
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAY 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
+ R+ IHRDL+++NIL+ + KI+DFG+AR+ + T+R + + A
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTA 171
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
PE A++G+F++KSDV+SFG+L+ E++T K Y ++L + +R P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVT--KGRVPYPGMNNREVLEQVERGYRMPCPQDCP 229
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
+ L + L L C ++DP ERP+ + L Y
Sbjct: 230 ISLHE-----------------LMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 84/311 (27%), Positives = 141/311 (45%), Gaps = 66/311 (21%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK----GVLPSGQE---IAVKRLSK-ASGQGAEEFKNEV 392
E N +G+G FG V++ G+LP + +AVK L + AS +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREA 59
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD------------------ 434
L+A+ H N+V+LLG C G+ L++E++ L+ FL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 435 -PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
L + + I +A G+ YL E + +HRDL N L+ M KI+DFG+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 494 AR-IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------G 545
+R I+ D + + + + +M PE + +++ +SDV+++GV++ EI + G
Sbjct: 177 SRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 546 KKNSN--FYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQE 603
+ +Y DG ++LS D PL+L + L LC +
Sbjct: 236 MAHEEVIYYVRDG--NVLSCP-----DNCPLELYN-----------------LMRLCWSK 271
Query: 604 DPAERPSMATI 614
P++RPS A+I
Sbjct: 272 LPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 77/274 (28%), Positives = 124/274 (45%), Gaps = 44/274 (16%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRL 406
+LG G G V K + P+G+ +AVK + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
G + + E++ SLD L E QG++ KI + +G+ YLHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
+IIHRD+K SNIL+++ K+ DFG++ V+ + T VGT YMAPE +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPERIQGNDY 176
Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG--TPLQLLDTNL--- 581
SVKSD++S G+ ++E+ TG+ + + D +LL +
Sbjct: 177 SVKSDIWSLGLSLIELATGR----------------FPYPPENDPPDGIFELLQYIVNEP 220
Query: 582 -----TDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
+ +S + + LC+ +DP ERPS
Sbjct: 221 PPRLPSGKFSP-DFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 67/197 (34%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
K+G+G FG+VYKGVL E+AVK S +F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
++ + +V E VP SL FL + +L + ++ A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 471 RDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
RDL A N L+ KISDFGM+R G+ +I + APE +G+++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 529 KSDVYSFGVLVLEIITG 545
+SDV+S+G+L+ E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 77/220 (35%), Positives = 127/220 (57%), Gaps = 21/220 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKG+ +P G+ + A+K L++ +G A EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHE 462
LG CL + LV + +P+ L ++++ + Q L+W + IA+G++YL E
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
R++HRDL A N+L+ + + KI+DFG+AR+ D+ + N +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLL 561
+ +F+ +SDV+S+GV + E++T G K + T DLL
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 86/287 (29%), Positives = 135/287 (47%), Gaps = 33/287 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ KLG G FGEV+ G + ++AVK L K + F E L+ LQH
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LVRL + E ++ E++ SL FL E G++ + IA G+ Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYI 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAP 518
R IHRDL+A+N+L+ + KI+DFG+AR+ ++ T+R + + AP
Sbjct: 120 E---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAP 173
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DGTPL 574
E G F++KSDV+SFG+L+ EI+T K Y +D++S + +R + P
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIP--YPGMSNSDVMSALQRGYRMPRMENCPD 231
Query: 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
+L D T C +E ERP+ + +L+ +
Sbjct: 232 ELYDIMKT-----------------CWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
LG G FG V+ G ++A+K + + + ++F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472
+V E++ N L +L + + + +W + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
L A N L+ + K+SDFG+AR DQ +QG + + PE + +FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV----KWAPPEVFDYSRFSSK 181
Query: 530 SDVYSFGVLVLEIITGKK 547
SDV+SFGVL+ E+ + K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 91/284 (32%), Positives = 145/284 (51%), Gaps = 28/284 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ D KLG+G FGEV+ G ++A+K L K E F E ++ KL+H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LV L + + EE I +V EF+ SL FL + + + L + + IA G+ Y
Sbjct: 61 DKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAY 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
+ R+ IHRDL+A+NIL+ + KI+DFG+AR+ + T+R + + A
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTA 171
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
PE A++G+F++KSDV+SFG+L+ E++T K Y ++L + +R P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVT--KGRVPYPGMVNREVLEQVERGYRMPCPQGCP 229
Query: 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
+ S +E+++ LC ++DP ERP+ I L Y
Sbjct: 230 E-------SLHELMK------LCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 71/248 (28%), Positives = 114/248 (45%), Gaps = 48/248 (19%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEF-KNE 391
DF+ ++ +GEG F V + +E A+K L K + ++ K E
Sbjct: 2 DFKFGKI----------IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE 51
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRY 447
++ +L H +++L + + EE + V E+ PN L ++ K G LD +R Y
Sbjct: 52 KEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFY 107
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ------ 501
I + YLH IIHRDLK NILLD +M+ KI+DFG A++ +
Sbjct: 108 --AAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 502 -------TQGNTSRI-----VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK--- 546
+Q +R VGT Y++PE SD+++ G ++ +++TGK
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 547 KNSNFYQT 554
+ SN Y T
Sbjct: 223 RGSNEYLT 230
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 81/293 (27%), Positives = 146/293 (49%), Gaps = 42/293 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASG---QGAEEFKNEVVLV 395
E+ + + +G G FGEV++G+L P +E+AV + G + ++F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H N++RL G + + +++ E++ N +LD +L D G+ + ++ GIA
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAA 118
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF-----GVDQTQGNTSRIV 510
G+ YL S + +HRDL A NIL+++ + K+SDFG++R+ G T G I
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570
T APE + +F+ SDV+SFG+++ E+ +S+ + + D
Sbjct: 176 WT----APEAIAYRKFTSASDVWSFGIVMWEV------------------MSFGERPYWD 213
Query: 571 GTPLQLLDTNLTDSYSRNEVIRC----IQLGLLCVQEDPAERPSMATIVLMLN 619
+ +++ + D + + C QL L C Q+D A RP IV +L+
Sbjct: 214 MSNHEVMKA-INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 82/279 (29%), Positives = 110/279 (39%), Gaps = 37/279 (13%)
Query: 352 KLGEGGFGEVYKG--VLPSGQEI--AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRL 406
KLG+G FG V +G G+ I AVK L ++F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
G L +V E P SL L G S IA G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGV--DQTQGNTSRIVGTYGYMAPEYAMHG 524
R IHRDL A NILL ++ KI DFG+ R D V + + APE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTR 175
Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584
FS SDV+ FGV + E + +Y + W + Q+L +
Sbjct: 176 TFSHASDVWMFGVTLWE------------------MFTYGEEPWAGLSGSQILK-KIDKE 216
Query: 585 YSRNEVIRCI-----QLGLLCVQEDPAERPSMATIVLML 618
R E + L C +PA+RP+ A + L
Sbjct: 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNL 403
F NK+G+G FG V+K V + + A+K+ LSK + + EE +E ++AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+R L+ + +V E+ N L L + L + ++ I G+ +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSK 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
+I+HRD+K+ N+ LDA N KI D G+A++ + NT IVGT Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
++ KSDV++ GV++ E TGK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 84/283 (29%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
E+ + +KLG G +GEVY+GV +AVK L K EEF E ++ +++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H NLV+LLG C ++ EF+ +L +L + +Q +++ + I+ + Y
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEY 119
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
L + + IHRDL A N L+ K++DFG++R T + + APE
Sbjct: 120 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPE 175
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQTDGAADLLSYAWKQWR-DG 571
+ +FS+KSDV++FGVL+ EI T G S Y +LL ++ R +G
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKGYRMERPEG 229
Query: 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
P Y +L C Q +P++RPS A I
Sbjct: 230 CP--------PKVY---------ELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
++G G FG V+ G +++A+K + + + E+F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
E LV+EF+ + L +L ++G+ + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFSV 528
DL A N L+ K+SDFGM R DQ +T GT + +PE ++S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 529 KSDVYSFGVLVLEIITGKK 547
KSDV+SFGVL+ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
F KLGEG +G VYK + +GQ +A+K + + +E E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 406 LLGFCLEGEEKILVYEF-----------VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
G + + +V E+ + NK+L E++ I+
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT------EEEIAA-------ILYQTL 109
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+G+ YLH + IHRD+KA NILL+ E K++DFG++ T + ++GT
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPF 164
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+MAPE ++ K+D++S G+ +E+ GK
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 72/222 (32%), Positives = 120/222 (54%), Gaps = 28/222 (12%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ + P+ + +AVK L + ++F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDP-----------EKQGQLDWSRRYKIIGG 452
G C +G+ I+V+E++ + L+ FL + P + +G+L S+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSRI 509
IA G++YL + +HRDL N L+ A + KI DFGM+R ++ D + G+T
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
+ +M PE M+ +F+ +SDV+SFGV++ EI T K F
Sbjct: 189 I---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHR 401
+ KLGEG +G VYK +G+ +A+K++ E E+ L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR--YKIIGGIARGIL 458
N+V+LL E K+ LV+E+ + L +L + + Y+++ RG+
Sbjct: 59 NIVKLLDVIH-TERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLL----RGLA 112
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
Y H S RI+HRDLK NIL++ + K++DFG+AR FG+ T +V T Y AP
Sbjct: 113 YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAP 167
Query: 519 EYAMHGQF---SVKSDVYSFGVLVLEIITGK 546
E + + +V D++S G + E+ITGK
Sbjct: 168 EILLGSKHYSTAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 92/311 (29%), Positives = 143/311 (45%), Gaps = 74/311 (23%)
Query: 352 KLGEGGFGEVY----KGVLPSGQEI--AVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ + P +I AVK L AS ++F E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL--YDPE----KQG----QLDWSRRYKIIGGIAR 455
G C+EG+ I+V+E++ + L+ FL + P+ +G +L S+ I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSRIVGT 512
G++YL + +HRDL N L+ + KI DFGM+R ++ D + G+T +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI-- 186
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572
+M PE M+ +F+ +SDV+S GV++ EI T Y + W
Sbjct: 187 -RWMPPESIMYRKFTTESDVWSLGVVLWEIFT------------------YGKQPW---- 223
Query: 573 PLQLLDTNLTDSYSRNEVIRCI-----------------QLGLLCVQEDPAERPSMATIV 615
QL S NEVI CI L L C Q +P R ++ I
Sbjct: 224 -YQL---------SNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273
Query: 616 LMLNSYSVTLP 626
+L + + P
Sbjct: 274 SLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 51/292 (17%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF----KNEVVLVAKLQHRNLVR 405
++GEG +G+VYK +G+ +A+K++ E F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQ---GQLDWSRRYK-IIGGIARGILY 459
L + +V+E++ + L L PE + Q+ K + + G+ Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQI------KCYMKQLLEGLQY 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
LH + I+HRD+K SNIL++ + K++DFG+AR + + T+R++ T Y PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 520 YAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK--------QWRD 570
+ ++ + D++S G ++ E+ GK +Q + L ++ W
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK---PIFQGSTELEQLEKIFELCGSPTDENWPG 228
Query: 571 GTPLQLLDTNLTDSYSRNEVIR----------CIQL--GLLCVQEDPAERPS 610
+ L + NL +R + L LL + DP +R S
Sbjct: 229 VSKLPWFE-NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL--DPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 42/276 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHR 401
F+ +G+G FGEVYK + + Q +A+K L +A + E+ + E+ +++ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL--- 458
+ + G L+G + ++ E+ S L K G+LD I I R +L
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLD----ETYIAFILREVLLGL 111
Query: 459 -YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
YLHE+ IHRD+KA+NILL E + K++DFG++ ++ NT VGT +MA
Sbjct: 112 EYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMA 166
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSNFYQTDGAADLLSYAWKQWRDGTPLQL 576
PE + K+D++S G+ +E+ G+ S+ + +L K P L
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH----PMRVLFLIPKN----NPPSL 218
Query: 577 LDTNLTDSYSRN--EVIRCIQLGLLCVQEDPAERPS 610
+ +S+ + + C+ +DP ERPS
Sbjct: 219 EG----NKFSKPFKDFVSL------CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKR-----LSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LG+G FG VY + +G+E+AVK+ S + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 407 LGFCLEGEEKILVY-EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
G CL +E + ++ E++P S+ L + G L + K I G+ YLH +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMA-RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
I+HRD+K +NIL D+ N K+ DFG + R+ + + + GT +M+PE
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+ K+DV+S G V+E++T K
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 71/207 (34%), Positives = 113/207 (54%), Gaps = 13/207 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L K E F E ++ KL+H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
LV+L + + EE I +V E++ SL FL E L + + IA G+ Y
Sbjct: 61 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMA 517
+ R+ +HRDL+A+NIL+ + K++DFG+AR+ + T+R + + A
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTA 171
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
PE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 45/106 (42%), Positives = 59/106 (55%), Gaps = 6/106 (5%)
Query: 144 SPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVS-NTKRFATRKANFTTFQTLYSLAQC 202
S T T N T + LN L +S + + A S + K FA + T+Y LAQC
Sbjct: 6 SNTSGNYTTANSTFESNLNAL----LSSLSSNAASSSGKGFAAG-TSGAAPDTVYGLAQC 60
Query: 203 TPDLSSSDCNTCLRGAVARLPSCCSGKQGGRVLFPSCNVRYELYPF 248
DLS+SDC +CL AV+ L CC K+GGR+ + SC +RYE YPF
Sbjct: 61 RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 24/212 (11%)
Query: 353 LGEGGFGEV----YKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
LG+G FG V Y + + G+ +AVK+L ++ + +F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 408 GFCLE-GEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
G C G + LV E++P SL DY E+ LD + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAPE 519
R +HRDL NIL+++E KI DFG+ ++ D+ + S I + APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPE 181
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN 550
+FSV SDV+SFGV++ E+ T K+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 72/228 (31%), Positives = 123/228 (53%), Gaps = 31/228 (13%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLS-KASGQGAEEFKNEV 392
I ++T +F + LGE FG+VYKG L Q +A+K L KA G EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------DPEKQG 439
++ ++LQH N+V LLG + + +++ + + L FL D +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFG 498
L+ + I+ IA G+ +L S ++H+DL N+L+ ++N KISD G+ R ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 499 VD--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
D + GN+ + +M+PE M+G+FS+ SD++S+GV++ E+ +
Sbjct: 177 ADYYKLMGNSLLPI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 69/209 (33%), Positives = 116/209 (55%), Gaps = 20/209 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSKASGQGA-EEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L +A+ A +E +E ++A +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIAR 455
+ ++ RLLG CL + L+ + +P L DY + G L+W + IA+
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 120
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
G+ YL E R++HRDL A N+L+ + KI+DFG+A++ G D+ + + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
MA E +H ++ +SDV+S+GV V E++T
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 75/220 (34%), Positives = 122/220 (55%), Gaps = 21/220 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKG+ +P G+ + A+K L + S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQ---LDWSRRYKIIGGIARGILYLHE 462
LG CL + LV + +P L DY + ++ G L+W + IA+G+ YL E
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+R++HRDL A N+L+ + + KI+DFG+AR+ +D+T+ + +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 523 HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLL 561
H +F+ +SDV+S+GV V E++T G K + DLL
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 82/289 (28%), Positives = 124/289 (42%), Gaps = 51/289 (17%)
Query: 353 LGEGGFGEVY----KGVLPSGQE--IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVR 405
LG G FGEV+ KG+ G E + VK L K + + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL------YDPEKQGQLDWSRRYKIIGGIARGILY 459
LLG C E E ++ E+ L FL + K L ++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG---YM 516
L S R +HRDL A N L+ ++ K+S +++ D ++ ++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIPLRWL 185
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQTDGAADLLSYAWKQWR 569
APE FS KSDV+SFGVL+ E+ T G + A L
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL---ELPV-P 241
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
+G P +L +L C +P +RPS + +V L
Sbjct: 242 EGCPSRLY-----------------KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLS------KASGQGAEEFKNEVVLVAKLQHRNLV 404
LG+G +G VY G+ GQ IAVK++ A+ + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+ LG CL+ + EFVP S+ L + G L K I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV----GTYGYMAPEY 520
++HRD+K +N++L K+ DFG AR G S ++ GT +MAPE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
+ KSD++S G V E+ TGK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 71/211 (33%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + KLG G FGEV+ ++AVK + K E F E ++ LQH
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKIIGGIAR 455
LV+L + E ++ EF+ SL FL E Q +D+S + IA
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAE 113
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY-- 513
G+ ++ + + IHRDL+A+NIL+ A + KI+DFG+AR+ + T+R +
Sbjct: 114 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPI 167
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+ APE G F++KSDV+SFG+L++EI+T
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
NK+G G FG+VY V L +G+ +AVK R+ + +E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS--RRYKIIGGIARGILYLHEDSR 465
G + E+ + E+ +L+ L E LD R Y + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH-- 118
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT----QGNTSRIVGTYGYMAPEYA 521
I+HRD+K +NI LD K+ DFG A + T + + + GT YMAPE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTPAYMAPEVI 175
Query: 522 MHGQFSVK---SDVYSFGVLVLEIITGKK 547
G+ +D++S G +VLE+ TGK+
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 33/281 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---KASGQGAEEFKNEVVLVAKLQ 399
F + K+G+G F VYK + L G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGIL 458
H N+++ L +E E +V E L + +KQ +L R +K + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
++H RI+HRD+K +N+ + A K+ D G+ R F T ++ +VGT YM+P
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 519 EYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK-QWRDGTPLQL 576
E +H ++ KSD++S G L+ E+ + S FY +L S K + D PL
Sbjct: 176 E-RIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK--MNLYSLCKKIEKCDYPPLP- 229
Query: 577 LDTNLTDSYS---RNEVIRCIQLGLLCVQEDPAERPSMATI 614
D YS R+ V RCI DP +RP ++ +
Sbjct: 230 -----ADHYSEELRDLVSRCINP-------DPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 80/282 (28%), Positives = 137/282 (48%), Gaps = 44/282 (15%)
Query: 353 LGEGGFGEVYKGVL--PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLL 407
+G G FGEV G L P +EI V + +G + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G + + ++V E++ N SLD FL + GQ + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------YMAPEYA 521
+HRDL A NIL+++ + K+SDFG++R+ D T+R G + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
+ +F+ SDV+S+G+++ E++ SY + + + + ++ +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVM------------------SYGERPYWEMSNQDVIKA-I 222
Query: 582 TDSYSRNEVIRC----IQLGLLCVQEDPAERPSMATIVLMLN 619
+ Y + C QL L C Q+D ERP IV +L+
Sbjct: 223 EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 12/205 (5%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
+LG G FG V+ G + ++A+K +++ + E+F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
+ + +V EF+ N L +L ++QG+L + + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSD 531
DL A N L+ + K+SDFGM R + +D ++S + PE ++S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 532 VYSFGVLVLEIIT-GK----KNSNF 551
V+SFGVL+ E+ T GK K SN+
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 20/208 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGA-------EEFKNEVVLVAKLQHRN 402
+G G FG VY G+ SG+ +AVK+ L S + E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ LG L+ + + E+VP S+ L G + + + I +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG--NTSR--IVGTYGYMAP 518
+R IIHRD+K +NIL+D + KISDFG+++ + N +R + G+ +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK 546
E ++ K+D++S G LV+E++TGK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 75/243 (30%), Positives = 121/243 (49%), Gaps = 27/243 (11%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNE 391
D+ IE K+GEG +G VYKG +GQ +A+K++ S+ G + + E
Sbjct: 1 DYTKIE----------KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-E 49
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
+ L+ +LQH N+V L ++ L++EF+ + L +L K +D +
Sbjct: 50 ISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
I +GIL+ H R++HRDLK N+L+D + K++DFG+AR FG+ + T +V
Sbjct: 109 QILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV- 163
Query: 512 TYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570
T Y APE + +S D++S G + E+ T K + D D L ++
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP---LFHGDSEIDQLFRIFRIL-- 218
Query: 571 GTP 573
GTP
Sbjct: 219 GTP 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 81/290 (27%), Positives = 123/290 (42%), Gaps = 51/290 (17%)
Query: 353 LGEGGFGEVYKGVL----PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LGEG FG V +G L S ++AVK +L + EEF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 407 LGFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIARGI 457
+G C E +++ F+ + L FL G L K + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQ-TQGNTSRIVGTYGY 515
YL S IHRDL A N +L +M ++DFG+++ I+ D QG +++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFYQTDGAADLLSYAWKQW 568
+A E ++ KSDV++FGV + EI T G +N Y Y
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD---------YLRHGN 232
Query: 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
R P LD L D C + DP +RP+ + +L
Sbjct: 233 RLKQPEDCLD-ELYDLMYS------------CWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 353 LGEGGFGEVYKGVLPSGQ-EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
LG+G +G VY S Q IA+K + + + + E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG--IARGILYLHEDSRLRII 469
E + E VP SL L K G L + + I I G+ YLH+ +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 470 HRDLKASNILLDAEMNP-KISDFGMA-RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-- 525
HRD+K N+L++ KISDFG + R+ G++ T GT YMAPE G
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRG 187
Query: 526 FSVKSDVYSFGVLVLEIITGK 546
+ +D++S G ++E+ TGK
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 69/199 (34%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
K + +GEG FG V +G +GQ++AVK + A+ F E ++ KL H+NLVR
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
LLG L I V E + +L FL + + + + +A G+ YL
Sbjct: 64 LLGVILHNGLYI-VMELMSKGNLVNFLRT-RGRALVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
+++HRDL A NIL+ + K+SDFG+AR V + S++ + APE H +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKL--PVKWTAPEALKHKK 173
Query: 526 FSVKSDVYSFGVLVLEIIT 544
FS KSDV+S+GVL+ E+ +
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 71/234 (30%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY------------KGVLPSGQE-----IAVKRLSK-ASG 382
E + KLGEG FGEV+ K + +AVK L AS
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 383 QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY--------D 434
E+F EV ++++L N+ RLLG C ++ E++ N L+ FL
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
L +S + IA G+ YL L +HRDL N L+ KI+DFGM+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 495 RIFGVDQTQGNTSRIVGT----YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
R + + R+ G +MA E + G+F+ KSDV++FGV + EI+T
Sbjct: 178 R----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 23/203 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQH---RNLVRLL 407
+G G +G VY+G +P+G+ +A+K ++ + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHED 463
G L+G ++ E+ S+ + K G + +Y I I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA--EKY--ISVIIREVLVALKYIHKV 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
+IHRD+KA+NIL+ N K+ DFG+A + +Q S VGT +MAPE
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITE 175
Query: 524 GQ-FSVKSDVYSFGVLVLEIITG 545
G+ + K+D++S G+ + E+ TG
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 34/271 (12%)
Query: 353 LGEGGFGEVYKGVL--PSGQE--IAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
LG G FGE+ +G L PS +E +A+ L + S + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G G ++V E++ N +LD FL E GQL + ++ G+A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE---MG 127
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMA---RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
+H+ L A +L+++++ KIS F + + T S ++ + APE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQYH 183
Query: 525 QFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583
FS SDV+SFG+++ E+++ G++ Y D++ K DG L
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP---YWDMSGQDVI----KAVEDGFRL--------- 227
Query: 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
RN QL L C Q++ ERP + I
Sbjct: 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 80/276 (28%), Positives = 138/276 (50%), Gaps = 30/276 (10%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLL 407
+G G FGEV +G L P +EI A+K L + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G + +++ EF+ N +LD FL + GQ + ++ GIA G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG---TYGYMAPEYAMHG 524
+HRDL A NIL+++ + K+SDFG++R D + + +G + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 525 QFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583
+F+ SDV+S+G+++ E+++ G++ Y D+++ + +R P+ T L
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDVINAIEQDYRLPPPMD-CPTALH- 241
Query: 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
QL L C Q+D RP IV L+
Sbjct: 242 -----------QLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-23
Identities = 91/369 (24%), Positives = 165/369 (44%), Gaps = 36/369 (9%)
Query: 267 PPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNADND 326
PP V + + T+ A + +A+ A GF F+R + + V +N+
Sbjct: 617 PPCKRVRKTPSWWFYITCTLGAFLV-LALVA----FGFVFIRGRNNLELKRV-----ENE 666
Query: 327 LTTLESLQFDFE-----TIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKA 380
T E FD + TI + +N + G G YKG + +G + VK ++
Sbjct: 667 DGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV 726
Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
+ + E + + KLQH N+V+L+G C + L++E++ K+L L +
Sbjct: 727 NSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
L W RR KI GIA+ + +LH ++ +L I++D + P + + + D
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560
+S Y+APE + KSD+Y FG++++E++TGK ++ + +
Sbjct: 836 TKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSI 888
Query: 561 LSYAWKQWRDGTPLQLLDTNLTD--SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
+ +A + D +D ++ S ++NE++ + L L C DP RP ++ L
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
Query: 619 NSYSVTLPS 627
S S + S
Sbjct: 949 ESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/220 (30%), Positives = 112/220 (50%), Gaps = 28/220 (12%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLS----KASGQGA--EEFKNEVVLVAKLQHRNLVR 405
LG G F Y+ + +G +AVK+++ +S Q E + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
+LG E L E++ S+ + L K G + + RG+ YLHE+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 466 LRIIHRDLKASNILLDAE-MNPKISDFGMA-----RIFGVDQTQGNTSRIVGTYGYMAPE 519
+IIHRD+K +N+L+D+ +I+DFG A + G + QG +++GT +MAPE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMAPE 178
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK------KNSNFYQ 553
Q+ DV+S G +++E+ T K K+SN
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 68/214 (31%), Positives = 118/214 (55%), Gaps = 31/214 (14%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEE-------FKNEVVLVAKLQHR 401
+G+G +G VY + + +G+ +AVK++ + +G+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 402 NLVRLLGFCLEGEEKILVY-EFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILY 459
N+V+ LGF EE + ++ E+VP S+ L + + QL +++ G+A Y
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA----Y 123
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR----IFGVDQTQGNTSRIVGTYGY 515
LH I+HRDLKA N+L+DA+ KISDFG+++ I+ DQ N S + G+ +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMS-MQGSVFW 176
Query: 516 MAPE--YAMHGQFSVKSDVYSFGVLVLEIITGKK 547
MAPE ++ +S K D++S G +VLE+ G++
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 61/206 (29%), Positives = 112/206 (54%), Gaps = 18/206 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
K++ K+G+G G VY + + +GQE+A+K+++ E NE++++ + +H N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YL 460
L L G+E +V E++ SL D + +D I + R L +L
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEG----QIAAVCRECLQALEFL 131
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H + ++IHRD+K+ NILL + + K++DFG +Q++ +T +VGT +MAPE
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 186
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
+ K D++S G++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-23
Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 353 LGEGGFGEVYKGV-LPSGQEI----AVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRL 406
LG G FG V+KG+ +P G I A+K + SG Q +E + ++ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
LG C G LV + P SL + + + LD R IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
R++HR+L A NILL ++ +I+DFG+A + D + S +MA E + G++
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 527 SVKSDVYSFGVLVLEIIT 544
+ +SDV+S+GV V E+++
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 72/216 (33%), Positives = 111/216 (51%), Gaps = 29/216 (13%)
Query: 352 KLGEGGFGEVYKG--VLPS---GQEIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LGE FG++YKG LP Q +A+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLY--------------DPEKQGQLDWSRRYKIIG 451
LLG + + +++E++ L FL D + LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD--QTQGNTSR 508
IA G+ YL S +H+DL A NIL+ +++ KISD G++R I+ D + Q +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+ +M PE M+G+FS SD++SFGV++ EI +
Sbjct: 189 PIR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 352 KLGEGGFGEVYK-GVLPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
++GEG G V+K +G+ +A+K+ L + G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
G +LV E++P+ L L D E+ + Y + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--F 526
+HRDLK +N+L+ A+ KI+DFG+AR+F ++ + + + V T Y APE ++G +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL-LYGARKY 178
Query: 527 SVKSDVYSFGVLVLEIITG 545
D+++ G + E++ G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYK-GVLPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNL 403
F KLG+G +G VYK L Q A+K L S + E+ NE+ ++A + H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-----QLDWSRRYKIIGGIARGIL 458
+ L+G + +V E+ P L + +K+ Q W R I + RG+
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI--QLLRGLQ 117
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
LHE +I+HRDLK++NILL A KI D G++++ + +GT YMAP
Sbjct: 118 ALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAP 170
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK 546
E +S KSD++S G L+ E+ T
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
K+GEG +G VYK +G+ +A+K++ ++ G + + E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLY-DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ LV+EF+ LD Y D LD + + +GI Y H S
Sbjct: 65 DVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH- 118
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-Q 525
R++HRDLK N+L+D E K++DFG+AR FGV + T +V T Y APE + Q
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSRQ 176
Query: 526 FSVKSDVYSFGVLVLEIITGK 546
+S D++S G + E++ +
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 30/269 (11%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
+LG G FG V G ++A+K + + S +EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
+ +V E++ N L +L E + S+ ++ + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYAMHGQFSV 528
DL A N L+D + K+SDFG++R D+ + VG+ + PE ++ +FS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180
Query: 529 KSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSR 587
KSDV++FGVL+ E+ + GK + + +S + +R P + YS
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVYAIMYS- 236
Query: 588 NEVIRCIQLGLLCVQEDPAERPSMATIVL 616
C E ERP+ ++
Sbjct: 237 ------------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 86/290 (29%), Positives = 138/290 (47%), Gaps = 34/290 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSK-ASGQGAEEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K +++ AS + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQGQL-----DWSRR 446
++ + ++VRLLG +G+ +++ E + L +L PE + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
++ G IA G+ YL+ + + +HRDL A N ++ + KI DFGM R I+ D +
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565
++ +M+PE G F+ SDV+SFGV++ EI T + YQ +L +
Sbjct: 179 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVLRFV- 234
Query: 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
+G L D N D +L +C Q +P RPS I+
Sbjct: 235 ---MEGGLLDKPD-NCPDML--------FELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 12/203 (5%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
+G G VY + LP+ +++A+KR L K +E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ G+E LV ++ SL + +G LD + ++ + +G+ YLH + +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 468 IIHRDLKASNILLDAEMNPKISDFGM-ARIF-GVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
IHRD+KA NILL + + KI+DFG+ A + G D+T+ VGT +MAPE M
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQV 181
Query: 526 --FSVKSDVYSFGVLVLEIITGK 546
+ K+D++SFG+ +E+ TG
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 75/280 (26%), Positives = 115/280 (41%), Gaps = 35/280 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRN 402
K ++LGEG G V K L + I + ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 403 LVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR-RYKIIGGIARGIL- 458
+V+ G F E I + E+ SLD +K+G R K++G IA +L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG----GRIGEKVLGKIAESVLK 116
Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
YLH +IIHRD+K SNILL + K+ DFG++ GT Y
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFY 169
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK--KNSNFYQTDGAADLLSYAWKQWRDGTP 573
MAPE +S+ SDV+S G+ +LE+ + G +LLSY
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PN 225
Query: 574 LQLLD---TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
+L D + S + I+ C+++DP RP+
Sbjct: 226 PELKDEPGNGIKWSEEFKDFIKQ------CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 34/232 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEV----------YKGVLPSGQE-----IAVKRL-SKASGQG 384
E + KLGEG FGEV + G + +AVK L + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444
+F E+ ++++L++ N++RLLG C+ + ++ E++ N L+ FL E + +
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 445 RRYKIIG---------GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
+ IA G+ YL + L +HRDL N L+ KI+DFGM+R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 496 -IFGVD--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
++ D + QG R V +MA E + G+F+ SDV++FGV + E+ T
Sbjct: 178 NLYSGDYYRIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 84/287 (29%), Positives = 128/287 (44%), Gaps = 50/287 (17%)
Query: 352 KLGEGGFGEVYKGVL---PSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLVRL 406
+LG G FG V KG+ S + +AVK L + A +E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+G C E E +LV E L+ FL +K + +++ ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVD----QTQGNTSRIVGTYGYMAPEYAM 522
+HRDL A N+LL + KISDFG+++ G D + + + V Y APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APECMN 171
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582
+ +FS KSDV+SFGVL+ E SY K ++ + +T
Sbjct: 172 YYKFSSKSDVWSFGVLMWEA------------------FSYGQKPYK-----GMKGNEVT 208
Query: 583 DSYSRNEVIRCIQ--------LGLLCVQEDPAERPSMATIVLMLNSY 621
E + C Q L LC ERP A + L L +Y
Sbjct: 209 QMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 30/274 (10%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
+G+G FG V K G+ + K + + + ++ +EV ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 408 G-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLH--E 462
+ + +V E+ L + +K+ + ++ ++I+ + + H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
D ++HRDLK +NI LDA N K+ DFG+A+I G D + T VGT YM+PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582
H + KSD++S G L+ E+ F A + L A K ++G + +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS--PPFT----ARNQLQLASK-IKEG---KFRR--IP 231
Query: 583 DSYSR--NEVIRCIQLGLLCVQEDPAERPSMATI 614
YS NEVI+ + DP +RPS +
Sbjct: 232 YRYSSELNEVIK------SMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 347 FSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHR 401
F +G+G FG+V V + + A+K ++K NE ++ +L H
Sbjct: 2 FELLRVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV L + + EE + LV + + L Y L ++ + + I I + YL
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYL 116
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H IIHRD+K NILLD + + I+DF +A T+ GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEV 170
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKK 547
+SV D +S GV E + GK+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 71/208 (34%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 353 LGEGGFGEV----YKGVLP----SGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNL 403
LGEG FG+V Y P +G+ +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 404 VRLLGFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V+ G C E K L+ E+VP SL +L + +L+ ++ I G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YM 516
IHRDL A N+LLD + KI DFG+A+ +G+ V G +
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWY 177
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
A E +FS SDV+SFGV + E++T
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLV 404
F+ ++G+G FGEVYKG+ +E+ A+K + + E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
R G L+G + ++ E++ S D K G L+ + I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
R IHRD+KA+N+LL + + K++DFG+A Q + NT VGT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 82/302 (27%), Positives = 136/302 (45%), Gaps = 51/302 (16%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
E+ ++ + LGEG FG+V K +AVK L A+ + + +E+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
++ + +H+N++ LLG C + +V E+ + +L FL G+ +
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 453 -------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFG 498
+ARG+ +L S+ + IHRDL A N+L+ + KI+DFG+AR I
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 499 VDQTQGNTS-RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557
+D + T+ R+ +MAPE ++ +SDV+SFGVL+ EI T G+
Sbjct: 185 IDYYRKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LGGS 233
Query: 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQ----LGLLCVQEDPAERPSMAT 613
Y G P++ L L + Y + C Q L C E P++RP+
Sbjct: 234 ----PYP------GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283
Query: 614 IV 615
+V
Sbjct: 284 LV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L K +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L Y +Y+ + G +R I G+ +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRR 115
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
I++RDLK N+LLD N +ISD G+A V+ G + GT GYMAPE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 527 SVKSDVYSFGVLVLEIITGK 546
D ++ G + E+I G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 11/195 (5%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLGFCL 411
LG+G FGEV+KG L +AVK + Q + +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
+ + +V E VP D+ + +K+ +L + K A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 472 DLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVK 529
DL A N L+ KISDFGM+R G+ + G + + APE +G++S +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSE 174
Query: 530 SDVYSFGVLVLEIIT 544
SDV+S+G+L+ E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGV--LPSGQEI--AVKRLSK-ASGQGAEEFKNEVVL 394
E+ + +GEG FG+VY+GV P ++I AVK S E+F E +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ + H ++V+L+G E +V E P L +L + LD + ++
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+ YL R +HRD+ A N+L+ + K+ DFG++R D++ S+
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIK 173
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
+MAPE +F+ SDV+ FGV + EI+ G K
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 26/207 (12%)
Query: 353 LGEGGFGEV----YKGVLP----SGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNL 403
LGEG FG+V Y P +G+++AVK L SG + K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 404 VRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V+ G C E L+ EF+P+ SL +L P + +++ ++ K I +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMA 517
SR + +HRDL A N+L+++E KI DFG+ + D+ + + V Y A
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---A 180
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
PE + +F + SDV+SFGV + E++T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQ 399
NK+ +GEG +G V K +G+ +A+K+ K S + E+ K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H N+V L LV+E+V L+ G L I + + I Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI---VGTYGYM 516
H IIHRD+K NIL+ K+ DFG AR S + V T Y
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARAL----RARPASPLTDYVATRWYR 168
Query: 517 APE----YAMHGQFSVKSDVYSFGVLVLEIITG 545
APE +G V DV++ G ++ E++ G
Sbjct: 169 APELLVGDTNYG-KPV--DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 346 KFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGA-EEFKNEVVLVAKL 398
LGEG FG+V K +AVK L + + + +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG----QLDWSRRYKIIGG-- 452
H ++++L G C + +L+ E+ SL FL + K G D +R +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 453 ---------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
I+RG+ YL E ++++HRDL A N+L+ KISDFG++R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+ + S+ +MA E ++ +SDV+SFGVL+ EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 76/280 (27%), Positives = 135/280 (48%), Gaps = 47/280 (16%)
Query: 353 LGEGGFGE--VYK----GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LG+G FGE +Y+ L +E+ + RLS+ + A NE+V+++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIAY 64
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYF----LYDP--EKQGQLDWSRRYKI--IGGIARGIL 458
++ + L+ E ++Y LYD ++GQL + + + I +
Sbjct: 65 YNHFMD--DNTLLIE------MEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVS 115
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
Y+H+ I+HRD+K NI L K+ DFG+++I G + + T +VGT YM+P
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSP 170
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578
E +++ KSD+++ G ++ E++T K+ T A + L+ K +Q
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKR------TFDATNPLNLVVK------IVQGNY 218
Query: 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
T + YS I L +Q+DP +RP+ ++
Sbjct: 219 TPVVSVYSSE----LISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 42/278 (15%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLL 407
+G+G FG VY G L GQ+I AVK L++ + + E+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 408 GFCLEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILYLHED 463
G CL E ++V ++ + L F+ + +IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR------IFGVDQTQGNTSRIVGTYGYMA 517
+ +HRDL A N +LD K++DFG+AR + V G + +MA
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----KWMA 170
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
E +F+ KSDV+SFGVL+ E++T + + Y + D+ Y + R P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLLQGRRLLQPEYCP 228
Query: 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
D ++ L C P RP+ + +V
Sbjct: 229 DP-------------LYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQHRNLVRLLG 408
K+GEG +G VYK +G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ--LDWSRRYKIIGGIARGILYLHEDSRL 466
+ LV+EF +D LY K Q L S + + +G+ + H
Sbjct: 66 VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE--YAMHG 524
I+HRDLK N+L++ E K++DFG+AR FG + V T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD-K 174
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+S D++S G + E+++ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 352 KLGEGGFGEVYKGV--LPSGQ-EIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLVRLL 407
+LG G FG V KGV + Q ++A+K L + + +E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
G C E E +LV E L+ FL K+ ++ S +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY--GYMAPEYAMHGQ 525
+HRDL A N+LL + KISDFG+++ G D + +R G + + APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174
Query: 526 FSVKSDVYSFGVLVLEIIT-GKK 547
FS +SDV+S+G+ + E + G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 1e-20
Identities = 56/202 (27%), Positives = 114/202 (56%), Gaps = 10/202 (4%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
K++ K+G+G G V+ + + +GQE+A+K+++ E NE++++ +L++ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L L G+E +V E++ SL D + +D ++ + + + +LH +
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN- 134
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
++IHRD+K+ N+LL + + K++DFG +Q++ +T +VGT +MAPE
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 190
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+ K D++S G++ +E++ G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 71/234 (30%), Positives = 115/234 (49%), Gaps = 37/234 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVL----------PSGQE---IAVKRLSKASGQ 383
E + + KLGEG FGEV+ +G+ SG + +AVK L + + +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 384 GAE-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
A +F E+ ++++L+ N++RLL C+ + ++ E++ N L+ FL E Q +
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 443 WSRRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ I IA G+ YL S L +HRDL N L+ KI+DFGM+
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 495 RIFGVDQTQGNTSRIVG----TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
R + G+ RI G +M+ E + G+F+ SDV++FGV + EI+T
Sbjct: 178 R----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 351 NKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
K+GEG G V +G+++AVK++ Q E NEVV++ QH N+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
L G+E +V EF+ +L D +++ + + + + + +LH +I
Sbjct: 85 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR---IVGTYGYMAPEYAMHGQF 526
HRD+K+ +ILL ++ K+SDFG Q R +VGT +MAPE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 527 SVKSDVYSFGVLVLEIITGK 546
+ D++S G++V+E++ G+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 43/229 (18%)
Query: 352 KLGEGGFGEVYKGVLPSGQE-----------------IAVKRL-SKASGQGAEEFKNEVV 393
KLGEG FGEV+ + + Q+ +AVK L A+ +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-----DPEKQGQ-------- 440
++++L+ N++RLLG C++ + ++ E++ N L+ FL D E+ G
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 441 ---LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
+ +S + IA G+ YL S L +HRDL N L+ + KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 497 FGVD--QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
+ D + QG R V +MA E + G+F+ SDV++FGV + EI+
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 87/290 (30%), Positives = 130/290 (44%), Gaps = 49/290 (16%)
Query: 353 LGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-QHRNLVRLL 407
+GEG FG+V K + + A+KR+ + AS +F E+ ++ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFL-------YDP------EKQGQLDWSRRYKIIGGIA 454
G C L E+ P+ +L FL DP L + +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
RG+ YL S+ + IHRDL A NIL+ KI+DFG++R G + T G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 183
Query: 515 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR 569
+MA E + ++ SDV+S+GVL+ EI++ Y A+L + +R
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQGYR 241
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
PL D EV ++ C +E P ERPS A I++ LN
Sbjct: 242 LEKPLNCDD----------EVYDLMR---QCWREKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 71/276 (25%), Positives = 134/276 (48%), Gaps = 47/276 (17%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLV 404
F+ ++G+G FGEV+KG+ Q++ A+K + + E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+ G L+G + ++ E++ S D + G D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
+ IHRD+KA+N+LL + + K++DFG+A Q + NT VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 525 QFSVKSDVYSFGVLVLEIITGK-KNSNFYQTDGAADLLSYAWKQWRDGTPLQLL------ 577
+ K+D++S G+ +E+ G+ NS+ + P+++L
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMH--------------------PMRVLFLIPKN 216
Query: 578 -DTNLTDSYSRN--EVIRCIQLGLLCVQEDPAERPS 610
LT +S+ E I C+ +DP+ RP+
Sbjct: 217 NPPTLTGEFSKPFKEFIDA------CLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKAS--GQGAEE-FKNEVVLVAKLQHRNLVRLLG 408
LG GGFG V V + A+K + K G +E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-----------DWSRRYKIIGGIARGI 457
F K + Y L + G+L +++ R+ I +
Sbjct: 59 ----------YRTFKDKKYI-YMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAF 106
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
YLH II+RDLK N+LLD+ K+ DFG A+ Q T GT Y+A
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVA 160
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
PE ++ + D +S G+L+ E++TG+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 34/293 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLSK-ASGQGAEEFKNEVV 393
EV+ K + +LG+G FG VY+G + G+ +AVK +++ AS + EF NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY----DPEK-QGQLDWSRRYK 448
++ ++VRLLG +G+ ++V E + + L +L + E G+ + +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 449 I--IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
I IA G+ YL+ + +HRDL A N ++ + KI DFGM R I+ D +
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565
++ MAPE G F+ SD++SFGV++ EI + + YQ +L +
Sbjct: 179 GKGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV- 234
Query: 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
DG L D N R L +C Q +P RP+ IV +L
Sbjct: 235 ---MDGGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 25/274 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---KASGQGAEEFKNEVVLVAKLQHRN 402
F + K+G G F EVY+ L + +A+K++ + ++ E+ L+ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGILYLH 461
+++ L +E E +V E L + +KQ +L R +K + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
SR R++HRD+K +N+ + A K+ D G+ R F T ++ +VGT YM+PE
Sbjct: 124 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 178
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK-QWRDGTPLQLLDTN 580
++ KSD++S G L+ E+ S FY +L S K + D PL
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM--AALQSPFYGDK--MNLFSLCQKIEQCDYPPLP----- 229
Query: 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
T+ YS E +R +L +C+ DP +RP + +
Sbjct: 230 -TEHYS--EKLR--ELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 28/223 (12%)
Query: 353 LGEGGFGEVYKGVLPSGQEI---AVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLL 407
LGEG FG V +G L I AVK + A + E+F +E V + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 408 GFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQ---LDWSRRYKIIGGIARGIL 458
G CL+ E +++ F+ + L FL L K + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-RIFGVD-QTQGNTSRIVGTYGYM 516
YL S IHRDL A N +L+ MN ++DFG++ +I+ D QG +++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSNFY 552
A E ++ KSDV+SFGV + EI T G +NS Y
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 68/200 (34%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 352 KLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFK-NEVVLVAKLQHRNLVRLLGF 409
KLGEG + VYKG + EI A+K + + +G E+ L+ +L+H N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD- 65
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
+ E K+ LV+E++ +K L ++ +G LD + + +GI + HE+ R+
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHGQ-F 526
+HRDLK N+L++ K++DFG+AR FG+ NT S V T Y AP+ + + +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 527 SVKSDVYSFGVLVLEIITGK 546
S D++S G ++ E+ITG+
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 23/201 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL-GFC 410
LG+G FG+VYK +G A K + S + E+F E+ ++++ +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEK---QGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
E + IL+ EF +LD + + E+ + Q+ + R + + +LH +
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQ-----MLEALNFLHSH---K 123
Query: 468 IIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
+IHRDLKA NILL + + K++DFG+ A+ Q + +GT +MAPE F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETF 180
Query: 527 S-----VKSDVYSFGVLVLEI 542
K+D++S G+ ++E+
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 9e-20
Identities = 57/202 (28%), Positives = 112/202 (55%), Gaps = 10/202 (4%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
K++ K+G+G G VY + + +GQE+A+K+++ E NE++++ + ++ N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L L G+E +V E++ SL D + +D + + + + +LH +
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN- 134
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
++IHRD+K+ NILL + + K++DFG +Q++ +T +VGT +MAPE
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 190
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+ K D++S G++ +E++ G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-20
Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 65/306 (21%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQHRNLVR 405
N++G G G VYK + P+G+ A+K + G + + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 406 LLGFCLEGEEKILVYEFVPNKSLD-------YFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
E ++ EF+ SL+ FL D +Q I+ GIA
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA---- 182
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
YLH R I+HRD+K SN+L+++ N KI+DFG++RI + QT + VGT YM+P
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSP 237
Query: 519 EYA----MHGQFS-VKSDVYSFGVLVLEIITGKKNSNF-----YQTDGAADLLSYAWKQW 568
E HG + D++S GV +LE G+ F Q D A+ + + Q
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR----FPFGVGRQGDWASLMCAICMSQP 293
Query: 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV---LMLNSYSVTL 625
+ T S I C C+Q +PA+R S ++ +L +
Sbjct: 294 PEAPA--------TASREFRHFISC------CLQREPAKRWSAMQLLQHPFILRAQPGQG 339
Query: 626 PSPQQP 631
Sbjct: 340 QGGPNL 345
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 57/202 (28%), Positives = 111/202 (54%), Gaps = 10/202 (4%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
K++ K+G+G G VY + + +GQE+A+++++ E NE++++ + ++ N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L L G+E +V E++ SL D + +D + + + + +LH +
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
++IHRD+K+ NILL + + K++DFG +Q++ S +VGT +MAPE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 191
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+ K D++S G++ +E+I G+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 67/208 (32%), Positives = 111/208 (53%), Gaps = 19/208 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 404 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQG---QLDWSRRYKIIGGIARGILY 459
V+LL + E K+ LV+EF+ ++ L F+ G L S ++++ G+A +
Sbjct: 62 VKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
H R++HRDLK N+L++ E K++DFG+AR FGV + T +V T Y APE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 170
Query: 520 YAMHGQF-SVKSDVYSFGVLVLEIITGK 546
+ ++ S D++S G + E++T +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 71/220 (32%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKA----SGQGAEE 387
DFE I+ LG G FG V +K SG+ A+K LSKA Q E
Sbjct: 2 DFEFIKT----------LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQ-VEH 47
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
NE ++ ++H LV L G + LV E+VP L L K G+ +R
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVAR 104
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
Y + + YLH L I++RDLK N+LLD++ KI+DFG A+ +G
Sbjct: 105 FY--AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGR 154
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
T + GT Y+APE + + D ++ G+L+ E++ G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 61/203 (30%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGA-EEFKNEVVLVAKLQHRNLV 404
F+ K+G+G FGEV+KG+ Q++ A+K + + E+ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 405 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ G L+ + ++ E++ S LD L +P G LD ++ I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
+ IHRD+KA+N+LL K++DFG+A + TQ + VGT +MAPE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
+ K+D++S G+ +E+ G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QH 400
T F +GEG +G+VYK +GQ +A+K + EE K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 401 RNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK------ 448
N+ G + ++ LV E S+ + +G +R K
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
I+ RG+ YLHE+ ++IHRD+K NILL K+ DFG++ +D T G +
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172
Query: 509 IVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
+GT +MAPE + +SDV+S G+ +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 352 KLGEGGFGEVYKGVLPSGQE-IAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
++G G FGEV+ G L + +AVK + +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
C + + +V E V FL + +L +++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 470 HRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
HRDL A N L+ + KISDFGM+R GV + G +I + APE +G++S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 528 VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD----GTPLQLLDTNLTD 583
+SDV+SFG+L+ E + GA + + +Q R+ G L +
Sbjct: 175 SESDVWSFGILLWEAF----------SLGAVPYANLSNQQTREAIEQGVRLPCPELCPDA 224
Query: 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
Y L C + DP +RPS +T+
Sbjct: 225 VYR---------LMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 34/271 (12%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
FS ++G G FG VY + + + +A+K++S + Q E++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
++ G L LV E+ + D + +++ + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+ +IHRD+KA NILL K+ DFG A I + VGT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 523 ---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579
GQ+ K DV+S G+ +E+ ++ + + + L A ++ +P L +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA----QNESP--ALQS 236
Query: 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
Y RN V C+ Q+ P +RP+
Sbjct: 237 GHWSEYFRNFVDSCL-------QKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 25/274 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---KASGQGAEEFKNEVVLVAKLQHRN 402
F + K+G G F EVY+ L G +A+K++ + + E+ L+ +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-YKIIGGIARGILYLH 461
+++ +E E +V E L + +KQ +L + +K + + ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
SR R++HRD+K +N+ + A K+ D G+ R F T ++ +VGT YM+PE
Sbjct: 124 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 178
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK-QWRDGTPLQLLDTN 580
++ KSD++S G L+ E+ S FY +L S K + D PL
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM--AALQSPFY--GDKMNLYSLCKKIEQCDYPPLP----- 229
Query: 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+D YS E +R QL +C+ DP +RP + +
Sbjct: 230 -SDHYS--EELR--QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 82/291 (28%), Positives = 122/291 (41%), Gaps = 61/291 (20%)
Query: 353 LGEGGFGEVYKGVL-PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQH-RNLVRLLG- 408
+G G FG V K + PSG +AVKR+ S + + ++ +V + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 409 --------FCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA---- 454
C+E + L Y++V PE+ I+G IA
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEE-----------ILGKIAVATV 117
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+ + YL E+ L+IIHRD+K SNILLD N K+ DFG I G +R G
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRP 172
Query: 515 YMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKK-----NSNFYQTDGAADLLSYAWK 566
YMAPE + V+SDV+S G+ + E+ TGK NS F Q
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL-----------T 221
Query: 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617
Q G P L + +S + LC+ +D ++RP ++
Sbjct: 222 QVVKGDPPI-LSNSEEREFS----PSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 355 EGGFGEVYKGVL---PSGQEIAVKRLSKASGQGAEE-----FKNEVVLVAKLQHRNLVRL 406
EG FG ++ G+L G+E V K A E E L+ L H+N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEV--FVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 407 LGFCLEGEEKILVYEFVPNKS-LDYFLYDP---EKQGQLDWSRRYKIIGG--IARGILYL 460
L C+E E V N L FL E S + + IA G+ YL
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD-QTQG-NTSRIVGTYGYMA 517
H + +IH+D+ A N ++D E+ KI+D ++R +F +D G N +R V +MA
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMA 187
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT 544
E ++ ++S SDV+SFGVL+ E++T
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 33/201 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G G ++AVK + + A+ F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 413 GEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGG---------IARGILYLH 461
+ + +V E++ SL DY SR ++GG + + YL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-----------SRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
++ +HRDL A N+L+ + K+SDFG+ + TQ +T ++ + APE
Sbjct: 120 ANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEAL 171
Query: 522 MHGQFSVKSDVYSFGVLVLEI 542
+FS KSDV+SFG+L+ EI
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 30/263 (11%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V +G+++AVK++ Q E NEVV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L G+E +V EF+ +L D +++ + + + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
RD+K+ +ILL ++ K+SDFG V + +VGT +MAPE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 531 DVYSFGVLVLEIITGKK---NSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSR 587
D++S G++V+E+I G+ N Q A ++ RD P + DS+
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQ----------AMRRIRDNLP-----PRVKDSHKV 244
Query: 588 NEVIRCIQLGLLCVQEDPAERPS 610
+ V+R L L+ V+E P++R +
Sbjct: 245 SSVLRGF-LDLMLVRE-PSQRAT 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 24/260 (9%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V SG+++AVK + Q E NEVV++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L GEE ++ EF+ +L D Q +L+ + + + + + YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
RD+K+ +ILL + K+SDFG D + + +VGT +MAPE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 531 DVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEV 590
D++S G++V+E++ G+ Y +D A K+ RD P +L + + R+ +
Sbjct: 199 DIWSLGIMVIEMVDGEPP---YFSDSPVQ----AMKRLRDSPPPKLKNAHKISPVLRDFL 251
Query: 591 IRCIQLGLLCVQEDPAERPS 610
R + +P ER +
Sbjct: 252 ERML-------TREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK-------NEVVLVA 396
K+ +GEG +G V K +GQ +A+K+ ++ E+ K E+ ++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLK 55
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIAR 455
+L+H NLV L+ + LV+EFV + LD D EK LD SR K + I R
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILR 111
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
GI + H + IIHRD+K NIL+ K+ DFG AR + + V T Y
Sbjct: 112 GIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWY 166
Query: 516 MAPEYAM-HGQFSVKSDVYSFGVLVLEIITG 545
APE + ++ D+++ G LV E++TG
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 353 LGEGGFGEV------YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LG+GGFGEV G + + +++ KRL K SG+ + E++ + + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL---EKVNSPFIVN 57
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L + E + + LV + L Y +Y+ ++G L+ R I GIL+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS--- 113
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAMHG 524
+ I++RD+K N+LLD + N ++SD G+A V+ G T ++ GT GYMAPE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+S D ++ G + E++ G+
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 23/202 (11%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG-F 409
+LG+G FG+VYK +G A K + S + E++ E+ ++A H +V+LLG F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL----YLHEDSR 465
+G+ I++ EF P ++D + +LD I I R +L YLH
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIML------ELDRGLTEPQIQVICRQMLEALQYLHS--- 128
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM--- 522
++IIHRDLKA N+LL + + K++DFG++ V Q S +GT +MAPE M
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCET 186
Query: 523 --HGQFSVKSDVYSFGVLVLEI 542
+ K+D++S G+ ++E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
++G G +G+VYK + +G+ +A+K + G E + E+ ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 410 CLEGEEKILVYEFVPNKSLD---YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
L ++ +V E+ SL P + Q+ + R + +G+ YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQGNTSRIVGTYGYMAPEYA---M 522
IHRD+K +NILL + + K++DFG+ A++ T +GT +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 523 HGQFSVKSDVYSFGVLVLE 541
G + K D+++ G+ +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 44/285 (15%)
Query: 353 LGEGGFGEVYK-------GVLPSGQEIAVKRLS-----KASGQGAEEFKNEVVLVAK-LQ 399
LG G FG VYK L + +EI V + + + + +EV ++ + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
H N+VR LE + +V + + L ++F EK+ + R + I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVGTYGYM 516
YLH++ R I+HRDL +NI+L + I+DFG+A+ Q Q + + +VGT Y
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK---QWRDGTP 573
PE + + K+DV++FG ++ ++ T FY T ++LS A K + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYST----NMLSLATKIVEAVYEPLP 234
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
+ ++TD + C+ D RP + + M+
Sbjct: 235 EGMYSEDVTDVITS------------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRL 406
+++G G FG VY E+ AVK++S + Q E++++ EV + +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
G L+ LV E+ + D + +++ + I G +G+ YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN-- 141
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM---H 523
+IHRD+KA NILL K++DFG A + N+ VGT +MAPE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVILAMDE 194
Query: 524 GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583
GQ+ K DV+S G+ +E+ ++ + + + L A ++ +P L TD
Sbjct: 195 GQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA----QNDSP-TLQSNEWTD 247
Query: 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
S+ C+Q+ P ERP+ A ++
Sbjct: 248 SFRG--------FVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 76/256 (29%), Positives = 118/256 (46%), Gaps = 27/256 (10%)
Query: 318 VPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSGQ-- 370
V ES N+ ++ Q + E N S LG G FG+V + G+ S
Sbjct: 7 VIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVM 66
Query: 371 EIAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
++AVK L A E +E+ +++ L H N+V LLG C G +++ E+ L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
FL +++ L +A+G+ +L + IHRDL A N+LL KI
Sbjct: 127 LNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 489 SDFGMARIFGVDQ---TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT- 544
DFG+AR D +GN V +MAPE + ++ +SDV+S+G+L+ EI +
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 545 GKK-------NSNFYQ 553
G +S FY+
Sbjct: 240 GSNPYPGMPVDSKFYK 255
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 31/218 (14%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHRNLVRL 406
KLGEG FGEVYK + +G+ +A+K++ + + + F E+ ++ KL+H N+V L
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPL 72
Query: 407 LGFCLE-----GEEKILVYEFVP--NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
+ +E ++ VY P + L L +P + L S+ + + GI Y
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYMLQLLEGINY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN----------TSRI 509
LHE+ I+HRD+KA+NIL+D + KI+DFG+AR + T+ +
Sbjct: 131 LHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 510 VGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
V T Y PE + +++ D++ G + E+ T +
Sbjct: 188 V-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 82/325 (25%), Positives = 138/325 (42%), Gaps = 68/325 (20%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-----EVVLVAKLQ 399
++ KLGEG + VYK +G+ +A+K++ + A++ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP--------NKSLDYFLYDPEKQGQLDWSRRYK-II 450
H N++ LL LV+EF+ +KS+ D K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD------------IKSYM 108
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
RG+ YLH I+HRDLK +N+L+ ++ K++DFG+AR FG + T ++V
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV 164
Query: 511 GTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKK----NSNFYQTD--------- 555
T Y APE G + V D++S G + E++ +S+ Q
Sbjct: 165 -TRWYRAPELLF-GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222
Query: 556 ------GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQL--GLLCVQEDPAE 607
G L Y + TPL+ + +D + L LL + +P +
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDD--------ALDLLQRLLTL--NPNK 272
Query: 608 RPSMATIVLMLNSYSVTLPSPQQPA 632
R + A L + Y P+P P+
Sbjct: 273 RIT-ARQALE-HPYFSNDPAPTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 84/262 (32%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L K +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y+ G D R I G+ LH R R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLH---RER 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
I++RDLK NILLD + +ISD G+A V+ +G T R VGT GYMAPE + ++
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYS 586
+ D + G L+ E+I GK S F Q K R+ ++ + S
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK--SPFRQ---------RKEKVKREEVERRVKEDQEEYSEK 227
Query: 587 RNEVIRCIQLGLLCVQEDPAER 608
+E R I LL +DP R
Sbjct: 228 FSEAARSICRQLLT--KDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 70/214 (32%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQE-IAVK--RLSKASGQGAEEFKNEVVLVAKLQHR 401
+++ K+GEG +G VYK E IA+K RL + E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ--GQLDWSRRYKIIGG----IA 454
N+VRL + E+++ LV+E+ LD D +K D+++ ++I I
Sbjct: 62 NIVRLQD-VVHSEKRLYLVFEY-----LDL---DLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTY 513
RGI Y H S R++HRDLK N+L+D N K++DFG+AR FG+ + T +V T
Sbjct: 113 RGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TL 167
Query: 514 GYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
Y APE + +S D++S G + E++ K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 353 LGEGGFGEVYK----GVLPSGQE----IAVKRLS-KASGQGAEEFKNEVVLVAKL-QHRN 402
LGEG FG+V + G+ S + +AVK L A+ + + +E+ L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------YDPE----KQGQLDWSRRYKI 449
++ LLG C + ++ E+ +L FL Y + + QL +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ--GNTS 507
+ARG+ YL +SR R IHRDL A N+L+ + KI+DFG+AR GV TS
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+MAPE ++ +SDV+SFG+L+ EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 6e-18
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LG+G FG VY + +G+E+A K++ S + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 407 LGFCLE--GEEKILVY-EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G CL E+ + ++ E++P S+ L + G L S K I G+ YLH +
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAM 522
I+HRD+K +NIL D+ N K+ DFG ++ G R + GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
+ K+DV+S G V+E++T K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 356 GGFGEVY---KGVLPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLGF 409
G +G V+ K +G A+K + KA ++ E ++++ Q +V+L +
Sbjct: 4 GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRYKIIGGIARGILYLHEDSRL 466
+G++ + LV E++P L L E G LD +R Y I I + YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIY--IAEIVLALEYLH---SN 112
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-------TSRIVGTYGYMAPE 519
IIHRDLK NIL+D+ + K++DFG+++ G+ + Q N RIVGT Y+APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITG 545
+ S D +S G ++ E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 19/203 (9%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLS-KASGQGAEEFK-NEVVLVAKLQ---HRNLV 404
++GEG +G VYK L +G+ +A+K++ S +G E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 405 RLLGFC----LEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
RLL C + E K+ LV+E V ++ L +L K G L ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
LH RI+HRDLK NIL+ ++ KI+DFG+ARI+ + TS +V T Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TS-VVVTLWYRAPE 176
Query: 520 YAMHGQFSVKSDVYSFGVLVLEI 542
+ ++ D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 19/205 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LG G FGEVY +G+E+AVK++ S+ + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
G + EEK L E++P S+ L + G L + +RRY I +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYT--RQILQGVSYLHS 124
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMA-RIFGVDQTQGNTSRIVGTYGYMAPEYA 521
+ I+HRD+K +NIL D+ N K+ DFG + RI + + + GT +M+PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGK 546
+ K+DV+S V+E++T K
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 34/271 (12%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
F+ ++G G FG VY + + + +A+K++S + Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ G L LV E+ + D + +++ + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHS 143
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+ +IHRD+KA NILL K++DFG A I + VGT +MAPE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 523 ---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579
GQ+ K DV+S G+ +E+ ++ + + + L A ++ +P L +
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA----QNESP--TLQS 246
Query: 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
N Y RN V C+ Q+ P +RP+
Sbjct: 247 NEWSDYFRNFVDSCL-------QKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 46/132 (34%), Positives = 71/132 (53%), Gaps = 13/132 (9%)
Query: 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476
+ EF+ SLD +K G + KI + G+ YL+ RI+HRD+K S
Sbjct: 79 CMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPS 133
Query: 477 NILLDAEMNPKISDFGMA--RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYS 534
NIL+++ K+ DFG++ I + T VGT YM+PE G+++VKSDV+S
Sbjct: 134 NILVNSRGQIKLCDFGVSGELINSIADT------FVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 535 FGVLVLEIITGK 546
G+ ++E+ GK
Sbjct: 188 LGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q E NEVV++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470
L G+E +V EF+ +L D +++ + + + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS 530
RD+K+ +ILL + K+SDFG V + +VGT +MAPE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 531 DVYSFGVLVLEIITGK 546
D++S G++V+E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L K +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y + G + R I G+ LH++ R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-QGNTSRIVGTYGYMAPEYAMHGQF 526
I++RDLK NILLD + +ISD G+A QT +G VGT GYMAPE + ++
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNERY 178
Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQ 553
+ D ++ G L+ E+I G+ S F Q
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ--SPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 39/290 (13%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQ 399
F+ LG+G FG V + L S Q++AVK L KA S EEF E + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 400 HRNLVRLLGFCLEGEEK------ILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKII 450
H N+++L+G L K +++ F+ + L FL E+ L + +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD-QTQGNTSR 508
IA G+ YL S IHRDL A N +L+ M ++DFG+++ I+ D QG S+
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568
+ ++A E ++ SDV++FGV + EI+T + Y +++ +Y K
Sbjct: 177 L--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYNYLIKGN 232
Query: 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
R P L+ D Y +L C +P RPS + L
Sbjct: 233 RLKQPPDCLE----DVY---------ELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
LG+G FG VY +G+E+AVK++ S + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
G + E+ L E +P S+ L + G L + K I G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMH 523
I+HRD+K +NIL D+ N K+ DFG ++ G + + GT +M+PE
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
+ K+D++S G V+E++T K
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A K+L K +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y+ G D R + G+ L R R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
I++RDLK NILLD + +ISD G+A V +G T R VGT GYMAPE + ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 527 SVKSDVYSFGVLVLEIITGK 546
+ D + G L+ E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 81/319 (25%), Positives = 131/319 (41%), Gaps = 96/319 (30%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
D E IE +LG G +G V K +P+G +AVKR+ +A+ E
Sbjct: 2 DLEVIE----------ELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQE-------- 42
Query: 395 VAKLQHR---------------NLVRLLGFCLEGEEKILVYEFVPNKSLDYF---LYDPE 436
Q R V G L E + + V + SLD F +YD
Sbjct: 43 ----QKRLLMDLDISMRSVDCPYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKG 97
Query: 437 KQGQLDWSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
D I+G IA I+ YLH +L +IHRD+K SN+L++ K+ DFG
Sbjct: 98 LTIPED------ILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 493 MA--RIFGVDQTQGNTSRIVGTYGYMAPEY---AMHGQ-FSVKSDVYSFGVLVLEIITGK 546
++ + V +T G YMAPE ++ + + VKSDV+S G+ ++E+ TG+
Sbjct: 150 ISGYLVDSVAKTID-----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
Query: 547 KNSNFYQTDGAADLLSYAWKQWRDGTPLQLL-----DTNLT---DSYSRNEVIRCIQLGL 598
+ + W+ TP Q L + + + +S +
Sbjct: 205 ----------------FPYDSWK--TPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK--- 243
Query: 599 LCVQEDPAERPSMATIVLM 617
C++++ ERP+ ++
Sbjct: 244 -CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 45/276 (16%)
Query: 353 LGEGGFGEVYKGVLPSGQ------EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
+G G FG V+ + Q +I V++++K A+ NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILYL 460
LE + ++V E+ P +L ++ E I+ + +L L
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----------ILHFFVQILLAL 114
Query: 461 HEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
H I+HRDLK NILLD +M KI DFG+++I ++ +VGT Y++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPE 171
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579
++ KSD+++ G ++ E+ + K+ AA+L + K GT
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFE------AANLPALVLKIMS-GT-----FA 219
Query: 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
++D YS ++ + I L +L DP++RP ++ I+
Sbjct: 220 PISDRYS-PDLRQLI-LSML--NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 353 LGEGGFGEVY------KGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVR 405
LG+GGFGEV G L + +++ KRL K G +GA K ++AK+ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR---ILAKVHSRFIVS 57
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLY--DPEKQGQLDWSRRYKIIGGIARGILYLHED 463
L + LV + L Y +Y D E G R I G+ +LH+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQR 116
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
RII+RDLK N+LLD + N +ISD G+A + Q T GT G+MAPE
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
++ D ++ GV + E+I +
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 83/289 (28%), Positives = 124/289 (42%), Gaps = 49/289 (16%)
Query: 353 LGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-QHRNLVRLL 407
+GEG FG+V K + + A+KR+ + AS +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFL-------YDPE------KQGQLDWSRRYKIIGGIA 454
G C L E+ P+ +L FL DP L + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
RG+ YL + + IHRDL A NIL+ KI+DFG++R G + T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171
Query: 515 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR 569
+MA E + ++ SDV+S+GVL+ EI++ Y A+L + +R
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQGYR 229
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
P N L C +E P ERPS A I++ L
Sbjct: 230 LEKP-------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 46/244 (18%)
Query: 346 KFSTDNKLGEGGFGEVYKGVL---PSGQEIAVKRL--SKASGQG-AEEFKNEVVLVAKLQ 399
K+ + +G G +G VYK G+E A+K+ K G ++ E+ L+ +L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYK---------- 448
H N+V L+ LE +K + F DY +D Q + + R+ K
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLF------DYAEHD---LWQIIKFHRQAKRVSIPPSMVK 111
Query: 449 -IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVD-QT 502
++ I G+ YLH + ++HRDLK +NIL+ E KI D G+AR+F +
Sbjct: 112 SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK----------KNSNF 551
+ +V T Y APE + + K+ D+++ G + E++T + K SN
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228
Query: 552 YQTD 555
+Q D
Sbjct: 229 FQRD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 67/229 (29%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVVLVAKLQHRN 402
+G G +G V V +G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHEN 60
Query: 403 LVRLL---------GFCLEGEEKILVYEFVP---------NKSLD-----YFLYDPEKQG 439
++ LL F + +V E + + L YFLY
Sbjct: 61 IIGLLDILRPPSPEDF----NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY------ 110
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
Q I RG+ YLH + +IHRDLK SNIL+++ + KI DFG+AR
Sbjct: 111 Q------------ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 500 DQ-TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
D+ +G + V T Y APE + ++ D++S G + E++T K
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRN 402
F+ ++G G FG VY + + + +A+K++S + Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ G L LV E+ + D + + K+ L I G +G+ YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKP-LQEVEIAAICHGALQGLAYLHS 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE--Y 520
R IHRD+KA NILL K++DFG A + + VGT +MAPE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVIL 184
Query: 521 AM-HGQFSVKSDVYSFGVLVLEI 542
AM GQ+ K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 19/218 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR---LSKASGQGAEEFKNEVVLVAKLQHRN 402
++ K+GEG FG++Y S E V + L+K + E K EV+L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG---GIARGILY 459
+V E +V E+ L + +Q + +S +I+ I+ G+ +
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSED-QILSWFVQISLGLKH 116
Query: 460 LHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
+H+ +I+HRD+K+ NI L M K+ DFG+AR T VGT Y++P
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLSP 171
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK---KNSNFYQ 553
E + ++ K+D++S G ++ E+ T K + +N +Q
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQ-HRNLVRLL 407
+LG+G FG VY +G+ +A+K++ K EE N EV + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
E +E V+E++ +L Y L K S II I +G+ ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-----IVGTYGYMAPEYAM 522
HRDLK N+L+ KI+DFG+AR + SR V T Y APE +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR--EIR------SRPPYTDYVSTRWYRAPEILL 171
Query: 523 HGQF-SVKSDVYSFGVLVLEIITGK 546
S D+++ G ++ E+ T +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 48/228 (21%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVV 393
FE TN++ +G G FG V +GQ +A+K++ K ++ A+ E+
Sbjct: 6 FEI----TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEF-------------VPNKSLDYFLYDPEKQG 439
L+ L+H N++ L + E I V E + + + YFLY
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ----- 116
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
I RG+ Y+H ++HRDLK SNIL++ + KI DFG+ARI
Sbjct: 117 -------------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI--- 157
Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
Q T V T Y APE + Q + V+ D++S G + E++ GK
Sbjct: 158 -QDPQMTG-YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 49/293 (16%)
Query: 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-QHRNLV 404
++ +GEG FG+V + ++ A+K L + AS +F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL-------YDPE------KQGQLDWSRRYKIIG 451
LLG C + E+ P +L FL DP L + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
+A G+ YL E + IHRDL A N+L+ + KI+DFG++R G +
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKK 175
Query: 512 TYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566
T G +MA E + ++ KSDV+SFGVL+ EI++ Y A+L +
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS--LGGTPYCGMTCAELYEKLPQ 233
Query: 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
+R P RN +L C ++ P ERP A I + L+
Sbjct: 234 GYRMEKP-------------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 352 KLGEGGFGEVYK------GVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LG+G FG+VYK GVL + + I K S + E++ E+ ++A H N+V+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVK 66
Query: 406 LL-GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
LL F E IL+ EF ++D + + E+ L + + + YLHE+
Sbjct: 67 LLDAFYYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-- 522
+IIHRDLKA NIL + + K++DFG++ +T +GT +MAPE M
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 523 ---HGQFSVKSDVYSFGVLVLEI 542
+ K+DV+S G+ ++E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411
+G G +G+VYKG ++A ++ +G EE K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 412 E------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
+ ++ LV EF S+ + + K L I I RG+ +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM--- 522
++IHRD+K N+LL K+ DFG++ +D+T G + +GT +MAPE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 523 --HGQFSVKSDVYSFGVLVLEIITG 545
+ KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 41/277 (14%)
Query: 352 KLGEGGFGEVY-----KGV----LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
+LG+G FG VY K V L +EI V L+ A + E L++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPA 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLH 461
+V+ LE + ++ E+ + LD L + + G+ L ++ + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
+ RI+HRDLKA NI L + KI DFG++R+ T GT YM+PE
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
H + KSD++S G ++ E+ F + LS + TP +L
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCC--LAHAF----EGQNFLSVVLRIVEGPTP------SL 225
Query: 582 TDSYSRNEVIRCIQLGLL---CVQEDPAERPSMATIV 615
++YSR QL + + +DP+ RPS A I+
Sbjct: 226 PETYSR-------QLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEV 392
Q D+E I+ ++G G +G+VYK L +G+ AVK + G + E+
Sbjct: 8 QHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEI 57
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYDPEKQGQLDWSRRYKII 450
+V + +H N+V G L E+ + E+ SL Y + P + Q+ + R +
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL- 116
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+G+ YLH ++ HRD+K +NILL + K++DFG+A + T +
Sbjct: 117 ----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFI 167
Query: 511 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 542
GT +MAPE A +G ++ D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 43/230 (18%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN---EV 392
+T+ +++ + +G G +G+V +G+++A+K+LS+ Q A K E+
Sbjct: 7 NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYREL 65
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQG 439
L+ + H N++ LL F P SL+ F L + K
Sbjct: 66 RLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQ 113
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+L ++ I RG+ Y+H IIHRDLK SNI ++ + KI DFG+AR
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR---- 166
Query: 500 DQTQGNTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
T + V T Y APE MH +V D++S G ++ E++TGK
Sbjct: 167 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
K+GEG +G V+K + + +A+KR+ G + + E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLY 65
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
L ++K+ LV+E+ YF G +D + + +G+ + H
Sbjct: 66 D-VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH--- 118
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ- 525
++HRDLK N+L++ K++DFG+AR FG+ S V T Y P+ +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKL 176
Query: 526 FSVKSDVYSFGVLVLEI 542
+S D++S G + E+
Sbjct: 177 YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 68/228 (29%), Positives = 114/228 (50%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SKASGQGAEEFKNE 391
EV ++ LGEG FG+V K ++AVK L S A+ + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEK-- 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L Y+P +
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
+ QL + +ARG+ YL + + IHRDL A N+L+ + KI+DFG+AR I
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+D + T+ + +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 191 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEV 392
Q DFE I+ ++G G +G+VYK + +G+ A+K + G+ + E+
Sbjct: 8 QEDFELIQ----------RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI 57
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYDPEKQGQLDWSRRYKII 450
+++ +H N+V G L ++ + EF SL Y + P + Q+ + R +
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL- 116
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+G+ YLH + +HRD+K +NILL + K++DFG++ + T +
Sbjct: 117 ----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFI 167
Query: 511 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 542
GT +MAPE A G ++ D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 23/198 (11%)
Query: 356 GGFGEVY--KGVLPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQHRNLVRLLGF 409
G FG VY K +G A+K L K+ + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLR 467
+ LV E++ + + G L DW+++Y I + G+ LH+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG--- 117
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
IIHRD+K N+L+D + K++DFG++R ++ + VGT Y+APE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDD 171
Query: 528 VKSDVYSFGVLVLEIITG 545
SD +S G ++ E + G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGFGEV V +G+ A KRL K +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
+ E ++ + LV + L + +Y+ G + R I G+ LH ++
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHREN--- 122
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
++RDLK NILLD + +ISD G+A V +G + R VGT GYMAPE + ++
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 527 SVKSDVYSFGVLVLEIITGK 546
++ D + G L+ E+I G+
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQ---HRNLVR 405
++G G +G VYK P SG +A+K + + + EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 406 LLGFC----LEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
L+ C + E K+ LV+E V Y P + + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H + I+HRDLK NIL+ + K++DFG+ARI+ Q + +V T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
+ ++ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLV 404
+ + +GEG +G V P+G ++A+K++S Q + E+ ++ + +H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 405 RLL------GFCLEGEEKILVYEFVP-------------NKSLDYFLYDPEKQGQLDWSR 445
+L F + +V E + N + YFLY
Sbjct: 67 GILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ----------- 114
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
I RG+ Y+H + ++HRDLK SN+LL+ + KI DFG+ARI D +
Sbjct: 115 -------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDH 162
Query: 506 TSRI---VGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
T + V T Y APE ++ + K+ D++S G ++ E+++ +
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 61/224 (27%), Positives = 117/224 (52%), Gaps = 29/224 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLV 395
+ +KF ++GEG +G+VYK +G+ +A+K++ + + E F E+ ++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 396 AKLQHRNLVRL----------LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
+L HRN+V L L F + LV+E++ D+ L + G + +S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSE 115
Query: 446 RY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+ + + G+ Y H+ + L HRD+K SNILL+ + K++DFG+AR++ ++++
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 504 GNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
T++++ T Y PE + ++ DV+S G ++ E+ T K
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 57/240 (23%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSKASGQGAEE 387
F ++EV + F+ + +G G G V Y V GQ +A+K+LS+
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRP------- 52
Query: 388 FKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF------- 431
F+N E+VL+ + H+N++ LL F P KSL+ F
Sbjct: 53 FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVM 100
Query: 432 -LYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
L D Q LD R ++ + GI +LH IIHRDLK SNI++ ++
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157
Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
KI DFG+AR G T +V Y Y APE + + D++S G ++ E+I G
Sbjct: 158 KILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 36/210 (17%)
Query: 353 LGEGGFGEVY--KGVLP--SGQEIAVKRLSKASGQGAEEF--KNEVVLVAKLQHRNLVRL 406
LG+G FG+V+ + + +GQ A+K L KA+ + + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK-----------IIGGIAR 455
+ + E K+ Y + D + G L ++R K + +A
Sbjct: 64 -HYAFQTEGKL------------YLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELAL 109
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
+ +LH L II+RDLK NILLD E + K++DFG+++ +D + S GT Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEY 164
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
MAPE + +D +SFGVL+ E++TG
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 36/213 (16%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRL---SKASGQGAEEFK----NEVVLVAKLQHRN 402
N++ EG +G VY+ +G+ +A+K+L + G F E+ ++ KLQH N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILLKLQHPN 65
Query: 403 LVRL----LGFCLEGEEKI-LVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYK-IIGGIA 454
+V + +G +KI +V E+V + KSL + P Q ++ K ++ +
Sbjct: 66 IVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV------KCLMLQLL 116
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
G+ +LH++ I+HRDLK SN+LL+ KI DFG+AR +G +++V T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS--PLKPYTQLVVTLW 171
Query: 515 YMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
Y APE + ++S D++S G + E++T K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFK---NEVVLVAKLQH 400
F ++G+GG+G+V+ EI A+KR+ K+ E + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
LV+LL + + +E + L E+VP L + G L D +R Y +A
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFY-----MAEMF 111
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
+ L IHRDLK N L+DA + K++DFG+++ T N+ +VG+ YMA
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMA 166
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITG 545
PE + D +S G ++ E + G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 28/228 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRLS-KASGQGAEEFKNE 391
E + +K + LGEG FG+V K +AVK L A+ + + +E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YDPEK-- 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L YD +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG+AR +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+D + T+ + +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 188 NNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 352 KLGEGGFGEVYKG--VLPSGQEIAVKRL---SKASGQGAEEFKNEVVL--VAKLQHRNLV 404
++GEG +G+V+K + G+ +A+KR+ + G + VL + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 405 RLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
RL C + E K+ LV+E V Y PE + + ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDF 125
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
LH R++HRDLK NIL+ + K++DFG+ARI+ Q + +V T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 520 YAMHGQFSVKSDVYSFGVLVLEI 542
+ ++ D++S G + E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 62/293 (21%)
Query: 353 LGEGGFGEVYKGVL---------PSGQEIAVKR-LSKASGQGAEEFKNEVVLVAKLQHRN 402
LG+G F +YKGVL GQE++V + + + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
LV+L G C+ +E I+V E+V LD FL+ + L W + + +A + YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 463 DSRLRIIHRDLKASNILL----DAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGY 515
+++H ++ NIL+ E K+SD G+ T + V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIPW 170
Query: 516 MAPEYAMHGQFSVKS--DVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ----WR 569
+APE +GQ S+ D +SFG +LEI +G L + + + ++
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI--------CS--NGEEPLSTLSSSEKERFYQ 220
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLL---CVQEDPAERPSMATIVLMLN 619
D L + D C +L L C DP +RPS I+ LN
Sbjct: 221 DQHRLPMPD--------------CAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLSK---ASGQGAEEFKNEV-VLVAKLQHRNLV 404
LG+G FG+V KG + + AVK L K E E VL +H L
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+L C + ++++ V E+V L ++ ++ G+ D R I G+ +LHE
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAM 522
II+RDLK N+LLD+E + KI+DFGM + G+ G T+ GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGI--LGGVTTSTFCGTPDYIAPEILS 169
Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
+ + D ++ GVL+ E++ G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS----GQGAEE 387
+FE + V LG G +G+V+ G +G+ A+K L KA+ + AE
Sbjct: 1 NFELLRV----------LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH 50
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
+ E ++ ++ + L + + + K+ L+ ++V L LY E S
Sbjct: 51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEV 107
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
I I + +LH+ L II+RD+K NILLD+E + ++DFG+++ F ++ +
Sbjct: 108 RVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164
Query: 507 SRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITG 545
S GT YMAPE G D +S GVL E++TG
Sbjct: 165 S-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 324 DNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG 382
D DL+ L FE +EV +G G +G+VYKG + +GQ A+K +
Sbjct: 5 DIDLSALRDPAGIFELVEV----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED 54
Query: 383 QGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE------GEEKILVYEFVPNKSLDYFLYDP 435
+ EE K E+ ++ K HRN+ G ++ ++ LV EF S+ + +
Sbjct: 55 E-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 436 EKQG-QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ + DW I I RG+ +LH ++IHRD+K N+LL K+ DFG++
Sbjct: 114 KGNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
Query: 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG 545
+D+T G + +GT +MAPE + +SD++S G+ +E+ G
Sbjct: 169 A--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 64/240 (26%), Positives = 104/240 (43%), Gaps = 53/240 (22%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN- 390
L D + N ++G G G+VYK +G +AVK++ + EE K
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRI 60
Query: 391 ----EVVL---------------VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
+VVL + + L+ CL+ + + +P L
Sbjct: 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILG-- 117
Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
K+ I + + YL E +IHRD+K SNILLDA N K+ DF
Sbjct: 118 ----------------KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDF 159
Query: 492 GMA-RIFGVDQTQGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGK 546
G++ R+ VD ++ T R G YMAPE + ++ +++DV+S G+ ++E+ TG+
Sbjct: 160 GISGRL--VD-SKAKT-RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 25/191 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQ 399
+K+ K+G+G FGEV+K + Q +A+K++ E F E+ ++ L+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLK 69
Query: 400 HRNLVRLLGFCLEGEEK--------ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
H N+V L+ C LV+EF + L L + + S K++
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMK 126
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV---DQTQGNTSR 508
+ G+ Y+H R +I+HRD+KA+NIL+ + K++DFG+AR F + + T+R
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 509 IVGTYGYMAPE 519
+V T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 60/220 (27%), Positives = 111/220 (50%), Gaps = 41/220 (18%)
Query: 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRL--SKASGQGAEEFKNEVVLVAKLQ 399
K+ K+GEG FG K +L G++ +K + SK S + EE + EV +++ ++
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57
Query: 400 HRNLVR-------------LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
H N+V+ ++ +C G+ +Y+ + + F PE Q LDW +
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLF---PEDQ-ILDWFVQ 109
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
I + ++H+ +I+HRD+K+ NI L + K+ DFG+AR+ ++ T
Sbjct: 110 ------ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA 158
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+GT Y++PE + ++ KSD+++ G ++ E+ T K
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVV------L 394
E++ + + LGEG FG+V V+ I + +K + K++ L
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 395 VAKLQ-------HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-------- 439
V++++ H+N++ LLG C + ++ E+ +L +L G
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 440 -----QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
QL + +ARG+ YL + + IHRDL A N+L+ + KI+DFG+A
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 495 R-IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
R + +D + T+ + +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 182 RDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 28/202 (13%)
Query: 353 LGEGGFGEVYKG-VLPSGQEIAVKRLS-KASGQGAEEFKNEVVLVAKLQHRNLVRLLG-F 409
LG G G VYK L + + +AVK + + + ++ +E+ ++ K ++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA----RGILYLHEDSR 465
+E I EF+ SLD + PE ++G IA +G+ YL
Sbjct: 69 FVENRISICT-EFMDGGSLDVYRKIPEH-----------VLGRIAVAVVKGLTYLWS--- 113
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHG 524
L+I+HRD+K SN+L++ K+ DFG++ Q + ++ VGT YMAPE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGE 168
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
Q+ + SDV+S G+ +E+ G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 78/280 (27%), Positives = 132/280 (47%), Gaps = 52/280 (18%)
Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKLQHRNLVRL 406
+G+G +GEV ++ G++ +K+L+ AS + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 407 LGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQL-------DWSRRYKIIGGIARGI 457
EGE+ +L V F L + L E++G+L +W + IA +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQ------IAMAL 115
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
YLHE I+HRDLK N+ L K+ D G+AR+ ++ S ++GT YM+
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMS 170
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
PE + ++ KSDV++ G V E+ T K N A D+ S ++ P
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFN------AKDMNSLVYRIIEGKLP---- 220
Query: 578 DTNLTDSYSRN--EVIRCIQLGLLCVQEDPAERPSMATIV 615
+ YS E+I +L + P +RPS+ +I+
Sbjct: 221 --PMPKDYSPELGELIA----TMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV--RLLGF 409
LG+G FG+V L G+ AVK L K +VVL+ +V R+L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL-----------KKDVVLIDDDVECTMVEKRVLAL 51
Query: 410 CLEG-------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
E E V EF+ L + + D +G+ D R I G
Sbjct: 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCG 108
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYG 514
+ +LH II+RDLK N++LD + + KI+DFGM + +FG S GT
Sbjct: 109 LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPD 161
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
Y+APE +++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 27/281 (9%)
Query: 352 KLGEGGFGEVYKGVLPSG---QEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
++G G FG+V G + SG ++ VK L AS Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSR 465
G C E +LV EF P L +L K + D + ++ IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA--MH 523
IH DL N LL A++ KI D+G++ + ++ ++APE +H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 524 GQFSV-----KSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578
G V +S+V+S GV + E+ + S Y+ +L+Y ++ + P L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236
Query: 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
L+D + EV++ L P +RPS + L+L+
Sbjct: 237 LPLSDRWY--EVMQFCWL-------QPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHRNLVRLL 407
LG+G FG+V+ L + Q A+K L K ++ + + VL +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
E V E++ L + + K D R I G+ +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG--- 116
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
I++RDLK NILLD + + KI+DFGM + + G T GT Y+APE + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQK 172
Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ--SPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 65/227 (28%), Positives = 113/227 (49%), Gaps = 50/227 (22%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVVLV 395
K+ KLG+G +G V+K + + + +A+K++ A F+N E++ +
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFL 60
Query: 396 AKL-QHRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL-DWSRRYKIIG 451
+L H N+V+LL E ++ I LV+E+ ++ L+ + L D +RY I+
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMY 114
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI-- 509
+ + + Y+H S +IHRDLK SNILL+++ K++DFG+AR + + + N
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVL 169
Query: 510 ---VGTYGYMAPEYAMHGQFSVKSDVYSFGV-------LVLEIITGK 546
V T Y APE + S Y+ GV ++ E++ GK
Sbjct: 170 TDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 24/194 (12%)
Query: 368 SGQEIAVKRLSKASGQGAEE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEK----ILVY 420
+G E+A+K L + + + F+ E L A+L H N+V LL GE V+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD---SGEAPPGLLFAVF 58
Query: 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
E+VP ++L L G L +++ + + H I+HRDLK NI++
Sbjct: 59 EYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112
Query: 481 ---DAEMNPKISDFGMARIF-GVD----QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDV 532
+ K+ DFG+ + GV T T+ ++GT Y APE + SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 533 YSFGVLVLEIITGK 546
Y++G++ LE +TG+
Sbjct: 173 YAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK 389
S E++ T+ + +G+G +G+VYK G AVK L S EE +
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66
Query: 390 NEVVLVAKL-QHRNLVRLLGFCLEGEEKI-----LVYEFVPNKSLDYFLYDPEKQGQ-LD 442
E ++ L H N+V+ G + ++ + LV E S+ + GQ LD
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
+ I+ G G+ +LH + RIIHRD+K +NILL E K+ DFG++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 503 QGNTSRIVGTYGYMAPEYAMHGQ-----FSVKSDVYSFGVLVLEIITG 545
+ NTS VGT +MAPE Q + + DV+S G+ +E+ G
Sbjct: 184 RRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 353 LGEGGFGEV----YKGVLPSGQEIAVKRLSKA---SGQGAEEFKNE--VVLVA-KLQHRN 402
LG G FG+V YK +G+ A+K L K + E E + A +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSL------DYFLYDPEKQGQLDWSRRYKIIGGIAR 455
LV L C + E+ + V E+ L D F E + Y +
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVF-----Y--AACVVL 112
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI-FGVDQTQGNTSRIVGTYG 514
G+ YLHE+ +I++RDLK N+LLD E KI+DFG+ + G TS GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPE 166
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
++APE ++ D + GVL+ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 55/245 (22%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA----SGQGAEEFKN 390
DFE I+V +G G FGEV+ ++ A+K L K+ Q A +
Sbjct: 2 DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRA 50
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD--WSRRY 447
E ++A +V+L + + EE + LV E++P L L ++ +R Y
Sbjct: 51 ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLI---RKDVFPEETARFY 106
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA------------- 494
IA +L L +L IHRD+K NIL+DA+ + K++DFG+
Sbjct: 107 -----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161
Query: 495 ------------RIFGVDQTQGNTSR--IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 540
+ D Q VGT Y+APE + ++ D +S GV++
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221
Query: 541 EIITG 545
E++ G
Sbjct: 222 EMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 26/146 (17%)
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
F +GE I + E + SLD L +K G++ + KI + RG+ YL E + +I
Sbjct: 68 FYSDGEISICM-EHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE--KHKI 121
Query: 469 IHRDLKASNILLDAEMNPKISDFG--------MARIFGVDQTQGNTSRIVGTYGYMAPEY 520
+HRD+K SNIL+++ K+ DFG MA F VGT YM+PE
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPER 169
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
++V+SD++S G+ ++E+ G+
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK--NEVVLVAKLQHRNLVRLLG 408
KLGEG + VYKG+ +GQ +A+K +S + +G F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
E V+E++ Y + P G L + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFS 527
+HRDLK N+L+ K++DFG+AR + +Q +S +V T Y P+ + +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYS 182
Query: 528 VKSDVYSFGVLVLEIITGK 546
D++ G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 71/238 (29%), Positives = 111/238 (46%), Gaps = 30/238 (12%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
N++GEG +G VY+ SG+ +A+K R+ E+ L+ L+H N+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 408 ----GFCLEGEEKILVYEFVPNK--SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
G L+ LV E+ SL + P + Q+ ++ + RG+ YLH
Sbjct: 73 EVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLRGLQYLH 125
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
E+ IIHRDLK SN+LL + KI+DFG+AR +G+ T ++V T Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVV-TLWYRAPELL 180
Query: 522 MHGQFSVKS-DVYSFGVLVLEIITGKK----NSNFYQTDGAADLL----SYAWKQWRD 570
+ + D+++ G ++ E++ K S Q D LL W + D
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIA---VKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
+++G G FG+V G G A VK L + A+ F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFL--------YDPEKQGQLDWSRRYKIIGGIARGIL 458
LG C+E +LV EF P L +L +K ++ +A G+L
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLL 114
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
+LH + IH DL N L A+++ KI D+G+A + ++AP
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 519 EYAMHGQFSV-------KSDVYSFGVLVLEIIT 544
E + KS+++S GV + E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 41/97 (42%), Positives = 59/97 (60%), Gaps = 11/97 (11%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSR-I 509
IA G+ +LH II+RDLK N++LDAE + KI+DFGM + IFG G T+R
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-----GKTTRTF 161
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
GT Y+APE + + D ++FGVL+ E++ G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK----NEVVLVAKLQHRNLVRLL 407
LG+G FG+V L SG+ AVK L K ++ + + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 408 GFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
C + +++ V EFV L ++ +K + D +R I +++LH+
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMAR--IF-GVDQTQGNTSRIVGTYGYMAPEYAMH 523
II+RDLK N+LLD E + K++DFGM + IF G TS GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-----TTSTFCGTPDYIAPEILQE 170
Query: 524 GQFSVKSDVYSFGVLVLEIITG 545
+ D ++ GVL+ E++ G
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
E +L+ + H +++R+ + G +V +P+ S D + Y ++ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
I G+ YLH RIIHRD+K NI ++ I D G A+ V +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLA 217
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
GT APE +++ K+D++S G+++ E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 68/234 (29%), Positives = 109/234 (46%), Gaps = 43/234 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSK--ASGQG 384
+F ++E+ + F+ + +G G G V Y +L + +A+K+LS+ +
Sbjct: 9 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH 66
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPE 436
A+ E+VL+ + H+N++ LL F P KSL+ F L D
Sbjct: 67 AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 437 K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+AR G T +V Y Y APE + + D++S G ++ E+I G
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 59/291 (20%)
Query: 353 LGEGGFGEVYKG----VLPSGQ----EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
LG+G F +++KG V G+ E+ +K L K+ +E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
G C+ G+E I+V E+V SLD +L + + W + ++ +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 465 RLRIIHRDLKASNILL-----DAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+ H ++ A N+LL NP K+SD G++ V + RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171
Query: 517 APEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575
PE + Q S+ +D +SFG + EI +G PL
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGD------------------------KPLS 207
Query: 576 LLDT----NLTDSYSRNEVIRCIQLGLL---CVQEDPAERPSMATIVLMLN 619
LD+ + + + +L L C+ +P RPS I+ LN
Sbjct: 208 ALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/232 (26%), Positives = 111/232 (47%), Gaps = 49/232 (21%)
Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKN------------EVVL 394
LGEG +G+V K +G+ +A+K+ + + S ++ + E+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK----QGQLDWSRRYKII 450
+ +++H N++ L+ +EG+ F+ N +D D +K + +L S+ I+
Sbjct: 74 MNEIKHENIMGLVDVYVEGD-------FI-NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN----- 505
I G+ LH+ +HRDL +NI ++++ KI+DFG+AR +G
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 506 --------TSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGK 546
TS++V T Y APE M + F+V D++S G + E++TGK
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 351 NKLGEGGFGEVYKG-VLPSGQEIAVKRLSKASGQGAEEFKN--EVVLVAKLQ-HRNLVRL 406
K+GEG F EV K +G+ A+K + K + E+ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFLYD---------PEKQGQLDWSRRYKIIGGIAR 455
+ + + LV+E +D LY+ PEK+ + Y + + +
Sbjct: 64 IEVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKR-----VKSY--MYQLLK 111
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
+ ++H R I HRD+K NIL+ + K++DFG R G+ T I T Y
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWY 164
Query: 516 MAPEYAM-HGQFSVKSDVYSFGVLVLEIIT 544
APE + G + K D+++ G + EI++
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 53/283 (18%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQEIAVK--RLSKASGQGAEEFK-NEVVLVAKLQHR---- 401
++LG+G +G VYK VL P+G +A+K RL +E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSP 59
Query: 402 NLVRLLG-FCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+V G F +EG VY E++ SLD + +I + +G+
Sbjct: 60 YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
+L E+ IIHRD+K +N+L++ K+ DFG++ + N +G YMA
Sbjct: 116 KFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMA 169
Query: 518 PEY------AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571
PE + ++V+SDV+S G+ +LE+ G+ Y + A++ + DG
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFA-QLSAIVDG 225
Query: 572 TPLQLLDTNLTDSYS--RNEVIRCIQLGLLCVQEDPAERPSMA 612
P L YS + + C+ + P RP+ A
Sbjct: 226 DP-----PTLPSGYSDDAQDFVA------KCLNKIPNRRPTYA 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 41/213 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
+G G +G V + +G ++A+K+L + S A+ E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 410 CLEGEEKILVYEFVPNKSLD----YFLYDP---------EKQGQLDWSRRYKIIGGIARG 456
F P+ SLD ++L P K +L R ++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+ Y+H IIHRDLK N+ ++ + KI DFG+AR QT + V T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYR 182
Query: 517 APEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
APE MH ++ D++S G ++ E++TGK
Sbjct: 183 APEVILNWMH--YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
+KLGEG + VYKG + +A+K + +GA EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
+ LV+E++ +K L +L D G K+ + + RG+ Y H R +
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCH---RRK 124
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
++HRDLK N+L++ K++DFG+AR + T+ ++ +V T Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDY 182
Query: 527 SVKSDVYSFGVLVLEIITGK 546
S + D++ G + E+ TG+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 43/233 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSK--ASGQGA 385
F ++EV + F+ + +G G G V Y VL + +A+K+LS+ + A
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
+ E+VL+ + H+N++ LL F P KSL+ F L D
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 108
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
AR G T +V Y Y APE + + D++S G ++ E++ K
Sbjct: 166 ARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 41/228 (17%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVL 394
+TI ++ + +G G +G V +G +AVK+LS+ S A+ E+ L
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQL 441
+ ++H N++ LL F P +SL+ F L + K +L
Sbjct: 70 LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+I I RG+ Y+H IIHRDLK SN+ ++ + KI DFG+AR
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 169
Query: 502 TQGNTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
T + V T Y APE MH ++ D++S G ++ E++TG+
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
KLGEG + V+KG + +A+K + +GA EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
+ LV+E++ +K L ++ D G + KI + I RG+ Y H R +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQF 526
++HRDLK N+L++ K++DFG+AR V T+ ++ +V T Y P+ + ++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 527 SVKSDVYSFGVLVLEIITGK 546
S + D++ G + E+ +G+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 43/232 (18%)
Query: 337 FETIEVATNKFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSK--ASGQGA 385
F +++VA + F+ + +G G G V + VL G +AVK+LS+ + A
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 64
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYDPEK 437
+ E+VL+ + H+N++ LL F P KSL+ F L D
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 112
Query: 438 ----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+
Sbjct: 113 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
AR + T +V Y Y APE + + D++S G ++ E++ G
Sbjct: 170 ARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-------EVVLVAKLQHRNL 403
K+GEG +G V+K +GQ +A+K+ ++ E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
V L+ + LV+E+ + L+ +P + KII + + + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH-- 117
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM- 522
+ IHRD+K NIL+ + K+ DFG ARI + + + V T Y APE +
Sbjct: 118 -KHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVG 174
Query: 523 HGQFSVKSDVYSFGVLVLEIITG 545
Q+ DV++ G + E++TG
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 52/248 (20%)
Query: 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
D +G G FG V+ P G+ +A+K++ F+N V K R L ++L
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVS--CKRVFREL-KMLC 54
Query: 409 FCLEGEEKIL-VYEFVPNKSLDYF--LYDPEKQGQLDWSRRYKIIGG------------- 452
F + +L + + +D F +Y + Q D +KII
Sbjct: 55 FF--KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDL---HKIIVSPQPLSSDHVKVFL 109
Query: 453 --IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
I RG+ YLH I+HRD+K N+L+++ KI DFG+AR+ D+++ T +V
Sbjct: 110 YQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 511 GTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK----KNSNFYQTDGAADLLSYAW 565
Y Y APE M + ++ D++S G + E++ + S Q D DLL
Sbjct: 167 TQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL---- 221
Query: 566 KQWRDGTP 573
GTP
Sbjct: 222 -----GTP 224
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVV---LVAKLQHRNLVRLLG 408
LG+G FG+V E+ A+K L K ++ + +V ++A + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
C + +++ V E+V L +Y ++ G+ + I+ G+ +LH
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--- 121
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHGQF 526
II+RDLK N++LD+E + KI+DFGM + VD G T+R GT Y+APE + +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 527 SVKSDVYSFGVLVLEIITGK 546
D +++GVL+ E++ G+
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
LG+G FG+V L E A+K L K ++ + + VL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 408 GFC-LEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
FC + +E + V E++ L ++ + G+ D +R I G+ +LH+
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG- 116
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
II+RDLK N+LLD + + KI+DFGM + + G +G S GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEILKG 170
Query: 524 GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
+++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ--SPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 40/219 (18%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRN 402
++++ ++G G +G V + +G+++A+K+LS+ S A+ E+ L+ +QH N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL----DYFLYDPEKQGQLDWSRRYK--------II 450
++ LL F S D++L P Q L + ++
Sbjct: 76 VIGLLDV------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ G+ Y+H IIHRDLK N+ ++ + KI DFG+AR + T V
Sbjct: 124 YQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YV 175
Query: 511 GTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
T Y APE MH +V D++S G ++ E++TGK
Sbjct: 176 VTRWYRAPEVILNWMHYNQTV--DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 30/207 (14%)
Query: 353 LGEGGFGEVYKGVL----PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
+GEG FG + +L S Q+ A+K RL K+S E+ + E VL+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 407 L-GFCLEGEEKILVYEFVPNKSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILY 459
F +G I V E+ L + PE L W + + G+ +
Sbjct: 64 KESFEADGHLYI-VMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQ------MCLGVQH 115
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
+HE R++HRD+K+ NI L K+ DFG AR+ T VGT Y+ PE
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPE 170
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
+ ++ KSD++S G ++ E+ T K
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLL---- 407
LG G G V+ V + +AVK++ Q + E+ ++ +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 408 --GFCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
G L + L ++ + ++ L + +QG L + + RG+ Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 463 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQT---QGNTSRIVGTYGYMAP 518
+ ++HRDLK +N+ ++ E + KI DFG+ARI VD +G S + T Y +P
Sbjct: 133 AN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWYRSP 187
Query: 519 EYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
+ K+ D+++ G + E++TGK
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLG-F 409
K+G G +G VYK G++ L + G G + E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ K+ L++++ + + +K QL ++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 464 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVD-QTQGNTSRIVGTYGYMA 517
++HRDLK +NIL+ E P KI+D G AR+F + + +V T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 518 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK----------KNSNFY---QTDGAADLLSY 563
PE + + K+ D+++ G + E++T + K SN Y Q D +++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 564 -AWKQWRDGTPLQLLDTNLTDSYSRNEVIRC 593
A K W D + T + D + RN C
Sbjct: 244 PADKDWEDIKKMPEHSTLMKD-FRRNTYTNC 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE-EFKNEVVLVAKLQHRNLVRLLG 408
+KLGEG + V+KG + +A+K + +GA EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
LV+E++ + Y + G L KI + + RG+ Y H + +
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
I+HRDLK N+L++ + K++DFG+AR V T+ ++ +V T Y P+ + ++
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 527 SVKSDVYSFGVLVLEIITGK 546
S D++ G ++ E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 23/169 (13%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IF-GVDQTQGNTSRIV 510
+ARG+ +L SR + IHRDL A NILL KI DFG+AR I+ D + ++R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR 569
+MAPE ++ +SDV+SFGVL+ EI + G Q + ++ +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLK 291
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
DGT ++ + + E+ R + L C Q DP ERP+ + +V +L
Sbjct: 292 DGTRMRAPE------NATPEIYRIM---LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
KLGEG + VYKG +G+ +A+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
E LV+E+V Y P G L + + RG+ Y+H+ I
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGV-DQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
+HRDLK N+L+ K++DFG+AR V T N V T Y P+ + ++
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTLWYRPPDVLLGSTEY 181
Query: 527 SVKSDVYSFGVLVLEIITG 545
S D++ G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 57/236 (24%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG--QGAEEFKNE 391
FD + ++ +G G +G V + SG+++A+K++ A A+ E
Sbjct: 1 FDVGS------RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE 54
Query: 392 VVLVAKLQHRNLVRLLG-FCLEGEEKILVY-----------------EFVPNKSLDYFLY 433
+ ++ +H N++ + G + VY + + + + YFLY
Sbjct: 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY 114
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ RG+ Y+H + +IHRDLK SN+L++ + +I DFGM
Sbjct: 115 Q------------------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 494 ARIFGVDQTQGNTSRI----VGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEII 543
AR G+ + V T Y APE ++ +++ D++S G + E++
Sbjct: 154 AR--GLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQE----IAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLV 404
LG G +G+V+ SG + A+K L KA+ + E + E ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
L + + + K+ L+ +++ L L E+ + + G I + +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ---IYSGEIVLALEHLH-- 122
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
+L II+RD+K NILLD+ + ++DFG+++ F D+ + S GT YMAP+
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRG 180
Query: 524 GQ--FSVKSDVYSFGVLVLEIITG 545
G D +S GVL+ E++TG
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEF------KNEVVLVAKLQHRNLVR 405
LG+G FG+V L E+ A+K L K ++ K + L AK H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 406 LLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L C + ++++ V E+V L ++ ++ + D R + +++LH
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-TSRIVGTYGYMAPEYAMH 523
+I+RDLK NILLDAE + K++DFGM + G T+ GT Y+APE
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 524 GQFSVKSDVYSFGVLVLEIITGK 546
++ D ++ GVL+ E++ G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 17/211 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + F ++LG G G V+K I ++L + A +N+++ ++ H
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLH 58
Query: 401 R-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
N ++GF +GE I + E + SLD L +K G++ K+ + +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIK 114
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
G+ YL E + +I+HRD+K SNIL+++ K+ DFG++ +D + VGT Y
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSY 168
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
M+PE +SV+SD++S G+ ++E+ G+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 23/169 (13%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IF-GVDQTQGNTSRIV 510
+ARG+ +L SR + IHRDL A NILL KI DFG+AR I+ D + +R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR 569
+MAPE ++ +SDV+SFGVL+ EI + G Q D + + +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCR----RLK 290
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
+GT ++ + Y+ E+ + L C +P +RP+ + +V +L
Sbjct: 291 EGTRMRAPE------YATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 33/223 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS----GQGAEE 387
+FE ++V LG G +G+V+ +G+ A+K L KA+ + E
Sbjct: 1 NFELLKV----------LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEH 50
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
+ E ++ ++ + L + + E K+ L+ ++V + LY + + D R
Sbjct: 51 TRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-DEVRF 109
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
Y G I + +LH +L I++RD+K NILLD+E + ++DFG+++ F + + + T
Sbjct: 110 Y--SGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERT 163
Query: 507 SRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITG 545
GT YMAPE HG+ D +S G+L+ E++TG
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGK---AVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRLLG 408
+G+G FG+V + Q I A+K + KA E + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
F + EK+ LV F+ L + L +++G+ D SR + + LH+
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FN 113
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
+I+RDLK NILLD + + + DFG+ ++ D + NT GT Y+APE + ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171
Query: 528 VKSDVYSFGVLVLEIITG 545
D ++ GVL+ E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
+G G FG V+ S A+K ++ + + NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 409 FCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG------IARGILYL 460
F E +++ L + E+VP L F Y L S R+ G I + YL
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGEL--FSY-------LRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H I++RDLK NILLD E + K++DFG A+ + + T + GT Y+APE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
+ D ++ G+L+ E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V + + AVK L K + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ + +K+ V ++V L +F E+ +R Y IA + YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL-FFHLQRERSFPEPRARFYA--AEIASALGYLHS---L 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
II+RDLK NILLD++ + ++DFG+ + G+ + TS GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGI-EHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557
D + G ++ E++ G FY D A
Sbjct: 174 DRTVDWWCLGAVLYEMLYGL--PPFYSRDTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 30/245 (12%)
Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSK- 379
N DN L E + +++ + +G G FGEV S Q++ A+K LSK
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 380 --ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFL--Y 433
+ F E ++A +V+L FC ++K L V E++P L + Y
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY 137
Query: 434 D-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
D PEK W++ Y A +L L + +IHRD+K N+LLD + K++DFG
Sbjct: 138 DVPEK-----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
Query: 493 MARIFGVDQT-QGNTSRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKK 547
+D+T VGT Y++PE G + + D +S GV + E++ G
Sbjct: 188 TC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-- 243
Query: 548 NSNFY 552
++ FY
Sbjct: 244 DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 67/248 (27%), Positives = 113/248 (45%), Gaps = 33/248 (13%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLG-F 409
K+G G +G VYK G++ L + G G + E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYD-----PEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ K+ L++++ + + +K QL S ++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 464 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVD-QTQGNTSRIVGTYGYMA 517
++HRDLK +NIL+ E P KI+D G AR+F + + +V T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 518 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK----------KNSNFYQTDGAADLLSY--- 563
PE + + K+ D+++ G + E++T + K SN + D + S
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 564 -AWKQWRD 570
A K W D
Sbjct: 244 PADKDWED 251
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 25/215 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + F ++LG G G V K I ++L + A +N+++ ++ H
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLH 58
Query: 401 R-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA- 454
N ++GF +GE I + E + SLD L + ++ + +I+G ++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPE-------EILGKVSI 110
Query: 455 ---RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
RG+ YL E + +I+HRD+K SNIL+++ K+ DFG++ +D + VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVG 164
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
T YM+PE +SV+SD++S G+ ++E+ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 73/271 (26%), Positives = 114/271 (42%), Gaps = 38/271 (14%)
Query: 295 VTAVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLG 354
VTA+++ LR+ N DN L+ E + + F +G
Sbjct: 3 VTALVYDCDIPALRK----------NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIG 52
Query: 355 EGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNEVVLVAKLQHRNLVRLLGFC 410
G FGEV S +++ A+K LSK + F E ++A +V+L
Sbjct: 53 RGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HY 110
Query: 411 LEGEEKIL--VYEFVPNKSLDYFL--YD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
++K L V E++P L + YD PEK W+R Y A +L L
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WARFY-----TAEVVLALDAIHS 160
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM--- 522
+ IHRD+K N+LLD + K++DFG + VGT Y++PE
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQG 219
Query: 523 -HGQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
G + + D +S GV + E++ G ++ FY
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKR-LSKASGQGAEEFK-NEVVLVAKLQHRN-LVRLL 407
K+GEG +G+VYK +G+ +A+K+ + +G E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 408 GFCLEGEEK-------ILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
+E E+ LV+E++ + + + G+ L + + +G+ +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
H + ++HRDLK N+L+D + KI+D G+ R F + + T IV T Y AP
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAP 180
Query: 519 EYAMHG-QFSVKSDVYSFGVLVLEIITG 545
E + +S D++S G + E+
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLL 407
+G+GG GEVY P + +A+K++ + + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK--------IIGGIARGILY 459
C +G+ ++ +L L ++ L K I I I Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI----------FGVDQTQGNTS-- 507
+H S+ ++HRDLK NILL I D+G A VD+ S
Sbjct: 129 VH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 508 ----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+IVGT YMAPE + S +D+Y+ GV++ +++T
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVV---LVAKLQHRNLVRLLG 408
LG+G FG+V E+ A+K L K ++ + +V ++A + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467
C + +++ V E+V L +Y ++ G+ IA G+ +LH
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS 527
II+RDLK N++LD+E + KI+DFGM + D T GT Y+APE + +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYG 179
Query: 528 VKSDVYSFGVLVLEIITGK 546
D ++FGVL+ E++ G+
Sbjct: 180 KSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKN----EVVLVAKLQ 399
NKF +GEG +G V K +EI A+K+ + + EE K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DWSRRYKIIGGIARGIL 458
N+V L + LV+E+V L+ L + G + R Y I + + I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSY--IYQLIKAIH 114
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
+ H++ I+HRD+K N+L+ K+ DFG AR + + N + V T Y +P
Sbjct: 115 WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSP 170
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGK 546
E + + D++S G ++ E+ G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 353 LGEGGFGEVYKGVLPSGQE----IAVKRLSKA----SGQGAEEFKNEVVLVAKLQHRNLV 404
LG+GG+G+V++ +G + A+K L KA + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHE 462
L+ G + L+ E++ L L E++G D + Y + I+ + +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFY--LSEISLALEHLH- 117
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN--TSRIVGTYGYMAPEY 520
+ II+RDLK NILLDA+ + K++DFG+ + + T GT YMAPE
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITG 545
M D +S G L+ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
+G G +G V Q++AVK+LS+ S A E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 410 CLEGEEKILVYEFVPNKSLDYF-------------LYDPEKQGQLDWSRRYKIIGGIARG 456
F P S++ F L + K +L +I + RG
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+ Y+H IIHRDLK SN+ ++ + +I DFG+AR Q + V T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYR 182
Query: 517 APEYA---MHGQFSVKSDVYSFGVLVLEIITGK 546
APE MH +V D++S G ++ E++ GK
Sbjct: 183 APEIMLNWMHYNQTV--DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASGQGAEEFKNEVVL 394
F++ ++ + +G+G +G+V+K VL +G + AVK L E +L
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNIL 68
Query: 395 VAKLQHRNLVRLLGFCLE-----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
A H N+V+ G + G++ LV E S+ + K+G+ I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPI 125
Query: 450 IGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
I I G+ +LH + + IHRD+K +NILL E K+ DFG++ + + N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 506 TSRIVGTYGYMAPEY-----AMHGQFSVKSDVYSFGVLVLEIITG 545
TS VGT +MAPE + + + DV+S G+ +E+ G
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRN--LVRL 406
+G GGFGEVY +G+ A+K L K QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
+ + +K+ + + + L Y L + G I G+ ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
+++RDLK +NILLD + +ISD G+A F + + VGT+GYMAPE G
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGT 171
Query: 526 -FSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
+ +D +S G ++ +++ G +S F Q
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG--HSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 46/140 (32%), Positives = 76/140 (54%), Gaps = 13/140 (9%)
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRL 466
C + E ++ V EFV L ++ ++Q +L + +R Y I+ + +LHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNFLHERG-- 116
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
II+RDLK N+LLDAE + K++D+GM + G+ + TS GT Y+APE +
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGI-RPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 527 SVKSDVYSFGVLVLEIITGK 546
D ++ GVL+ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 353 LGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V S G AVK L K + +E + + VL+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ + EK+ V ++V L +F E+ +R Y +A I YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYA--AEVASAIGYLHS---L 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
II+RDLK NILLD++ + ++DFG+ + GV+ + TS GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEP-EETTSTFCGTPEYLAPEVLRKEPY 173
Query: 527 SVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
D + G ++ E++ G FY D
Sbjct: 174 DRTVDWWCLGAVLYEMLYGL--PPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 62/225 (27%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVVLVAKLQHRN 402
+G G +G V + +++A+K+++ A F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 403 LVRLLGFCLEGEEK------ILVYEFV---------PNKSL-----DYFLYDPEKQGQLD 442
++ + + + +VYE + +++L YFLY
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ-------- 116
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
+ RG+ Y+H + ++HRDLK SN+LL+A + KI DFG+AR +
Sbjct: 117 ----------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEK 161
Query: 503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGK 546
+ V T Y APE ++ +++ DV+S G + E++ K
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 52/228 (22%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
+G+G FG+VY+ + I A+K LSK +VAK + + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK------------EIVAKKEVAHTI------- 41
Query: 412 EGEEKILV--------------YEFVPNKSLDYFLYDPEKQGQLDW---------SRRYK 448
GE ILV + F + L Y + D G+L W R K
Sbjct: 42 -GERNILVRTLLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAK 99
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
IA +L L + I++RDLK NILLDA + + DFG+++ D NT
Sbjct: 100 FY--IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-- 155
Query: 509 IVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
GT Y+APE + + ++ D +S GVLV E+ G S FY D
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 347 FSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQ 399
F LG G FG V +KG +G+ A+K L K + + E ++ +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
H +V ++ + + EFV L L K G+ D ++ Y A +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYH-----AELV 128
Query: 458 L---YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
L YLH II+RDLK N+LLD + + K++DFG A+ + T + GT
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
Y+APE D ++ GVL+ E I G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFK--NEVVLVAKLQHRNLVRLLG 408
KLGEG + VYKG +GQ +A+K + +GA F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI-IGGIARGILYLHEDSRLR 467
+ LV+E++ + L ++ + G ++ + + RG+ Y H + R
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYCH---QRR 123
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QF 526
++HRDLK N+L+ K++DFG+AR V ++ ++ +V T Y P+ + ++
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 527 SVKSDVYSFGVLVLEIITG 545
S D++ G + E+ TG
Sbjct: 182 STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD--QTQGNTSRIV 510
I G+ Y+H + ++HRDLK N+L++A+ KI DFG+AR F + + G + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 511 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 546
T Y APE + Q K+ DV+S G ++ E++ K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 353 LGEGGFGEVY---KGVLPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRN--LV 404
+G GGFGEVY K +G+ A+K L K QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 405 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ + +K+ + + + L Y L + G + I G+ ++H
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH-- 114
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH 523
+R +++RDLK +NILLD + +ISD G+A D ++ VGT+GYMAPE
Sbjct: 115 NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 524 G-QFSVKSDVYSFGVLVLEIITG 545
G + +D +S G ++ +++ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-10
Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 36/246 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAK 397
E N++ K+G G FGEV+ QE + G E EV ++ +
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 398 LQHRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ-GQLDWSRRYKIIGGIA 454
L+H+N+VR + F + +K+ ++ EF L + K G+++ I +
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 455 RGILYLHE----DSRLRIIHRDLKASNILLD----------AEMN-------PKISDFGM 493
+ Y H + R++HRDLK NI L A+ N KI DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGK----K 547
++ G++ VGT Y +PE +H + KSD+++ G ++ E+ +GK K
Sbjct: 189 SKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 548 NSNFYQ 553
+NF Q
Sbjct: 246 ANNFSQ 251
|
Length = 1021 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 45/140 (32%), Positives = 76/140 (54%), Gaps = 13/140 (9%)
Query: 410 CLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRL 466
C + E ++ V E+V L ++ ++Q +L + +R Y I+ + YLHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNYLHERG-- 116
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
II+RDLK N+LLD+E + K++D+GM + G+ + TS GT Y+APE +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGL-RPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 527 SVKSDVYSFGVLVLEIITGK 546
D ++ GVL+ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE----FKNEVVLVAKLQ 399
F + +G G FGEV + +I A+K + K+ A+E F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISN 59
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
+ +L + + LV E+ P L L E Q D ++ Y +A +L
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLA 114
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
+H ++ +HRD+K N+L+D + K++DFG A ++ N+ VGT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPE 173
Query: 520 Y--AMHG----QFSVKSDVYSFGVLVLEIITGK 546
M+G + V+ D +S GV+ E+I G+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 23/166 (13%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IF-GVDQTQGNTSRIV 510
+A+G+ +L SR + IHRDL A NILL KI DFG+AR I+ D + +R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR 569
+MAPE ++++SDV+SFGVL+ EI + G + D ++ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLK 296
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
+GT ++ D + Y Q L C +P++RP+ + +V
Sbjct: 297 EGTRMRAPDYTTPEMY---------QTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 36/162 (22%)
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQT---QGNTSRIVGTYGYMAPEYAMHGQ 525
IHRD+ A N+LL KI DFG+AR D +GN V +MAPE
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290
Query: 526 FSVKSDVYSFGVLVLEIIT-GKK-------NSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
++V+SDV+S+G+L+ EI + GK NS FY K + G +
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY-------------KMVKRGYQMSRP 337
Query: 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
D ++ E+ ++ +C +P ERP+ + I ++
Sbjct: 338 D------FAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 50/146 (34%), Positives = 70/146 (47%), Gaps = 26/146 (17%)
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI-FGVDQTQGNTSRIVGTY 513
R + Y+H + + HRDLK NIL +A+ KI DFG+AR+ F T + V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 514 GYMAPEY--AMHGQFSVKSDVYSFGVLVLEIITGK-----KNSNFYQTDGAADLLSYAWK 566
Y APE + +++ D++S G + E++TGK KN +Q D DLL
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLITDLL----- 224
Query: 567 QWRDGTPLQLLDTNLTDSYSRNEVIR 592
GTP + T S RNE R
Sbjct: 225 ----GTP-----SPETISRVRNEKAR 241
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG--VDQTQGNTSRIVGTYG 514
+L +H +IHRD+K++NILL + K+ DFG ++++ V G T GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPY 210
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA--DLLSYAWKQWRDGT 572
Y+APE +S K+D++S GVL+ E++T K+ DG +++ D
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR-----PFDGENMEEVMHKTLAGRYDPL 265
Query: 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS---YSVTLPSPQ 629
P S S ++ I LL DP RPS + ++ M S L Q
Sbjct: 266 P---------PSISPE--MQEIVTALLS--SDPKRRPSSSKLLNMPICKLFISGLLEIVQ 312
Query: 630 -QPAFFIGSRT--ERDL-PTKEFECSDKSTSKSIPWSVDEASITEV 671
QP F R R + TK+ ++ + I ++E+ T
Sbjct: 313 TQPGFSGPLRDTISRQIQQTKQLLQVER---RRIVRQMEESLSTAA 355
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 33/229 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNE 391
DFE I+V +G G FGEV + + I A+K L+K E F+ E
Sbjct: 2 DFEIIKV----------IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE 51
Query: 392 --VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
V++ Q + L + + E + LV ++ L L E + D +R Y
Sbjct: 52 RNVLVNGDCQ---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY- 107
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
IA +L +H +L +HRD+K N+LLD + +++DFG D T +S
Sbjct: 108 ----IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSV 162
Query: 509 IVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
VGT Y++PE AM G++ + D +S GV + E++ G+ + FY
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 59/305 (19%)
Query: 348 STDNKLGE----GGFGEVYKGVLPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHR 401
+G+ + K P+ +AVK+ L S + + + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N++ + + E +V + S + L +G + + + I+ + + Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------- 514
IHR +KAS+ILL + +S + G R+V +
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNL 172
Query: 515 -YMAPEY---AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570
+++PE + G ++ KSD+YS G+ E+ G + F LL +
Sbjct: 173 PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG--HVPFKDMPATQMLL-----EKVR 224
Query: 571 GTPLQLLDTN--------LTDSYSRNEVIRCI-----------------QLGLLCVQEDP 605
GT LLD + ++ S S NE Q LC+Q DP
Sbjct: 225 GTVPCLLDKSTYPLYEDSMSQSRSSNE-HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDP 283
Query: 606 AERPS 610
RPS
Sbjct: 284 ESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLG 408
N +G G FG VY+ + + + +++A+K++ + ++KN E++++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 409 F----CLEGEEKIL----VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
+ C + EK + V EF+P Y + L + R + Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
H I HRDLK N+L+D + K+ DFG A+ + Q + S I + Y APE
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRF-YRAPE 240
Query: 520 YAMHG-QFSVKSDVYSFGVLVLEIITG 545
+ ++ D++S G ++ E+I G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
E ++ + H ++++L G + L+ +P D + Y K+ + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ R I YLHE+ RIIHRD+KA NI ++ + + DFG A F VD
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556
GT APE + D++S G+++ E+ T + ++ DG
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH--DSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 9/138 (6%)
Query: 410 CLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468
C + ++ LV E+V L ++ ++Q +L I + +LHE I
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---I 117
Query: 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV 528
I+RDLK N+LLDA+ + K++D+GM + G+ TS GT Y+APE ++
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK-EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 529 KSDVYSFGVLVLEIITGK 546
D ++ GVL+ E++ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 80/262 (30%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKAS----GQGAEE 387
DFE+I+V +G G FGEV K +G A+K+L K+ Q
Sbjct: 2 DFESIKV----------IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQ-VAH 47
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFL--YD--PEKQGQL 441
+ E ++A+ + +V+L + +E L+ E++P + L D E++
Sbjct: 48 VRAERDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--- 102
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-------- 493
+R Y IA IL + +L IHRD+K N+LLDA+ + K+SDFG+
Sbjct: 103 --TRFY-----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155
Query: 494 ----ARIFGVDQTQGNTSR--------------------------IVGTYGYMAPEYAMH 523
RI + + VGT Y+APE +
Sbjct: 156 RTEFYRI--LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213
Query: 524 GQFSVKSDVYSFGVLVLEIITG 545
++ + D +S GV++ E++ G
Sbjct: 214 TGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V G+ AVK L K +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
+ + EK+ V +FV L + L +++ R IA + YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
I++RDLK NILLD++ + ++DFG+ + G+ Q+ T+ GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSD-TTTTFCGTPEYLAPEVIRKQPY 173
Query: 527 SVKSDVYSFGVLVLEIITG 545
D + G ++ E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT---QGNTSRI 509
+A+G+ +L + IHRDL A NILL KI DFG+AR D +GN
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
V +MAPE + ++ +SDV+S+G+L+ EI +
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQ--EIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHR 401
F+ LG G FG V + +A+KR K+ + + +E ++ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V L G + LV EFV FL K+ D Y A+ +L
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYA-----AQIVLIFE 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
L I++RDLK N+LLD + K++DFG A++ T + GT Y+APE
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEIL 200
Query: 522 MHGQFSVKSDVYSFGVLVLEIITG 545
++ +D ++ G+ + EI+ G
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 346 KFSTDNKLGEGGFGEVY--------------KGVLPSGQEIA-----VKRLSKASGQGAE 386
F + L G FG+++ +GV + Q + + KA + A
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE---FVPNKSLDYFLYDPEKQGQLDW 443
+ +NE++ + +L H N++++ E+IL E ++ + D+ LY DW
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 444 SRR------YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
R I+ + + Y+H+ ++IHRD+K NI L+ + + DFG A F
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
++ + VGT +PE + +D++S G+++L++++
Sbjct: 318 EKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 353 LGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVV--LVAKLQHRNLVRL 406
LG+G FG+V +L SG+ A+K L K +E + + V K +
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L + + ++++ V E+V L +F E+ D +R Y I + YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYG--AEIVSALDYLHSG-- 114
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
+I++RDLK N++LD + + KI+DFG+ + D T GT Y+APE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDND 171
Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
+ D + GV++ E++ G+ FY D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 352 KLGEGGFGEVYKGVL---PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLVRLL 407
++G G FG+V + + VK L + AS + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR-------YKIIGGIARGILYL 460
G C+E +LV+E+ L +L Q W RR ++ IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
H + +H DL N L +++ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 353 LGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV----VLVAKLQHRNLVRLL 407
+G+G FG+V + ++ AVK L K + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 408 GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRL 466
F + +K+ V +++ L Y L +++ R IA + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526
I++RDLK NILLD++ + ++DFG+ + + G TS GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 527 SVKSDVYSFGVLVLEIITG 545
D + G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 30/88 (34%), Positives = 51/88 (57%)
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+L L E +++HRDLK++NI L K+ DFG ++ + + S GT Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIIT 544
APE ++S K+D++S GV++ E++T
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 353 LGEGGFGEVYKGVLP---------SGQEIAVKRLSKASGQGAEE----FKNEVVLVAKLQ 399
LG G ++Y G+L E +K + K + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H+++V L G C+ E I+V EFV LD F++ K L ++K+ +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSY 120
Query: 460 LHEDSRLRIIHRDLKASNILL-----DAEMNP--KISDFGMARIFGVDQTQGNTSRIVGT 512
L ED L +H ++ NILL D E P K+SD G+ V Q RI
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI--- 172
Query: 513 YGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEI 542
++APE + S+ +D +SFG + EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+A G+ +L + +HRDL A N+L+ KI DFG+AR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+MAPE + ++ SDV+SFG+L+ EI T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 68/249 (27%), Positives = 104/249 (41%), Gaps = 73/249 (29%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLV 395
DFE ++V +G G FGEV AV ++ K +GQ V
Sbjct: 2 DFEILKV----------IGRGAFGEV-----------AVVKM-KNTGQ---------VYA 30
Query: 396 AKLQHR--NLVRLLGFCLEGEEKILV-----------YEFVPNKSLDYFLYDPEKQGQL- 441
K+ ++ L R C E +LV Y F +L Y + D G L
Sbjct: 31 MKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNL-YLVMDYYVGGDLL 89
Query: 442 ------------DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
D +R Y +A +L + +L +HRD+K N+LLD + +++
Sbjct: 90 TLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLA 144
Query: 490 DFGMARIFGVDQT-QGNTSRIVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEII 543
DFG D T Q N + VGT Y++PE AM G++ + D +S GV + E++
Sbjct: 145 DFGSCLRLLADGTVQSNVA--VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
Query: 544 TGKKNSNFY 552
G+ + FY
Sbjct: 203 YGE--TPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ARG+ +L + +HRDL A N+LL KI DFG+AR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
+MAPE ++ SDV+S+G+L+ EI +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 72/276 (26%), Positives = 113/276 (40%), Gaps = 74/276 (26%)
Query: 361 VYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420
V K + PS ++IA+ AS L++++ H +L + G C+ G E I+V
Sbjct: 48 VLKVLDPSHRDIALAFFETAS------------LMSQVSHIHLAFVHGVCVRGSENIMVE 95
Query: 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL- 479
EFV + LD L + + + W + + +A + YL ED L +H ++ A NIL
Sbjct: 96 EFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYL-EDKNL--VHGNVCAKNILL 150
Query: 480 ----LDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDV 532
L +P K+SD G++ F + RI ++APE G S +D
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVS--FTALSREERVERI----PWIAPECVPGGNSLSTAADK 204
Query: 533 YSFGVLVLEII----------TGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582
+SFG +LEI T + FY+ K+ R P
Sbjct: 205 WSFGTTLLEICFDGEVPLKERTPSEKERFYE------------KKHRLPEP--------- 243
Query: 583 DSYSRNEVIRCIQLGLL---CVQEDPAERPSMATIV 615
C +L L C+ +P +RPS TI+
Sbjct: 244 ---------SCKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVG 511
I + YLH +++RDLK N++LD + + KI+DFG+ + + G T G
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
T Y+APE + D + GV++ E++ G+ FY D
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 353 LGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRL 406
LG+G FG+V +L +G+ A+K L K +E + V LQ+ +
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L + + +++ V E+ L +F E+ + +R Y I + YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSALEYLHSRD- 115
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGYMAPEYAMHG 524
+++RD+K N++LD + + KI+DFG+ + G+ + G T + GT Y+APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK-EGI--SDGATMKTFCGTPEYLAPEVLEDN 170
Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
+ D + GV++ E++ G+ FY D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 36/236 (15%)
Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL---PSGQEIAVKRLSKAS 381
N +L L + E+ KL +G FG+V VL P+ + K +
Sbjct: 1 NMDKSLSELVQFLKNCEIVKKL-----KLIDGKFGKVS--VLKHKPTQKLFVQKIIK--- 50
Query: 382 GQGAEEFKNEV-VLVAKL--QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
A+ F N + +V +L + N ++L + +L+ +++ + L L +K+
Sbjct: 51 ---AKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKE 103
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIF 497
G+L + KII + + LH + IIH D+K N+L D + + D+G+ +I
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK---KNSN 550
G GT Y +PE + V D ++ GVL E++TGK K
Sbjct: 161 GTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 36/268 (13%)
Query: 297 AVLFILGFCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEG 356
A+++ L F LR+ N DN L + + + + +G G
Sbjct: 5 ALVYDLDFPALRKN----------KNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRG 54
Query: 357 GFGEVYKGVLPSGQEI-AVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413
FGEV S +++ A+K LSK + F E + + V L + +
Sbjct: 55 AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114
Query: 414 EEKI-LVYEFVPNKSLDYFL--YD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
+ + +V E++P L + YD PEK W+R Y A +L L + I
Sbjct: 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYT-----AEVVLALDAIHSMGFI 164
Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVD-QTQGNTSRIVGTYGYMAPEY----AMHG 524
HRD+K N+LLD + K++DFG + + +T+ VGT Y++PE G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDG 222
Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFY 552
+ + D +S GV + E++ G ++ FY
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEE---FKNE 391
DFE ++V +G G FGEV L + ++ A+K L+K E F+ E
Sbjct: 2 DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 51
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
++ ++ + L + + E + LV ++ L L E + D +R Y
Sbjct: 52 RDVLVNGDNQ-WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--- 107
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+A ++ + +L +HRD+K NIL+D + +++DFG D T +S V
Sbjct: 108 --LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAV 164
Query: 511 GTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
GT Y++PE AM G++ + D +S GV + E++ G+ + FY
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 353 LGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRL 406
LG+G FG+V +L +G+ A+K L K +E + + LQ+ +
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 407 LGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L + + +++ V E+ L +F E+ D +R Y I + YLH S
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYG--AEIVSALDYLH--SE 114
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
+++RDLK N++LD + + KI+DFG+ + D T GT Y+APE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDND 172
Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
+ D + GV++ E++ G+ FY D
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 9/190 (4%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412
L G GEV+ G E K + KA G + E+ ++ + HR ++ L+
Sbjct: 100 LTPGSEGEVFVCT-KHGDEQRKKVIVKA-VTGGKTPGREIDILKTISHRAIINLIH---A 154
Query: 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472
K V +P D F Y ++ G L + I + + YLH IIHRD
Sbjct: 155 YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRD 210
Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDV 532
+K NI LD N + DFG A GT +PE + K+D+
Sbjct: 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270
Query: 533 YSFGVLVLEI 542
+S G+++ E+
Sbjct: 271 WSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 66/258 (25%), Positives = 102/258 (39%), Gaps = 71/258 (27%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
F T +G+G FGEV + V +G+ A+K L K+ E FK + + K +
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAERDV 54
Query: 403 L--------VRLLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQGQLDWSRRYKIIGG 452
L V L + + L+ EF+P L L YD + D +R Y
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE---DVTRFY----- 106
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--------------- 497
+A +L + +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 498 -------------GVDQ---TQGNTSRI--------------VGTYGYMAPEYAMHGQFS 527
VD T + +I VGT Y+APE + +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 528 VKSDVYSFGVLVLEIITG 545
+ D +S G ++ E + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 50/195 (25%), Positives = 97/195 (49%), Gaps = 25/195 (12%)
Query: 367 PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
P+G + V+ L + + + +NEVVL +H N++ G ++ F+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 425 NKSLDYFL--YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
S + L Y PE + + I+ G RG+ YLH++ IHR++KAS+IL+
Sbjct: 83 YGSANSLLKTYFPEGMSE---ALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISG 136
Query: 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYG--------YMAPEYA---MHGQFSVKSD 531
+ +S G++ ++ + + G +++V + +++PE ++G ++VKSD
Sbjct: 137 DGLVSLS--GLSHLYSLVR-NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSD 192
Query: 532 VYSFGVLVLEIITGK 546
+YS G+ E+ TG+
Sbjct: 193 IYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 61/248 (24%), Positives = 104/248 (41%), Gaps = 55/248 (22%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEE---FKNE 391
DFE+++V +G G FGEV +G A+K L KA E+ + E
Sbjct: 2 DFESLKV----------IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAE 51
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
++ + +V++ + L+ EF+P + L + + + ++ Y
Sbjct: 52 RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSE-EATQFY---- 106
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM------------------ 493
IA +L + +L IHRD+K N+LLDA+ + K+SDFG+
Sbjct: 107 -IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 494 ----------------ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
A + ++ Q S VGT Y+APE M ++ D +S GV
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 538 LVLEIITG 545
++ E++ G
Sbjct: 225 IMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 60/249 (24%), Positives = 104/249 (41%), Gaps = 57/249 (22%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV-YKGVLPSGQEIAVKRLSKASGQGAEE---FKNE 391
DFE+++V +G G FGEV +G A+K L KA E+ + E
Sbjct: 2 DFESLKV----------IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAE 51
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
++ + +V++ + L+ EF+P + L + + + ++ Y
Sbjct: 52 RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTE-EETQFY---- 106
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG------- 504
IA +L + +L IHRD+K N+LLD++ + K+SDFG+ G+ +
Sbjct: 107 -IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNL 163
Query: 505 -------------NTSR---------------IVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
N+ R VGT Y+APE M ++ D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 537 VLVLEIITG 545
V++ E++ G
Sbjct: 224 VIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 37/196 (18%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 361 VYKGVLPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK- 416
+YKG+ + +E+ ++ K + +NE+ + ++ N++++ GF ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 417 ---ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRD 472
L+ E+ L L K+ L + + + +G+ L++ ++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148
Query: 473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA--MHGQFSVKS 530
L + + L+ KI G+ +I + V Y + + + ++++K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 531 DVYSFGVLVLEIITGK 546
D+YS GV++ EI TGK
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 16/100 (16%)
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI-------------FGVDQTQGN 505
YLH I+HRDLK N+L+ + + K++DFG+++I D +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
++ GT Y+APE + + D ++ G+++ E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 53/175 (30%), Positives = 69/175 (39%), Gaps = 32/175 (18%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSKASGQGAEE-FKNEVVL------VAK 397
F KLGEG FG VYK L + Q + L KA+ GA E + NE V A
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE-----------KQGQL--DWS 444
+ L + + +E LV+ + +L + E K L
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251
Query: 445 RRYKIIGGIARGILY----LHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMA 494
R KII I R IL+ LH I+HRD+K NI+ KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
E I+V+T +F + LGEG FG+V + +E ++ + + + K E+ + K
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 398 LQHRN------LVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
++ + L+++ + G I++ ++ P LD+ + K G +I
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCL-LDWIM----KHGPFSHRHLAQI 236
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNP-------------KISDFGM 493
I + Y H + L ++H DLK NIL+ D ++P +I D G
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
D+ T+ IV T Y +PE + + +D++S G ++ E+ TGK
Sbjct: 295 C----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 31/149 (20%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 352 KLGEGGFGEVYKGVLPSGQE-IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV--RLLG 408
L G VY L + E +K S + + + EV ++ L + L ++L
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG-IARGILYLHEDSRLR 467
L+ E++ ++LD + + + + +A+ LH+ L
Sbjct: 61 SGESDGWSYLLMEWIEGETLD-----EVSEEEKEDIAE--QLAELLAK----LHQLPLLV 109
Query: 468 IIHRDLKASNILLDAEMNPKISDFGMARI 496
+ H DL NIL+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 67/247 (27%)
Query: 353 LGEGGFGEVYKGVLPSGQEI----AVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVR 405
+G G FGEV L + A+K L KA A K E ++A+ + +V+
Sbjct: 9 IGIGAFGEVC---LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYL 460
L + + ++ + V +++P + L E D +R Y I + I +
Sbjct: 66 LY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE-----DLARFY--IAELTCAIESV 117
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-------------------------- 494
H ++ IHRD+K NIL+D + + K++DFG+
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 495 ---------------RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539
R + +VGT Y+APE + ++ D +S GV++
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 540 LEIITGK 546
E++ G+
Sbjct: 235 YEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 32/124 (25%)
Query: 389 KNEVVLVAKLQHRNLVRLLGFC------LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLD 442
+ E ++AK R G ++ + ++V E++ + L L
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI------ 496
R ++ + R + LH+ I+H DL SNI+L DFG+
Sbjct: 91 EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVED 146
Query: 497 FGVD 500
VD
Sbjct: 147 KAVD 150
|
Length = 204 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 20/49 (40%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
K I +A + YLH IIHRDLK N+L+ E + K++DFG++++
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 63/247 (25%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG G FGEV + + A+K L K + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 409 FCLEGEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+ + V +++P + L PE +R Y IA L +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV-----LARFY-----IAELTLAIESVH 118
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT-----QGNTSR----------- 508
++ IHRD+K NIL+D + + K++DFG+ F +G+ R
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 509 -----------------------------IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539
+VGT Y+APE + ++ D +S GV++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 540 LEIITGK 546
E++ G+
Sbjct: 239 FEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 24/161 (14%)
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI 449
+E L+ +L H ++ LL + G LV +P D + Y + L ++
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 450 IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
+ +AR +L Y+H + IIHRD+K N+L++ + + DFG A +G+
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF-----ARGS 313
Query: 506 TSR-----IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 541
S I GT APE ++ D++S G+++ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 61/235 (25%), Positives = 90/235 (38%), Gaps = 55/235 (23%)
Query: 352 KLGEGGFGEVY----KGVLPSGQEIAVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLV 404
LG+G G V+ KG +G+ A+K L K + K E ++A L H L
Sbjct: 8 LLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL-YDPEKQGQLDWSRRYKIIGGIARGIL---YL 460
L LV ++ P L L P K + +R Y A +L YL
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY-----AAEVLLALEYL 119
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDF---------GMARIFG------------- 498
H L I++RDLK NILL + +SDF
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 499 -----VDQTQGNTSRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 545
++ ++ VGT Y+APE HG +V D ++ G+L+ E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 674 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.22 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.16 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.38 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.32 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.22 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.03 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.96 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.95 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.92 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.9 | |
| PLN02236 | 344 | choline kinase | 96.87 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.74 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.18 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.14 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.96 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.82 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.77 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.65 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.62 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.51 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.0 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.71 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.58 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-55 Score=460.88 Aligned_cols=288 Identities=47% Similarity=0.811 Sum_probs=255.7
Q ss_pred cccccchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
....|++.++..+|++|...+.||+|+||.||+|.+++|+.||||++.....+...+|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999999999999988775544145699999999999999999999999
Q ss_pred EeCC-eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEe
Q 005846 411 LEGE-EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (674)
Q Consensus 411 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~ 489 (674)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875444 89999999999999999999999988899999999999999999999999
Q ss_pred eeCCccccCCCCCCCccccc-cccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 490 DFGMARIFGVDQTQGNTSRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
|||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+..|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999764321 1111112 79999999999999999999999999999999999998877655555666999999999
Q ss_pred cCCCcceecccccC-CCCCh-hHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 569 RDGTPLQLLDTNLT-DSYSR-NEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 569 ~~~~~~~~~d~~~~-~~~~~-~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.++...+++|+.+. ..++. .++.++..++.+|++.+|.+||+|.||+++|+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999987 66664 6888999999999999999999999999999554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=396.72 Aligned_cols=261 Identities=33% Similarity=0.525 Sum_probs=211.1
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccCccC--HHHHHHHHHHHHhcCCCceeeEEeEEEeCC-eeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG--AEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 422 (674)
++...+.||+|+||+||+|.+.....||||++....... .+.|.+|+.+|.+++|||||+|+|+|.+.. ..+|||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456699999999999999544449999997643222 568999999999999999999999999988 79999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~~~~~ 501 (674)
|++|+|..+++.. ....+++..+++|+.|||+||.|||++++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999754 46789999999999999999999999874 99999999999999998 99999999998764322
Q ss_pred CCCccccccccCCccCccccc--cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAM--HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.|+..... .+.+......+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~-------- 262 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGG-------- 262 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC--------
Confidence 2233368999999999999 56899999999999999999999999753221 12222222121
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 626 (674)
.+...+......+..|+.+||+.||..||++.+|+.+|+.+.....
T Consensus 263 -~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 -LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred -CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1222233355678889999999999999999999999987654443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.69 Aligned_cols=261 Identities=32% Similarity=0.505 Sum_probs=215.7
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++..+.+..+++||+|.||+||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++..+|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3444556678999999999999999977779999999765 344578899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
|||+.|+|.++|.. ..+..++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+
T Consensus 281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999965 35667999999999999999999999998 999999999999999999999999999955443
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhC-CCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.... .....-+..|.|||.+..+.++.|||||||||+||||+|- +.|++ .-...+.+..+.+..
T Consensus 357 ~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~---~msn~ev~~~le~Gy----------- 421 (468)
T KOG0197|consen 357 EYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP---GMSNEEVLELLERGY----------- 421 (468)
T ss_pred ceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC---CCCHHHHHHHHhccC-----------
Confidence 3322 2222346789999999999999999999999999999994 44432 222333443333333
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
+-..|...+..+.+||..||+.+|++|||++.+...|+++..
T Consensus 422 --Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 --RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 333345566789999999999999999999999999987643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=405.75 Aligned_cols=269 Identities=32% Similarity=0.497 Sum_probs=221.8
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
...++.+.+.+..++||+|.||+||+|+.. +...||||.++..... ..++|++|+++++.++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334556677788899999999999999843 3457999999876655 788999999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCC-------c----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEE
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPE-------K----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIl 479 (674)
.+++..++|+|||..|+|.+||.... . ..+|+..+.+.|+.|||.||.||-++. +|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 99999999999999999999996321 1 223889999999999999999999877 999999999999
Q ss_pred EcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCcc
Q 005846 480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAA 558 (674)
Q Consensus 480 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~ 558 (674)
|.++..+||+||||++.....++........-..+|||||.+..+++|.++|||||||+|||++| |+.|+.... .+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---n~ 712 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---NQ 712 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---hH
Confidence 99999999999999998766655554444455789999999999999999999999999999998 556643222 22
Q ss_pred chHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
+.++.+ +.+.. -..+...+.+++.||..||+.+|.+||+++||-..|+......
T Consensus 713 EVIe~i----~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 EVIECI----RAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHH----HcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 233222 22222 2345667789999999999999999999999999998765443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=363.28 Aligned_cols=251 Identities=28% Similarity=0.399 Sum_probs=207.2
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-eeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 421 (674)
.+++..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|.... ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35566789999999999999974 6788999999543 3445678999999999999999999999999988 5999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
||++|+|+.++. ..+.+++...-+|+.+|++||.|||+.. +||||||||+|||++..|++||+|||.++.+-..
T Consensus 159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999984 3467999999999999999999999632 4999999999999999999999999999877433
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC--CCCccchHHHHHhhhcCCCcceeccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ--TDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .....+++.++.. +.+..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~----~ppP~---- 301 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD----EPPPR---- 301 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc----CCCCC----
Confidence 3456799999999999999999999999999999999999998875431 2233334433321 11111
Q ss_pred ccCCCCCh-hHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 580 NLTDSYSR-NEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 580 ~~~~~~~~-~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+. ....++.+++..||++||.+||++.|++++
T Consensus 302 -----lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 -----LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122 245578899999999999999999998863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=385.46 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=211.1
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..|...+.||+|||+.+|+++. ..|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 88999999999763 3455678899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
|+|++++|..++. ..+.+++.++..++.||+.||.|||+.+ |+|||||..|+||++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999884 5678999999999999999999999998 999999999999999999999999999987544
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. ....+.+|||.|+|||++.....+..+||||+|||||-||.|++||+-.. +.......+...
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~-------- 234 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNE-------- 234 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcC--------
Confidence 3 34456899999999999999999999999999999999999999975321 111111111111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
-.+|........+||..+|+.||.+|||+++|+..
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01223344567789999999999999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=366.72 Aligned_cols=198 Identities=33% Similarity=0.556 Sum_probs=178.9
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..+|...++||+|.||+||+|+++ ++.+||||.+.+. .....+.+..||.+|++++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999964 6799999999776 4555677889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC------CCeEEeeeCCc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE------MNPKISDFGMA 494 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~------~~~ki~DfGla 494 (674)
|||.||+|..+++ +.+.+++.....++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999995 4557999999999999999999999998 9999999999999765 45899999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCC
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~ 550 (674)
+.+.. .....+.+|++.|||||++...+|+.|+|+||+|+|+||+++|+.|+.
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 98863 334456799999999999999999999999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.91 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=202.3
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCcc-------CHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ-------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788899999999999999984 57999999999753211 1233579999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC---CCeEEeee
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDF 491 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~ki~Df 491 (674)
..||||||++||.|-+++. ..+.+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ -.+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999988884 4556888888899999999999999999 9999999999999766 67999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCC---CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
|+|+..+ ......+.+||+.|.|||++.... +..|+|+||+||+||-+++|.+||.-...+. .+.+++.
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~--- 395 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQIL--- 395 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHh---
Confidence 9999875 334566789999999999997654 3358999999999999999999975322221 1222221
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.... .+ ..-....++.++||.+||..||++|||+.|+++
T Consensus 396 -~G~y~f--~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 -KGRYAF--GP----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -cCcccc--cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111100 00 011234567889999999999999999999885
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=348.27 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=207.3
Q ss_pred cCCCcccccccCCcEEEEEee-cCCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEe-EEEeCCe-eEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLG-FCLEGEE-KILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~-~~~~~~~-~~lv 419 (674)
.+|++.++||+|.||+|||+. +.+|..+|.|.+.-. +....+....|+.+|++|+|||||++++ .+.++.+ +.||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468889999999999999998 568999999988632 3444567889999999999999999999 4444444 7899
Q ss_pred EEecCCCcccccccCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 420 YEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSR-LRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
||+|..|+|...+....+ +..+++..+|+++.|++.||.++|++-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999988865444 4458999999999999999999998431 23999999999999999999999999999988
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... .......+|||.||+||.+.+..|+.|+||||+||++|||..-++||.. .++++...+. ..+....+.
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g------~n~~~L~~KI-~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG------DNLLSLCKKI-EQGDYPPLP 249 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc------ccHHHHHHHH-HcCCCCCCc
Confidence 543 3345668999999999999999999999999999999999999999742 1344333322 222111111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..-....+..|+..|+..||+.||+...+++.+..
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 13445678889999999999999986666555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.91 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=206.4
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|+...++|+|+||+|||++.+ +|+.||||++.... +...+-..+||++|++++|+|+|.++.+|.......||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888999999999999999965 69999999986533 2334456799999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
||+..-|+++-. ....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+..
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 999988877653 3445899999999999999999999998 99999999999999999999999999998864
Q ss_pred CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC----------
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD---------- 570 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~---------- 570 (674)
.....+..+.|.+|+|||.+.+ .+|+..+|||++||++.||++|.+-|+. ....+++-.+.+...+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG---~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG---RSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC---cchHHHHHHHHHHHcccCHHHHHHhc
Confidence 3334566789999999999987 7899999999999999999999986543 3333444433332221
Q ss_pred -CCcce------eccc-ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 -GTPLQ------LLDT-NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 -~~~~~------~~d~-~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.... .-++ .+...++ ....-+++++..||+.||++|++-+|++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11100 0000 0111222 22336789999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=353.24 Aligned_cols=270 Identities=26% Similarity=0.375 Sum_probs=203.7
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHH--hcCCCceeeEEeEEEeCC----eeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVA--KLQHRNLVRLLGFCLEGE----EKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~h~niv~l~~~~~~~~----~~~lv 419 (674)
.....+.||+|+||.||||++ +++.||||++..... +.|++|-.+.+ .++|+||++|++.-..+. +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 455678899999999999999 569999999976544 45666655555 469999999999987766 89999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
+||.++|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+||||
T Consensus 287 t~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999 456799999999999999999999975 357899999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCC-CC-----ccccEEeechhhhHhHhCCCCCCccCCCC----------c
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-FS-----VKSDVYSFGVLVLEIITGKKNSNFYQTDG----------A 557 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DvwS~Gv~l~elltg~~p~~~~~~~~----------~ 557 (674)
|..+............+||.+|||||++.+.- +. .+.||||+|.|||||++.-.........+ .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99998777777777789999999999986542 22 46999999999999998664321100000 0
Q ss_pred cchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCC
Q 005846 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626 (674)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 626 (674)
-.-++..+......+..-.+...... ...+..+.+.+..||..||+.|.|+.=+-+.+.......+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 00111111111111110011111111 1345567899999999999999999998888877655444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=358.81 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=214.7
Q ss_pred hcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
...|....+||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4568888999999999999998 457889999999877777778889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
|++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999888 3445999999999999999999999998 99999999999999999999999999988754443
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.....+||+.|||||+.....|++|+||||||++++||+-|++|+-. ++-+...+.....+.+.-
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLIa~ng~P~l------- 489 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPKL------- 489 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHHhhcCCCCc-------
Confidence 45567999999999999999999999999999999999999998632 233444444444443321
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.|+++||++.|+|+
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 112334557889999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=324.30 Aligned_cols=277 Identities=26% Similarity=0.408 Sum_probs=221.0
Q ss_pred cCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.+|...++||+|.||.||+|+ ..+|+.||||+++.... .......+||+.|+.++|+||+.++++|-..+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999 45799999999865422 223456899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
||+ .+|+..+.+ +...++..++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 578777754 4557999999999999999999999998 9999999999999999999999999999987554
Q ss_pred CCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
..... .+-|.+|+|||.+.+. +|+..+||||.|||+.||+-|.+- ...+...+.+..+.+.+......+.-+-.
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~---fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF---FPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC---CCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 43322 3778999999998875 699999999999999999998864 34455566666666655544433322211
Q ss_pred cCCC--------------CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCCCCcee
Q 005846 581 LTDS--------------YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFF 634 (674)
Q Consensus 581 ~~~~--------------~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~ 634 (674)
-..+ .-.......++|+..+|..||.+|+++.|++++ .+..+.|.|+.|..+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~~l 296 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPSKL 296 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChhhC
Confidence 1111 111234456899999999999999999998864 566667777766544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=376.30 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=215.3
Q ss_pred hcCCCcccccccCCcEEEEEeecC----CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.....+.++||.|.||+|++|+++ ....||||.++... +....+|..|..+|.+++||||++|.|+.......+|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 345678899999999999999974 23468999998753 4456789999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|.|||+||+|+.||.. +.+++++.++..++++||.||.||-+.+ +|||||.++|||++.+..+||+||||++.+.
T Consensus 708 iTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999965 4467999999999999999999999888 9999999999999999999999999999886
Q ss_pred CCCCCCcc-ccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQGNT-SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.+.....+ ....-..+|.|||.+..++++.++||||||++|||.++ |.+|+- + |.+.+..+.
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW--d--------------mSNQdVIka 846 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--D--------------MSNQDVIKA 846 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc--c--------------cchHHHHHH
Confidence 55422222 11223679999999999999999999999999999987 667742 1 112222333
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
++...+...|++.+..+.+||+.|||+|-.+||++.+|+.+|.++
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 444455556777888999999999999999999999999999763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.02 Aligned_cols=242 Identities=27% Similarity=0.367 Sum_probs=200.9
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||+||.++. ++++.+|+|++++.. ....+....|..+|.+++||.||+++-.|.+.+.++||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46899999999999999999984 468889999997643 23456778999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+||+.||.|..+| ++++.+++..+.-++..|+.||.|||+++ ||||||||+|||||++|.++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999998 45678999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
. ...+.+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||.... ...+..+.....
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-------- 241 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc--------
Confidence 2 234455899999999999999999999999999999999999999975322 112221211111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERP 609 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 609 (674)
....+.-...+..+++...|+.||++|-
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0111112334677899999999999995
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.03 Aligned_cols=280 Identities=24% Similarity=0.371 Sum_probs=213.2
Q ss_pred hcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 418 (674)
.+.|+.+++||+|.||.|||++ ..+|+.||+|++.... ........+||.+|++|.||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568888999999999999999 4679999999997654 33445567999999999999999999998876 68999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|+|||++. |.-++. ...-.+++.++..++.|+++||.|+|+.+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99999764 444442 23456999999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
...... .+..+-|.+|+|||++.+. .|+.++|+||.||||.||++|++.+. .....+.+..+.+..........-
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~---G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ---GRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC---CccHHHHHHHHHHHhCCCChhccc
Confidence 655444 3445679999999999875 69999999999999999999998753 333444444444332221111100
Q ss_pred --c----ccc--CCCCCh-------hHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCCCCceee
Q 005846 578 --D----TNL--TDSYSR-------NEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFI 635 (674)
Q Consensus 578 --d----~~~--~~~~~~-------~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 635 (674)
+ ..+ ...+.. ......++|+..+|..||.+|.|+.++++ .+++...|.|..|..+.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF~t~p~~~~p~~Lp 416 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYFTTEPLPCDPSSLP 416 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--CcccccCCCCCCcccCC
Confidence 0 000 111111 12335678999999999999999999875 34555556666565543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.76 Aligned_cols=273 Identities=29% Similarity=0.466 Sum_probs=215.9
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 412 (674)
...+++++..+.+.+...||+|.||+||+|.|.+ .||||++.... ....+.|++|+..+++-+|.||+=|+|+|.+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4557788888889999999999999999999943 59999997643 4457889999999999999999999999998
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
... .||+.||+|.+|..++|..+ ..++..+.+.|+.||++||.|||.++ |||||||+.||+|.+++.+||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 777 99999999999999997643 56899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCcccccc---CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhc
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR 569 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 569 (674)
|+..-..-..........|...|||||+++. .+|++.+||||||+++|||+||..|+.....+. ++ |.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq---Ii------fm 604 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ---II------FM 604 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---eE------EE
Confidence 9865322222222334567889999999974 469999999999999999999999965221111 11 11
Q ss_pred CCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCC
Q 005846 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPS 627 (674)
Q Consensus 570 ~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 627 (674)
-++-.-..|.. ........++.+|+..||..++++||.+.+|+.+|+.....+|.
T Consensus 605 VGrG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 605 VGRGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred ecccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 11100000100 01223455788899999999999999999999998886555443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.17 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=203.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--eeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 421 (674)
.++...+.||+|.||.||++... +|+..|||.+........+.+.+|+.+|++++|||||+++|.....+ .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777889999999999999965 48999999987664444677899999999999999999999855444 6899999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeCCccccCC-
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGV- 499 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~~~~~- 499 (674)
|+++|+|.+++.... +.|++..+..+..||++||.|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999995422 27999999999999999999999998 999999999999999 79999999999987653
Q ss_pred CCCCCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
...........||+.|||||++.++. ...++|||||||++.||+||++|+... .+...+..........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence 11122334578999999999999643 335999999999999999999997532 1112222222222211
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
..++........+++.+|++.||++|||+++++..-
T Consensus 242 ----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 ----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 123344556788999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.77 Aligned_cols=253 Identities=30% Similarity=0.433 Sum_probs=207.4
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++..+....++-||.|+.|.||+|++ .++.||||+++... ..+|+-|++|+|+||+.|.|+|.....++|||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 33334445678899999999999999 57899999885432 45788999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
|||..|-|...|. .+..+.......|..+||.||.|||.+. |||||||+-||||..+..+||+|||-++.+...
T Consensus 192 EfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 192 EFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999994 4567889999999999999999999987 999999999999999999999999999876432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....+.||..|||||++++.+.++|+|||||||||||||||..|+.--.. ...+| .-+ ...
T Consensus 266 ---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIw---GVG------sNs 327 (904)
T KOG4721|consen 266 ---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIW---GVG------SNS 327 (904)
T ss_pred ---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------heeEE---ecc------CCc
Confidence 344567899999999999999999999999999999999999998531111 11111 111 112
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
+....+...+.-+.-|+++||+..|..||++++|+..|+-....+
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 223345555667778999999999999999999999997654443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=354.19 Aligned_cols=268 Identities=29% Similarity=0.440 Sum_probs=219.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+.......+.++||+|.||+|..+....+..||||+++..... ...+|.+||++|.+++||||++++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 4556778889999999999999999977899999999875544 458899999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+|||++|+|..|+...... .+......+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+..
T Consensus 614 ~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999643222 2466777889999999999999887 99999999999999999999999999998776
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh--CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt--g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
........+.+-..+|||||.+..++++.++|||+||+++||+++ ..+|+... ..++.++..-..++.+.....+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHHHHhhhhhcCCCCcceec
Confidence 666666666777899999999999999999999999999999875 45554322 2223333333333333222221
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..|.-.+..+.++++.||..|-++||+++++...|.+.
T Consensus 767 ------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 ------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12344556788999999999999999999999988764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=353.15 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=205.5
Q ss_pred hhcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHH--HHHHHHHHhcC-CCceeeEEeEEEeCC-eeE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF--KNEVVLVAKLQ-HRNLVRLLGFCLEGE-EKI 417 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-h~niv~l~~~~~~~~-~~~ 417 (674)
.-++|...++||.|.||.||+|+ ...|+.||||++++.... +++. .+|++.|++|. ||||+++..++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34688999999999999999998 457899999999775443 4443 47999999998 999999999999988 999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|||||+ -+|..++.+. ...+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||+||..
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999995 4677777553 678999999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCCccccccccCCccCccccc-cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
... .-.+..+.|.+|+|||++. .+-|+.+.|||++|||++||.+-++-|+... ..+.+-.+...+........
T Consensus 161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s---E~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS---EIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc---HHHHHHHHHHHhCCCccccc
Confidence 433 2345678899999999875 6789999999999999999999987654322 22222222222222111111
Q ss_pred cc-----------------cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 577 LD-----------------TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 577 ~d-----------------~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.. ..+..-.+ ....++++++.+|+++||++|||+.|.+++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 10 00111112 255678999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=358.17 Aligned_cols=263 Identities=30% Similarity=0.451 Sum_probs=204.8
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccCc-cCHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 412 (674)
++..++|++.++||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999963 2356799999875432 2345688999999999 89999999998876
Q ss_pred CC-eeEEEEEecCCCcccccccCCCc------------------------------------------------------
Q 005846 413 GE-EKILVYEFVPNKSLDYFLYDPEK------------------------------------------------------ 437 (674)
Q Consensus 413 ~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 437 (674)
.+ ..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 44 57899999999999888753211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcccccccc
Q 005846 438 -----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512 (674)
Q Consensus 438 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt 512 (674)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 234888999999999999999999987 999999999999999999999999999865433222222234567
Q ss_pred CCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHH
Q 005846 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVI 591 (674)
Q Consensus 513 ~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 591 (674)
..|+|||++.+..++.++|||||||++|||++ |..|+...... .. .......+.... .+.....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~---~~---~~~~~~~~~~~~---------~~~~~~~ 304 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---EE---FCQRLKDGTRMR---------APENATP 304 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc---HH---HHHHHhcCCCCC---------CCCCCCH
Confidence 88999999999999999999999999999997 88886532211 11 111111211111 1222345
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 592 RCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 592 ~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+.+|+.+||+.||++|||+.+|+++|++.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=337.00 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=208.0
Q ss_pred hcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.+.|+...+||.|..++||+|+ .+.++.||||++.-.. ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999999 5678999999996543 3336889999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
||.+|++.+++...... .+++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999988654433 4999999999999999999999998 9999999999999999999999999876554332
Q ss_pred CCC-cc-ccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 502 TQG-NT-SRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 502 ~~~-~~-~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... .. ...+||+.|||||+++. ..|+.|+||||||++..||.+|..|+.-+..- ......+.+ .+....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn-~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQN-DPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcC-CCCCcc
Confidence 221 12 56789999999999654 35999999999999999999999997543321 111111211 111111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
-..+..+........+.+++..||++||.+|||+++++..
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111122233467889999999999999999999853
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=375.65 Aligned_cols=262 Identities=32% Similarity=0.486 Sum_probs=211.8
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC--CCc----eeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP--SGQ----EIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
+...+....+.||+|.||.||+|... +|. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 33556777889999999999999853 233 4899999775 4566788999999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCC----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 415 EKILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
..+|++|||++|+|..||.+.+ ....|...+.+.++.|||+|+.||++++ +|||||..+|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999997542 1346899999999999999999999987 99999999999999999999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCC-CCCCccCCCCccchHHHHHhhhc
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-KNSNFYQTDGAADLLSYAWKQWR 569 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~-~p~~~~~~~~~~~~l~~~~~~~~ 569 (674)
||||+.+.............-..+|||||.+..+.++.|+|||||||+||||+|.. .|+. .....+++.... +
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~---~~~n~~v~~~~~---~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP---SRSNFEVLLDVL---E 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC---CcchHHHHHHHH---h
Confidence 99999655444433333333456999999999999999999999999999999955 4432 222223332221 1
Q ss_pred CCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 570 ~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.+ +-..+...+..+++||..||+.+|++||++..|+..+..+.
T Consensus 920 gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 920 GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 21 12234556678899999999999999999999999886643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=344.45 Aligned_cols=267 Identities=28% Similarity=0.403 Sum_probs=203.9
Q ss_pred hcCCCcccccccCCcEEEEEeecCC-----------------CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVR 405 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 405 (674)
.++|.+.++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678899999999999999997532 3369999987543 333567899999999999999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCcccccccCCC----------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 005846 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE----------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469 (674)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 469 (674)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999988874321 1134788999999999999999999988 99
Q ss_pred EeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCC
Q 005846 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 549 (674)
Q Consensus 470 HrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~ 549 (674)
||||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++..+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998654332222233345678999999999899999999999999999999854433
Q ss_pred CccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 550 NFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
++... ...+.+......+........ ...+...+..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 241 p~~~~-~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGEL-TDEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcC-CHHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 22221 122223222222221111000 00112234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=346.46 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=207.3
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 418 (674)
-++|...+.||+|+|++|++++. ..++++|||++.+. .+...+.+..|-..|.+| .||.|++|+.-|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46899999999999999999984 57899999998653 233344567788899999 89999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|+||+++|.|-.+|. +.+.+++.-...++.+|+.||+|||+.| ||||||||+|||||.||++||+|||-|+.+.
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999994 4578999999999999999999999998 9999999999999999999999999999885
Q ss_pred CCCCC---------Ccc--ccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh
Q 005846 499 VDQTQ---------GNT--SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 499 ~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
..... ... ...+||..|.+||++..+..+..+|+|+||||||+|+.|++||.... ..-..+.+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~~- 301 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQA- 301 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHHH-
Confidence 43222 111 45899999999999999999999999999999999999999974221 1111111110
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
++ -.++....+.+.+|+.+.|..||.+|+|..+|.+..
T Consensus 302 ---------l~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 ---------LD----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ---------hc----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 122333345778899999999999999999998763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.18 Aligned_cols=268 Identities=31% Similarity=0.425 Sum_probs=210.8
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecCC--C--ce-eEEEEecc---cCccCHHHHHHHHHHHHhcCCCceeeEEeE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPS--G--QE-IAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 409 (674)
..++...++....++||+|.||+||+|.+.. + .. ||||..+. .......+|.+|.++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445555666777999999999999999643 2 23 89998875 335567789999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEe
Q 005846 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (674)
Q Consensus 410 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~ 489 (674)
+...+.++||||+|+||+|+++|... ...++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999999542 336999999999999999999999998 9999999999999999999999
Q ss_pred eeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhh
Q 005846 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
||||++... ..........-+.+|+|||.+..+.|+.++|||||||++||+++ |..|+.. ....++..++ .
T Consensus 305 DFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g---~~~~~v~~kI---~ 376 (474)
T KOG0194|consen 305 DFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG---MKNYEVKAKI---V 376 (474)
T ss_pred ccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC---CCHHHHHHHH---H
Confidence 999987543 11111111234679999999999999999999999999999998 6666432 2222222222 1
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCC
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPS 627 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 627 (674)
.++.. ...+...+..+..++..||..+|++||+|.++.+.|+........
T Consensus 377 ~~~~r---------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 KNGYR---------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred hcCcc---------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 22211 122234456777888899999999999999999999886555443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=388.61 Aligned_cols=264 Identities=26% Similarity=0.492 Sum_probs=213.0
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
....+...+.||+|+||.||+|+. .++..||||++....... .+|++.+++++||||++++|++.+++..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345688889999999999999996 578999999986543222 356889999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++|+|.++++ .++|.++.+|+.||++||+|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999983 38999999999999999999996655569999999999999999988876 666543321
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.....|++.|||||++.+..++.|+|||||||++|||+||+.|++... ........|.+..+........+|+.+
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccc
Confidence 112367899999999999999999999999999999999999974322 223445566655544444444555555
Q ss_pred CC--CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 582 TD--SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 582 ~~--~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
.. ..+.++..++.+++.+||+.||++||+|+||+++|+.....
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 33 23446677889999999999999999999999999876443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.95 Aligned_cols=245 Identities=18% Similarity=0.326 Sum_probs=198.0
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccC---HHHHHHHHHHHHhcCCCceeeEEeEEEe----CCeeEEEEEe
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG---AEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEF 422 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 422 (674)
...||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78999999997654333 4678899999999999999999999877 3467899999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
+++|+|.+++.. ...+++...++++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999853 45689999999999999999999984 5 7899999999999999999999999998653221
Q ss_pred CCCccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.|+.... ..++..... ..+..
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~---~~~~~------ 240 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLII---NKNNS------ 240 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH---hcCCC------
Confidence 23467889999999976 689999999999999999999999975321 122222211 11110
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 241 ---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 ---LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 011222345688999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=336.75 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=206.9
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..|...+.||+|.||.||||.. ..++.||+|++.-. .....+++++|+.++.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577778999999999999995 46889999999653 445568899999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
|.+|++.+.+. .+..+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+|++|||++..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999883 3445688899999999999999999998 99999999999999999999999999987654433
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
...+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+.-... -+.+.++.....
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~P 228 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAP 228 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCC
Confidence 33668999999999999988999999999999999999999999532211 111222222222
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..........+.+++..||++||+.||++.++++.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22222344568899999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.42 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=203.9
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 412 (674)
+...++|++.++||+|+||.||++++ .++..||||+++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 44456899999999999999999863 245689999986533 33456788999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCCC--------------------------------------------------------
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPE-------------------------------------------------------- 436 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 436 (674)
++..++||||+++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999988875321
Q ss_pred ----------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 437 ----------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 437 ----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
....+++..+++++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 1125789999999999999999999987 999999999999999999999999999866433
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
..........++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ...... ....+...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~----~~~~~~~~----- 336 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYK----MIKEGYRM----- 336 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHH----HHHhCccC-----
Confidence 22222222345678999999999999999999999999999998 7766532211 111111 11111110
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+......+.+|+.+||+.||++||++.+|+++|+.
T Consensus 337 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 ----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0111123468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.64 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=214.7
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. ....+.+.+|++++++++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999964 57889999987643 3446678999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+.| +|..++. ..+.++++.+..|+.++..||.|||+.+ |+|||+||.||||+.++.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9987 9988884 4567999999999999999999999987 99999999999999999999999999997653
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.....+.+.|||.|||||+..++.|+..+|+||+|||+||+++|++||-. ..+.+.+.....++.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v--------- 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPV--------- 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCC---------
Confidence 23345668899999999999999999999999999999999999999631 222333332222211
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HhcCCCCCCCCCCCcee
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM--LNSYSVTLPSPQQPAFF 634 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~~p~~p~~~ 634 (674)
.++......+..++...|++||.+|.+-.+++.. .+........|..+.+.
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 1233455678889999999999999999998853 23333333444555543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.21 Aligned_cols=264 Identities=27% Similarity=0.423 Sum_probs=204.7
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 411 (674)
+....++|++.+.||+|+||.||+++. .++..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 344556899999999999999999873 234579999997543 23345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCC-------------------------------------------------------
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------- 436 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 436 (674)
.....++||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999988874311
Q ss_pred ------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 437 ------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 437 ------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
....+++.++++++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 1134788999999999999999999987 9999999999999999999999999998654332221
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|||||++.+..++.++|||||||++|||++ |+.|+...... ... +.....+.. .
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~----~~~~~~~~~---------~ 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKF----YKMVKRGYQ---------M 334 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHH----HHHHHcccC---------c
Confidence 2222345678999999999999999999999999999997 98886532211 111 111111100 0
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+++.+||+.||++||++.+|+++|++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11112235688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.78 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=205.3
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc----Cc-cCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA----SG-QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE 414 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 414 (674)
...++|...+.||+|.||.|+.|.. .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999974 46899999977653 22 33456778999999998 999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC-CCeEEeeeCC
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 493 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~ki~DfGl 493 (674)
..++||||+.+|.|.+++. ..+.+.+.....++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999984 3567999999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCC-CC-ccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-FS-VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. . +.....++.. .+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~---~~~~l~~ki~-~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---S---NVPNLYRKIR-KG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---c---cHHHHHHHHh-cC
Confidence 98763 2233445679999999999999877 86 789999999999999999999754 1 1111111211 11
Q ss_pred CcceecccccCCCCChhH-HHHHHHHHhhcccCCCCCCCCHHHHH
Q 005846 572 TPLQLLDTNLTDSYSRNE-VIRCIQLGLLCVQEDPAERPSMATIV 615 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~-~~~~~~li~~Cl~~dP~~RPt~~evl 615 (674)
.. .++... ...+..|+.+|+..||.+|+++.+|+
T Consensus 239 ~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Cc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 112222 56788999999999999999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.46 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=199.8
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999985 478999999986532 2223457889999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++|+|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998777432 2346899999999999999999999988 9999999999999999999999999998653221
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+........ ...........
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~---------- 220 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKED---------- 220 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcc----------
Confidence 12335789999999999999999999999999999999999999754322111 11111111110
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
...++......+.+|+.+||+.||++||+ ++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122233456788999999999999997 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.74 Aligned_cols=247 Identities=29% Similarity=0.389 Sum_probs=208.7
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.-|+..+.||.|+-|.|-.|++ .+|+.+|||++.+.. ......+.+||.+|+.+.||||+++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3577889999999999999985 579999999997653 222355789999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|-|.+++ ..++++++.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+-.
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 999999998888 46778999999999999999999999988 9999999999999999999999999997632
Q ss_pred CCCCccccccccCCccCccccccCCCC-ccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
......+.+|++.|.+||++.+.+|. .++||||.||||+.||||+.||+ ++....++..+.+ |.
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~----G~------- 228 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQR----GV------- 228 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHc----Cc-------
Confidence 22334556999999999999999985 79999999999999999999975 3333344433322 11
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
-.+|.....++.+|+.+|+..||++|.|++||++.
T Consensus 229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 11234455678899999999999999999999975
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=331.35 Aligned_cols=257 Identities=32% Similarity=0.500 Sum_probs=205.4
Q ss_pred cCCCcccccccCCcEEEEEeecCC------CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
++|++.+.||+|+||.||+|.... ...|++|.+.... ......|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478889999999999999998532 2578999886543 233467899999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC
Q 005846 418 LVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~ 484 (674)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999988854211 145889999999999999999999988 99999999999999999
Q ss_pred CeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHH
Q 005846 485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSY 563 (674)
Q Consensus 485 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~ 563 (674)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+..... .+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIE- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence 999999999986543332223334466889999999998999999999999999999998 8888642211 12211
Q ss_pred HHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 564 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.+..+.. ...+...+..+.+|+.+||+.||++||++.+|++.|++
T Consensus 238 ---~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 11123345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.80 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=202.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 58899999997532 233456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3456899999999999999999999988 99999999999999999999999999976532
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .+..... ..+... +...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i-~~~~~~-----~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENL-KYWKET-----LQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHH-Hhcccc-----ccCC
Confidence 23345789999999999999999999999999999999999999753221 1111111 111110 0000
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
............+.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001234567889999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.81 Aligned_cols=248 Identities=26% Similarity=0.357 Sum_probs=193.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|+..++||+|+||.||+++.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667889999999999999854 689999999865432 3346788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.... ..++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 3567788899999999999999988 99999999999999999999999999987643221
Q ss_pred CCccccccccCCccCcccccc-----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 503 QGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
......||..|+|||++.. ...+.++|||||||++|||++|+.|+......+ ........... ..
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~-~~---- 293 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMS-QP---- 293 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhcc-CC----
Confidence 1233578999999998743 234568999999999999999999976322211 11111111000 00
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
...+......+.+|+.+||+.||++||++.||++.
T Consensus 294 -----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112334568899999999999999999999863
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.52 Aligned_cols=258 Identities=30% Similarity=0.468 Sum_probs=207.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
...++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456799999999999999999998778889999986543 345678999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999985422 346899999999999999999999987 9999999999999999999999999998765222
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.. .......+..|+|||++.+..++.++||||||+++|||+| |+.|+... .....+... .....
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~----~~~~~------- 222 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM---TNAEVLQQV----DQGYR------- 222 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHH----HcCCC-------
Confidence 11 1111223458999999999899999999999999999999 88775421 111122111 11110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 --MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011222345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.79 Aligned_cols=274 Identities=25% Similarity=0.320 Sum_probs=204.2
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHH--hcCCCceeeEEeEEEe
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVA--KLQHRNLVRLLGFCLE 412 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~h~niv~l~~~~~~ 412 (674)
.++-..+....+....+.||+|.||+||+|.| .|+.||||++....+.. +.+|.++.. .|+|+||+.|++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhcccc
Confidence 33344566778899999999999999999999 68999999997655443 455555554 5699999999998765
Q ss_pred CC----eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCcEEEeecccccEEEcCC
Q 005846 413 GE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-----DSRLRIIHRDLKASNILLDAE 483 (674)
Q Consensus 413 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~iiHrDlkp~NIll~~~ 483 (674)
+. .+|||.+|.++|||.+|| +...++.+..++++..+|.||+|||. +|++.|.|||||++|||+..+
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 54 679999999999999999 34679999999999999999999995 478999999999999999999
Q ss_pred CCeEEeeeCCccccCCCCCC--CccccccccCCccCccccccCC------CCccccEEeechhhhHhHhCC---------
Q 005846 484 MNPKISDFGMARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMHGQ------FSVKSDVYSFGVLVLEIITGK--------- 546 (674)
Q Consensus 484 ~~~ki~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~k~DvwS~Gv~l~elltg~--------- 546 (674)
+.+.|+|+|||-....+... ......+||.+|||||++...- .-..+||||||+|+||+.-.-
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999876544221 2334568999999999986432 224699999999999996532
Q ss_pred -CCCCccCCCCccchHHHHHhhhcCCCcceecccccCC-CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 547 -KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD-SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 547 -~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.|+ ++......-.+... +-.-.+.+.+.+.. -.+.+.+..+.+||..||..+|.-|-|+--|-+.|.+..
T Consensus 433 ~~Py--yd~Vp~DPs~eeMr----kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 433 QLPY--YDVVPSDPSFEEMR----KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCc--ccCCCCCCCHHHHh----cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 222 21111111111111 11111111111111 123466778899999999999999999999998887654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=327.96 Aligned_cols=250 Identities=38% Similarity=0.593 Sum_probs=192.9
Q ss_pred cccccccCCcEEEEEeecC-----CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 349 TDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999875 35679999996533 33468899999999999999999999999988889999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++|+|.+++... ....+++..++.|+.||++||.|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999643 2457999999999999999999999987 99999999999999999999999999987633222
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
........+...|+|||.+....++.++||||||+++|||++ |+.|+... ...+..... ..+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~----~~~~~~------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL----KQGQRL------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH----HTTEET-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----cccccc-------
Confidence 222233456789999999999999999999999999999999 56664321 222222222 121111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
..+......+.+++..||+.+|++||++.+|++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11222345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.38 Aligned_cols=198 Identities=27% Similarity=0.372 Sum_probs=173.9
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999964 67889999886542 2334678999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999884 3346899999999999999999999853 3999999999999999999999999998765322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCC
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~ 550 (674)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2234568999999999999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.44 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=202.7
Q ss_pred hcCCCcccccccCCcEEEEEeecC----CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457889999999999999999753 356899999876432 334578899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|++++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999988532 346899999999999999999999987 9999999999999999999999999876532
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... ........++..|+|||.+.+..++.++|||||||++||+++ |+.|+.... ..+.+... .++..
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~~~~~----~~~~~---- 226 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIKAV----EDGFR---- 226 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHH----HCCCC----
Confidence 211 111112345678999999999999999999999999999875 888864321 11222211 11111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+...+..+.+++..||+.+|++||++.+|++.|+..
T Consensus 227 -----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011223345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=345.06 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=206.4
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCc-cCHHHHHHHHHHHHhcC-CCceeeEEeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCL 411 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~ 411 (674)
++...++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445678999999999999999999742 234799999965432 33467899999999996 999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCC-------------------------------------------------------
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------- 436 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 436 (674)
+....+|||||+++|+|.++++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999988875321
Q ss_pred --------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccE
Q 005846 437 --------------------------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (674)
Q Consensus 437 --------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NI 478 (674)
....+++..++.++.||++||.|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 0124788899999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCc
Q 005846 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGA 557 (674)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~ 557 (674)
|++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 999999999999999987643332222233456788999999999999999999999999999997 87776422111
Q ss_pred cchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
... +.....+... ..+......+.+++.+||+.||++||++.+|+++|+..
T Consensus 347 ~~~----~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 347 STF----YNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHH----HHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111 1111111111 11122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.46 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=206.7
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 346889999999999999999998888899999886533 3457889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999988542 3456899999999999999999999987 99999999999999999999999999987543221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
. ......++..|+|||++..+.++.++||||||+++|||+| |+.|+... ............+. .
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~~~~~~----~------- 223 (261)
T cd05072 159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM---SNSDVMSALQRGYR----M------- 223 (261)
T ss_pred e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC---CHHHHHHHHHcCCC----C-------
Confidence 1 1222345678999999998899999999999999999999 88776421 11222222211111 0
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.........+.+++.+||+.+|++||++++++++|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 --PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111233468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=309.85 Aligned_cols=236 Identities=29% Similarity=0.368 Sum_probs=197.9
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc---CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ---GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|+..+.||.|+||.|..++.+ +|..+|+|++++..-. ..+...+|..+|+.+.||.++++.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888999999999999999954 6888999999775432 2455678999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||.+||-|..+++ +.++++++...-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999994 5678999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
..+-+.+|||.|+|||++....+..++|.|+|||++|||+.|.+||...+. ....+.+ +...
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI------------~~~~ 257 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKI------------LEGK 257 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHH------------HhCc
Confidence 235568999999999999999999999999999999999999999743322 1111111 1111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCC
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAER 608 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~R 608 (674)
-.+|.-....+.+|+...|+.|-.+|
T Consensus 258 --v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 --VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12333344567788888899998888
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=329.91 Aligned_cols=260 Identities=28% Similarity=0.473 Sum_probs=203.1
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
+.+++|+..+.||+|+||.||+|.+. .+..||+|++.... .....++.+|+.+++.++|+||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998742 34679999886432 233456889999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEK-------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999988854221 234688899999999999999999987 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..|+... .....+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~---~~~~~~~~~-- 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM---SNEQVLRFV-- 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH--
Confidence 999999876543322222222345778999999998899999999999999999999 56665322 111222111
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
...... ..+......+.+++.+||+.+|++||++.|++++|++
T Consensus 235 --~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 --MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111110 1112233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=326.35 Aligned_cols=257 Identities=31% Similarity=0.502 Sum_probs=211.1
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
....+|+..++||.|+||.||+|...++..+++|.+........+++.+|+.+++.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44567999999999999999999988889999999987666567789999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999998653 3456899999999999999999999987 9999999999999999999999999997654322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+.... ..+.+.......+
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~----------- 222 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYR----------- 222 (261)
T ss_pred cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCc-----------
Confidence 11 123345678999999998899999999999999999998 777764321 1222222221110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
...+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 --MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11122334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.71 Aligned_cols=261 Identities=30% Similarity=0.482 Sum_probs=208.5
Q ss_pred cCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.+|...+.||+|+||.||+++.. ++..+++|.+........+.+.+|++.+++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999742 345689999876655556778999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC
Q 005846 419 VYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~ 485 (674)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999885421 1245899999999999999999999988 999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYA 564 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 564 (674)
++|+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |+.|+.... ....+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~--- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS---NTEVI--- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHH---
Confidence 99999999976543322222233456789999999999999999999999999999999 888753221 11121
Q ss_pred HhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 565 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
.....+..... +...+..+.+++.+||+.+|++||++.+|+++|++....
T Consensus 236 -~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 -ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11222221111 112345688999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.65 Aligned_cols=241 Identities=23% Similarity=0.279 Sum_probs=194.8
Q ss_pred cccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+.||+|+||.||+++. .+|+.||+|++++.. ......+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999987532 233456788999999999999999999999999999999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 506 (674)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 9988874 3457899999999999999999999988 999999999999999999999999998753211 1223
Q ss_pred ccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCC
Q 005846 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYS 586 (674)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 586 (674)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+... +......... .+. ..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~~~----~~~----------~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELIL----MEE----------IRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC---CHHHHHHHHH----cCC----------CCCC
Confidence 3457999999999999999999999999999999999999986421 1111111111 110 0112
Q ss_pred hhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 587 RNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 587 ~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 23345688999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.38 Aligned_cols=243 Identities=26% Similarity=0.357 Sum_probs=203.4
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 415 (674)
...-++|...++||+|.||+|+++.++ +++.+|||.+++.. ..+.+..+.|-.++... +||.|++++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999965 57789999998753 44556677888888777 59999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
+++||||..||++..+. ..+.+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954433 4567999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
..-. ....+.+++|||.|||||++.+..|+..+|.|||||+|||||.|+.||...+ .+++.+
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---Eee~Fd------------- 578 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---EEEVFD------------- 578 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHH-------------
Confidence 6431 2346778999999999999999999999999999999999999999975322 222222
Q ss_pred ecccccC--CCCChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 576 LLDTNLT--DSYSRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 576 ~~d~~~~--~~~~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
..+. ..||.....+.+.|+.++|.++|++|--+
T Consensus 579 ---sI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 ---SIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---HHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2221 12455566778899999999999999866
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.72 Aligned_cols=258 Identities=30% Similarity=0.497 Sum_probs=205.8
Q ss_pred hcCCCcccccccCCcEEEEEeecCC------CceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
.++|.+.+.||+|+||.||+|...+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568889999999999999998633 478999998765444 456899999999999999999999999999999
Q ss_pred EEEEEecCCCcccccccCCC-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC
Q 005846 417 ILVYEFVPNKSLDYFLYDPE-----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~ 485 (674)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999885321 2345889999999999999999999988 999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYA 564 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 564 (674)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+.... ....+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH
Confidence 99999999976533322222223356788999999999999999999999999999999 888853221 12222222
Q ss_pred HhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 565 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
. .+... ..+......+.+++.+||+.||++||++.||++.|++
T Consensus 238 ~----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 T----QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 11111 1112234568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.43 Aligned_cols=265 Identities=21% Similarity=0.257 Sum_probs=200.6
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999975 57889999986532 2335678899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|++++++..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988875542 2346899999999999999999999987 9999999999999999999999999998754322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHH--------HHhhh-cCCC
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY--------AWKQW-RDGT 572 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~--------~~~~~-~~~~ 572 (674)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.|+......+....+.. .++.+ ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 122345789999999999988999999999999999999999998753221110000000 00000 0000
Q ss_pred cceecccccC------CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLT------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~------~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......+... ..+.......+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0011113346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=319.38 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=201.8
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
++|++.+.||+|+||.||++.+.++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999888888999988643 3335678999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999888532 246899999999999999999999988 999999999999999999999999998765322211
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+.+........ ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~---~~~~~~~~i~~~~~----~~-------- 221 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVEMISRGFR----LY-------- 221 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCCC----CC--------
Confidence 1122235668999999988889999999999999999999 77775321 12222222221111 00
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
.+......+.+++.+||+.+|++||++.++++.|.
T Consensus 222 -~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 -RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.11 Aligned_cols=256 Identities=28% Similarity=0.480 Sum_probs=201.0
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCc----eeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
..+|+..+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 357999999999999999999853 333 38999986543 33456788999999999999999999998764 567
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998853 2345899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.............++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ..++. .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~----~~~~~~~~~-- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEIS----SILEKGERL-- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHH----HHHhCCCCC--
Confidence 54332222222334678999999999999999999999999999998 888864221 11111 111111100
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+++.+||+.+|++||++.+++..|...
T Consensus 231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01112234678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.37 Aligned_cols=245 Identities=25% Similarity=0.302 Sum_probs=199.3
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57889999999999999999964 58899999986532 233466889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999998884 3456899999999999999999999988 999999999999999999999999999865322
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+... ...... .....+..
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~----~~i~~~~~------- 232 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD---TPFRIY----EKILAGRL------- 232 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC---CHHHHH----HHHhcCCc-------
Confidence 22357899999999999999999999999999999999999996421 111111 11111111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~~ 617 (674)
.++......+.+++..||+.||.+||+ +++++..
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111122346789999999999999997 6777643
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=326.27 Aligned_cols=257 Identities=32% Similarity=0.470 Sum_probs=202.7
Q ss_pred cCCCcccccccCCcEEEEEeec-----CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++|++.++||+|+||.||+|.+ ..+..+++|.+.... ......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 356789999987533 3334678899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCC--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC
Q 005846 419 VYEFVPNKSLDYFLYDPE--------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~ 484 (674)
||||+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999998874221 1235889999999999999999999987 99999999999999999
Q ss_pred CeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHH
Q 005846 485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSY 563 (674)
Q Consensus 485 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~ 563 (674)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.... .......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence 999999999986543332222333446778999999988899999999999999999999 777753211 1111111
Q ss_pred HHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 564 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
. ...... ..+......+.+++.+||+.||++||++.+|.++|..
T Consensus 239 ~----~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111111 1122234567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=332.14 Aligned_cols=245 Identities=23% Similarity=0.289 Sum_probs=199.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999964 68899999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999998884 3456899999999999999999999988 999999999999999999999999999865321
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+.... ........ ..+..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i----~~~~~------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKI----LAGKL------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCc-------
Confidence 223568999999999998889999999999999999999999864321 11111111 11110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~~ 617 (674)
.++......+.+++.+||+.||.+||+ ++++++.
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112222346789999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=307.38 Aligned_cols=279 Identities=25% Similarity=0.349 Sum_probs=212.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccC--HHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQG--AEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 419 (674)
++|+.+++|++|.||.||+|+.+ +++.||+|+++...+.. --.-.+||.+|.+.+|||||.+-.+..-. +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57888999999999999999964 67889999997643221 22347899999999999999999887643 578999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||||+. +|..++... ..++...++..++.|+++|++|||.++ |+|||||++|+|+...|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999975 566666432 257899999999999999999999998 99999999999999999999999999998864
Q ss_pred CCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC------
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT------ 572 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~------ 572 (674)
. ....+..+-|.+|+|||++.+. .|+..+|+||+|||+.||+++++-+.. ....+.+..+.+.+..+.
T Consensus 230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G---~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG---KSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC---CchHHHHHHHHHHhCCCccccCCC
Confidence 4 3345567889999999999876 599999999999999999999986543 333344444433222111
Q ss_pred --cceec---------ccccCCCCChh-HHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCCCCceeec
Q 005846 573 --PLQLL---------DTNLTDSYSRN-EVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFIG 636 (674)
Q Consensus 573 --~~~~~---------d~~~~~~~~~~-~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~~ 636 (674)
....+ ...+...+... ....-.+|+...|..||.+|-|++|.+. ..+....|.|..|.++..
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPSMFPT 378 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChhhcCC
Confidence 00000 01111222221 2345678888899999999999999775 467777788887877643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=329.47 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=193.8
Q ss_pred cccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999999985 468999999987532 233456778999999999999999999999999999999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 506 (674)
+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9988774 3456899999999999999999999988 9999999999999999999999999987532211 122
Q ss_pred ccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCC
Q 005846 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYS 586 (674)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 586 (674)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ........ .... . .++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~~---~~~~-~----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELI---LMEE-I----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH---hcCC-C----------CCC
Confidence 34578999999999999999999999999999999999999864221 11111111 1110 0 112
Q ss_pred hhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 587 RNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 587 ~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 22345678999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.82 Aligned_cols=200 Identities=28% Similarity=0.389 Sum_probs=173.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..++|++.++||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999965 57888999886542 233467899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 83 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999884 3456899999999999999999999753 3999999999999999999999999998765321
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234689999999999988999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.20 Aligned_cols=260 Identities=30% Similarity=0.489 Sum_probs=206.6
Q ss_pred hcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46789999999999999999974 234568999987766555678999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCC----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 418 LVYEFVPNKSLDYFLYDPE----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999988885321 2235899999999999999999999987 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ....+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~~~~~~~--- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIEC--- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH---
Confidence 999999986543222222223345778999999998899999999999999999999 777753221 1111111
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
...+.... .+......+.+++.+||+.||.+|||+.+|+..|++..
T Consensus 235 -i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 -ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred -HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111111 01122346889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.56 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=203.5
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCc-cCHHHHHHHHHHHHhc-CCCceeeEEeEEEeC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG 413 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 413 (674)
...++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 44568999999999999999999632 347899999865332 2345678899999999 899999999988654
Q ss_pred -CeeEEEEEecCCCcccccccCCCc-------------------------------------------------------
Q 005846 414 -EEKILVYEFVPNKSLDYFLYDPEK------------------------------------------------------- 437 (674)
Q Consensus 414 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 437 (674)
...++++||+++++|..++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999888743211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCC
Q 005846 438 ---QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514 (674)
Q Consensus 438 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~ 514 (674)
...+++..+.+++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 136899999999999999999999987 99999999999999999999999999987643332222333456778
Q ss_pred ccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHH
Q 005846 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRC 593 (674)
Q Consensus 515 y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 593 (674)
|+|||++.+..++.++|||||||++|||++ |..|+...... +. .......+... ..+......+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~---~~~~~~~~~~~---------~~~~~~~~~~ 305 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EE---FCRRLKEGTRM---------RAPEYATPEI 305 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HH---HHHHHhccCCC---------CCCccCCHHH
Confidence 999999999999999999999999999998 88876432111 11 11111111111 1112234568
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 594 IQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 594 ~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+++.+||+.+|++||++.||+++|+..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.88 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=204.3
Q ss_pred hcCCCcccccccCCcEEEEEeecCC----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|++.+.||+|+||.||+|.+.. ...||||.++... .....+|.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999998642 3578999886543 3334678899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++.. ....+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999853 2347899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ........ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~----~~~~~~--- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAV----EDGYRL--- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH----HcCCCC---
Confidence 2222222222345678999999998999999999999999999998 887753211 11111111 111100
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=323.30 Aligned_cols=267 Identities=28% Similarity=0.398 Sum_probs=201.7
Q ss_pred CCcccccccCCcEEEEEeec-----CCCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEE
Q 005846 347 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 418 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 418 (674)
|+..+.||+|+||+||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999987642 3577899999875432 3456788999999999999999999988654 35789
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++.. ..+++.+++.++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998842 35999999999999999999999987 9999999999999999999999999998664
Q ss_pred CCCCCCc-cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
....... .....++..|+|||.+.+..++.++||||||+++|||+||..|+...... ..+.+.............+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence 3222111 12234566799999999889999999999999999999999886432211 111111111001111111111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
+.......+......+.+++..||+.+|++|||+++|+++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 22222222333456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.65 Aligned_cols=263 Identities=28% Similarity=0.418 Sum_probs=206.5
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 411 (674)
++...++|+..+.||+|+||.||++... ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3455678899999999999999999853 23578999887532 23345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCC-------------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccE
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NI 478 (674)
.+...+++|||+++|+|..++... .....+++..+++++.||+.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999888532 22456899999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCc
Q 005846 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGA 557 (674)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~ 557 (674)
|+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+.... .
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~ 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---V 240 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---H
Confidence 999999999999999987643322222222345678999999988899999999999999999998 777753211 1
Q ss_pred cchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+.. .....+.. ...+......+.+|+.+||+.||++|||+.++++.|++.
T Consensus 241 ~~~~----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 EELF----KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111 11111111 111223345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=345.84 Aligned_cols=252 Identities=17% Similarity=0.221 Sum_probs=203.0
Q ss_pred CCCcccccccCCcEEEEEeecC-C-CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-S-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.|.+.+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 3 5778888776555555567888999999999999999999999999999999999
Q ss_pred CCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 424 PNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 424 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999998887542 23446899999999999999999999987 99999999999999999999999999987654333
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....++... ... ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~---~~~~~~~~~---~~~-~~~-------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP---SQREIMQQV---LYG-KYD-------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH---HhC-CCC--------
Confidence 22334567999999999999999999999999999999999999996421 111111111 111 100
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++..||+.||++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111223346889999999999999999999874
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.24 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=191.9
Q ss_pred cccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
||+|+||.||++... +++.||+|++.+. .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 5788999998653 233446678899999999999999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcccc
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 508 (674)
.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 98884 3456899999999999999999999988 9999999999999999999999999997542221 22334
Q ss_pred ccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+... ...... ....... ..++..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~---~~~~~~---~~~~~~~-----------~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE---NVNEMY---RKILQEP-----------LRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC---CHHHHH---HHHHcCC-----------CCCCCc
Confidence 57999999999999999999999999999999999999996421 111111 1111110 011222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 589 EVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
....+.+++.+||+.||++||++..+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 335678999999999999998654443443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=328.06 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=211.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe-eEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-KILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 420 (674)
++|...+++|+|+||.++..+.+ ++..+++|.+.-. +....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998854 5678999988543 34445567899999999999999999999999988 89999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
+|++||+|.+.+... ++..++++++++|+.||+.|+.|||++. |+|||||+.||+++.+..+||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998653 3567999999999999999999999776 999999999999999999999999999998654
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|.. .+....+.+..+..
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a------~~m~~Li~ki~~~~--------- 222 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA------SNMSELILKINRGL--------- 222 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc------cchHHHHHHHhhcc---------
Confidence 4 234567999999999999999999999999999999999999988643 22223333332221
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
....+......+..++..|++.+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123344556688899999999999999999999976
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.47 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=195.0
Q ss_pred cccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+.||+|+||.||++.. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999985 468899999997532 233466788999999999999999999999999999999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 506 (674)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 9988774 3456899999999999999999999988 999999999999999999999999998753221 1122
Q ss_pred ccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCC
Q 005846 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYS 586 (674)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 586 (674)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ........ .... ..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~~~---~~~~-----------~~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELI---LMED-----------IKFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHHHHh---ccCC-----------ccCC
Confidence 34579999999999999999999999999999999999999974221 11111111 1110 0112
Q ss_pred hhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 587 RNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 587 ~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
......+.+++.+||+.||++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23345678999999999999997 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=324.81 Aligned_cols=266 Identities=27% Similarity=0.398 Sum_probs=201.3
Q ss_pred hcCCCcccccccCCcEEEEEeecCC---------------CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS---------------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLL 407 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~ 407 (674)
.++|++.++||+|+||.||++...+ ...||+|.+.... ....+.|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987532 2248999986542 33346789999999999999999999
Q ss_pred eEEEeCCeeEEEEEecCCCcccccccCCC---------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccE
Q 005846 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPE---------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (674)
Q Consensus 408 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NI 478 (674)
+++......++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999998885321 1124789999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCcc
Q 005846 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA 558 (674)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~ 558 (674)
++++++.+||+|||++..+.............++..|+|||++.++.++.++||||||+++|||+++..+..+.... ..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-DE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-hH
Confidence 99999999999999997654322222222334577899999999899999999999999999999854332222111 11
Q ss_pred chHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
+.+......+......... ..+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2222221112111100000 111123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=334.22 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=214.6
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeecCC-CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
.++++....+....++||-|.||.||.|.|+. .-.||||.++.+. ...++|..|..+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35666667788889999999999999999864 5679999997653 457899999999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.|||+|||..|+|.++|... +...++...++.++.||+.||.||..++ +|||||..+|+|+.++..+||+||||++
T Consensus 338 FYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999653 3445788888999999999999999988 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
+...+.+.. .....-...|.|||.+....++.|+|||+|||+||||.| |..|+. ..+. ..++..+
T Consensus 414 lMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP---Gidl----SqVY~LL------ 479 (1157)
T KOG4278|consen 414 LMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP---GIDL----SQVYGLL------ 479 (1157)
T ss_pred hhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC---CccH----HHHHHHH------
Confidence 875443322 112223578999999999999999999999999999998 444532 2221 2222222
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
+...+.+-+...+.++++||+.||+++|.+||++.||-+.++.
T Consensus 480 ---EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 480 ---EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ---hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 2233333455667789999999999999999999999988753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.30 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=197.3
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.++||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46899999999999999999854 68899999986533 22345678999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 77777642 2345889999999999999999999988 9999999999999999999999999997653222
Q ss_pred CCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc--------
Q 005846 503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP-------- 573 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~-------- 573 (674)
.......+++.|+|||.+.+ ..++.++|||||||++|||+||+.|+.... ..+.+............
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST---VKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHHhhcccc
Confidence 12233468899999998875 568999999999999999999999874322 12222222211111000
Q ss_pred ----ceecccccCC----CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 ----LQLLDTNLTD----SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ----~~~~d~~~~~----~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.....+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 000112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.30 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=204.4
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..+|...++||+|+||.||+|... .++.||+|++... .....++.+|++++++++|+||+++++++..+...++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 356888899999999999999864 5788999998654 33456789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999988532 2346899999999999999999999987 99999999999999999999999999986543221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
. ......++..|+|||++.+..++.++||||||+++|||++ |..|+... ...+. +.......
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~---~~~~~----~~~~~~~~--------- 222 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQV----YELLEKGY--------- 222 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHH----HHHHHCCC---------
Confidence 1 1112234568999999998999999999999999999998 77775422 11111 11111111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+...+..+.+++.+||+.+|++||++.+++++|+..
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111222345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.69 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=197.7
Q ss_pred CCCcccccccCCcEEEEEeec----CCCceeEEEEecccC----ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
+|++.++||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 357899999986532 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999988884 3456899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
+..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.|+.......... .........
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~---- 226 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC---- 226 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC----
Confidence 533222 222345799999999998765 47899999999999999999999975432222111 111111111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
++ ..+......+.+++.+||+.||++|| +++++++.
T Consensus 227 --~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 11222344678899999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=332.63 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=199.4
Q ss_pred hcCCCcccccccCCcEEEEEeecCC--CceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|++.+.||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578999999999999999998543 368999998643 22334668899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999998884 3456899999999999999999999988 9999999999999999999999999998653
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ...... . ...+..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~---~-i~~~~~----- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQ---K-ILEGII----- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHH---H-HhcCCC-----
Confidence 21 234579999999999998889999999999999999999999974221 111111 1 111110
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
.++......+.+++.+||+.||++|+ +++++++.
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222234577899999999999995 89988764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.93 Aligned_cols=264 Identities=25% Similarity=0.313 Sum_probs=210.1
Q ss_pred HhhcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----e
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----E 415 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~ 415 (674)
+..++|++.++||+|||+-||.++ ..++..+|+|++.-.+..+.+..++|++..++++||||++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 5678899999998777777888999999999999999999999886544 4
Q ss_pred eEEEEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 416 KILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
.||+++|...|+|.+.+.... ++..+++.++++|+.+|.+||.+||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999988775433 3447999999999999999999999986 57999999999999999999999999998
Q ss_pred cccCCCCCCCc-------cccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHH
Q 005846 495 RIFGVDQTQGN-------TSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYA 564 (674)
Q Consensus 495 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~ 564 (674)
........... -.....|..|.|||.+. +...++++|||||||+||+|+-|..||+....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 76532221111 11234688999999884 55688999999999999999999999763211
Q ss_pred HhhhcCCCcc--eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 565 WKQWRDGTPL--QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 565 ~~~~~~~~~~--~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+... .+....+.-.-.....+.+.+++..|++.||.+||++.+++..+.+.
T Consensus 247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 11111111111122567899999999999999999999999988753
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.93 Aligned_cols=265 Identities=30% Similarity=0.417 Sum_probs=206.0
Q ss_pred hcCCCcccccccCCcEEEEEeecCC-----------------CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVR 405 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 405 (674)
.++|++.++||+|+||.||++...+ +..||+|++.... ....+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999987532 2458999987543 334567889999999999999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCcccccccCCC--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
+++++..++..++++||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999885432 1236899999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh--CCCCCCccCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSNFYQTD 555 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt--g~~p~~~~~~~ 555 (674)
|+++.++.++|+|||+++...............++..|+|||++....++.++||||||+++|||++ |..|+.. .
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~---~ 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH---L 237 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC---c
Confidence 9999999999999999986543332222334456789999999998899999999999999999998 4444322 1
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
...+.+......++........+ .+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ChHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 12223333333322221111111 112233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.25 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=196.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.++||+|+||.||++... +++.||||++..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999964 688999999865432 223457889999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCCc-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9964 55555532 2356899999999999999999999988 9999999999999999999999999987543221
Q ss_pred CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc------
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL------ 574 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~------ 574 (674)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.|+.... +..+.+......+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK--DIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhCCCChhhccchh
Confidence 12233568899999998865 458899999999999999999999975321 1222222221111110000
Q ss_pred ---eecccccCCCCC---------hhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 ---QLLDTNLTDSYS---------RNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ---~~~d~~~~~~~~---------~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...........+ ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=324.28 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=201.4
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
+...++|+.+..||+|+||.||.++- .+|..+|+|++++.. ....+..+.|-.+|....++.||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44567899999999999999999984 479999999998753 33455677899999999999999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
||||||++||++..+| .+.+.|++.....++.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999998 46678999999999999999999999998 99999999999999999999999999854
Q ss_pred cCC----------------------CCCCC----c-------------------cccccccCCccCccccccCCCCcccc
Q 005846 497 FGV----------------------DQTQG----N-------------------TSRIVGTYGYMAPEYAMHGQFSVKSD 531 (674)
Q Consensus 497 ~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~k~D 531 (674)
+.. ..... . ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 311 00000 0 01257999999999999999999999
Q ss_pred EEeechhhhHhHhCCCCCCccCCCCccc-hHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC
Q 005846 532 VYSFGVLVLEIITGKKNSNFYQTDGAAD-LLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610 (674)
Q Consensus 532 vwS~Gv~l~elltg~~p~~~~~~~~~~~-~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt 610 (674)
+||||||+||||.|.+||.......... ++.|. ..|.... ......+..+||.+|+. ||++|--
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-ETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-hhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999975433222111 11111 0111100 01112467788888888 9999975
Q ss_pred ---HHHHHH
Q 005846 611 ---MATIVL 616 (674)
Q Consensus 611 ---~~evl~ 616 (674)
++||.+
T Consensus 436 ~~G~~EIK~ 444 (550)
T KOG0605|consen 436 SKGAEEIKK 444 (550)
T ss_pred cccHHHHhc
Confidence 666654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.65 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=201.5
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--------------ccCHHHHHHHHHHHHhcCCCcee
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--------------GQGAEEFKNEVVLVAKLQHRNLV 404 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~Ei~~l~~l~h~niv 404 (674)
-....++|++.+.||+|.||.|-+++. .+++.||||++.+.. ....+...+||.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 344567899999999999999999984 468999999996531 11246788999999999999999
Q ss_pred eEEeEEEe--CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC
Q 005846 405 RLLGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 405 ~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~ 482 (674)
+|+.+..+ .+..|||+|||..|.+...= .....++..+.+++++++..||+|||.++ ||||||||+|+||++
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99998765 35789999999998875432 22223999999999999999999999998 999999999999999
Q ss_pred CCCeEEeeeCCccccCCCCCC---CccccccccCCccCccccccCC----CCccccEEeechhhhHhHhCCCCCCccCCC
Q 005846 483 EMNPKISDFGMARIFGVDQTQ---GNTSRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555 (674)
Q Consensus 483 ~~~~ki~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwS~Gv~l~elltg~~p~~~~~~~ 555 (674)
+|++||+|||.+..+...... ......+|||.|||||...++. .+.+.||||+||+||.|+-|+.||.. +
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~ 322 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---D 322 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---c
Confidence 999999999999877433221 1234478999999999987743 45789999999999999999999631 1
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
..+....+ ++...+.-....++-..+.+|++++|++||+.|.+..+|....
T Consensus 323 ---~~~~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 323 ---FELELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ---hHHHHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11111111 1122221111224556788999999999999999999998765
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.22 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=201.5
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
++|.+.+.||+|+||.||++.+.++..+|+|.+.... ...+++.+|+.++.+++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999998777789999886433 345678999999999999999999999999889999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999988532 236899999999999999999999987 999999999999999999999999998865432211
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|++||.+....++.++||||||+++|||++ |+.|+..... .+..... ..+...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~--------- 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKV----SQGLRL--------- 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH----hcCCCC---------
Confidence 1112235678999999988889999999999999999999 8887643221 1111111 111110
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
..+......+.+++.+||+.+|.+||++.+|+..|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011122457889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=322.64 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=198.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCc----eeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++|++.+.||+|+||+||+|.+. +++ .+++|.+..... ....++..|+..++++.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888899999999999999863 344 477787754332 23456788888999999999999999875 456788
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
++||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 2346899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.... ...... .+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~----~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR---PHEVPD----LLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HHHCCCcCC--
Confidence 3332223334557789999999999999999999999999999998 887764221 111111 111111111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
. +......+.+++.+||..||++||++.|+++.|....
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0 1112245678999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=299.66 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=207.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
-++|++.+.||+|.||.||.|+.+ ++..||+|++.+. ......++.+|+++-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 468999999999999999999954 5778999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+||.++|.|...|.. ....++++.....++.|+|.||.|+|..+ +|||||||+|+|++.++..||+|||-+..-
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 999999999988854 24567999999999999999999999887 999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
........+||..|.+||...+..++.++|+|++|++.||++.|.+||.... ..+....+.+. ++
T Consensus 175 --p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~-------~~--- 239 (281)
T KOG0580|consen 175 --PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKV-------DL--- 239 (281)
T ss_pred --CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHc-------cc---
Confidence 2445567899999999999999999999999999999999999999976433 11222222111 11
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.++......+.++|..|+.++|.+|.+..|++..
T Consensus 240 ----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1223344567899999999999999999999863
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.53 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=201.5
Q ss_pred cCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.+|++.++||+|+||.||+|... .+..||+|+++..... ..+.+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35777899999999999999853 2478999999754332 2456889999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCC-------------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC
Q 005846 418 LVYEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~ 484 (674)
+++||+++++|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999998887421 11235889999999999999999999987 99999999999999999
Q ss_pred CeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHH
Q 005846 485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSY 563 (674)
Q Consensus 485 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~ 563 (674)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+... ...+.+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~---~~~~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQDVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Confidence 999999999886543322222233456789999999998899999999999999999998 66664321 11122211
Q ss_pred HHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 564 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
. ..+.. ...+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 239 i----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 I----RNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H----HcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11111 11122334567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.71 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=200.4
Q ss_pred CCcccccccCCcEEEEEeecCC----CceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe-----
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----- 415 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 415 (674)
|.+.+.||+|+||.||+|.+.. +..||+|+++... ....+.+.+|+..++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998632 3679999987532 2334678999999999999999999999876554
Q ss_pred -eEEEEEecCCCcccccccCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 416 -KILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 416 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999988875432 2346899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
|+++...............++..|+|||++....++.++||||||+++|||++ |..|+... ...+.+.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~---~~~~~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV---ENHEIYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHc----
Confidence 99987644332222222345678999999988899999999999999999999 77765321 12222222211
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
+... ..+......+.+++.+||+.||.+||++.+|+..|++.
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11223345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=323.20 Aligned_cols=264 Identities=28% Similarity=0.456 Sum_probs=201.6
Q ss_pred cCCCcccccccCCcEEEEEeec-----CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 417 (674)
++|++.+.||+|+||.||++.. .++..||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999874 35788999999776666667899999999999999999999987543 4678
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|+||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999998853 2346899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCCc-cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc---
Q 005846 498 GVDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP--- 573 (674)
Q Consensus 498 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~--- 573 (674)
........ .....++..|+|||++.+..++.++||||||+++|||++|..+...... .. .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~----~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA----EF----MRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch----hh----hhhccccccccc
Confidence 43322111 1112334569999999988999999999999999999998765321110 00 000000000
Q ss_pred -----ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 574 -----LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 574 -----~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+.+........+......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000010111111223345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=333.55 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=201.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999964 68999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999998853 357999999999999999999999987 999999999999999999999999999866433
Q ss_pred C---------------------------CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC
Q 005846 501 Q---------------------------TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553 (674)
Q Consensus 501 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~ 553 (674)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.|+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234578999999999999999999999999999999999999975322
Q ss_pred CCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 005846 554 TDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-MATIVLM 617 (674)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-~~evl~~ 617 (674)
. ........ .+.... .+ .........+.+++..|++ ||.+||+ ++++++.
T Consensus 235 ~---~~~~~~i~-~~~~~~--~~-------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 L---QETYNKII-NWKESL--RF-------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H---HHHHHHHh-ccCCcc--cC-------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 11111111 110100 00 0001124567889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=313.09 Aligned_cols=248 Identities=22% Similarity=0.388 Sum_probs=208.2
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..+|++.+.||+|.||.|-++.. ..|+.||||.+++. ++++.-.+.+||++|+.|+||||+.++.+|.+.+..+||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788899999999999999984 68999999999764 345556688999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||..+|.|.+++. ..+.|++.+...+++||..|+.|+|.+. ++|||||.+|||||+|+++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999994 5667999999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCCC-ccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
. ...++++|++-|.+||++.+..|. +.+|-|||||+||-|+.|.-||+..+ ...++.+ ...+...+.
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQ----Is~GaYrEP-- 273 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQ----ISRGAYREP-- 273 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHH----hhcccccCC--
Confidence 2 345678999999999999998875 79999999999999999999976432 2222222 222221111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
..+....-||.+||..||++|-|+.+|....
T Consensus 274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1222455789999999999999999998765
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.47 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=194.4
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.|+..+.||+|+||+||+++. .+++.||||++.... ....+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 467899999996532 2334568899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++|+|.+++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998884 3456899999999999999999999987 9999999999999999999999999986432110
Q ss_pred CC---------------------------------------------CccccccccCCccCccccccCCCCccccEEeec
Q 005846 502 TQ---------------------------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536 (674)
Q Consensus 502 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~G 536 (674)
.. ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001235799999999999988999999999999
Q ss_pred hhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhh--cccCCCCCCCCHHHH
Q 005846 537 VLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLL--CVQEDPAERPSMATI 614 (674)
Q Consensus 537 v~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~--Cl~~dP~~RPt~~ev 614 (674)
|++|||++|+.|+...... ...... ..+.. ...+ . ........+.+++.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~---~~~~~i-~~~~~--~~~~-~------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPT---ETQLKV-INWEN--TLHI-P------PQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHH---HHHHHH-Hcccc--ccCC-C------CCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999997532211 111101 01110 0000 0 001122345566655 666777789999999
Q ss_pred HHH
Q 005846 615 VLM 617 (674)
Q Consensus 615 l~~ 617 (674)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.65 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=193.1
Q ss_pred cCCCcccccccCCcEEEEEeec--CCCceeEEEEecccC--ccCHHHHHHHHHHHHhc---CCCceeeEEeEEEe-----
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLE----- 412 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~----- 412 (674)
++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4788999999999999999985 246789999886532 22234566777777766 69999999999863
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
....++||||++ ++|..++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 5777777432 2345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++|+..... .+.+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCC
Confidence 99865432 223345689999999999988999999999999999999999998753221 122222211110000
Q ss_pred cc----------eecccccC---CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PL----------QLLDTNLT---DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~----------~~~d~~~~---~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. ........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000000 0001122345679999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=345.09 Aligned_cols=259 Identities=26% Similarity=0.324 Sum_probs=211.4
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCC-ceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeE-EEe-----
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-QEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGF-CLE----- 412 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~----- 412 (674)
.+...++++.+.|.+|||+.||.+....+ .++|+|++-..++...+.+.+||++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 44566788899999999999999997665 999999998878888899999999999997 9999999993 322
Q ss_pred -CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 413 -GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 413 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
.-+.+|.||||.+|.|-+++.... ...|++.++++|+.++++|+++||... ++|||||||-+||||..+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 236789999999999999985433 344999999999999999999999985 78999999999999999999999999
Q ss_pred CCccccCCCCCCCcc-------ccccccCCccCcccc---ccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 492 GMARIFGVDQTQGNT-------SRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 492 Gla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
|.+............ -...-|+.|+|||.+ .+...++|+|||+|||+||-|+-...||+.
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~---------- 260 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE---------- 260 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc----------
Confidence 998754322211100 112458999999987 466799999999999999999999999642
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.-...+++....-.-......++..||..||+.||.+||++-+|+..+-.
T Consensus 261 ---------sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 261 ---------SGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ---------CcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 22334454444333334677899999999999999999999999987744
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.29 Aligned_cols=241 Identities=26% Similarity=0.361 Sum_probs=193.2
Q ss_pred cccccCCcEEEEEeec----CCCceeEEEEecccC----ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++||+|+||.||+++. ..++.||+|+++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999974 357889999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|..++. ..+.+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999988874 3456888999999999999999999988 9999999999999999999999999987542221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.......|++.|+|||++.+..++.++|||||||++|||++|+.|+.... ....+. .... +..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~---~~~~-~~~--------- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTID---KILK-GKL--------- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHH---HHHc-CCC---------
Confidence 12234578999999999998889999999999999999999999974321 111111 1111 110
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
..+......+.+++.+||+.||++|| ++.+++.
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11222334678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=322.61 Aligned_cols=257 Identities=30% Similarity=0.469 Sum_probs=203.4
Q ss_pred hcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
..+|+..++||+|+||.||++.. .++..+++|.+........+.+.+|+++++.++|+||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35678889999999999999963 235678999987766666778999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC
Q 005846 418 LVYEFVPNKSLDYFLYDPEK------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~ 485 (674)
+++||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999988854221 135899999999999999999999988 999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYA 564 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 564 (674)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+.-.. ..+.+...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~ 237 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS---NTEAIECI 237 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC---HHHHHHHH
Confidence 99999999976543222122223345788999999999999999999999999999998 777753211 11111111
Q ss_pred HhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 565 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
. .+... ..+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 238 ~----~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T----QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H----cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 11110 011122346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=316.81 Aligned_cols=248 Identities=28% Similarity=0.399 Sum_probs=194.6
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 68899999876533 33346789999999999999999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcccc
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 508 (674)
.+++.. ....+++..++.++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998843 2346899999999999999999999987 99999999999999999999999999875432211111111
Q ss_pred ccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCCh
Q 005846 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSR 587 (674)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 587 (674)
..++..|+|||.+.++.++.++||||||+++|||++ |..|+..... ....... .... ....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~~~----~~~~---------~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTREAI----EQGV---------RLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHHHH----HcCC---------CCCCcc
Confidence 123457999999999999999999999999999998 7776532211 1111111 1110 011122
Q ss_pred hHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 588 NEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 588 ~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
.....+.+++.+||+.+|++||++.+|.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.51 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=204.2
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecc--cCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe-----CC
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-----GE 414 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----~~ 414 (674)
....|...+.||+|+||.|+++.. .+|+.||||++.. .+....++..+|+++|+.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666688999999999999985 4789999999973 445556778899999999999999999998865 34
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++|+|+| +.+|...+. .+..|+...+..++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 677877773 3445999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccc-cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+...........+..+.|.+|.|||++. ...|+.++||||.|||+.||++|++-|..... .+.+..+......+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~---v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY---VHQLQLILELLGTPSE 249 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch---HHHHHHHHHhcCCCCH
Confidence 9876543333446778899999999886 45799999999999999999999987654432 2222222222211111
Q ss_pred cee--cc----------------cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 LQL--LD----------------TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ~~~--~d----------------~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+ +. ..+...++ ......++|+.+||..||.+|+|++|.++.
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 00 00001111 233467899999999999999999999864
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.52 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=206.6
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCC-----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe-CC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GE 414 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~ 414 (674)
+..++|.+.+.||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999999755 6889999886542 3335668899999999999999999998876 46
Q ss_pred eeEEEEEecCCCcccccccCCCcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEe
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQ-----GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~ 489 (674)
..++++||+++++|..++...... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999988543222 46899999999999999999999987 9999999999999999999999
Q ss_pred eeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhh
Q 005846 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+... ...+...+ .
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~~~~----~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---DPFEMAAY----L 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC---CHHHHHHH----H
Confidence 9999986543322222222345678999999988889999999999999999999 88886421 11122111 1
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
..+... ..+......+.+++.+||+.||++|||+.+++++|++...
T Consensus 233 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111100 0111223467899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.84 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=200.4
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.+|++.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+.++++++|+||+++++++......++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3578899999999999999998777789999886432 234578899999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|.+++... ...+++..++.++.||++||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 99999988532 336899999999999999999999988 999999999999999999999999999765322111
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+..... ..... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~---------~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESV----SAGYR---------L 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHH----HcCCc---------C
Confidence 1111223467999999999999999999999999999999 6777643221 1111111 11110 0
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
..+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11122345788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=322.12 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=205.8
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
+..++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++..+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34568899999999999999999853 24679999986543 233457889999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCC-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 415 EKILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
..++||||+++++|..++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 9999999999999998885422 1235789999999999999999999987 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||+++...............++..|+|||.+.++.++.++||||||+++|||+| |+.|+... .........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~---~~~~~~~~~-- 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL---SNEEVLKFV-- 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC---CHHHHHHHH--
Confidence 999999986643332222333456789999999998899999999999999999998 77775422 122222211
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+.... .+......+.+++.+||+.+|++|||+.+++..|++
T Consensus 235 --~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 --IDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 122234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=323.94 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=194.4
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||++... +++.||+|++++. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999854 5788999998753 223345677898888877 899999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence 99987773 3456999999999999999999999988 999999999999999999999999998753211 112
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCC--ccchHHHHHhhhcCCCcceecccccCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG--AADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~--~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ......+.+........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 334578999999999999999999999999999999999999975322211 11112222222211111
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCC------HHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPS------MATIVL 616 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt------~~evl~ 616 (674)
.++......+.+++.+||+.||++||+ +.+++.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 122233456789999999999999998 466653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=323.75 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=198.4
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|.+.+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999985 468899999997532 233456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988532 356999999999999999999999988 999999999999999999999999999876433
Q ss_pred CCCCccccccccCCccCccccc------cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.|+.... ....+. .........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~---~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT---SAKTYN---NIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC---HHHHHH---HHHcCCCcc
Confidence 221 223346899999999986 4567899999999999999999999964221 111111 111111111
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+ .......+.+|+..||+ +|.+||++.+++.
T Consensus 229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1100 11223467788889998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.38 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=205.2
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-- 414 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 414 (674)
.+...++|.+.+.||+|+||+||+++. .+|+.||||++... .......+.+|+..+..++|+|+++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557999999999999999999984 47899999998653 2334566789999999999999999988775432
Q ss_pred ------eeEEEEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 415 ------EKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 415 ------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3679999999999998885432 2346899999999999999999999987 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+... .....+. ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~~~~---~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEEVMH---KT 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHH---HH
Confidence 99999998765433333334567999999999999999999999999999999999999997421 1111111 11
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
. .+.. ...+......+.+++..||+.||.+||++.+++.+
T Consensus 258 ~-~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 L-AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred h-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1111 11122334578899999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.83 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=197.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999864 68899999996532 233456788999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999884 3456999999999999999999999988 999999999999999999999999998764321
Q ss_pred CCCC------------------------------------ccccccccCCccCccccccCCCCccccEEeechhhhHhHh
Q 005846 501 QTQG------------------------------------NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544 (674)
Q Consensus 501 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt 544 (674)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 005846 545 GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS---MATIVLM 617 (674)
Q Consensus 545 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt---~~evl~~ 617 (674)
|..|+.... ......... .+.. ...... .......+.+++.+|+. +|.+|++ +.+++..
T Consensus 235 G~~Pf~~~~---~~~~~~~i~-~~~~--~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDN---PQETYRKII-NWKE--TLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCC---HHHHHHHHH-cCCC--ccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999974321 111111111 1111 001000 00123456778888886 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.75 Aligned_cols=247 Identities=31% Similarity=0.464 Sum_probs=195.4
Q ss_pred ccccCCcEEEEEeec---CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 352 KLGEGGFGEVYKGVL---PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.+++.++|+||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 357889999986543 233567899999999999999999999875 55778999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC-c
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-N 505 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~-~ 505 (674)
+|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||.||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999884 3346899999999999999999999988 9999999999999999999999999998764332211 1
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+.... ........ ..+.. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~i----~~~~~---------~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK---GNEVTQMI----ESGER---------ME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HCCCC---------CC
Confidence 122234678999999988889999999999999999998 888864321 11222211 11111 11
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+......+.+++.+||+.||++||++.+|+..|+++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.74 Aligned_cols=255 Identities=31% Similarity=0.479 Sum_probs=203.4
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3457889999999999999999988888999999875433 3567899999999999999999999875 4568899999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999988542 2345899999999999999999999987 99999999999999999999999999986543221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.|+... ...+...... .+.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~---~~~~~~~~~~----~~~--------- 220 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQVE----RGY--------- 220 (260)
T ss_pred c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHH----cCC---------
Confidence 1 1122345678999999988899999999999999999999 77776421 1222222211 110
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
....+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=324.72 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=195.3
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||++... +++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999864 67899999997532 23345678899999988 799999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 99988773 3457999999999999999999999988 999999999999999999999999998742211 122
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCC--ccchHHHHHhhhcCCCcceecccccCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG--AADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~--~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|++.....+ ......+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 334679999999999999999999999999999999999999986432221 11111222222211110
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCC------HHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPS------MATIVL 616 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt------~~evl~ 616 (674)
..+......+.+++.+||+.||.+||+ +++++.
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112223456789999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.56 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=201.9
Q ss_pred CCCcccccccCCcEEEEEeecC------CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
+|++.+.||+|+||.||+|+.. ....+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999842 235688888865432 334678899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCC---------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 419 VYEFVPNKSLDYFLYDPE---------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998874321 1235889999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 9999999999999999986543322222223345678999999988889999999999999999999 887763221
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+ +....... ....+......+.+++..||+.+|++||++.+++..|++.
T Consensus 235 ~~~~----~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 235 PERL----FNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHHH----HHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1122 22111111 0111222345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=321.54 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=201.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecCC------CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
.+++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45679999999999999999998743 5678899886443 2334568999999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC---CeEE
Q 005846 416 KILVYEFVPNKSLDYFLYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKI 488 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~ki 488 (674)
.++||||+++++|.+++..... ...+++..+++++.||+.||.|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 235899999999999999999999987 99999999999998765 5999
Q ss_pred eeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhh
Q 005846 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..|+.... ..........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~---~~~~~~~~~~- 236 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT---NQEVMEFVTG- 236 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHc-
Confidence 99999986632222111222234568999999999999999999999999999997 877754221 1122211111
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
... ...+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 237 --~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 --GGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 1112233457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.49 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=196.3
Q ss_pred CCcccccccCCcEEEEEeecCCCc---eeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------Ce
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPSGQ---EIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------EE 415 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~ 415 (674)
|.+.++||+|+||.||+|++.++. .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999965432 5899988653 233456788999999999999999999987542 24
Q ss_pred eEEEEEecCCCcccccccCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 416 KILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
.++++||+++|+|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988763221 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+++...............+++.|++||++.+..++.++||||||+++|||++ |+.|+.. ......... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~---~~~~~~~~~----~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG---VENSEIYDY----LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHH----HHcC
Confidence 9987643322111222345778999999999999999999999999999999 6777532 111222222 2222
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.... .+......+.+++.+||+.||++|||+.+|++.|++
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111 111233467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=313.44 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=198.0
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe-----eEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-----KILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----~~lv 419 (674)
.|...+.+|.|+||.||+|++. +++.||||++-.+.... .+|+++|++++|||||+++-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5677889999999999999954 56899999986554322 568999999999999999998875432 3589
Q ss_pred EEecCCCcccccccC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC-CCeEEeeeCCcccc
Q 005846 420 YEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIF 497 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~ki~DfGla~~~ 497 (674)
||||+.. |...+.+ ...+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~t-L~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPET-LYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchHH-HHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 9999864 4444432 223456888888889999999999999987 9999999999999976 99999999999988
Q ss_pred CCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|. .+...+.+..+.+.+.-....++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp---G~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP---GDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC---CCCHHHHHHHHHHHhCCCCHHHH
Confidence 654433 234568899999999875 69999999999999999999998654 34455555555554443322221
Q ss_pred c----------cccc-----CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 577 L----------DTNL-----TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 577 ~----------d~~~-----~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
- .+.+ ..-+......+.++++.++++.+|.+|.++.|++.+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1 1111 111333455678899999999999999999998854
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.14 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=205.9
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCc-cCHHHHHHHHHHHHhcC-CCceeeEEeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCL 411 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~ 411 (674)
++...++|.+.++||+|+||.||++++. .+..||+|+++.... ...+.+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 5566678899999999999999999853 346799999975432 22456889999999997 999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCC-------------------------------------------------------
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPE------------------------------------------------------- 436 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 436 (674)
.....++|+||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999998885421
Q ss_pred ----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccc
Q 005846 437 ----------------------------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (674)
Q Consensus 437 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~ 476 (674)
....+++..+++++.||+.||.|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124678889999999999999999887 999999999
Q ss_pred cEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCC
Q 005846 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTD 555 (674)
Q Consensus 477 NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~ 555 (674)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986533222122223456789999999998889999999999999999998 7777543211
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+. .......+.. ...+......+.+|+.+||+.+|.+||++++|+..|+..
T Consensus 348 --~~~---~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 --NEQ---FYNAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --hHH---HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1111111110 011222345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=331.22 Aligned_cols=260 Identities=19% Similarity=0.228 Sum_probs=195.1
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
..++|++.++||+|+||.||++.. .+++.||+|.... +.+.+|+.++++++||||+++++++..+...++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 346799999999999999999985 4688999996532 346889999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
++. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 164 RYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred cCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 995 56766663 2346899999999999999999999987 999999999999999999999999999753221
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCC----CccchHHHHHhhhcCCC---cc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD----GAADLLSYAWKQWRDGT---PL 574 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~----~~~~~l~~~~~~~~~~~---~~ 574 (674)
.........||+.|+|||++.+..++.++|||||||++|||++|+.|+-..... .....+........... +.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 112233457999999999999999999999999999999999999774321110 01111111111110000 00
Q ss_pred -------eec---------ccccCCCC--ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 -------QLL---------DTNLTDSY--SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 -------~~~---------d~~~~~~~--~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.. .+...... .......+.+|+.+||+.||++|||++|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00000000 0123456889999999999999999999985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.33 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=193.6
Q ss_pred cccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999985 468899999987532 233456788999999999999999999999999999999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
+|..++. ....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9988774 34568999999999999999999997 56 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ......... .. . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~---~~~~~~~i~---~~-~----------~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELIL---ME-E----------IRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC---HHHHHHHHh---cC-C----------CCC
Confidence 234569999999999999999999999999999999999999874321 111111111 00 0 011
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
+......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 222344678899999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.95 Aligned_cols=265 Identities=28% Similarity=0.404 Sum_probs=201.4
Q ss_pred hcCCCcccccccCCcEEEEEeecC-----------------CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-----------------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVR 405 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 405 (674)
.++|++.++||+|+||.||++... ++..+|+|++.... ....+++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 23468999987543 334567899999999999999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCcccccccCCC--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
+++++..++..++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999998885422 1234788999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh--CCCCCCccCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSNFYQTD 555 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt--g~~p~~~~~~~ 555 (674)
||++.++.++|+|||+++.+.............++..|++||....+.++.++|||||||++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 9999999999999999986543322222223345678999999888899999999999999999999 4455432111
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.+.+......+......... ..+......+.+++.+||+.||++||++.+|++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 --EQVIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111111000000 0112233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=332.37 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=193.9
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----eeE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 417 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 417 (674)
+|++.++||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999985 46899999998643 2233456889999999999999999999886432 479
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+. ++|..++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 57777763 3446999999999999999999999988 999999999999999999999999999864
Q ss_pred CCCCCC-CccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh-------
Q 005846 498 GVDQTQ-GNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ------- 567 (674)
Q Consensus 498 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~------- 567 (674)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.|+..... ...+......
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Confidence 322211 12234578999999999865 6789999999999999999999998743221 1111111110
Q ss_pred ----hcCCCcceecc---c----ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 568 ----WRDGTPLQLLD---T----NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 568 ----~~~~~~~~~~d---~----~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+........+. . .+...+ ......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 0 000000 0123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.33 Aligned_cols=251 Identities=31% Similarity=0.420 Sum_probs=208.4
Q ss_pred CCCcccccccCCcEEEEEeecC--CCc--eeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+....++||+|.||+|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445688999999999999974 344 5799999876544 67889999999999999999999999887 7889999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
|.++.|+|.+.|++ .....|-......++.|||.||.||.+++ +|||||..+|+||-....+||+||||.+-++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999976 56677889999999999999999999987 999999999999999999999999999988766
Q ss_pred CCCCccc-cccccCCccCccccccCCCCccccEEeechhhhHhHhCCC-CCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 501 QTQGNTS-RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 501 ~~~~~~~-~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~-p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
....... ...-...|+|||.+.+..++.++|||+|||++|||+|+.. || ...+.-.+++.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW----------------~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW----------------VGCRGIQILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC----------------CCCCHHHHHHhcc
Confidence 5544322 2234668999999999999999999999999999999664 42 2222222334445
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+-.-.-+....++++++++.||..+|++|||+..|.+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 444444566778899999999999999999999999743
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.21 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=195.3
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.++||+|+||.||++.. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999985 468899999986532 233466888999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999998884 3456899999999999999999999988 999999999999999999999999999643211
Q ss_pred CCC------------C---------------------------------ccccccccCCccCccccccCCCCccccEEee
Q 005846 501 QTQ------------G---------------------------------NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSF 535 (674)
Q Consensus 501 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~ 535 (674)
... . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred chhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCC---CCHH
Q 005846 536 GVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER---PSMA 612 (674)
Q Consensus 536 Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R---Pt~~ 612 (674)
||++|||++|+.|+.... ..+.+.... .+.. ...+.+ .......+.+++.+|++ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~---~~~~~~~i~-~~~~--~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN---SHETYRKII-NWRE--TLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCC---HHHHHHHHH-ccCC--ccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999974321 112211111 1111 011100 00123456788888987 66665 5999
Q ss_pred HHHHH
Q 005846 613 TIVLM 617 (674)
Q Consensus 613 evl~~ 617 (674)
+++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.60 Aligned_cols=256 Identities=32% Similarity=0.491 Sum_probs=204.8
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
+..++|++.++||+|+||.||++..++++.||+|.+.... ...+++.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4457899999999999999999998889999999987543 34567899999999999999999999864 456899999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999887532 3456899999999999999999999987 9999999999999999999999999997654222
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.. ......++..|+|||++....++.++||||||+++|||++ |+.|+.... ..+.... .......
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~----~~~~~~~------ 222 (260)
T cd05067 157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQN----LERGYRM------ 222 (260)
T ss_pred cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHH----HHcCCCC------
Confidence 11 1122345678999999998899999999999999999999 888864221 1111111 1111110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+......+.+++.+||+.+|++||++++++..|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.52 Aligned_cols=256 Identities=29% Similarity=0.451 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.++|++.++||+|+||.||+|++.++..||+|+++... ...+.+.+|+.++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 46799999999999999999998777789999987533 34467899999999999999999999874 45678999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998532 2346899999999999999999999987 999999999999999999999999999766433211
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......++..|+|||++.+..++.++||||||+++|||+| |+.|+... ......... ..+..
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~---~~~~~~~~~----~~~~~--------- 221 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV----ERGYR--------- 221 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---ChHHHHHHH----hcCCC---------
Confidence 1222346678999999998999999999999999999999 66665321 111111111 11110
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
...+......+.+++.+||+.+|++||++.+++++|+.+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0112233456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.04 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=194.6
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.+|++.++||+|+||.||+++. .+++.||||++.+.. ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999985 458899999986532 233456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999884 3456889999999999999999999988 999999999999999999999999997533210
Q ss_pred CC-----------------------------------------CCccccccccCCccCccccccCCCCccccEEeechhh
Q 005846 501 QT-----------------------------------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539 (674)
Q Consensus 501 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l 539 (674)
.. ........||+.|||||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0011235799999999999999999999999999999
Q ss_pred hHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCC---CHHHHHH
Q 005846 540 LEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP---SMATIVL 616 (674)
Q Consensus 540 ~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP---t~~evl~ 616 (674)
|||++|+.|+..... .+..... ..+... ..+ .........+.+++.+|+ .+|.+|+ ++.+++.
T Consensus 235 yell~G~~Pf~~~~~---~~~~~~i-~~~~~~--~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTP---AETQLKV-INWETT--LHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCH---HHHHHHH-hccCcc--ccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999753221 1111111 111110 000 001112234556666665 4999999 8888875
Q ss_pred H
Q 005846 617 M 617 (674)
Q Consensus 617 ~ 617 (674)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=316.47 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=200.0
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.|+..++||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999985 468899999986532 1223457789999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998887532 2346899999999999999999999988 9999999999999999999999999997653222
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ..............
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~---~~~~~~~~~~~~~~---------- 220 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE---KVKREEVERRVKED---------- 220 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch---hhHHHHHHHHhhhc----------
Confidence 12234689999999999988999999999999999999999999753221 11111111111110
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
...++......+.+++.+||+.||++|| ++.+++..
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112223445678999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=312.35 Aligned_cols=259 Identities=22% Similarity=0.380 Sum_probs=205.3
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.++||+|+||.||+|+. .+++.||||.+.... ......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999985 468999999875422 233456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||+++++|..++.... +...+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988774322 2345899999999999999999999987 99999999999999999999999999886543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... .+....... .......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~-~~~~~~~----- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLCQK-IEQCDYP----- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc----ccHHHHHHH-HhcCCCC-----
Confidence 221 1223468889999999998889999999999999999999999863211 111111111 1111100
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 001122345688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.84 Aligned_cols=255 Identities=22% Similarity=0.252 Sum_probs=199.6
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
...++|++.++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999864 6889999998643 2233455788999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++|+|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999998884 235888899999999999999999987 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCCccCccccccC----CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+.... ...... ........
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~---~i~~~~~~ 265 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYS---KIMDHKNS 265 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHH---HHHcCCCc
Confidence 43221 122345799999999998643 48899999999999999999999974321 111111 11111111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAE--RPSMATIVLM 617 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPt~~evl~~ 617 (674)
....+ .......+.+++..||+.+|.+ ||++.+++..
T Consensus 266 ~~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11100 1123456788999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=305.36 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=202.2
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCcc--CHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCC-----
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRN-LVRLLGFCLEGE----- 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~----- 414 (674)
...|...++||+|.||+||+|+. .+|+.||+|++.-.... ......+|+.++++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788899999999999994 47889999998654332 2345688999999999999 999999998877
Q ss_pred -eeEEEEEecCCCcccccccCCCcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 415 -EKILVYEFVPNKSLDYFLYDPEKQ-GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 415 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
..++|+||+ ..+|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 788999999 45677777443221 35777889999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+|+.+..+.. ..+..++|..|+|||++.+. .|+...||||+|||+.||+++++-|.. ....+++..+.+.....
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG---~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG---DSEIDQLFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHHHcCCC
Confidence 9997654332 34556889999999999877 699999999999999999998876543 22344444444433222
Q ss_pred C---ccee-----cccccCCCC-----Ch---hHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 572 T---PLQL-----LDTNLTDSY-----SR---NEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 572 ~---~~~~-----~d~~~~~~~-----~~---~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
. +... .+....... .. .......+++.+|++.+|.+|.|++.++.+
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 1111 010110000 00 111367899999999999999999998864
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=323.02 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=192.5
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHH---HhcCCCceeeEEeEEEeCCeeEEE
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLV---AKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
|++.+.||+|+||.||++... +++.||||++++.. ....+.+.+|+.++ +.++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999854 68899999997532 22345566676655 566899999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|..++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987773 346999999999999999999999988 99999999999999999999999999875322
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.|+.... ..+.+... .....
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i----~~~~~------ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSI----VNDEV------ 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCC------
Confidence 1 122334679999999999999999999999999999999999999964321 11111111 11110
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
.++......+.+++.+||+.||.+|| ++.++++
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11222345678899999999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=315.11 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=194.0
Q ss_pred cccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
||+|+||+||++... +++.||+|.+..... ...+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 688999999865322 2335678899999999999999999999999999999999999999
Q ss_pred cccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccc
Q 005846 429 DYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507 (674)
Q Consensus 429 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 507 (674)
..++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 87774322 3456899999999999999999999988 99999999999999999999999999976543222 223
Q ss_pred cccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCCh
Q 005846 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSR 587 (674)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~ 587 (674)
...|++.|+|||++.+..++.++||||||+++|||++|+.|+........ . .......... . ..++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~--------~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N-KELKQRILND--------S--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--H-HHHHHhhccc--------C--CCCcc
Confidence 45789999999999999999999999999999999999999753221110 0 1111110000 0 01222
Q ss_pred hHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 588 NEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 588 ~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
.....+.+++..||+.||++|| ++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3445788999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.90 Aligned_cols=238 Identities=26% Similarity=0.295 Sum_probs=191.1
Q ss_pred cccccCCcEEEEEeec----CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 351 NKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|++++++++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 367899999997532 2234457789999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|..++. +...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999988884 3456899999999999999999999988 9999999999999999999999999987643221 1
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
......|++.|+|||.+.+..++.++|||||||++|||++|+.|+... .....+... .... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~---~~~~~~~~i---~~~~-----------~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMI---LKAK-----------LG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC---CHHHHHHHH---HcCC-----------CC
Confidence 223457899999999999888999999999999999999999986432 111122111 1110 01
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMAT 613 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~e 613 (674)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12223346778999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.58 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=198.0
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|+..+.||+|+||.||+++. .+++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 468899999986542 33346788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 4788899999999999999999988 999999999999999999999999999765322
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+.......................... +
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~- 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----L- 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----C-
Confidence 22335789999999999998999999999999999999999999754322211111001111111111100 0
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
........+.+++.+||+.+|++||+++++++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011223467899999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.43 Aligned_cols=200 Identities=27% Similarity=0.368 Sum_probs=173.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|+..+.||+|+||+||++... +++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999854 58899999996532 223456788999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999884 3457999999999999999999999988 999999999999999999999999998754321
Q ss_pred CCC---------------------------------CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCC
Q 005846 501 QTQ---------------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547 (674)
Q Consensus 501 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~ 547 (674)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCC
Q 005846 548 NSN 550 (674)
Q Consensus 548 p~~ 550 (674)
|+.
T Consensus 235 Pf~ 237 (363)
T cd05628 235 PFC 237 (363)
T ss_pred CCC
Confidence 974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.07 Aligned_cols=262 Identities=29% Similarity=0.455 Sum_probs=203.8
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
++..++|++.++||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345678999999999999999998743 245799998864432 2334678899999999999999999999999
Q ss_pred CeeEEEEEecCCCcccccccCCC-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCe
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 486 (674)
...++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 99999999999999999985421 1234677889999999999999999987 9999999999999999999
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHH
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~ 565 (674)
||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..|+... ...+......
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~---~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL---SNEQVLKFVM 235 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHH
Confidence 9999999986543322222222345678999999999999999999999999999999 56665321 1112222111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+... ..+......+.+++.+||+.||++||++.++++.|++.
T Consensus 236 ----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 ----DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ----cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11100 01122235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.91 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=192.5
Q ss_pred cccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||++.. .+++.||+|++++.. ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 457889999997542 23345678899999888 699999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 99988773 3456999999999999999999999988 999999999999999999999999998753211 112
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...............+........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CC
Confidence 23457999999999999999999999999999999999999998543322222222233322222110 11
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
+......+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22233467889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=330.75 Aligned_cols=199 Identities=26% Similarity=0.378 Sum_probs=170.7
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.|+..++||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999985 467889999986532 2334568899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999988843 356889999999999999999999988 9999999999999999999999999975432100
Q ss_pred C---------------------------------------------CCccccccccCCccCccccccCCCCccccEEeec
Q 005846 502 T---------------------------------------------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536 (674)
Q Consensus 502 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~G 536 (674)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234799999999999999999999999999
Q ss_pred hhhhHhHhCCCCCC
Q 005846 537 VLVLEIITGKKNSN 550 (674)
Q Consensus 537 v~l~elltg~~p~~ 550 (674)
|++|||++|+.|+.
T Consensus 236 vil~elltG~~Pf~ 249 (382)
T cd05625 236 VILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.30 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=203.7
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC--------CCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
++..++|.+.+.||+|+||.||++... ++..+|+|.+.... .....++.+|+.++.++ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344568999999999999999998742 23469999987542 33456788899999999 799999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
..+...++||||+++++|.+++..... ...+++.++++++.||+.||+|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 999999999999999999999854321 235899999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 9999999999999999876543221111222234568999999998899999999999999999998 777753211
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+.... ....... ..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 248 ~~~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 248 VEELFKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHHHH----HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 1111111 11222345778899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.70 Aligned_cols=258 Identities=20% Similarity=0.238 Sum_probs=198.5
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
.+....++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999964 5788999998642 2223456789999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++||||+++|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999884 235889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccC----CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
+...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.|+.... .... .......
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~---~~~i~~~ 262 (370)
T cd05621 190 MKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGT---YSKIMDH 262 (370)
T ss_pred eecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHH---HHHHHhC
Confidence 8754221 1122345799999999998653 37899999999999999999999974321 1111 1111111
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAE--RPSMATIVLM 617 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPt~~evl~~ 617 (674)
.....+.+ .......+.+++..|++.++.+ ||++.|+++.
T Consensus 263 ~~~~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111100 1122345667888888755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=321.91 Aligned_cols=240 Identities=28% Similarity=0.380 Sum_probs=188.7
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||++... +++.||+|+++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57889999987532 22334556677777654 899999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99988874 3456899999999999999999999987 9999999999999999999999999997543222 22
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ...++... .... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~i----~~~~----------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSI----LNDR----------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCC----------CCC
Confidence 334579999999999999899999999999999999999999975321 11111111 1111 111
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMA-TIV 615 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~-evl 615 (674)
+......+.+++.+||+.||.+||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222334677899999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.23 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=205.3
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec--------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
+...++|.+.+.||+|+||.||+++. .++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 34466888999999999999999963 124578999886532 34456789999999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
......++||||+++++|.+++.... ....+++.+++.++.||++||.|||+.+ ++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 99999999999999999999886432 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+... .
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---P 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC---C
Confidence 9999999999999999987644332222333445678999999998889999999999999999998 66664321 1
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..++.. ....+... ..+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 245 ~~~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 VEELFK----LLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 111111 11111111 11122345688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=321.60 Aligned_cols=237 Identities=25% Similarity=0.316 Sum_probs=186.7
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||+||+++.. +|+.||+|++.+.. .....++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986532 222334455544 56789999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 99988874 3456899999999999999999999988 999999999999999999999999998753221 122
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+... +..+.... .... . . . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~---~~~~~~~~---i~~~-~-~-----~----~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DTAEMYDN---ILNK-P-L-----R----L 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC---CHHHHHHH---HHcC-C-C-----C----C
Confidence 33457899999999999999999999999999999999999986422 11111111 1111 0 0 0 1
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMA 612 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~ 612 (674)
+......+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112245688999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.27 Aligned_cols=259 Identities=29% Similarity=0.485 Sum_probs=203.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
..++|+..+.||+|+||.||++... ++..||+|++.... .....++.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567999999999999999999853 46789999986543 2334678899999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCC-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccc
Q 005846 416 KILVYEFVPNKSLDYFLYDPE-------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~ 476 (674)
.++|+||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999998885321 1235788999999999999999999987 999999999
Q ss_pred cEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCC
Q 005846 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTD 555 (674)
Q Consensus 477 NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~ 555 (674)
||+++.++.++|+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--- 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--- 236 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 99999999999999999876543322222222345678999999998899999999999999999998 66664211
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
...+.+. ....+... ..+......+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 237 ~~~~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIY----YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 11111111 1112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=313.10 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=200.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.++||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++++..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999995 46788999998765555556788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 99999998884 2356899999999999999999999987 9999999999999999999999999998653221
Q ss_pred CCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.|+........ .. .+.... ...+
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~-----~~~~~~---~~~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF-----LMSKSN---FQPP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he-----eeecCC---CCCC
Confidence 1122346888999999874 34578899999999999999999988632111100 00 000000 0000
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
.... .......+.+++.+||+.+|++||++++|++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1100 112335788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=322.46 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=192.8
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 57899999987532 23345577888888876 899999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99988874 3456899999999999999999999988 9999999999999999999999999987542221 22
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ....+... ... .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i---~~~-~~----------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESI---LHD-DV----------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHH---HcC-CC----------CC
Confidence 334578999999999999899999999999999999999999975322 12222211 111 10 01
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCC-------CHHHHHHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERP-------SMATIVLM 617 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RP-------t~~evl~~ 617 (674)
+......+.+++..||+.||++|| ++.++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111234678899999999999999 78887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=312.10 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=194.2
Q ss_pred ccccCCcEEEEEeecC---CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCc
Q 005846 352 KLGEGGFGEVYKGVLP---SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 427 (674)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 355799999866533 33467899999999999999999999875 457899999999999
Q ss_pred ccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc-c
Q 005846 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-T 506 (674)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~-~ 506 (674)
|.+++.. ....+++..+++++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9988853 2456899999999999999999999987 99999999999999999999999999986543322111 1
Q ss_pred ccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
....++..|+|||.+....++.++||||||+++|||++ |+.|+... ...+... ....+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~~~----~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM---KGPEVMS----FIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC---CHHHHHH----HHHCCCC---------CCC
Confidence 11233578999999988889999999999999999996 88886421 1111111 1111111 111
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=312.13 Aligned_cols=258 Identities=23% Similarity=0.402 Sum_probs=206.9
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999975 7899999988642 2233567889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||+++++|..++.... ....+++.+++.++.++++||.|||+.+ ++||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998875432 2345899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .+..... .....+..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~~------ 225 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLC-KKIEKCDY------ 225 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHH-hhhhcCCC------
Confidence 221 1223468889999999998899999999999999999999999864221 1111111 11111110
Q ss_pred ccCCCCCh-hHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 580 NLTDSYSR-NEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 580 ~~~~~~~~-~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+. .....+.+++.+||+.+|++||++.+|+++|++.
T Consensus 226 ---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 ---PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111 3345678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=321.82 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=204.2
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 412 (674)
....++|.+.+.||+|+||.||++.. ..+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 34456799999999999999999873 134579999887543 23346789999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
.+..++||||+++++|..++... ....+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999988532 2234899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... ........ ..+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~~~----~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYKLI----KEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHHHH----HcC
Confidence 9986543322111222345778999999999999999999999999999998 8877532111 11111111 111
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.. ...+......+.+++.+||+.+|++||++.+|++.|++
T Consensus 261 ~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 YR---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred Cc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 10 01111223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.77 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=200.2
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCc----eeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|+..++||+|+||+||+|.+ .++. .||+|++.... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45788899999999999999985 3444 47999886543 3345678899999999999999999999875 4567
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+++||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999988853 2346899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+... +..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~----~~~~~~~~- 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDL----LEKGERLP- 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HHCCCcCC-
Confidence 53332222222345678999999998899999999999999999998 777754221 1111111 11111110
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+......+.+++.+||+.||++||++.+++..|+..
T Consensus 232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1112334678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.43 Aligned_cols=240 Identities=23% Similarity=0.294 Sum_probs=187.8
Q ss_pred cccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+++. .+|+.+|+|++.+.. ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468899999986532 222344555554 56778999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99987773 3457899999999999999999999988 999999999999999999999999998753211 122
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+... +...+.. ..... .. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~---~~~~~~~---~~~~~-~~------~----~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR---DVAEMYD---NILHK-PL------V----L 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC---CHHHHHH---HHHcC-Cc------c----C
Confidence 33457999999999999999999999999999999999999986422 1111111 11111 00 0 1
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMATIV 615 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~evl 615 (674)
+......+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 112334677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.01 Aligned_cols=241 Identities=27% Similarity=0.350 Sum_probs=192.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCC-ceeeEEeEEEeCCeeEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 420 (674)
+|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|+.++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999864 5678999998753 223446678899999999764 6888999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988874 3456899999999999999999999987 999999999999999999999999998753211
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.|+... ...+.+.... ...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~i~----~~~-------- 217 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQSIM----EHN-------- 217 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHH----cCC--------
Confidence 1 1233457899999999999999999999999999999999999997422 1122222111 110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
..++......+.+++.+||+.||.+|++.
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122234467889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.51 Aligned_cols=258 Identities=33% Similarity=0.509 Sum_probs=207.4
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
+..++|.+.++||+|+||.||++..+++..||||.+.... ...+++.+|+.++++++|+||+++++++..+...++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567899999999999999999998788889999987543 345678999999999999999999999998889999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999998542 2346899999999999999999999988 9999999999999999999999999998664321
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+... .....+......+..
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~---~~~~~~~~~~~~~~~---------- 223 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQVERGYRM---------- 223 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC----------
Confidence 1 11112234568999999998899999999999999999999 88776321 112222222111110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 224 ---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 11112245688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.31 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=200.2
Q ss_pred cCCCcccccccCCcEEEEEeecCC-C---ceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..|++.+.||+|+||.||+|.+.. + ..||||.+... ......+|.+|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999998643 2 35999998754 333456799999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++.. ..+.+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998853 2356899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCCCcccccc---ccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 500 DQTQGNTSRIV---GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 500 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
........... .+..|+|||++....++.++||||||+++||+++ |+.|+.... ..+........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~~~~~~----- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDYRL----- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCcC-----
Confidence 22211111111 2457999999999999999999999999999887 888753211 11222222111100
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+.+.+..+.+++..||+.+|.+||++.+|+.+|+.
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.22 Aligned_cols=257 Identities=29% Similarity=0.507 Sum_probs=202.6
Q ss_pred hcCCCcccccccCCcEEEEEeecCC-C---ceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|+..+.||+|+||.||+|+... + ..+++|.+.... ....+.+.+|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999998642 3 368999886542 3345678999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|..++.. ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998853 2356899999999999999999999987 9999999999999999999999999997664
Q ss_pred CCCCCCcc-ccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQGNT-SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
........ .....+..|+|||++....++.++||||||+++|||++ |+.|+.... ..+..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~~~~~i----~~~~---- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKAI----NDGF---- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHH----hcCC----
Confidence 32221111 11223457999999998899999999999999999998 888864221 11111111 1111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011122345688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.66 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=191.1
Q ss_pred cccccCCcEEEEEeecCC---CceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998533 45789998865432 33457889999999999999999999999999999999999999
Q ss_pred cccccccCCCc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 427 SLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 427 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99998854321 234677888899999999999999987 9999999999999999999999999987543322222
Q ss_pred ccccccccCCccCccccccC-------CCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 505 NTSRIVGTYGYMAPEYAMHG-------QFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
......++..|+|||++... .++.++||||||+++|||++ |+.|+..... .+....... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYTVR----EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHhh----cccCCC
Confidence 22334578899999988542 35789999999999999996 9888743221 122222111 111111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
.++.+.. .....+.+++..|| .+|++|||+++|++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1222111 12235667888899 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.92 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=202.0
Q ss_pred cCCCcccccccCCcEEEEEeec-----CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cee
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 416 (674)
..|++.++||+|+||.||++.+ .++..||+|.++... ....+.+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999873 357889999987543 33356789999999999999999999998775 568
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999998843 2335899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCC-CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCC--------CCccchHHHHHhh
Q 005846 497 FGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT--------DGAADLLSYAWKQ 567 (674)
Q Consensus 497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~--------~~~~~~l~~~~~~ 567 (674)
+...... .......++..|+|||++.+..++.++||||||+++|||+|++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 112234567789999999988999999999999999999998765321100 0000011111111
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+.. ...+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 111223345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.59 Aligned_cols=241 Identities=26% Similarity=0.339 Sum_probs=192.6
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999864 57789999987532 22334566788888777 6899999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988874 3456899999999999999999999987 999999999999999999999999998754321
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.|+.... ...++..... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~----~~-------- 217 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIME----HN-------- 217 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHh----CC--------
Confidence 1 12334578999999999999999999999999999999999999975321 1222222111 11
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
..++......+.+++.+||+.||.+|++.
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01222334567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.45 Aligned_cols=236 Identities=28% Similarity=0.371 Sum_probs=189.3
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5789999998653 223345677888888876 699999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence 99988874 3456899999999999999999999988 999999999999999999999999998753221 122
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ...++... ..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i----~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAI----LNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHH----hcCCC----------CC
Confidence 334579999999999999999999999999999999999999975322 11122111 11110 01
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
+......+.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11233467889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.03 Aligned_cols=250 Identities=36% Similarity=0.523 Sum_probs=202.3
Q ss_pred cccccCCcEEEEEeecCC----CceeEEEEecccCccC-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||++.... +..|++|.+....... .+.+.+|++.+..++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7889999987654333 67889999999999999999999999999999999999999
Q ss_pred CcccccccCCCc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 426 KSLDYFLYDPEK------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 426 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
++|.+++..... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865321 367999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
...........++..|+|||.+....++.++||||||++++||++ |..|+... ...++.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~----~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEEVLEYL----RKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHH----HcCCC-----
Confidence 432223334567889999999988899999999999999999999 57776433 111222111 11111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
...+......+.+++.+||+.+|.+||++.+++..|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=311.47 Aligned_cols=255 Identities=32% Similarity=0.486 Sum_probs=201.6
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.++|++.++||+|+||.||++.+..+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688899999999999999998777789999886533 34567899999999999999999999875 45678999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999988542 2345899999999999999999999987 999999999999999999999999999765432211
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......++..|+|||.+.+..++.++||||||+++|||+| |+.|+... ......... ..+...
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~----~~~~~~-------- 222 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQV----ERGYRM-------- 222 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH----HcCCCC--------
Confidence 1122345678999999998899999999999999999999 77775321 111222211 111100
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+...+..+.+++.+||+.||++||++++|++.|+++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.64 Aligned_cols=262 Identities=28% Similarity=0.413 Sum_probs=203.5
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC--------CCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 411 (674)
...++|.+.++||+|+||.||+++.. ....+|+|.++... .....++.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34467889999999999999998731 24568999887532 33356788999999999 6999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccE
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NI 478 (674)
.+...++++||+++|+|..++.... ....+++.++.+++.||+.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9899999999999999998885422 1245899999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCc
Q 005846 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGA 557 (674)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~ 557 (674)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+... ..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~---~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI---PV 242 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC---CH
Confidence 999999999999999986543222222222234567999999998899999999999999999999 77775322 11
Q ss_pred cchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.+..... ..+.... .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus 243 ~~~~~~~----~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 EELFKLL----REGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHH----HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1222211 1111111 12223346778999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=334.88 Aligned_cols=261 Identities=21% Similarity=0.339 Sum_probs=192.3
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--------
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 413 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------- 413 (674)
..++|++.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 456899999999999999999986 468899999885432 2345799999999999999999887432
Q ss_pred CeeEEEEEecCCCcccccccC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeee
Q 005846 414 EEKILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDF 491 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~Df 491 (674)
...++||||+++ +|..++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135789999986 45444422 234457999999999999999999999988 99999999999998665 7999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|++|+.... ..+.+......+..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS---SVDQLVRIIQVLGT 289 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCC
Confidence 9998654322 22235689999999998754 68999999999999999999998864321 11222222211111
Q ss_pred CCc---------------ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 571 GTP---------------LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 571 ~~~---------------~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
... ..+....+...++......+.+|+.+||+.||.+|||+.|+++.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 100 00000111111222334578899999999999999999998843
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=319.29 Aligned_cols=257 Identities=30% Similarity=0.438 Sum_probs=199.1
Q ss_pred cCCCcccccccCCcEEEEEeecCC-Cc--eeEEEEeccc-CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 419 (674)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998643 33 4688887643 233456789999999999 799999999999999999999
Q ss_pred EEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCe
Q 005846 420 YEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 486 (674)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999998885321 1235889999999999999999999987 9999999999999999999
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHH
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~ 565 (674)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |+.|+.... ..+....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---~~~~~~~-- 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAELYEK-- 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH--
Confidence 99999998643211 11111223557999999988889999999999999999998 888863221 1111111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
...+. ....+......+.+++.+||+.+|.+||++++|++.|+....
T Consensus 231 --~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 --LPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred --HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11110 111122233567899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.57 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=205.4
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||++.. .+++.++||.+.... ....+++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 578999999876432 223457889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||+++++|.+++.... ....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999998875322 2456899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... +..... +...... .+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~-----~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEQCD-----YP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHh-hhhhcCC-----CC
Confidence 221 12234688999999999988899999999999999999999998642111 111111 1111110 00
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.. ........+.+++.+||+.||++||||.+|++++++.
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00 1112345788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.75 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=203.2
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..+|+..+.||+|+||.||+|+. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35889999999999999999985 46889999999776655667889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++. ...+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999883 345899999999999999999999988 99999999999999999999999999876532221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......|++.|+|||.+.+..++.++|||||||++|||++|+.|+..... ...+ ......... ..
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~~~---~~~~~~~~~-~~------ 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRAL---YLIATNGTP-EL------ 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HHhH---HHHhcCCCC-CC------
Confidence 12234688999999999988899999999999999999999999742211 1111 111111111 00
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.+|++||++.+|+.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 012223356788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.32 Aligned_cols=249 Identities=29% Similarity=0.402 Sum_probs=202.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||+|++|.||+++.. +++.|++|.+... .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999864 6889999988643 334456788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988643 2457899999999999999999999987 99999999999999999999999999886643221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......|++.|+|||++.+..++.++||||||+++|||++|+.|+.... ........ . .+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~---~-~~~~--------- 218 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKI---I-RGVF--------- 218 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---H-cCCC---------
Confidence 2233468899999999999999999999999999999999999865322 11111111 1 1111
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.82 Aligned_cols=247 Identities=28% Similarity=0.396 Sum_probs=196.7
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCccc
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 429 (674)
+.||+|+||.||+|...++..+|+|.+..... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876543 23456889999999999999999999999999999999999999999
Q ss_pred ccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccc
Q 005846 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509 (674)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 509 (674)
+++.. ....+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 88843 2346899999999999999999999987 999999999999999999999999998754322111 11122
Q ss_pred cccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 510 ~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
.++..|+|||++..+.++.++||||||+++||+++ |..|+.... ........ ..+.. ...+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~~~~~~----~~~~~---------~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQAREQV----EKGYR---------MSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHH----HcCCC---------CCCCCC
Confidence 34567999999998999999999999999999998 887764221 11111111 11111 111223
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 589 EVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
....+.+++.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.90 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=200.0
Q ss_pred hhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG- 413 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~- 413 (674)
..++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456899999999999999999963 356789999997543 22345688999999999 789999999988654
Q ss_pred CeeEEEEEecCCCcccccccCCCc--------------------------------------------------------
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEK-------------------------------------------------------- 437 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 437 (674)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999888753210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccc
Q 005846 438 --------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509 (674)
Q Consensus 438 --------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 509 (674)
...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124788899999999999999999987 999999999999999999999999999865332222222223
Q ss_pred cccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 510 ~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
.++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .... .....+..... +..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~~~~~---------~~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC----RRLKEGTRMRA---------PDY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH----HHHhccCCCCC---------CCC
Confidence 45678999999998899999999999999999997 77775432111 1111 11111111110 111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 589 EVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+.+++..||+.+|++||++.+|++.|+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 224678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.78 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=213.4
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC---CCc--eeEEEEecc-cCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP---SGQ--EIAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~--~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
++.++.....+.||.|.||.||+|++. .|+ .||||.-+. ......+.|..|..+|++++||||++++|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 444555666788999999999999853 233 578898876 345557889999999999999999999999975 5
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..|||||.++-|-|..+|.. +...|+......++.||..+|+|||+.. +|||||..+|||+....-+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 78999999999999999953 4556999999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+.+..+..... ++..-...|||||.+.-.+++.++|||.|||.+||++. |.+||.. ..+.+.
T Consensus 539 R~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg----------------vkNsDV 601 (974)
T KOG4257|consen 539 RYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG----------------VKNSDV 601 (974)
T ss_pred hhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc----------------ccccce
Confidence 98875544433 34455779999999999999999999999999999986 7777532 223333
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.-.++.+-+...|...+..+..|+.+||..+|.+||.+.+|...|++
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 33445555556677888899999999999999999999999988854
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.04 Aligned_cols=264 Identities=21% Similarity=0.264 Sum_probs=200.6
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC---CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
....+|++.++||+|+||.||++... .+..||+|.+... ....+|+.++++++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34568999999999999999998742 4578999988643 234689999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|||++. ++|..++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 164 v~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999996 5666666 23467999999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc----
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL---- 574 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---- 574 (674)
............||+.|+|||++....++.++|||||||++|||++|+.|+...........+....+........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 4433333345679999999999999999999999999999999999999875433322222222221111110000
Q ss_pred ---ee------cccccCCCCC-------hhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 575 ---QL------LDTNLTDSYS-------RNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 575 ---~~------~d~~~~~~~~-------~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+ ........+. ......+.+++.+||+.||++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0123457789999999999999999999864
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.61 Aligned_cols=250 Identities=30% Similarity=0.459 Sum_probs=203.8
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.++|++.+.||.|+||.||++.. .|+.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999997 478999999976544 4678899999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999988532 2236899999999999999999999988 99999999999999999999999999986532211
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
...++..|+|||++..+.++.++||||||+++|||++ |..|+... ...++.......+ ..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~~~~----~~-------- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPHVEKGY----RM-------- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHhcCC----CC--------
Confidence 2234568999999998899999999999999999998 88775422 1122222221111 10
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+...+..+.+++.+||+.+|++||++.+++.+|++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 -EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.95 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=204.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
+..++|++.++||+|+||.||++...++..+++|.+.... ...+.+.+|+.++++++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4467899999999999999999998777889999886542 234678899999999999999999999887 77899999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999988542 3456899999999999999999999987 9999999999999999999999999997654322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. .......++..|+|||++..+.++.++||||||+++||++| |+.|+... ....+.... ..+...
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~----~~~~~~------ 222 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRAL----ERGYRM------ 222 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC---CHHHHHHHH----hCCCCC------
Confidence 1 11222345678999999998889999999999999999999 77775421 111111111 111111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+......+.+++.+||+.+|++||++.+++++|+.
T Consensus 223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.61 Aligned_cols=248 Identities=31% Similarity=0.431 Sum_probs=197.0
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCccc
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 429 (674)
++||+|+||.||++...+++.|++|++...... ..+.+.+|+.++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999988765433 4567899999999999999999999999999999999999999999
Q ss_pred ccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccc
Q 005846 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509 (674)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 509 (674)
+++.. ....+++..++.++.+++.||.|||+++ ++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 88853 2346889999999999999999999987 999999999999999999999999999765322211111122
Q ss_pred cccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 510 ~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
.++..|+|||.+.++.++.++||||||+++|||+| |..|+..... ...... ..... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~----~~~~~---------~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRER----IESGY---------RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHH----HhcCC---------CCCCCcc
Confidence 34567999999988899999999999999999999 6666532211 111111 11110 0111223
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 589 EVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
....+.+++.+||+.+|.+||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.04 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=204.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC--------CCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
+....+|.+.+.||+|+||.||++... .+..||+|.+.... ....+++.+|+.+++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 444567899999999999999999742 12368999886532 33456789999999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
..+...++++||+++|+|.+++.... ....+++.+++.++.||++||.|||+.+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999998885421 2235889999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+... .
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~ 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---P 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---C
Confidence 9999999999999999986543222222222344568999999999999999999999999999998 66665321 1
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
..+.... ...+... ..+......+.+++.+||+.+|++||++.+++..|+....
T Consensus 242 ~~~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 VEELFKL----LKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHH----HHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1111111 1111111 1112234468899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=320.97 Aligned_cols=245 Identities=30% Similarity=0.463 Sum_probs=203.2
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCccc
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 429 (674)
-+||+|.||+||.|+.. +...+|||-+........+-+.+||.+.+.|+|+|||+++|.+.+++..-|.||-.+||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999964 45578999998877777788899999999999999999999999999999999999999999
Q ss_pred ccccCCCcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeEEeeeCCccccCCCCCCCcc
Q 005846 430 YFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGVDQTQGNT 506 (674)
Q Consensus 430 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ki~DfGla~~~~~~~~~~~~ 506 (674)
.+|.. +=+++ ++..+--+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+. .....+
T Consensus 661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 99853 34556 78888889999999999999987 99999999999995 57899999999998763 233445
Q ss_pred ccccccCCccCccccccCC--CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 507 SRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~--~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
.+..||..|||||++..++ |+.++|||||||.+.||.||++||-....... ..++-+. . .....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm--y----KvHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM--Y----KVHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc--e----ecCCC
Confidence 6678999999999998764 89999999999999999999999743222110 0111111 0 11234
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+|.+...++..++++|+..||.+||++.++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56777888999999999999999999999875
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=318.58 Aligned_cols=256 Identities=31% Similarity=0.443 Sum_probs=198.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCc--eeEEEEeccc-CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ--EIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 418 (674)
.++|++.+.||+|+||.||+|.+. ++. .+++|.++.. .......+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999864 344 4577777543 233446788999999999 89999999999999999999
Q ss_pred EEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC
Q 005846 419 VYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~ 485 (674)
|+||+++++|..++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999998885422 1235899999999999999999999987 999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYA 564 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 564 (674)
+||+|||+++..... .......++..|+|||++....++.++|||||||++|||+| |..|+.... ..+.....
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL 236 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC---hHHHHHHH
Confidence 999999998642211 11111234668999999988889999999999999999998 888764221 11111111
Q ss_pred HhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 565 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.... ....+......+.+++.+||+.+|++||++.+++++|++.
T Consensus 237 ----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 237 ----PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred ----hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1110 0011112234678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.36 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=200.3
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-----ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++|+..+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999985 468899999886432 1223568899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|+||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999988874 3356889999999999999999999988 9999999999999999999999999997653
Q ss_pred CCCCCCc-cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE------AMAAIFKIATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc------hHHHHHHHhccCCC----
Confidence 2211111 123457889999999999899999999999999999999999864211 11111111111111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
...+......+.+++..||+.+|.+|||+.++++.
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122334467889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.48 Aligned_cols=263 Identities=29% Similarity=0.450 Sum_probs=203.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-----CCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCee
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEK 416 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 416 (674)
+.|+..+.||+|+||.||++.+. +++.+|||.+...... ..+.|.+|+.+++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999853 3678999999765443 46789999999999999999999999887 5578
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998532 235999999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCcc--------chHHHHHhh
Q 005846 497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA--------DLLSYAWKQ 567 (674)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~--------~~l~~~~~~ 567 (674)
........ ......++..|++||.+.+..++.++||||||+++|||+||+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322211 111234456799999999889999999999999999999999875432111100 001111111
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+ .....+......+.+++.+||+.+|++||++.||+++|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 01111122335788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.46 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=196.0
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----eeE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 417 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 417 (674)
+|+..++||+|+||.||++.. .+|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999985 478999999986532 233467889999999999999999999998776 789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|+||+.+ +|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999974 5655552 3456999999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce-
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ- 575 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~- 575 (674)
..... .......+++.|+|||++.+. .++.++|||||||++|||++|+.|+..... .+.+..............
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP---IQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCCCHHHH
Confidence 43222 122334678999999998764 579999999999999999999998753221 111111111110000000
Q ss_pred ----------ecc-----ccc--CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 576 ----------LLD-----TNL--TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 576 ----------~~d-----~~~--~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+.. +.. ...........+.+++.+||+.||++|||+.|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 000 001111224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.79 Aligned_cols=240 Identities=28% Similarity=0.402 Sum_probs=190.1
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57889999987542 23345566778888764 999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99998884 3356899999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ...+.... ....+ .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i----~~~~~----------~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSI----RMDNP----------CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCC----------CC
Confidence 334578999999999999899999999999999999999999874321 11222211 11110 01
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMA-TIV 615 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~-evl 615 (674)
+......+.+++.+||+.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 112234677899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.61 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=198.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999854 57888999886542 23345688999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. ...+++..+..++.||++||.|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999843 356899999999999999999999742 3999999999999999999999999998754322
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc--------
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL-------- 574 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-------- 574 (674)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...........+.............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1233568899999999988889999999999999999999999864322111100000000000000000
Q ss_pred ---------eeccccc---CCCCC-hhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 575 ---------QLLDTNL---TDSYS-RNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 575 ---------~~~d~~~---~~~~~-~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+..+... ....+ ......+.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00000 0123468899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.97 Aligned_cols=241 Identities=28% Similarity=0.360 Sum_probs=192.9
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||++... +++.||||++++.. ....+.+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57889999997532 23345677888998888 799999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99988874 3446999999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+.... ....... ...... .+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~----i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQS----ILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHH----HHcCCC----------CC
Confidence 234568999999999999999999999999999999999999974321 1111111 111110 11
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSM-----ATIVL 616 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~-----~evl~ 616 (674)
+......+.+++.+||+.||.+||++ .+++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 22234567899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.37 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=200.9
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 412 (674)
...++...++|++.+.||+|+||.||++... +++.+|+|++.+. .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445566789999999999999999999864 5788999998642 22234557889999999999999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
+...++||||+++|+|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999998884 235888999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccC----CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+.... .........
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~ 260 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIM 260 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHHH
Confidence 9987643221 122345799999999998653 37899999999999999999999975321 111111212
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCC--CCCHHHHHHHH
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAE--RPSMATIVLML 618 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPt~~evl~~L 618 (674)
.......+.+ .......+.+++..|++.++.+ ||++++|++..
T Consensus 261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111111 1123346778888999844433 78999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.75 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=201.1
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777889999999999999854 577899999877666666789999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeCCcccc
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIF 497 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~~~ 497 (674)
|+||+++++|..++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999998854222112388889999999999999999987 999999999999976 679999999998765
Q ss_pred CCCCCCCccccccccCCccCccccccCC--CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
..... ......|+..|+|||++.+.. ++.++||||||+++|||++|+.|+....... ...+......
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~------ 228 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK------ 228 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc------
Confidence 32211 122345789999999986644 7899999999999999999998864321110 0000000000
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.....+......+.+++.+||+.+|.+|||+.+++.
T Consensus 229 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011122233456788999999999999999999885
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.06 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=201.4
Q ss_pred cCCCcccccccCCcEEEEEeecC----CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.+|++.+.||+|+||.||+|++. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999853 23368999886543 23346789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999853 2346899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCCc-cccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 500 DQTQGN-TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
...... .....++..|++||++.+..++.++||||||+++||+++ |+.|+.... ..+........++
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~---~~~~~~~~~~~~~-------- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS---NQDVIKAIEEGYR-------- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC---HHHHHHHHhCCCc--------
Confidence 322111 112233568999999998899999999999999999887 888864221 1122222211110
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
...+...+..+.+++.+||+.+|.+||+|.++++.|+.
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.77 Aligned_cols=253 Identities=29% Similarity=0.465 Sum_probs=208.6
Q ss_pred CCCcccccccCCcEEEEEeec-CCCc----eeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..+.+++||+|+||+||||.| ++|+ +||||++... ..+..+++.+|+..|.+++||||++|+|+|.... ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 345678999999999999985 4554 5788988654 4455788999999999999999999999998766 8899
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
++||+.|+|.++++. .+..+..+..+.|..|||+||.|||++. ++||||..+|||+..-..+||.|||+++.+..
T Consensus 776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999864 4567889999999999999999999876 99999999999999999999999999999887
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
+..........-.+.|||-|.+....|+.++|||||||.+|||+| |..|......++..++ + .
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------l---------e 914 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------L---------E 914 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------H---------h
Confidence 766666655566789999999999999999999999999999998 6666543222222221 2 2
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
...+-.-|.....++..++.+||..|++.||+++++...+.+
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 222223355566788999999999999999999999877654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.96 Aligned_cols=240 Identities=29% Similarity=0.391 Sum_probs=190.2
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+++.. +|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 57899999987532 23345567788888764 899999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 99988874 3456899999999999999999999988 999999999999999999999999998743211 122
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....+.... .... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~---~~~~~~~~~----~~~~----------~~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESI----RVDT----------PHY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHH----HhCC----------CCC
Confidence 33467899999999999999999999999999999999999997422 111222111 1111 011
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMA-TIV 615 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~-evl 615 (674)
+......+.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 122334678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=309.42 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=192.3
Q ss_pred cccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
||+|+||.||++... +|+.||+|++.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 58999999986422 12234456799999999999999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcccc
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 508 (674)
..++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8877532 3345899999999999999999999988 9999999999999999999999999987654321 1223
Q ss_pred ccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+....... .............. .. . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~--~~----~----~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDEV--KF----E----HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcccc--cc----c----ccc
Confidence 468999999999998899999999999999999999999975322211 11111111111110 00 0 011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 589 EVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
....+.+++.+||+.||++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 234678999999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.12 Aligned_cols=249 Identities=31% Similarity=0.439 Sum_probs=198.3
Q ss_pred cccccCCcEEEEEeecCC--C--ceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLPS--G--QEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+..+++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 2689999977655 556788999999999999999999999988 889999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC-
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG- 504 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 504 (674)
++|..++..... ..+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998865322 56899999999999999999999987 9999999999999999999999999998764422211
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+... ...+....... .... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~---~~~~---------~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL---SGSQILKKIDK---EGER---------L 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHh---cCCc---------C
Confidence 1223456789999999998899999999999999999999 98886422 11122221111 1100 0
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.56 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=187.3
Q ss_pred cccccCCcEEEEEeecCC-------------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 351 NKLGEGGFGEVYKGVLPS-------------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
+.||+|+||.||+|++.. ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358889886655555667889999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC-------eEEee
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-------PKISD 490 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-------~ki~D 490 (674)
+||||+++++|+.++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 3346899999999999999999999987 999999999999987664 89999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccc-cCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhh
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
||++..... .....++..|+|||.+. +..++.++|||||||++|||++ |..|+..... .+ . ...+
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~---~-~~~~ 222 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL---AE---K-ERFY 222 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch---hH---H-HHHH
Confidence 999865421 12245788899999887 4668999999999999999984 6666432111 00 0 0111
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
... . .. .......+.+|+.+||+.||++||++.+|++.|+
T Consensus 223 ~~~-~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ-C-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC-c-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 0 00 1112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.98 Aligned_cols=255 Identities=22% Similarity=0.250 Sum_probs=193.3
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999954 5889999998642 2233456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998843 2446899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCCCccccccccCCccCcccccc-----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.|+... ...+.. ...........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~---~~~~~~---~~i~~~~~~~~ 228 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETY---GKIMNHKEHFQ 228 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC---CHHHHH---HHHHcCCCccc
Confidence 21 11223468999999999863 45788999999999999999999996421 111111 11111111111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhccc--CCCCCCCCHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQ--EDPAERPSMATIVLM 617 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~--~dP~~RPt~~evl~~ 617 (674)
+.. . .......+.+++.+|+. .++..||++.+++..
T Consensus 229 ~~~-~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPP-D-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCC-c-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 100 0 01123355666666554 444458899998865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=316.00 Aligned_cols=237 Identities=25% Similarity=0.326 Sum_probs=185.9
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+++.. +++.||+|++.+.. ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 67899999986532 122334555554 67889999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
++|..++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 99987773 3456889999999999999999999987 999999999999999999999999998753221 122
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.|+... +........ ... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i---~~~--~~---------~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DVSQMYDNI---LHK--PL---------QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC---CHHHHHHHH---hcC--CC---------CC
Confidence 33457899999999999989999999999999999999999986422 111111111 111 00 11
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMA 612 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~ 612 (674)
+......+.+++.+||+.||.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 223345678999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.87 Aligned_cols=248 Identities=33% Similarity=0.491 Sum_probs=195.3
Q ss_pred cccccCCcEEEEEeecCC----CceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997422 26899999875543 24567889999999999999999999875 5568999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999853 336899999999999999999999987 99999999999999999999999999987643322111
Q ss_pred -cccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 506 -TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+....... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~---~~~~~~~~~~~----~~~~--------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAEVIAMLES----GERL--------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC---CHHHHHHHHHc----CCcC---------
Confidence 111223568999999998899999999999999999998 88886432 12222222211 1111
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11222335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.13 Aligned_cols=256 Identities=29% Similarity=0.485 Sum_probs=198.6
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCc----eeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|+..+.||+|+||.||+|++. +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457888899999999999999853 344 468888865432 2234688999999999999999999998754 467
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 89999999999988853 2346899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+.... ...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~----~~~~~~~~- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDL----LEKGERLP- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHCCCCCC-
Confidence 43332222223445778999999998899999999999999999998 887763211 1111111 11111100
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+......+.+++..||..+|++||++.++++.|+..
T Consensus 232 --------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 --------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0112234678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.98 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=197.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++|+|++++++.+..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999854 688999999865322 223456789999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999998887532 2345899999999999999999999987 9999999999999999999999999987543221
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+...................
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~------------- 220 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------------- 220 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-------------
Confidence 1123468999999999999999999999999999999999999975322111111111110000
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
...++......+.+++..||+.||++||| +.|++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00112223346788999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.94 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=187.6
Q ss_pred cccccCCcEEEEEeecCC---CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 351 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
++||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997533 3467888775433 233456889999999999999999999999999999999999999
Q ss_pred cccccccCCCc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 427 SLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 427 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865322 233578888999999999999999987 9999999999999999999999999987543222111
Q ss_pred ccccccccCCccCcccccc-------CCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 505 NTSRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+... ...+.+... .... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~~~---~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL---SDEQVLKQV---VREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC---CHHHHHHHH---hhcc-CccC
Confidence 2223346778999998743 357889999999999999999 56664321 111122111 1111 1111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
.++.+. ......+.+++..|| .||++||++++|+++|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 122221 122345567788888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.45 Aligned_cols=245 Identities=29% Similarity=0.413 Sum_probs=196.9
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecc---cCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
-|..++.||.|+||.||-++. .+.+.||||++.- .+...|+++..|+..|.+++|||++.+.|++..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 467788999999999999985 4678899999964 344557889999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
||- |+-.+++. ...+++.+.++..|..+.++||+|||+.+ .||||||+.||||++.|.+||+|||.+.+...
T Consensus 107 YCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 995 45555552 23467999999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
...++|||.|||||++. .|+|+-|+||||||++..||...++|.- ... .....+. ...+..
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF--nMN----AMSALYH-IAQNes----- 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMN----AMSALYH-IAQNES----- 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc--Cch----HHHHHHH-HHhcCC-----
Confidence 33579999999999884 6899999999999999999999998731 111 1111111 111111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+.+. ..+-...+..++..||++-|.+|||.++++..
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111 23445577889999999999999999988754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.00 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=199.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.++||+|+||.||+++. .+++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788889999999999999985 46889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++. ..+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999998874 3456899999999999999999999988 9999999999999999999999999987653221
Q ss_pred CCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+..... .... ......... .+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--~~~~----~~~~~~~~~----~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--MRAL----FLMTKSNFQ----PP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--hhhH----HhhhccCCC----CC
Confidence 2223457899999999874 45688999999999999999999988532111 1111 111101000 00
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.... .......+.+++.+||+.+|++||++++|+.
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 0012235778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.47 Aligned_cols=194 Identities=24% Similarity=0.302 Sum_probs=165.9
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|+.++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346999999999999999999965 478899996422 2457899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+. ++|..++.. ....+++.+++.|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 567666632 2346999999999999999999999988 99999999999999999999999999987643322
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 549 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~ 549 (674)
........||..|+|||++.+..++.++|||||||+||||++|..+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22233457999999999999999999999999999999999988653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.94 Aligned_cols=200 Identities=27% Similarity=0.379 Sum_probs=172.6
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 68899999986532 233466788999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999884 3456899999999999999999999988 999999999999999999999999998754321
Q ss_pred CCC---------------------------------CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCC
Q 005846 501 QTQ---------------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547 (674)
Q Consensus 501 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~ 547 (674)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCC
Q 005846 548 NSN 550 (674)
Q Consensus 548 p~~ 550 (674)
|+.
T Consensus 235 Pf~ 237 (360)
T cd05627 235 PFC 237 (360)
T ss_pred CCC
Confidence 974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.14 Aligned_cols=239 Identities=26% Similarity=0.375 Sum_probs=185.6
Q ss_pred ccccCCcEEEEEeecCC-------------------------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeE
Q 005846 352 KLGEGGFGEVYKGVLPS-------------------------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l 406 (674)
+||+|+||.||+|.+.. ...|++|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13488898866544445678899999999999999999
Q ss_pred EeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC--
Q 005846 407 LGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-- 484 (674)
Q Consensus 407 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-- 484 (674)
++++.++...++||||+++|+|+.++.. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988843 3456899999999999999999999987 99999999999997654
Q ss_pred -----CeEEeeeCCccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhH-hCCCCCCccCCCCc
Q 005846 485 -----NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEII-TGKKNSNFYQTDGA 557 (674)
Q Consensus 485 -----~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~ell-tg~~p~~~~~~~~~ 557 (674)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 227 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP--- 227 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh---
Confidence 3799999988643211 12356788999998865 56899999999999999995 67777542211
Q ss_pred cchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
........... ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 228 ~~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 SEKERFYEKKH---------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHHHhcc---------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111110000 001111235788999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=302.79 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=200.5
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999854 6889999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++.. .....+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999887743 23446899999999999999999999988 99999999999999999999999999976543221
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......|++.|+|||++.+..++.++||||||+++|+|++|+.|+... ..... ..... .+....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~---~~~~~---~~~~~-~~~~~~-------- 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---SWKNL---ILKVC-QGSYKP-------- 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC---CHHHH---HHHHh-cCCCCC--------
Confidence 223356889999999999889999999999999999999999986421 11111 11111 111110
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+......+.+++.+||+.||++||++.+|+..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.35 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=196.7
Q ss_pred CCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
|+..+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+.++++++|+|++++++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999986 468899999986532 22234578899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999998887542 2346999999999999999999999987 9999999999999999999999999987643221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+...... ...............
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~---~~~~~~~~~~~~~~~--------- 222 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK---VKREEVDRRVLETEE--------- 222 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhhcccc---------
Confidence 122346899999999999889999999999999999999999997532111 111111111111110
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
.++......+.+|+..||+.||++||+ +.+++.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111222345678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.38 Aligned_cols=262 Identities=28% Similarity=0.375 Sum_probs=196.1
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 68899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
++ ++|..++........+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 577777654444467999999999999999999999987 9999999999999999999999999997654322
Q ss_pred CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh--------cCCCc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW--------RDGTP 573 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~--------~~~~~ 573 (674)
.......+++.|+|||.+.+. .++.++||||||+++|||+||+.|+...... ..... ....+ .....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFR-IFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-HHHHhCCCChhhhhcchh
Confidence 112233578899999988654 5789999999999999999999886432111 00000 00000 00000
Q ss_pred ce----eccc---ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 LQ----LLDT---NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ~~----~~d~---~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. ..+. ............++.+++.+||+.||++|||+.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0000 0000001123346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=309.06 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=197.2
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
|++.++||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999965 4678899988766655667889999999999999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
++|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999887743 2356999999999999999999999987 9999999999999999999999999987643221 12
Q ss_pred cccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 506 TSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....++..|+|||++. +..++.++|||||||++|||++|+.|+.... .... ....... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~---~~~~~~~-~~~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN---PMRV---LLKIAKS-EPPTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC---HHHH---HHHHhhc-CCCCCC---
Confidence 23356889999999984 4457889999999999999999998864321 1111 1111111 100100
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+......+.+++.+||+.||.+||++.++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122346789999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.99 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=195.9
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999864 57889999986543 22334678899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 976 66666532 2345899999999999999999999988 9999999999999999999999999997643222
Q ss_pred CCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc-------
Q 005846 503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL------- 574 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~------- 574 (674)
.......+++.|+|||.+.+ ..++.++||||||+++|||+||+.|+...... +.+....+.+......
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE---DELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHhhhcc
Confidence 12223467899999998865 46899999999999999999999987533221 1221111111100000
Q ss_pred --eecccccCC-------CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 --QLLDTNLTD-------SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 --~~~d~~~~~-------~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+..+..... .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000122346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=315.92 Aligned_cols=241 Identities=25% Similarity=0.310 Sum_probs=187.2
Q ss_pred cccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHH-HHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+++.. +++.||+|++.+.. ......+..|. .+++.++|+||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 56789999986532 12223344444 456788999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
++|..++. ....+.+..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 99988884 3456888899999999999999999988 999999999999999999999999999754221 122
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+... .....+... .... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i---~~~~--~~---------~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNI---LNKP--LQ---------L 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC---CHHHHHHHH---HhCC--cC---------C
Confidence 33457999999999999999999999999999999999999997421 111111111 1110 00 1
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+......+.+++.+||+.||.+||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1123346788999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.47 Aligned_cols=251 Identities=34% Similarity=0.508 Sum_probs=196.5
Q ss_pred cccccCCcEEEEEeecCC-------CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+.||+|+||.||+|+..+ +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998642 2578999876543 23456788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCC----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-----CeEEeeeCC
Q 005846 423 VPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-----NPKISDFGM 493 (674)
Q Consensus 423 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-----~~ki~DfGl 493 (674)
+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999886432 2234889999999999999999999887 99999999999999887 899999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
++...............++..|+|||++.++.++.++||||||+++|||+| |+.|+.... ..+..... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHH----hcCC
Confidence 976543322222223345778999999999999999999999999999998 888764221 11121111 1111
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
. ...+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 231 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 01122334577899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=314.07 Aligned_cols=197 Identities=26% Similarity=0.434 Sum_probs=159.1
Q ss_pred ccccccCCcEEEEEeecC---CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCeeEEEEEecC
Q 005846 350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVP 424 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 424 (674)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999986542 23457889999999999999999998864 456789999986
Q ss_pred CCcccccccCC------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE----cCCCCeEEeeeCCc
Q 005846 425 NKSLDYFLYDP------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMA 494 (674)
Q Consensus 425 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~ki~DfGla 494 (674)
+ +|..++... .+...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 555554211 12235899999999999999999999988 9999999999999 45678999999999
Q ss_pred cccCCCCCC-CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCcc
Q 005846 495 RIFGVDQTQ-GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFY 552 (674)
Q Consensus 495 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~ 552 (674)
+.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|++|+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876433221 223346789999999998764 5899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.47 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=202.6
Q ss_pred hcCCCcccccccCCcEEEEEeecCC-Cc----eeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQ----EIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
..+|++.+.||+|+||.||+|.+.+ |. .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578888999999999999998542 33 589998865543 345678899999999999999999999987 7889
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998853 2345899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.............++..|+|||.+....++.++||||||+++|||++ |+.|+.... ..+..... ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~----~~~~~--- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---AVEIPDLL----EKGER--- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHH----hCCCC---
Confidence 53322222222234568999999988899999999999999999999 888864322 11211111 11111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
...+......+.+++.+||..+|.+||++.+++..|++...
T Consensus 230 ------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01111233467889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=342.43 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=201.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.++||+|+||.||+|+.. +|+.||+|++..... ...+++.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999864 588999999875322 23457899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 421 EFVPNKSLDYFLYDPE--------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
||+++++|.+++.... ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999998875321 1234677888999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCC----------------CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCC
Q 005846 493 MARIFGVDQTQ----------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556 (674)
Q Consensus 493 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~ 556 (674)
+++........ ......+||+.|||||++.+..++.++|||||||++|||+||+.|+.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 99876211100 011235799999999999999999999999999999999999999643111
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHhcC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-SMATIVLMLNSY 621 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-t~~evl~~L~~~ 621 (674)
..... . .... .+.... . ....+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 237 -~ki~~-~-~~i~--~P~~~~---p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 237 -RKISY-R-DVIL--SPIEVA---P----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred -hhhhh-h-hhcc--Chhhcc---c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11100 0 0000 000000 0 012334677899999999999996 677777777664
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.19 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=197.7
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeC------
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG------ 413 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~------ 413 (674)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678899999999999999999854 57889999986543 3456788999999998 799999999998753
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
...+++|||+++++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999988542 3456899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+..... . .......
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~-~~~~~~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----M-RALFLIP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----H-HHHHHHh
Confidence 97653221 2233457899999999986 34588899999999999999999998642211 0 1111111
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... .... ........+.+++.+||+.+|.+|||+.+++.
T Consensus 230 ~~~-~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNP-APRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCC-CCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 0000 01122346789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.66 Aligned_cols=249 Identities=32% Similarity=0.461 Sum_probs=192.4
Q ss_pred cccccCCcEEEEEeecCC-Cc--eeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||+|++.+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999643 33 46888886432 33456788999999999 899999999999999999999999999
Q ss_pred CcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 426 KSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 426 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99998885422 1235889999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
++...... ........+..|+|||++....++.++||||||+++|||++ |..|+... ...+..... ..+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~---~~~~~~~~~----~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKL----PQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc---CHHHHHHHH----hCC
Confidence 98632211 11111223567999999988889999999999999999997 88876321 111111111 111
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
... ..+......+.+++.+||+.+|.+||++.+++..|+..
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 110 11112234678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.30 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=200.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 357889999999999999999864 5889999999876666677889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 999999877643 2346899999999999999999999987 999999999999999999999999998754221
Q ss_pred CCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 503 QGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
........+++.|+|||++. ...++.++|||||||++|||++|+.|+..... ....... ........
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~-~~~~~~~~- 235 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKI-AKSEPPTL- 235 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHH-hcCCCccC-
Confidence 12223456888999999985 34578899999999999999999988643211 1111111 11111000
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.+|++||+++++++
T Consensus 236 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 ------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011223346788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.30 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=191.6
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 420 (674)
+|+..+.||+|+||.||++... +|+.||+|++.+.. ....+.+..|+.++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999854 68899999987532 233456778888888885 577888999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988873 3456999999999999999999999988 999999999999999999999999998754322
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.... .......... . .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~---~-~-------- 217 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIME---H-N-------- 217 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHh---C-C--------
Confidence 1 12234568999999999999899999999999999999999999975321 1122221111 1 0
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
..++......+.+++.+||+.+|.+|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122233467889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=302.86 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=197.9
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEE-eCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL-EGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 423 (674)
++|.+.+.||+|+||.||++.. .|..|++|.++... ..+.+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4788899999999999999987 47889999886543 3467899999999999999999999765 455789999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++... ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999988532 2335899999999999999999999987 9999999999999999999999999987543221
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+... ...++..... .+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~----~~~~~-------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVE----KGYKM-------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHh----cCCCC--------
Confidence 12234568999999998899999999999999999998 88775321 1112221111 11111
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=303.10 Aligned_cols=252 Identities=29% Similarity=0.490 Sum_probs=201.0
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.+|++.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999998778899999886543 334678999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 9999988843 2346899999999999999999999987 999999999999999999999999998765332211
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|+|||.+.++.++.++||||||+++|||++ |+.|+... .....+... ..+. ....
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~---~~~~~~~~~----~~~~--~~~~----- 222 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR---SNSEVVETI----NAGF--RLYK----- 222 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC---CHHHHHHHH----hCCC--CCCC-----
Confidence 1112234678999999998899999999999999999998 77775421 111222211 1110 0011
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
+......+.+++.+||+.+|++||++.+++++|.
T Consensus 223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112357889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=311.12 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..+|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999985 57899999999766555567788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|..++. ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999873 345899999999999999999999987 99999999999999999999999999876533221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.|+....... .+. .....+.+.
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~----~~~~~~~~~-------- 234 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY----LIATNGTPE-------- 234 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--hee----eeccCCCCC--------
Confidence 1223468889999999998889999999999999999999999874321110 000 001011000
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|++||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012223345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=305.49 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=191.3
Q ss_pred cccccCCcEEEEEeecC----CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCeeEEEEEecC
Q 005846 351 NKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVP 424 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 424 (674)
+.||+|+||.||+|.+. ++..+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357899988543 23345678899999999999999999998764 556789999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC-
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ- 503 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~- 503 (674)
+++|..++... ...+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998532 334688888999999999999999987 999999999999999999999999999765322111
Q ss_pred -CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 504 -GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+. ......+.....+ .....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~--~~~~~~~~~~~~~---~~~~~--------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVDSFDITVYLL---QGRRL--------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC--CCCCHHHHHHHHh---cCCCC---------
Confidence 11123345778999999988899999999999999999999665421 1112222222221 11100
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+...+..+.+++..||+.+|++||++.+|+..|++.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=307.42 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=201.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999954 68899999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999988843 27899999999999999999999987 9999999999999999999999999998765332
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.......++..|+|||++.+..++.++||||||+++|||+||+.|+.... ....+.... ......+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~----~~~~~~~~----- 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH---PMRVLFLIP----KNNPPSLE----- 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc---hHHHHHHhh----hcCCCCCc-----
Confidence 22233568889999999998889999999999999999999999874322 111111111 11111111
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. .....+.+++.+||..+|++||+++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 03346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=305.35 Aligned_cols=251 Identities=30% Similarity=0.444 Sum_probs=198.9
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccCc------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+|...+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999987899999998864321 1235688999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 346899999999999999999999987 99999999999999999999999999876532
Q ss_pred CCC----CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 500 DQT----QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 500 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
... ........|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ..... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~----~~~~~~~~-- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--LAAMF----YIGAHRGL-- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--HHHHH----HhhhccCC--
Confidence 111 1112234688999999999988899999999999999999999998742211 11110 00000000
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+. .+......+.+++.+||+.+|.+||++.+++.
T Consensus 227 --~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 --MPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011 12223456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.21 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=194.4
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----- 414 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 414 (674)
..++|+..+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999985 46889999998653 2233567789999999999999999999986543
Q ss_pred -eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 415 -EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 415 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 469999999765 433332 24888999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh-----
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW----- 568 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----- 568 (674)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... .+.+....+..
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH---IDQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCcH
Confidence 9754322 122345789999999999999999999999999999999999998753221 11111111100
Q ss_pred -------------cCCCc-------ceecccccC---CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 569 -------------RDGTP-------LQLLDTNLT---DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 569 -------------~~~~~-------~~~~d~~~~---~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..... .+....... ..........+.+++.+||+.||++|||+.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 000000000 00111123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.11 Aligned_cols=252 Identities=33% Similarity=0.484 Sum_probs=198.7
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHH--HHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAE--EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
|+..+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999965 4568999999776543332 3456999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++. ....+++..++.++.||++||.+||+.+ ++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999884 4567899999999999999999999988 9999999999999999999999999997641 122
Q ss_pred CccccccccCCccCccccc-cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 504 GNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.......++..|+|||.+. +..++.++||||+|+++|+|++|..|+.... ..+......+..... . ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~----~-~~~~- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN---SDDQLEIIEKILKRP----L-PSSS- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS---HHHHHHHHHHHHHTH----H-HHHT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---chhhhhhhhhccccc----c-cccc-
Confidence 2334457899999999998 8889999999999999999999998865321 111111111111000 0 0000
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.........+.+++..||+.||++||++.++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111267889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=309.36 Aligned_cols=260 Identities=27% Similarity=0.361 Sum_probs=191.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhc---CCCceeeEEeEEEe-----CC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKL---QHRNLVRLLGFCLE-----GE 414 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~-----~~ 414 (674)
+|++.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999864 688999999865322 2234456777777665 69999999998864 24
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++|+||+++ +|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 676666432 2345899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|++|+.... ..+.+.............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC---HHHHHHHHHHHhCCCChh
Confidence 8654221 2233568899999999998899999999999999999999998864321 111222111111000000
Q ss_pred ----------eecccccC---CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 ----------QLLDTNLT---DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ----------~~~d~~~~---~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0011123346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=309.17 Aligned_cols=261 Identities=26% Similarity=0.332 Sum_probs=198.6
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999965 58899999886432 2234567899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|+.++. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999999987763 3346899999999999999999999987 9999999999999999999999999998764322
Q ss_pred CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh-----------hc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ-----------WR 569 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~-----------~~ 569 (674)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+...... +.+...... +.
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV---DQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhcc
Confidence 1 1223457889999999875 56889999999999999999999887532211 111111110 00
Q ss_pred CCCcce-ecccccCCCC-----ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 570 DGTPLQ-LLDTNLTDSY-----SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 570 ~~~~~~-~~d~~~~~~~-----~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...... ...+...... .......+.+++.+||+.+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 0000000000 0122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=305.30 Aligned_cols=249 Identities=30% Similarity=0.490 Sum_probs=198.2
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccCcc---------CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ---------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
+|.+...||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999985 35789999988653322 12567889999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++|+||+++++|..++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999884 3356899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCC----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 496 IFGVDQTQ----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 496 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIG-EN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHh-cc
Confidence 76432111 111234578899999999988999999999999999999999998753211 11111111 00
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.....+......+.+++.+||+.||.+||++.+|++
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011112233456788999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=311.31 Aligned_cols=249 Identities=26% Similarity=0.434 Sum_probs=202.3
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.+|+..+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999984 578999999997665556678899999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|..++. ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 9999998873 345899999999999999999999988 99999999999999999999999999876543322
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+..... ....... ...... .+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~~~~~~---~~~~~~-~~------- 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLI---ATNGTP-EL------- 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhcCCc-cc-------
Confidence 12234688899999999988899999999999999999999998643221 1111111 111100 00
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.||++||++.+|+.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122346778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=308.11 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=199.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999965 6899999988653 233346788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|..++........+++..+..++.||+.||.|||+.. +++||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999988854333447999999999999999999999742 3999999999999999999999999998765322
Q ss_pred CCccccccccCCccCccccccC------CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+..... ......... .......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~-~~~~~~~-- 228 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSA-IVDGDPP-- 228 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHH-HhhcCCC--
Confidence 12234578899999998544 358899999999999999999998643211 111111111 1111111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 -------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112234456788999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.14 Aligned_cols=257 Identities=28% Similarity=0.388 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.++||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888999999999999999854 58889999876543 3345778999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|..++. +.+.+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999988874 3456899999999999999999999742 3999999999999999999999999998654221
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCC-----CccchHHHHHhhhcCCCccee
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD-----GAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~-----~~~~~l~~~~~~~~~~~~~~~ 576 (674)
......|+..|+|||++.++.++.++|||||||++|||++|+.|+...... ................ ..
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-- 231 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PP-- 231 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CC--
Confidence 122457899999999998889999999999999999999999997643321 1111122221111111 00
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
.+. .......+.+++.+||+.||++||++.|++++.
T Consensus 232 ---~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 ---RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 011334678899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=303.59 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=201.8
Q ss_pred cCCCcccccccCCcEEEEEeecCC-CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
++|+..++||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999754 78999999865433 678999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998843 2456899999999999999999999987 99999999999999999999999999986643221
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... .. ........ ..+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~-----~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AI----FMIPNKPP-----PTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hh----hhhccCCC-----CCC--
Confidence 2233457889999999998899999999999999999999999865321111 00 00000000 000
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.||++||++.+|+.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011222346788999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.51 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=199.0
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999854 57889999886443 33456789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999988873 346899999999999999999999987 9999999999999999999999999997654321
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.......|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ...... ..... .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~----~~~~~---------~ 218 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP---MRVLFL----IPKNS---------P 218 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch---hhHHhh----hhcCC---------C
Confidence 112234678899999999988899999999999999999999988642211 111100 11111 1
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..........+.+++.+||+.+|++||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11122334567899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.02 Aligned_cols=254 Identities=20% Similarity=0.349 Sum_probs=187.8
Q ss_pred cccccCCcEEEEEeecCCC---ceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 351 NKLGEGGFGEVYKGVLPSG---QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
++||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 345667665433 334568899999999999999999999999999999999999999
Q ss_pred cccccccCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 427 SLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 427 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
+|..++..... ...+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99998864322 234677788899999999999999987 99999999999999999999999999864322211122
Q ss_pred cccccccCCccCcccccc-------CCCCccccEEeechhhhHhHhCC-CCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 506 TSRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIITGK-KNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwS~Gv~l~elltg~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.....++..|+|||++.. ..++.++||||||+++|||+++. .|+.. ....+.+.... . +....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~---~~~~~~~~~~~---~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH---LSDREVLNHVI---K-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHH---h-hcccccC
Confidence 234567889999998753 24578999999999999999854 45421 11112222221 1 1112223
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
++.+...+ ...+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 345677888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=304.93 Aligned_cols=238 Identities=26% Similarity=0.447 Sum_probs=186.9
Q ss_pred cccccCCcEEEEEeecCCCc-----------eeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 351 NKLGEGGFGEVYKGVLPSGQ-----------EIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975432 4778877554333 6788999999999999999999999988 778999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-------CeEEeeeC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-------NPKISDFG 492 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-------~~ki~DfG 492 (674)
+||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998532 226899999999999999999999987 99999999999999888 79999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccC--CCCccccEEeechhhhHhHhC-CCCCCccCCCCccchHHHHHhhhc
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITG-KKNSNFYQTDGAADLLSYAWKQWR 569 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~ 569 (674)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+...... .... . +.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~-~---~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKER-F---YQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHH-H---Hh
Confidence 9976532 2223567789999999876 789999999999999999995 4444322111 1100 1 11
Q ss_pred CCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 570 ~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
.... .+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1000 01111257889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.03 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=203.4
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999864 5788999999776555678899999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999988743 2256899999999999999999999987 9999999999999999999999999987654221
Q ss_pred CCccccccccCCccCccccccC---CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.......++..|+|||.+.+. .++.++||||||+++|||+||+.|+..... ...... ....... ..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--~~~~~~----~~~~~~~----~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--MRALFL----ISKSNFP----PP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhccCC----Cc
Confidence 122234678899999998776 889999999999999999999998642211 111111 0001000 00
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+ .........+.+++.+||+.+|.+|||+.+|+.
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 112233457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.82 Aligned_cols=248 Identities=25% Similarity=0.427 Sum_probs=201.4
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..|+..++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++++.|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778889999999999999864 57899999886542 34456789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999998873 346899999999999999999999987 9999999999999999999999999997654322
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.......++..|+|||++.+..++.++||||||+++|||+||+.|+...... .... . +.....
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~---~----------~~~~~~ 218 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLF---L----------IPKNNP 218 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhh---h----------hhcCCC
Confidence 1222346788999999999888999999999999999999999886422111 1110 0 001111
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..........+.+++.+||+.+|++||++.+++..
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233455678899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=307.93 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=201.4
Q ss_pred cCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
++|++.+.||+|+||.||+++.. +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999853 3457899988654433 4567899999999999999999999999989999
Q ss_pred EEEEecCCCcccccccCCCcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQ------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
+||||+++++|.+++...... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643322 26899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
|+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ....+. ....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~~----~~~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVLN----RLQA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHHH----HHHc
Confidence 9987543221 112223456778999999988889999999999999999999 566653211 111111 1111
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
+.... ..+......+.+++.+||+.+|++||++.+++..|+
T Consensus 234 ~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 011223357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.37 Aligned_cols=240 Identities=26% Similarity=0.442 Sum_probs=188.7
Q ss_pred cccccCCcEEEEEeecCC--------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVLPS--------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 235888888665555567789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC--------eEEeeeCCc
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PKISDFGMA 494 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--------~ki~DfGla 494 (674)
+++|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998532 336899999999999999999999987 999999999999987765 589999988
Q ss_pred cccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCC-CCccCCCCccchHHHHHhhhcCCC
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKN-SNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p-~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
..... .....++..|+|||++.+. .++.++||||||+++|||++|..+ +.... ....... ... .
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~~~----~~~-~ 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKLQF----YED-R 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHHHH----HHc-c
Confidence 65421 2234678899999999864 589999999999999999999643 22111 1111100 000 0
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
...+......+.+++.+||+.||++|||+++|++.|+
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0112223356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.24 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=194.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999864 5788999998652 2223455788999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999853 2346899999999999999999999988 999999999999999999999999999765432
Q ss_pred CCCCccccccccCCccCcccccc-----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
.. .......|++.|+|||++.+ +.++.++|||||||++|||++|+.|+.... ..+. ............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~---~~~i~~~~~~~~ 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVET---YGKIMNHEERFQ 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHH---HHHHHcCCCccc
Confidence 22 12233569999999999875 568899999999999999999999974211 1111 111111111111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAE--RPSMATIVLM 617 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPt~~evl~~ 617 (674)
+ ... .......+.+++.+|+..++++ |+++++++..
T Consensus 229 ~-p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 F-PSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-CCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 100 1122346778888888765544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.02 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=200.9
Q ss_pred hcCCCcccccccCCcEEEEEeecCC----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|.+.++||+|+||.||+|.+.+ ...|+||...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568888999999999999998643 2468999886554 3445678999999999999999999998865 55789
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999853 2345899999999999999999999987 9999999999999999999999999998664
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.|+.... ..+.+.... .+...
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~~----~~~~~--- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK---NNDVIGRIE----NGERL--- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHH----cCCcC---
Confidence 332211 122234568999999988889999999999999999996 888864221 112221111 11111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
..+......+.+++.+||..+|++|||+.+++..|+...
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223457888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.44 Aligned_cols=193 Identities=24% Similarity=0.362 Sum_probs=163.8
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
....+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++..+...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999964 4678899975432 2356899999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
|++. ++|..++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 566666632 3456899999999999999999999988 999999999999999999999999999753221
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCC
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 549 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~ 549 (674)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999976553
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.14 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=201.9
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||.|+||.||.++. .+++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999998874 46888999987643 334456788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999988542 2456899999999999999999999987 99999999999999999999999999986643332
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... .......... +....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQ-GNYTP------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc-CCCCC-------
Confidence 2234568999999999988889999999999999999999998864211 1111111111 11110
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.20 Aligned_cols=252 Identities=26% Similarity=0.327 Sum_probs=207.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecCC-CceeEEEEecccCcc---CHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ---GAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~ 417 (674)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678888999999999999999664 999999999765432 4468899999999998 999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC----CCeEEeeeCC
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISDFGM 493 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~----~~~ki~DfGl 493 (674)
+|||++.||.|.+.+... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999998888543 3999999999999999999999988 9999999999999543 4799999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||....... ... ....+..
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~~-----~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IFL-----AILRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HHH-----HHHcCCC
Confidence 998654 345667899999999999999999999999999999999999999975332221 111 1111111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+....-......+.+++..++..||.+|+|+.++++.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111112334567789999999999999999999983
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=307.31 Aligned_cols=255 Identities=21% Similarity=0.233 Sum_probs=193.6
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.++||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999864 4678999998642 2223345788999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999853 2346899999999999999999999988 999999999999999999999999998765322
Q ss_pred CCCCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.|+... +................
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~------~~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC------CHHHHHHHHhCCCcccc
Confidence 21 1223357999999999986 346889999999999999999999997421 11111212211111111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCC--CCCCCCHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQED--PAERPSMATIVLM 617 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~d--P~~RPt~~evl~~ 617 (674)
+ .. ........+.+++.+|+..+ +..|++++++++.
T Consensus 229 ~-p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F-PA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-CC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00 01122345667777777554 4447899998865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.09 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=204.2
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.+.||.|+||+||+|.. .++..+++|++.... ....+.+.+|++.++.++|+||+++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4788999999999999999985 367889999986533 33567789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999854333456899999999999999999999988 99999999999999999999999999987654332
Q ss_pred CC--ccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 503 QG--NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 503 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.. ......|+..|+|||++... .++.++||||||+++|||++|+.|+...... ....+..... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~----- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQND-PP----- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCC-CC-----
Confidence 21 22335688999999998877 7899999999999999999999997432211 1111111111 00
Q ss_pred ccCCCC-ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSY-SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~-~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.... .......+.+++.+||+.||++||++.+|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011100 1123456789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=290.17 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=199.3
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-----Ccc---CHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-----SGQ---GAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~---~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 411 (674)
..-++|...+.||.|..++|-+... ++|.+.|+|++... .+. ..+.-.+|+.+|+++ .||+|+.+.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788889999999999998875 46889999988532 111 123345799999998 7999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
.....++|+|.|+.|-|.++|. ..-.+++++..+|+.|+.+|+.|||..+ |+||||||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999994 3456999999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccc------cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
|+++.+... ......+|||+|+|||.+. +..|+..+|+|+.|||+|-|+.|.+||-.. .+++ ..
T Consensus 168 GFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-----kQml--ML 237 (411)
T KOG0599|consen 168 GFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-----KQML--ML 237 (411)
T ss_pred ceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----HHHH--HH
Confidence 999877533 3455679999999999884 345889999999999999999999996311 0110 11
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+...++.. ++-.+.. .+......+|+.+||+.||.+|.|++|.++
T Consensus 238 R~ImeGky-qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKY-QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhccc-ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11112211 1111111 123345678999999999999999999885
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=308.68 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=201.4
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.++||+|+||.||++... +++.|++|+++.. .....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999865 5789999988643 23335678999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|++++++..+.. +...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999988876652 3345899999999999999999999987 9999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh-----------c
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW-----------R 569 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~-----------~ 569 (674)
. .......++..|+|||++... .++.++||||||+++|||++|+.|+..... .+.+......+ .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD---IDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHhhhcc
Confidence 2 122335678899999999888 889999999999999999999988653221 11111111100 0
Q ss_pred CCCcc---eecccc----cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 570 DGTPL---QLLDTN----LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 570 ~~~~~---~~~d~~----~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..... +..+.. ....++......+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000 001122223567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.25 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=201.5
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-C-----CceeeEEeEEEeC
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-H-----RNLVRLLGFCLEG 413 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~ 413 (674)
+...-+|++++.||+|.||.|.|+.. .+++.||||+++.... ...+-..|+.+|..|+ | -|+|+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 33444899999999999999999984 5699999999976543 3455678999999996 4 3899999999999
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC--CeEEeee
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM--NPKISDF 491 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~--~~ki~Df 491 (674)
++.|||+|.+ .-+|.+++... +-..++...+..|+.||+.||.+||+.+ |||+||||+||||.+-. .+||+||
T Consensus 261 ~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 9999999988 66888888653 3445999999999999999999999988 99999999999996544 6999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
|.++...... . ..+.+..|+|||++.+.+|+.+.||||||||+.||++|.+-+ ..+...+++..+.+.+...
T Consensus 336 GSSc~~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf---pG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 336 GSSCFESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF---PGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred ccccccCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc---CCCCHHHHHHHHHHHhCCC
Confidence 9998754322 1 456788999999999999999999999999999999997643 3444444444432211100
Q ss_pred ---------Ccceeccc-----------c------------------cCCCCC-----------hhHHHHHHHHHhhccc
Q 005846 572 ---------TPLQLLDT-----------N------------------LTDSYS-----------RNEVIRCIQLGLLCVQ 602 (674)
Q Consensus 572 ---------~~~~~~d~-----------~------------------~~~~~~-----------~~~~~~~~~li~~Cl~ 602 (674)
+....++. . .....+ ...-..+++++++||+
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 00000000 0 000011 1233467899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 005846 603 EDPAERPSMATIVLM 617 (674)
Q Consensus 603 ~dP~~RPt~~evl~~ 617 (674)
+||.+|+|..+.++.
T Consensus 488 ~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 488 WDPAERITPAQALNH 502 (586)
T ss_pred cCchhcCCHHHHhcC
Confidence 999999999998864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=333.70 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=190.8
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCC------ceeeEEeEEE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR------NLVRLLGFCL 411 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~l~~~~~ 411 (674)
+++..+++|++.++||+|+||+||++.. ..++.||||+++... ....++..|+.++++++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445578899999999999999999985 457889999986432 2234566788888877654 5888998887
Q ss_pred eC-CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCC-----
Q 005846 412 EG-EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM----- 484 (674)
Q Consensus 412 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~----- 484 (674)
.+ ...++|||++ +++|.+++. +...+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 64 4788999988 666766663 345799999999999999999999974 6 99999999999998765
Q ss_pred -----------CeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC
Q 005846 485 -----------NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553 (674)
Q Consensus 485 -----------~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~ 553 (674)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875422 12334679999999999999999999999999999999999999975432
Q ss_pred CCCccchHHHHHhhhc-------C----CCcceec----------ccc----cCCCC---ChhHHHHHHHHHhhcccCCC
Q 005846 554 TDGAADLLSYAWKQWR-------D----GTPLQLL----------DTN----LTDSY---SRNEVIRCIQLGLLCVQEDP 605 (674)
Q Consensus 554 ~~~~~~~l~~~~~~~~-------~----~~~~~~~----------d~~----~~~~~---~~~~~~~~~~li~~Cl~~dP 605 (674)
. .+.+....+... . .....+. ++. +.... .......+.+|+..||+.||
T Consensus 350 ~---~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 350 N---LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred h---HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 2 111111111100 0 0000000 000 00000 00112456799999999999
Q ss_pred CCCCCHHHHHH
Q 005846 606 AERPSMATIVL 616 (674)
Q Consensus 606 ~~RPt~~evl~ 616 (674)
++|||++|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.06 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=201.6
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEE-
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL- 411 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~- 411 (674)
+.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|++.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34556667788999999999999999999985 457889999876432 2235678899999999 6999999999885
Q ss_pred ----eCCeeEEEEEecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCe
Q 005846 412 ----EGEEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (674)
Q Consensus 412 ----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 486 (674)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999998877532 23456899999999999999999999987 9999999999999999999
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCcccccc-----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
||+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|||++|+.|+..... ...
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~---~~~- 237 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---MRA- 237 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch---hHH-
Confidence 999999987653221 12233468999999998853 4578999999999999999999998642211 011
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
... ..........+ +......+.+++.+||+.||++||++.||++.
T Consensus 238 --~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 --LFK-IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --Hhh-ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 100 11111111111 11122467889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.84 Aligned_cols=195 Identities=28% Similarity=0.441 Sum_probs=157.7
Q ss_pred cccccCCcEEEEEeecC---CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 425 (674)
.+||+|+||.||+++.. ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999864 45789999886543 23467899999999999999999998854 4577999999976
Q ss_pred CcccccccC------CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE----cCCCCeEEeeeCCcc
Q 005846 426 KSLDYFLYD------PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAR 495 (674)
Q Consensus 426 gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~ki~DfGla~ 495 (674)
+|..++.. ......+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 44444321 112235889999999999999999999988 9999999999999 566789999999998
Q ss_pred ccCCCCCC-CccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCc
Q 005846 496 IFGVDQTQ-GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
........ .......||+.|+|||++.+ ..++.++|||||||++|||+||++|+..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76433221 12334578999999999876 4589999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.35 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=198.7
Q ss_pred CCCcccccccCCcEEEEEeecCC--CceeEEEEeccc----------CccCHHHHHHHHHHHHh-cCCCceeeEEeEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSKA----------SGQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLE 412 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~ 412 (674)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 678999987532 12233456788888875 799999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998877432 23456899999999999999999999632 3999999999999999999999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
|++....... ......|+..|++||.+.++.++.++||||||+++|||++|+.|+.... ....... ....
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~-~~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATK-IVEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHH-Hhhc
Confidence 9998654322 2334568899999999998889999999999999999999998863211 1111111 1111
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..... . .......+.+++.+||+.||++||++.|+..++++
T Consensus 229 ~~~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYEPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCCcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11000 0 11123467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.04 Aligned_cols=240 Identities=24% Similarity=0.313 Sum_probs=184.1
Q ss_pred cccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc---CCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
||+|+||+||+++.. +++.||||++.+.. ......+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 68899999986532 12223345566666655 699999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|..++. +...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988874 3456899999999999999999999988 9999999999999999999999999987532221 22
Q ss_pred cccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
.....||+.|+|||.+.+. .++.++|||||||++|||++|+.|+... ..... +.....+.. .+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~---~~~~~----~~~i~~~~~-~~~-----~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE---DTQQM----YRNIAFGKV-RFP-----K- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC---CHHHH----HHHHHcCCC-CCC-----C-
Confidence 3345799999999998765 4899999999999999999999986421 11111 111111110 000 0
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCC----CHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERP----SMATIVL 616 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RP----t~~evl~ 616 (674)
......+.+++.+||+.||.+|| ++.++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01234677899999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.34 Aligned_cols=260 Identities=26% Similarity=0.314 Sum_probs=194.7
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 413 (674)
..++|+..+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999985 358899999987532 23346678899999999999999999988643
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
...++||||++++ |...+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 3469999999764 444442 24889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh-----
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW----- 568 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~----- 568 (674)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.|+..... .+.........
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCP 239 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 9864322 122345789999999999998999999999999999999999998753221 11111111100
Q ss_pred -------------cCCCc--cee-----cccccC---CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 569 -------------RDGTP--LQL-----LDTNLT---DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 569 -------------~~~~~--~~~-----~d~~~~---~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
....+ ..+ ....+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 000 000000 01111223467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.15 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=192.7
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-----ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cee
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 416 (674)
.+|+..+.||+|+||.||++.. .++..|++|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788999999999999999986 458899999886432 12235688899999999999999999988753 567
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++++||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999998884 3345899999999999999999999887 99999999999999999999999999876
Q ss_pred cCCCCC-CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 497 FGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 497 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... ........++..|+|||++.+..++.++||||||+++|||++|+.|+.... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~~~~~~~~~~~~--- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE------AMAAIFKIATQPT--- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcCCC---
Confidence 532111 111223457889999999998889999999999999999999999864221 1111111111110
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....+......+..++ .||..+|++||+++||+.
T Consensus 227 ------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111222223445555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=301.49 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=197.8
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc----------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG----------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
+|...+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999985 4688999998753211 11246788999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998843 357899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCC--CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+...............|+..|+|||.+.... ++.++||||||+++||+++|+.|+... +.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE------EAIAAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc------chHHHHHHhhcccc
Confidence 7653322222233456888999999987654 889999999999999999999986321 11111121111111
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+ .. .........+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPI-PP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcC-Cc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 11 111223457888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.23 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=197.6
Q ss_pred CCcccccccCCcEEEEEeecC----CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 414 (674)
|.+.+.||+|+||.||+|.+. ++..||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3678999998653 2334567889999999999999999999886543
Q ss_pred eeEEEEEecCCCcccccccCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 415 EKILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
..++++||+++|+|..++.... +...+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999987764321 2235789999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
|+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+.. ....+...+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~---~~~~~~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG---VENSEIYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC---CCHHHHHHHHH----c
Confidence 99986643332222223345678999999998889999999999999999999 7776532 11222222221 1
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..... .+......+.+++.+||+.+|++||++.++++.|++.
T Consensus 231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11100 1112345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.61 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=196.3
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|.+.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999864 57889999986433 23345678899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
++ ++|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 477777643 2346899999999999999999999987 9999999999999999999999999997643222
Q ss_pred CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC---Ccceecc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG---TPLQLLD 578 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~d 578 (674)
.......+++.|+|||.+.+. .++.++||||||+++|||+||+.|+.... ..+.+......+... ....+++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST---VEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCChhhchhhhc
Confidence 112234578899999988654 58899999999999999999998875322 112222111111100 0000000
Q ss_pred ---------cccCC----CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 ---------TNLTD----SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ---------~~~~~----~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001122346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.55 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=199.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-----ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999975 78999999886533 22456788999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998843 346899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCCCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.. ......|+..|++||.+.... ++.++|+||||+++|+|++|+.|+.... .....+........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~----- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRSKEL----- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHHHhcccC-----
Confidence 22 223456889999999988776 8999999999999999999999864322 11111111110111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|.+||++.+++.
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112223456788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.91 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=201.1
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.++||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457899999999999999999964 6889999998776666667889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 999999998843 2346999999999999999999999988 9999999999999999999999999987643221
Q ss_pred CCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 503 QGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.......+++.|++||.+. ...++.++||||||+++|||++|+.|+..... ...+ .. +.......+.
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~---~~-~~~~~~~~~~ 229 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVL---LK-ILKSEPPTLD 229 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHH---HH-HhcCCCCCcC
Confidence 1223456889999999875 34577899999999999999999998643211 1111 11 1111110000
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+......+.+++..||+.+|.+||++.+|++
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 230 -------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 01122346778999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.72 Aligned_cols=249 Identities=26% Similarity=0.344 Sum_probs=198.7
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 421 (674)
+|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999854 57889999986432 3345678899999999999999999998764 446789999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++... ....+++.+++.++.+++.||.+||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888542 3446899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.......+++.|+|||++.+..++.++||||||++++||++|+.|+.... .. ........ +..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~---~~~~~~~~-~~~-------- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MN---SLVYRIIE-GKL-------- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HH---HHHHHHHh-cCC--------
Confidence 12234568899999999999999999999999999999999998864221 11 11111111 111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112234457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.95 Aligned_cols=260 Identities=25% Similarity=0.306 Sum_probs=194.6
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 413 (674)
..++|+..+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356899999999999999999985 357889999987532 33346678999999999999999999987543
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
...++||||+++ +|..++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 4544442 24889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC---
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD--- 570 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~--- 570 (674)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..... .+...........
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 9865322 122345789999999999999999999999999999999999998753221 1111111111000
Q ss_pred ---------------CCcc-------eeccccc---CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 571 ---------------GTPL-------QLLDTNL---TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 571 ---------------~~~~-------~~~d~~~---~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+. +...... ...........+.+++.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000000 000111123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=309.72 Aligned_cols=261 Identities=28% Similarity=0.377 Sum_probs=198.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|+..++||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 588999998865332 234568899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|+.+.. ....+++..++.++.||++||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988763 2345899999999999999999999987 9999999999999999999999999987654322
Q ss_pred CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC--ccee--
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT--PLQL-- 576 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~-- 576 (674)
.......++..|+|||++.+ ..++.++||||||+++|||++|++|+.... ..+...........-. ..+.
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS---DIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc---hHHHHHHHHHHhCCCchhhHHHhc
Confidence 22233467889999999875 457889999999999999999998764221 1111111111000000 0000
Q ss_pred ----c----ccccCC-----CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 ----L----DTNLTD-----SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ----~----d~~~~~-----~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. .+.... .........+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=300.37 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=200.2
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|++.+.||+|+||.||++.. .+|+.||+|++... .....+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 578899999999999999985 46889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999888743 22345889999999999999999999987 99999999999999999999999999976543221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......|++.|+|||++.+..++.++||||||++++||++|+.|+... ...+ ........ ...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~---~~~~~~~~-~~~-------- 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKN---LVLKIIRG-SYP-------- 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHH---HHHHHhcC-CCC--------
Confidence 122345788999999999889999999999999999999999886421 1111 11111111 110
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112233456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.64 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=196.1
Q ss_pred CCCcccccccCCcEEEEEeecC---CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKI 417 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 417 (674)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999997633 33446778899999999999999999999988 7899
Q ss_pred EEEEecCCCcccccccC-CCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC----CCCeEEeee
Q 005846 418 LVYEFVPNKSLDYFLYD-PEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----EMNPKISDF 491 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~-~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~----~~~~ki~Df 491 (674)
+||||+++. |..++.. ... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCcC-HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999999864 4444422 122 236899999999999999999999988 999999999999999 999999999
Q ss_pred CCccccCCCCC-CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCcc------chHHH
Q 005846 492 GMARIFGVDQT-QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA------DLLSY 563 (674)
Q Consensus 492 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~------~~l~~ 563 (674)
|+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+......... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122345678899999988764 5889999999999999999999987643332200 00111
Q ss_pred HHhhhcCCC------------cceecccccCCCCC---------h--hHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 564 AWKQWRDGT------------PLQLLDTNLTDSYS---------R--NEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 564 ~~~~~~~~~------------~~~~~d~~~~~~~~---------~--~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....+.... .....+......++ . .....+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111110000 00000000001111 0 23356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.08 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=200.5
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecc--cCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++.|++.+.||+|.|+.|++... ++|+.+|+|++.. -+....+++.+|+.+.+.|+||||++|.....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346788889999999999999874 5799999998743 3445778899999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeEEeeeCCccc
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARI 496 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ki~DfGla~~ 496 (674)
+|+|.|+.|-.-+- .+-.+++..+-..+.||+++|.|.|.++ |||||+||+|+||.. .--+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999854442 2234677778889999999999999998 999999999999943 33589999999998
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
++ ........+|||+|||||++...+|+..+|||+-|||||-|+.|.+||.. ++...+.+.+....-+
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd------ 230 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYD------ 230 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccC------
Confidence 76 22333456899999999999999999999999999999999999999632 2233344333222111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
++..... ...+...+|+.+||..||.+|.|+.|.+.
T Consensus 231 ~~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YPSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111111 22346778999999999999999998874
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.21 Aligned_cols=247 Identities=30% Similarity=0.477 Sum_probs=196.9
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
++|++.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999986 67889999986532 346789999999999999999999998654 5799999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|..++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999988542 2345899999999999999999999987 999999999999999999999999998754321
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......+..|+|||++.++.++.++||||||+++|||++ |+.|+.... ........ ..+...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~----~~~~~~--------- 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS---LKEVKECV----EKGYRM--------- 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHH----hCCCCC---------
Confidence 112234568999999998899999999999999999998 887754221 11111111 111111
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=309.58 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=198.5
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.|.....||+|+||.||++.. .++..||||.+........+.+.+|+..++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 444457799999999999985 4688999999876555556778999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 999988873 345899999999999999999999987 9999999999999999999999999987653222 1
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... ....+.... ... ...+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~~----~~~-----~~~~~~- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP---PLQAMRRIR----DNL-----PPRVKD- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH----hcC-----CCcccc-
Confidence 2233568899999999988889999999999999999999999864211 111111111 110 111111
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.......+..++.+||+.||.+|||++++++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11223357788999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=337.82 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=198.3
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-- 413 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-- 413 (674)
..+...++|.+.++||+|+||+||++... .+..+|+|.+... .......|..|+.++.+++||||+++++++...
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34455678999999999999999999864 5678899988643 233356788999999999999999999988653
Q ss_pred CeeEEEEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CcEEEeecccccEEEcCC-----
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSR----LRIIHRDLKASNILLDAE----- 483 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~iiHrDlkp~NIll~~~----- 483 (674)
...+|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999998885422 23569999999999999999999998542 249999999999999642
Q ss_pred ------------CCeEEeeeCCccccCCCCCCCccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCCC
Q 005846 484 ------------MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNS 549 (674)
Q Consensus 484 ------------~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p~ 549 (674)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||+||+.||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 348999999998654322 2234578999999999864 45889999999999999999999997
Q ss_pred CccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 550 NFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.... ....+ ...+....... .......+.+|+..||+.+|.+||++.|++.
T Consensus 244 ~~~~--~~~ql----i~~lk~~p~lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKAN--NFSQL----ISELKRGPDLP----------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCC--cHHHH----HHHHhcCCCCC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 4211 11111 11111111000 0112346789999999999999999999983
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.57 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=197.4
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc-----CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ-----GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+|+..+.||+|+||.||+|... +++.|+||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999964 6889999998754322 234567899999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+ +++|..++... ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 89999888532 236999999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc-----
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP----- 573 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~----- 573 (674)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|.+++.... ..+.+............
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS---DIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc---cHHHHHHHHHHcCCCchhhhhh
Confidence 321 1222356788999998864 457899999999999999999976653221 11222111111100000
Q ss_pred ----ceecccccCCC-----CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 ----LQLLDTNLTDS-----YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ----~~~~d~~~~~~-----~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
........... ........+.+++.+||+.+|++|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 112234578899999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.41 Aligned_cols=198 Identities=19% Similarity=0.277 Sum_probs=163.8
Q ss_pred cccccccC--CcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 349 TDNKLGEG--GFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 349 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+.++||+| +|++||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999985 578999999986542 233456778999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999988432 2345899999999999999999999988 999999999999999999999999865433211110
Q ss_pred -----CccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCCCC
Q 005846 504 -----GNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSN 550 (674)
Q Consensus 504 -----~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p~~ 550 (674)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.|+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 01122356778999999876 458999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.02 Aligned_cols=251 Identities=38% Similarity=0.557 Sum_probs=198.6
Q ss_pred CCcccccccCCcEEEEEeecCC-----CceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
|.+.+.||.|+||.||+++..+ +..||+|++...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999643 378999999765433 5678899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999885321 122899999999999999999999987 999999999999999999999999999876543
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
...... ...+++.|+|||.+....++.++||||||++++||++ |..|+.. ....+...... ......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~~~~~~~~~~~----~~~~~~---- 224 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG---MSNEEVLEYLK----KGYRLP---- 224 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHh----cCCCCC----
Confidence 222111 2336789999999988889999999999999999999 6666432 11122222211 111111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
.+......+.+++.+||+.+|++|||+.++++.|
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112345688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=299.75 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=200.3
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
+|+..+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 5788999999864321 124678899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCcccc
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF 497 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~ 497 (674)
|+||+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999884 3456899999999999999999999988 99999999999998776 5999999998776
Q ss_pred CCCCCC--CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 498 GVDQTQ--GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... .......|+..|+|||.+.+..++.++||||+|++++||++|+.|+...... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~----- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---NHLALIFKIASA----- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc---chHHHHHHHhcc-----
Confidence 433111 1122346889999999998888999999999999999999999986432211 111111111110
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......+......+.+++.+||+.+|++||++.+++.
T Consensus 227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111223334457888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.10 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=193.5
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG----- 413 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----- 413 (674)
...++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 467899999986532 22345678899999999999999999987543
Q ss_pred -CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 414 -EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 414 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
...++++|++ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 778877762 346999999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.... ..+.+..........
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~ 235 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND---YIDQLKRIMEVVGTP 235 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhCCC
Confidence 99865321 233578999999999876 568999999999999999999998864321 111111111111000
Q ss_pred Ccceecccc----------cCCCCC--------hhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 TPLQLLDTN----------LTDSYS--------RNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ~~~~~~d~~----------~~~~~~--------~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. .+..... .....+ ......+.+++.+||+.||++|||+.|++.
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 236 S-PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred C-HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000 000000 011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=297.44 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=205.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999975 489999999876543 4467889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
+++++|.+++.. ...+++..++.++.|+++||.|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999843 3678999999999999999999999 87 9999999999999999999999999998764332
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.. .....++..|+|||.+.+..++.++||||||+++|||+||+.|+.........+...... .....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~------- 221 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPP------- 221 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCC-------
Confidence 22 224567889999999999899999999999999999999999875433212222222221 11111
Q ss_pred CCCCChh-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 582 TDSYSRN-EVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 582 ~~~~~~~-~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+.. ....+.+++..||+.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11112 34578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.22 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=202.5
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36889999999999999999985 46788999998765555567789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999884 235889999999999999999999988 99999999999999999999999999876543221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......|++.|++||.+.+..++.++||||||+++||+++|+.|+....... .+ ......+.+ .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~---~~~~~~~~~--------~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---AL---YLIATNGTP--------E 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---he---eehhcCCCC--------C
Confidence 2233468889999999988889999999999999999999999875322111 00 000111110 0
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
...+......+.+++..||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112233467789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.08 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=200.3
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|++.+.||+|+||.||+|.. .+|+.|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999996 468899999987543 33356789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+ +++|.+++... ...+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999887532 256999999999999999999999987 99999999999999999999999999987643322
Q ss_pred CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc--------
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP-------- 573 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~-------- 573 (674)
.......|+..|+|||.+.+. .++.++||||+|++++||++|++++.. ......+............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG---ENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC---CCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 122334688999999998654 468999999999999999999766432 1112222222221111100
Q ss_pred ----ceeccccc----CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 ----LQLLDTNL----TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ----~~~~d~~~----~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+..+.. ......+....+.+++.+||+.+|++||++++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000111234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.21 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=199.2
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.|+...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445568999999999999853 688999999876555556778899999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|..++. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 102 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 102 GGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 999988763 346899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+.... ....+.. +........ .
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~~----~~~~~~~~~-----~-- 238 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKR----LRDSPPPKL-----K-- 238 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HhccCCCCc-----c--
Confidence 2233568899999999998899999999999999999999999864221 1111111 111110000 0
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
........+.+++.+||+.+|++||+++++++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011223457789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=302.26 Aligned_cols=262 Identities=27% Similarity=0.372 Sum_probs=201.7
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 412 (674)
+....+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34455566788999999999999999999986 468899999986532 2345678899999999 89999999999875
Q ss_pred C-----CeeEEEEEecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCe
Q 005846 413 G-----EEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (674)
Q Consensus 413 ~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 486 (674)
. ...++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999998887532 23456899999999999999999999987 9999999999999999999
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCC-----CCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-----FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
||+|||++........ ......|+..|+|||.+.... ++.++|||||||++|||++|+.|+..... .
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------V 239 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------H
Confidence 9999999886542221 122346888999999986443 68999999999999999999988642211 1
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....... ......+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLFKIP-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHh-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 111111111 1122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.83 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=194.5
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||+|+||.||+++.. +|+.+|+|++.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999964 68899999986432 22235678899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++ +|..++.. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 56555532 2356899999999999999999999988 9999999999999999999999999998654322
Q ss_pred CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc------ce
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP------LQ 575 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~------~~ 575 (674)
.......++..|+|||.+.+. .++.++|||||||++|||+||+.|+.. ..+....+....+....... ..
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC--CCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 112234578899999998765 478999999999999999999988522 12222222221111100000 00
Q ss_pred eccc----ccC-----CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDT----NLT-----DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~----~~~-----~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+. ... ..........+.+++.+||+.||.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000 0011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.50 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=198.7
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
-|+..++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477788999999999999985 467899999886432 233467889999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|..++. ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999998873 346899999999999999999999987 9999999999999999999999999987654321
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
.......++..|+|||.+.+..++.++|||||||++|||++|..|+..... .... .. ...... .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~---~~-~~~~~~---------~ 219 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVL---FL-IPKNNP---------P 219 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHH---HH-HhcCCC---------C
Confidence 112234678899999999888899999999999999999999988642211 1111 11 111111 1
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122234567889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=295.34 Aligned_cols=255 Identities=23% Similarity=0.264 Sum_probs=204.0
Q ss_pred hcCCCcccccccCCcEEEEEeecCC-CceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
-+.|+..+.||+|.-|+||.+.+.+ +..+|+|++.+.. .....+.+.|-++|+.++||.++.|++.+..++..+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3467788999999999999999754 5789999997753 33445667799999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||||+||+|..+++ .+..+.+++..+.-++..|+-||+|||-.| ||.|||||+||||.++|.+-|+||.|+.....
T Consensus 156 meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999988874 356677999999999999999999999998 99999999999999999999999998754311
Q ss_pred C--------------------------------C-C---------------------CCccccccccCCccCccccccCC
Q 005846 500 D--------------------------------Q-T---------------------QGNTSRIVGTYGYMAPEYAMHGQ 525 (674)
Q Consensus 500 ~--------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 525 (674)
. . . .......+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0 01123468999999999999999
Q ss_pred CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCC
Q 005846 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDP 605 (674)
Q Consensus 526 ~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP 605 (674)
.+.++|+|+|||++|||+.|..||....... .+.. ++-..+.-.........+.+||.+.|.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHH-------------HhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999975433221 1111 111111111112445678899999999999
Q ss_pred CCCCC----HHHHHHH
Q 005846 606 AERPS----MATIVLM 617 (674)
Q Consensus 606 ~~RPt----~~evl~~ 617 (674)
.+|.- +.||-+.
T Consensus 377 ~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhccccchHHhhcC
Confidence 99998 7887653
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=299.73 Aligned_cols=247 Identities=26% Similarity=0.468 Sum_probs=197.7
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-CccCHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCeeEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 420 (674)
.|+..+.||+|+||.||+|.. .+++.|++|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 577889999999999999995 56889999998654 3344567889999999996 999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++.. ..+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 36899999999999999999999988 999999999999999999999999999876433
Q ss_pred CCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
. .......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+..... ..... ....... +
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~-~~~~~~~-----~ 220 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMM-LIPKSKP-----P 220 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhh-ccccCCC-----C
Confidence 2 222334688999999988754 478999999999999999999998743211 11110 0111111 1
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+... .....+.+++.+||+.||++||++.+++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 13346788999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=298.48 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=201.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|+..+.||+|+||.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999975 58899999987653 33456788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
+++++|.+++... ...+++..+..++.|+++||.|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999988532 2578999999999999999999998 76 9999999999999999999999999987653221
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
. ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ............. ......
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~------ 223 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIV-NEPPPR------ 223 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHh-cCCCCC------
Confidence 1 125688899999999988999999999999999999999998753321 1111222221111 111101
Q ss_pred CCCCChh-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRN-EVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~-~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.. ....+.+++..||..||++|||+.+++.
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 ---LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0111 3446789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=301.90 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=198.9
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe--
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE-- 412 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-- 412 (674)
..++....+.|++.+.||+|+||.||+|.. .+++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 344445667899999999999999999996 467889999886543 2345678899999998 79999999999863
Q ss_pred ----CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEE
Q 005846 413 ----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (674)
Q Consensus 413 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki 488 (674)
+...+++|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999888542 3345889999999999999999999987 999999999999999999999
Q ss_pred eeeCCccccCCCCCCCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHH
Q 005846 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~ 563 (674)
+|||++....... .......|+..|+|||.+. +..++.++|||||||++|||++|+.|+...... ....
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~-- 236 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--RALF-- 236 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--hhhh--
Confidence 9999987653221 1223356889999999875 346888999999999999999999986422111 0010
Q ss_pred HHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 564 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... ...... . ........+.+++.+||+.||.+||++.||+.
T Consensus 237 --~~~-~~~~~~-----~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 --LIP-RNPPPK-----L---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hHh-hCCCCC-----C---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 000000 0 01123346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=301.66 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=195.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
+++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.++|+||+++++++..+...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46899999999999999999985 4688999999865432 223467889999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 555555432 2345788899999999999999999987 9999999999999999999999999987543221
Q ss_pred CCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc-------
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP------- 573 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~------- 573 (674)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+..... ..+.+...|..+.....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhhh
Confidence 112234578899999998754 578999999999999999999998753221 22222223322111000
Q ss_pred ------ceecccccCCCC-----ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 ------LQLLDTNLTDSY-----SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ------~~~~d~~~~~~~-----~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
............ .......+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0012346778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.31 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=196.0
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999965 678999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++ +|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 787777432 346899999999999999999999987 99999999999999999999999999875432211
Q ss_pred CCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee-----
Q 005846 503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL----- 576 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~----- 576 (674)
......++..|+|||++.+ ..++.++||||||+++|||++|+.|+.... ...+.+...+..+........
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST--DVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1122346789999998875 458899999999999999999998864322 112222222222111100000
Q ss_pred -----------c-ccccCCCC-ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 -----------L-DTNLTDSY-SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 -----------~-d~~~~~~~-~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. ...+.... .......+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=296.42 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=198.4
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999885 46788999998653 233456789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~~~~~ 501 (674)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++||||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2345899999999999999999999987 99999999999998654 57999999998764322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+.... ........ ... ....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~---~~~-~~~~------ 220 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKI---MSG-TFAP------ 220 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---hHHHHHHH---Hhc-CCCC------
Confidence 1223568889999999998889999999999999999999998864321 11111111 111 1001
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+......+.+++..||+.+|++|||+.|+++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11123446789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=298.39 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=194.7
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-----ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cee
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 416 (674)
++|++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999864 58899999875321 12245788899999999999999999988764 467
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+++|||+++++|.+++. ....+++..+.+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999998874 2345889999999999999999999988 99999999999999999999999999886
Q ss_pred cCCCCC-CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 497 FGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 497 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... .. ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~-~~~~~~~~~~~--- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-----AM-AAIFKIATQPT--- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-----hH-HHHHHHhcCCC---
Confidence 532211 112233468889999999988889999999999999999999999864221 11 11111111100
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....+......+.+++.+||. +|++||++++|++
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111233344567788888885 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=306.51 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=200.0
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|+..+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999864 57889999986543 223456789999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999984 3356899999999999999999999987 999999999999999999999999998742111
Q ss_pred CCC-------------CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh
Q 005846 501 QTQ-------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 501 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+... ...+++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---~~~~~~~~~--- 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQV--- 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH---
Confidence 000 0111245788999999999889999999999999999999999986421 111122111
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
. .+.. ..+.. .......+.+++.+||+.+|++||++.++.++|+.
T Consensus 229 ~-~~~~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 I-SDDI---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred H-hccc---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 1100 00000 01223467899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=299.30 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=200.1
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCeeEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVY 420 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 420 (674)
+|++.+.||.|+||.||++.. .+++.+|+|++... .....+.+.+|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 46788999988643 23335668899999999999999999998764 45679999
Q ss_pred EecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 421 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
||+++++|..++... .....+++..++.++.||+.||.|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999888542 22457999999999999999999999332 234999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.... ....... ...+.
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~----~~~~~----- 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASK----IKEGK----- 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHH----HhcCC-----
Confidence 43321 1223468999999999998889999999999999999999999865322 1111111 11111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
....+......+.+++.+||+.+|++||++.+|+++
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111223344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=302.17 Aligned_cols=264 Identities=25% Similarity=0.333 Sum_probs=197.2
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 419 (674)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47889999999999999999975 578899999864332 2234567899999999999999999999877 789999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+||+++ +|..++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 78777643 2236899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchH--------HHHHhhhcC
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL--------SYAWKQWRD 570 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l--------~~~~~~~~~ 570 (674)
.. .......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+...........+ ...|..+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999988754 4689999999999999999999887533221110000 001111100
Q ss_pred ------CCcceecccccCCCCChh-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 ------GTPLQLLDTNLTDSYSRN-EVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 ------~~~~~~~d~~~~~~~~~~-~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..........+...++.. ....+.+++.+||+.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111222222 3556789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=292.78 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=206.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
-|.++.+||+|+||.|||+.++ +|..+|||.+... .+.+++..||.+|.+.+.|++|+++|.+.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4677889999999999999864 6999999998655 456889999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
-|+..+++. .+.++|++.++..++...++||+|||... -||||||+.||||+.+|.+||+|||.+..+.. ...
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 999999985 35678999999999999999999999875 79999999999999999999999999976632 333
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
...++.||+.|||||++..-.|..++||||||+...||..|++|+.-...- +....+.......
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPT 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPT 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCC
Confidence 455688999999999999999999999999999999999999985321110 1111222222122
Q ss_pred C--ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 585 Y--SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 585 ~--~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+ +..-....-+++..||-++|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2 33445578899999999999999999988764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=291.84 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=205.2
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY 420 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 420 (674)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999975 688999999866542 4467889999999999999999999999988 8899999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++.. ...+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999998843 337999999999999999999999987 999999999999999999999999999876544
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
..........++..|++||.+.+...+.++||||||+++++|++|+.|+.... +.....+.......
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~-------- 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGE-------- 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCC--------
Confidence 32212334568889999999988889999999999999999999999875432 22222222221111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....+......+.+++.+||+.+|++||++.+++.
T Consensus 222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122233567889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=294.93 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=199.6
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc--CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|...+.||+|+||.||+|... +++.|++|.+...... ..+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 6889999998765442 567889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998843 345889999999999999999999988 99999999999999999999999999987643322
Q ss_pred CCc--cccccccCCccCccccccCC---CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 503 QGN--TSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 503 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... .....++..|+|||++.... ++.++||||||+++|||++|+.|+.... .. ......... +....+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~--~~---~~~~~~~~~-~~~~~~- 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD--NE---FQIMFHVGA-GHKPPI- 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc--ch---HHHHHHHhc-CCCCCC-
Confidence 111 12346788999999998766 8899999999999999999999974321 11 111111110 110000
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. . .......+.+++.+||+.+|.+||++.+++.
T Consensus 228 ~----~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 P----D--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred C----c--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0 0112446778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.73 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=199.6
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 420 (674)
++|+..++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999964 578899999875432 3456789999999999999999999988654 3689999
Q ss_pred EecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||+++++|.+++... .....+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23456899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCC--CCccchHHHHHhhhcCCCcceec
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT--DGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ....+...+.. ......+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~- 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPEL- 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhh-
Confidence 21 1234578899999999999999999999999999999999999764322 11112222111 1111111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..... ........+.+++.+||+.+|.+|||+.||++
T Consensus 229 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 10000 00123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=305.59 Aligned_cols=253 Identities=24% Similarity=0.266 Sum_probs=199.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc---CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ---GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|+..+.||+|+||.||++... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999965 4889999998764322 4456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+.+++|.+++.. .....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998853 23457999999999999999999999987 999999999999999999999999998765322
Q ss_pred CCC---------------------------CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC
Q 005846 501 QTQ---------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553 (674)
Q Consensus 501 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~ 553 (674)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123468889999999998899999999999999999999999964322
Q ss_pred CCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 005846 554 TDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS----MATIVL 616 (674)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt----~~evl~ 616 (674)
. ...+. ...... ............+.+++.+||+.||++||+ +.+++.
T Consensus 237 ~---~~~~~---~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R---DETFS---NILKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h---HHHHH---HHhcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111 111110 000001113567889999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.87 Aligned_cols=244 Identities=28% Similarity=0.346 Sum_probs=198.3
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999864 58899999986532 233466889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++. ....+++..+..++.||++||.|||+.+ ++||||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999998884 3357899999999999999999999987 999999999999999999999999999865432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.|+.... ..... .....+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~~~------- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIY----EKILEGKV------- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHhcCCc-------
Confidence 233468899999999988889999999999999999999999864322 11111 11111110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
..+......+.+++.+||+.||.+|| +++|++.
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11222245778999999999999999 6777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=296.32 Aligned_cols=247 Identities=27% Similarity=0.320 Sum_probs=200.0
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
+|++.+.||+|+||.||++... +++.||+|.+.+.. ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999965 58899999987533 2345678999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+.+++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999988843 357899999999999999999999987 9999999999999999999999999987654322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ..........
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~---------- 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQETA---------- 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhccc----------
Confidence 22334678899999999888899999999999999999999999754332211 1111111110
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCH--HHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSM--ATIV 615 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~--~evl 615 (674)
....+......+.+++.+||+.||.+||++ .|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011122234678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.86 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=199.3
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++..++..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455568999999999999985 4688899999866555556678899999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999988843 46899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+... ......... ........ .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~---~~~~~~~~~----~~~~~~~~-----~-- 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE---PPLQAMKRI----RDNLPPKL-----K-- 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHH----HhcCCCCC-----c--
Confidence 222346889999999998888999999999999999999999986421 111111111 11111011 0
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+......+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01123357889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=310.31 Aligned_cols=268 Identities=22% Similarity=0.356 Sum_probs=197.2
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----ee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~ 416 (674)
+++|++.++||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 468899999986432 233456788999999999999999999876543 57
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++|+||+.+ +|..++ ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 665555 2346999999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCCC-ccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 497 FGVDQTQG-NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
........ ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+.... ..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~---~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCHH
Confidence 54322111 1233568899999998754 468999999999999999999998874321 111111111111111000
Q ss_pred e---ecccc---------cCCCC-----ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HhcCC
Q 005846 575 Q---LLDTN---------LTDSY-----SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM--LNSYS 622 (674)
Q Consensus 575 ~---~~d~~---------~~~~~-----~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~--L~~~~ 622 (674)
. +.+.. ..... .......+.+++.+||+.+|++|||+.+++.. ++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 00000 00000 01123468899999999999999999999976 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.47 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=204.1
Q ss_pred cCCCcccccccCCcEEEEEeecCC-CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+.|.++..||.|+||.|||++.++ +...|.|++...+....++|.-||++|+...||+||+|++.+...+.+||..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345667889999999999999764 3345778888888888899999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
.||-.+.++.. -+..|.+.++.-++.|++.||.|||++. |||||||+.|||++.+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 99999888753 4567999999999999999999999998 9999999999999999999999999986432 223
Q ss_pred CccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 504 GNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.....+.|||+|||||+.. ..+|+.++||||||+.|.||.-+.+|..- .+......+. ....+..++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKi-aKSePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKI-AKSEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHH-hhcCCCcccC
Confidence 3455689999999999873 56799999999999999999999988421 1222222222 2223333332
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+ ..-...+.+++.+||.+||+.||++.++++.
T Consensus 258 P-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 P-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2 2233467789999999999999999998853
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.09 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=196.3
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEEEEE
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVYE 421 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 421 (674)
|++.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999865 57899999997653 33446788999999999999999999999988 78999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 777776432 246899999999999999999999987 9999999999999999999999999998764432
Q ss_pred CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc---c---
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP---L--- 574 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~---~--- 574 (674)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ...+............ .
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhccccc
Confidence 2 11223456789999998765 4588999999999999999999988643221 1112211111110000 0
Q ss_pred -----------eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 -----------QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 -----------~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......+...+.......+.+++.+||+.+|.+||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000001111112557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.42 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=202.1
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEec--ccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS--KASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
+.+....|+++++||.||.+.||++...+.+.+|+|++. ....+...-|.+||.+|.+| .|.+|++|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 344566799999999999999999998778888988764 35566678899999999999 599999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+|||||= .-+|..+|... .....+| .+..+..||+.++.++|+++ |||.||||.|.|+- .|.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999964 56788888432 2223345 77788999999999999998 99999999999985 46899999999999
Q ss_pred cCCCCCCCccccccccCCccCccccccCC-----------CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-----------FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
...+.........+||+.||+||.+.... .++++||||+|||||+|+-|+.||..+. +. |
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~----~ 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQ----I 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HH----H
Confidence 88777777777789999999999985432 5689999999999999999999974321 11 1
Q ss_pred hhhcCCCcceecccccCCCCChh-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRN-EVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~-~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+ ..+.++...-.|+.- ...+++++++.||+.||.+||+..++++
T Consensus 580 aKl-----~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 AKL-----HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHH-----HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 111 122333222222211 1112889999999999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=293.05 Aligned_cols=269 Identities=25% Similarity=0.356 Sum_probs=218.1
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
.++.+...+++....+-+|.||.||+|.|. +.+.|-+|.++.. +......+..|-.++..+.|||++++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 455666778888899999999999999653 3456778888654 444456788999999999999999999998
Q ss_pred EeC-CeeEEEEEecCCCccccccc-----CCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC
Q 005846 411 LEG-EEKILVYEFVPNKSLDYFLY-----DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (674)
Q Consensus 411 ~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~ 484 (674)
.++ +..+++|.++.-|+|..||. +....+.++..+...++.|++.|++|||+.+ +||.||..+|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 764 56799999999999999997 5555566888999999999999999999988 99999999999999999
Q ss_pred CeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHH
Q 005846 485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSY 563 (674)
Q Consensus 485 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~ 563 (674)
++||+|-.+++.+-..+.+.-......+..||+||.+.+..|+.++|||||||+||||+| |+.|.. +.+..+...+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya---eIDPfEm~~y 510 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA---EIDPFEMEHY 510 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc---ccCHHHHHHH
Confidence 999999999998766666655555556789999999999999999999999999999998 566632 2233333333
Q ss_pred HHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 564 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
....++-. -|.+.+.++..++.-||..+|++||+++|++.-|.++..++
T Consensus 511 lkdGyRla-------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 511 LKDGYRLA-------------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred Hhccceec-------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 33332222 23445668899999999999999999999999998865443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.78 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=194.7
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||.|++|.||+++.. +|+.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999864 68899999886533 22345788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+. ++|..++... ....+++..+..++.||++||+|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 5777776432 3456899999999999999999999987 9999999999999999999999999987654322
Q ss_pred CCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc--------
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP-------- 573 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~-------- 573 (674)
.......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+..... ...... ..........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFR-IFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH-HHHHhCCCChhhhhhhhH
Confidence 1122335688999999887654 68899999999999999999998643211 111111 1111100000
Q ss_pred --------ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 --------LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 --------~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+. .........+.+++.+||+.||.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 001112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=297.04 Aligned_cols=262 Identities=27% Similarity=0.397 Sum_probs=197.5
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+|+..++||.|++|.||+|+.. +|+.||||++..... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999964 688999999876433 23456788999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++ +|.+++........+++..+..++.||++||.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 77777654333456999999999999999999999987 99999999999999999999999999976543211
Q ss_pred CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc--------c
Q 005846 504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP--------L 574 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~--------~ 574 (674)
......++..|++||.+.+. .++.++||||||+++|||++|+.|+..... .+........+..... .
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN---EDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhHHHHhcC
Confidence 12234578899999988654 578999999999999999999988643221 1111111111110000 0
Q ss_pred eecccccC-------CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 QLLDTNLT-------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ~~~d~~~~-------~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
........ ..........+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011122346789999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=294.74 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=190.7
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHH-HHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999964 68999999987543 2223445556664 566799999999999999999999999
Q ss_pred ecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 422 FVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|++ ++|..++... .....+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 5676665432 2345699999999999999999999986 5 99999999999999999999999999986532
Q ss_pred CCCCCccccccccCCccCcccccc----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
.. ......|+..|+|||.+.+ ..++.++|+||||+++|||++|+.|+..... . .......... ....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~---~~~~~~~~~~-~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--P---FQQLKQVVEE-PSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--C---HHHHHHHHhc-CCCC
Confidence 21 1223467889999998864 4578999999999999999999998642111 1 1111111111 1111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+. .......+.+++.+||+.+|++||++.+|+.
T Consensus 228 ~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 0112346789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=297.29 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=206.5
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..-|...+.||+|.|.+|-.+++ -.|+.||||++.+..- ...-.+.+|+.-|+.++|||||+|+.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34578889999999999999873 3899999999976533 33456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE-cCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll-~~~~~~ki~DfGla~~~~~ 499 (674)
|.-.+|+|.+|+... ...+++....+++.||..|+.|+|+.+ +|||||||+||.+ .+-|-+||.|||++..+..
T Consensus 97 ELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999998543 345999999999999999999999887 9999999999976 5678899999999987654
Q ss_pred CCCCCccccccccCCccCccccccCCCC-ccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
. ......+|+..|-|||++.+..|+ +++||||||||||.|++|++||.-..+.+. ...++|
T Consensus 172 G---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImD 233 (864)
T KOG4717|consen 172 G---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMD 233 (864)
T ss_pred c---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhc
Confidence 3 344567999999999999999987 689999999999999999999753332211 111223
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
-. -..|.....+|.+||..||..||.+|-+.+||+..
T Consensus 234 CK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 234 CK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22 12355667789999999999999999999999853
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=290.21 Aligned_cols=249 Identities=30% Similarity=0.473 Sum_probs=201.9
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999975 688999999977655566788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|.+++... ...+++..+..++.|++++|.+||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999888432 256899999999999999999999987 99999999999999999999999999976643321
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
.....++..|++||++....++.++||||||+++++|++|+.|+.... ....+... .. ........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~---~~-~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP---PMKALFKI---AT-NGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHH---Hh-cCCCCcCc------
Confidence 334568899999999988889999999999999999999998864221 11111111 10 11111110
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+.+++..||+.||++|||+.++++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111356889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.71 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=193.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCe-----
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE----- 415 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~----- 415 (674)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999964 68899999876533 223457888999999994 6999999999887665
Q ss_pred eEEEEEecCCCcccccccCCCc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeC
Q 005846 416 KILVYEFVPNKSLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFG 492 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfG 492 (674)
.++||||+++ +|..++..... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 67666643222 346899999999999999999999987 999999999999998 8999999999
Q ss_pred CccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.|+.... ....+.. ........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~--~~~~~~~-~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS--ELQQLLH-IFKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHH-HHHHhCCC
Confidence 9986533221 1222356889999998865 457899999999999999999998864321 1111111 11111000
Q ss_pred Ccc---eecc-------cccC----CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 TPL---QLLD-------TNLT----DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ~~~---~~~d-------~~~~----~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... .... +... ..........+.+++.+||+.||.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000 0000 0001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=298.18 Aligned_cols=247 Identities=28% Similarity=0.391 Sum_probs=193.0
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.+.|+..++||+|+||.||+|+.. +++.||+|.+..... ...+++.+|+++++.++||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356889999999999999999864 688999998864332 2335688999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+||+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999975 55444422 2346899999999999999999999987 99999999999999999999999999875432
Q ss_pred CCCCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
. ....++..|+|||++. .+.++.++||||||+++|||+||+.|+.... ........... .....
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------~~~~~~~~~~~-~~~~~ 234 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQN-DSPTL 234 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------HHHHHHHHhcC-CCCCC
Confidence 1 2346788999999874 4568899999999999999999998853211 11111111101 00000
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
........+.+++.+||+.+|++||++.+|+..
T Consensus 235 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 --------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011233468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.37 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=203.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..++.|+..+.||+|+||.||++... ++..+++|++..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35667888999999999999999975 688999999976544 4567889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999985422 37999999999999999999999987 999999999999999999999999998755322
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.. ......++..|++||++.+..++.++||||||+++|||++|+.|+...... ...... .........+
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~~~~~-- 238 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLI----TTKGIPPLKN-- 238 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----HhcCCCCCcc--
Confidence 21 222345788999999998888999999999999999999999986422111 111111 1111101000
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+.+++.+||+.+|.+||++.+|+.
T Consensus 239 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 -----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112346788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=284.07 Aligned_cols=284 Identities=24% Similarity=0.343 Sum_probs=202.7
Q ss_pred hcCCCcccccccCCcEEEEEeecC---C--CceeEEEEecccCcc--CHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP---S--GQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~ 415 (674)
...|+...+||+|.||.|||+.-. + .+.+|||+++..... ......+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 347889999999999999999632 2 347899998754322 23456889999999999999999999988 778
Q ss_pred eEEEEEecCCCcccccccC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC----CCeEEee
Q 005846 416 KILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISD 490 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~----~~~ki~D 490 (674)
.++++||.+...+.-+-+. ..+...++...+..|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+|
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 8999999987665433322 223457899999999999999999999999 9999999999999887 8999999
Q ss_pred eCCccccCCCCCCC-ccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCC------ccchHH
Q 005846 491 FGMARIFGVDQTQG-NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG------AADLLS 562 (674)
Q Consensus 491 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~------~~~~l~ 562 (674)
||+++++...-..- ....++-|.+|.|||.+.+. .|+.+.|||+.|||+.||+|-++-|...+... ..+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999986543222 44567889999999999876 59999999999999999999887653322111 112222
Q ss_pred HHHhhhcCCCcceecccc-----------cC-CCCCh-----------hHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 563 YAWKQWRDGTPLQLLDTN-----------LT-DSYSR-----------NEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~-----------~~-~~~~~-----------~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
.+.+.+.........+-. +. ..+.. .......+|+.++|+.||.+|.|+++.++..
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~- 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP- 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-
Confidence 232222211111100000 00 00000 0111267889999999999999999987643
Q ss_pred cCCCCCCCCCCCc
Q 005846 620 SYSVTLPSPQQPA 632 (674)
Q Consensus 620 ~~~~~~~~p~~p~ 632 (674)
++...+.|.+|.
T Consensus 339 -yF~~d~lpp~pt 350 (438)
T KOG0666|consen 339 -YFTEDPLPPLPT 350 (438)
T ss_pred -ccccCCCCCCcc
Confidence 444444443343
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.78 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=193.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|...++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5666789999999999999854 58899999986543 234457889999999996 99999999999999999999999
Q ss_pred cCCCccccc---ccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 423 VPNKSLDYF---LYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 423 ~~~gsL~~~---l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
+.. +|..+ +.. .....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 44332 211 1235699999999999999999999975 5 9999999999999999999999999997654
Q ss_pred CCCCCCccccccccCCccCccccccC---CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.|+.... .......+.... ...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~~~- 229 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG-DPP- 229 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC-CCC-
Confidence 222 11233578899999998776 68999999999999999999999975322 111222211111 111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+...........+.+++.+||+.+|++|||+++|+..
T Consensus 230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112344578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.20 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=198.4
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC------
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~------ 414 (674)
.+++|++.+.||+|+||.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999964 578899998865433 346789999999999 7999999999997644
Q ss_pred eeEEEEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 415 EKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999988875422 2457899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCcccccc-----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
+....... .......|+..|+|||++.. ..++.++||||||++++||++|+.|+.... .. ..+. ...
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~-~~~~---~~~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH--PM-RALF---KIP 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc--hH-HHHH---Hhh
Confidence 87653222 22233568899999998753 347789999999999999999999864211 11 1111 111
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......+ ..+......+.+++.+||..||++|||+.++++
T Consensus 232 -~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 011123457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=296.73 Aligned_cols=249 Identities=28% Similarity=0.369 Sum_probs=200.6
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
...+.|+.-+.||+||||+||-.+. .+|+.+|.|++.+. .........+|-.+|.+++.+.||.+-..+...+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456788999999999999999884 47999999988542 2334455688999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|+..|.||+|..+|++.. ...+++..+.-++.+|+.||.+||... ||.|||||+|||||+.|+++|+|+|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999997643 357999999999999999999999987 999999999999999999999999999877
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
...... ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||.........+-++ .+.. .
T Consensus 338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~--~------ 404 (591)
T KOG0986|consen 338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTL--E------ 404 (591)
T ss_pred CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHh--c------
Confidence 544322 22389999999999999999999999999999999999999975322211110000 0000 0
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt 610 (674)
....++....+++..|....|++||++|.-
T Consensus 405 ---~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 ---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ---chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 012344445567777888889999999964
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.03 Aligned_cols=260 Identities=27% Similarity=0.350 Sum_probs=195.6
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 413 (674)
..++|+..+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999985 46889999998643 223345677899999999999999999988643
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
...++||||+.+ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999965 66665521 2889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh-------
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK------- 566 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~------- 566 (674)
++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+..... .........
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 98654321 12234678899999999999999999999999999999999988753221 111111100
Q ss_pred -----------hhcCCCc-------ceeccccc----CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 567 -----------QWRDGTP-------LQLLDTNL----TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 567 -----------~~~~~~~-------~~~~d~~~----~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+..... .+...... ...........+.+++.+||+.||++|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00000000 001112335567899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.53 Aligned_cols=266 Identities=25% Similarity=0.356 Sum_probs=192.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-------
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------- 414 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 414 (674)
++|+..++||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47999999999999999999864 68899999886432 222345678999999999999999999987654
Q ss_pred -eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 415 -EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 415 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
..++||||+.+ +|..++.. ....+++.+++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 34999999975 66655532 2346899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCC--CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 494 ARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 494 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+...+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 112234578899999988664 4789999999999999999999886433221111111111111000
Q ss_pred CCc-----ceecccc-cCCCC---------ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 GTP-----LQLLDTN-LTDSY---------SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 ~~~-----~~~~d~~-~~~~~---------~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... ....+.. ..... +......+.+++.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 0000000 00000 0012245678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.06 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=196.3
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeC--Cee
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG--EEK 416 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~--~~~ 416 (674)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999964 5789999988542 223345677899999999 999999999998653 368
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 478777632 27899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCC---CccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh-----
Q 005846 497 FGVDQTQ---GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ----- 567 (674)
Q Consensus 497 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~----- 567 (674)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||+||+.|+...... +........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~ 233 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL---NQLEKIIEVIGPPS 233 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Confidence 6433221 12234568999999998765 46789999999999999999999886432211 111111110
Q ss_pred ------hcCCCcceecccccC------CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 568 ------WRDGTPLQLLDTNLT------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 568 ------~~~~~~~~~~d~~~~------~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+.......+++.... ..........+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000001100000 00001134578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.70 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=194.0
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 418 (674)
.++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 689999999864322 2223467899999999999999999998765 46899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+.+ +|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 67666643 2356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC-----
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT----- 572 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~----- 572 (674)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.... ..+.+...........
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS---EIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCChhhch
Confidence 3221 1222345788999999865 457899999999999999999998865321 1222222211111000
Q ss_pred ------cceec--ccccCCCC---ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 573 ------PLQLL--DTNLTDSY---SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 573 ------~~~~~--d~~~~~~~---~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..... ........ .......+.+++.+||+.||++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000000 00124466789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.45 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=194.4
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
|+..++||.|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999854 78999999986543 223456889999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
+ ++|..++... ....+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 6788877432 2246899999999999999999999987 99999999999999999999999999976533221
Q ss_pred CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC---------c
Q 005846 504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT---------P 573 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~---------~ 573 (674)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+..... ...+.. ..+...... .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHHhCCCChHHhhhhhhc
Confidence 12223568899999988664 578999999999999999999988643211 111111 111000000 0
Q ss_pred ceec------ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 LQLL------DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ~~~~------d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.. ...............+.+++.+||+.+|++|||++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 000000111223357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.55 Aligned_cols=265 Identities=23% Similarity=0.347 Sum_probs=196.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC---
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--- 414 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 414 (674)
+...++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456678999999999999999999974 58899999986532 233456788999999999999999999987655
Q ss_pred -------eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 415 -------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 415 -------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
..++|+||+++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999987 45444432 2346899999999999999999999987 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++|+.... ....+.....
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~---~~~~~~~~~~ 232 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ---ELAQLELISR 232 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHH
Confidence 999999986643321 11122346778999998865 457899999999999999999998864321 1122222222
Q ss_pred hhcCCCcc---ee--------ccc------ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 567 QWRDGTPL---QL--------LDT------NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 567 ~~~~~~~~---~~--------~d~------~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
........ .+ .+. ..... ....+..+.+++..||+.+|.+||++++|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111000 00 000 00000 0112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=308.75 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=193.2
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEe--cc--cCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe--eEEE
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRL--SK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE--KILV 419 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lv 419 (674)
.+...+||+|.|-+||||.+. +|.+||--.+ .. .+....+.|..|+.+|+.|+||||++++.++.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345578999999999999863 4667763222 21 344556889999999999999999999999987665 7899
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeEEeeeCCccccC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFG 498 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ki~DfGla~~~~ 498 (674)
+|.+..|+|..++. +.+.++...+..|++||++||.|||++. +||||||||-+||+|+ .-|.+||+|+|||....
T Consensus 122 TEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999984 4567899999999999999999999985 7899999999999996 45899999999999864
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.. ....++|||.|||||... ..|...+||||||+.++||+|+..|+. .-....++ ++....|....-+
T Consensus 198 ~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs--EC~n~AQI----YKKV~SGiKP~sl- 265 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS--ECTNPAQI----YKKVTSGIKPAAL- 265 (632)
T ss_pred cc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh--hhCCHHHH----HHHHHcCCCHHHh-
Confidence 32 233479999999999776 789999999999999999999998853 22222222 2222222221111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..-....+.++|.+|+.. ..+|||+.|+|.
T Consensus 266 -------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 -------SKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------hccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111234678899999999 999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=294.60 Aligned_cols=257 Identities=22% Similarity=0.287 Sum_probs=190.4
Q ss_pred CCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeC--CeeEEEEE
Q 005846 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVYE 421 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 421 (674)
|++.++||+|+||.||++.. .+++.||+|+++... ........+|+..+.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999985 468899999987542 222234457888898885 99999999999987 88999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 66666532 2346899999999999999999999987 999999999999999 999999999998654322
Q ss_pred CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh-----------c
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW-----------R 569 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~-----------~ 569 (674)
. .....++..|+|||++.. +.++.++|||||||++|||++|+.|+..... .+.+....... .
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence 1 123457889999997654 5578999999999999999999988743221 11222111111 0
Q ss_pred CCCcceecccccC----CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 570 DGTPLQLLDTNLT----DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 570 ~~~~~~~~d~~~~----~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.........+... ..........+.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 0001133567899999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.60 Aligned_cols=270 Identities=19% Similarity=0.282 Sum_probs=186.0
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCC--CceeEEE------------------EecccCccCHHHHHHHHHHHHhcCC
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVK------------------RLSKASGQGAEEFKNEVVLVAKLQH 400 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~h 400 (674)
....++|++.++||+|+||+||++.++. +...++| .+. ........+.+|+.++++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3445789999999999999999986432 2222222 111 112234567899999999999
Q ss_pred CceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccE
Q 005846 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK--QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (674)
Q Consensus 401 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NI 478 (674)
+||+++++++...+..++|+|++.+ +|..++..... ........+..|+.||+.||.|||+.+ |+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999999999999999999865 44444432111 122345677889999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCC-CCc
Q 005846 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT-DGA 557 (674)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~-~~~ 557 (674)
|++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++..... ...
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999987643222 122335799999999999999999999999999999999999854322111 111
Q ss_pred cchHHHHHhhhcC--CCcc-------eecccc-cC---CCCC-----hhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 558 ADLLSYAWKQWRD--GTPL-------QLLDTN-LT---DSYS-----RNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 558 ~~~l~~~~~~~~~--~~~~-------~~~d~~-~~---~~~~-----~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+.... ..... .... ..++.. .. ...+ ......+.+++.+||+.||.+|||+.|++.+
T Consensus 378 ~~~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111 11100 0000 000000 00 0000 0112345677889999999999999999863
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=290.15 Aligned_cols=242 Identities=25% Similarity=0.329 Sum_probs=193.6
Q ss_pred cccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
||.|+||.||+++.. +++.+++|++.+.. ....+.+.+|+.+++.++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 48899999986533 23346789999999999999999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcccc
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 508 (674)
.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345899999999999999999999987 9999999999999999999999999998764332 2223
Q ss_pred ccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
..++..|++||.+.+..++.++|+||||+++|||++|+.|+.....+ ............. ...++..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~---------~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG---------KLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC---------CCCCCcc
Confidence 46788999999998888999999999999999999999987543221 1111111111000 1112222
Q ss_pred HHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 589 EVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
....+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2457889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.71 Aligned_cols=204 Identities=31% Similarity=0.489 Sum_probs=176.9
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------eeE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------EKI 417 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~ 417 (674)
.+...+.||+|+||.||+|+. ..|+.||||.+.... ....+...+|+++|++++|+|||++++.-.... ..+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355678899999999999994 579999999987643 344567789999999999999999999865443 578
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE--cCCCC--eEEeeeCC
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DAEMN--PKISDFGM 493 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll--~~~~~--~ki~DfGl 493 (674)
+|||||.+|+|...+....+...|++.+.+.++.++..||.|||+++ |+||||||.||++ .++|+ -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999999999999999999999999999999988 9999999999998 33344 69999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccc-cCCCCccccEEeechhhhHhHhCCCCCCccCCC
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~ 555 (674)
|+.+..+. .....+||..|++||... .+.|+..+|.|||||++|+.+||..||......
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99876443 456789999999999998 488999999999999999999999998654433
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.18 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=185.5
Q ss_pred ccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHHHh---cCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAK---LQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.||+|+||.||++.. .+++.+|+|.+.+... .....+.+|..++.. .+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 4688999998865321 112334455444443 479999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999988874 3456999999999999999999999988 9999999999999999999999999987553221
Q ss_pred ccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+......... ........ .. .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~----~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VN----V 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CC----c
Confidence 223468999999998864 55899999999999999999999997533222111 11111000 01 1
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
..+......+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11223345788999999999999999 59988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=289.69 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=198.2
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999964 57889999986532 23446788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC-eEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-~ki~DfGla~~~~~~~ 501 (674)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999888542 2345899999999999999999999987 999999999999998864 6999999998764322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.... ........... ....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~------ 221 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG-YFAP------ 221 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-cCCC------
Confidence 1 1223468899999999988889999999999999999999999864211 11122211111 1100
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
........+.+++.+||+.+|++|||+.+|++
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.06 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=196.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Ce
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 415 (674)
.++|.+.+.||+|+||.||+++. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999985 46889999998653 223345677899999999999999999987654 34
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++|+||+. ++|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 57776663 3456999999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC--
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT-- 572 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~-- 572 (674)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.|+.... ....+......+....
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD---YVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCChH
Confidence 654322 12233467889999998865 468999999999999999999999874321 1111111111111000
Q ss_pred ---------cceec-------ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 573 ---------PLQLL-------DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 573 ---------~~~~~-------d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
....+ +.... .........+.+++.+||+.+|++|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 00000 0011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=296.49 Aligned_cols=258 Identities=17% Similarity=0.209 Sum_probs=182.7
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCC----CceeEEEEecccCccCHH-----------HHHHHHHHHHhcCCCceeeE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASGQGAE-----------EFKNEVVLVAKLQHRNLVRL 406 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~Ei~~l~~l~h~niv~l 406 (674)
+..++|++.++||+|+||.||+|...+ +..+|+|+.......... ....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345689999999999999999999654 345666654322221111 11223344556789999999
Q ss_pred EeEEEeCC----eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC
Q 005846 407 LGFCLEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 407 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~ 482 (674)
++++.... ..++++|++.. ++.+.+. .....++..+..++.|+++||.|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99776543 34677777643 4444442 2234678889999999999999999987 999999999999999
Q ss_pred CCCeEEeeeCCccccCCCCCC-----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCc
Q 005846 483 EMNPKISDFGMARIFGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557 (674)
Q Consensus 483 ~~~~ki~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~ 557 (674)
++.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~-- 239 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN-- 239 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--
Confidence 999999999999876432211 1122346999999999999999999999999999999999999997543211
Q ss_pred cchHHHHH----hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 558 ADLLSYAW----KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 558 ~~~l~~~~----~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
........ .....+.. . .......+.+++..||+.+|++||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111111 11111110 0 0112356788999999999999999999998763
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=296.83 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=196.3
Q ss_pred CcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 348 STDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
....+||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++|+|++++++++..++..++||||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 3346899999999999986 468899999986555555667899999999999999999999999999999999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 506 (674)
+|.+++. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... ...
T Consensus 103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~ 173 (292)
T cd06657 103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 173 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence 9988773 345899999999999999999999987 9999999999999999999999999987653221 112
Q ss_pred ccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCC
Q 005846 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYS 586 (674)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~ 586 (674)
....|+..|++||.+.+..++.++||||||+++|||++|+.|+... .....+....... ... +.. .
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~---~~~~~~~~~~~~~----~~~-----~~~--~ 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNL----PPK-----LKN--L 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhhC----Ccc-----cCC--c
Confidence 3346889999999998888999999999999999999999986421 1111111111111 100 000 1
Q ss_pred hhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 587 RNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 587 ~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......+.+++.+||+.+|.+||++.+++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112346778999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.45 Aligned_cols=244 Identities=27% Similarity=0.359 Sum_probs=191.1
Q ss_pred cccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 353 LGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 353 lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
||+|+||+||++.. .+|+.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468899999986532 22344567899999999999999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcccc
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 508 (674)
.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 9888543 2246899999999999999999999988 9999999999999999999999999987654311 1223
Q ss_pred ccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+........... ....... . ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~-~---------~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRRTLE-M---------AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhcccc-c---------cccCCcc
Confidence 4578899999999888899999999999999999999999753322111111 1110000 0 0111222
Q ss_pred HHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 589 EVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
....+.+++.+||+.+|.+|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 345788999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=298.68 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=193.5
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+.|+..+.||+|+||.||+++. .++..||+|++..... .....+.+|+.++++++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477889999999999999985 4688999999864322 23456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++ +|.+++.. ....+++.++..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 56555532 2456899999999999999999999987 99999999999999999999999999865432
Q ss_pred CCCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.|+.... ....+. ........ .
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~---~~~~~~~~-~-- 243 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALY---HIAQNESP-T-- 243 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHH---HHHhccCC-C--
Confidence 22346788999999874 4578999999999999999999998863211 111111 11111100 0
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
.........+.+++.+||+.+|.+||++.+|++.+-
T Consensus 244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 001123346789999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=288.10 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=202.9
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||.|+||.||++... ++..+++|++..... ...+.+.+|++++++++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999964 588999999875433 4556788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
+++++|.+++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999998885422 2367999999999999999999999987 9999999999999999999999999998764432
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+.... ...... ... ....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~---~~~-~~~~-------- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL---KIL-KGQY-------- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHH---HHh-cCCC--------
Confidence 12233568899999999988889999999999999999999998864322 111111 111 1111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 221 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112233456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=294.45 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=197.2
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc--CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ--GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
|+..+.||+|++|.||++... +++.+++|++...... ....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 6888999998654322 3567889999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++ +|..++.. ....+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 67666643 2357899999999999999999999988 9999999999999999999999999998765433
Q ss_pred CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc---ceecc-
Q 005846 504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP---LQLLD- 578 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~d- 578 (674)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.|+..... .+.+............ ....+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhh
Confidence 112234578899999998876 789999999999999999999988643221 1111111111111100 00000
Q ss_pred ----------cc--cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 ----------TN--LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ----------~~--~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. ............+.+++..||+.||.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 000011223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.51 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=193.2
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999864 688999998865322 234568899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeCCccccCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVD 500 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~~~~~~ 500 (674)
|+++ +|..++.. .....+++..+..++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9965 66555532 22334688889999999999999999987 999999999999985 567999999999765432
Q ss_pred CCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec--
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL-- 577 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-- 577 (674)
. .......+++.|+|||++.+. .++.++||||||+++|+|+||+.|+..... .+.+......+.... ....
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~-~~~~~~ 230 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRILGTPN-EETWPG 230 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCC-hhhccc
Confidence 1 112234578899999988764 578999999999999999999988643211 111111111111100 0000
Q ss_pred -----c-----cccC----CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 -----D-----TNLT----DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 -----d-----~~~~----~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+ +... ..........+.+++.+|++.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000 0011123456789999999999999999999986
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=292.04 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=195.6
Q ss_pred cccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
||.|+||.||+++.. +|+.+++|.+..... ...+.+.+|+.++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC------
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT------ 502 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~------ 502 (674)
.+++.. ...+++..+..++.||++||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 988843 347899999999999999999999987 99999999999999999999999999876533221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
........++..|++||.+.+...+.++||||||+++|||++|+.|+.... ........ . .+... ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~---~-~~~~~-~~----- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNI---L-NGKIE-WP----- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---h-cCCcC-CC-----
Confidence 112234567889999999988889999999999999999999999864322 11111111 1 11100 00
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
. .......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 222 ~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0 00124577899999999999999999777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.91 Aligned_cols=264 Identities=20% Similarity=0.315 Sum_probs=196.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 416 (674)
.++|++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999854 68999999987542 2345667889999999999999999998763 3467
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++|+||+. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 57877774 3345999999999999999999999987 99999999999999999999999999976
Q ss_pred cCCCCCC--CccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhc----
Q 005846 497 FGVDQTQ--GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR---- 569 (674)
Q Consensus 497 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~---- 569 (674)
....... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.|+..... ...+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~---~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY---VHQLKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh---HHHHHHHHHHhCCChh
Confidence 5432221 11234578899999998865 4689999999999999999999998743211 111111111000
Q ss_pred -------CCCcceecccc-cCCCC-----ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 570 -------DGTPLQLLDTN-LTDSY-----SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 570 -------~~~~~~~~d~~-~~~~~-----~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.....+..+.. ..... .......+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 00000 11234678899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=288.71 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=188.1
Q ss_pred cccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHH-HhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLV-AKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.||+|+||.||++.. .+++.||+|.+.+... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999986 4588999999865432 1122344454443 445899999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
++|..++. ....+++..+..++.||++||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999884 3346899999999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
.....++..|++||.+.+..++.++||||||+++|||++|..|+..... ... +......... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAV----FDNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhcccC------CCCcc
Confidence 2234678899999999888899999999999999999999999743211 111 1111111100 00011
Q ss_pred ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 586 SRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 586 ~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11234568899999999999999988766666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.39 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=200.8
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999864 578899999876543 3456789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999988843 357999999999999999999999987 99999999999999999999999999987653322
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
. .....++..|+|||...+..++.++|||+||+++|+|++|+.|+.... .....+.......
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~---------- 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------PMAALFRIVQDDH---------- 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccCC----------
Confidence 1 223467889999999988889999999999999999999998864221 1111111111110
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112223456789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=289.61 Aligned_cols=248 Identities=29% Similarity=0.381 Sum_probs=200.7
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|++.++||+|+||.||+++. .+++.+++|.+.... .....++.+|++++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999975 467889999986532 33355678899999999999999999999999999999999
Q ss_pred cCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
+++++|..++.... ....+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999998875422 2356899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
......++..|++||.+.+..++.++|+||||+++|||++|+.|+.... ...+... ......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~----~~~~~~-------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS---MQDLRYK----VQRGKY-------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HhcCCC--------
Confidence 1222457889999999999899999999999999999999999864322 1111111 111111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|++||++.++++
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112234456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=320.07 Aligned_cols=265 Identities=28% Similarity=0.396 Sum_probs=208.3
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecC----C----CceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEe
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP----S----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLG 408 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~ 408 (674)
.++...++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56677777778889999999999999742 1 4578999987643 34567899999999998 7999999999
Q ss_pred EEEeCCeeEEEEEecCCCcccccccCCC-----cC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccc
Q 005846 409 FCLEGEEKILVYEFVPNKSLDYFLYDPE-----KQ--------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA 475 (674)
Q Consensus 409 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp 475 (674)
+|.+....++|+||+..|+|..++...+ .. ..++....+.++.|||.||+||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996544 00 23889999999999999999999887 99999999
Q ss_pred ccEEEcCCCCeEEeeeCCccccCCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCC-CCCccC
Q 005846 476 SNILLDAEMNPKISDFGMARIFGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSNFYQ 553 (674)
Q Consensus 476 ~NIll~~~~~~ki~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~-p~~~~~ 553 (674)
+|||+.++..+||+|||+++......... ......-...|||||.+....|+.|+|||||||+||||+|.+. |+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 99999999999999999999654333222 1111012457999999999999999999999999999999554 4321
Q ss_pred CCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 554 TDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.....++++ ..+.+..++ .|.....++.++|+.||+.+|++||++.+++..++..
T Consensus 525 ~~~~~~l~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 IPPTEELLE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCcHHHHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111223322 233332222 2333456788999999999999999999999999873
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.35 Aligned_cols=263 Identities=26% Similarity=0.350 Sum_probs=192.6
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 414 (674)
.++|++.++||+|+||.||++... +++.+|+|++..... .....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999954 688999998864322 22345788999999999999999999875543
Q ss_pred --eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 415 --EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 415 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
..++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999976 45444432 2346999999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCC---------ccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHH
Q 005846 493 MARIFGVDQTQG---------NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS 562 (674)
Q Consensus 493 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~ 562 (674)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|++|+..... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~---~~~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD---IDQLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence 998654322111 11234678899999987654 588999999999999999999988643221 12222
Q ss_pred HHHhhhcCCCcc---------e----e----cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 563 YAWKQWRDGTPL---------Q----L----LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 563 ~~~~~~~~~~~~---------~----~----~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+..+...... . . ..+.+...+ ......+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 222211110000 0 0 000000000 112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.03 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=193.1
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEec
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
|++.+.||+|+||.||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578899999865432 22234467999999999 999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 778877774322 346899999999999999999999987 9999999999999999999999999997654322
Q ss_pred CccccccccCCccCccccc-cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh--------hcCC---
Q 005846 504 GNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ--------WRDG--- 571 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~--------~~~~--- 571 (674)
......++..|+|||.+. ...++.++||||||++++||++|+.|+......+ .+...... |.+.
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID---QLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH---HHHHHHHhcCCCChhhhhhHhhh
Confidence 122346788999999875 4468999999999999999999998864332111 11100000 0000
Q ss_pred --CcceecccccC---CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 --TPLQLLDTNLT---DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 --~~~~~~d~~~~---~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.....+..... ..........+.+++.+||+.+|++|||++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 0011112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.45 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=195.6
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-----CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cee
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 416 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 416 (674)
.+|++.+.||+|+||.||++.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999985 45889999987532 123345788999999999999999999998764 457
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++++||+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999988874 3345889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCC-CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 497 FGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 497 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+... .. ..........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~---~~~~~~~~~~~---- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY---EA---MAAIFKIATQP---- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc---CH---HHHHHHHHcCC----
Confidence 532111 11122356889999999999888999999999999999999999986421 11 11111111111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.....+......+.+++.+||+ +|..||+..+++.
T Consensus 226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111233344568899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.96 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=192.8
Q ss_pred cccccccCCcEEEEEeecCCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566667777777766 7899999998654 3445578999999999999999999999999999999999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC----
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT---- 502 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~---- 502 (674)
+|.+++... ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999988543 2345889999999999999999999987 99999999999999999999999999875532211
Q ss_pred -CCccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhc----CC----
Q 005846 503 -QGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DG---- 571 (674)
Q Consensus 503 -~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~----~~---- 571 (674)
........++..|+|||++.. ..++.++|||||||++|||++|+.|+..... ....++....... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhh
Confidence 111223456788999999876 3588999999999999999999999753221 1111111100000 00
Q ss_pred ---Ccce----ecccc----cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 ---TPLQ----LLDTN----LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ---~~~~----~~d~~----~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.... ..+.. ............+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00000 011112233456788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=290.49 Aligned_cols=255 Identities=25% Similarity=0.328 Sum_probs=198.7
Q ss_pred CCCcccccccCCcEEEEEeec----CCCceeEEEEecccC----ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
+|++.+.||+|+||.||+++. .+++.||||.+.+.. ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 356889999986432 22345678999999999 599999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++++|..++. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999988874 2356899999999999999999999987 99999999999999999999999999886
Q ss_pred cCCCCCCCccccccccCCccCccccccCC--CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
+...... ......|+..|++||.+.+.. .+.++||||||+++|||++|..|+....... .............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK--- 228 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC---
Confidence 5433211 122346889999999987665 7889999999999999999999865322111 1111111111110
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
...+......+.+++.+||+.||++|||+.++...|+.
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 --------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01112223467889999999999999999998887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=284.56 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=188.0
Q ss_pred HhhcCCCccccc--ccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeE
Q 005846 342 VATNKFSTDNKL--GEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 342 ~~~~~~~~~~~l--G~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 417 (674)
...++|++.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +|+||+++++.+...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334677777776 9999999999985 4678899998865322211 22222223 7999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARI 496 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~ 496 (674)
+||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999999998843 337999999999999999999999988 99999999999999998 999999999876
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.|+...... ..+...+.... .....
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---~~~~~- 228 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ---QKKLP- 228 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh---cccCC-
Confidence 5322 2235788999999999989999999999999999999999997522211 11111111111 11001
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-MATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-~~evl~ 616 (674)
........+.+++.+||+.+|.+||+ ++++++
T Consensus 229 --------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 --------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11133457889999999999999996 688874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.80 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=204.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
...|.+...||+|.|++|..+++ .++.+||||.+.+... ...+.+.+|+++|..+.|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 46789999999999999999984 4799999999977432 33456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||..+|.+.+++. +.+.+.+.....++.|+.++++|||+++ |+|||||++||||+.++++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence 9999999999994 4566777888999999999999999998 99999999999999999999999999988752
Q ss_pred CCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.......+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+...... +-+.
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~r 266 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPR 266 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccch
Confidence 334456789999999999998876 589999999999999999999975322111 1111
Q ss_pred ccCCC--CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 580 NLTDS--YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 580 ~~~~~--~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+... .+.-...+|-+|+.++|-.+|.+|+++++|.+.
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111 122233468899999999999999999999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=319.08 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=190.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 413 (674)
.-..+|++.+.||+||||.|||++.+ +|+.||||++... +......+.+|+..+++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34568999999999999999999954 8999999998654 334456688999999999999999987544310
Q ss_pred --------------------------------------------------------------------------------
Q 005846 414 -------------------------------------------------------------------------------- 413 (674)
Q Consensus 414 -------------------------------------------------------------------------------- 413 (674)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHH
Q 005846 414 ---------------------------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460 (674)
Q Consensus 414 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L 460 (674)
..+||-||||+..+|.+++.+..-. -.....|+++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0135778888888887777432111 13677899999999999999
Q ss_pred HhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC----------------CCCCCCccccccccCCccCccccccC
Q 005846 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG----------------VDQTQGNTSRIVGTYGYMAPEYAMHG 524 (674)
Q Consensus 461 H~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 524 (674)
|+.| ||||||||.||+|+++..+||+|||++.... ........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998721 00111134567899999999999754
Q ss_pred ---CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcc
Q 005846 525 ---QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCV 601 (674)
Q Consensus 525 ---~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl 601 (674)
.|+.|+|+||+||||+||+- ||.. ..+.. .+...++.+..... ..+...+...-.++|.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa-~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERA-SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCc-----hHHHH-HHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 59999999999999999985 3221 11111 12233444433222 1222334445568999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005846 602 QEDPAERPSMATIVL 616 (674)
Q Consensus 602 ~~dP~~RPt~~evl~ 616 (674)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999885
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=286.35 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=192.2
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhc---CCCceeeEEeEEEeCCe-----
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKL---QHRNLVRLLGFCLEGEE----- 415 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~----- 415 (674)
|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999975 489999999864322 2234566788777666 59999999999988776
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+++|||+++ +|.+++... ....+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 677776432 2235899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc-
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL- 574 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~- 574 (674)
....... .....++..|+|||++.+..++.++||||||+++|||++|++|+.... ..+.+.............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS---EADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC---hHHHHHHHHHHcCCCChHh
Confidence 7643321 123357889999999999999999999999999999999988764322 111111111111000000
Q ss_pred ---------eecccccCC---CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 ---------QLLDTNLTD---SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ---------~~~d~~~~~---~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......... .........+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 011123456789999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.50 Aligned_cols=262 Identities=25% Similarity=0.346 Sum_probs=199.0
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----eeE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 417 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 417 (674)
+|++.+.||+|+||.||+++.. +++.|++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999964 48899999987643 344567899999999999999999999988775 789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++ +|..++.. ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 77777742 347999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCC-CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC----
Q 005846 498 GVDQTQ-GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG---- 571 (674)
Q Consensus 498 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~---- 571 (674)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+..... .+.+..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY---IDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHhcCCCChhH
Confidence 443210 122334678899999999887 799999999999999999999998643321 11111111111000
Q ss_pred -------Ccceeccc-ccCC-----CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 572 -------TPLQLLDT-NLTD-----SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 572 -------~~~~~~d~-~~~~-----~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.....+.. .... .........+.+++.+||+.+|++||++++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 0000 0011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=289.37 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=195.0
Q ss_pred CCCcccccccCCcEEEEEeec----CCCceeEEEEecccC----ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999885 368899999986532 22346678899999999 699999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++|+||+++++|.+++. ....+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999998884 3356889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccCCccCccccccC--CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
...... .......|+..|+|||.+... .++.++||||||+++|+|++|+.|+...... ..............
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE--- 228 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC---
Confidence 543221 122235688999999998753 4788999999999999999999987532211 11111111111111
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
..++......+.+++.+||+.||++|| ++.+++.
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011222344678899999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.28 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=190.3
Q ss_pred cccccC--CcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEG--GFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
..||+| +||+||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999986 478999999986432 23346788999999999999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC-
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG- 504 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 504 (674)
++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998885432 235899999999999999999999987 9999999999999999999999998654332111100
Q ss_pred ----ccccccccCCccCccccccC--CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh------------
Q 005846 505 ----NTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK------------ 566 (674)
Q Consensus 505 ----~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~------------ 566 (674)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+...... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence 01112345679999998764 4789999999999999999999987532211 111000000
Q ss_pred ----h-------hc---------CCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 567 ----Q-------WR---------DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 567 ----~-------~~---------~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
. +. .+......+..+...........+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00 000000111111111223345678999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=285.76 Aligned_cols=241 Identities=25% Similarity=0.308 Sum_probs=185.1
Q ss_pred ccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHH---HHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVV---LVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.||+|+||.||++.. .+++.||+|.+.+... .....+.+|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4588999999865321 11222344443 3444579999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+++|..++. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++..+...
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 999988874 3456999999999999999999999987 999999999999999999999999998765322
Q ss_pred ccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......|+..|+|||.+.++ .++.++||||+|+++|||++|+.|+.......... ........ . .
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~------~----~ 216 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM------A----V 216 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhcc------C----C
Confidence 12234689999999998755 68999999999999999999999875332211111 11111000 0 1
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
..+......+.+++.+||+.+|.+|| ++.++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11222345788999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=325.85 Aligned_cols=254 Identities=28% Similarity=0.397 Sum_probs=201.7
Q ss_pred hhcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.+-++....+||.|.||.||.+. ..+|+..|+|-+.... ......+.+|+.++..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44567778899999999999998 4568888999775432 33445678999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||||++|+|.+.+. .+...++.....+..|++.|++|||+.| ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999983 3445667777778899999999999998 99999999999999999999999999998765
Q ss_pred CC--CCCccccccccCCccCccccccCC---CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 500 DQ--TQGNTSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 500 ~~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
+. -........||+.|||||++.+.. ...++||||+|||++||+||++||..++.+ |..+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIM------ 1451 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIM------ 1451 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHH------
Confidence 42 112234568999999999997643 567899999999999999999997533221 1111
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
-.+-.+-...+|......-.+++..||+.||++|-++.|+++.
T Consensus 1452 y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0111122233344455667889999999999999888877653
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.18 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=194.6
Q ss_pred hcCCCc-ccccccCCcEEEEEeecC-CCceeEEEEecccCccC--------------HHHHHHHHHHHHhcCCCceeeEE
Q 005846 344 TNKFST-DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQG--------------AEEFKNEVVLVAKLQHRNLVRLL 407 (674)
Q Consensus 344 ~~~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~ 407 (674)
.++|.. .+.||+|+||+||++... +++.||||.++...... ...+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 467999999999999854 68899999886532221 12467899999999999999999
Q ss_pred eEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 408 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
+++..++..++||||+. ++|.+++. ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 57777773 3446899999999999999999999987 99999999999999999999
Q ss_pred EeeeCCccccCCCCC------------CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCC
Q 005846 488 ISDFGMARIFGVDQT------------QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554 (674)
Q Consensus 488 i~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~ 554 (674)
|+|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~- 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN- 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 999999986641110 1111223467889999998764 47899999999999999999998865322
Q ss_pred CCccchHHHHHhhhcCCCccee-----------c----ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 555 DGAADLLSYAWKQWRDGTPLQL-----------L----DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~-----------~----d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+.+............... . ..... .........+.+++..||+.+|++||+++|++.
T Consensus 239 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 --EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 22222222222211111000 0 00000 001122456789999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.69 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=192.2
Q ss_pred hhcCCCcccccccCCcEEEEEeecCC-CceeEEEEecccC-ccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 419 (674)
..++|++.+.||+|+||.||++.+.+ ++.||||+++... .....++..|+.++.+.. |+||+++++++..+...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999764 8899999987543 223455677887777775 99999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|||+++ +|..++.. ....+++..+..++.||+.||.|||+. + |+||||+|+||++++++.+||+|||++..+.
T Consensus 93 ~e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999854 56555532 234789999999999999999999974 5 9999999999999999999999999987653
Q ss_pred CCCCCCccccccccCCccCccccccCC----CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
.... .....++..|+|||.+.... ++.++||||||+++|||++|+.|+..... ..+.+. ........
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~---~~~~~~~~- 237 (296)
T cd06618 167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLT---KILQEEPP- 237 (296)
T ss_pred CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHH---HHhcCCCC-
Confidence 2221 12235788999999986543 88999999999999999999998643211 111111 11111110
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.. . ........+.+++.+||+.||.+||++.+++.+
T Consensus 238 ~~-~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SL-P------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-C------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 011233568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.84 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=200.8
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 419 (674)
++|.+.+.||+|+||.||+++.. +++.|++|++... .....+.+.+|++++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999864 6899999998653 2233466889999999998 99999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++. +...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999998884 3347999999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCC------------------CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 500 DQTQ------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 500 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
.... .......++..|+|||.+....++.++||||||++++++++|+.|+.... ....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH
Confidence 3221 22233567899999999988889999999999999999999999865322 11111
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM----ATIVL 616 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~----~evl~ 616 (674)
... ... ...++......+.+++.+||+.+|.+||++ ++++.
T Consensus 232 ~~~---~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKI---LKL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH---Hhc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 100 011222234578899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.59 Aligned_cols=243 Identities=30% Similarity=0.432 Sum_probs=189.2
Q ss_pred CCcccccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
|...++||+|+||+||+|+. .+++.|++|++..... ...+.+.+|++++++++|+|++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999985 4688999999865332 2345678899999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+.+ +|.+++.. ....+++.++..++.||+.+|.|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 965 55555532 2346899999999999999999999988 9999999999999999999999999986432
Q ss_pred CCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
......|+..|+|||++. .+.++.++||||||+++|||++|+.|+.... . ............+ ...
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~---~---~~~~~~~~~~~~~-~~~-- 241 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---A---MSALYHIAQNDSP-TLQ-- 241 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---h---HHHHHHHHhcCCC-CCC--
Confidence 122356888999999984 4668899999999999999999998853221 1 1111111111110 000
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+.+++.+||+.+|.+||++.+++.
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112235778999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.13 Aligned_cols=246 Identities=29% Similarity=0.401 Sum_probs=191.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+.|...+.||+|+||.||+|+.. ++..+++|.+... .....+++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999954 5788999988642 2233456788999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 566655532 2345899999999999999999999987 999999999999999999999999998765321
Q ss_pred CCCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
....++..|+|||.+. .+.++.++|||||||++|||++|+.|+.... ..+.+. . +........
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~---~-~~~~~~~~~- 234 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALY---H-IAQNESPAL- 234 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc---HHHHHH---H-HhhcCCCCc-
Confidence 2346788999999874 3568899999999999999999998853211 111111 1 111111000
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
........+.+++.+||+.+|++||++.+++..
T Consensus 235 -------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 011233467889999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=292.89 Aligned_cols=263 Identities=26% Similarity=0.361 Sum_probs=195.3
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCee
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEK 416 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~ 416 (674)
...+++|++.+.||.|+||.||++... +++.||+|++.+. .....+.+.+|++++++++||||+++++++.. +...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999854 7889999988542 22334678899999999999999999999876 5678
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++|+||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 567877763 346888899999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHH--------HHHhh
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS--------YAWKQ 567 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~--------~~~~~ 567 (674)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+. ..+..
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 422 1223467889999998766 568999999999999999999998875322110000000 00000
Q ss_pred hcCCCcceecccc-cCCCCC-----hhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 568 WRDGTPLQLLDTN-LTDSYS-----RNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 568 ~~~~~~~~~~d~~-~~~~~~-----~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+......+++... .....+ ......+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011111110000 000111 112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=274.53 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=209.7
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHH---HHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
-++|..++.||+|.||.|..++- ..++.+|+|++++..-...+ .-..|-.+|..-+||.+..|...|...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788999999999999999985 36899999999875433333 335688899999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||..||.|..+|. +...+++....-+...|..||.|||+.+ ||.||||.+|.|||.+|.+||+||||++.--
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988883 4566888888889999999999999988 9999999999999999999999999998532
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.....+...+|||.|+|||++....|..++|.|.+||++|||++|+.||.....+. +.+.+.. + |
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl~---e-------d- 384 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELILM---E-------D- 384 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHHh---h-------h-
Confidence 22345667899999999999999999999999999999999999999974332221 2221110 0 0
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHH--h------cCCCCCCCCCCCcee
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLML--N------SYSVTLPSPQQPAFF 634 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~L--~------~~~~~~~~p~~p~~~ 634 (674)
-.+|.....+...|+...|.+||.+|. .+.||.+.- . -+...+++|.+|...
T Consensus 385 ---~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 385 ---LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 123334444666788888999999995 355555431 1 234567778777643
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=266.21 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=192.2
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEeccc-CccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+.+.+..||.|.-|.||+.++. .|..+|||.+.+. +....+++...+.++.+-+ .|.||+.+|+|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4455678999999999999965 5788999999764 3444566777777776654 89999999999999999999998
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
| ...++.++.. -.+++++.-+-++...+.+||.||.+++ .|+|||+||+|||+|+.|++|++|||++..+-..
T Consensus 173 M-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 173 M-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred H-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 8 4455555532 3456888888899999999999998865 6999999999999999999999999999765432
Q ss_pred CCccccccccCCccCcccccc---CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
...++..|-+.|||||.+.- ..|+.++||||||+.++||.||+.|+..-. ...+.+..+ .. +.+ +
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkv---ln-~eP-----P 313 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKV---LN-EEP-----P 313 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHH---Hh-cCC-----C
Confidence 23445678999999999863 468999999999999999999999965322 122222222 21 111 1
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.. ........+++...||++|+.+||...++++
T Consensus 314 ~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1111 1113456788999999999999999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=293.27 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=191.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 414 (674)
.++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999985 468999999986532 223456789999999999999999999987543
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 555443 235899999999999999999999987 999999999999999999999999998
Q ss_pred cccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC-
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT- 572 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~- 572 (674)
+.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+.... ....+...+.......
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCH
Confidence 75422 1223467889999999876 468999999999999999999999875321 1111111111110000
Q ss_pred ----------cceecc---cccCCCC---ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 573 ----------PLQLLD---TNLTDSY---SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 573 ----------~~~~~d---~~~~~~~---~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
...... ....... .......+.+++.+||+.||++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0000000 01123467899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=297.27 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=196.3
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
..++...+++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566789999999999999999999984 578899999986532 22345678899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 414 ------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 414 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
...+++++++ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2367788876 778877763 345899999999999999999999988 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ...+.....
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~---~~~~~~~~~ 232 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILR 232 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHH
Confidence 999999875422 1223467889999998866 5688999999999999999999988643221 111111111
Q ss_pred hhc-----------CCCccee---cccccCCCC---ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 567 QWR-----------DGTPLQL---LDTNLTDSY---SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 567 ~~~-----------~~~~~~~---~d~~~~~~~---~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
... ....... ++......+ .......+.+++..|++.||.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0000000 000000000 00123467899999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=295.07 Aligned_cols=262 Identities=20% Similarity=0.306 Sum_probs=192.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC---------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--------- 413 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------- 413 (674)
..+|...+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999985 46889999998766656667789999999999999999999776543
Q ss_pred -----CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeE
Q 005846 414 -----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPK 487 (674)
Q Consensus 414 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~k 487 (674)
...++|+||++ ++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 57776662 346899999999999999999999987 99999999999997 456789
Q ss_pred EeeeCCccccCCCCCCC-ccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 488 ISDFGMARIFGVDQTQG-NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
|+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.|+...... .......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL---EQMQLIL 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 99999997653221111 1123457889999998754 56889999999999999999999987422110 0000000
Q ss_pred hhhcC-----------CCcceecccccCC-----CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 566 KQWRD-----------GTPLQLLDTNLTD-----SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 566 ~~~~~-----------~~~~~~~d~~~~~-----~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..... ............. .........+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000000000000 001122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=285.38 Aligned_cols=259 Identities=29% Similarity=0.381 Sum_probs=196.0
Q ss_pred CCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
|+..+.||+|+||.||+|+.. +++.+++|++.... ....+.+.+|+.++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999987653 333467789999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
+ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 5888888432 146999999999999999999999987 99999999999999999999999999987643221
Q ss_pred CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHH-----------HhhhcCC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYA-----------WKQWRDG 571 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~-----------~~~~~~~ 571 (674)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ...+... |..+..-
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 22233457789999998776 789999999999999999999887643221 1111111 1111000
Q ss_pred C-cceeccc---ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 T-PLQLLDT---NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ~-~~~~~d~---~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. ....... .............+.+++..||+.+|++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000 0000000112457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.19 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=194.5
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-- 414 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 414 (674)
+....++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344577899999999999999999984 468899999986432 223456889999999999999999999987553
Q ss_pred ----eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 415 ----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 415 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
..++||||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 458999998 778877763 346899999999999999999999987 99999999999999999999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh---
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK--- 566 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~--- 566 (674)
||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+..... ...+.....
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~ 233 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH---LDQLMEIMKVTG 233 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcC
Confidence 9999754321 223457889999998876 4688999999999999999999998642211 111110000
Q ss_pred --------hhcCCCcceecc--cccC----CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 567 --------QWRDGTPLQLLD--TNLT----DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 567 --------~~~~~~~~~~~d--~~~~----~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.......... +... ..........+.+++.+|++.||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000 0001122345789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=284.92 Aligned_cols=244 Identities=28% Similarity=0.397 Sum_probs=197.8
Q ss_pred ccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 350 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
.+.||.|.||+||-|+. ++|+.||||++.+. ......++++|+.+|.+++||.||.|.-.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999985 57999999999753 3344577899999999999999999999999999999999999877
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC---CCeEEeeeCCccccCCCCCC
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~ki~DfGla~~~~~~~~~ 503 (674)
-|+-+|. ...+.|++..-.-++.||+.||.|||.++ |+|.||||+||||... -++||+|||+|++++..
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--- 720 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--- 720 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence 7776664 34567898888889999999999999998 9999999999999654 46899999999998643
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
.....++||+.|+|||+++...|...-|+||.|||+|--++|.-||+ ++++..+.++.+.-.+... .+.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~---------PW~ 789 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPN---------PWS 789 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCC---------chh
Confidence 33456799999999999999999999999999999999999997754 4455555544332222211 111
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.....++||...||..-++|-+..+-+.
T Consensus 790 ----eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 790 ----EISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ----hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 12235678888888999999998877653
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=283.80 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=192.9
Q ss_pred CCCcccccccCCcEEEEEeecCC-CceeEEEEeccc-----CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+|.+.++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998543 444556655431 122334567899999999999999999999999999999
Q ss_pred EEecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 420 YEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
+||+++++|..++... .....+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998887532 23456999999999999999999999987 999999999999975 569999999987654
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+... ............ ..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------~~~~~~~~~~~~-~~----- 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIVEG-PT----- 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHcC-CC-----
Confidence 3221 222345788999999998888999999999999999999999886421 111111111111 10
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112234457888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=292.43 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=189.7
Q ss_pred CCCcccccccCCcEEEEEeecC-C--CceeEEEEecccC--ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeC----Ce
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-S--GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEG----EE 415 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~ 415 (674)
+|++.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+.++.++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999964 3 6789999986532 22345678899999999 599999999976433 34
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++++||+. ++|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 57777763 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCC--CccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhc---
Q 005846 496 IFGVDQTQ--GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR--- 569 (674)
Q Consensus 496 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~--- 569 (674)
.+...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.|+..... ...+........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCC
Confidence 65432211 12234578999999998765 4689999999999999999999988643221 111111111000
Q ss_pred --------CCCccee------cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 570 --------DGTPLQL------LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 570 --------~~~~~~~------~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....... ................+.+++.+||+.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0000000000112346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=278.99 Aligned_cols=259 Identities=28% Similarity=0.399 Sum_probs=197.1
Q ss_pred HhhcCCCcccccccCCcEEEEEee-cCCCceeEEEEec--ccCc-----cCHHHHHHHHHHHHhcCCCceeeEEeEEE-e
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS--KASG-----QGAEEFKNEVVLVAKLQHRNLVRLLGFCL-E 412 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~--~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~ 412 (674)
...++|-.++.||+|||++|||+. +...+.||||+-. +... ...+...+|..+.+.|.||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345678889999999999999998 4567888999743 2211 11234568999999999999999999986 5
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc---CCCCeEEe
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKIS 489 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~ki~ 489 (674)
.+..+-|+|||+|.+|+.+|. ....+++.++..|+.||..||.||.+.. ++|||-||||.||||- .-|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 567899999999999999994 4556899999999999999999999874 7899999999999995 45679999
Q ss_pred eeCCccccCCCCCCC-----ccccccccCCccCccccccC----CCCccccEEeechhhhHhHhCCCCCCccCCCCccch
Q 005846 490 DFGMARIFGVDQTQG-----NTSRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560 (674)
Q Consensus 490 DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~ 560 (674)
||||+++...+.... .++...||.+|++||.+.-+ +.+.|+||||.|||+|..+-|++||..... ..++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH
Confidence 999999986554432 34567899999999988533 578999999999999999999999864332 1222
Q ss_pred HHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005846 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615 (674)
Q Consensus 561 l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl 615 (674)
++ .+.+...-+-.+.. -.....+...+|.+||+..-++|....++.
T Consensus 694 Lq-------eNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQ-------ENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hh-------hhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 22 22222211111100 112234566889999999999998776653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=292.44 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=194.3
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe----
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE---- 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 415 (674)
..++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999964 5788999988643 22234567789999999999999999998776554
Q ss_pred --eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 416 --KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 416 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
.++|+||+ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 568887773 346999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhc---
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR--- 569 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~--- 569 (674)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ...+........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTPD 236 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Confidence 9765322 223467889999998865 4688999999999999999999998743211 111111111110
Q ss_pred --------CCCcceeccc---ccCCCC---ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 570 --------DGTPLQLLDT---NLTDSY---SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 570 --------~~~~~~~~d~---~~~~~~---~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+.. .....+ .......+.+++.+||+.+|++|||+.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000 000000 0112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=243.80 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=195.5
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+|...++||+|.||+|||++. .+++.||+|+++-+. +.......+||-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 566778999999999999995 467889999886432 33345678999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
|.. +|..+.. .-.+.++.+....++.|+++||.+.|+++ +.||||||.|.||+.+|.+|++|||+++.++....
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 4544442 23467899999999999999999999988 99999999999999999999999999998865432
Q ss_pred CCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce------
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ------ 575 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~------ 575 (674)
..+..+-|.+|.+|.++.+.+ |+...|+||-|||+.||.....|. +...+..+.+..+.+........+
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl--fpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC--CCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 223346689999999998875 889999999999999999766652 333344444444443332221111
Q ss_pred ecccccCCCCCh-----hHHH----HHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSR-----NEVI----RCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~-----~~~~----~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.|-.....++. +.+. .-.++..+.+.-+|.+|.++++.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 112111122221 1111 2246666777779999999998765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=275.37 Aligned_cols=236 Identities=28% Similarity=0.367 Sum_probs=190.5
Q ss_pred cccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 353 LGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
||+|+||.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 588999999876432 2345788999999999999999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcccc
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 508 (674)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 988843 346899999999999999999999987 9999999999999999999999999997654322 12334
Q ss_pred ccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
..++..|++||.+.+...+.++|+||||+++|||++|+.|+..... ....... . ... ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~-~~~----------~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---L-KDP----------LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---h-cCC----------CCCCCC
Confidence 5678899999999888899999999999999999999998643211 1111111 1 100 111222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHH
Q 005846 589 EVIRCIQLGLLCVQEDPAERPSMAT 613 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt~~e 613 (674)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2457789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=310.76 Aligned_cols=145 Identities=29% Similarity=0.397 Sum_probs=130.2
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999965 68899999986543 223467889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
||+.+++|..++.. ...+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998843 346889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=290.65 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=208.7
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 412 (674)
..++.+...++.|++.+.||+|.+|.||+++ .++++.+|||++...... .+++..|..+++.+ .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444555567889999999999999999998 457888999988765433 46678889999888 69999999999874
Q ss_pred -----CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 413 -----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 413 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
++.+|||||||.+|+..+++.... +..+.|+.+..|+..++.||.+||... ++|||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 568999999999999999997654 778999999999999999999999886 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCcccccc-----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHH
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS 562 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~ 562 (674)
+.|||++..+. .+.....+.+||+.|||||++.- ..|+..+|+||||++..||--|.+|..-.... .
T Consensus 164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------r 235 (953)
T KOG0587|consen 164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------R 235 (953)
T ss_pred Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------h
Confidence 99999998763 34445566799999999999853 34778999999999999999999884311110 0
Q ss_pred HHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 563 YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...... .+ +.....-+..-..++.++|..||.+|-++||++.++++
T Consensus 236 aLF~Ip-RN-------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ALFLIP-RN-------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhccCC-CC-------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 011111 11 11111224455678899999999999999999998875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=267.88 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=194.0
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc-cCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++.+.+..||.|.||+|+|-.+ +.|+..|||+++.... ...+++..|.+...+- +.||||+++|.+..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3445567899999999999885 5799999999976544 4556788888766554 78999999999999999999999
Q ss_pred ecCCCcccccc---cCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 422 FVPNKSLDYFL---YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 422 ~~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
.| ..||+.+- +. .+...+++.-+-.|..-...||.||.... +|||||+||+||||+..|.+||+|||++..+.
T Consensus 144 LM-d~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HH-hhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99 45554332 22 23456888888889999999999998764 69999999999999999999999999987653
Q ss_pred CCCCCCccccccccCCccCccccccC--CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.. ...+.-+|-..|||||.+... .|+.++||||||++|+|+.||+.|..-+.. ++++..... .+.+..+
T Consensus 220 ~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l 290 (361)
T KOG1006|consen 220 DS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPIL 290 (361)
T ss_pred HH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCee
Confidence 22 223344678899999998643 489999999999999999999998654322 333333222 2333332
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+. ........+..++..|+.+|-.+||...++..
T Consensus 291 ~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2211 11234557888999999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=267.15 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=195.3
Q ss_pred cccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
+.||+|+|+.|-.++ +.+|.++|||++.+.......+..+|++++..- .|+||++|+.+|.+++..|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999887 678999999999998888888999999999988 599999999999999999999999999999
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC---eEEeeeCCccccCCCC--C-
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARIFGVDQ--T- 502 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~ki~DfGla~~~~~~~--~- 502 (674)
..++. ++..+++.+..++..+|+.||.+||.+| |.||||||+|||..+-.. +||+||.|+.-..... +
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 88884 5567999999999999999999999998 999999999999976554 6999999875432221 1
Q ss_pred --CCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 503 --QGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 503 --~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
.....+.+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||...-..+- .|..++.-.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---------GWdrGe~Cr 308 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---------GWDRGEVCR 308 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---------CccCCCccH
Confidence 12234568999999999763 23588999999999999999999999854332211 121211111
Q ss_pred -----eccccc--CCCCChhH----HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 -----LLDTNL--TDSYSRNE----VIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 -----~~d~~~--~~~~~~~~----~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+++..- .-++|..+ .....+++...+..|+.+|-++.+++.
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000 01233332 234567778888899999999998876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=286.59 Aligned_cols=240 Identities=26% Similarity=0.323 Sum_probs=190.5
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.++.|.....+|.|+|+.|-++.. .+++..++|++.+...+ -.+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788888899999999999884 56889999999776322 24566555554 8999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE-cCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll-~~~~~~ki~DfGla~~~~~ 499 (674)
|.+.++-|.+.+. .. ......+..|+.+|+.++.|||++| ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~---~~-~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIR---SK-PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHH---hc-chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999997766553 22 2233777789999999999999988 9999999999999 6999999999999987654
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
. ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ .++ ......
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~--------- 528 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQM--------- 528 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcC---------
Confidence 3 22335688999999999999999999999999999999999997543322 111 111111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..++........+|+.+||+.||.+||+|.++..
T Consensus 529 ---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 ---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1222344557789999999999999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=255.91 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=192.2
Q ss_pred hhcCCCcc-cccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe----CCe
Q 005846 343 ATNKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE----GEE 415 (674)
Q Consensus 343 ~~~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~ 415 (674)
.+++|++. ++||-|-.|.|-.... .+|+.+|+|++... ...++|+++.-.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566654 5799999999998875 46889999988543 4457888876554 79999999998864 346
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeEEeeeC
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFG 492 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ki~DfG 492 (674)
+.+|||.|+||.|...+.+ +....+++.++..|+.||..|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999877754 34456999999999999999999999988 999999999999964 4568999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+|+... ......+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-..... .+..-.....+.+.
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQ 283 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccC
Confidence 998643 233445567899999999999999999999999999999999999996322211 11111111111111
Q ss_pred cceecccccCCCCCh----hHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 573 PLQLLDTNLTDSYSR----NEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~----~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
-.++. ...+...++|+.+|..+|.+|-|+.+++..
T Consensus 284 ----------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 ----------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 12232 234566789999999999999999998853
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=268.03 Aligned_cols=219 Identities=21% Similarity=0.183 Sum_probs=174.2
Q ss_pred CCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcccccccC
Q 005846 356 GGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434 (674)
Q Consensus 356 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 434 (674)
|.+|.||+++. .+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999985 468899999987643 234455555666899999999999999999999999999999888743
Q ss_pred CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCC
Q 005846 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514 (674)
Q Consensus 435 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~ 514 (674)
...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++++|||++...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 345899999999999999999999987 999999999999999999999999988655322 112345678
Q ss_pred ccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHH
Q 005846 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCI 594 (674)
Q Consensus 515 y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 594 (674)
|+|||.+.+..++.++||||+|+++|||++|+.|+...... ..... ....+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~---------~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHT---------TLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccccc---------ccCCcccCCHHHH
Confidence 99999998888999999999999999999999764321100 00000 0011222335678
Q ss_pred HHHhhcccCCCCCCCCH
Q 005846 595 QLGLLCVQEDPAERPSM 611 (674)
Q Consensus 595 ~li~~Cl~~dP~~RPt~ 611 (674)
+++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 89999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=287.60 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=181.4
Q ss_pred hhcCCCcccccccCCcEEEEEeec-----------------CCCceeEEEEecccCccCHHH--------------HHHH
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-----------------PSGQEIAVKRLSKASGQGAEE--------------FKNE 391 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 391 (674)
..++|++.++||+|+||+||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 245679999986543322223 3347
Q ss_pred HHHHHhcCCCce-----eeEEeEEEe--------CCeeEEEEEecCCCcccccccCCC---------------------c
Q 005846 392 VVLVAKLQHRNL-----VRLLGFCLE--------GEEKILVYEFVPNKSLDYFLYDPE---------------------K 437 (674)
Q Consensus 392 i~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------~ 437 (674)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 678887753 356899999999999988886321 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccC
Q 005846 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517 (674)
Q Consensus 438 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~a 517 (674)
...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123577889999999999999999987 99999999999999999999999999976533221 11122345789999
Q ss_pred ccccccCCC----------------------CccccEEeechhhhHhHhCCC-CCCccCCC----CccchHHHHHhhhcC
Q 005846 518 PEYAMHGQF----------------------SVKSDVYSFGVLVLEIITGKK-NSNFYQTD----GAADLLSYAWKQWRD 570 (674)
Q Consensus 518 PE~~~~~~~----------------------s~k~DvwS~Gv~l~elltg~~-p~~~~~~~----~~~~~l~~~~~~~~~ 570 (674)
||.+..... ..+.||||+||+++||++|.. |+...... ...+.....|+.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 235799999999999999875 43211000 000111112332222
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDP---AERPSMATIVL 616 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP---~~RPt~~evl~ 616 (674)
... +-.. .........+|+.++|..+| .+|+|++|+++
T Consensus 459 ~~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 211 1001 11223467788888888766 78999999985
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=269.43 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=194.9
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc---CHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ---GAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 415 (674)
.+...+|..+.+||+|+||.|..+..+ +.+.+|||+++++.-. +.+--+.|-++|+.. +-|.+++++.+|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344568999999999999999999864 4567899999875322 222234566677665 56889999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
+++||||+.||+|-.++ +.-+.+.+..+.-++..||-||-+||+++ ||.||||.+||||+.+|.+||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999998877 34567888899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
.-- .....+.+.+||+.|+|||++...+|+..+|.|||||+||||+.|++|++. ++..++.+.+..+
T Consensus 499 Eni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI~eh-------- 565 (683)
T KOG0696|consen 499 ENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAIMEH-------- 565 (683)
T ss_pred ccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHc--------
Confidence 532 223345668999999999999999999999999999999999999999753 3333443333221
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP 609 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 609 (674)
.-.|+.....+...+....+.+.|.+|.
T Consensus 566 ------nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ------NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1234555556677777888899999885
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=265.41 Aligned_cols=268 Identities=22% Similarity=0.275 Sum_probs=198.3
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcC-C-C----ceeeEEeEE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-H-R----NLVRLLGFC 410 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-~----niv~l~~~~ 410 (674)
...+..+++|.+...+|+|.||.|-+.... .+..||||+++.-. ...+..+-|++++.++. + | -+|.+.++|
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 344556889999999999999999998853 46889999986532 23355577999999993 2 2 277888889
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC--------
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------- 482 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-------- 482 (674)
.-.++.+||+|.+ |.|+.+|+.. .+..+++...+..|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence 9999999999988 6688888854 34557899999999999999999999987 999999999999832
Q ss_pred ------------CCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCC
Q 005846 483 ------------EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550 (674)
Q Consensus 483 ------------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~ 550 (674)
+..+||+|||.|..-.. ..+.++.|..|.|||++.+-.++...||||+||||.||.||..-|.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 33479999999976432 2356788999999999999999999999999999999999997653
Q ss_pred ccCCCCccchHHHHH--------------hhhcCCCcc--e---------ecccc--c--CCCCChhHHHHHHHHHhhcc
Q 005846 551 FYQTDGAADLLSYAW--------------KQWRDGTPL--Q---------LLDTN--L--TDSYSRNEVIRCIQLGLLCV 601 (674)
Q Consensus 551 ~~~~~~~~~~l~~~~--------------~~~~~~~~~--~---------~~d~~--~--~~~~~~~~~~~~~~li~~Cl 601 (674)
..+..+...+.+.+. +.+..+... + ..+.. + .......+...+++|+..||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 322111111111111 111111000 0 00000 0 00112356678999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005846 602 QEDPAERPSMATIVL 616 (674)
Q Consensus 602 ~~dP~~RPt~~evl~ 616 (674)
..||.+|+|+.|++.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=259.85 Aligned_cols=265 Identities=23% Similarity=0.378 Sum_probs=191.6
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------- 413 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------- 413 (674)
...|+...+||+|.||+||+++.+ .|+.||+|++-..+ ...-....+|+.+|..|+|+|++.++..|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 346777889999999999999964 57788988764322 22234558899999999999999999888542
Q ss_pred -CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 414 -EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 414 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
...++||++|+. +|.-+|.+ ....++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 347899999975 44455532 2346899999999999999999999887 9999999999999999999999999
Q ss_pred CccccCCCCCC--CccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH---h
Q 005846 493 MARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW---K 566 (674)
Q Consensus 493 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~---~ 566 (674)
+++.+...... ...+..+-|..|++||.+.+ .+|+++.|||.-|||+.||+||.+-+. .......+..+. .
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq---gnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ---GNTEQQQLHLISQLCG 246 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc---CChHHHHHHHHHHHhc
Confidence 99887544322 23344566999999998875 579999999999999999999987543 333333333322 1
Q ss_pred hhcCCCcce-----ecccc----c-CCCCC--hhH------HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 567 QWRDGTPLQ-----LLDTN----L-TDSYS--RNE------VIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 567 ~~~~~~~~~-----~~d~~----~-~~~~~--~~~------~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
....+.+.+ +.... + ...+. .+. .....+|+..++..||.+|+++.+++..
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111111 11100 0 00000 011 1245688888999999999999998764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=293.65 Aligned_cols=260 Identities=22% Similarity=0.248 Sum_probs=167.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-C----CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeE------EE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-S----GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF------CL 411 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~------~~ 411 (674)
..++|++.++||+|+||.||+|++. + +..||||++...... +.+.+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999964 4 689999988643221 111111 1222223333322221 24
Q ss_pred eCCeeEEEEEecCCCcccccccCCCc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecc
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPEK-----------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlk 474 (674)
.+...++|+||+++++|.+++..... ........+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999888753210 001123446679999999999999987 9999999
Q ss_pred cccEEEcC-CCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccC----------------------CCCcccc
Q 005846 475 ASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG----------------------QFSVKSD 531 (674)
Q Consensus 475 p~NIll~~-~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D 531 (674)
|+|||+++ ++.+||+|||+++.+..... .......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986543222 223346789999999965322 2345679
Q ss_pred EEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc----eeccccc----CCCC--ChhHHHHHHHHHhhcc
Q 005846 532 VYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL----QLLDTNL----TDSY--SRNEVIRCIQLGLLCV 601 (674)
Q Consensus 532 vwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~----~~~d~~~----~~~~--~~~~~~~~~~li~~Cl 601 (674)
||||||+||||+++..+.+. ++..........+... ..+.... ...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999997654221 1111110000000000 0000000 0000 0011224558999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 005846 602 QEDPAERPSMATIVLM 617 (674)
Q Consensus 602 ~~dP~~RPt~~evl~~ 617 (674)
+.||++|||+.++++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=259.98 Aligned_cols=238 Identities=29% Similarity=0.397 Sum_probs=191.6
Q ss_pred CcEEEEEeecC-CCceeEEEEecccCccC-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcccccccC
Q 005846 357 GFGEVYKGVLP-SGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434 (674)
Q Consensus 357 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 434 (674)
+||.||+++.. +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48999999997665544 68899999999999999999999999999999999999999999988843
Q ss_pred CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCC
Q 005846 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514 (674)
Q Consensus 435 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~ 514 (674)
...+++..++.++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 223899999999999999999999987 9999999999999999999999999998765332 2334567889
Q ss_pred ccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHH
Q 005846 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCI 594 (674)
Q Consensus 515 y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 594 (674)
|++||.+....++.++|||+||+++++|++|..|+... ......... ......... .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKK----IGKPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHH----HhccCCCCc-------cccccCCHHHH
Confidence 99999999888999999999999999999999886432 111111111 111111000 00000335788
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 005846 595 QLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 595 ~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=295.79 Aligned_cols=262 Identities=23% Similarity=0.252 Sum_probs=204.2
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
-....++...++|.+++.||+|+||.|..++++ +++.||+|++++. ......-|..|-.+|..-..+=|++++-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 344566777889999999999999999999975 5788899999762 334455688899999888899999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
.+...+|+|||||+||+|-.++.. ...+++..+.-++..|.-||.-||+.| +|||||||+|||||..|++||+|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 999999999999999999998843 347999999999999999999999988 99999999999999999999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccc----c-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM----H-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
||.+-.+..+. .......+|||.|++||++. + +.|+...|.||+||++|||+.|..||.- ..+.+---
T Consensus 219 FGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~ 291 (1317)
T KOG0612|consen 219 FGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYG 291 (1317)
T ss_pred chhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHH
Confidence 99987765332 23445679999999999984 3 6799999999999999999999999742 12222222
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS---MATIVLM 617 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt---~~evl~~ 617 (674)
+.+.......+.+. .+.+....+||...+ -+|+.|-. ++++-..
T Consensus 292 KIm~hk~~l~FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 292 KIMNHKESLSFPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHhchhhhcCCCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 33333222222211 123344555555544 37888887 8887654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=254.19 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=198.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 415 (674)
....++|..+++||+|+|..|-.+++. +.+.+|+|++++. ...+.+-.+.|-.+..+. +||.+|.++.+|..+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 344578999999999999999999864 5678899998763 233334456676666665 79999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
+++|.||.+||+|-.++ +.+..|+++.+.-+...|.-||.|||+.| ||.||||.+|||||.+|.+||+|+|+++
T Consensus 326 lffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 99999999999997766 45667999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCcc-chHHHHHhhhcCCCcc
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA-DLLSYAWKQWRDGTPL 574 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~ 574 (674)
.-- .....+++.+|||.|+|||++++..|...+|.|+|||+++||+.|+.||+.-..+... +--.+..+...+
T Consensus 400 e~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---- 473 (593)
T KOG0695|consen 400 EGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---- 473 (593)
T ss_pred cCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh----
Confidence 532 2234566789999999999999999999999999999999999999998865433221 111222221111
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCC
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP 609 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 609 (674)
.. -.++.....+...+++.-|.+||.+|.
T Consensus 474 ----kq--iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 ----KQ--IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----hc--ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 112334445666788889999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.36 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=186.2
Q ss_pred CCcccccccCCcE-EEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 347 FSTDNKLGEGGFG-EVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 347 ~~~~~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
|...+.+|.|.-| .||+|.+ +|++||||++-... .....+||..|..- +|||||++++.-.+.+..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 5556778999987 5799999 78999999985432 23457899999887 7999999999999999999999999
Q ss_pred CCcccccccCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---C--CCeEEeeeCCccccC
Q 005846 425 NKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---E--MNPKISDFGMARIFG 498 (674)
Q Consensus 425 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~--~~~ki~DfGla~~~~ 498 (674)
.-+|++++..... .........+.++.|+++||+|||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5678888854211 111122455788999999999999987 999999999999976 3 468999999999987
Q ss_pred CCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHhC-CCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.+...- ......||.+|+|||.+....-+.++||||+||++|+.++| +.||.- .+...............
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--------~~~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--------SLERQANILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--------hHHhhhhhhcCccceee
Confidence 654432 34567899999999999998888999999999999999998 567531 11111111222211111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.+ .... ...+||.+|+..+|..||++.+|+.
T Consensus 735 L~~-------~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 LEP-------LPDC-EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ecc-------CchH-HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 1111 6678999999999999999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=273.58 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=203.5
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCc-eeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
....+++.+..||-|+||.|-.+...+.+ .+|+|++++.. ....+.+..|-.+|.+.+.|.||+++.-|.+....|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34456777888999999999999875443 37888887642 333566788999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+.||-|-||.|...|. ..+.++.....-++..+.+|++|||.++ ||.|||||+|.+|+.+|-+||.|||+|+.+
T Consensus 497 mLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999994 5677999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... ..+-+.+||+.|.|||++.+...+.++|.||||+++|||++|.+||...+.-...++ +.+...
T Consensus 571 ~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~---ILkGid-------- 636 (732)
T KOG0614|consen 571 GSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL---ILKGID-------- 636 (732)
T ss_pred ccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH---HHhhhh--------
Confidence 543 355678999999999999999999999999999999999999999764333222222 222110
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~~ 617 (674)
.-.+|........+|+++....+|.+|.- +.+|-+.
T Consensus 637 ----~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 ----KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ----hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11233444456678888888999999975 5566544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=237.47 Aligned_cols=212 Identities=27% Similarity=0.386 Sum_probs=170.8
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-CccCHHHHHHHHHHHHh-cCCCceeeEEeEEE
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAK-LQHRNLVRLLGFCL 411 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~ 411 (674)
+....+++..+.......||+|++|.|-+-++ .+|...|+|++... ..+...+..+|+.+..+ ..+|.+|.|+|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 33444677777888889999999999988874 57999999999653 23444566777776655 47999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
.....++.||.| ..||+.|-.+. .+++.+++..+-+|+..|.+||.|||++- .+||||+||+|||++.+|++||+|
T Consensus 116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 999999999999 56776654332 34567899999999999999999999864 699999999999999999999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCcccccc----CCCCccccEEeechhhhHhHhCCCCCCcc
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSNFY 552 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwS~Gv~l~elltg~~p~~~~ 552 (674)
||++..+.... ..+--.|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++.+
T Consensus 193 FGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 193 FGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99998764322 1222357778999998853 36899999999999999999999986543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-31 Score=251.69 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=189.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CeeE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEKI 417 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~ 417 (674)
+.+-.+.||.|.||.||..+.+ +|+.||.|++..- +-...+.+.+|+++|.-++|.|++..++...-. ++.+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455688999999999999864 7999999988642 233456788999999999999999998865432 2457
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+++|.| ..+|..++ .....++...+.-++.||++||.|||+.+ |.||||||.|.|++.|-.+||+|||+++..
T Consensus 134 V~TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 888888 45666666 34556888889999999999999999988 999999999999999999999999999987
Q ss_pred CCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC------
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD------ 570 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~------ 570 (674)
..+.....+ ..+-|-.|.|||++++. .|+.++||||.|||+.||+..+.-|.... ..+.++.+...+..
T Consensus 207 e~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~---PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 207 DQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG---PIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred chhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC---hHHHHHHHHHHhCCCcHHHH
Confidence 665554443 34568899999999875 69999999999999999998775543222 22222222211111
Q ss_pred -----CCcceecccccC---------CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 571 -----GTPLQLLDTNLT---------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 571 -----~~~~~~~d~~~~---------~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
+-...++....+ -.-+...-.....+..+++..||++|.+.++.+..+
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 100011111000 000111112344566678899999999999888765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=263.50 Aligned_cols=203 Identities=26% Similarity=0.363 Sum_probs=172.2
Q ss_pred hcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..-|..++.||-|+||+|.++. .++...+|+|.+++..- ......+.|-.+|+....+=||+|+-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4458888999999999999987 44567889999977543 2334567899999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||++||++-.+|. +.+.+.+..+.-++..+..|+++.|..| +|||||||+|||||.+|.+||+||||+.-+..
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999988874 4567888888889999999999999988 99999999999999999999999999865421
Q ss_pred C--------CCC--------------------------------CccccccccCCccCccccccCCCCccccEEeechhh
Q 005846 500 D--------QTQ--------------------------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539 (674)
Q Consensus 500 ~--------~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l 539 (674)
. ..+ ......+||+.|+|||++....|+...|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0 000 001246899999999999999999999999999999
Q ss_pred hHhHhCCCCCCcc
Q 005846 540 LEIITGKKNSNFY 552 (674)
Q Consensus 540 ~elltg~~p~~~~ 552 (674)
|||+.|+.||--.
T Consensus 862 ~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 862 YEMLVGQPPFLAD 874 (1034)
T ss_pred HHHhhCCCCccCC
Confidence 9999999997543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=235.53 Aligned_cols=210 Identities=38% Similarity=0.600 Sum_probs=182.3
Q ss_pred cccCCcEEEEEeecCC-CceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcccc
Q 005846 353 LGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 430 (674)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998765432 35678999999999999999999999999999999999999999999
Q ss_pred cccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeCCccccCCCCCCCccccc
Q 005846 431 FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQTQGNTSRI 509 (674)
Q Consensus 431 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~~~~~~~~~~~~~~~ 509 (674)
++.... ..+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 884321 46899999999999999999999987 999999999999999 89999999999987643321 12334
Q ss_pred cccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChh
Q 005846 510 VGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRN 588 (674)
Q Consensus 510 ~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 588 (674)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 888999999999999998
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 589 EVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 589 ~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 367789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=234.19 Aligned_cols=256 Identities=20% Similarity=0.328 Sum_probs=192.0
Q ss_pred hcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC--eeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--EKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~~lv 419 (674)
.++|++.+++|+|.+++||.|. ..++++++||+++.- ..+.+.+|+.+|..|. ||||+.+++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4689999999999999999998 457889999999754 2356899999999997 999999999987654 46799
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccccC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFG 498 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~~ 498 (674)
+||..+.+...+- ..|+...+...+.+++.||.|+|+.| |+|||+||.|++||... .++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999887765443 35778889999999999999999998 99999999999998654 68999999999876
Q ss_pred CCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce--
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ-- 575 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~-- 575 (674)
.....+ ..+.+..|--||.+.. ..|+..-|+|||||+|.+|+..+.||- ...+..+.+..+.+.+.......
T Consensus 185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF--hG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc--CCCCCHHHHHHHHHHhChHHHHHHH
Confidence 554333 3356778899999875 458899999999999999999999863 33333333322222111100000
Q ss_pred -----ecccccC----------------CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 -----LLDTNLT----------------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 -----~~d~~~~----------------~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
-+|+.+. .+-..-...+.++++.+.|..|-.+|||+.|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0111110 0000011246788899999999999999999764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=258.54 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=202.1
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
..++|+....+|.|.||.|||++. .+++..|+|+++-.......-+++||-+++.-+|+||+.++|.+...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 346889999999999999999995 4688899999988777777778899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
||.+|+|.+.-+ ..+++++.++..+.+..++||.|||+.+ -+|||||-.|||++++|.+|++|||.+..+. .
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit--a 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT--A 164 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--h
Confidence 999999988763 4568999999999999999999999998 7999999999999999999999999987653 2
Q ss_pred CCCccccccccCCccCcccc---ccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 502 TQGNTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.-.+.....||+.|||||+. +.+.|..++|||+.|+...|+-.-++|.. +.-....+.-.. -....+..+-|
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf--dlhpmr~l~LmT---kS~~qpp~lkD 239 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF--DLHPMRALFLMT---KSGFQPPTLKD 239 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc--ccchHHHHHHhh---ccCCCCCcccC
Confidence 33345567899999999987 46679999999999999999977666521 111111110000 00111111212
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+ ..-...+.++++.|+.++|++||+++.+++
T Consensus 240 k-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 K-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 122345778999999999999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=240.14 Aligned_cols=131 Identities=27% Similarity=0.408 Sum_probs=108.0
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-----C---CceeeEEeEEEe---
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----H---RNLVRLLGFCLE--- 412 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~~~--- 412 (674)
.+|...++||+|.|++||++.. .+.+.||+|+.+.+. ...+....||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 7899999999999999999985 457789999986543 33456788999999983 3 469999999964
Q ss_pred -CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE
Q 005846 413 -GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480 (674)
Q Consensus 413 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll 480 (674)
+.+.++|+|++....| .++.. ...+.++...+.+|+.||+.||.|||.+. +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvLGdnLL-klI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLL-KLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhhHHH-HHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5689999999955444 44432 34456899999999999999999999875 69999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=230.06 Aligned_cols=197 Identities=34% Similarity=0.504 Sum_probs=170.7
Q ss_pred CCcccccccCCcEEEEEeecCC-CceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
|+..+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 889999999765544 56788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
+++|..++... .. +++..+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 99999988432 23 899999999999999999999987 99999999999999999999999999987654321
Q ss_pred CccccccccCCccCcccc-ccCCCCccccEEeechhhhHhHhCCCCCC
Q 005846 504 GNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNSN 550 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwS~Gv~l~elltg~~p~~ 550 (674)
.......++..|++||.+ ....++.++|||+||++++||++|+.|+.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 122335678899999998 66678889999999999999999999863
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=244.79 Aligned_cols=194 Identities=27% Similarity=0.426 Sum_probs=162.5
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--------cCHHHHHHHHHHHHhcC---CCceeeEEeEEEeC
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--------QGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEG 413 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~ 413 (674)
+|...+.||.|+||.|+.+.++ +..+|+||.+.+..- ...-..-.||.+|+.++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5889999999999999999975 456789998865321 11112456999999997 99999999999999
Q ss_pred CeeEEEEEecCC-CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 414 EEKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 414 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
+.++|+||-... -+|.+++ ..+..+++.+...|+.||+.|+++||+++ |||||||-+||.++.+|-+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 999999997544 4666666 34567999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCC-ccccEEeechhhhHhHhCCCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNS 549 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwS~Gv~l~elltg~~p~ 549 (674)
.+..... .-....+||..|.|||++.+.+|- ..-|||++|++||.++-..-|+
T Consensus 716 saa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 716 SAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred chhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9976532 234567899999999999988875 5689999999999998766553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=229.40 Aligned_cols=261 Identities=26% Similarity=0.305 Sum_probs=189.3
Q ss_pred hcCCCcccccccCCcEEEEEee-cCCCceeEEEEecc--cCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 414 (674)
..+|...+.+|.|.- .|-.+. .-.++.||+|++.. .....++...+|..++..++|+|+++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888898888 444444 23578999998754 34455677889999999999999999999986443
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
+.++|||+| ..+|...+. -.++-+++..|..|+..|+.|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 568999999 456666653 34788899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCcc---------------c
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA---------------D 559 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~---------------~ 559 (674)
+.-..+ -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-+.....-+.. +
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 864332 3445678899999999999888999999999999999999999754421110000 0
Q ss_pred hHHHHHhhhcCCCcce-------ec-ccccCC--CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 560 LLSYAWKQWRDGTPLQ-------LL-DTNLTD--SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 560 ~l~~~~~~~~~~~~~~-------~~-d~~~~~--~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+...-+.+....+.. .+ |..+.. ..+....-...+++.+||-.||++|.+++++++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000001111111100 11 111111 1111233456789999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=241.18 Aligned_cols=270 Identities=20% Similarity=0.223 Sum_probs=203.0
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcC------CCceeeEE
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ------HRNLVRLL 407 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~ 407 (674)
+.+...+....+|.+....|+|-|++|.+|... .|..||||++..+. ...+.=+.|+++|++|. .-|.++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 444556778889999999999999999999853 47899999997642 22233367999999995 35899999
Q ss_pred eEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-Ce
Q 005846 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NP 486 (674)
Q Consensus 408 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ 486 (674)
-.|...+++|||+|-+ .-+|.+.|........|....+..++.|+.-||..|...+ |+|.||||.|||+++.. .+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 9999999999999977 5678888876666667888999999999999999999887 99999999999998765 57
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
||||||.|...... ..+...-+..|.|||++.+-.|+...|+||.||.||||.||+..|+.. ...+++.+...
T Consensus 577 KLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~---TNN~MLrl~me 649 (752)
T KOG0670|consen 577 KLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR---TNNQMLRLFME 649 (752)
T ss_pred eeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC---CcHHHHHHHHH
Confidence 99999999765432 222233456799999999999999999999999999999999865432 22333333221
Q ss_pred --------hhcCCCc---------------------------ceeccc------ccCC--CCCh---hHHHHHHHHHhhc
Q 005846 567 --------QWRDGTP---------------------------LQLLDT------NLTD--SYSR---NEVIRCIQLGLLC 600 (674)
Q Consensus 567 --------~~~~~~~---------------------------~~~~d~------~~~~--~~~~---~~~~~~~~li~~C 600 (674)
.++.+.. +..+.+ .+.. .++. ..+..+.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 1111100 000000 0000 1222 3345678899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005846 601 VQEDPAERPSMATIVL 616 (674)
Q Consensus 601 l~~dP~~RPt~~evl~ 616 (674)
+..||++|.|..+.|.
T Consensus 730 l~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 730 LILDPEKRITVNQALK 745 (752)
T ss_pred hccChhhcCCHHHHhc
Confidence 9999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=230.82 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=195.8
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecC----CCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGE 414 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 414 (674)
+....+.|..+++||.|.|++||++.+. ..+.||+|.+...+.. ..+.+|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999853 4678999998765443 5689999999999 5999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeCC
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGM 493 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGl 493 (674)
...+|+||+++....++.. .++..++..++..+..||.++|.+| ||||||||+|+|.+. -+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999988887773 3778999999999999999999998 999999999999975 45678999999
Q ss_pred ccccCCCC------------------------------------------CCCccccccccCCccCcccccc-CCCCccc
Q 005846 494 ARIFGVDQ------------------------------------------TQGNTSRIVGTYGYMAPEYAMH-GQFSVKS 530 (674)
Q Consensus 494 a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~ 530 (674)
|....... .........||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211000 0000112469999999999865 4678999
Q ss_pred cEEeechhhhHhHhCCCCCCccCCCCccchHHHHH----h-------------hhcCCCc---cee------cc-ccc-C
Q 005846 531 DVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW----K-------------QWRDGTP---LQL------LD-TNL-T 582 (674)
Q Consensus 531 DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~----~-------------~~~~~~~---~~~------~d-~~~-~ 582 (674)
||||-|||++-+++++.||- ...++...+.+.+. . .|..... .++ ++ ... .
T Consensus 260 Diws~GVI~Lslls~~~PFf-~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF-KAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred ceeeccceeehhhccccccc-cCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999999863 22222222222210 0 1110000 000 00 000 0
Q ss_pred --------CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 --------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 --------~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..........+++++.+|+..||.+|.|+++.|.
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0111122336889999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=213.65 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=189.5
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeE-EEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGF-CLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 420 (674)
.+.|.+.+.||+|.||.+-.+.++ +.+.+++|-+.... ....+|.+|...--.| .|.||+.-+++ |...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467899999999999999999864 57788999886532 3356788887765555 68999988865 45556788999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc--CCCCeEEeeeCCccccC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMARIFG 498 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~ki~DfGla~~~~ 498 (674)
||++.|+|..-+. ...+.+....+++.|++.|+.|||+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999987763 355788888999999999999999998 99999999999993 44589999999987543
Q ss_pred CCCCCCccccccccCCccCccccccC-----CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
.. .....-+..|.+||..... +..+.+|||.||++++.++||+.|+. .....+..-|.|..|.....
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ---ka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ---KASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch---hhhccCchHHHHHHHhcccC
Confidence 22 1222345679999976432 24678999999999999999999964 33344445566777766554
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
..+.+ .+. ....+++++..+-+..+|++|-...++..+-
T Consensus 247 ~~~P~-----~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPK-----KFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCch-----hhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 43322 111 1234566777888999999996666665554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=268.69 Aligned_cols=197 Identities=19% Similarity=0.247 Sum_probs=137.9
Q ss_pred hcCC-CceeeEEeEE-------EeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 005846 397 KLQH-RNLVRLLGFC-------LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (674)
Q Consensus 397 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 468 (674)
.++| +||++++++| .+.+..++++||+ +++|.+++.. ....+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3555 5788888877 3334567888987 6689999853 2356999999999999999999999988 9
Q ss_pred EEeecccccEEEcCC-------------------CCeEEeeeCCccccCCCCC--------------CCccccccccCCc
Q 005846 469 IHRDLKASNILLDAE-------------------MNPKISDFGMARIFGVDQT--------------QGNTSRIVGTYGY 515 (674)
Q Consensus 469 iHrDlkp~NIll~~~-------------------~~~ki~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 515 (674)
+||||||+||||+.. +.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4556666666653211000 0001124588999
Q ss_pred cCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHH
Q 005846 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQ 595 (674)
Q Consensus 516 ~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 595 (674)
||||++.+..++.++|||||||+||||++|..|+.. ........... .+.+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~-----~~~~~~~~~~~--------~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE-----KSRTMSSLRHR--------VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh-----HHHHHHHHHHh--------hcChhh-----hhcCHHHHH
Confidence 999999999999999999999999999998876321 00111101000 011100 111234567
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 005846 596 LGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 596 li~~Cl~~dP~~RPt~~evl~~ 617 (674)
++.+||+.+|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=205.85 Aligned_cols=166 Identities=19% Similarity=0.180 Sum_probs=123.3
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|.+++.. .+..+++.+++.|+.||++||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 677788743 2456999999999999999999999875 999999999999999 99998654321
Q ss_pred cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~ 585 (674)
..|++.|||||++.+..++.++|||||||++|||+||+.|+.... .....+.............. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~-------~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER--ELSAILEILLNGMPADDPRD-------RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc--hhcHHHHHHHHHhccCCccc-------ccc
Confidence 258899999999999999999999999999999999999864221 11112222211111110000 001
Q ss_pred ChhHH--HHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 586 SRNEV--IRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 586 ~~~~~--~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..... ..+.+++.+||+.+|++||++.++++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11122 258899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-25 Score=212.69 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=190.9
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecc--cCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
....+|.+...|+.|+|++ .|..+++|++.. -.....++|.+|.-.|+.+.||||++++|.|.....+.+|..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3456789999999999999 466777787753 2334456789999999999999999999999999999999999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCc
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 505 (674)
|+|...++.. ..-..+..+..+++.+||+|++|||+..+ -|.---|.+..|++|++.+++|+ .+-.++. -.
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfs------fq 342 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFS------FQ 342 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceee------ee
Confidence 9999999753 33457888999999999999999999863 24445699999999999998884 1111110 00
Q ss_pred cccccccCCccCccccccCCC---CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 506 TSRIVGTYGYMAPEYAMHGQF---SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~---s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.....-.+.||+||.+...+- -.++|+|||.+++|||.|...||.-...-+ . + +++.-+.++
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------c-------g--mkialeglr 407 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------C-------G--MKIALEGLR 407 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------h-------h--hhhhhcccc
Confidence 111234678999999976653 368999999999999999999875332211 0 1 122223445
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..++......+.+|+..|+.+||.+||.+..|+-.|+..
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 555666677888999999999999999999999998763
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=187.33 Aligned_cols=103 Identities=45% Similarity=0.857 Sum_probs=78.3
Q ss_pred cccCC-C-Cccc-CCCchHHHHHHHHHHhcccccCCCCCCCCCceeeccCCCCCcEEEEEEccCCCCccchHHHHHHHHH
Q 005846 33 THVCS-T-TANF-TRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQDPNRVYGLFLCRGDQTTSDCQDCVTFAAR 109 (674)
Q Consensus 33 ~~~C~-~-~~~~-~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~f~~~~~g~~~~~vygl~~C~~D~~~~~C~~Cl~~a~~ 109 (674)
|+.|+ + .++| +++++|++||+.||..|+++++.++ +.+|+++..|.++++||||+||++|+++.+|..||+.|+.
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~--~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~ 78 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS--SKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVA 78 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT---TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc--ccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence 57898 3 4567 6788899999999999999986321 4689999889999999999999999999999999999999
Q ss_pred HHhhhCCCCcceEEEcceeEEEEcCccc
Q 005846 110 DVLQLCPVSKETILWYAECLLRYSDQSI 137 (674)
Q Consensus 110 ~~~~~C~~~~~~~~~~~~C~lry~~~~f 137 (674)
.+...|+.+++|+||++.|+||||+++|
T Consensus 79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 79 NISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 9999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=219.34 Aligned_cols=170 Identities=19% Similarity=0.204 Sum_probs=132.0
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecC--CCceeEEEEeccc-----CccCHHHHHHHHHHHHhcCCCceeeEEeEEE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 411 (674)
......++|.+.+.||+|+||+||++.+. +++.||||++... .....+.|.+|+++|++++|+|+++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34456678999999999999999999864 5777899987533 11234568999999999999999853322
Q ss_pred eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeec-ccccEEEcCCCCeEEee
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKISD 490 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDl-kp~NIll~~~~~~ki~D 490 (674)
....++||||+++++|.... .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++++||+|
T Consensus 90 -~~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -cCCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 24579999999999996321 11 1 1467889999999999988 999999 99999999999999999
Q ss_pred eCCccccCCCCCCCc------cccccccCCccCccccccC
Q 005846 491 FGMARIFGVDQTQGN------TSRIVGTYGYMAPEYAMHG 524 (674)
Q Consensus 491 fGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 524 (674)
||+++.+........ .....+++.|+|||++...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999997754322111 1356788999999998644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=211.16 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=189.8
Q ss_pred CCCcccccccCCcEEEEEeecCCC--ceeEEEEecccCccCHHHHHHHHHHHHhcCC----CceeeEEeEE-EeCCeeEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSG--QEIAVKRLSKASGQGAEEFKNEVVLVAKLQH----RNLVRLLGFC-LEGEEKIL 418 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~~~~l 418 (674)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999996543 4788888765433333367889999998873 6888999888 47778899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC-----CCeEEeeeCC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-----MNPKISDFGM 493 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-----~~~ki~DfGl 493 (674)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 888888764333 567999999999999999999999998 9999999999999765 4689999999
Q ss_pred ccccC--CCCC----CCc--cccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 494 ARIFG--VDQT----QGN--TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 494 a~~~~--~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
++.+. .... ... .....||.+|+++....+...+.+.|+||++.++.|++.|..|+...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98332 1111 111 223559999999999999999999999999999999999998874333221111111111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
... .... ........+.++...+-..+..++|....+...|+..
T Consensus 254 ~~~-------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 RKL-------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhh-------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 000 0000 1111222344444445557999999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-21 Score=198.42 Aligned_cols=261 Identities=31% Similarity=0.415 Sum_probs=196.5
Q ss_pred CCcccccccCCcEEEEEeecCCCceeEEEEecccCcc---CHHHHHHHHHHHHhcCCC-ceeeEEeEEEeCCeeEEEEEe
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ---GAEEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 422 (674)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999975 78899998764433 367889999999999988 799999999777778999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~~~~~ 501 (674)
+.++++..++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866532111136889999999999999999999998 99999999999999998 79999999998654433
Q ss_pred CCC----ccccccccCCccCcccccc---CCCCccccEEeechhhhHhHhCCCCCCccCCC-CccchHHHHHhhhcCCCc
Q 005846 502 TQG----NTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD-GAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 502 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~-~~~~~l~~~~~~~~~~~~ 573 (674)
... ......|+..|++||.+.+ ...+...|+|++|++++++++|..|+...... .........+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2356789999999999987 67899999999999999999999984432221 011222222211111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467788888999999999998887653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=182.92 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=190.2
Q ss_pred hhcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 420 (674)
...+|..+++||.|+||.+|.|. ..+|++||||.-+..... .++.-|..+...|+| ..|..+..+..++..-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45789999999999999999998 578999999987655433 356778888888976 67777888888888899999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC---CCeEEeeeCCcccc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIF 497 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~ki~DfGla~~~ 497 (674)
|.+ |-+|+++..- -...++..+++-++-|++.-++|+|..+ +|||||||+|.|..-+ .++.++|||+++.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 7788877632 2346889999999999999999999998 9999999999999643 46889999999987
Q ss_pred CCCCC-----CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 498 GVDQT-----QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 498 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
....+ ........||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||.........+-.+.+.+. .-..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek-K~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK-KMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-hcCC
Confidence 43322 22334578999999999888888999999999999999999999996432222111111111110 0011
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
+. ..+...+|. +..-.+.-|-..--++-|....+-++..
T Consensus 244 ~i----e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 244 PI----EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred CH----HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 11 122233333 3334455566667777787666555544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=188.40 Aligned_cols=198 Identities=24% Similarity=0.356 Sum_probs=168.8
Q ss_pred CCCcccccccCCcEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEec
Q 005846 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+|++.++||+|.||+++.|+ +-+++.||||.-...++. .++..|....+.| ..++|..++-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 78999999999999999998 458999999987655433 4678888888888 5689999998888888999999988
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-----CCCeEEeeeCCccccC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMARIFG 498 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~ki~DfGla~~~~ 498 (674)
|-||+++.. --+..++.++++.++.|++.-++|+|++. +|.|||||+|.||.. ...+.|+|||+|+.+.
T Consensus 107 -GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 778877662 23557999999999999999999999998 999999999999964 3458999999999886
Q ss_pred CCCCCC-----ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCc
Q 005846 499 VDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 499 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
...+.. ......||.+||+-....+.+.+.+.|+-|||-++.+.|-|..||..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 544332 34557899999999999999999999999999999999999999754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-22 Score=221.98 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=184.4
Q ss_pred CcccccccCCcEEEEEeecC-CCceeEEEEec----c-cCccC-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLS----K-ASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~----~-~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.....+|.|.+|.|+..... ..+..+.|... . ..... ...+..|+.+-..++|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977766532 23333333322 1 11111 112556777777889999988887777766666669
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++ +|..++. ....+...++..++.|+..|+.|||+.| |.|||||++|++++.++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 8888773 2346888999999999999999999998 999999999999999999999999999888655
Q ss_pred CCC--CccccccccCCccCccccccCCCCc-cccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 501 QTQ--GNTSRIVGTYGYMAPEYAMHGQFSV-KSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 501 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... ......+|+..|+|||++...+|.+ ..||||.|+++..|++|+.||......+... ..........+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccccc
Confidence 544 4556688999999999999999885 5899999999999999998865443332211 000000000000
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. -........+.+...++.++|+.||.+|-|+++|++
T Consensus 548 ~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 E--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 001112234556788999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-21 Score=186.55 Aligned_cols=173 Identities=14% Similarity=0.191 Sum_probs=135.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHH---------HHHHHHHHHhcCCCceeeEEeEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEE---------FKNEVVLVAKLQHRNLVRLLGFCL 411 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~h~niv~l~~~~~ 411 (674)
+...++|+..+.||.|+||.||.... ++..+|||.+.......... +.+|+..+.++.|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999665 67789999997543332222 678999999999999999998866
Q ss_pred eC--------CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC
Q 005846 412 EG--------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 483 (674)
Q Consensus 412 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~ 483 (674)
.. ...+|+|||++|.+|.++. .++. ....+|+.+|..||+.+ ++|||+||+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 43 3578999999999997763 1222 24569999999999998 9999999999999999
Q ss_pred CCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhH
Q 005846 484 MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543 (674)
Q Consensus 484 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ell 543 (674)
+ ++|+|||.......+... ..+.....+..++|+|+||+.+..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988654211100 11344556778999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=181.68 Aligned_cols=139 Identities=18% Similarity=0.191 Sum_probs=108.4
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCcc--C-------H-----------------HHHHHHHHHHHhcCCCce
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--G-------A-----------------EEFKNEVVLVAKLQHRNL 403 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~h~ni 403 (674)
...||+|+||.||+|...+|+.||||+++..... . . ....+|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998653211 0 0 122359999999988776
Q ss_pred eeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEEeecccccEEEcC
Q 005846 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 404 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiHrDlkp~NIll~~ 482 (674)
.....+.. ...+|||||++++++...+. ....+++.....++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 43333222 23389999999987765431 235689999999999999999999 6777 99999999999998
Q ss_pred CCCeEEeeeCCcccc
Q 005846 483 EMNPKISDFGMARIF 497 (674)
Q Consensus 483 ~~~~ki~DfGla~~~ 497 (674)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-21 Score=164.40 Aligned_cols=101 Identities=45% Similarity=0.783 Sum_probs=77.4
Q ss_pred ccccc---ccCC-CchhHHHHHHHHHHHHHHHHhhcc-CCceEEEeeccCCCceeeEEEeecCCCCccchhHHHHHHHhc
Q 005846 147 VSLLN---TQNV-TDQGRLNELVGTQMSQVVTQAVSN-TKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVAR 221 (674)
Q Consensus 147 ~~~~~---~~~~-~~~~~f~~~~~~ll~~l~~~a~~~-~~~fa~~~~~~~~~~~vy~laQC~~dls~~dC~~Cl~~~~~~ 221 (674)
|..|+ .+++ ++.+.|..++..||..|+..|+.+ +.+|++++. ..+.++||||+||++||++.||..||+.++..
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 45677 3344 456669999999999999998865 479999986 45678999999999999999999999999999
Q ss_pred cCcCCCCCcCcEEEccccccccccCcc
Q 005846 222 LPSCCSGKQGGRVLFPSCNVRYELYPF 248 (674)
Q Consensus 222 ~~~~c~~~~g~~~~~~~C~lry~~~~f 248 (674)
++.+|+++.||+|++++|+|||+.++|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=175.57 Aligned_cols=140 Identities=20% Similarity=0.224 Sum_probs=111.1
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCcc---------------------C-----HHHHHHHHHHHHhcCCCce
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ---------------------G-----AEEFKNEVVLVAKLQHRNL 403 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~Ei~~l~~l~h~ni 403 (674)
...||+|+||.||+|...+|+.||||++...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999878999999998754211 0 1223578999999999987
Q ss_pred eeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcC
Q 005846 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 404 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~ 482 (674)
.....+... ..+|||||++++++..... ....++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3489999999886543321 23457888999999999999999999 77 99999999999999
Q ss_pred CCCeEEeeeCCccccC
Q 005846 483 EMNPKISDFGMARIFG 498 (674)
Q Consensus 483 ~~~~ki~DfGla~~~~ 498 (674)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.5e-20 Score=196.11 Aligned_cols=218 Identities=24% Similarity=0.365 Sum_probs=163.2
Q ss_pred HHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecc
Q 005846 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474 (674)
Q Consensus 395 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlk 474 (674)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....++|.....++++|+.||.|||... . ..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 3568999999999999999999999999999999999964 4557999999999999999999999754 2 3999999
Q ss_pred cccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccC-------CCCccccEEeechhhhHhHhCCC
Q 005846 475 ASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-------QFSVKSDVYSFGVLVLEIITGKK 547 (674)
Q Consensus 475 p~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwS~Gv~l~elltg~~ 547 (674)
+.|++++..+.+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776421111112222335679999998763 15778999999999999999999
Q ss_pred CCCccCCCC-ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 548 NSNFYQTDG-AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 548 p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
|++...... ..+++..+.+.. .....+.+.... +....+..++..||..+|++||++++|-..++....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~-----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGG-----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHhcC-----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 987533222 223333332211 111111111110 222368899999999999999999999988876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-20 Score=208.11 Aligned_cols=250 Identities=20% Similarity=0.226 Sum_probs=179.6
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccC-ccCHHHHHHHHHHH--HhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS-GQGAEEFKNEVVLV--AKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l--~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++...+.||.+.|=+|.+++.++|. |+||++-+.. ....+.|.++++-+ ..++|||.+++..+-....-.+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999998887 8899886544 44556666555444 445999999999887777777888888
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
..+ +|.+.+ ..+.-|...+...|+.|++.||..+|..+ |+|||||.+||||+.-..+.|+||.-.+.......
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 855 444444 23445778888999999999999999998 99999999999999999999999998775533222
Q ss_pred CC-c----cccccccCCccCccccccC-----------CCCccccEEeechhhhHhHhC-CCCCCccCCCCccchHHHHH
Q 005846 503 QG-N----TSRIVGTYGYMAPEYAMHG-----------QFSVKSDVYSFGVLVLEIITG-KKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 503 ~~-~----~~~~~gt~~y~aPE~~~~~-----------~~s~k~DvwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~ 565 (674)
.. . ..+...-..|+|||.+... ..+++-||||+||++.||++- +++|+.. +++.+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhc
Confidence 11 1 1122233479999987431 167899999999999999985 5555421 2222211
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
. ........+. .+. ...+..+++.|++.||.+|-++++.++.-+
T Consensus 250 ~--~~~~~e~~Le-----~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 250 G--NADDPEQLLE-----KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred c--CccCHHHHHH-----hCc---CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1 0111111111 111 125778999999999999999999998743
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=167.19 Aligned_cols=137 Identities=21% Similarity=0.312 Sum_probs=107.3
Q ss_pred CCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhc-----CCCceeeEEeEEEeCC---e-eE
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-----QHRNLVRLLGFCLEGE---E-KI 417 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 417 (674)
+...+.||+|+||.||. ++.....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 44567899999999996 433344479988765444567899999999999 5799999999998864 3 34
Q ss_pred EEEEe--cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCcEEEeecccccEEEcC----CCCeEEee
Q 005846 418 LVYEF--VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI-LYLHEDSRLRIIHRDLKASNILLDA----EMNPKISD 490 (674)
Q Consensus 418 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~iiHrDlkp~NIll~~----~~~~ki~D 490 (674)
+|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 557999999943 235555 35678888777 9999998 999999999999974 34799999
Q ss_pred eCCc
Q 005846 491 FGMA 494 (674)
Q Consensus 491 fGla 494 (674)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=164.99 Aligned_cols=184 Identities=16% Similarity=0.147 Sum_probs=137.5
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecccCcc----CHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEe
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ----GAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.....|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 6778887777554321 1225789999999995 5889999886 446999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeec-ccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDl-kp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
+.|.+|...+. . ....++.|++++|.++|+.| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998854321 0 12357789999999999998 999999 7999999999999999999998654322
Q ss_pred CC----Cc-------cccccccCCccCccccccC-CCC-ccccEEeechhhhHhHhCCCCC
Q 005846 502 TQ----GN-------TSRIVGTYGYMAPEYAMHG-QFS-VKSDVYSFGVLVLEIITGKKNS 549 (674)
Q Consensus 502 ~~----~~-------~~~~~gt~~y~aPE~~~~~-~~s-~k~DvwS~Gv~l~elltg~~p~ 549 (674)
.. .. ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 00 1112357788888754322 233 5678889999999999999764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-19 Score=189.93 Aligned_cols=225 Identities=26% Similarity=0.290 Sum_probs=174.4
Q ss_pred ccccCCcEEEEEee----cCCCceeEEEEecccCccC--HHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEecC
Q 005846 352 KLGEGGFGEVYKGV----LPSGQEIAVKRLSKASGQG--AEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
.+|+|.||.|+... .+.|.-+|+|.+++..... ......|-.++...+ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 3457778999887643211 124456778888886 9999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+|.|...+. +...+++.........++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999877763 3445677777778889999999999988 99999999999999999999999999987532221
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
.+||..|||||++. .....+|.||||++++||+||-.|+.. +....+ .+ ....
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~I---l~-----------~~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRI---LK-----------AELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHH---hh-----------hccC
Confidence 18899999999998 567889999999999999999988642 111111 10 1122
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
++.+......+++..++..+|..|--.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 344555566777788888888888754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-18 Score=172.20 Aligned_cols=233 Identities=19% Similarity=0.293 Sum_probs=146.3
Q ss_pred CCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCC-----------CceeeEEeEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH-----------RNLVRLLGFC 410 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h-----------~niv~l~~~~ 410 (674)
.+...+.||.|+++.||.+++. +|+++|+|++... .....+++++|......+.+ .-++++--.-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456788999999999999964 5899999987432 23346677777766555432 1222222111
Q ss_pred E--------eCC--------eeEEEEEecCCCccccccc---CCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEE
Q 005846 411 L--------EGE--------EKILVYEFVPNKSLDYFLY---DPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470 (674)
Q Consensus 411 ~--------~~~--------~~~lv~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 470 (674)
. ... ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 111 125677766 556655542 1111 122445566778899999999999998 999
Q ss_pred eecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCcccccc--------CCCCccccEEeechhhhHh
Q 005846 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--------GQFSVKSDVYSFGVLVLEI 542 (674)
Q Consensus 471 rDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DvwS~Gv~l~el 542 (674)
+||||+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988765432111 1234578999997643 2478899999999999999
Q ss_pred HhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCC
Q 005846 543 ITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER 608 (674)
Q Consensus 543 ltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R 608 (674)
++|..|++....+...+. .+ .... +.++.+..||..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999865433221111 11 1223 566788899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-18 Score=192.10 Aligned_cols=200 Identities=21% Similarity=0.253 Sum_probs=161.1
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCe
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEE 415 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~ 415 (674)
+.+...++|.+.+.||+|+||.||+|...+|+.||+|+-+..+.-. |.--.+++.+|+ -+.|..+.....-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3455667899999999999999999998889999999876654321 121223444444 2345555555566778
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-------CCCCeEE
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-------AEMNPKI 488 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-------~~~~~ki 488 (674)
.+||+||.+.|+|.+++. ..+.++|.....++.|++..+.+||..+ |||+||||+|.||. ++.-++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999984 5567999999999999999999999988 99999999999994 2345899
Q ss_pred eeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCC
Q 005846 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 547 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~ 547 (674)
+|||.+-.+..-.........++|-.+--+|...+..++..+|.|.|.-+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999876654444445556778899999999999999999999999999999999985
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=163.17 Aligned_cols=142 Identities=19% Similarity=0.223 Sum_probs=111.4
Q ss_pred CCCcccccccCCcEEEEEee--cCCCceeEEEEecccCcc------------------------CHHHHHHHHHHHHhcC
Q 005846 346 KFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSKASGQ------------------------GAEEFKNEVVLVAKLQ 399 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 399 (674)
-|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 568999999998643210 0123568999999997
Q ss_pred CC--ceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 400 HR--NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 400 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
+. .+.+++++ ...++||||+++++|..... ....+...+...++.||+.+|.+||+.+ +++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 63 34444443 23589999999988866542 2334566677899999999999999876 49999999999
Q ss_pred EEEcCCCCeEEeeeCCcccc
Q 005846 478 ILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~ 497 (674)
|+++ ++.++|+|||++...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-19 Score=183.14 Aligned_cols=174 Identities=26% Similarity=0.395 Sum_probs=132.5
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..+|.|++|...+|.+|+.........++...+.++.|++.|+.| ++ .+|||+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999776777778999999999999999999 55 999999999999999999999999998
Q ss_pred cccCCCC----CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhC-CCCCCccCCCCccchHHHHHhhhc
Q 005846 495 RIFGVDQ----TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSNFYQTDGAADLLSYAWKQWR 569 (674)
Q Consensus 495 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~ 569 (674)
....... .....+..+||..||+||.+.+.+|+.|+||||||+||+||++- ...++ -......++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence 7654333 12244567899999999999999999999999999999999972 11110 001112223
Q ss_pred CCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHH
Q 005846 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMAT 613 (674)
Q Consensus 570 ~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~e 613 (674)
++.+ ++....+++. -..++.+++...|.+||++.+
T Consensus 474 ~g~i----p~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGII----PPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCC----ChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 3222 2222223332 346788899999999994443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-17 Score=159.25 Aligned_cols=134 Identities=22% Similarity=0.324 Sum_probs=113.0
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCcc--------CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
+.||+|++|.||+|.+ .|..+++|+....... ....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 6788999976543211 124577899999999999988877777778888999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++|++|.+++.. ..+ .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999888732 112 78899999999999999988 99999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=155.99 Aligned_cols=141 Identities=20% Similarity=0.214 Sum_probs=110.8
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCcc----------------------CHHHHHHHHHHHHhcC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ----------------------GAEEFKNEVVLVAKLQ 399 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~~l~ 399 (674)
.....|...+.||+|+||.||++..++|+.||||++...... ....+..|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333448888999999999999999888999999987542210 1123567899999998
Q ss_pred CCc--eeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 400 HRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 400 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
|++ +...++ ....++||||+++++|..... ......++.+++.++.++|+.+ ++||||||+|
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence 874 444443 244589999999999876541 0345678899999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccC
Q 005846 478 ILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~ 498 (674)
|++++++.++|+|||++..+.
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=155.84 Aligned_cols=130 Identities=22% Similarity=0.379 Sum_probs=106.3
Q ss_pred ccccCCcEEEEEeecCCCceeEEEEecccCcc--------CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.||+|+||.||+|.+ +|..+++|+....... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 6788999986542211 1255778999999999887666555666677789999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+|++|.+++... . . .++.+++.+|.+||+.+ ++|||++|+||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~---~------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---N------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---H------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998876321 0 0 78999999999999988 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.1e-17 Score=180.32 Aligned_cols=139 Identities=21% Similarity=0.349 Sum_probs=113.3
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEE-ecccCc-------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR-LSKASG-------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
.....|...+.||+|+||+||+|.+... .+++|+ +.+... ...+.+.+|++++.+++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3345567789999999999999987544 444443 222111 1235678999999999999999888888887
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
...++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 78899999999999988773 45778999999999999988 9999999999999 678999999999
Q ss_pred ccc
Q 005846 494 ARI 496 (674)
Q Consensus 494 a~~ 496 (674)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.6e-16 Score=155.22 Aligned_cols=197 Identities=22% Similarity=0.284 Sum_probs=132.2
Q ss_pred CCCceeeEEeEEEe---------------------------CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHH
Q 005846 399 QHRNLVRLLGFCLE---------------------------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451 (674)
Q Consensus 399 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 451 (674)
+|||||++.++|.+ +...|+||...+ -+|..++. ....+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 69999999987764 224578887663 35666663 23456667777899
Q ss_pred HHHHHHHHHHhcCCCcEEEeecccccEEE--cCCC--CeEEeeeCCccccCCCC----CCCccccccccCCccCcccccc
Q 005846 452 GIARGILYLHEDSRLRIIHRDLKASNILL--DAEM--NPKISDFGMARIFGVDQ----TQGNTSRIVGTYGYMAPEYAMH 523 (674)
Q Consensus 452 ~ia~~L~~LH~~~~~~iiHrDlkp~NIll--~~~~--~~ki~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 523 (674)
|+++|+.|||.++ |.|||||++|||| ++|. .+.|+|||.+---.... .....-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999998 4444 46889999874322110 1111122346778999998854
Q ss_pred CC------CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHH
Q 005846 524 GQ------FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG 597 (674)
Q Consensus 524 ~~------~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li 597 (674)
.+ .-.|+|.|+.|.+.||+++..-||-- +.+-..+.. .+++.. ....+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r-----~Yqe~q---------LPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTR-----TYQESQ---------LPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechh-----hhhhhh---------CCCCcccCChHHHHHH
Confidence 32 23689999999999999988877531 111111111 111111 1122334455678899
Q ss_pred hhcccCCCCCCCCHHHHHHHH
Q 005846 598 LLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 598 ~~Cl~~dP~~RPt~~evl~~L 618 (674)
...|+.||.+||+..=....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999866555444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.8e-15 Score=137.08 Aligned_cols=135 Identities=21% Similarity=0.195 Sum_probs=115.4
Q ss_pred cccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999844 7899998865443 5678999999999977 58999999888888899999999988
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
.+..+ +......++.+++++|.+||.....+++|+||+|+||++++++.+++.|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5567788899999999999986545699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.8e-15 Score=143.86 Aligned_cols=137 Identities=20% Similarity=0.234 Sum_probs=98.6
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccC--HHH----------------------HHHHHHHHHhcCCCc--e
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG--AEE----------------------FKNEVVLVAKLQHRN--L 403 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~Ei~~l~~l~h~n--i 403 (674)
.+.||+|+||.||++...+|+.||||++....... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999886532111 111 134566666664432 4
Q ss_pred eeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcC
Q 005846 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 404 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~ 482 (674)
.+.++. ...++||||++++.+........ ... .+...++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 24689999999965432211100 011 5678899999999999998 76 99999999999999
Q ss_pred CCCeEEeeeCCccccC
Q 005846 483 EMNPKISDFGMARIFG 498 (674)
Q Consensus 483 ~~~~ki~DfGla~~~~ 498 (674)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=144.25 Aligned_cols=135 Identities=21% Similarity=0.269 Sum_probs=104.4
Q ss_pred ccccc-cCCcEEEEEeecCCCceeEEEEecccC-------------ccCHHHHHHHHHHHHhcCCCce--eeEEeEEEeC
Q 005846 350 DNKLG-EGGFGEVYKGVLPSGQEIAVKRLSKAS-------------GQGAEEFKNEVVLVAKLQHRNL--VRLLGFCLEG 413 (674)
Q Consensus 350 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~ 413 (674)
...|| .||.|+||+... .+..++||++.... ......+.+|+.++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 889999999887 47789999875321 1223457889999999998875 6777765433
Q ss_pred C----eeEEEEEecCC-CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEE
Q 005846 414 E----EKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (674)
Q Consensus 414 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki 488 (674)
. ..++|+|++++ .+|.+++.. ..++.. .+.+|+++|.+||+.| |+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 688877632 235543 3568999999999998 999999999999999999999
Q ss_pred eeeCCccc
Q 005846 489 SDFGMARI 496 (674)
Q Consensus 489 ~DfGla~~ 496 (674)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-15 Score=169.86 Aligned_cols=208 Identities=22% Similarity=0.290 Sum_probs=137.4
Q ss_pred cCCCcccccccCCcEEEEEeecCC-CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.+|..++.|-.|+||.||..+++. .+.+|+| +.+++-. .++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee-------------------
Confidence 578889999999999999998753 4556774 3222110 011 11112223222
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
|+=...+. .-+.++.. ++.+++|||+.+ |+|||+||+|.+|+.=|.+|++|||+.+........
T Consensus 136 --gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 22222221 22233332 277899999988 999999999999999999999999998864221111
Q ss_pred -------------CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 504 -------------GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 504 -------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
-....++||+.|+|||++....|...+|+|++|+|+||.+-|+.|+.. +..++++..+....
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG---dtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG---DTPEELFGQVISDD-- 274 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC---CCHHHHHhhhhhhh--
Confidence 112346899999999999999999999999999999999999998643 33334444332211
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCC
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP 609 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 609 (674)
..+.+ -......+..+++.+.|+.+|.+|-
T Consensus 275 i~wpE---------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 275 IEWPE---------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccccc---------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 00111 1112234567788889999999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-15 Score=170.43 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=186.9
Q ss_pred cCCCcccccccCCcEEEEEeecCC--CceeEEEEecccC--ccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 419 (674)
..|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456777789999999998877533 3445666655432 233344556777777776 99999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEEEeecccccEEEcCCC-CeEEeeeCCcccc
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH-EDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF 497 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~ 497 (674)
.||..++++...+... .....+....-..+.|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998777311 1114556667778999999999999 777 99999999999999999 9999999999887
Q ss_pred CC-CCCCCccccccc-cCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 498 GV-DQTQGNTSRIVG-TYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 498 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ... .|.+...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~-----~~~~~~~- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYS-----SWKSNKG- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cce-----eeccccc-
Confidence 65 444444455678 9999999998874 456789999999999999999999765443321 111 1111110
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......-........++..+++..+|..|.+.+++..
T Consensus 249 -----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000011122234567778888899999999888753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.7e-13 Score=144.29 Aligned_cols=144 Identities=22% Similarity=0.303 Sum_probs=100.7
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCH----------------------------------------
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGA---------------------------------------- 385 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 385 (674)
.|+ .+.||.|++|.||+|++++|+.||||+.+.......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 367999999999999999999999999854321100
Q ss_pred HHHHHHHHHHHhc----CCCceeeEEeEEE-eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHH-HHHH
Q 005846 386 EEFKNEVVLVAKL----QHRNLVRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR-GILY 459 (674)
Q Consensus 386 ~~~~~Ei~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~ 459 (674)
-+|.+|...+.++ +|.+-+.+-.++. .....+|||||++|++|.++.... ....+ ..+++..+++ .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCCC---HHHHHHHHHHHHHHH
Confidence 0244455555555 2333333333332 245679999999999998876321 11122 3456666666 4678
Q ss_pred HHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 460 LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
+|..| ++|+|+||.||+++.++++++.|||++..+.
T Consensus 273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 89887 9999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=136.00 Aligned_cols=203 Identities=22% Similarity=0.273 Sum_probs=141.2
Q ss_pred HHHHhcCCCceeeEEeEEEeC-----CeeEEEEEecCCCcccccccCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005846 393 VLVAKLQHRNLVRLLGFCLEG-----EEKILVYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRL 466 (674)
Q Consensus 393 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 466 (674)
.-|-.+.|.|||+++.|+.+. .+..++.|||..|+|..+|....+ +..+......+|+.||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345556899999999998654 356899999999999999976443 345888888999999999999999975 7
Q ss_pred cEEEeecccccEEEcCCCCeEEeeeCCccccCCC---CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhH
Q 005846 467 RIIHRDLKASNILLDAEMNPKISDFGMARIFGVD---QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 543 (674)
Q Consensus 467 ~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ell 543 (674)
+|+|+++.-+.|++..++-+||.---- ..+... ..........+.++|.+||+-...+.+..+|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999999888842111 111100 0111122345678999999888888889999999999999998
Q ss_pred hCCCCCCccC-CCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 544 TGKKNSNFYQ-TDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 544 tg~~p~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
-+..-..... ....+..+..+ ...+...+. ..++..|++-.|..||+|++++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~---------i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV---------IIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhh---------eeeccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 8764311110 00000000000 011111111 246778999999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.8e-12 Score=118.93 Aligned_cols=131 Identities=21% Similarity=0.188 Sum_probs=97.8
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCcee-eEEeEEEeCCeeEEEEEecCCCcc
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
.+.|+.|.++.||+.... +..+++|....... ....+.+|+..++.+.+.+++ +++.+ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 457899999999999874 77899998755432 223467899999998765554 44443 33345899999999887
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
.... . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5431 0 11345678999999999876 23469999999999999 67899999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-12 Score=139.64 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=179.0
Q ss_pred hcCCCccccccc--CCcEEEEEeec---CCCceeEEEEecc--cCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCe
Q 005846 344 TNKFSTDNKLGE--GGFGEVYKGVL---PSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 415 (674)
...|.+.+.+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+...+++ .|+|.++....+..++.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 346777888999 99999999986 3577889987432 2222222235566666666 59999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCcEEEeecccccEEEcCC-CCeEEee
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISD 490 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~ki~D 490 (674)
.++-+|.+. .+|..+.+. ....++...++.+..+..+ ||.++|... ++|-|+||.||++..+ ...+++|
T Consensus 193 lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 999999885 666666543 3344777888888888888 999999987 9999999999999999 8899999
Q ss_pred eCCccccCCCCCCCcc---ccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh
Q 005846 491 FGMARIFGVDQTQGNT---SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 491 fGla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
||+...+......... .+..|...|++||.. .+-++.+.|+|++|.++.+..++.......-. -.|..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~ 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQ 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccc
Confidence 9999887654432221 233678899999965 45788999999999999999888765321100 01222
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+... + ..++-..-..++...+..+++.+|..|++.+.+..
T Consensus 338 ~r~~~---i-----p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQGY---I-----PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccc---C-----chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 22211 1 11111111223444778899999999998887764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.1e-11 Score=134.11 Aligned_cols=145 Identities=16% Similarity=0.182 Sum_probs=94.3
Q ss_pred hhcCCCcccccccCCcEEEEEeecCC-CceeEEEEecccCcc----------------------------------CHH-
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQ----------------------------------GAE- 386 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~- 386 (674)
....|+. +.||.|++|.||++++++ |++||||+++..-.. ..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999877 999999998643110 011
Q ss_pred -----HHHHHHHHHHhcC----CCceeeEEeEEEe-CCeeEEEEEecCCCcccccccCCCcC---CCCCHHHHHHHHHHH
Q 005846 387 -----EFKNEVVLVAKLQ----HRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQ---GQLDWSRRYKIIGGI 453 (674)
Q Consensus 387 -----~~~~Ei~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~i 453 (674)
+|.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+ ..+....+..++.||
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 1333444444442 4444444344333 45678999999999997642111111 012222223333333
Q ss_pred HHHHHHHHhcCCCcEEEeecccccEEEcCCC----CeEEeeeCCccccC
Q 005846 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGMARIFG 498 (674)
Q Consensus 454 a~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~ki~DfGla~~~~ 498 (674)
+..| ++|+|+||.||+++.++ ++++.|||+...++
T Consensus 277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3455 99999999999999988 99999999998764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.8e-10 Score=108.07 Aligned_cols=137 Identities=15% Similarity=0.118 Sum_probs=98.8
Q ss_pred cccccCCcEEEEEeecCC-------CceeEEEEeccc-------------C---------ccCHHHHH----HHHHHHHh
Q 005846 351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSKA-------------S---------GQGAEEFK----NEVVLVAK 397 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~Ei~~l~~ 397 (674)
..||.|.-+.||.|.-.+ +..+|||+.+.. . ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999976421 0 01122333 79999999
Q ss_pred cCC--CceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEEeecc
Q 005846 398 LQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRDLK 474 (674)
Q Consensus 398 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiHrDlk 474 (674)
+.. -++...+++ ...+|||||+.++.+.... .+...++..+...+..+++.+|..| |..+ |+||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 456666654 5678999999875442211 1122355566778889999999999 7777 9999999
Q ss_pred cccEEEcCCCCeEEeeeCCccccC
Q 005846 475 ASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 475 p~NIll~~~~~~ki~DfGla~~~~ 498 (674)
+.|||++ ++.+.|+|||.+-...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-11 Score=129.25 Aligned_cols=247 Identities=23% Similarity=0.217 Sum_probs=174.9
Q ss_pred HhhcCCCcccccccCCcEEEEEeec--CCCceeEEEEecccCccCHHHH--HHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASGQGAEEF--KNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
....+|..+..||.|.|+.|++... .++..+++|.+.+.......++ ..|+.+...+ .|.++++....+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456899999999999999999763 4677899998876544433332 3566666666 699999988888888888
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC-CCeEEeeeCCcc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAR 495 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~ki~DfGla~ 495 (674)
++--||+.++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999987665 23345788889999999999999999887 9999999999999886 788999999986
Q ss_pred ccCCCCCCCccccccccCCcc--CccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 496 IFGVDQTQGNTSRIVGTYGYM--APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
.+.... . ...+.-++. +++......+-.+.|+||||.-+.|.+++..-..-.. .|...+.+.
T Consensus 416 ~~~~~~----~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~~~- 479 (524)
T KOG0601|consen 416 RLAFSS----G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRSGD- 479 (524)
T ss_pred ccceec----c-cccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cceeeeccc-
Confidence 321111 1 112233444 5555556678899999999999999999875321100 011111111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
....+. .......+...+...++..||.+.++..+.+
T Consensus 480 --------~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 --------TPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --------ccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111111 1144556666788899999999988776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.2e-10 Score=110.81 Aligned_cols=142 Identities=19% Similarity=0.280 Sum_probs=111.5
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCC--ceeeEEeEEEeCC---eeEEEEEecC
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHR--NLVRLLGFCLEGE---EKILVYEFVP 424 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~ 424 (674)
+.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999986678999998755332 2345788999999999764 4567777766542 5689999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS---------------------------------------- 464 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 464 (674)
|.++...+.. ..++..+...++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776521 35788888889999999999998531
Q ss_pred -------------CCcEEEeecccccEEEcC--CCCeEEeeeCCccc
Q 005846 465 -------------RLRIIHRDLKASNILLDA--EMNPKISDFGMARI 496 (674)
Q Consensus 465 -------------~~~iiHrDlkp~NIll~~--~~~~ki~DfGla~~ 496 (674)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.2e-10 Score=124.05 Aligned_cols=165 Identities=18% Similarity=0.232 Sum_probs=124.1
Q ss_pred CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHH
Q 005846 367 PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446 (674)
Q Consensus 367 ~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~ 446 (674)
.++.+|.|...+..+....+...+-++.|+.++||||++++......+..|||+|.+. .|...+. .+.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk------~l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK------ELGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH------HhHHHHH
Confidence 4678888888877666445667888999999999999999999999999999999763 3344442 2335666
Q ss_pred HHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCC
Q 005846 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF 526 (674)
Q Consensus 447 ~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 526 (674)
...+.||+.||.|||+.+ .++|++|.-..|+++..|..||++|.++......... .....---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc-
Confidence 778899999999999765 5999999999999999999999999988654322110 11111122456666543322
Q ss_pred CccccEEeechhhhHhHhC
Q 005846 527 SVKSDVYSFGVLVLEIITG 545 (674)
Q Consensus 527 s~k~DvwS~Gv~l~elltg 545 (674)
-..|.|.||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-09 Score=99.59 Aligned_cols=131 Identities=22% Similarity=0.351 Sum_probs=100.4
Q ss_pred cccccCCcEEEEEeecCCCceeEEEE-ecccCcc-------CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKR-LSKASGQ-------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..+++|+-+.+|.+.+. |..+++|. +++.-.. ..+.-.+|..++.+++--.|.--+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999873 44566664 3332111 123456799999998766666556666788888999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 2556777777888899998 99999999999998775 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=98.28 Aligned_cols=143 Identities=24% Similarity=0.334 Sum_probs=105.6
Q ss_pred cccccccCCcEEEEEeecCCCceeEEEE-ecccC-------ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKR-LSKAS-------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
....|-||+-+.|+++.+ .|+...||. +.+.- .....+.++|+..+.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567789999999999999 677777774 33321 112345678999999987656555555666777788999
Q ss_pred EecCC-CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC---eEEeeeCCccc
Q 005846 421 EFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARI 496 (674)
Q Consensus 421 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~ki~DfGla~~ 496 (674)
||+++ .++.+++...... .........++..|-+.+.-||.++ |+|+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4677777543222 2233334778889999999999998 999999999999966553 58999999854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.2e-09 Score=112.80 Aligned_cols=169 Identities=22% Similarity=0.327 Sum_probs=127.6
Q ss_pred cEEEEEee-cCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCeeEEEEEecCCC-ccccc
Q 005846 358 FGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEFVPNK-SLDYF 431 (674)
Q Consensus 358 fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g-sL~~~ 431 (674)
-.+.||+. ..+|..|++|++.....+.......-+++++++.|.|||+|..++.. +..+++||+|.++. +|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35678887 34899999999955443333334566889999999999999998873 34679999999874 55443
Q ss_pred ccCC------------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 432 LYDP------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 432 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
-+.. ......++..+|.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3321 22345788999999999999999999998 88899999999999999999998888776543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCC
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
+.. |-+. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 331 1111 12356777899999999999754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.3e-09 Score=122.85 Aligned_cols=251 Identities=19% Similarity=0.199 Sum_probs=163.6
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
...+.+.+.+-+-.|.++.++-..-. .|...++|...... ....+....+-.++-..+||-++...--+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45567778888889999999876522 23333333332211 111112222222222234566666555555667889
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
|+++|+.+++|...++. .+..+.+-....+..+.+.+++||... +.|+|++|.|+|...++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999888753 334565566667778889999999875 899999999999999999999999844322
Q ss_pred CCC---------------------CC--------CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCC
Q 005846 498 GVD---------------------QT--------QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 498 ~~~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
..- .. ........||+.|.+||...+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0112346789999999999999999999999999999999999998
Q ss_pred CCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHH
Q 005846 549 SNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612 (674)
Q Consensus 549 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~ 612 (674)
++-...... . +....... . ....+........+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~---f----~ni~~~~~-~------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI---F----ENILNRDI-P------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh---h----hccccCCC-C------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 653222111 1 11101000 0 0111223344566777778888999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.4e-08 Score=100.08 Aligned_cols=134 Identities=17% Similarity=0.141 Sum_probs=96.9
Q ss_pred cEEEEEeecCCCceeEEEEecccCcc-----------CHHHHHHHHHHHHhcCCCc--eeeEEeEEEe-----CCeeEEE
Q 005846 358 FGEVYKGVLPSGQEIAVKRLSKASGQ-----------GAEEFKNEVVLVAKLQHRN--LVRLLGFCLE-----GEEKILV 419 (674)
Q Consensus 358 fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv 419 (674)
...|.+..+ +|+.+.||+....... ....+.+|...+.++...+ ....+++... ....+||
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344667766 6788999977432211 1124778999888885433 3344555543 2356899
Q ss_pred EEecCCC-cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-------CCCeEEeee
Q 005846 420 YEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------EMNPKISDF 491 (674)
Q Consensus 420 ~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-------~~~~ki~Df 491 (674)
+|++++. +|.+++.+.. ....+......++.+++..+.-||..| |+|+|++++|||++. +..+.++||
T Consensus 114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999986 7888873221 234566777899999999999999998 999999999999975 467899999
Q ss_pred CCccc
Q 005846 492 GMARI 496 (674)
Q Consensus 492 Gla~~ 496 (674)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-08 Score=94.80 Aligned_cols=125 Identities=26% Similarity=0.368 Sum_probs=82.4
Q ss_pred EEEEeecCCCceeEEEEecccC--------------c-------cC-----HHHHHHHHHHHHhcCCC--ceeeEEeEEE
Q 005846 360 EVYKGVLPSGQEIAVKRLSKAS--------------G-------QG-----AEEFKNEVVLVAKLQHR--NLVRLLGFCL 411 (674)
Q Consensus 360 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------~~-----~~~~~~Ei~~l~~l~h~--niv~l~~~~~ 411 (674)
.||.|..++|..+|||+.+... . .. .....+|.+.|.++..- ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998889999999764210 0 00 12356799999999766 45666654
Q ss_pred eCCeeEEEEEecC--CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCcEEEeecccccEEEcCCCCeEE
Q 005846 412 EGEEKILVYEFVP--NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY-LHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (674)
Q Consensus 412 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~iiHrDlkp~NIll~~~~~~ki 488 (674)
...+|||||++ |..+..+.. ..++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999999 655654431 112234456677788886665 46777 9999999999999988 9999
Q ss_pred eeeCCcccc
Q 005846 489 SDFGMARIF 497 (674)
Q Consensus 489 ~DfGla~~~ 497 (674)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.9e-08 Score=109.70 Aligned_cols=152 Identities=23% Similarity=0.344 Sum_probs=103.7
Q ss_pred HHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC-------ccccccccCCccCccccc
Q 005846 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-------NTSRIVGTYGYMAPEYAM 522 (674)
Q Consensus 450 ~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 522 (674)
+.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+.......... ...-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999754 69999999999999999999999999876543311111 111123456899999999
Q ss_pred cCCCCccccEEeechhhhHhHhCCCC-CCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcc
Q 005846 523 HGQFSVKSDVYSFGVLVLEIITGKKN-SNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCV 601 (674)
Q Consensus 523 ~~~~s~k~DvwS~Gv~l~elltg~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl 601 (674)
+...+.++|+||+|+++|.+..|+.+ +.... ..+.+....... ..-...++.+.+.++.+-+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-----~~~~~~~~~~~~--------~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANG-----GLLSYSFSRNLL--------NAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccC-----Ccchhhhhhccc--------ccccccccccCcHHHHHHHHHHh
Confidence 98899999999999999999955543 22111 111111111111 11112233455567777788899
Q ss_pred cCCCCCCCCHHHHHH
Q 005846 602 QEDPAERPSMATIVL 616 (674)
Q Consensus 602 ~~dP~~RPt~~evl~ 616 (674)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.5e-07 Score=90.86 Aligned_cols=135 Identities=21% Similarity=0.271 Sum_probs=97.7
Q ss_pred CCcccccccCCcEEEEEeecCCCceeEEEEecc----------c-------Ccc-----CHHHHHHHHHHHHhcCCC--c
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSK----------A-------SGQ-----GAEEFKNEVVLVAKLQHR--N 402 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~----------~-------~~~-----~~~~~~~Ei~~l~~l~h~--n 402 (674)
..+..+||-|.-+.||.|..++|.++|||.=+. . ... .....++|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455688999999999999999999999994211 0 001 123356899999999655 6
Q ss_pred eeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC
Q 005846 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 403 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~ 482 (674)
+.+.+++ +...+|||+++|-.|...- ++.+..-.++..|++-+..+-..| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666654 4568999999987664332 233344445555555555555556 999999999999999
Q ss_pred CCCeEEeeeCCccc
Q 005846 483 EMNPKISDFGMARI 496 (674)
Q Consensus 483 ~~~~ki~DfGla~~ 496 (674)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.6e-07 Score=91.71 Aligned_cols=264 Identities=15% Similarity=0.151 Sum_probs=154.7
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEE------EeC-CeeEEE
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFC------LEG-EEKILV 419 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~------~~~-~~~~lv 419 (674)
...+.||+|+-+.+|--- +-..-+.|+.......... +.+..|... .||-+-.-+.+- -++ ...-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345789999999999643 1122356776554333222 223333333 455433312111 112 225577
Q ss_pred EEecCCCcccccccC----CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 420 YEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
|..+++.-=-..++. .+.....+|...++.++.+|.+.+.||..| .+-+|++++|+|+.+++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 777766522122222 122334789999999999999999999998 8899999999999999999998865544
Q ss_pred ccCCCCCCCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhC-CCCCCccCC-CCccchHHH--HHh
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG-KKNSNFYQT-DGAADLLSY--AWK 566 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg-~~p~~~~~~-~~~~~~l~~--~~~ 566 (674)
+. .........+|...|.+||... +-.-+...|.|.|||++++|+.| +.|+..... .+.-..++- +..
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 32 2222334467899999999754 33456789999999999999987 667643221 111111110 000
Q ss_pred hhc--CCCcceecccccCCCCChh-HHHHHHHHHhhcccC--CCCCCCCHHHHHHHHhcCCCC
Q 005846 567 QWR--DGTPLQLLDTNLTDSYSRN-EVIRCIQLGLLCVQE--DPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 567 ~~~--~~~~~~~~d~~~~~~~~~~-~~~~~~~li~~Cl~~--dP~~RPt~~evl~~L~~~~~~ 624 (674)
.+. .....-...+ ....+.. ....+.-+..+|+.. ++.-|||++-.+..|.....+
T Consensus 243 ~f~ya~~~~~g~~p~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRRGLKPP--PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccCCCCCC--CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000 0000000000 0111111 122455566677765 367899999999888654333
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.4e-06 Score=83.84 Aligned_cols=139 Identities=16% Similarity=0.125 Sum_probs=102.3
Q ss_pred cccCCcEEEEEeecCCCceeEEEEecccC------ccCHHHHHHHHHHHHhcCCC--ceeeEEeEEEeC----CeeEEEE
Q 005846 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKAS------GQGAEEFKNEVVLVAKLQHR--NLVRLLGFCLEG----EEKILVY 420 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~----~~~~lv~ 420 (674)
-|+||-+-|++-.+ +|+.+-+|+-.... +.....|.+|+..|.+|... .+.+.+...... ..-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46788888999877 45578899875211 33567899999999998532 244444222221 2358999
Q ss_pred EecCC-CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC--eEEeeeCCccc
Q 005846 421 EFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMARI 496 (674)
Q Consensus 421 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--~ki~DfGla~~ 496 (674)
|-+++ -+|.+++.+. ...+.+...+..++.+|++.++-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98765 4777776332 2235677888899999999999999998 999999999999987677 89999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.5e-07 Score=88.18 Aligned_cols=107 Identities=27% Similarity=0.312 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHHhcCCC--ceeeEEeEEEeCC----eeEEEEEecCCC-cccccccCCCcCCCCCHHHHHHHHHHHHHHH
Q 005846 385 AEEFKNEVVLVAKLQHR--NLVRLLGFCLEGE----EKILVYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457 (674)
Q Consensus 385 ~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 457 (674)
.....+|...+..+... .+.+.+++..... ..+||+|++++. +|.+++... ..++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 34577888888877433 3455666655432 458999999985 788887431 2266777889999999999
Q ss_pred HHHHhcCCCcEEEeecccccEEEcCCC---CeEEeeeCCcccc
Q 005846 458 LYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIF 497 (674)
Q Consensus 458 ~~LH~~~~~~iiHrDlkp~NIll~~~~---~~ki~DfGla~~~ 497 (674)
.-||..| |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.8e-06 Score=82.61 Aligned_cols=132 Identities=20% Similarity=0.230 Sum_probs=86.1
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEEeEEEeCCeeEEEEEecCCCc-
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKS- 427 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 427 (674)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567888876533 3355788999999986544 4677777777778889999999963
Q ss_pred ccccccCCCcCCCCCHHHHHHHHHHHHHHHH---------------------------------------HHHh-cCCCc
Q 005846 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGIL---------------------------------------YLHE-DSRLR 467 (674)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~---------------------------------------~LH~-~~~~~ 467 (674)
+...+. .+......++..+++.+. +|.. .....
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221110 001111111111222111 2211 12335
Q ss_pred EEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 468 IIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 468 iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 79999999999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.6e-06 Score=79.92 Aligned_cols=140 Identities=15% Similarity=0.159 Sum_probs=96.1
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHH---------HHHHHHHHhcCCC---ceeeEEe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEF---------KNEVVLVAKLQHR---NLVRLLG 408 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~h~---niv~l~~ 408 (674)
....++|...+.+-......|.+-.. +|..+++|..+......++.| .+++..+.+++.. ....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34567888888888888888888777 678899998866543333332 2344444444332 2223222
Q ss_pred EEE-----eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC
Q 005846 409 FCL-----EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 483 (674)
Q Consensus 409 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~ 483 (674)
+.. .....+|+|||++|-.|.++.. ++. .+...|.+.+.-||+.| ++|+|..|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 222 2235579999999988866541 222 24566778899999998 9999999999999965
Q ss_pred CCeEEeeeCCccc
Q 005846 484 MNPKISDFGMARI 496 (674)
Q Consensus 484 ~~~ki~DfGla~~ 496 (674)
+ +++.||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 5 99999987753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.7e-06 Score=95.03 Aligned_cols=146 Identities=18% Similarity=0.283 Sum_probs=94.8
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCcc--------------------------CH----H--------
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--------------------------GA----E-------- 386 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~----~-------- 386 (674)
.+|+. ..|+.++-|.||+|++++|+.||||+....-.. .. +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34442 679999999999999999999999987543110 00 1
Q ss_pred --HHHHHHHHHHhc----CCCceeeEEeEEE-eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHH
Q 005846 387 --EFKNEVVLVAKL----QHRNLVRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459 (674)
Q Consensus 387 --~~~~Ei~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 459 (674)
++.+|..-+.++ ++..-+++=.+++ -....+|+|||++|-.+.+...- +....+.+.+.....++. +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHH
Confidence 123444444444 2222233333333 35678999999999999887532 223455444433322222 222
Q ss_pred HHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 460 LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
+-..| ++|.|..|.||+++.++++.+.|||+...++
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22234 9999999999999999999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.1e-05 Score=76.81 Aligned_cols=152 Identities=19% Similarity=0.250 Sum_probs=96.5
Q ss_pred hhhHHHhhcCCCccc---ccccCCcEEEEEeecCCCceeEEEEecccCcc-------------------CHHH-----HH
Q 005846 337 FETIEVATNKFSTDN---KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ-------------------GAEE-----FK 389 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~---~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-----~~ 389 (674)
.+.+.....+..+.. .|..|.-+.||+|...++..+|||+.+..... ...+ ..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 334444444444444 45678888999999878999999998542211 0111 12
Q ss_pred HHHHHHHhcC--CCceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005846 390 NEVVLVAKLQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467 (674)
Q Consensus 390 ~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 467 (674)
.|+.-|.++. +-.+.+-+++ ..-.|||||+....+-.-. .+.-.+...+...+..++++.+.-|-... +
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 4555566552 2333344433 2347999999765221111 11222333356777788888888877632 3
Q ss_pred EEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 468 IIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 468 iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
+||+||..-|||+. ++.+.|+|||-+....
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999886543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.2e-07 Score=98.18 Aligned_cols=191 Identities=17% Similarity=0.123 Sum_probs=138.6
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCCeeEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKIL 418 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~l 418 (674)
++..+..+...+.+++|.++.++|.+-...+....+.+... ....-++++|.+++||| .++.++-+..++..++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34445556667778999999999987533344445555332 34466899999999999 7777777767778899
Q ss_pred EEEecCCC-cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 419 VYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 419 v~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+++++..+ +-.... ......+...+...+.+.-++++++||+.- -+|+| ||+..+ +..|..||+....+
T Consensus 312 ~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999887 222111 011223445556667778888999999864 48998 777665 67899999998766
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCC
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
.... ......+++.|+|||+...+.+..+.|+|++|+-..++--|-+|
T Consensus 382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 4332 34456789999999999999999999999999977777766655
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.5e-05 Score=79.30 Aligned_cols=143 Identities=22% Similarity=0.230 Sum_probs=85.3
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCC--ceeeEEeEEEeC---CeeEEEEEecC
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR--NLVRLLGFCLEG---EEKILVYEFVP 424 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 424 (674)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999866 68999987554 4456778899998888533 356667654333 34689999999
Q ss_pred CCccccc----------------c---cCC-CcCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005846 425 NKSLDYF----------------L---YDP-EKQGQLDWSR---------RYKI------------IGGIAR-GILYLHE 462 (674)
Q Consensus 425 ~gsL~~~----------------l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~~LH~ 462 (674)
+..+... + +.. .....+.+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 9988760 0 000 0111111110 0000 111222 2333332
Q ss_pred ----cCCCcEEEeecccccEEEc-CCCCeEEeeeCCcc
Q 005846 463 ----DSRLRIIHRDLKASNILLD-AEMNPKISDFGMAR 495 (674)
Q Consensus 463 ----~~~~~iiHrDlkp~NIll~-~~~~~ki~DfGla~ 495 (674)
.....++|+|+.|.|||++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 66666899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.8e-05 Score=78.28 Aligned_cols=139 Identities=17% Similarity=0.146 Sum_probs=85.0
Q ss_pred cccCCc-EEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEecCCCcccc
Q 005846 353 LGEGGF-GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430 (674)
Q Consensus 353 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 430 (674)
|-.|.. ..||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444444 788998764 4678888875543 345678999888883 4446677777766667899999999988764
Q ss_pred ccc-------------------CCCc-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 005846 431 FLY-------------------DPEK-QGQLDW--SRRYKIIG--------------------GIARGILYLHE----DS 464 (674)
Q Consensus 431 ~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~~LH~----~~ 464 (674)
... .... ...+.. ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 0000 001110 00000000 01111222211 12
Q ss_pred CCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 465 ~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+.++|+|+.|.|||++++....|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3559999999999999998878999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=2e-05 Score=75.68 Aligned_cols=105 Identities=23% Similarity=0.200 Sum_probs=83.4
Q ss_pred HHHHHHHHhcCC-CceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005846 389 KNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLR 467 (674)
Q Consensus 389 ~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 467 (674)
.+|..++..+++ +++.+++|+|- .++|.||...+++...-..-..-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 69999999993 4789999988766422100011124789999999999999999999865455
Q ss_pred EEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 468 IIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 468 iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+.-.|++++|+-+++++++|+.|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00011 Score=87.06 Aligned_cols=80 Identities=13% Similarity=0.297 Sum_probs=58.6
Q ss_pred ccccccCCcEEEEEeecCCC---ceeEEEEecccC-ccCHHHHHHHHHHHHhcC-CCce--eeEEeEEEeC---CeeEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQ-HRNL--VRLLGFCLEG---EEKILV 419 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 419 (674)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876543 367778764432 223456889999999995 6664 7888887664 357899
Q ss_pred EEecCCCccc
Q 005846 420 YEFVPNKSLD 429 (674)
Q Consensus 420 ~e~~~~gsL~ 429 (674)
|||++|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999987643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.2e-05 Score=83.87 Aligned_cols=142 Identities=13% Similarity=0.219 Sum_probs=91.8
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccC---------------------------HH----------HHHHHH
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG---------------------------AE----------EFKNEV 392 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------~~----------~~~~Ei 392 (674)
.+.||.-+.|.||++++++|+.||||+-+..-... .+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999865421110 01 133344
Q ss_pred HHHHh----cCCCceee---EEeEEE-eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 005846 393 VLVAK----LQHRNLVR---LLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464 (674)
Q Consensus 393 ~~l~~----l~h~niv~---l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 464 (674)
+-..+ ++|-++.. +=.+++ -....+|+||||+|..+++...- ....++...+..-+.++..-+-+-| |
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~--G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT--G 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc--C
Confidence 43333 34555111 222222 23578999999999988877432 3334666655444444333222222 3
Q ss_pred CCcEEEeecccccEEEcC----CCCeEEeeeCCccccC
Q 005846 465 RLRIIHRDLKASNILLDA----EMNPKISDFGMARIFG 498 (674)
Q Consensus 465 ~~~iiHrDlkp~NIll~~----~~~~ki~DfGla~~~~ 498 (674)
++|.|=.|.||++.. ++.+.+-|||+...+.
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6789999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00016 Score=69.69 Aligned_cols=130 Identities=22% Similarity=0.352 Sum_probs=91.1
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecccC----------------ccCHHHHHHHHHHHHhcC------CCceee
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----------------GQGAEEFKNEVVLVAKLQ------HRNLVR 405 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~ 405 (674)
+....||+|+.-.||. ++++....||+..... .....+..+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3456799999999996 4566778889886654 223456677777766666 789999
Q ss_pred EEeEEEeCCeeEEEEEecCC--Cc----ccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEE
Q 005846 406 LLGFCLEGEEKILVYEFVPN--KS----LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479 (674)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~--gs----L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIl 479 (674)
++|+...+....+|+|.+.+ |+ |.+++ ..+.++. ...+.+.++ ..||-+.+ |+.+||+|.||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEE
Confidence 99999999999999998754 33 44444 3344555 444444444 45555555 999999999999
Q ss_pred EcCCC----CeEEee
Q 005846 480 LDAEM----NPKISD 490 (674)
Q Consensus 480 l~~~~----~~ki~D 490 (674)
+.... .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 95432 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00013 Score=73.14 Aligned_cols=74 Identities=19% Similarity=0.266 Sum_probs=46.7
Q ss_pred cccccCCcE-EEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCC---ceeeEEeEEEeC---CeeEEEEEec
Q 005846 351 NKLGEGGFG-EVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR---NLVRLLGFCLEG---EEKILVYEFV 423 (674)
Q Consensus 351 ~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 423 (674)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 48875 235777765432 2345788999999888532 344444433222 1348899999
Q ss_pred CCCcccc
Q 005846 424 PNKSLDY 430 (674)
Q Consensus 424 ~~gsL~~ 430 (674)
+|.++..
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9988753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00027 Score=73.25 Aligned_cols=80 Identities=13% Similarity=0.096 Sum_probs=59.1
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCC---CceeeEEeEEEeC---CeeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH---RNLVRLLGFCLEG---EEKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~---~~~~lv 419 (674)
.....+.||.|..+.||+-...++ .+++|..+.. .....+..|.+.|+.|.. -.+.++++++..+ +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 445567899999999999876555 4666764331 123578899999998853 3678888887543 568999
Q ss_pred EEecCCCcc
Q 005846 420 YEFVPNKSL 428 (674)
Q Consensus 420 ~e~~~~gsL 428 (674)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00016 Score=66.97 Aligned_cols=129 Identities=19% Similarity=0.266 Sum_probs=87.3
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceee-EEeEEEeCCeeEEEEEecCCC
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR-LLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g 426 (674)
...+.|++|++|.||+|.+ .|.++|+|+-..++. ...+..|.++|..+.-.++-+ ++.|- +-++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 4467899999999999999 456889997765543 467889999999997666544 44432 234559999998
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecc-cccEEEcCCCCeEEeeeCCccc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK-ASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlk-p~NIll~~~~~~ki~DfGla~~ 496 (674)
.|...... .+..++.. +++.---|-..| |-|+.|. |..++|..+..+.|+||.-|..
T Consensus 98 ~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88665421 13333333 333322343334 8888876 5555555555999999999863
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00025 Score=67.88 Aligned_cols=125 Identities=29% Similarity=0.438 Sum_probs=89.1
Q ss_pred cCCCcccccccCCc-EEEEEeecCCCceeEEEEecc---cC---------c---------cCHHHHHHHHHHHHhcC---
Q 005846 345 NKFSTDNKLGEGGF-GEVYKGVLPSGQEIAVKRLSK---AS---------G---------QGAEEFKNEVVLVAKLQ--- 399 (674)
Q Consensus 345 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~---------~---------~~~~~~~~Ei~~l~~l~--- 399 (674)
.+++.++.||.|.- |.|||..+ +|+.+|+|.++. .. . ....-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57888999999999 99999999 678999999321 00 0 11234778888877774
Q ss_pred CCce--eeEEeEEEeCC------------------eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHH
Q 005846 400 HRNL--VRLLGFCLEGE------------------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459 (674)
Q Consensus 400 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~ 459 (674)
+.++ |+.+||..-.. ...||.||.+... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 5566 89999874321 1346777665432 122 2335567777888
Q ss_pred HHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 460 LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99888 999999999986 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00028 Score=70.52 Aligned_cols=141 Identities=20% Similarity=0.241 Sum_probs=82.9
Q ss_pred ccccccCCcEEEEEeecCC--CceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCeeEEEEEecCCC
Q 005846 350 DNKLGEGGFGEVYKGVLPS--GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 426 (674)
.+.|..|-...+|+....+ ++.|++|+........ ....+|+.++..+...++ .++++.+. ..++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788888999988764 6788899775432221 223578888888854444 34444322 24899999998
Q ss_pred ccccc-----------------ccCCCcC--------CCCC-HHHHHHHHH----------------------HHHHHHH
Q 005846 427 SLDYF-----------------LYDPEKQ--------GQLD-WSRRYKIIG----------------------GIARGIL 458 (674)
Q Consensus 427 sL~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~ 458 (674)
++... +|..... .... +..+..+.. .+.+-+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76421 0110100 0111 222222211 1111111
Q ss_pred HH----Hhc-CCCcEEEeecccccEEEcC-CCCeEEeeeCCcc
Q 005846 459 YL----HED-SRLRIIHRDLKASNILLDA-EMNPKISDFGMAR 495 (674)
Q Consensus 459 ~L----H~~-~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~ 495 (674)
.| ... ....++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 111 2346999999999999998 5789999999874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00027 Score=71.72 Aligned_cols=139 Identities=15% Similarity=0.075 Sum_probs=80.4
Q ss_pred ccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCeeEEEEEecCCCcccc
Q 005846 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKSLDY 430 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 430 (674)
.+..|-...+|+... ++..+++|..............+|..+++.+....+ .++++... .++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356677889998874 567888887654332221235778889988864433 34444321 368999999987653
Q ss_pred c-----------------ccCCC-cCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCcEEEeeccccc
Q 005846 431 F-----------------LYDPE-KQGQLDWSR-RYKIIGGI---------ARGILYLHED-----SRLRIIHRDLKASN 477 (674)
Q Consensus 431 ~-----------------l~~~~-~~~~l~~~~-~~~i~~~i---------a~~L~~LH~~-----~~~~iiHrDlkp~N 477 (674)
. +|... ....++... +.....++ .+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 11110 111122221 11111111 1112222111 12358999999999
Q ss_pred EEEcCCCCeEEeeeCCccc
Q 005846 478 ILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~ 496 (674)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00084 Score=69.68 Aligned_cols=143 Identities=21% Similarity=0.189 Sum_probs=87.1
Q ss_pred cccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEEeE------EEeCCeeEEEE
Q 005846 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVY 420 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~ 420 (674)
..+.|..|....+|+....+ ..+++|+... ...+.+..|+.++..+.+.+ +.+++.. ...++..++|+
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 35667888888999987644 4688888754 23455677888888885433 4444431 12344568999
Q ss_pred EecCCCccccc--------------ccCCC---c-----CCCCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 005846 421 EFVPNKSLDYF--------------LYDPE---K-----QGQLDWSRRY----------KIIGGIARGILYLHE----DS 464 (674)
Q Consensus 421 e~~~~gsL~~~--------------l~~~~---~-----~~~l~~~~~~----------~i~~~ia~~L~~LH~----~~ 464 (674)
+|++|..+... +|... . .....|.... .....+...+.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99999876431 00000 0 0111222111 011123334445443 12
Q ss_pred CCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 465 RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 465 ~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
...++|+|+.|.|||++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2359999999999999998778999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0018 Score=69.39 Aligned_cols=76 Identities=13% Similarity=0.182 Sum_probs=54.8
Q ss_pred ccccccCCcEEEEEeecCCC-ceeEEEEeccc-------CccCHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCeeEE
Q 005846 350 DNKLGEGGFGEVYKGVLPSG-QEIAVKRLSKA-------SGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~l 418 (674)
.+.||.|.+..||+....+| +.++||.-... .....+++..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998776 48999974321 1234566777888888762 2456777776 4456789
Q ss_pred EEEecCCCc
Q 005846 419 VYEFVPNKS 427 (674)
Q Consensus 419 v~e~~~~gs 427 (674)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00031 Score=81.58 Aligned_cols=196 Identities=23% Similarity=0.245 Sum_probs=135.4
Q ss_pred HHHHHHHHHhcCCCceeeEEeEEEeCCeeE----EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005846 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463 (674)
Q Consensus 388 ~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 463 (674)
..-|++.+.++.|+|++.+++|..+....- +..|++..-++...+ .....++....+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777788889999999999987765443 344677777776666 3445688899999999999999999988
Q ss_pred CCCcEEEeecccc---cEEEcCCCCeEEe--eeCCccccCCCCCCCccccccccCCccCccccccCCCCc--cccEEeec
Q 005846 464 SRLRIIHRDLKAS---NILLDAEMNPKIS--DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSV--KSDVYSFG 536 (674)
Q Consensus 464 ~~~~iiHrDlkp~---NIll~~~~~~ki~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~DvwS~G 536 (674)
. ..|.-|..+ +-..+.++...++ ||+..+.+...... ....-+..|.+||......... ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 666666555 5556777777877 99888765432211 1123355678888777665544 47999999
Q ss_pred hhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 537 VLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 537 v~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+..+..|..+...... +..+++.. ... ........|+..++++|++..+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~------------------~~~~l~~~-----~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV------------------PVSLLDVL-----STS---ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc------------------hhhhhccc-----cch---hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999988765321110 01111110 000 3456667899999999999999987
Q ss_pred HH
Q 005846 617 ML 618 (674)
Q Consensus 617 ~L 618 (674)
+.
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 64
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0048 Score=64.79 Aligned_cols=142 Identities=17% Similarity=0.184 Sum_probs=79.0
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEEe------EEEeCCeeEEEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLG------FCLEGEEKILVYE 421 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e 421 (674)
.+.|+.|....+|+....+| .+++|+... ...+....|+.++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677788889999886555 688898752 12334445666666653222 333332 1223456789999
Q ss_pred ecCCCccccc--------------ccCCCc--------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 005846 422 FVPNKSLDYF--------------LYDPEK--------QGQLDW-SRRYK------------IIGG-IARGILYLHED-- 463 (674)
Q Consensus 422 ~~~~gsL~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~~~-ia~~L~~LH~~-- 463 (674)
|++|..+... +|.... ...+.| ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9999865321 010000 011112 21111 1111 11122333211
Q ss_pred --CCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 464 --SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 464 --~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
-+..++|+|+.+.|||++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23459999999999999977656899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.012 Score=61.49 Aligned_cols=143 Identities=20% Similarity=0.196 Sum_probs=83.5
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEEeE------EEeCCeeEEEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYE 421 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 421 (674)
.+.++.|....+|+....+| .+++|+..... ..+++..|+.++..|...+ +.+++.. ...++..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 57788765422 2345566777777774322 3444431 122456789999
Q ss_pred ecCCCccccc--------------ccCCCcC---------CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 005846 422 FVPNKSLDYF--------------LYDPEKQ---------GQLDWSRRYK------------IIGGIARGILYLHE---- 462 (674)
Q Consensus 422 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~------------i~~~ia~~L~~LH~---- 462 (674)
|++|..+... +|..... ..-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9999765321 1110000 0111211110 11123344555532
Q ss_pred cCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 463 ~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
..+..++|+|+.+.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223469999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0011 Score=47.59 Aligned_cols=44 Identities=43% Similarity=0.671 Sum_probs=31.9
Q ss_pred CCCCCCCCCCceeeccCCCCCCCCcccccCCCCCCCC--CCCccCcccceeccCC
Q 005846 622 SVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKS--IPWSVDEASITEVYPR 674 (674)
Q Consensus 622 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~r 674 (674)
...+|.|++|+|+.++..... +.+++.. ..+|+|++|++.+++|
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~---------~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSET---------DSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCc---------CCCcccccCCCCCeeeEEEEeEecC
Confidence 467999999999987653221 1222222 5789999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.008 Score=62.55 Aligned_cols=140 Identities=26% Similarity=0.331 Sum_probs=83.5
Q ss_pred cccccCCcEEEEEeecCC-------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 422 (674)
+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 455667777899888654 47888998755432 22345788888888854333 345555432 368999
Q ss_pred cCCCccccc-c----------------cCCCcCC------CCC--HHHHHH--------------------------HHH
Q 005846 423 VPNKSLDYF-L----------------YDPEKQG------QLD--WSRRYK--------------------------IIG 451 (674)
Q Consensus 423 ~~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 451 (674)
++|..+... + |...... ..+ |..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 999877431 1 1111000 010 111111 111
Q ss_pred HHHHHHHHHHh------cCCCcEEEeecccccEEEcCC----CCeEEeeeCCcc
Q 005846 452 GIARGILYLHE------DSRLRIIHRDLKASNILLDAE----MNPKISDFGMAR 495 (674)
Q Consensus 452 ~ia~~L~~LH~------~~~~~iiHrDlkp~NIll~~~----~~~ki~DfGla~ 495 (674)
.+..-+..|.. ..+..++|+|+.+.|||++++ +.+.++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 234569999999999999985 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0014 Score=66.44 Aligned_cols=136 Identities=19% Similarity=0.189 Sum_probs=93.0
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEec-----------------ccCccCHH-----HHHHHHHHHHhcCC--C
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS-----------------KASGQGAE-----EFKNEVVLVAKLQH--R 401 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~-----------------~~~~~~~~-----~~~~Ei~~l~~l~h--~ 401 (674)
-+...++||-|.-+.||.+...+|++.++|.=. ......|- ...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367789999999999999999999999988321 00111121 23568888888843 2
Q ss_pred ceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc
Q 005846 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (674)
Q Consensus 402 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~ 481 (674)
-+.+.+++ ...++|||++.+-.|...-+ ..+..++..-+.. -+--|-..| +||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~---~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMG---LIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHH---HHHHHHHcC---ceecccchheeEEe
Confidence 24444443 45689999999888754431 2344444443333 334455556 99999999999999
Q ss_pred CCCCeEEeeeCCcccc
Q 005846 482 AEMNPKISDFGMARIF 497 (674)
Q Consensus 482 ~~~~~ki~DfGla~~~ 497 (674)
+++.++++||--.-..
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999765433
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.011 Score=61.01 Aligned_cols=137 Identities=20% Similarity=0.287 Sum_probs=83.0
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecc--cCccCHHHHHHHHHHHHhcCC--CceeeEEeEEEeCC--eeEEEEEecC
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGE--EKILVYEFVP 424 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~ 424 (674)
+.+-.|..-.+|.... .++.++++ ... ..........+|..+++.+.- --+...++.|.++. ..+.||+|.+
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3333333334444443 37778777 331 222334556778888887743 23455677777666 6699999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHH-HHHHHHHHHHHh-----------------------------------------
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKII-GGIARGILYLHE----------------------------------------- 462 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L~~LH~----------------------------------------- 462 (674)
|..+...+... ... .+++ ..+++.|+-||+
T Consensus 109 Ge~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 109 GEVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred ceeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 85443332110 001 1111 244444444443
Q ss_pred ---------c-----CCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 463 ---------D-----SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 463 ---------~-----~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+ +++.++|+|+.+.||+++.+.-+-|.||+++..-
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 3456999999999999999999999999998653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0067 Score=64.28 Aligned_cols=141 Identities=22% Similarity=0.283 Sum_probs=83.1
Q ss_pred cccccCCcEEEEEeecCC-----CceeEEEEecccCccCHHHHHHHHHHHHhcCCCcee-eEEeEEEeCCeeEEEEEecC
Q 005846 351 NKLGEGGFGEVYKGVLPS-----GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 424 (674)
+.|-.|-.-.+|+..+.+ ++.|++|+.........++ .+|..+++.+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345457777888876532 3678888876654433333 6788888888654444 455555332 5899998
Q ss_pred CCccccc-----------------ccCCC-cC-C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 005846 425 NKSLDYF-----------------LYDPE-KQ-G-QLDWSRRYKIIGGI-----------------ARGILYL----HE- 462 (674)
Q Consensus 425 ~gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~~L~~L----H~- 462 (674)
+.+|... +|... .. . ...+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8777421 11111 00 1 11233333333222 1112222 21
Q ss_pred cCCCcEEEeecccccEEEcC-CCCeEEeeeCCccc
Q 005846 463 DSRLRIIHRDLKASNILLDA-EMNPKISDFGMARI 496 (674)
Q Consensus 463 ~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~~ 496 (674)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 46899999998853
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.014 Score=59.87 Aligned_cols=31 Identities=26% Similarity=0.538 Sum_probs=25.9
Q ss_pred CcEEEeecccccEEEcCCCC-eEEeeeCCccc
Q 005846 466 LRIIHRDLKASNILLDAEMN-PKISDFGMARI 496 (674)
Q Consensus 466 ~~iiHrDlkp~NIll~~~~~-~ki~DfGla~~ 496 (674)
..++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.013 Score=60.08 Aligned_cols=76 Identities=18% Similarity=0.283 Sum_probs=48.9
Q ss_pred CCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCeeEEEEEec
Q 005846 347 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.+..+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678999999999988 4778899998762 22346788888888883 445778898888777889999999
Q ss_pred CCC
Q 005846 424 PNK 426 (674)
Q Consensus 424 ~~g 426 (674)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 887
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.021 Score=59.93 Aligned_cols=73 Identities=16% Similarity=0.215 Sum_probs=48.4
Q ss_pred ccccCCcEEEEEeecCCC-ceeEEEEec-------ccCccCHHHHHHHHHHHHhcC--CC-ceeeEEeEEEeCCeeEEEE
Q 005846 352 KLGEGGFGEVYKGVLPSG-QEIAVKRLS-------KASGQGAEEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~~~~~-~~vavK~~~-------~~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 420 (674)
.||.|-...||++..++| +.|+||.-. ...+...++..-|.+.|.... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 589999532 122344455566777776652 24 34455544 556667999
Q ss_pred EecCCC
Q 005846 421 EFVPNK 426 (674)
Q Consensus 421 e~~~~g 426 (674)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.067 Score=57.27 Aligned_cols=74 Identities=12% Similarity=0.122 Sum_probs=50.1
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEeccc----C---ccCHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCeeEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA----S---GQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~---~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv 419 (674)
.+.||.|....||+.... +..++||+-... . +...++-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998874 557889975411 1 123333445566666553 357788888865 456888
Q ss_pred EEecCCC
Q 005846 420 YEFVPNK 426 (674)
Q Consensus 420 ~e~~~~g 426 (674)
||+++++
T Consensus 114 ME~L~~~ 120 (418)
T PLN02756 114 MRYLEPP 120 (418)
T ss_pred EeecCCc
Confidence 9999773
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.062 Score=55.77 Aligned_cols=141 Identities=19% Similarity=0.225 Sum_probs=93.8
Q ss_pred cccccccCCcEEEEEeecCCCceeEEEEeccc------C----------------ccCHHH----HHHHHHHHHhcCCCc
Q 005846 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA------S----------------GQGAEE----FKNEVVLVAKLQHRN 402 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------~----------------~~~~~~----~~~Ei~~l~~l~h~n 402 (674)
+...|..|.-..||.+.-.+|..+|||+++-. . ....+. ...|+.-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34568889999999999889999999987421 0 001111 235666677765433
Q ss_pred eeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC
Q 005846 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 403 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~ 482 (674)
|.----... ...+|||+|+... .|-.-..+...++...+..+-.+++.-|.-|-+.. ++||.||.--|+|+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrd---gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRD---GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCC---CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 221111111 1237899999643 23222234456777788888889999888887765 699999999999885
Q ss_pred CCCeEEeeeCCcccc
Q 005846 483 EMNPKISDFGMARIF 497 (674)
Q Consensus 483 ~~~~ki~DfGla~~~ 497 (674)
+|.+.|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 568999998876543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.016 Score=56.89 Aligned_cols=123 Identities=21% Similarity=0.254 Sum_probs=60.6
Q ss_pred CceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCeeEEEEEecCCCccccc-ccC------------
Q 005846 369 GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKSLDYF-LYD------------ 434 (674)
Q Consensus 369 ~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~------------ 434 (674)
++.|+||+...... ..-.-.+|..+++.+...++ .++++++.+ .+|+||+++..|..- +.+
T Consensus 2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 46788888766533 33455788888888865444 455555422 257799987776431 110
Q ss_pred ----C----CcCCCCCHHHHHHH----------------------HHHHHHHHHHHHh----c-CCCcEEEeecccccEE
Q 005846 435 ----P----EKQGQLDWSRRYKI----------------------IGGIARGILYLHE----D-SRLRIIHRDLKASNIL 479 (674)
Q Consensus 435 ----~----~~~~~l~~~~~~~i----------------------~~~ia~~L~~LH~----~-~~~~iiHrDlkp~NIl 479 (674)
. .....--|..+..+ ...+..-+..+.+ . ...-+.|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0 00001112222222 0111111222211 1 1235899999999999
Q ss_pred E-cCCCCeEEeeeCCccc
Q 005846 480 L-DAEMNPKISDFGMARI 496 (674)
Q Consensus 480 l-~~~~~~ki~DfGla~~ 496 (674)
+ +.++.++++||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.046 Score=57.63 Aligned_cols=140 Identities=17% Similarity=0.244 Sum_probs=80.0
Q ss_pred cccccCCcEEEEEeecCC----CceeEEEEecccCccCHHHHHHHHHHHHhcCCCcee-eEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 425 (674)
+.|..|=...+|+....+ +..|++|+......... .-.+|..+++.+...++- ++++++.. . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 344447777888876432 23788888765443322 236788888888655553 55655532 2 58999988
Q ss_pred Cccccc-----------------ccCCC-c-CC-CCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 005846 426 KSLDYF-----------------LYDPE-K-QG-QLDWSRRYKIIGGI----------------------ARGILYLH-- 461 (674)
Q Consensus 426 gsL~~~-----------------l~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~L~~LH-- 461 (674)
..|..- +|... . .. .--|..+.++..++ .+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 776321 11110 0 01 11233333322221 11111111
Q ss_pred --h-cCCCcEEEeecccccEEEcC-CCCeEEeeeCCcc
Q 005846 462 --E-DSRLRIIHRDLKASNILLDA-EMNPKISDFGMAR 495 (674)
Q Consensus 462 --~-~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~ 495 (674)
. ..+.-++|+|+.+.|||+++ ++.++++||..+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 12235899999999999975 5789999999885
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.1 Score=54.47 Aligned_cols=32 Identities=25% Similarity=0.346 Sum_probs=28.4
Q ss_pred CCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 465 ~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+..++|+|+.++|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999999999999998853
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.03 Score=59.50 Aligned_cols=74 Identities=12% Similarity=0.144 Sum_probs=50.3
Q ss_pred ccccccCCcEEEEEeecCC-CceeEEEEec------ccCccCHHHHHHHHHHHHhcC--CC-ceeeEEeEEEeCCeeEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLS------KASGQGAEEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~------~~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lv 419 (674)
.+.||.|--..||++...+ ++.|+||.-. ...+...++..-|.+.|+... -| .+.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999743 5679999532 122444566677777777652 34 45556654 55566788
Q ss_pred EEecCC
Q 005846 420 YEFVPN 425 (674)
Q Consensus 420 ~e~~~~ 425 (674)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888865
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.11 Score=54.10 Aligned_cols=65 Identities=18% Similarity=0.262 Sum_probs=40.1
Q ss_pred EEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCC--ceeeEEeE------EEeCCeeEEEEEecCCCccc
Q 005846 360 EVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR--NLVRLLGF------CLEGEEKILVYEFVPNKSLD 429 (674)
Q Consensus 360 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~~~gsL~ 429 (674)
.||+....+| .+++|+.... ...+..|+..+..|... .+++++.. ...++..++++||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888776444 6888987532 23455567767666433 33343321 22356789999999997764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.17 Score=53.06 Aligned_cols=139 Identities=21% Similarity=0.274 Sum_probs=81.7
Q ss_pred cccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc------eeeEEeEE--EeC--CeeEEEEEe
Q 005846 353 LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN------LVRLLGFC--LEG--EEKILVYEF 422 (674)
Q Consensus 353 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~--~~~--~~~~lv~e~ 422 (674)
|.+ .-..+|+....+|+. ++|+.... ....++..|+..+..|.-.+ +..+-|-. .-. ...+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 556788888766665 88887665 34466677888888773221 22222211 112 367889999
Q ss_pred cCCCcccc-ccc--------------C---------CCcCCCCCHHH-------------HHHHHHHHHHHHHHHHhc--
Q 005846 423 VPNKSLDY-FLY--------------D---------PEKQGQLDWSR-------------RYKIIGGIARGILYLHED-- 463 (674)
Q Consensus 423 ~~~gsL~~-~l~--------------~---------~~~~~~l~~~~-------------~~~i~~~ia~~L~~LH~~-- 463 (674)
++|..+.. ... . ........|.. -.....++...+..+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99998873 110 0 00111233330 011223344444444432
Q ss_pred --CC---CcEEEeecccccEEEcCCCC-eEEeeeCCcc
Q 005846 464 --SR---LRIIHRDLKASNILLDAEMN-PKISDFGMAR 495 (674)
Q Consensus 464 --~~---~~iiHrDlkp~NIll~~~~~-~ki~DfGla~ 495 (674)
-. ..+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 22999999999999999885 8999999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.074 Score=51.35 Aligned_cols=152 Identities=14% Similarity=0.143 Sum_probs=89.4
Q ss_pred CCcEEEEEeecCCCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCCcccccccC
Q 005846 356 GGFGEVYKGVLPSGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434 (674)
Q Consensus 356 G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 434 (674)
++-.+.-+|+.+-|. ..+|++..-.-. ...-|.++..++++++ .|+++..- ++-..-+|.|+|-.-..
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 444555555543333 445555433222 3456788899998875 57777632 44456789998832111
Q ss_pred CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCC
Q 005846 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514 (674)
Q Consensus 435 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~ 514 (674)
.. ..++..=+..|.-.|+.+ ...+|||-.|+||+-|..|.+||.|-+..-.- +..
T Consensus 142 ------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~ 196 (308)
T PF07387_consen 142 ------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVN 196 (308)
T ss_pred ------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh--------------eee
Confidence 11 112222246677889654 46999999999999999999999997754210 111
Q ss_pred ccCccccccCCCCccccEEeechhhhHhHhCC
Q 005846 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546 (674)
Q Consensus 515 y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~ 546 (674)
|.--| ....+.++.+-+|=.-+++++...
T Consensus 197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 197 MVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred EEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 22211 123466666666666666665543
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.25 Score=48.20 Aligned_cols=76 Identities=17% Similarity=0.234 Sum_probs=53.7
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
.+++.-|.--..|+... +...+.||+-. ......|..|+.-|..|. --++.+++.+-.+..+.++|+||++-+
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34455555555565554 45678888643 233456788888777774 356788888888899999999999998
Q ss_pred ccc
Q 005846 427 SLD 429 (674)
Q Consensus 427 sL~ 429 (674)
.++
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 886
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.43 Score=50.16 Aligned_cols=72 Identities=13% Similarity=0.096 Sum_probs=45.9
Q ss_pred CCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEE---e--EEEeCCeeEEEEEecCCCcc
Q 005846 356 GGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLL---G--FCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 356 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~e~~~~gsL 428 (674)
+.-..||+....++..+++|+.... .....++..|++.+..|.... ++..+ | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 4456789988777888999977532 234566778888887773221 22211 1 22234567889999988765
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.21 Score=53.63 Aligned_cols=74 Identities=18% Similarity=0.299 Sum_probs=44.8
Q ss_pred cccccCCcEEEEEeecCCC--ce-----eEEEEecccCccCHHHHHHHHHHHHhcCCCcee-eEEeEEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVLPSG--QE-----IAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 422 (674)
+.|..|-...+|+....++ .. |.++.......... +-.+|+.+++.+...++- ++++.+. -++|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4555688889999875433 22 33333222222222 226789999999765555 4455443 2699999
Q ss_pred cCCCccc
Q 005846 423 VPNKSLD 429 (674)
Q Consensus 423 ~~~gsL~ 429 (674)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9998875
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.28 Score=59.56 Aligned_cols=141 Identities=21% Similarity=0.287 Sum_probs=77.3
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC-------CCceeeEE-e----EEE--eCC-e
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-------HRNLVRLL-G----FCL--EGE-E 415 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-------h~niv~l~-~----~~~--~~~-~ 415 (674)
+.|+ |..-.+|+....+|..+++|+...... ......|...|..|. -|.+++.. | ... ++. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 345778888877788899999875432 233344555555442 23333322 1 111 111 4
Q ss_pred eEEEEEecCCCcccccccC------------------------CCcCCCCCHHH-----------------HHHHHHHHH
Q 005846 416 KILVYEFVPNKSLDYFLYD------------------------PEKQGQLDWSR-----------------RYKIIGGIA 454 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~------------------------~~~~~~l~~~~-----------------~~~i~~~ia 454 (674)
.+-+++|++|..+...... ......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5778999999877541100 00011122321 122223333
Q ss_pred HHHH-----HHHhcCCCcEEEeecccccEEEcCCC--CeE-EeeeCCcc
Q 005846 455 RGIL-----YLHEDSRLRIIHRDLKASNILLDAEM--NPK-ISDFGMAR 495 (674)
Q Consensus 455 ~~L~-----~LH~~~~~~iiHrDlkp~NIll~~~~--~~k-i~DfGla~ 495 (674)
+... .|.+ -+..+||+|+.+.|||++.+. ++. |+|||.+.
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3222 1211 134599999999999999875 554 99999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.11 Score=53.83 Aligned_cols=70 Identities=20% Similarity=0.249 Sum_probs=55.2
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+++|++. |+++... ..-.|++...++.+.+.-+.-+..+ .+.-|||+.-.||||+ +|++-|+||-+++
T Consensus 301 ~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 301 LYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence 45666654 4555322 2357899999999988888888764 4699999999999999 9999999999998
Q ss_pred c
Q 005846 496 I 496 (674)
Q Consensus 496 ~ 496 (674)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 674 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-26 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-25 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-24 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-21 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-21 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-21 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-21 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-21 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-21 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-21 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-21 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-21 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-21 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-21 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-21 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-21 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-20 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-20 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-20 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-157
Identities = 111/314 (35%), Positives = 162/314 (51%), Gaps = 19/314 (6%)
Query: 322 NADNDLTTLESLQFDFETIEVATNKFS------TDNKLGEGGFGEVYKGVLPSGQEIAVK 375
N +++ F F ++ TN F NK+GEGGFG VYKG + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60
Query: 376 RLSK----ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
+L+ + + ++F E+ ++AK QH NLV LLGF +G++ LVY ++PN SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
L + L W R KI G A GI +LHE+ IHRD+K++NILLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
G+AR TSRIVGT YMAPE + G+ + KSD+YSFGV++LEIITG +
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 552 YQTDGAADLLSYAWKQWRDGTPL-QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
++ LL + + + +D + D V + C+ E +RP
Sbjct: 237 HREPQ--LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 611 MATIVLMLNSYSVT 624
+ + +L + +
Sbjct: 294 IKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 438 bits (1130), Expect = e-151
Identities = 121/288 (42%), Positives = 176/288 (61%), Gaps = 5/288 (1%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE-EFKNEVV 393
F ++VA++ FS N LG GGFG+VYKG L G +AVKRL + QG E +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGG 452
+++ HRNL+RL GFC+ E++LVY ++ N S+ L + PE Q LDW +R +I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
ARG+ YLH+ +IIHRD+KA+NILLD E + DFG+A++ T T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD--LLSYAWKQWRD 570
G++APEY G+ S K+DV+ +GV++LE+ITG++ + + D LL + ++
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
L+D +L +Y EV + IQ+ LLC Q P ERP M+ +V ML
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-135
Identities = 111/312 (35%), Positives = 174/312 (55%), Gaps = 6/312 (1%)
Query: 309 RKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS 368
K K N++ ++ + + L ES + +E ATN F +G G FG+VYKGVL
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 369 GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
G ++A+KR + S QG EEF+ E+ ++ +H +LV L+GFC E E IL+Y+++ N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 429 DYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487
LY + + W +R +I G ARG+ YLH + IIHRD+K+ NILLD PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 488 ISDFGMARIF-GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
I+DFG+++ +DQT +T + GT GY+ PEY + G+ + KSDVYSFGV++ E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 547 KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPA 606
+L +A + +G Q++D NL D + + + C+
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 607 ERPSMATIVLML 618
+RPSM ++ L
Sbjct: 299 DRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-106
Identities = 69/314 (21%), Positives = 126/314 (40%), Gaps = 34/314 (10%)
Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
+ E + + G FG V+K L + +AVK Q + + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYE 68
Query: 392 VVLVAKLQHRNLVRLLGFCLEGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
V + ++H N+++ +G G + L+ F SL FL K + W+
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELC 124
Query: 448 KIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
I +ARG+ YLHED + I HRD+K+ N+LL + I+DFG+A F
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
++ G+T VGT YMAPE ++ D+Y+ G+++ E+ + ++ +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 556 GAADLLSYAWKQWRDGTPLQL--------LDTNLTDSYSRNEVIRCI-QLGLLCVQEDPA 606
+L + + + + + L D + ++ + + + C D
Sbjct: 245 ---YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 607 ERPSMATIVLMLNS 620
R S + +
Sbjct: 302 ARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-83
Identities = 67/336 (19%), Positives = 121/336 (36%), Gaps = 45/336 (13%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE- 391
++ + + +G G +G VYKG L + +AVK S A+ Q F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56
Query: 392 -VVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
+ V ++H N+ R + E +LV E+ PN SL +L DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112
Query: 446 RYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF-- 497
++ + RG+ YLH + + I HRDL + N+L+ + ISDFG++
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 498 ----GVDQTQGNTSRIVGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGK 546
+ VGT YMAPE + D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 547 KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT--------NLTDSYSRNEVIRCIQLGL 598
+ ++ +++ + T + +++ N +
Sbjct: 233 TDLFPGESVPEY-QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 599 L--CVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632
+ C +D R + + + + +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 9e-75
Identities = 86/330 (26%), Positives = 144/330 (43%), Gaps = 35/330 (10%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
K ++ + + + D + +++ + K+G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 370 QEIAVKRL--SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 427
++AVK L + EF EV ++ +L+H N+V +G + +V E++ S
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487
L L+ + QLD RR + +A+G+ YLH I+HR+LK+ N+L+D + K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK- 546
+ DFG++R+ T ++ GT +MAPE + KSDVYSFGV++ E+ T +
Sbjct: 180 VCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 547 --KNSNFYQTDGAADLLSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLC 600
N N Q A +K R Q+ +I C
Sbjct: 238 PWGNLNPAQVVAAV-----GFKCKRLEIPRNLNPQVAA-----------IIE------GC 275
Query: 601 VQEDPAERPSMATIVLMLNSYSVTLPSPQQ 630
+P +RPS ATI+ +L + P
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-71
Identities = 82/337 (24%), Positives = 133/337 (39%), Gaps = 49/337 (14%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
+ + + +G G FG V K +++A+K++ S + F E+ ++++ H
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
N+V+L G CL LV E+ SL L+ E + ++G+ YL
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 461 HEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
H +IHRDLK N+LL A KI DFG A Q + + G+ +MAPE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKK-----NSNFYQTDGAADLLSYAWKQWR----D 570
+S K DV+S+G+++ E+IT +K ++ A R
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH------NGTRPPLIK 227
Query: 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQ 630
P + ++ C +DP++RPSM IV ++ P +
Sbjct: 228 NLPKPI-----------ESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
Query: 631 PAFFIGSRTERDLPTKE-FECSDKSTSKSIP--WSVD 664
P + + LP E WSVD
Sbjct: 271 PLQY---PCQHSLPPGEDGRVEPYVDFAEFYRLWSVD 304
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-70
Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 42/300 (14%)
Query: 351 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
LG+G FG+ K +G+ + +K L + + F EV ++ L+H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
+ + + E++ +L + + Q WS+R IA G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR------------IVGTYGYMA 517
HRDL + N L+ N ++DFG+AR+ ++TQ R +VG +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
PE + K DV+SFG+++ EII D P +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRV-------------------NADPDYLPRTMD 231
Query: 578 DTNLTDSYSRNEVIR-C----IQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632
+ C + + C DP +RPS + L + + L
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 8e-69
Identities = 80/320 (25%), Positives = 140/320 (43%), Gaps = 59/320 (18%)
Query: 323 ADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKAS 381
++ IE + ++G+GGFG V+KG L +A+K L
Sbjct: 4 GGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 382 GQGA-------EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD 434
+G +EF+ EV +++ L H N+V+L G +V EFVP L + L D
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-----AEMNPKIS 489
+ WS + +++ IA GI Y+ + I+HRDL++ NI L A + K++
Sbjct: 115 KAH--PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEIITGK- 546
DFG+++ + + S ++G + +MAPE A ++ K+D YSF +++ I+TG+
Sbjct: 172 DFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 547 --KNSNFYQTDGAADLLSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLC 600
++ + + + R + P +L + LC
Sbjct: 227 PFDEYSYGK---IKFINMIREEGLRPTIPEDCPPRL-----------------RNVIELC 266
Query: 601 VQEDPAERPSMATIVLMLNS 620
DP +RP + IV L+
Sbjct: 267 WSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-67
Identities = 86/304 (28%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL----SKASGQGAEEFKNE 391
DF + + + +G GGFG+VY+ G E+AVK + Q E + E
Sbjct: 5 DFAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
L A L+H N++ L G CL+ LV EF L+ L +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAV 112
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMARIFGVDQTQ 503
IARG+ YLH+++ + IIHRDLK+SNIL+ ++ KI+DFG+AR +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHR 168
Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK---KNSNFYQTDGAADL 560
G Y +MAPE FS SDV+S+GVL+ E++TG+ + +
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-- 226
Query: 561 LSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616
A + P +L C DP RPS I+
Sbjct: 227 ---AMNKLALPIPSTCPEPF-----------------AKLMEDCWNPDPHSRPSFTNILD 266
Query: 617 MLNS 620
L +
Sbjct: 267 QLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-64
Identities = 65/294 (22%), Positives = 118/294 (40%), Gaps = 46/294 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--SKASGQGAEEFKNEVVLVAKL 398
+ + + KL E GE++KG G +I VK L S + + +F E +
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 399 QHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
H N++ +LG C + ++P SL L++ +D S+ K +ARG
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARG 123
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+ +LH L I L + ++++D +M +IS + F Q+ G ++
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRM----YAPAWV 175
Query: 517 APEYAMHGQ---FSVKSDVYSFGVLVLEIITGK---KNSNFYQTDGAADLLSYAWKQWR- 569
APE +D++SF VL+ E++T + + + + A + R
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-----ALEGLRP 230
Query: 570 ---DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
G + +++ +C+ EDPA+RP IV +L
Sbjct: 231 TIPPGISPHVSK-----------LMK------ICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-63
Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKL 398
E+ + + ++G G FG VYKG ++AVK L+ + Q + FKNEV ++ K
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
+H N++ +G+ + I V ++ SL + L+ E + + + I ARG+
Sbjct: 78 RHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMD 134
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
YLH IIHRDLK++NI L + KI DFG+A ++ G+ +MAP
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 519 E---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575
E +S +SDVY+FG+++ E++TG+ + +
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ-------------------LPYSNINNRD 232
Query: 576 LLDTNLTDSYSRNEVIRC--------IQLGLLCVQEDPAERPSMATIVLMLNS 620
+ + ++ + +L C+++ ERPS I+ +
Sbjct: 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 9e-63
Identities = 73/334 (21%), Positives = 124/334 (37%), Gaps = 50/334 (14%)
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--S 378
A L+ FE +E+ +G+G FG+VY G E+A++ +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEI-------GELIGKGRFGQVYHGRW--HGEVAIRLIDIE 66
Query: 379 KASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ 438
+ + + FK EV+ + +H N+V +G C+ ++ ++L + D +
Sbjct: 67 RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI- 125
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
LD ++ +I I +G+ YLH I+H+DLK+ N+ D I+DFG+ I G
Sbjct: 126 -VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180
Query: 499 VDQTQGNTSRI---VGTYGYMAPE---------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
V Q ++ G ++APE FS SDV++ G + E+ +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 547 ---KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQE 603
K G L + S + L C
Sbjct: 241 WPFKTQPAEAIIWQM----------GTGMKPNLSQIGMGKEISD--------ILLFCWAF 282
Query: 604 DPAERPSMATIVLMLNSYSVTLPSPQQPAFFIGS 637
+ ERP+ ++ ML P F S
Sbjct: 283 EQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-54
Identities = 72/306 (23%), Positives = 123/306 (40%), Gaps = 50/306 (16%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE--VVLVAKLQHRNLVRLL 407
++G+G +GEV+ G G+++AVK + E + ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 408 GFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
++G L+ ++ N SL +L K LD K+ G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 464 SRLR-----IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTYGYM 516
I HRDLK+ NIL+ I+D G+A F D + + VGT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 517 APE------YAMHGQFSVKSDVYSFGVLVL-EIITGKKNSNFYQTDGAADLLSYAWKQ-- 567
PE H Q + +D+YSFG L+L E+ + G + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRC------VSGGIVEEYQLPYHDLV 266
Query: 568 WRDGTPLQLLDT--------NLTDSYSRNEVIRCIQLGLL---CVQEDPAERPSMATIVL 616
D + + + + + +S +E +R Q+G L C +PA R + +
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR--QMGKLMTECWAHNPASRLTALRVKK 324
Query: 617 MLNSYS 622
L S
Sbjct: 325 TLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-54
Identities = 62/300 (20%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE--VVLVAKLQHRNLVRLLG 408
+G+G +GEV++G G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 409 FCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+ L+ + SL +L + LD +I+ IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 465 RLR-----IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTYGYMA 517
I HRDLK+ NIL+ I+D G+A + Q + VGT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 518 PE------YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW--R 569
PE + D+++FG+++ E+ ++G + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM------VSNGIVEDYKPPFYDVVPN 239
Query: 570 DGTPLQLLDT--------NLTDSYSRNEVIRCI-QLGLLCVQEDPAERPSMATIVLMLNS 620
D + + N+ + + + + + +L C ++P+ R + I L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-52
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 46/302 (15%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNE--VVLVAKLQHRNLVRLL 407
+G+G FGEV++G G+E+AVK S + + E + L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 408 GFCLEGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ LV ++ + SL +L + + K+ A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 464 -----SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI--VGTYGYM 516
+ I HRDLK+ NIL+ I+D G+A + + VGT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 517 APE------YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF---YQTDGAADLLSYAWKQ 567
APE H + ++D+Y+ G++ EI YQ L Y
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-------LPYYDLV 271
Query: 568 WRDGTPLQLLDT--------NLTDSYSRNEVIRCI-QLGLLCVQEDPAERPSMATIVLML 618
D + ++ N+ + + E +R + ++ C + A R + I L
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
Query: 619 NS 620
+
Sbjct: 332 SQ 333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 77/312 (24%), Positives = 129/312 (41%), Gaps = 56/312 (17%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
++LG+G FG V +G +AVK+L + +F+ E+ ++ L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G + LV E++P+ L FL + +LD SR I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
R +HRDL A NIL+++E + KI+DFG+A++ +D+ + S I + AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI----FWYAP 199
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578
E FS +SDV+SFGV++ E+ T Y K +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT------------------YCDKSCSPSAEFLRMM 241
Query: 579 TNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATIVLMLNSY 621
D + + ++ ++ G LC P +RPS + + L+
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
Query: 622 SVTLPSPQQPAF 633
+ AF
Sbjct: 302 WSGSRGCETHAF 313
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-51
Identities = 72/300 (24%), Positives = 126/300 (42%), Gaps = 55/300 (18%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LG+G FG V +G+ +AVK+L ++ + +F+ E+ ++ LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G C + L+ E++P SL +L + + ++D + + I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
R IHRDL NIL++ E KI DFG+ ++ D+ + S I + AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYAP 186
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578
E +FSV SDV+SFGV++ E+ T + S + + + Q
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---------- 236
Query: 579 TNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATIVLMLNSY 621
+I ++ C + +RPS + L ++
Sbjct: 237 -------IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-51
Identities = 87/348 (25%), Positives = 148/348 (42%), Gaps = 70/348 (20%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLV 395
E+ S D +G G FGEV G L PS +EI A+K L + + +F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H N++RL G + + ++V E++ N SLD FL + Q + ++ GIA
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIAS 158
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT--- 512
G+ YL S + +HRDL A NIL+++ + K+SDFG+ R+ D T+R G
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIP 213
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDG 571
+ +PE + +F+ SDV+S+G+++ E+++ G++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER------------------------ 249
Query: 572 TPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATI 614
P S +VI+ + G L C Q+D RP I
Sbjct: 250 -PYW--------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 615 VLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKSIP-W 661
V +L+ + +P + + D +T ++ W
Sbjct: 301 VSILDKL---IRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDW 345
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-51
Identities = 72/300 (24%), Positives = 126/300 (42%), Gaps = 55/300 (18%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
+LG+G FG V +G+ +AVK+L ++ + +F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
G C + L+ E++P SL +L + + ++D + + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMAP 518
R IHRDL NIL++ E KI DFG+ ++ D+ + S I + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYAP 217
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578
E +FSV SDV+SFGV++ E+ T + S + + + Q
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---------- 267
Query: 579 TNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATIVLMLNSY 621
+I ++ C + +RPS + L ++
Sbjct: 268 -------IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 77/291 (26%), Positives = 119/291 (40%), Gaps = 40/291 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKL 398
+ ++G G FGEV+ G L +AVK +F E ++ +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
H N+VRL+G C + + +V E V FL + +L +++G A G+
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGME 227
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--- 515
YL IHRDL A N L+ + KISDFGM+R ++ G + G
Sbjct: 228 YLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVK 280
Query: 516 -MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR---- 569
APE +G++S +SDV+SFG+L+ E + G Y + K R
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLPCP 337
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
+ P + + +L C +P +RPS +TI L S
Sbjct: 338 ELCPDAV--------F---------RLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 85/335 (25%), Positives = 152/335 (45%), Gaps = 74/335 (22%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE---IAVKRLSK-ASGQGAEEFKNEVVL 394
E+ + + +G G FGEVYKG+L SG++ +A+K L + + +F E +
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ + H N++RL G + + +++ E++ N +LD FL + + G+ + ++ GIA
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIA 157
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
G+ YL + + +HRDL A NIL+++ + K+SDFG++R+ D T+ G
Sbjct: 158 AGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----G 209
Query: 515 ------YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQ 567
+ APE + +F+ SDV+SFG+++ E++T G++
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------------- 249
Query: 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPS 610
P S +EV++ I G + C Q++ A RP
Sbjct: 250 -----PYW--------ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPK 296
Query: 611 MATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPT 645
A IV +L+ + P + R LP+
Sbjct: 297 FADIVSILDKL-IRAPDSLKTLADFDPRVSIRLPS 330
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-50
Identities = 70/301 (23%), Positives = 126/301 (41%), Gaps = 59/301 (19%)
Query: 351 NKLGEGGFGEVYKGVLP-----SGQEIAVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLV 404
LGEG FG+V +G+++AVK L ++ G + K E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 405 RLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ G C E L+ EF+P+ SL +L P+ + +++ ++ K I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYGYMA 517
+ +HRDL A N+L+++E KI DFG+ + D+ S + + A
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----FWYA 197
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576
PE M +F + SDV+SFGV + E++T +S+ ++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT------- 250
Query: 577 LDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATIVLMLN 619
++ ++ G C + P+ R S ++
Sbjct: 251 ------------RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 620 S 620
+
Sbjct: 299 A 299
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-50
Identities = 78/316 (24%), Positives = 134/316 (42%), Gaps = 84/316 (26%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SKASGQGAEEFKNEVVLV 395
E+ ++ + +G G GEV G L P +++ A+K L + + + +F +E ++
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H N++RL G G ++V E++ N SLD FL + GQ + ++ G+
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGA 162
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
G+ YL S L +HRDL A N+L+D+ + K+SDFG++R+ D
Sbjct: 163 GMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAA 208
Query: 516 ------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLS 562
APE FS SDV+SFGV++ E++ G++
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER--------------- 253
Query: 563 YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDP 605
P + + +VI ++ G L C +D
Sbjct: 254 ----------PYW--------NMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDR 295
Query: 606 AERPSMATIVLMLNSY 621
A+RP + IV +L++
Sbjct: 296 AQRPRFSQIVSVLDAL 311
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 71/314 (22%), Positives = 122/314 (38%), Gaps = 77/314 (24%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKASGQGAEEFKNEV 392
++ + LG+G F +++KGV E+ +K L KA +E F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
+++KL H++LV G C+ G+E ILV EFV SLD +L + + ++ + ++
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK--KNKNCINILWKLEVAKQ 121
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMARIFGVDQTQG 504
+A + +L +IH ++ A NILL E + K+SD G++ V
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDI 176
Query: 505 NTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLS 562
RI ++ PE + ++ +D +SFG + EI + G K
Sbjct: 177 LQERI----PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK--------------- 217
Query: 563 YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG---------------LLCVQEDPAE 607
PL + ++ + C+ +P
Sbjct: 218 ----------PLS--------ALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDH 259
Query: 608 RPSMATIVLMLNSY 621
RPS I+ LNS
Sbjct: 260 RPSFRAIIRDLNSL 273
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 74/342 (21%), Positives = 125/342 (36%), Gaps = 64/342 (18%)
Query: 322 NADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKR 376
+ L L D T LGEG FG+V +G+ +AVK
Sbjct: 10 HHHGALEVLFQGPGD-PT-VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 377 L-SKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLY 433
L + A Q +K E+ ++ L H ++++ G C + LV E+VP SL +L
Sbjct: 68 LKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL- 126
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ + ++ I G+ YLH IHRDL A N+LLD + KI DFG+
Sbjct: 127 ---PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGL 180
Query: 494 ARIFGVDQ-----TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
A+ + S + + APE +F SDV+SFGV + E++T
Sbjct: 181 AKAVPEGHEYYRVREDGDSPV----FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236
Query: 548 NSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG---------- 597
+ + ++ + + ++ G
Sbjct: 237 SQSPPTKFLELIGIAQ-------------------GQMTVLRLTELLERGERLPRPDKCP 277
Query: 598 -------LLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632
C + + + RP+ ++ +L + Q P+
Sbjct: 278 AEVYHLMKNCWETEASFRPTFENLIPILKTV-HEKYQGQAPS 318
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-49
Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 46/296 (15%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQE---IAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVR 405
D +LG G FG V +GV ++ +A+K L + EE E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
L+G C E +LV E L FL K+ ++ S +++ ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------YMAPE 519
+HRDL A N+LL KISDFG+++ G D + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPE 183
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTPL 574
+FS +SDV+S+GV + E ++ G+K Y+ +++++ + R P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVMAFIEQGKRMECPPECPP 240
Query: 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQ 630
+L Y L C +RP T+ + + +L S +
Sbjct: 241 EL--------Y---------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-49
Identities = 84/328 (25%), Positives = 134/328 (40%), Gaps = 83/328 (25%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASGQGAEEFKNEVVL 394
+ +LGEG FG+V+ +AVK L + ++F+ E L
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQL 441
+ LQH ++V+ G C +G+ I+V+E++ + L+ FL + +G+L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVD 500
S+ I IA G++YL + +HRDL N L+ A + KI DFGM+R ++ D
Sbjct: 131 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 501 QTQGNTS-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
+ R +M PE M+ +F+ +SDV+SFGV++ EI T
Sbjct: 188 YYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT----------- 230
Query: 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------L 598
Y P S EVI CI G L
Sbjct: 231 -------YG------KQPWF--------QLSNTEVIECITQGRVLERPRVCPKEVYDVML 269
Query: 599 LCVQEDPAERPSMATIVLMLNSYSVTLP 626
C Q +P +R ++ I +L++ P
Sbjct: 270 GCWQREPQQRLNIKEIYKILHALGKATP 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-49
Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 36/288 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
+ ++ + ++G G FG V+ G + ++A+K + + E+F E ++ KL H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L G CLE LV EF+ + L +L G + + G+ YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--MAP 518
+IHRDL A N L+ K+SDFGM R DQ TS + +P
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASP 174
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
E ++S KSDV+SFGVL+ E+ + GK Y+ ++++ +R
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP---YENRSNSEVVEDISTGFRLYKPRLAS 231
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
+ Y Q+ C +E P +RP+ + ++ L
Sbjct: 232 THV--------Y---------QIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-48
Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 64/302 (21%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + + +LG G FG V G ++AVK + K +EF E + KL H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+ G C + +V E++ N L +L L+ S+ ++ + G+ +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMA 517
+ IHRDL A N L+D ++ K+SDFGM R DQ VGT + A
Sbjct: 121 ---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----VSSVGTKFPVKWSA 173
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576
PE + ++S KSDV++FG+L+ E+ + GK P
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM-------------------------PYD- 207
Query: 577 LDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATIVLMLN 619
Y+ +EV+ + G C E P +RP+ ++ +
Sbjct: 208 -------LYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
Query: 620 SY 621
Sbjct: 261 PL 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 34/288 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
E+ + +KLG G +GEVY+GV +AVK L K EEF E ++ +++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 67
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H NLV+LLG C ++ EF+ +L +L + +Q ++ + I+ + Y
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 126
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGNTSRIVGTYGYMAP 518
L + IHRDL A N L+ K++DFG++R+ D T ++ + AP
Sbjct: 127 L---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAP 181
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
E + +FS+KSDV++FGVL+ EI T G Y + + K +R +G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---YPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
++ Y +L C Q +P++RPS A I +
Sbjct: 239 EKV--------Y---------ELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 69/308 (22%), Positives = 122/308 (39%), Gaps = 64/308 (20%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
+ + E+ + +LG G FG V G ++A+K + K +EF E +
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKV 72
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ L H LV+L G C + ++ E++ N L +L E + + + ++ +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVC 130
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT-- 512
+ YL + +HRDL A N L++ + K+SDFG++R D+ + VG+
Sbjct: 131 EAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSVGSKF 183
Query: 513 -YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRD 570
+ PE M+ +FS KSD+++FGVL+ EI + GK
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK------------------------ 219
Query: 571 GTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMAT 613
P + ++ +E I G C E ERP+
Sbjct: 220 -MPYE--------RFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKI 270
Query: 614 IVLMLNSY 621
++ +
Sbjct: 271 LLSNILDV 278
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 85/324 (26%), Positives = 139/324 (42%), Gaps = 84/324 (25%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
E++ + +LGE FG+VYKG L Q +A+K L A G EEF++E +
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQ 440
L A+LQH N+V LLG + + +++ + + L FL D +
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGV 499
L+ ++ IA G+ YL S ++H+DL N+L+ ++N KISD G+ R ++
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 500 D--QTQGNTS---RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554
D + GN+ R +MAPE M+G+FS+ SD++S+GV++ E+ +
Sbjct: 182 DYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------- 225
Query: 555 DGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG----------------- 597
Y P YS +V+ I+
Sbjct: 226 --------YG------LQPYC--------GYSNQDVVEMIRNRQVLPCPDDCPAWVYALM 263
Query: 598 LLCVQEDPAERPSMATIVLMLNSY 621
+ C E P+ RP I L ++
Sbjct: 264 IECWNEFPSRRPRFKDIHSRLRAW 287
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-48
Identities = 69/300 (23%), Positives = 120/300 (40%), Gaps = 40/300 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLV 395
E+ + +GEG FG+V++G+ P + A+K S E+F E + +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H ++V+L+G E ++ E L FL + LD + ++
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLST 127
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG 514
+ YL R +HRD+ A N+L+ + K+ DFG++R + + + ++
Sbjct: 128 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIK 182
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR---- 569
+MAPE +F+ SDV+ FGV + EI+ G K +Q D++ R
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIENGERLPMP 239
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQ 629
P L Y L C DP+ RP + L++ + Q
Sbjct: 240 PNCPPTL--------Y---------SLMTKCWAYDPSRRPRFTELKAQLSTI-LEEEKAQ 281
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-48
Identities = 84/328 (25%), Positives = 133/328 (40%), Gaps = 82/328 (25%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEI--AVKRLSKASGQGAEEFKNEVVL 394
+ +LGEG FG+V+ P ++ AVK L +AS ++F+ E L
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL------------YDPEKQGQLD 442
+ LQH+++VR G C EG ++V+E++ + L+ FL + G L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQ 501
+ + +A G++YL + L +HRDL N L+ + KI DFGM+R I+ D
Sbjct: 157 LGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 502 TQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556
+ VG +M PE ++ +F+ +SDV+SFGV++ EI T
Sbjct: 214 YR------VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT------------ 255
Query: 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LL 599
Y P S E I CI G
Sbjct: 256 ------YG------KQPWY--------QLSNTEAIDCITQGRELERPRACPPEVYAIMRG 295
Query: 600 CVQEDPAERPSMATIVLMLNSYSVTLPS 627
C Q +P +R S+ + L + + P
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 91/301 (30%), Positives = 143/301 (47%), Gaps = 40/301 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L K + F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
+ LVRL + E ++ E++ N SL FL P +L ++ + IA G+ ++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--MAP 518
IHRDL+A+NIL+ ++ KI+DFG+AR+ ++ T+R + AP
Sbjct: 126 ---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 179
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
E +G F++KSDV+SFG+L+ EI+T G+ Y +++ + +R D P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQ---Q 630
+L Y QL LC +E P +RP+ + +L + T Q Q
Sbjct: 237 EEL--------Y---------QLMRLCWKERPEDRPTFDYLRSVLEDF-FTATEGQYQPQ 278
Query: 631 P 631
P
Sbjct: 279 P 279
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 65/305 (21%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVLV 395
+A + LGEG FGEVY+GV G++I AVK K + E+F +E V++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
L H ++V+L+G E E ++ E P L ++L + L I +
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICK 124
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRI-VGTY 513
+ YL + +HRD+ NIL+ + K+ DFG++R I D + + +R+ +
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573
+M+PE +F+ SDV+ F V + EI++ + + +
Sbjct: 180 -WMSPESINFRRFTTASDVWMFAVCMWEILS------------------FGKQPFFW--- 217
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATIVL 616
+VI ++ G C DP++RP +V
Sbjct: 218 -----------LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266
Query: 617 MLNSY 621
L+
Sbjct: 267 SLSDV 271
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-47
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 50/293 (17%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
+ + +G+G FG+V G G ++AVK + + A+ F E ++ +L+H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 245
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEY 304
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG----- 514
L +HRDL A N+L+ + K+SDFG+ +
Sbjct: 305 L---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPV 350
Query: 515 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR--- 569
+ APE +FS KSDV+SFG+L+ EI + G+ Y D++ K ++
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMDA 407
Query: 570 -DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
DG P + Y + C D A RP+ + L
Sbjct: 408 PDGCPPAV--------Y---------DVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-47
Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 47/288 (16%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEVVLVAKLQHRNL 403
LG G FG VYKG+ E +A+K L +A+ A +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
RLLG CL L+ + +P L ++ E + + IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG-----YMAP 518
R++HRDL A N+L+ + KI+DFG+A++ G ++ + + G +MA
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMAL 188
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
E +H ++ +SDV+S+GV V E++T G K Y A+++ S K R
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASEISSILEKGERLPQPPICT 245
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
+ + Y + C D RP +++ +
Sbjct: 246 IDV--------Y---------MIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-47
Identities = 82/300 (27%), Positives = 140/300 (46%), Gaps = 32/300 (10%)
Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAE 386
T+ + +++ E+ + +KLG G +GEVY+GV +AVK L K E
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE 261
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
EF E ++ +++H NLV+LLG C ++ EF+ +L +L + +Q ++
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVL 320
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-TQGN 505
+ I+ + YL + IHR+L A N L+ K++DFG++R+ D T
Sbjct: 321 LYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565
++ + APE + +FS+KSDV++FGVL+ EI T + Y + +
Sbjct: 378 GAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSPYPGIDLSQVYELLE 433
Query: 566 KQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
K +R +G P ++ Y +L C Q +P++RPS A I +
Sbjct: 434 KDYRMERPEGCPEKV--------Y---------ELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 4e-47
Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 50/293 (17%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
+ + +G+G FG+V G G ++AVK + + A+ F E ++ +L+H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRH 73
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEY 132
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG----- 514
L +HRDL A N+L+ + K+SDFG+ + + +
Sbjct: 133 L---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EAS-------STQDTGKLPV 178
Query: 515 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR--- 569
+ APE +FS KSDV+SFG+L+ EI + G+ Y D++ K ++
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMDA 235
Query: 570 -DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
DG P + Y ++ C D A RPS + L
Sbjct: 236 PDGCPPAV--------Y---------EVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 350 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + +AVK L +E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
R++G C E +LV E L+ +L ++ + +++ ++ G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG------YMAP 518
+HRDL A N+LL + KISDFG+++ D+ + AP
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAP 189
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
E + +FS KSDV+SFGVL+ E + G+K Y+ +++ + K R G P
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEVTAMLEKGERMGCPAGCP 246
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQ 630
++ Y L LC D RP A + L L +Y + +
Sbjct: 247 REM--------Y---------DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-46
Identities = 83/296 (28%), Positives = 135/296 (45%), Gaps = 37/296 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + KLG G FGEV+ ++AVK + K E F E ++ LQH
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 242
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L + E ++ EF+ SL FL E + + IA G+ ++
Sbjct: 243 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI 300
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--MAP 518
+ IHRDL+A+NIL+ A + KI+DFG+AR+ ++ T+R + AP
Sbjct: 301 ---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAP 354
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTP 573
E G F++KSDV+SFG+L++EI+T G+ Y +++ + +R + P
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALERGYRMPRPENCP 411
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQ 629
+L Y + + C + P ERP+ I +L+ + T Q
Sbjct: 412 EEL--------Y---------NIMMRCWKNRPEERPTFEYIQSVLDDF-YTATESQ 449
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 78/299 (26%), Positives = 125/299 (41%), Gaps = 46/299 (15%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK-ASGQGAEEFKNEVVL 394
I ++ + +G G FG VY G L G++I AVK L++ +F E ++
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 395 VAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
+ H N++ LLG CL E L V ++ + L F+ + +
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQV 137
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
A+G+ YL + +HRDL A N +LD + K++DFG+AR D +
Sbjct: 138 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKT 190
Query: 514 G------YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWK 566
G +MA E +F+ KSDV+SFGVL+ E++T G Y D+ Y +
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLLQ 247
Query: 567 QWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
R + P L Y ++ L C RPS + +V +++
Sbjct: 248 GRRLLQPEYCPDPL--------Y---------EVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 84/318 (26%), Positives = 136/318 (42%), Gaps = 48/318 (15%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSK--ASGQG 384
E LQ E + + N LGEG FG V +G L G + AVK + +S +
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFL---YDPE 436
EEF +E + H N++RLLG C+E + +++ F+ L +L
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR- 495
+ K + IA G+ YL S +HRDL A N +L +M ++DFG+++
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 496 IFGVDQ-TQGNTSRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFY 552
I+ D QG +++ V ++A E ++ KSDV++FGV + EI T G Y
Sbjct: 197 IYSGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP---Y 250
Query: 553 QTDGAADLLSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER 608
++ Y R + +L Y ++ C + DP +R
Sbjct: 251 PGVQNHEMYDYLLHGHRLKQPEDCLDEL--------Y---------EIMYSCWRTDPLDR 293
Query: 609 PSMATIVLMLNSYSVTLP 626
P+ + + L L +LP
Sbjct: 294 PTFSVLRLQLEKLLESLP 311
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-46
Identities = 83/296 (28%), Positives = 134/296 (45%), Gaps = 30/296 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L K E F E ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L E E +V E++ SL FL + L + + IA G+ Y+
Sbjct: 239 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYV 296
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
R+ +HRDL+A+NIL+ + K++DFG+AR+ ++ + APE
Sbjct: 297 ---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEA 352
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DGTPLQL 576
A++G+F++KSDV+SFG+L+ E+ T K Y ++L + +R P L
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410
Query: 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632
+ L C +++P ERP+ + L Y + QP
Sbjct: 411 --------H---------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-46
Identities = 75/296 (25%), Positives = 126/296 (42%), Gaps = 40/296 (13%)
Query: 349 TDNKLGEGGFGEVYKGVL-PSGQEI--AVKRL-SKASGQGAEEFKNEVVLVAKLQHRNLV 404
D +LG G FG V +GV ++I A+K L EE E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
RL+G C E +LV E L FL K+ ++ S +++ ++ G+ YL
Sbjct: 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT---YGYMAPEYA 521
+HR+L A N+LL KISDFG+++ G D + + APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECI 511
Query: 522 MHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGTPLQL 576
+FS +SDV+S+GV + E ++ G+K Y+ +++++ + R P +L
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVMAFIEQGKRMECPPECPPEL 568
Query: 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632
Y L C +RP T+ + + +L S +
Sbjct: 569 --------Y---------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 82/329 (24%), Positives = 141/329 (42%), Gaps = 61/329 (18%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEVVLVAKL 398
+F LG G FG VYKG+ E +A+K L +A+ A +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
+ ++ RLLG CL L+ + +P L ++ E + + IA+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG---- 514
YL R++HRDL A N+L+ + KI+DFG+A++ G ++ + + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 515 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR--- 569
+MA E +H ++ +SDV+S+GV V E++T G K Y A+++ S K R
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASEISSILEKGERLPQ 240
Query: 570 -DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY------- 621
+ + Y + + C D RP +++ +
Sbjct: 241 PPICTIDV--------Y---------MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 283
Query: 622 -------SVTLPSPQQPAFFIGSRTERDL 643
+ LPSP F+ E D+
Sbjct: 284 LVIQGDERMHLPSPTDSNFYRALMDEEDM 312
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 29/223 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL---SKASGQGAEEFKNEVV 393
+ KLG+G FG V +G PSG+ + AVK L + + ++F EV
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQ---GQL-DWSRRYK 448
+ L HRNL+RL G L + +V E P SL L + G L ++
Sbjct: 74 AMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--- 128
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
+A G+ YL R IHRDL A N+LL KI DFG+ R +
Sbjct: 129 ---QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 509 IVGT---YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547
+ + APE FS SD + FGV + E+ T G++
Sbjct: 183 --HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 82/325 (25%), Positives = 133/325 (40%), Gaps = 49/325 (15%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSK--ASGQG 384
+ L+ E + + +F+ LG+G FG V + L S ++AVK L +
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 385 AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFVPNKSLDYFL---YDP 435
EEF E + + H ++ +L+G L K ++ F+ + L FL
Sbjct: 69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 436 EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
E L + + IA G+ YL S IHRDL A N +L +M ++DFG++R
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 496 -IFGVDQ-TQGNTSRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF 551
I+ D QG S++ V ++A E ++V SDV++FGV + EI+T G+
Sbjct: 186 KIYSGDYYRQGCASKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--- 239
Query: 552 YQTDGAADLLSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAE 607
Y A++ +Y R ++ Y L C DP +
Sbjct: 240 YAGIENAEIYNYLIGGNRLKQPPECMEEV--------Y---------DLMYQCWSADPKQ 282
Query: 608 RPSMATIVLMLNSYSVTLPSPQQPA 632
RPS + + L + L
Sbjct: 283 RPSFTCLRMELENILGHLSVLSTSQ 307
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 88/335 (26%), Positives = 124/335 (37%), Gaps = 85/335 (25%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L + S Q +F E +
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKI 449
+++K H+N+VR +G L+ + ++ E + L FL P + L +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAR-IFGVDQTQGN 505
IA G YL IHRD+ A N LL KI DFGMAR I+ +
Sbjct: 146 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-- 200
Query: 506 TSRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560
G M PE M G F+ K+D +SFGVL+ EI +
Sbjct: 201 ----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------- 240
Query: 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQE 603
P S S EV+ + G C Q
Sbjct: 241 --LG------YMPYP--------SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQH 284
Query: 604 DPAERPSMATIVLMLNSY-------SVTLPSPQQP 631
P +RP+ A I+ + + LP P
Sbjct: 285 QPEDRPNFAIILERIEYCTQDPDVINTALPIEYGP 319
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-46
Identities = 80/302 (26%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQE----IAVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLV 404
D +G+G FG VY G + A+K LS+ Q E F E +L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 405 RLLGFCLEGEEKIL-VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
L+G L E + ++ + L F+ P++ +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL--- 140
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG-----YMA 517
+ + +HRDL A N +LD K++DFG+AR I + + + A
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ----HRHARLPVKWTA 196
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR----DGT 572
E +F+ KSDV+SFGVL+ E++T G Y+ DL + + R +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP---YRHIDPFDLTHFLAQGRRLPQPEYC 253
Query: 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSP---Q 629
P L Y Q+ C + DPA RP+ +V + L Q
Sbjct: 254 PDSL--------Y---------QVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQ 296
Query: 630 QP 631
P
Sbjct: 297 LP 298
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 86/334 (25%), Positives = 142/334 (42%), Gaps = 57/334 (17%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
EVA K + +LG+G FG VY+GV +A+K +++ AS + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------YDPEKQGQLDWSRR 446
++ + ++VRLLG +G+ +++ E + L +L + S+
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGN 505
++ G IA G+ YL+ + +HRDL A N ++ + KI DFGM R I+ D +
Sbjct: 141 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-- 195
Query: 506 TSRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAAD 559
G G M+PE G F+ SDV+SFGV++ EI T ++ YQ
Sbjct: 196 ----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQ 248
Query: 560 LLSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
+L + + D P L + +L +C Q +P RPS I+
Sbjct: 249 VLRFVMEGGLLDKPDNCPDML--------F---------ELMRMCWQYNPKMRPSFLEII 291
Query: 616 LMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFE 649
+ + + F S + +E +
Sbjct: 292 SSIKEE---MEPGFREVSFYYSEENKLPEPEELD 322
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-45
Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L K E F E ++ KL+H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 321
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG-----QLDWSRRYKIIGGIAR 455
LV+L E E +V E++ SL FL + +D + IA
Sbjct: 322 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA------QIAS 374
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
G+ Y+ R+ +HRDL+A+NIL+ + K++DFG+AR+ ++ +
Sbjct: 375 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKW 430
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR----DG 571
APE A++G+F++KSDV+SFG+L+ E+ T K Y ++L + +R
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE 488
Query: 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQP 631
P L + L C +++P ERP+ + L Y + QP
Sbjct: 489 CPESL--------H---------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531
Query: 632 A 632
Sbjct: 532 G 532
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 88/336 (26%), Positives = 125/336 (37%), Gaps = 85/336 (25%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L + S Q +F E +
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YDPEKQGQLDWSRRYKI 449
+++K H+N+VR +G L+ + ++ E + L FL P + L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAR-IFGVDQTQGN 505
IA G YL IHRD+ A N LL KI DFGMAR I+ +
Sbjct: 187 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-- 241
Query: 506 TSRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560
G M PE M G F+ K+D +SFGVL+ EI +
Sbjct: 242 ----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------- 281
Query: 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQE 603
P S S EV+ + G C Q
Sbjct: 282 --LG------YMPYP--------SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQH 325
Query: 604 DPAERPSMATIVLML-------NSYSVTLPSPQQPA 632
P +RP+ A I+ + + + LP P
Sbjct: 326 QPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPL 361
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 88/381 (23%), Positives = 145/381 (38%), Gaps = 55/381 (14%)
Query: 264 LSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFLRRKAKKKYNAVPESNA 323
+SP P +S I+ P + I L KK +
Sbjct: 1 MSPIDPMGHHHHH-HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59
Query: 324 DNDLTTLESLQFDFET--------IEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI- 372
+ ++ + E I ++ + +G G FG VY G L G++I
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 373 -AVKRLSK-ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLD 429
AVK L++ +F E +++ H N++ LLG CL E L V ++ + L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
F+ + +A+G+ +L + + +HRDL A N +LD + K++
Sbjct: 180 NFIRNET--HNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVA 234
Query: 490 DFGMARIFGVDQTQGNTSRIVGTYG------YMAPEYAMHGQFSVKSDVYSFGVLVLEII 543
DFG+AR D + G +MA E +F+ KSDV+SFGVL+ E++
Sbjct: 235 DFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 544 T-GKKNSNFYQTDGAADLLSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGL 598
T G Y D+ Y + R + P L Y ++ L
Sbjct: 291 TRGAPP---YPDVNTFDITVYLLQGRRLLQPEYCPDPL--------Y---------EVML 330
Query: 599 LCVQEDPAERPSMATIVLMLN 619
C RPS + +V ++
Sbjct: 331 KCWHPKAEMRPSFSELVSRIS 351
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 70/299 (23%), Positives = 119/299 (39%), Gaps = 55/299 (18%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEVVL 394
+ LG G FG V+KGV E + +K + SG+ + + + ++
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQ---GQL-DWSRRYKII 450
+ L H ++VRLLG C LV +++P SL + L +W
Sbjct: 69 IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV----- 122
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
IA+G+ YL ++HR+L A N+LL + +++DFG+A + D Q S
Sbjct: 123 -QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-- 176
Query: 511 GTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYA 564
+MA E G+++ +SDV+S+GV V E++T G + Y A++
Sbjct: 177 ---AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP---YAGLRLAEVPDLL 230
Query: 565 WKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
K R + + Y + + C D RP+ +
Sbjct: 231 EKGERLAQPQICTIDV--------Y---------MVMVKCWMIDENIRPTFKELANEFT 272
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-44
Identities = 81/332 (24%), Positives = 131/332 (39%), Gaps = 92/332 (27%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG------QEIAVKRL-SKASGQGAEEFKNEVV 393
E N +GEG FG V++ P +AVK L +AS +F+ E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--------------------- 432
L+A+ + N+V+LLG C G+ L++E++ L+ FL
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 433 YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
L + + I +A G+ YL S + +HRDL N L+ M KI+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 493 MAR-IFGVD--QTQGNTS---RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
++R I+ D + GN + R +M PE + +++ +SDV+++GV++ EI +
Sbjct: 220 LSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS-- 271
Query: 547 KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG--------- 597
Y P + EVI ++ G
Sbjct: 272 ----------------YG------LQPYY--------GMAHEEVIYYVRDGNILACPENC 301
Query: 598 --------LLCVQEDPAERPSMATIVLMLNSY 621
LC + PA+RPS +I +L
Sbjct: 302 PLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 75/336 (22%), Positives = 127/336 (37%), Gaps = 85/336 (25%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQ 383
E L +D E ++ LG G FG+V + + + +AVK L A+
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 384 GAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFL--------- 432
+E+ ++ + H N+V LLG C + ++V EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 433 ----YDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
+ + L +A+G+ +L + + IHRDL A NILL + KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 489 SDFGMAR-IFGVDQTQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
DFG+AR I+ + +MAPE ++++SDV+SFGVL+ EI
Sbjct: 190 CDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 543 ITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG----- 597
+ +P + + E R ++ G
Sbjct: 244 FS------------------LG------ASPYPGVKID-------EEFCRRLKEGTRMRA 272
Query: 598 ------------LLCVQEDPAERPSMATIVLMLNSY 621
L C +P++RP+ + +V L +
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 31/269 (11%)
Query: 350 DNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRL 406
D ++G G F VYKG+ + E+A + K + + FK E ++ LQH N+VR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ +LV E + + +L +L ++ + I +G+ +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 463 DSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
+ IIHRDLK NI + + KI D G+A + + ++GT +MAPE
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM- 201
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
++ DVY+FG+ +LE+ T + + + AA + +++ G D +
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEY--PYSECQNAAQI----YRRVTSGVKPASFD-KV 254
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
+ + CI+ + ER S
Sbjct: 255 AIPEVKEIIEGCIRQ-------NKDERYS 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 74/327 (22%), Positives = 125/327 (38%), Gaps = 87/327 (26%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRL-SKASGQGAEEFKNE 391
E +K + LGEG FG+V +AVK L A+ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L +
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
+ Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG+AR I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 497 FGVDQTQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
+D T G +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 208 NNID------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-------------- 597
G+P E+ + ++ G
Sbjct: 255 -----------LG------GSPYP--------GIPVEELFKLLKEGHRMDKPANCTNELY 289
Query: 598 ---LLCVQEDPAERPSMATIVLMLNSY 621
C P++RP+ +V L+
Sbjct: 290 MMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-43
Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 40/300 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SKASGQGAEEFKNEVVLV 395
E+ + +GEG FG+V++G+ P + A+K + S E+F E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H ++V+L+G E ++ E L FL ++ LD + ++
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 502
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYG 514
+ YL R +HRD+ A N+L+ + K+ DFG++R + + + ++
Sbjct: 503 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIK 557
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWR---- 569
+MAPE +F+ SDV+ FGV + EI+ G K +Q D++ R
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIENGERLPMP 614
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQ 629
P L Y L C DP+ RP + L++ + Q
Sbjct: 615 PNCPPTL--------Y---------SLMTKCWAYDPSRRPRFTELKAQLSTI-LEEEKLQ 656
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 83/307 (27%), Positives = 126/307 (41%), Gaps = 55/307 (17%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE---IAVKRL-SKASGQGAEEFKNEVVLVA 396
+ N + +GEG FG+V K + A+KR+ AS +F E+ ++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 397 KL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLD 442
KL H N++ LLG C L E+ P+ +L FL L
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502
+ +ARG+ YL S+ + IHRDL A NIL+ KI+DFG++R V
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197
Query: 503 QGNTS---RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAA 558
+ R +MA E + ++ SDV+S+GVL+ EI++ G Y A
Sbjct: 198 KTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCA 248
Query: 559 DLLSYAWKQWR----DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+L + +R ++ Y L C +E P ERPS A I
Sbjct: 249 ELYEKLPQGYRLEKPLNCDDEV--------Y---------DLMRQCWREKPYERPSFAQI 291
Query: 615 VLMLNSY 621
++ LN
Sbjct: 292 LVSLNRM 298
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 74/327 (22%), Positives = 125/327 (38%), Gaps = 87/327 (26%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRL-SKASGQGAEEFKNE 391
E +K + LGEG FG+V +AVK L A+ + + +E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L +
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
+ Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG+AR I
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 497 FGVDQTQGNTSRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
+D T G +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 254 NNID------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 300
Query: 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-------------- 597
G+P E+ + ++ G
Sbjct: 301 -----------LG------GSPYP--------GIPVEELFKLLKEGHRMDKPANCTNELY 335
Query: 598 ---LLCVQEDPAERPSMATIVLMLNSY 621
C P++RP+ +V L+
Sbjct: 336 MMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 82/366 (22%), Positives = 127/366 (34%), Gaps = 98/366 (26%)
Query: 308 RRKAKKKYN---AVPESNADNDLTTLESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
+ K K KY + ES N T ++ Q + E E N LG G FG+V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 GVL------PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
+ ++AVK L S A E +E+ +++ L QH N+V LLG C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEFVPNKSLDYFL-----------YDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+++ E+ L FL +A+G+ +L +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---A 181
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY--------- 515
IHRD+ A N+LL KI DFG+AR I+ Y
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDSNYIVKGNARLP 229
Query: 516 ---MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572
MAPE ++V+SDV+S+G+L+ EI +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------------------LG------LN 265
Query: 573 PLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDPAERPSMATIV 615
P + N ++ + ++ G C +P RP+ I
Sbjct: 266 PYPGILVN-------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318
Query: 616 LMLNSY 621
L
Sbjct: 319 SFLQEQ 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 73/333 (21%), Positives = 117/333 (35%), Gaps = 98/333 (29%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
E N+ S LG G FG+V + + +AVK L A E +E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------------YDPEK 437
+++ L H N+V LLG C G +++ E+ L FL +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ LD +A+G+ +L + IHRDL A NILL KI DFG+AR
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD- 194
Query: 498 GVDQTQGNTSRIVGTYGY------------MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
I Y MAPE + ++ +SDV+S+G+ + E+ +
Sbjct: 195 -----------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS- 242
Query: 546 KKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-------- 597
+P + + ++ + I+ G
Sbjct: 243 -----------------LG------SSPYPGMPVD-------SKFYKMIKEGFRMLSPEH 272
Query: 598 ---------LLCVQEDPAERPSMATIVLMLNSY 621
C DP +RP+ IV ++
Sbjct: 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 70/302 (23%), Positives = 124/302 (41%), Gaps = 37/302 (12%)
Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSKASGQGA 385
L + F+++ V +S ++G GG +V++ + Q A+K L +A Q
Sbjct: 11 VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70
Query: 386 EEFKNEVVLVAKLQHRNL--VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
+ ++NE+ + KLQ + +RL + + + +V E N L+ +L +K+ +D
Sbjct: 71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDP 126
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
R + + +H+ I+H DLK +N L+ + K+ DFG+A D T
Sbjct: 127 WERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182
Query: 504 GNTSRIVGTYGYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFY 552
VGT YM PE + S KSDV+S G ++ + GK + F
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQ 240
Query: 553 QTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612
Q L ++D N + + C++ DP +R S+
Sbjct: 241 QIINQISKL------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 613 TI 614
+
Sbjct: 289 EL 290
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-43
Identities = 78/340 (22%), Positives = 135/340 (39%), Gaps = 88/340 (25%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRL-SKASGQGAEEFKNE 391
E+ ++ LGEG FG+V ++AVK L S A+ + + +E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-I 496
+ QL +ARG+ YL + + IHRDL A N+L+ + KI+DFG+AR I
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 497 FGVDQTQGNTS-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
+D + T+ + +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 242 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------- 288
Query: 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-------------- 597
G+P E+ + ++ G
Sbjct: 289 -----------LG------GSPYP--------GVPVEELFKLLKEGHRMDKPSNCTNELY 323
Query: 598 ---LLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFF 634
C P++RP+ +V L+ V L S Q+ ++
Sbjct: 324 MMMRDCWHAVPSQRPTFKQLVEDLDRI-VALTSNQEMGYY 362
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 39/293 (13%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSK--ASGQGAEEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K ++ A Q + ++NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 396 AKLQHRNL--VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
KLQ + +RL + ++ I +V E N L+ +L +K+ +D R
Sbjct: 62 NKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 116
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ + +H+ I+H DLK +N L+ + K+ DFG+A D T VGT
Sbjct: 117 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 513 YGYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561
YM PE + S KSDV+S G ++ + GK + F Q L
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL 230
Query: 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
++D N + + C++ DP +R S+ +
Sbjct: 231 ------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 73/331 (22%), Positives = 119/331 (35%), Gaps = 92/331 (27%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVV 393
E LGEG FG+V K +AVK L AS + +E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD--PEKQGQLDWSRRYKIIG 451
++ ++ H ++++L G C + +L+ E+ SL FL + G L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 452 G-------------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492
I++G+ YL + ++++HRDL A NIL+ KISDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 493 MAR-IFGVDQTQGNTS-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
++R ++ D + + +MA E ++ +SDV+SFGVL+ EI+T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT-- 247
Query: 547 KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG--------- 597
G P + ++ G
Sbjct: 248 ----------------LG------GNPYP--------GIPPERLFNLLKTGHRMERPDNC 277
Query: 598 --------LLCVQEDPAERPSMATIVLMLNS 620
L C +++P +RP A I L
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 75/376 (19%), Positives = 124/376 (32%), Gaps = 104/376 (27%)
Query: 304 FCFLRRKAKKKYNAVPESNADNDLTTLESLQFDFETI-EVATNKFSTDNKLGEGGFGEVY 362
+ R + ++DN+ ++ +++++ E LG G FG+V
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVM 62
Query: 363 KGVL------PSGQEIAVKRL-SKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGE 414
++AVK L KA E +E+ ++ +L H N+V LLG C
Sbjct: 63 NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122
Query: 415 EKILVYEFVPNKSLDYFL--------------------YDPEKQGQLDWSRRYKIIGGIA 454
L++E+ L +L + E L + +A
Sbjct: 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+G+ +L +HRDL A N+L+ KI DFG+AR I+
Sbjct: 183 KGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD------------IMSDSN 227
Query: 515 Y------------MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS 562
Y MAPE G +++KSDV+S+G+L+ EI +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS------------------ 269
Query: 563 YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLG-----------------LLCVQEDP 605
P + + + IQ G C D
Sbjct: 270 LG------VNPYPGIPVD-------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 316
Query: 606 AERPSMATIVLMLNSY 621
+RPS + L
Sbjct: 317 RKRPSFPNLTSFLGCQ 332
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 61/297 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVL 394
DF+ IE +G GGFG+V+K G+ +KR+ + E+ + EV
Sbjct: 12 DFKEIE----------LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKA 57
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY---------------DPEKQG 439
+AKL H N+V G + ++S L+ + +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+LD ++ I +G+ Y+H ++I+RDLK SNI L KI DFG+
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-- 172
Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD 559
+ G +R GT YM+PE + + D+Y+ G+++ E++ ++T
Sbjct: 173 -KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETSKFFT 229
Query: 560 LLSYAWKQWRDGTPLQLLDTNLTDSYSR--NEVIRCIQLGLLCVQEDPAERPSMATI 614
L RDG ++D + + +++ + + P +RP+ + I
Sbjct: 230 DL-------RDGI--------ISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 70/276 (25%), Positives = 107/276 (38%), Gaps = 38/276 (13%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK--NEVVLVAKL-QHR 401
F ++LG G +GEV+K G+ AVKR + + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILYL 460
VRL EG L E SL E G L ++ + + + +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H ++H D+K +NI L K+ DFG+ G T G G YMAPE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE- 226
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
+ G + +DV+S G+ +LE+ + + +G W+Q R G L
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME--LPHGGEG--------WQQLRQGY----LPPE 272
Query: 581 LTDSYSR--NEVIRCIQLGLLCVQEDPAERPSMATI 614
T S V+ + ++ DP R + +
Sbjct: 273 FTAGLSSELRSVLV------MMLEPDPKLRATAEAL 302
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 70/311 (22%), Positives = 120/311 (38%), Gaps = 36/311 (11%)
Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
+ K PE+ + + E L+ + + ++G G FGEV++
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 367 PSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
+G + AVK RL E+V A L +V L G EG + E +
Sbjct: 81 QTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484
SL + ++ G L R +G G+ YLH RI+H D+KA N+LL ++
Sbjct: 134 GGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDG 187
Query: 485 NP-KISDFGMARIFGVDQTQGNTSR---IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 540
+ + DFG A D + I GT +MAPE M K D++S ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 541 EIITGKK-NSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLL 599
++ G + +++ K + P++ + + Q
Sbjct: 248 HMLNGCHPWTQYFR-------GPLCLKIASEPPPIREIPPSCAPL--------TAQAIQE 292
Query: 600 CVQEDPAERPS 610
++++P R S
Sbjct: 293 GLRKEPVHRAS 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-41
Identities = 76/323 (23%), Positives = 133/323 (41%), Gaps = 46/323 (14%)
Query: 310 KAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSG 369
K ++++ P+ D+D S E I V +S ++G GG +V++ +
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSS---ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKK 80
Query: 370 QEIAVKR--LSKASGQGAEEFKNEVVLVAKLQHRNL--VRLLGFCLEGEEKILVYEFVPN 425
Q A+K L +A Q + ++NE+ + KLQ + +RL + + + +V E N
Sbjct: 81 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-N 139
Query: 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
L+ +L +K+ +D R + + +H+ I+H DLK +N L+ +
Sbjct: 140 IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGM 192
Query: 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-----------YAMHGQFSVKSDVYS 534
K+ DFG+A D T VG YM PE + S KSDV+S
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 535 FGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL---LDTNLTDSYSRNEVI 591
G ++ + GK F Q L ++ + +L D V+
Sbjct: 253 LGCILYYMTYGKT--PFQQIINQISKL---HAIIDPNHEIEFPDIPEKDLQD------VL 301
Query: 592 RCIQLGLLCVQEDPAERPSMATI 614
+C C++ DP +R S+ +
Sbjct: 302 KC------CLKRDPKQRISIPEL 318
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 70/303 (23%), Positives = 112/303 (36%), Gaps = 55/303 (18%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-EEFKNEVV 393
DFE I+ LG GGFG V++ A+KR+ + + A E+ EV
Sbjct: 6 DFEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55
Query: 394 LVAKLQHRNLVRLLGFCLEGEE---------KILVY---EFVPNKSLDYFLYDPEKQGQL 441
+AKL+H +VR LE K+ +Y + ++L ++ +
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+ S I IA + +LH ++HRDLK SNI + K+ DFG+ D+
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 502 TQGNT----------SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551
+ + VGT YM+PE +S K D++S G+++ E++ F
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PF 227
Query: 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611
R+ L E + + P ERP
Sbjct: 228 S----TQMERVRTLTDVRNLKFPPLF-----TQKYPCEY----VMVQDMLSPSPMERPEA 274
Query: 612 ATI 614
I
Sbjct: 275 INI 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 72/299 (24%), Positives = 116/299 (38%), Gaps = 50/299 (16%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
+ F LG+G FG+V K + A+K++ + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYF---------LYD--PEKQGQLDWSRRYKIIG 451
+VR LE + V KS + LYD + +++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF------------GV 499
I + Y+H IIHRDLK NI +D N KI DFG+A+ +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 500 DQTQGNTSRIVGTYGYMAPE-YAMHGQFSVKSDVYSFGVLVLEIITG-KKNSNFYQTDGA 557
+ N + +GT Y+A E G ++ K D+YS G++ E+I
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI--- 237
Query: 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNE--VIRCIQLGLLCVQEDPAERPSMATI 614
K+ R + + D+ + E +IR L + DP +RP T+
Sbjct: 238 -------LKKLRSVSI--EFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPGARTL 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 67/298 (22%), Positives = 109/298 (36%), Gaps = 45/298 (15%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK 397
+ + + KLGEGGF V L G A+KR+ Q EE + E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 398 LQHRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGG 452
H N++RL+ +CL E L+ F +L + + +G L + ++ G
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV-- 510
I RG+ +H HRDLK +NILL E P + D G + + +
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 511 -----GTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL- 561
T Y APE H ++DV+S G ++ ++ G+ + D +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVA 257
Query: 562 -----SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+ Q +S QL + DP +RP + +
Sbjct: 258 LAVQNQLSIPQS--------------PRHSS----ALWQLLNSMMTVDPHQRPHIPLL 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 34/298 (11%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQ 399
+ + + + LG+G V++G +G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 400 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
H+N+V+L K+L+ EF P SL L +P L S ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 458 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
+L E I+HR++K NI+ D + K++DFG AR D Q + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 514 GYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITG----------KKNSNFYQ-- 553
Y+ P+ ++ D++S GV TG ++N
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 554 TDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611
G ++ +G D ++ S SR + + ++ D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 63/304 (20%), Positives = 126/304 (41%), Gaps = 39/304 (12%)
Query: 314 KYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEI 372
+ V + ++E + ++ K+GEG FG+ G++
Sbjct: 7 HSSGVDLGTENLYFQSME----KYVRLQ----------KIGEGSFGKAILVKSTEDGRQY 52
Query: 373 AVK--RLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 430
+K +S+ S + EE + EV ++A ++H N+V+ E +V ++ L
Sbjct: 53 VIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFK 112
Query: 431 FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
+ +K + I + ++H+ +I+HRD+K+ NI L + ++ D
Sbjct: 113 RINA-QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGD 168
Query: 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550
FG+AR+ +GT Y++PE + ++ KSD+++ G ++ E+ T K
Sbjct: 169 FGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH--A 224
Query: 551 FYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
F A + + K P ++ YS + L + +P +RPS
Sbjct: 225 FE----AGSMKNLVLKIISGSFP------PVSLHYSYD----LRSLVSQLFKRNPRDRPS 270
Query: 611 MATI 614
+ +I
Sbjct: 271 VNSI 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 14/230 (6%)
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK 379
+ + + L++D+E E LG+G +G VY G L + IA+K + +
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPE 57
Query: 380 ASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
+ ++ E+ L L+H+N+V+ LG E + E VP SL L
Sbjct: 58 RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL 117
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFG 498
+ + I G+ YLH++ +I+HRD+K N+L++ KISDFG ++
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174
Query: 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGK 546
T GT YMAPE G + +D++S G ++E+ TGK
Sbjct: 175 GINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 69/278 (24%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE---FKNEVVLVAKLQH 400
F + K+G G F EVY+ L G +A+K++ A+ E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
N+++ +E E +V E L + +KQ + + +K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
+H R++HRD+K +N+ + A K+ D G+ R F T ++ +VGT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT-PLQLLD 578
++ KSD++S G L+ E+ + FY +L S K + PL
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS--PFYGD--KMNLYSLCKKIEQCDYPPL---- 258
Query: 579 TNLTDSYSR--NEVIRCIQLGLLCVQEDPAERPSMATI 614
+D YS +++ +C+ DP +RP + +
Sbjct: 259 --PSDHYSEELRQLVN------MCINPDPEKRPDVTYV 288
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 34/297 (11%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQ 399
+ + + + LG+G V++G +G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 400 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
H+N+V+L K+L+ EF P SL L +P L S ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 458 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
+L E I+HR++K NI+ D + K++DFG AR D Q + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 514 GYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITG----------KKNSNFYQ-- 553
Y+ P+ ++ D++S GV TG ++N
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 554 TDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
G ++ +G D ++ S SR + + ++ D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 30/280 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHR 401
+ +G G +G K G+ + K + + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 402 NLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGIL 458
N+VR ++ L V E+ L + K+ Q LD +++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 459 YLHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
H D ++HRDLK +N+ LD + N K+ DFG+ARI D + T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576
+PE ++ KSD++S G L+ E+ F A A K
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFT----AFSQKELAGKIREGKFR--- 234
Query: 577 LDTNLTDSYSR--NEVIRCIQLGLLCVQEDPAERPSMATI 614
+ YS NE+I + RPS+ I
Sbjct: 235 ---RIPYRYSDELNEIIT------RMLNLKDYHRPSVEEI 265
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-37
Identities = 68/290 (23%), Positives = 107/290 (36%), Gaps = 30/290 (10%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNL 403
+ +LG GGFG V + + +G+++A+K+ + E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 404 VRLL------GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
V + +L E+ L +L E L ++ I+ +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYG 514
YLHE RIIHRDLK NI+L KI D G A+ VGT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGTLQ 188
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-------KNSNFYQTDGAADLLSYAWKQ 567
Y+APE +++V D +SFG L E ITG + ++
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 568 WRDGT---PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
G L N ++ R +Q L +R +
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-37
Identities = 66/308 (21%), Positives = 115/308 (37%), Gaps = 54/308 (17%)
Query: 329 TLESLQFDFETIEVATNK--FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAE 386
+LE D ET V K F + LG G G + + +++AVKR+ A+
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD 65
Query: 387 EFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWS 444
EV L+ + +H N++R + + + E +Y +K
Sbjct: 66 ---REVQLLRESDEHPNVIRYFCTE-KDRQFQYIAIELCAATLQEYVE---QKDFAHLGL 118
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMARIFGV 499
++ G+ +LH L I+HRDLK NIL+ ++ ISDFG+ + V
Sbjct: 119 EPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 500 DQ-TQGNTSRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG---------K 546
+ + S + GT G++APE + D++S G + +I+ +
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235
Query: 547 KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPA 606
+ +N + D L + E+I + DP
Sbjct: 236 RQANILLGACSLDCLHPEKH----------------EDVIARELIEK------MIAMDPQ 273
Query: 607 ERPSMATI 614
+RPS +
Sbjct: 274 KRPSAKHV 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 60/302 (19%), Positives = 109/302 (36%), Gaps = 65/302 (21%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKL-Q 399
T +F K+G G FG V+K V G A+KR A + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGIL 458
H ++VR E + ++ E+ SL + + + + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNP-------------------KISDFGMARIFGV 499
Y+H ++H D+K SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFS--VKSDVYSFGVLVLEIITGK---KNSNFYQT 554
Q + G ++A E + ++ K+D+++ + V+ + +N +
Sbjct: 187 PQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235
Query: 555 DGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSR--NEVIRCIQLGLLCVQEDPAERPSMA 612
W + R G + + S+ E+++ + + DP RPS
Sbjct: 236 ---------QWHEIRQGRLPR-----IPQVLSQEFTELLK------VMIHPDPERRPSAM 275
Query: 613 TI 614
+
Sbjct: 276 AL 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 27/268 (10%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVK--RLSKASGQGAEE-FKNEVVLVAKLQHRNLVR 405
KLG GG VY +L ++A+K + + + F+ EV ++L H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
++ E + LV E++ +L ++ E G L I GI + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
+RI+HRD+K NIL+D+ KI DFG+A+ + + T+ ++GT Y +PE A
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585
+D+YS G+++ E++ G+ + + A +S A K +D P D
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP---FNGETA---VSIAIKHIQDSVPNVTTDVRKDIPQ 242
Query: 586 SRNEVIRCIQLGLLCVQEDPAERPSMAT 613
S + VI L ++D A R
Sbjct: 243 SLSNVI------LRATEKDKANRYKTIQ 264
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 74/321 (23%), Positives = 124/321 (38%), Gaps = 54/321 (16%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVA 396
+T+E+ + L EGGF VY+ + SG+E A+KRL + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 397 KLQ-HRNLVRLLGFCL-------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
KL H N+V+ G+ + L+ + L FL E +G L K
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
I R + ++H + IIHRDLK N+LL + K+ DFG A +++
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 509 I----------VGTYGYMAPE-YAMHGQFSV--KSDVYSFGVLVLEIITGKKNSNFYQTD 555
T Y PE ++ F + K D+++ G ++ + + F
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPFE--- 254
Query: 556 GAADLLSYAWKQWRDGTPLQLLDTNLT----DSYSRNEVIRCIQLGLLCVQEDPAERPSM 611
DG L++++ + D+ L +Q +P ER S+
Sbjct: 255 --------------DGAKLRIVNGKYSIPPHDTQYT----VFHSLIRAMLQVNPEERLSI 296
Query: 612 ATIV----LMLNSYSVTLPSP 628
A +V + + +V SP
Sbjct: 297 AEVVHQLQEIAAARNVNPKSP 317
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGF + ++ + + A K + K+ E+ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDS 464
E + + +V E +SL + +++ L +R Y + I G YLH
Sbjct: 83 -FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY--LRQIVLGCQYLH--- 132
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
R R+IHRDLK N+ L+ ++ KI DFG+A D + + GT Y+APE
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 190
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
S + DV+S G ++ ++ GK
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKAS--GQGAEE-FKNEVVLVAKLQHRNLVRLLG 408
LG+G F VY+ + +G E+A+K + K + G + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSR 465
E + LV E N + Y + + +R + + I G+LYLH
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEM--NRYLKNRVKPFSENEARHF--MHQIITGMLYLH---S 130
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
I+HRDL SN+LL MN KI+DFG+A + + T + GT Y++PE A
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSA 188
Query: 526 FSVKSDVYSFGVLVLEIITGK 546
++SDV+S G + ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQHRNLVRLLG 408
LG+GGF + ++ + + A K + K+ E+ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDS 464
E + + +V E +SL + +++ L +R Y + I G YLH
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYY--LRQIVLGCQYLH--- 158
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
R R+IHRDLK N+ L+ ++ KI DFG+A D + + GT Y+APE
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 216
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
S + DV+S G ++ ++ GK
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 48/290 (16%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK---NEV-V 393
++EV + +LG G +G V K +PSGQ +AVKR+ +E K ++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-YDPEKQGQLDWSRRYKIIGG 452
+ + V G + + E + + SLD F +K + I+G
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP----EDILGK 113
Query: 453 IARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
IA I+ +LH S+L +IHRD+K SN+L++A K+ DFG++ VD +
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID- 169
Query: 509 IVGTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF-YQTDGAA-DLLS 562
G YMAPE +SVKSD++S G+ ++E+ + F Y + G L
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQLK 224
Query: 563 YAWKQWRDGTPLQLLDTNLTDSYSR--NEVIRCIQLGLLCVQEDPAERPS 610
+ QL D +S + C++++ ERP+
Sbjct: 225 QV----VEEPSPQLPA----DKFSAEFVDFTSQ------CLKKNSKERPT 260
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 4e-34
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 52/316 (16%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFK 389
L + E+ + F ++LG G G V+K PSG +A K +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRN 76
Query: 390 ---NEVVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
E+ ++ + +V G F +GE I E + SLD L +K G++
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVL---KKAGRIP--- 129
Query: 446 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+I+G ++ ++ YL E +I+HRD+K SNIL+++ K+ DFG++
Sbjct: 130 -EQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--ID 184
Query: 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK------KNSNFYQTD 555
+ N+ VGT YM+PE +SV+SD++S G+ ++E+ G+
Sbjct: 185 SMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGL----------------- 598
G A R TP + L+ DS + + +
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 599 ----LCVQEDPAERPS 610
C+ ++PAER
Sbjct: 303 DFVNKCLIKNPAERAD 318
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 73/272 (26%), Positives = 113/272 (41%), Gaps = 47/272 (17%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH 400
F LG+G FG VY S +A+K L KA + + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
N++RL G+ ++ L+ E+ P ++ L +K + D R I +A + Y
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSY 124
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
H R+IHRD+K N+LL + KI+DFG + ++ + GT Y+ PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPPE 177
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK---------------KNSNF----YQTDGAADL 560
K D++S GVL E + GK F + T+GA DL
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237
Query: 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIR 592
+S +LL N + EV+
Sbjct: 238 IS------------RLLKHNPSQRPMLREVLE 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 352 KLGEGGFGEVYKGVLPS-GQEIAVKRLSK--ASGQGAEE-FKNEVVLVAKLQHRNLVRLL 407
+G GG G+VY+ + +A+K +S+ +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 408 GFCLEGEEKILVY---EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
F GE +Y + L L +QG L R I+ I + H
Sbjct: 101 DF---GEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
HRD+K NIL+ A+ + DFG+A D+ VGT YMAPE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 525 QFSVKSDVYSFGVLVLEIITGK 546
+ ++D+Y+ ++ E +TG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 57/204 (27%), Positives = 112/204 (54%), Gaps = 10/204 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
K++ K+G+G G VY + + +GQE+A+++++ E NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V L L G+E +V E++ SL D + +D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+ ++IHRD+K+ NILL + + K++DFG +Q++ +T +VGT +MAPE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
+ K D++S G++ +E+I G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
+ K+GEG G V SG+++AVK + Q E NEVV++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V + L GEE ++ EF+ +L D Q +L+ + + + + + YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+IHRD+K+ +ILL + K+SDFG D + + +VGT +MAPE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
++ + D++S G++V+E++ G+
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 49/301 (16%)
Query: 331 ESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
L+ E + ++G G +G V K V PSGQ +AVKR+ E+
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---TVDEKE 63
Query: 389 KNEV-----VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
+ ++ V++ +V+ G + + E + + S D F K
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVL 118
Query: 444 SRRY--KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+I+G I + +L E+ L+IIHRD+K SNILLD N K+ DFG++
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 498 GVDQTQGNTSRIVGTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF-Y 552
+ G YMAPE A + V+SDV+S G+ + E+ TG+ F Y
Sbjct: 177 VDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR----FPY 229
Query: 553 QTDGA-ADLLSYAWKQWRDGTPLQLLDTNLTDSYSR--NEVIRCIQLGLLCVQEDPAERP 609
+ D L+ K G P QL ++ +S + C+ +D ++RP
Sbjct: 230 PKWNSVFDQLTQVVK----GDPPQLSNSE-EREFSPSFINFVNL------CLTKDESKRP 278
Query: 610 S 610
Sbjct: 279 K 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 34/228 (14%), Positives = 70/228 (30%), Gaps = 22/228 (9%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGAEEFKNE 391
++ + + LGEG F +VY+ + Q+ +K A+
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YDPEKQGQLDWSRRYKI 449
+ + ++ L +LV E +L + Y + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILL-----------DAEMNPKISDFGMARIFG 498
+ I +H+ IIH D+K N +L D + D G +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+ + T G+ E + ++ + D + V ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 62/306 (20%), Positives = 103/306 (33%), Gaps = 63/306 (20%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEV-VLVAKLQHRNL 403
N ++ LG G G V G+ +AVKR+ + E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 404 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFL---YDPEKQGQLDWSRRYKIIGGIARGILY 459
+R + + + E D E ++ IA G+ +
Sbjct: 72 IRYYCSE-TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP-------------KISDFGMARIFGVDQT--QG 504
LH L+IIHRDLK NIL+ ISDFG+ + Q+ +
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 505 NTSRIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG---------KKN 548
N + GT G+ APE + + D++S G + I++ +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 549 SNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER 608
SN + G L R + + + + I DP +R
Sbjct: 248 SNIIR--GIFSLDEMKCLHDRSLIAE-----------ATDLISQMIDH-------DPLKR 287
Query: 609 PSMATI 614
P+ +
Sbjct: 288 PTAMKV 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 47/256 (18%), Positives = 98/256 (38%), Gaps = 43/256 (16%)
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA 380
+ ++ + L L + + N + L +G F ++ + A+K+ K+
Sbjct: 7 KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKS 65
Query: 381 -----------------SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEF 422
++FKNE+ ++ +++ + G + +++ ++YE+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEY 124
Query: 423 VPNKSL-DY------FLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA 475
+ N S+ + + + + I + Y+H + I HRD+K
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCI--IKSVLNSFSYIH--NEKNICHRDVKP 180
Query: 476 SNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-----YAMHGQFSVKS 530
SNIL+D K+SDFG + GTY +M PE + +G K
Sbjct: 181 SNILMDKNGRVKLSDFGESEYM----VDKKIKGSRGTYEFMPPEFFSNESSYNGA---KV 233
Query: 531 DVYSFGVLVLEIITGK 546
D++S G+ + +
Sbjct: 234 DIWSLGICLYVMFYNV 249
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVK--RLSKASGQGAEE-FKNEVVLVAKLQHRNLVR 405
LG GG EV+ +++AVK R A F+ E A L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 406 LL--GFCLEGEEKI--LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
+ G + +V E+V +L + +G + R ++I + + + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR-IFGVDQTQGNTSRIVGTYGYMAPEY 520
+ IIHRD+K +NI++ A K+ DFG+AR I + T+ ++GT Y++PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGK 546
A +SDVYS G ++ E++TG+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 77/306 (25%), Positives = 140/306 (45%), Gaps = 59/306 (19%)
Query: 320 ESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS 378
S + L +++L+ D E + F+ K+G+G FGEV+KG+ + + +A+K +
Sbjct: 3 HSPVQSGLPGMQNLKADPEEL------FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID 56
Query: 379 KASGQGA-EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEK 437
+ E+ + E+ ++++ + + G L+ + ++ E++ S D +
Sbjct: 57 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLE 112
Query: 438 QGQLDWSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
G LD I I R IL YLH + + IHRD+KA+N+LL K++DFG+
Sbjct: 113 PGPLD----ETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
A Q + NT VGT +MAPE + K+D++S G+ +E+ G+
Sbjct: 166 AGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP------ 217
Query: 554 TDGAADLLSYAWKQWRDGTP---LQLLDTN----LTDSYSR--NEVIRCIQLGLLCVQED 604
++ + P L L+ N L +YS+ E + C+ ++
Sbjct: 218 --------PHS-----ELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE------ACLNKE 258
Query: 605 PAERPS 610
P+ RP+
Sbjct: 259 PSFRPT 264
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 32/207 (15%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVRLL 407
+ GG G +Y + +G+ + +K L + A+ E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 408 GFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
F E +V E+V +SL +L + + I + Y
Sbjct: 146 NF---VEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
LH + +++ DLK NI+L E K+ D G + + GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPE 247
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGK 546
G +V +D+Y+ G + +
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDL 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 30/303 (9%), Positives = 63/303 (20%), Gaps = 61/303 (20%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
L G V+ + ++ A+K + S E A+L +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 409 FC----------LEGEEKI----------------LVYEFVP---NKSLDYFLYDPEKQG 439
++ + L+ + +G
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499
+ + + R L ++H N+ + + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 500 DQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK-----KNSNFY 552
Y E+ F+ + + G+ + +
Sbjct: 247 -----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 553 QTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612
+ L G+ L D V I L D R
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPD----------FVKTLIG-RFLNF--DRRRRLLPL 348
Query: 613 TIV 615
+
Sbjct: 349 EAM 351
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHR 401
+ F KLG G FG+V+ SG E +K ++K Q E + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 402 NLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
N++++ E + +V E L + + + L +++ + + Y
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 460 LHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
H ++H+DLK NIL KI DFG+A +F D+ + GT YM
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYM 193
Query: 517 APEYAMHGQFSVKSDVYSFGV 537
APE + K D++S GV
Sbjct: 194 APE-VFKRDVTFKCDIWSAGV 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 68/304 (22%), Positives = 126/304 (41%), Gaps = 43/304 (14%)
Query: 321 SNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK 379
S + T L + + N ++G G G+V+K +G IAVK++ +
Sbjct: 3 SGSSGKQTGY--LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 380 ASGQGAEEFKN---EV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP 435
+ + EE K ++ V++ +V+ G + + + E + +
Sbjct: 61 SGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK-- 115
Query: 436 EKQGQLDWSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
QG + +I+G + I+ YL E +IHRD+K SNILLD K+ DF
Sbjct: 116 RMQGPIP----ERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDF 169
Query: 492 GMARIFGVDQTQGNTSRIVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
G++ VD + S G YMAPE + +++DV+S G+ ++E+ TG+
Sbjct: 170 GISGRL-VDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 547 KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPA 606
+ ++L+ ++ LL ++ S ++ C+ +D
Sbjct: 227 --FPYKNCKTDFEVLTKVLQE-----EPPLLPGHMGFSGDFQSFVKD------CLTKDHR 273
Query: 607 ERPS 610
+RP
Sbjct: 274 KRPK 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 64/274 (23%), Positives = 110/274 (40%), Gaps = 51/274 (18%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQH 400
+ F LG+G FG VY + +A+K L K+ + + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRYKIIGGIARGI 457
N++R+ + ++I L+ EF P L L +K G+ S + + +A +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATF--MEELADAL 127
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
Y H ++IHRD+K N+L+ + KI+DFG + + T GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM--CGTLDYLP 180
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK---------------KNSNF----YQTDGAA 558
PE K D++ GVL E + G N + + +DG+
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240
Query: 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIR 592
DL+S +LL + V+
Sbjct: 241 DLIS------------KLLRYHPPQRLPLKGVME 262
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH 400
+ + KLG G +GEV + E A+K + K S + EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARG 456
N+++L F E + LV E L D + + + + II + G
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEII----HRMKF--NEVDAAVIIKQVLSG 148
Query: 457 ILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
+ YLH+ I+HRDLK N+LL + + KI DFG++ +F + +GT
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTA 202
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
Y+APE + ++ K DV+S GV++ ++ G
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-31
Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 24/224 (10%)
Query: 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEF 388
S + + +++ LG+G FGEV K + QE AVK ++KA +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRR 446
EV L+ KL H N+++L E +V E L D + K+ + S
Sbjct: 69 LREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII----KRKRF--SEH 121
Query: 447 Y--KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQ 501
+II + GI Y+H+ I+HRDLK NILL + + + KI DFG++ F +
Sbjct: 122 DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
+GT Y+APE + G + K DV+S GV++ +++G
Sbjct: 179 KM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
+ +LG+G FG+VYK +G A K + S + E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+LLG + ++ EF P ++D + E L + + + + +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
RIIHRDLKA N+L+ E + +++DFG++ + ++ +GT +MAPE M
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 523 HGQFS-----VKSDVYSFGVLVLEIITGK 546
K+D++S G+ ++E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 57/314 (18%), Positives = 97/314 (30%), Gaps = 57/314 (18%)
Query: 344 TNKFSTDNKLGEG--GFGEVYKGV-LPSGQEIAVKR--LSKASGQGAEEFKNEVVLVAKL 398
+ +G+G V P+G+ + V+R L S + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
H N+V + E +V F+ S D L ++ I I +G+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMN----ELAIAYILQGV 137
Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-----SR 508
L Y+H +HR +KAS+IL+ + +S +
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 509 IVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK----------------KNS 549
V +++PE + G + KSD+YS G+ E+ G +
Sbjct: 195 SVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253
Query: 550 NFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGL----------- 598
D + L +LT S R
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313
Query: 599 --LCVQEDPAERPS 610
C+Q +P RPS
Sbjct: 314 VEQCLQRNPDARPS 327
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE---FKNEVVLVAKLQ 399
++++ LG+G FGEV +GQE AVK +SK + + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKIIGG 452
H N+++L F + LV E L F E +II
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAA-------RIIRQ 134
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRI 509
+ GI Y+H+ +I+HRDLK N+LL + N +I DFG++ F +
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDK 188
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
+GT Y+APE +HG + K DV+S GV++ +++G
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS-KASGQGAEEFKNEVVLVAKLQHRN 402
+ + +G G V P +++A+KR++ + +E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-----DYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+V + +E LV + + S+ K G LD I I R +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD----ESTIATILREV 130
Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-ARIFGVDQTQGNTSR--IV 510
L YLH++ IHRD+KA NILL + + +I+DFG+ A + N R V
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 511 GTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
GT +MAPE + + K+D++SFG+ +E+ TG
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
F KLGEG +G VYK + +GQ +A+K++ +E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ G + + +V E+ S+ + + L I+ +G+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
R IHRD+KA NILL+ E + K++DFG+A + NT ++GT +MAPE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 523 HGQFSVKSDVYSFGVLVLEIITGK 546
++ +D++S G+ +E+ GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLL 407
LGEG +G+V + + + AVK L K G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 408 G-FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLHED 463
E ++K+ +V E+ + PEK+ + + Y ++I G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH-- 126
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV-GTYGYMAPEYAM 522
I+H+D+K N+LL KIS G+A +T R G+ + PE A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH-PFAADDTCRTSQGSPAFQPPEIAN 184
Query: 523 -----HGQFSVKSDVYSFGVLVLEIITGK 546
G K D++S GV + I TG
Sbjct: 185 GLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 68/346 (19%), Positives = 105/346 (30%), Gaps = 96/346 (27%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVV 393
DFE I+ +G GGFG V++ A+KR+ + + A E EV
Sbjct: 7 DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKI---- 449
+AKL+H +VR LE + E D P + KI
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 450 -----------IGGIARGILYLH-----------------------EDSRLRI------- 468
+ LY+ L I
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 469 ---------IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS----------RI 509
+HRDLK SNI + K+ DFG+ D+ +
Sbjct: 177 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR 569
VGT YM+PE +S K D++S G+++ E++ R
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS---------TQMERVRIITDVR 287
Query: 570 DGTPLQLLDTNLTDSYSR-NEVIRCIQLGLLCVQEDPAERPSMATI 614
+ T Y + + +++ + P ERP I
Sbjct: 288 NLK----FPLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDI 323
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQH 400
+++ LG+G FGEV K + QE AVK ++KAS + + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGIL 458
N+++L E +V E L D + K+ + +II + GI
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGIT 135
Query: 459 YLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
Y+H+ I+HRDLK NILL + + + KI DFG++ F + +GT Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 516 MAPEYAMHGQFSVKSDVYSFGV 537
+APE + G + K DV+S GV
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGV 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
++ +N +G G +GEV V + A K++ K + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
++RL E I LV E L + + + S +I+ + + Y
Sbjct: 68 IIRLYETF-EDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYC 122
Query: 461 HEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
H+ L + HRDLK N L + K+ DFG+A F + VGT Y++
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 518 PEYAMHGQFSVKSDVYSFGV 537
P+ + G + + D +S GV
Sbjct: 177 PQ-VLEGLYGPECDEWSAGV 195
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVV 393
D + F +G G +G+VYKG + +GQ A+K + +G EE K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKI------LVYEFVPNKSL-DYFLYDPEKQGQLDWSR 445
++ K HRN+ G ++ LV EF S+ D L K L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK--- 127
Query: 446 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501
+ I I R IL +LH+ ++IHRD+K N+LL K+ DFG++
Sbjct: 128 -EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 502 TQGNTSRIVGTYGYMAPEYAMHGQFS-----VKSDVYSFGVLVLEIITGK 546
+ NT +GT +MAPE + KSD++S G+ +E+ G
Sbjct: 184 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-------------EEFK 389
+ KLG G +GEV E A+K + K+ EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY 447
NE+ L+ L H N+++L E ++ LV EF L + + + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQII----NRHKF--DECD 147
Query: 448 --KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQT 502
I+ I GI YLH+ I+HRD+K NILL ++ +N KI DFG++ F D
Sbjct: 148 AANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 545
+GT Y+APE + +++ K DV+S GV++ ++ G
Sbjct: 205 L---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 31/199 (15%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V + + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 411 LEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDS 464
L E+ L D E + ++R+ +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE----- 519
+ I HRD+K N+LLD N KISDFG+A +F + + +++ GT Y+APE
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 520 -YAMHGQFSVKSDVYSFGV 537
+ H + DV+S G+
Sbjct: 183 EF--HAE---PVDVWSCGI 196
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 34/246 (13%)
Query: 309 RKAKKKYNAVPESNADNDLTTLESLQFDFETIEVAT----NKFSTDNKLGEGGFGEVYKG 364
K + KY+ ++ D + ++ + +EV + + +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWK-KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC 70
Query: 365 V-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423
V +G+ K ++ KNE+ ++ +L H L+ L + E +L+ EF+
Sbjct: 71 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 424 P---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474
+ E + + G+ ++HE I+H D+K
Sbjct: 131 SGGELFDRIAAEDYKM----SEAEVI-------NYMRQACEGLKHMHE---HSIVHLDIK 176
Query: 475 ASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDV 532
NI+ + + KI DFG+A D+ T + APE +D+
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDM 233
Query: 533 YSFGVL 538
++ GVL
Sbjct: 234 WAIGVL 239
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 38/325 (11%), Positives = 80/325 (24%), Gaps = 70/325 (21%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQ--------- 399
LG+ + +G+ V ++ K EV+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 400 -------------HRNLVRLLGFCLEGEEKILVYEFVPNKS--------LDYFLYDPEKQ 438
+++ L+ + ++ F + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
L R ++ + R + LH ++H L+ +I+LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 499 VDQTQGNTSRIVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
R A + D ++ G+ + I
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNT- 318
Query: 554 TDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMAT 613
D L + + + +R + G L + +R
Sbjct: 319 ----------------DDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPLQ 360
Query: 614 IV------LMLNSYSVTLPSPQQPA 632
+ + S LP Q
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDG 385
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK---NEVVLVAKLQ 399
FS ++G G FG VY + + + +A+K++S + Q E+++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDP----EKQGQLDWSRRYKIIGGIAR 455
H N ++ G L LV E+ + D E + I +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----------IAAVTH 161
Query: 456 GIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
G L YLH +IHRD+KA NILL K+ DFG A I N+ VG
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVG 212
Query: 512 TYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGK 546
T +MAPE + GQ+ K DV+S G+ +E+ K
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 31/199 (15%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V + + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 411 LEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDS 464
L E+ L D E + ++R+ +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE----- 519
+ I HRD+K N+LLD N KISDFG+A +F + + +++ GT Y+APE
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 520 -YAMHGQFSVKSDVYSFGV 537
+ H + DV+S G+
Sbjct: 183 EF--HAE---PVDVWSCGI 196
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 29/239 (12%), Positives = 63/239 (26%), Gaps = 54/239 (22%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQ--------- 399
LG+ + +G+ V ++ K EV+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 400 ----------------HRNLVRLLG-FCLEGEEKILVYEFVPNKSL----DYFLYDPEKQ 438
+ ++R+ +L + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 439 GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498
L R ++ + R + LH ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 499 VDQTQGNTSRIVGTYGYMAPEY-----------AMHGQFSVKSDVYSFGVLVLEIITGK 546
+ G+ PE + D ++ G+++ I
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 16/239 (6%)
Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFST----DNKLGEGGFGEVYK 363
+ + SN DN + + Q+ + +E+ + +LG G FG V++
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWK-QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175
Query: 364 GV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422
+G A K + E + E+ ++ L+H LV L + E +++YEF
Sbjct: 176 VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235
Query: 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
+ L F ++ ++ + + + +G+ ++HE +H DLK NI+
Sbjct: 236 MSGGEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTT 290
Query: 483 EMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 539
+ + K+ DFG+ Q + GT + APE A +D++S GVL
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 36/209 (17%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
F LG G F EV+ +G+ A+K + K+ +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 403 LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL-DW--SRRY-------KIIG 451
+V L E LV + V G+L D R +I
Sbjct: 68 IVTLEDIY-ESTTHYYLVMQLVSG-------------GELFDRILERGVYTEKDASLVIQ 113
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSR 508
+ + YLHE I+HRDLK N+L + I+DFG++++ G S
Sbjct: 114 QVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMST 166
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
GT GY+APE +S D +S GV
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
S LG G FG+V+K +G ++A K + + EE KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 405 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+L + +LV E+V L D + + +LD + I GI ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL---FMKQICEGIRHMHQ- 205
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
+ I+H DLK NIL KI DFG+AR + + GT ++APE
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVV 260
Query: 522 MHGQFSVKSDVYSFGVL 538
+ S +D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVI 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 30/207 (14%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
K+ LG G FG V++ V S + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
++ L EE ++++EF+ + + E++ + +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL----NEREIV-------SYVHQV 111
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVG 511
+ +LH I H D++ NI+ + KI +FG AR +
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFT 165
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVL 538
Y APE H S +D++S G L
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTL 192
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 35/209 (16%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
+G+G F +V + +G+E+A+K + K + ++ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81
Query: 410 CLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHED 463
+E E+ + L+ E+ + DY + G++ +R +I+ + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQ----YCH-- 131
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE---- 519
+ RI+HRDLKA N+LLDA+MN KI+DFG + F V + G Y APE
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAF--CGAPPYAAPELFQG 187
Query: 520 --YAMHGQFSVKSDVYSFGVLVLEIITGK 546
Y + DV+S GV++ +++G
Sbjct: 188 KKYD-----GPEVDVWSLGVILYTLVSGS 211
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 58/264 (21%)
Query: 311 AKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ 370
+ N V + D+ ++ L D +T E ++ +G G FG V++ L
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD 65
Query: 371 EIAVKRLSKASGQGAEEFKN-EVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFV 423
E+A+K++ + + FKN E+ ++ ++H N+V L F +K LV E+V
Sbjct: 66 EVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120
Query: 424 P-------------NKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
P +++ ++Y QL R + Y+H
Sbjct: 121 PETVYRASRHYAKLKQTMPMLLIKLYMY------QL------------LRSLAYIH---S 159
Query: 466 LRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
+ I HRD+K N+LLD K+ DFG A+I + N S I Y Y APE + G
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPE-LIFG 215
Query: 525 --QFSVKSDVYSFGVLVLEIITGK 546
++ D++S G ++ E++ G+
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---------EEFKNEVV 393
+ LG G V + + P+ +E AVK + G E EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 394 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIG 451
++ K+ H N+++L LV++ + L DY ++ L KI+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMR 131
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
+ I LH+ L I+HRDLK NILLD +MN K++DFG + + + G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 185
Query: 512 TYGYMAPE------YAMHGQFSVKSDVYSFGV 537
T Y+APE H + + D++S GV
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 31/213 (14%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSKASGQGAEEFKNEVVLVAK 397
+ + +G+G F V + + +GQ+ AVK + + + G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYK 448
L+H ++V LL +V+EF+ ++ F+Y E
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY-SEAVAS-------H 134
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGN 505
+ I + Y H+ IIHRD+K +LL ++ N K+ FG+A G
Sbjct: 135 YMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
VGT +MAPE + DV+ GV+
Sbjct: 192 G--RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS------GQGAEEFKNEVVLVA 396
+ + +LG G F V K +G E A K + K G EE + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
++ H N++ L + +L+ E V L + E++
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEAT-------SF 120
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
I I G+ YLH +I H DLK NI+L + P K+ DFG+A
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
I GT ++APE + +++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA------SGQGAEEFKNEVVLVA 396
+ + +LG G F V K +G E A K + K G EE + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
++ H N++ L + +L+ E V L + E++
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEAT-------SF 120
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
I I G+ YLH +I H DLK NI+L + P K+ DFG+A
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
I GT ++APE + +++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH 400
++ + +LG+G F V + V +G E A K ++ S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
N+VRL E LV++ V L + + + + I I I Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAY 120
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
H I+HR+LK N+LL ++ K++DFG+A + GT GY+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYL 174
Query: 517 APEYAMHGQFSVKSDVYSFGV 537
+PE +S D+++ GV
Sbjct: 175 SPEVLKKDPYSKPVDIWACGV 195
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/251 (22%), Positives = 101/251 (40%), Gaps = 53/251 (21%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--------SGQGAEEFKNEVVLVA 396
K+ST + LG G FG V+ V +E+ VK + K + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 397 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRY--KIIG 451
+++H N++++L E + LV E + LD F + ++ +L + +++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAF-IDRHPRLDEPLASYIFRQLVS 141
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIV 510
+ YL IIHRD+K NI++ + K+ DFG A +G
Sbjct: 142 AVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLFYTFC 190
Query: 511 GTYGYMAPE------YAMHGQFSVKSDVYSFGVL--VL-----------EIITGKKNSNF 551
GT Y APE Y G + +++S GV L E + + +
Sbjct: 191 GTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY 245
Query: 552 YQTDGAADLLS 562
+ L+S
Sbjct: 246 LVSKELMSLVS 256
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 56/269 (20%), Positives = 96/269 (35%), Gaps = 54/269 (20%)
Query: 328 TTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSKAS 381
+ E+L F ++ K+ +G+G +G V + + A+K ++ + +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 382 GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFV----------------- 423
+ E K EV L+ KL H N+ RL E E+ I LV E
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 424 --------------PNKSLDYFLYDPEKQGQLDWSRRY------KIIGGIARGILYLHED 463
+ + + + I+ I + YLH
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN- 186
Query: 464 SRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQGNT--SRIVGTYGYMAPE 519
I HRD+K N L + K+ DFG+++ F + GT ++APE
Sbjct: 187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 520 --YAMHGQFSVKSDVYSFGVLVLEIITGK 546
+ + K D +S GVL+ ++ G
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 31/249 (12%)
Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
K N E D+ + K+ + +G G V + V
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 367 PSGQEIAVKRLSKASGQGAEE--------FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI 417
+G E AVK + + + + E + E ++ ++ H +++ L+
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 418 LVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLK 474
LV++ + L DY ++ L S + I+ + + +LH I+HRDLK
Sbjct: 177 LVFDLMRKGELFDYLT----EKVAL--SEKETRSIMRSLLEAVSFLHA---NNIVHRDLK 227
Query: 475 ASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE------YAMHGQFSV 528
NILLD M ++SDFG + + + GT GY+APE H +
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 529 KSDVYSFGV 537
+ D+++ GV
Sbjct: 285 EVDLWACGV 293
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA------SGQGAEEFKNEVVLVA 396
+ + +LG G F V K +G+E A K + K G EE + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
+++H N++ L + +L+ E V L + E + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TEDEAT-------QF 113
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
+ I G+ YLH RI H DLK NI+L + P K+ DFG+A
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
I GT ++APE + +++D++S GV+
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-27
Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA---SGQGAEEFKNE 391
F V LG+GGFGEV + + ++ A K+L K +G NE
Sbjct: 185 TFRQYRV----------LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQG-QLDWSRRYKI 449
++ K+ R +V L + E ++ + LV + L + +Y + G + Y
Sbjct: 235 KQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY-- 291
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRI 509
I G+ LH RI++RDLK NILLD + +ISD G+A QT
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 510 VGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
VGT GYMAPE + FS D ++ G L+ E+I G+ S F Q
Sbjct: 346 VGTVGYMAPEVVKNERYT-FSP--DWWALGCLLYEMIAGQ--SPFQQRK 389
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSKA---SGQGAEEFKNE 391
DF + +G GGFGEVY +G+ A+K L K QG NE
Sbjct: 190 DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 392 ---VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
+ LV+ +V + + +K+ + + + L Y L + G +
Sbjct: 240 RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMR 295
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
I G+ ++H +++RDLK +NILLD + +ISD G+A F +
Sbjct: 296 FYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--- 349
Query: 508 RIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFYQ 553
VGT+GYMAPE G S D +S G ++ +++ G S F Q
Sbjct: 350 -SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH--SPFRQ 393
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--------FKNEVVL 394
+++ LG G GEV + +++A++ +SK + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGI 453
+ KL H ++++ F + E+ +V E + L D + +L + +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQM 248
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIV 510
+ YLHE IIHRDLK N+LL ++ KI+DFG ++I G +
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302
Query: 511 GTYGYMAPE---YAMHGQFSVKSDVYSFGVLV 539
GT Y+APE ++ D +S GV++
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 27/210 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--------FKNEVVL 394
+++ LG G GEV + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGI 453
+ KL H ++++ F + E+ +V E + L D + +L + +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQM 123
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ YLHE IIHRDLK N+LL + + KI+DFG ++I G +
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 511 GTYGYMAPE---YAMHGQFSVKSDVYSFGV 537
GT Y+APE ++ D +S GV
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA------SGQGAEEFKNEVVLVA 396
+ + T +LG G F V K +G + A K + K G E+ + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYDPEKQGQLDWSRRYKI 449
++QH N++ L + IL+ E V L + E++ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEAT-------EF 119
Query: 450 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGN 505
+ I G+ YLH L+I H DLK NI+L P KI DFG+A
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 173
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
I GT ++APE + +++D++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 57/225 (25%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA--------------------------SGQGA 385
+G+G +G V A+K LSK
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLE-----GEEKI-LVYEFVPNKSLDYFLYDPEKQG 439
E+ E+ ++ KL H N+V+L+ E E+ + +V+E V + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132
Query: 440 QL--DWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
L D +R Y +I GI YLH +IIHRD+K SN+L+ + + KI+DFG++
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 496 IFGVDQTQGNTSRIVGTYGYMAPE--YAMHGQFS-VKSDVYSFGV 537
F + + VGT +MAPE FS DV++ GV
Sbjct: 186 EFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN------EVVLVAKLQHR--NL 403
LG GGFG VY G+ + +A+K + K E N EVVL+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 404 VRLLGFCLEGEEKI-LVYEFV-PNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARG 456
+RLL + E + L+ E P + L D+ ++G L + +R + +++ +
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVR-- 163
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
+ H ++HRD+K NIL+D K+ DFG + + GT Y
Sbjct: 164 --HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVY 214
Query: 516 MAPEYAMHGQFS-VKSDVYSFGVL--VL-----------EIITGKKNSNFYQTDGAADLL 561
PE+ + ++ + V+S G+L + EII G+ + L+
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274
Query: 562 S 562
Sbjct: 275 R 275
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 34/235 (14%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA---SGQGAEEFKNE 391
F V LG GGFGEV+ + + ++ A K+L+K +G + E
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL---DWSRRY 447
++AK+ R +V L + E + + LV + + Y +Y+ ++ + Y
Sbjct: 236 KKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
I G+ +LH+ II+RDLK N+LLD + N +ISD G+A QT+
Sbjct: 295 --TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 508 RIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD 559
GT G+MAPE + FSV D ++ GV + E+I + F +
Sbjct: 350 --AGTPGFMAPELLLGEEYD-FSV--DYFALGVTLYEMIAAR--GPFRARGEKVE 397
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH 400
++ + +LG+G F V + V +G E A K ++ S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGI 457
N+VRL E LV++ V L + + + S I I I
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFY--SEADASHCIQQILESI 141
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYG 514
Y H I+HR+LK N+LL ++ K++DFG+A + GT G
Sbjct: 142 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 195
Query: 515 YMAPEYAMHGQFSVKSDVYSFGV 537
Y++PE +S D+++ GV
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGV 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 42/213 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG G FG+V G +G ++AVK L++ S + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHE 462
+ +V E+V L DY K G++ +RR +I+ + Y H
Sbjct: 79 -VISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVD----YCH- 128
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN---TSRIVGTYGYMAPE 519
R ++HRDLK N+LLDA MN KI+DFG++ + + G TS G+ Y APE
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPE 180
Query: 520 ------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
Y G + D++S GV++ ++ G
Sbjct: 181 VISGRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 49/243 (20%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSK------ASGQGAEEFKNEVVLVAKL----QHR 401
LG+GGFG V+ G L ++A+K + + + + EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 402 NLVRLLGFCLEGEEKI-LVYEF-VPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIA 454
++RLL + E +E LV E +P + L DY ++G L SR + +++ I
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTY 513
+ H ++HRD+K NIL+D K+ DFG + + GT
Sbjct: 154 ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTR 202
Query: 514 GYMAPEYAMHGQFS-VKSDVYSFGVL--VL-----------EIITGKKNSNFYQTDGAAD 559
Y PE+ Q+ + + V+S G+L + EI+ + + + +
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA 262
Query: 560 LLS 562
L+
Sbjct: 263 LIR 265
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS---GQGAEEF 388
DF+ ++ LGEG F V + +E A+K L K
Sbjct: 31 DFKFGKI----------LGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYV 77
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
E ++++L H V+L F + +EK+ + N L ++ K G +R
Sbjct: 78 TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTR 133
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
Y I + YLH IIHRDLK NILL+ +M+ +I+DFG A++ + Q
Sbjct: 134 FY--TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 506 TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK---KNSNFYQT 554
+ VGT Y++PE SD+++ G ++ +++ G + N Y
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 32/206 (15%)
Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHR-NLV 404
T +LG G F V + + +GQE A K L K E +E+ ++ + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 405 RLLGFCLEGEEKILVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
L E IL+ E+ + + E ++I I
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVI-------RLIKQILE 142
Query: 456 GILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
G+ YLH+ I+H DLK NILL + KI DFGM+R G I+GT
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGT 196
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVL 538
Y+APE + + +D+++ G++
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGII 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 74/354 (20%), Positives = 140/354 (39%), Gaps = 58/354 (16%)
Query: 352 KLGEGGFGEVYKGV---LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
K+G G +G VYK ++ A+K++ + +G + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 409 FCLE-GEEKI-LVYEFVPN---KSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLH 461
L + K+ L++++ + + + + + R ++ I GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 462 EDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGV-DQTQGNTSRIVGTYGYM 516
+ ++HRDLK +NIL+ E KI+D G AR+F + + +V T+ Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 517 APEYAMHG--QFSVKSDVYSFGVLVLEIITGK----------KNSNFYQTD--------- 555
APE + G ++ D+++ G + E++T + K SN Y D
Sbjct: 203 APELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261
Query: 556 ---------GAADLLSYA--WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQED 604
+ ++ K +R T + + + L + D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321
Query: 605 PAERPSMATIVLMLNSYSVTLPSPQQPAFFIGSRTERDLPTKEFECSDKSTSKS 658
P +R + M + Y + P P F + P +EF ++ K
Sbjct: 322 PIKRITSEQA--MQDPYFLEDPLPTSDVFA---GCQIPYPKREFLTEEEPDDKG 370
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 59/232 (25%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKLQHR 401
++ +G G FG VY+ L SG+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 402 NLVRLLGFCLEGEEKI------LVYEFVP-------------NKSLD-----YFLYDPEK 437
N+VRL F EK LV ++VP ++L ++Y
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---- 163
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMARI 496
QL R + Y+H I HRD+K N+LLD + K+ DFG A+
Sbjct: 164 --QL------------FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 546
+ + N S I Y Y APE + G ++ DV+S G ++ E++ G+
Sbjct: 207 L--VRGEPNVSYICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-----EVVLVA 396
AT+++ ++G G +G VYK SG +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 397 KLQ---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
+L+ H N+VRL+ + E K+ LV+E V ++ L +L D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
++ RG+ +LH + I+HRDLK NIL+ + K++DFG+ARI+ T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPV 179
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+V T Y APE + ++ D++S G + E+ K
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKN----EVVLVAK 397
K+ +GEG +G V K +G+ +A+K S + K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
L+H NLV LL C + + LV+EFV + L+ LD+ K + I
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQVVQKYLFQII 134
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
GI + H IIHRD+K NIL+ K+ DFG AR + + T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRW 189
Query: 515 YMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
Y APE Y +V DV++ G LV E+ G+
Sbjct: 190 YRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE--FKNEVVLVAKLQH 400
T ++ +LG+G F V + V + +GQE A ++ + + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL-DW--SRRY-------KII 450
N+VRL E L+++ V G+L + +R Y I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYSEADASHCI 116
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTS 507
I +L+ H+ + ++HR+LK N+LL K++DFG+A +Q
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172
Query: 508 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 537
GT GY++PE + D+++ GV
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 41/212 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LGEG FG+V + Q++A+K +S+ + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 409 FCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHED 463
+ I +V E+ + DY + ++ ++ D RR+ +II I Y H
Sbjct: 77 V-ITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 464 SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN---TSRIVGTYGYMAPE- 519
R +I+HRDLK N+LLD +N KI+DFG++ I T GN TS G+ Y APE
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTS--CGSPNYAAPEV 178
Query: 520 -----YAMHGQFSVKSDVYSFGVLVLEIITGK 546
Y G + DV+S G+++ ++ G+
Sbjct: 179 INGKLY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN--------EVVLVA 396
K+ K+GEG +G VYK G+ +A+KR+ + E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
+L H N+V L+ LV+EF+ K L L + + L S+ + + RG
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+ + H+ RI+HRDLK N+L++++ K++DFG+AR FG+ + T +V T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYR 186
Query: 517 APEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
AP+ M ++S D++S G + E+ITGK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-----EVVLVA 396
++++F KLG G + VYKG+ +G +A+K + +EE E+ L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIREISLMK 58
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPN--KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+L+H N+VRL + LV+EF+ N K L+ + +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+G+ + HE+ +I+HRDLK N+L++ K+ DFG+AR FG+ +S +V T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TLW 173
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
Y AP+ M +S D++S G ++ E+ITGK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 345 NKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQGAEEFKN--------EVVL 394
++ ++GEG +G+V+K + G+ +A+KR+ + + EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 395 VAKLQ---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRR 446
+ L+ H N+VRL + E K+ LV+E V ++ L +L D + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
++ + RG+ +LH R++HRDLK NIL+ + K++DFG+ARI+ T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
S +V T Y APE + ++ D++S G + E+ K
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 57/244 (23%), Positives = 99/244 (40%), Gaps = 35/244 (14%)
Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
+ ++V S A + + D + ++ F +++LG G VY+
Sbjct: 16 ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQK 75
Query: 367 PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
+ + A+K L K + + + E+ ++ +L H N+++L E LV E V
Sbjct: 76 GTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV--- 130
Query: 427 SLDYFLYDPEKQGQL-DW--SRRY-------KIIGGIARGILYLHEDSRLRIIHRDLKAS 476
G+L D + Y + I + YLHE I+HRDLK
Sbjct: 131 ----------TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPE 177
Query: 477 NILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVY 533
N+L + KI+DFG+++I + GT GY APE + + D++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 534 SFGV 537
S G+
Sbjct: 235 SVGI 238
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKN--------EVVLVA 396
K+ K+GEG +G VYK G+ A+K++ E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 397 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+L+H N+V+L + ++++ LV+E + + L L +G L+ + +
Sbjct: 56 ELKHSNIVKLYD-VIHTKKRLVLVFEHLD-QDLKKLLDV--CEGGLESVTAKSFLLQLLN 111
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
GI Y H+ R++HRDLK N+L++ E KI+DFG+AR FG+ + T IV T Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWY 166
Query: 516 MAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
AP+ M ++S D++S G + E++ G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 42/213 (19%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLG 408
LG G FG+V G +G ++AVK L++ S + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 409 FCLEGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHE 462
+ I +V E+V L DY K G+L SRR +I+ G+ Y H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVD----YCH- 133
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN---TSRIVGTYGYMAPE 519
R ++HRDLK N+LLDA MN KI+DFG++ + + G TS G+ Y APE
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPE 185
Query: 520 ------YAMHGQFSVKSDVYSFGVLVLEIITGK 546
YA + D++S GV++ ++ G
Sbjct: 186 VISGRLYA-----GPEVDIWSSGVILYALLCGT 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--------EVVLV 395
++ + LGEG F VYK + Q +A+K++ E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 396 AKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+L H N++ LL + I LV++F+ L+ + D L S +
Sbjct: 67 QELSHPNIIGLLD-AFGHKSNISLVFDFME-TDLEVIIKDN--SLVLTPSHIKAYMLMTL 122
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+G+ YLH+ I+HRDLK +N+LLD K++DFG+A+ FG + T ++V T
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRW 177
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
Y APE + V D+++ G ++ E++
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKN----EVVLVAK 397
K+ K+GEG +G V+K +GQ +A+K S+ K E+ ++ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD----PVIKKIALREIRMLKQ 58
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
L+H NLV LL LV+E+ + LD Q + I
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD------RYQRGVPEHLVKSITWQTL 112
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+ + + H + IHRD+K NIL+ K+ DFG AR+ + + T
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRW 167
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
Y +PE + Q+ DV++ G + E+++G
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 63/244 (25%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKR-LSKASGQGAEEFKN---- 390
E ++F + G+G FG V G +G +A+K+ + F+N
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQ 68
Query: 391 EVVLVAKLQHRNLVRLLGFCLEGEEK-------ILVYEFVP-------------NKSLD- 429
+ +A L H N+V+L + E+ +V E+VP +
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128
Query: 430 ----YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485
FL+ QL R I LH S + + HRD+K N+L++
Sbjct: 129 ILIKVFLF------QL------------IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG 169
Query: 486 P-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEI 542
K+ DFG A+ + N + I Y Y APE + G ++ D++S G + E+
Sbjct: 170 TLKLCDFGSAKKLSPSEP--NVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEM 225
Query: 543 ITGK 546
+ G+
Sbjct: 226 MLGE 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN 402
T+ + +G G + + + + E AVK + K+ EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGILY 459
++ L +G+ +V E + L D L +Q S R ++ I + + Y
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFF--SEREASAVLFTITKTVEY 131
Query: 460 LHEDSRLRIIHRDLKASNILL-DAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGY 515
LH ++HRDLK SNIL D NP +I DFG A+ + T T +
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANF 186
Query: 516 MAPEYAMHGQFSVKSDVYSFGVL 538
+APE + D++S GVL
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVL 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 23/202 (11%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFC 410
LGEG V + L + QE AVK + K G EV ++ + Q HRN++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 411 LEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
E + LV+E + S+ + K+ + ++ +A + +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHN---KGIA 133
Query: 470 HRDLKASNILL---DAEMNPKISDFGMARIF-----GVDQTQGNTSRIVGTYGYMAPE-- 519
HRDLK NIL + KI DF + + G+ YMAPE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 520 ---YAMHGQFSVKSDVYSFGVL 538
+ + D++S GV+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVI 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--------EVVLV 395
K+ K+GEG +G V+K + + +A+KR+ ++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 396 AKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+L+H+N+VRL L ++K+ LV+EF + L + G LD + +
Sbjct: 56 KELKHKNIVRLHD-VLHSDKKLTLVFEFCD-QDLKKYFDS--CNGDLDPEIVKSFLFQLL 111
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+G+ + H ++HRDLK N+L++ K+++FG+AR FG+ + ++ +V T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLW 166
Query: 515 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKK 547
Y P+ +S D++S G + E+ +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN--------EVVLV 395
+++ KLGEG +GEVYK + + + +A+KR+ E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+LQHRN++ L L++E+ L ++ +K + + +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLIN 143
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVDQTQGNTSRIV 510
G+ + H R +HRDLK N+LL KI DFG+AR FG+ + T I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII 199
Query: 511 GTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
T Y PE + +S D++S + E++
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKN-----EVVLVAKL 398
+ +KLGEG + VYKG + +A+K + EE EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDL 57
Query: 399 QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+H N+V L + E+ + LV+E++ +K L +L D ++ + + RG+
Sbjct: 58 KHANIVTLHD-IIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLFLFQLLRGL 113
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
Y H +++HRDLK N+L++ K++DFG+AR + T+ + +V T Y
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRP 168
Query: 518 PEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
P+ + +S + D++ G + E+ TG+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 36/200 (18%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
+G G FG + + +AVK + + + E + E++ L+H N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKE-VI 85
Query: 412 EGEEKI-LVYEFVPNKSL-DYFLYDPEKQGQL--DWSRRY--KIIGGIARGILYLHEDSR 465
+ ++ E+ L + G+ D +R + +++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERIC----NAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 466 LRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE---- 519
++I HRDLK N LLD KI DFG ++ V +Q ++ VGT Y+APE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST--VGTPAYIAPEVLLR 191
Query: 520 --YAMHGQFSVKSDVYSFGV 537
Y G+ +DV+S GV
Sbjct: 192 QEYD--GK---IADVWSCGV 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 33/225 (14%)
Query: 331 ESLQFDFETIEVATNKFS-----TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG 384
L+ F+ E + + LG G G+V + +GQ+ A+K L +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---- 65
Query: 385 AEEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKI----LVYEFVPNKSL-DYFLYDPEKQ 438
+ + EV ++V +L ++ E + L ++
Sbjct: 66 -PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ER 120
Query: 439 GQLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGM 493
G ++ R +I+ I I +LH I HRD+K N+L + + K++DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
A+ TQ T Y+APE ++ D++S GV+
Sbjct: 178 AKET----TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 348 STDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVR 405
D LGEG F K V S Q AVK +SK + E+ + + H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 406 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L + LV E + L +K+ + I+ + + ++H+
Sbjct: 71 LHEVF-HDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMRKLVSAVSHMHD-- 124
Query: 465 RLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
+ ++HRDLK N+L + + KI DFG AR+ D T T Y APE
Sbjct: 125 -VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELL 181
Query: 522 MHGQFSVKSDVYSFGVL 538
+ D++S GV+
Sbjct: 182 NQNGYDESCDLWSLGVI 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKN----EVVLVAK 397
+K+ K+G+G FGEV+K +GQ++A+K + E F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQL 72
Query: 398 LQHRNLVRLLGFCLEGEEKI--------LVYEFVPN--KSLDYFLYDPEKQGQLDWSRRY 447
L+H N+V L+ C LV++F + L L + + S
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNV--LVKFTLSEIK 127
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-- 505
+++ + G+ Y+H + +I+HRD+KA+N+L+ + K++DFG+AR F + +
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 506 -TSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 546
T+R+V T Y PE + + D++ G ++ E+ T
Sbjct: 185 YTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKA---SGQGAEEF 388
DFE ++V +G G F EV K +GQ A+K ++K F
Sbjct: 62 DFEILKV----------IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
+ E ++ R + +L F + E + LV E+ L L ++ + +R Y
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS 507
+ I I +H L +HRD+K NILLD + +++DFG D T +
Sbjct: 168 --LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SL 221
Query: 508 RIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG 545
VGT Y++PE G + + D ++ GV E+ G
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-22
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKA---SGQGAEEFKNE 391
DFE ++V +G G FGEV L + ++ A+K L+K F+ E
Sbjct: 75 DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
++ + + L + + + + LV ++ L L E + + +R Y +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--L 181
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
+ I +H+ L +HRD+K NIL+D + +++DFG D T +S V
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAV 237
Query: 511 GTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITG 545
GT Y++PE G++ + D +S GV + E++ G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-22
Identities = 55/249 (22%), Positives = 104/249 (41%), Gaps = 55/249 (22%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN-EVVLVAKL 398
E ++ K+S LG G FG V + + SG+ A+K++ + +KN E+ ++ L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVL 57
Query: 399 QHRNLVRLLGF---CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR--------- 446
H N+++L+ + + E K NK + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 447 -------YKIIGG-------------------IARGILYLHEDSRLRIIHRDLKASNILL 480
+K++ + R + ++H L I HRD+K N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 481 DAEMNP-KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGV 537
+++ N K+ DFG A+ ++ + + I + Y APE M G +++ D++S G
Sbjct: 175 NSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL-MLGATEYTPSIDLWSIGC 230
Query: 538 LVLEIITGK 546
+ E+I GK
Sbjct: 231 VFGELILGK 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 59/302 (19%), Positives = 103/302 (34%), Gaps = 62/302 (20%)
Query: 248 FYNESATAPPAPAPVLLSPPPPGSVTTSRGKSGISSSTIIAIVAPIAVTAVLFILGFCFL 307
N +PP P P PP P + +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQ------------------- 42
Query: 308 RRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-L 366
+ K + NA D D++ LG G G+V +
Sbjct: 43 FPQFHVKSGLQIKKNAIID---------DYKVTS---------QVLGLGINGKVLQIFNK 84
Query: 367 PSGQEIAVKRLSKASGQGAEEFKNEV-VLVAKLQHRNLVRLLGFC---LEGEEKI-LVYE 421
+ ++ A+K L + + EV + Q ++VR++ G + + +V E
Sbjct: 85 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 422 FVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479
+ L + +G ++ R +I+ I I YLH + I HRD+K N+L
Sbjct: 140 CLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLL 193
Query: 480 L---DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 536
K++DFG A+ + + T Y+APE ++ D++S G
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 537 VL 538
V+
Sbjct: 251 VI 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 48/246 (19%)
Query: 317 AVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEI 372
++P +N+ + FE + +G+G FG+V + +
Sbjct: 1 SMPPVFDENEDVNFD----HFEILRA----------IGKGSFGKVCIVQKND---TKKMY 43
Query: 373 AVKRLSKASGQGAEEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL 428
A+K ++K E +N E+ ++ L+H LV L + + EE + +V + + L
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL 102
Query: 429 DYFLYDPEKQGQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
Y L ++ + + + I + + YL RIIHRD+K NILLD +
Sbjct: 103 RYHL---QQNVHFKEETVKLF--ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHV 154
Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE------YAMHGQFSVKSDVYSFGVLVL 540
I+DF +A + + + + GT YMAPE A + F+V D +S GV
Sbjct: 155 HITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYS-FAV--DWWSLGVTAY 208
Query: 541 EIITGK 546
E++ G+
Sbjct: 209 ELLRGR 214
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 55/244 (22%)
Query: 332 SLQFDFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG 384
+F ++E+ + F+ + +G G G V + +A+K+LS+
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---- 61
Query: 385 AEEFKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF---- 431
F+N E+VL+ + H+N++ LL F P KSL+ F
Sbjct: 62 ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVY 106
Query: 432 ---------LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482
L + Y ++ + GI +LH IIHRDLK SNI++ +
Sbjct: 107 IVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 542
+ KI DFG+AR + T V T Y APE + + D++S G ++ E+
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 543 ITGK 546
I G
Sbjct: 220 IKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 44/234 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
F +V + +G G +G V + SG+++A+K+LS+ F
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------F 61
Query: 389 KN---------EVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLY 433
++ E++L+ +QH N++ LL L LV F + L
Sbjct: 62 QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQ 116
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ +Y ++ + +G+ Y+H ++HRDLK N+ ++ + KI DFG+
Sbjct: 117 KIMGLKFSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
AR + T V T Y APE + ++ D++S G ++ E++TGK
Sbjct: 173 ARHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 31/288 (10%), Positives = 81/288 (28%), Gaps = 56/288 (19%)
Query: 352 KLGEGGFGEVYKG---VLPSGQEIAVKRL---SKASGQGAEEFKNEVVLVAKLQHRNLVR 405
G + ++ L +++A+ + +E + + ++++ + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSR 465
+L ++V E++ SL + + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147
Query: 466 LRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
+ S + +S G + M
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPDA------ 179
Query: 526 FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSY 585
+ + D+ G + ++ + G L+ A + G P++ D + +
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP---LPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPF 234
Query: 586 SRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAF 633
+ V VQ D R + +T++ ++ + +
Sbjct: 235 QISAVA------ARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGP 275
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 40/236 (16%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSKAS----GQGAEE 387
+FE ++V LG G +G+V+ K ++ A+K L KA+ + E
Sbjct: 55 NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 388 FKNE-VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
+ E VL Q LV L + + E K+ L+ +++ L L ++ +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS---QRERFTEHE 160
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+ Y +G I + +LH+ L II+RD+K NILLD+ + ++DFG+++ F D+T+
Sbjct: 161 VQIY--VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 504 GNTSRIVGTYGYMAPE---YAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
GT YMAP+ G +V D +S GVL+ E++TG S F
Sbjct: 216 R-AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDG 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 38/232 (16%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSKAS--GQGAEEFK 389
FE ++V LG+G FG+V+ K +++ A+K L KA+ + K
Sbjct: 25 QFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK 74
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSRR 446
E ++ ++ H +V+L + + E K+ L+ +F+ L L K+ + +
Sbjct: 75 MERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKF 130
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
Y + +A + +LH L II+RDLK NILLD E + K++DFG+++ +D +
Sbjct: 131 Y--LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK-A 183
Query: 507 SRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
GT YMAPE H Q S D +SFGVL+ E++TG F D
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQ-SA--DWWSFGVLMFEMLTGT--LPFQGKD 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 41/237 (17%)
Query: 332 SLQFDFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG 384
+ F ++EV + F+ + +G G G V + +A+K+LS+
Sbjct: 43 KVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---- 98
Query: 385 AEEFKN---------EVVLVAKLQHRNLVRLL------GFCLEGEEKILVYEFVPNKSLD 429
F+N E+VL+ + H+N++ LL E ++ LV E +D
Sbjct: 99 ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MD 150
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
L + Y ++ + GI +LH IIHRDLK SNI++ ++ KI
Sbjct: 151 ANLCQVIQMELDHERMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
DFG+AR G T + V T Y APE + + D++S G ++ E++ K
Sbjct: 207 DFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 40/234 (17%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSKAS----GQGAEE 387
FE + V LG+GG+G+V+ K + +I A+K L KA +
Sbjct: 18 CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWS 444
K E ++ +++H +V L+ + + K+ L+ E++ L L ++G D +
Sbjct: 68 TKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTA 123
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
Y + I+ + +LH+ II+RDLK NI+L+ + + K++DFG+ + D T
Sbjct: 124 CFY--LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178
Query: 505 NTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
+T GT YMAPE + H + +V D +S G L+ +++TG F +
Sbjct: 179 HT--FCGTIEYMAPEILMRSGHNR-AV--DWWSLGALMYDMLTGA--PPFTGEN 225
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 54/266 (20%), Positives = 107/266 (40%), Gaps = 63/266 (23%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFK 389
ES ++ + + KLG G + EV++ + + + +++ VK L ++ K
Sbjct: 26 ESHVVEWGNQD----DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIK 78
Query: 390 NEVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLD------------YFLYD 434
E+ ++ L+ N++ L + + LV+E V N +++Y
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY- 137
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 493
++ + + Y H S I+HRD+K N+++D E ++ D+G+
Sbjct: 138 -----EI------------LKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGKK----- 547
A + Q R+ Y + PE + Q S D++S G ++ +I K+
Sbjct: 178 AEFYHPGQEY--NVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 548 NSNFYQTDGAADLLSYAWKQWRDGTP 573
+ N+ Q A +L GT
Sbjct: 235 HDNYDQLVRIAKVL---------GTE 251
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 38/237 (16%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEE-- 387
+ ++ + + + G +G V GV G +A+KR+ G
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 388 FKN---------EVVLVAKLQHRNLVRLLG----FCLEGEEKI-LVYEFVPNKSLDYFLY 433
+ E+ L+ H N++ L F K+ LV E + L
Sbjct: 67 LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLA 121
Query: 434 DPEKQGQLDWSR---RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
++ S +Y + I G+ LHE ++HRDL NILL + I D
Sbjct: 122 QVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177
Query: 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
F +AR D N + V Y APE M F+ D++S G ++ E+ K
Sbjct: 178 FNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 37/176 (21%)
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ--TQGNTSRIV 510
+A+G+ +L + + IHRDL A NILL + KI DFG+AR D + +R+
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-G-------KKNSNFYQTDGAADLLS 562
+MAPE ++++SDV+SFGVL+ EI + G K + F
Sbjct: 258 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------- 306
Query: 563 YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
++ ++GT ++ D + Y Q L C +P++RP+ + +V L
Sbjct: 307 ---RRLKEGTRMRAPDYTTPEMY---------QTMLDCWHGEPSQRPTFSELVEHL 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 19/174 (10%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SKASGQ 383
E L +D E ++ LG G FG+V + + + +AVK L A+
Sbjct: 8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 384 GAEEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFLYDPEKQGQL 441
+E+ +L+ H N+V LLG C + ++V EF +L +L
Sbjct: 68 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------- 118
Query: 442 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495
S+R + + +G + + I DLK + + + S F +
Sbjct: 119 -RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 46/228 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKA---SGQGAEEF 388
D+E ++V +G G FGEV K + + A+K LSK + F
Sbjct: 70 DYEVVKV----------IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYD---PEKQGQLDWS 444
E ++A +V+L + + + + +V E++P L + + PE W+
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-----KWA 170
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
R Y + + +H + IHRD+K N+LLD + K++DFG +
Sbjct: 171 RFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 505 NTSRIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG 545
VGT Y++PE +G+ D +S GV + E++ G
Sbjct: 226 -CDTAVGTPDYISPEVLKSQGGDGYYGR-EC--DWWSVGVFLYEMLVG 269
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 71/240 (29%), Positives = 108/240 (45%), Gaps = 55/240 (22%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
DF + V LG+G FG+V KG + + AVK L K ++
Sbjct: 21 DFNFLMV----------LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQ----DDD 63
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
V VL + L +L C + +++ V E+V L Y + + G+
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK 119
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFG 498
+ Y IA G+ +L II+RDLK N++LD+E + KI+DFGM + I+
Sbjct: 120 EPHAVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174
Query: 499 VDQTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
T T GT Y+APE Y +G SV D ++FGVL+ E++ G+ + F D
Sbjct: 175 GVTT--KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 225
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 57/241 (23%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
F EV + +G G +G V V +G ++A+K+L + F
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------F 62
Query: 389 KN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------- 431
++ E+ L+ ++H N++ LL F P+++LD F
Sbjct: 63 QSELFAKRAYRELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMP 110
Query: 432 -----LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486
L K +L R ++ + +G+ Y+H IIHRDLK N+ ++ +
Sbjct: 111 FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 167
Query: 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITG 545
KI DFG+AR + T V T Y APE + +++ D++S G ++ E+ITG
Sbjct: 168 KILDFGLARQADSEMTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 546 K 546
K
Sbjct: 223 K 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 53/231 (22%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
DF+ + V +G G + +V K + + A+K + K +
Sbjct: 10 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVND----DED 52
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
+ V H LV L C + E ++ V E+V L + + +Q +L
Sbjct: 53 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 108
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFG 498
+ +R Y I+ + YLHE II+RDLK N+LLD+E + K++D+GM + +
Sbjct: 109 EEHARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163
Query: 499 VDQTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 546
D T +T GT Y+APE +G FSV D ++ GVL+ E++ G+
Sbjct: 164 GDTT--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 45/235 (19%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
+FE I V LG+G FG+V + ++ AVK L K ++V
Sbjct: 24 NFEFIRV----------LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ----DDDVEC 69
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
+L H L +L C + +++ V EFV L + + K +
Sbjct: 70 TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEAR 125
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+R Y I +++LH+ II+RDLK N+LLD E + K++DFGM + +
Sbjct: 126 ARFY--AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 504 GNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
T GT Y+APE ++G +V D ++ GVL+ E++ G + F +
Sbjct: 181 TAT--FCGTPDYIAPEILQEMLYG-PAV--DWWAMGVLLYEMLCGH--APFEAEN 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 49/237 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
DF ++V +G+G FG+V + + AVK L K + K E
Sbjct: 39 DFHFLKV----------IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKH 84
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DW 443
VL+ ++H LV L F + +K+ V +++ L Y L ++
Sbjct: 85 IMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPR 140
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQ 501
+R Y IA + YLH L I++RDLK NILLD++ + ++DFG+ + I
Sbjct: 141 ARFY--AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195
Query: 502 TQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
T +T GT Y+APE + +V D + G ++ E++ G FY +
Sbjct: 196 T--ST--FCGTPEYLAPEVLHKQPYD-RTV--DWWCLGAVLYEMLYGL--PPFYSRN 243
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKA---SGQGAEEF 388
F+ I+ LG G FG V K SG A+K L K + E
Sbjct: 42 QFDRIKT----------LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHT 88
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWSR 445
NE ++ + LV+L F + + +V E+V + L + G+ +R
Sbjct: 89 LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHAR 144
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN 505
Y I YLH L +I+RDLK N+L+D + +++DFG A+ G
Sbjct: 145 FY--AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GR 194
Query: 506 TSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITG 545
T + GT +APE + + + +V D ++ GVL+ E+ G
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNK-AV--DWWALGVLIYEMAAG 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 53/231 (22%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
DF+ + V +G G + +V K + + A++ + K +
Sbjct: 53 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVND----DED 95
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL- 441
+ V H LV L C + E ++ V E+V L + + +Q +L
Sbjct: 96 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 151
Query: 442 -DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFG 498
+ +R Y I+ + YLHE II+RDLK N+LLD+E + K++D+GM + +
Sbjct: 152 EEHARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206
Query: 499 VDQTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 546
D T +T GT Y+APE +G FSV D ++ GVL+ E++ G+
Sbjct: 207 GDTT--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 8e-19
Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 45/235 (19%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
DF + V LG+G FG+V E+ AVK L K ++V
Sbjct: 342 DFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVEC 387
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
VL + L +L C + +++ V E+V L Y + + G+
Sbjct: 388 TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPH 443
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQ 503
IA G+ +L II+RDLK N++LD+E + KI+DFGM + I+ T
Sbjct: 444 AVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT- 499
Query: 504 GNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
T GT Y+APE Y +G SV D ++FGVL+ E++ G+ + F D
Sbjct: 500 -KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 546
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 70/238 (29%), Positives = 106/238 (44%), Gaps = 51/238 (21%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSKASGQGAEEFKNE 391
DF ++ LG+G FG+V +K + Q A+K L K ++
Sbjct: 18 DFILHKM----------LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLM----DDD 60
Query: 392 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLD 442
V VL +H L + + +E + V E++ L Y + + D
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD 116
Query: 443 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVD 500
SR I G+ +LH I++RDLK NILLD + + KI+DFGM + + G
Sbjct: 117 LSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 501 QTQGNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
+T NT GT Y+APE + SV D +SFGVL+ E++ G+ S F+ D
Sbjct: 174 KT--NT--FCGTPDYIAPEILLGQKYN-HSV--DWWSFGVLLYEMLIGQ--SPFHGQD 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 31/228 (13%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEF---KNE 391
+FE +++ LG+G FG+V + A+K L K +E E
Sbjct: 149 EFEYLKL----------LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKII 450
++ +H L L + + +++ V E+ L + L E+ D +R Y
Sbjct: 199 NRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFY--G 254
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIV 510
I + YLH S +++RDLK N++LD + + KI+DFG+ + D T
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FC 310
Query: 511 GTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
GT Y+APE +G+ +V D + GV++ E++ G+ FY D
Sbjct: 311 GTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 353
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSKASGQGAEEFKNEV-- 392
DF+ +++ LG+G FG+V + A+K L K K+EV
Sbjct: 6 DFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILRKEVIIA----KDEVAH 51
Query: 393 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSR 445
VL +H L L + + +++ V E+ L + L E+ + +R
Sbjct: 52 TVTESRVL-QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERAR 108
Query: 446 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR--IFGVDQTQ 503
Y I + YLH +++RD+K N++LD + + KI+DFG+ + I
Sbjct: 109 FY--GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM- 162
Query: 504 GNTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555
T GT Y+APE +G+ +V D + GV++ E++ G+ FY D
Sbjct: 163 -KT--FCGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 209
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 43/234 (18%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEF 388
F E+ + + +G G +G V +G +AVK+LS+ F
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------F 66
Query: 389 KN---------EVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLY 433
++ E+ L+ ++H N++ LL LE + LV + L
Sbjct: 67 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLN 121
Query: 434 DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493
+ K +L +I I RG+ Y+H IIHRDLK SN+ ++ + KI DFG+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
AR + T V T Y APE + ++ D++S G ++ E++TG+
Sbjct: 179 ARHTADEMTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 40/244 (16%), Positives = 93/244 (38%), Gaps = 61/244 (25%)
Query: 311 AKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSG 369
++++ + ++ ++ D++ +++ + +G G +G V +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQI----PDRYEIRHLIGTGSYGHVCEAYDKLEK 78
Query: 370 QEIAVKRLSKASGQGAEEFKN---------EVVLVAKLQHRNLVRLLGFC----LEGEEK 416
+ +A+K++ + F++ E+ ++ +L H ++V++L +E ++
Sbjct: 79 RVVAIKKILRV-------FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131
Query: 417 I-LVYEFVP---------NKSLD-----YFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
+ +V E L LY + G+ Y+H
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLY------N------------LLVGVKYVH 173
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
S I+HRDLK +N L++ + + K+ DFG+AR + + I M
Sbjct: 174 --SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 522 MHGQ 525
H +
Sbjct: 231 PHTK 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 45/224 (20%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSKAS----GQGAEE 387
DF+ + LG G FG V+ + +G+ A+K L K Q E
Sbjct: 7 DFQILRT----------LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQ-VEH 52
Query: 388 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQL--DWS 444
+E ++++ + H ++R+ + ++I ++ +++ L L K + +
Sbjct: 53 TNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVA 108
Query: 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504
+ Y + + YLH II+RDLK NILLD + KI+DFG A+
Sbjct: 109 KFY--AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----D 158
Query: 505 NTSRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITG 545
T + GT Y+APE + + S+ D +SFG+L+ E++ G
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNK-SI--DWWSFGILIYEMLAG 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 44/230 (19%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVV 393
+++ LG GG G V+ V + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 394 LVAKLQHRNLVRLL--------------GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
++ +L H N+V++ G E +V E+ ++ L + +QG
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG 115
Query: 440 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFG 498
L + + RG+ Y+H + ++HRDLK +N+ ++ E + KI DFG+ARI
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 499 VDQTQGNT-SRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 546
+ S + T Y +P + ++ D+++ G + E++TGK
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 53/248 (21%), Positives = 98/248 (39%), Gaps = 70/248 (28%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN------ 390
+ ++ F + LGEG +G V P+G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 391 ---EVVLVAKLQHRNLVRLL-----GFCLEGEEKILVYEFVP--------NKSLD----- 429
E+ ++ +H N++ + E ++ E + + L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 430 YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489
YF+Y Q R + LH + +IHRDLK SN+L+++ + K+
Sbjct: 116 YFIY------Q------------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154
Query: 490 DFGMARIFGVDQTQGNTSRIVGTYGYM----------APEYAM-HGQFSVKSDVYSFGVL 538
DFG+AR +D++ + S G M APE + ++S DV+S G +
Sbjct: 155 DFGLAR--IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212
Query: 539 VLEIITGK 546
+ E+ +
Sbjct: 213 LAELFLRR 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 52/240 (21%), Positives = 103/240 (42%), Gaps = 59/240 (24%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN----- 390
+ +++ + +GEG +G V + +A+K++S F++
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70
Query: 391 ----EVVLVAKLQHRNLVRLLGF----CLEGEEKI-LVYEF--------VPNKSLD---- 429
E+ ++ + +H N++ + +E + + +V + + + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 430 -YFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488
YFLY Q I RG+ Y+H + ++HRDLK SN+LL+ + KI
Sbjct: 131 CYFLY------Q------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 169
Query: 489 SDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 546
DFG+AR+ D + V T Y APE + ++ D++S G ++ E+++ +
Sbjct: 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 57/211 (27%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN---------EVV 393
+ + + +G G +G VY + + +A+K++++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77
Query: 394 LVAKLQHRNLVRLLGFCL-----EGEEKILVYEFVP---------NKSLD-----YFLYD 434
++ +L+ ++RL + + +E +V E L LY
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136
Query: 435 PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494
+ G ++HE IIHRDLK +N LL+ + + K+ DFG+A
Sbjct: 137 -----N------------LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
R ++ + + + Q
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 36/161 (22%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEV-VLVAKLQHRNLVRLLGF 409
LG G G+V + + ++ A+K L + + EV + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 410 C---LEGEEKI-LVYEFVP---------NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
G + + +V E + ++ F E++ +I+ I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREAS-------EIMKSIGEA 129
Query: 457 ILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMA 494
I YLH + I HRD+K N+L K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 74/255 (29%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN------ 390
K+ KLG+G +G V+K + +G+ +AVK++ A F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54
Query: 391 ---EVVLVAKLQ-HRNLVRLLG-FCLEGEEKI-LVYEFVP--------NKSLD-----YF 431
E++++ +L H N+V LL + + + LV++++ L+ Y
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV 114
Query: 432 LYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491
+Y Q + + I YLH S ++HRD+K SNILL+AE + K++DF
Sbjct: 115 VY------Q------------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADF 153
Query: 492 GMARIFGVDQTQGNTSRI-------------------VGTYGYMAPEYAM-HGQFSVKSD 531
G++R F + N + V T Y APE + +++ D
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213
Query: 532 VYSFGVLVLEIITGK 546
++S G ++ EI+ GK
Sbjct: 214 MWSLGCILGEILCGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 64/270 (23%), Positives = 104/270 (38%), Gaps = 63/270 (23%)
Query: 306 FLRRKAKKKYNAVPESNADNDLTTLESLQFDFETI--EVATNKFSTDNKLGEGGFGEVYK 363
F + KK V D+D +D+ E +++ D+ +G+G FG+V K
Sbjct: 20 FQSMSSHKKERKVYNDGYDDD-------NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVK 72
Query: 364 GV-LPSGQEIAVK------RLSKASGQGAEEFKNEVVLVAKLQHR------NLVRLLGF- 409
+ +A+K + + EV L+ + +V L
Sbjct: 73 AYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLELMNKHDTEMKYYIVHLKRHF 125
Query: 410 ------CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ-----LDWSRRYKIIGGIARGIL 458
CL V+E L Y LYD + L+ +R++ + +L
Sbjct: 126 MFRNHLCL-------VFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQ--QMCTALL 171
Query: 459 YLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+L L IIH DLK NILL KI DFG + G Q SR Y
Sbjct: 172 FLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YR 225
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+PE + + + D++S G +++E+ TG+
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 51/223 (22%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ----------- 399
KLG G F V+ + + +A+K + + E ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 400 HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYDPEKQGQLDWSRRY--KIIGGI 453
++++LL F +G + +V+E L L K+ + R + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYE---HRGIPLIYVKQI 136
Query: 454 ARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------KISDFGMARIFGVDQTQ 503
++ +L Y+H R IIH D+K N+L++ +P KI+D G A + T
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+R Y +PE + + +D++S L+ E+ITG
Sbjct: 195 SIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 8e-14
Identities = 37/253 (14%), Positives = 73/253 (28%), Gaps = 55/253 (21%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--------SKASGQGAEEFKNEVV 393
+ T K K+GEG FGEV++ + +A+K + + + + EE E++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 394 LVAKLQ---------HRNLVRLLGFCL-------------------EGEEKILVYEFVPN 425
+ +L + L +G F +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 426 KSLDYFLYDP-------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478
+ ++ + + I+ + + LR HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538
LL K+ + + + V Y G V+ +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI----PSCGLQVSIIDYTLSRLERDGIV-----VFCDVSM 244
Query: 539 VLEIITGKKNSNF 551
++ TG + F
Sbjct: 245 DEDLFTGDGDYQF 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 66/365 (18%), Positives = 122/365 (33%), Gaps = 107/365 (29%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ 399
++ ++ KLG G F V+ + + +A+K + K++ E +E+ L+ ++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVR 91
Query: 400 --------HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYDPEKQG-QLDWSRR 446
+V+LL F + G +V+E V L ++ QG L ++
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----------------------- 483
II + +G+ YLH ++ RIIH D+K NILL
Sbjct: 151 --IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 484 --------------------------MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
+ KI+D G A T+ + T Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRS 261
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGK------KNSNFYQTD----------GA--AD 559
E + ++ +D++S + E+ TG + + + G
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321
Query: 560 LLSYA------------WKQWRDGTPLQLLDTNLTDSY--SRNEVIRCIQLGLLCVQEDP 605
L+ K P L + L + Y S+ E L ++ P
Sbjct: 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV-LVEKYEWSQEEAAGFTDFLLPMLELIP 380
Query: 606 AERPS 610
+R +
Sbjct: 381 EKRAT 385
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 52/231 (22%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK------RLSKASGQGAEEFKNEVV 393
+ ++ +G+G FG+V K Q +A+K R + + E+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIR 145
Query: 394 LVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
++ L+ + N++ +L C+ +E L LY+ K+ +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICM-------TFE-----LLSMNLYELIKKNK 193
Query: 441 ---LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMAR 495
K I + + LH + RIIH DLK NILL + K+ DFG +
Sbjct: 194 FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
Q + + Y APE + ++ + D++S G ++ E++TG
Sbjct: 251 Y--EHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 37/197 (18%), Positives = 68/197 (34%), Gaps = 28/197 (14%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI------AVKRLSKASGQGAEEFKNEVVLVAKL 398
+ +G+GGFG +Y + S + + VK +G E K
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYDPEKQGQLDWSRR---YKII 450
Q + +R G K Y + + Q + + + K +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 451 GGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARIFGVDQT-- 502
++ IL Y+HE +H D+KASN+LL+ + ++ D+G+A + +
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 503 ---QGNTSRIVGTYGYM 516
GT +
Sbjct: 212 AYAADPKRCHDGTIEFT 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 34/194 (17%), Positives = 68/194 (35%), Gaps = 25/194 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIA---VKRLSKASGQGAEEFKNEVVLVAKLQH 400
N++ K+G GGFG +Y ++ A VK + +G E K + K
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYDPEKQGQLDWSRRY--KIIGGI 453
+ + G K Y + Q + + + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 454 ARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARIFGVDQT----- 502
+L Y+HE+ +H D+KA+N+LL + ++ +D+G++ + +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 503 QGNTSRIVGTYGYM 516
+ GT +
Sbjct: 214 ENPRKGHNGTIEFT 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 34/205 (16%), Positives = 69/205 (33%), Gaps = 44/205 (21%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV---------LPSGQEIAVKRLSKASGQGAEEFKNEVVLV 395
++ + G +Y+ P Q+ ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 396 AKLQHRNLVRL-----LGF-------CLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLD 442
LQ +L L + + + LV + +SL P+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE- 158
Query: 443 WSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMARI 496
+ + +A +L +LHE+ +H ++ A NI +D E ++ + +G A
Sbjct: 159 -----RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 497 F-----GVDQTQGNTSRIVGTYGYM 516
+ V +G+ S G ++
Sbjct: 211 YCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 27/170 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-RN 402
N++ K+G G FG++Y G + +G+E+A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRY--KIIGGIARGIL- 458
+ + EG+ ++V E + SL D F R++ K + +A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLF----NFCS-----RKFSLKTVLLLADQMIS 116
Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMARIFGVDQT 502
Y+H + IHRD+K N L+ I DFG+A+ + +T
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 33/169 (19%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHR 401
+ ++GEG FG +++G L + Q++A+K + S Q +E++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR---TYKLLAGCT 66
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGI 457
+ + F EG +LV + + SL D D R K + A+ +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLEDLL----------DLCGRKFSVKTVAMAAKQM 115
Query: 458 L----YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMARIF 497
L +HE S +++RD+K N L+ + + DFGM + +
Sbjct: 116 LARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 38/167 (22%), Positives = 63/167 (37%), Gaps = 29/167 (17%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
F K+G G FGE+ G L + + +A+K S + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGI 67
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGIL- 458
++ F G+ +V E + SL D F D R K + IA ++
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLIS 116
Query: 459 ---YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMARIF 497
Y+H + +I+RD+K N L+ N I DF +A+ +
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
NKF K+G G FGE+Y G + + +E+A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 404 V-RLLGFCLEGEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRR---YKIIGGIARGIL 458
+ + F +EG+ +LV + + SL D F ++ R K + +A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLF----------NFCSRKLSLKTVLMLADQMI 113
Query: 459 ----YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMARIFGVDQTQG-----NT 506
++H S +HRD+K N L+ I DFG+A+ + T
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 507 SRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGK 546
+ GT Y A G S + D+ S G +++ + G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 46/252 (18%), Positives = 91/252 (36%), Gaps = 76/252 (30%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVK------RLSKASGQGAEEFKNEV 392
+ ++ LGEG FG+V + + ++A+K + +A+ + E+
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEI 67
Query: 393 VLVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
++ K++ + V + + C+ +E L ++ K+
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKEN 115
Query: 440 QLDWSRRYKI--IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------- 486
+ Y + + +A + +LHE ++ H DLK NIL
Sbjct: 116 NF---QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 487 ------------KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYS 534
+++DFG A F + + IV T Y PE + ++ DV+S
Sbjct: 170 SCEEKSVKNTSIRVADFGSA-TF-DHEHH---TTIVATRHYRPPEVILELGWAQPCDVWS 224
Query: 535 FGVLVLEIITGK 546
G ++ E G
Sbjct: 225 IGCILFEYYRGF 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 4e-07
Identities = 54/339 (15%), Positives = 104/339 (30%), Gaps = 118/339 (34%)
Query: 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-------RN 402
D + GE + YK +L ++ V + ++ ++ ++ H +
Sbjct: 8 DFETGEHQYQ--YKDILSVFEDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSL--DY-FLYDPEKQGQLDWSRRYKIIGGIARGILY 459
L + L +++ +V +FV + L +Y FL P K Q S + +Y
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFV-EEVLRINYKFLMSPIKTEQRQPSMMTR---------MY 112
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ-----TQGNTSRIVGTYG 514
+ + RL + D N + + ++R+ + + ++ V G
Sbjct: 113 IEQRDRL---YND------------NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEI-----ITGKKNSNFYQTDGAADLLSYAWKQWR 569
+ G S K+ + L++ + K + + W
Sbjct: 158 -------VLG--SGKT------WVALDVCLSYKVQCKMDFKIF------------W---- 186
Query: 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDP--AERPS-MATIVLMLNSY----S 622
NL + S V+ L L Q DP R + I L ++S
Sbjct: 187 ---------LNLKNCNSPETVL--EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 623 VTLPSPQQP----------------AFFIGSR---TERD 642
L S AF + + T R
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 60/261 (22%), Positives = 93/261 (35%), Gaps = 90/261 (34%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK------RLSKASGQGAEEFKNEVV 393
+ N F K+G+G FG V + + + AVK + ++++ K E
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEAD 83
Query: 394 LVAKLQHR-----NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQL 441
++ K+Q+ N+V+ G CL ++E L LY+
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYE------- 124
Query: 442 DWSRRYKIIG-------GIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP---- 486
R G IL YL + + + H DLK NILLD
Sbjct: 125 -IITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLI 180
Query: 487 ---------------------KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ 525
K+ DFG A F I+ T Y APE ++
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCA-TF-KSDYH---GSIINTRQYRAPEVILNLG 235
Query: 526 FSVKSDVYSFGVLVLEIITGK 546
+ V SD++SFG ++ E+ TG
Sbjct: 236 WDVSSDMWSFGCVLAELYTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 57/252 (22%), Positives = 97/252 (38%), Gaps = 76/252 (30%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGV--LPSGQEIAVK------RLSKASGQGAEEFKNEV 392
+V + ++ + LGEG FG+V + + G+ +AVK R +A+ ++E+
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEI 62
Query: 393 VLVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYDPEKQG 439
++ L V++L + C +V+E L YD K+
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKEN 110
Query: 440 QLDWSRRYKI--IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------- 486
+++ I +A I +LH ++ H DLK NIL
Sbjct: 111 GF---LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 487 ------------KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYS 534
K+ DFG A + D+ S +V T Y APE + +S DV+S
Sbjct: 165 KRDERTLINPDIKVVDFGSA-TY-DDEHH---STLVSTRHYRAPEVILALGWSQPCDVWS 219
Query: 535 FGVLVLEIITGK 546
G +++E G
Sbjct: 220 IGCILIEYYLGF 231
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 36/203 (17%), Positives = 64/203 (31%), Gaps = 37/203 (18%)
Query: 307 LRRKAKKKYNAVPESNADNDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL 366
+ + +K Y + L +L L + + +GEG V+
Sbjct: 59 VVQNRQKDYEGSTFTFIGLSLYSLHRLVRSGKVDAI-------GKLMGEGKESAVFNCYS 111
Query: 367 PSGQEIAVK--RLSKAS--------GQGAEEFKNEVVLVAKLQHRNLVRLLGFC----LE 412
E VK ++ S G F + A+ + R L +L G
Sbjct: 112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 171
Query: 413 GEEKILVYEFVPNKSL-DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
E ++ E + K L + +P++ +I + I+H
Sbjct: 172 WEGNAVLMELIDAKELYRVRVENPDEV--------LDMILEEVAKFYHRG------IVHG 217
Query: 472 DLKASNILLDAEMNPKISDFGMA 494
DL N+L+ E I DF +
Sbjct: 218 DLSQYNVLVSEEG-IWIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 674 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.94 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.88 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.46 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.45 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.41 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.7 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.6 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.0 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.69 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 80.42 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=448.99 Aligned_cols=262 Identities=30% Similarity=0.472 Sum_probs=216.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|.+.++||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467888999999999999999853 46789999998777777788999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCC----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 418 LVYEFVPNKSLDYFLYDPE----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
||||||++|+|.++|+... ....++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996421 2356999999999999999999999987 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |+.|+... ...+++.....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~---~~~~~~~~i~~ 245 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNEVIECITQ 245 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHHHHHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHc
Confidence 999999987654443333444679999999999999999999999999999999999 89886432 22233332222
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
+... ..+...+..+.+|+.+||+.||++||||+||+++|++....
T Consensus 246 ----~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 ----GRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 11233445788999999999999999999999999876433
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=450.46 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=207.5
Q ss_pred hcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778899999999999999853 47889999998877777788999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCC------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC
Q 005846 418 LVYEFVPNKSLDYFLYDPE------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~ 485 (674)
||||||++|+|.++++... ....++|.+++.|+.||++||.|||+.+ |+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999986532 2346999999999999999999999987 999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYA 564 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~ 564 (674)
+||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.|+... ...+++..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~---~~~~~~~~i 273 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL---SNTEAIDCI 273 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS---CHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC---CHHHHHHHH
Confidence 99999999997754444444455689999999999999999999999999999999999 89886432 222333322
Q ss_pred HhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 565 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
... ... ..+...+..+.+|+.+||+.||++||||.||+++|+...
T Consensus 274 ~~g----~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 274 TQG----REL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHT----CCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcC----CCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 221 111 112233457889999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=445.70 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=213.3
Q ss_pred cCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667789999999999999862 46789999997543 345678999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC
Q 005846 418 LVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~ 484 (674)
||||||++|+|.++|.... ....++|.+++.|+.|||+||.|||+.+ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999986432 1346999999999999999999999987 99999999999999999
Q ss_pred CeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHH
Q 005846 485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSY 563 (674)
Q Consensus 485 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~ 563 (674)
++||+|||+++...............||++|||||++.++.|+.++|||||||+||||+| |+.|+... ...+++..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~---~~~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC---CHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---CHHHHHHH
Confidence 999999999987754444444556789999999999999999999999999999999999 78886432 22233332
Q ss_pred HHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 564 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
+. .+... ..+...+..+.+|+.+||+.||++||||.||++.|+...
T Consensus 260 i~----~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 IR----NRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HH----TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HH----cCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22 22111 123334557889999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=443.90 Aligned_cols=268 Identities=27% Similarity=0.446 Sum_probs=208.0
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++..+++.+.++||+|+||+||+|++.+ .||||+++.. .....+.|.+|+.++++++|||||+++|++.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4455788899999999999999999753 5999998643 33446789999999999999999999998865 56899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|||||++|+|.++++. ....++|.+++.|+.|||+||.|||+++ ||||||||+||||++++.+||+|||+|+...
T Consensus 109 VmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999999864 3456999999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCCCCccccccccCCccCcccccc---CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.... ....+.............
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~--~~~~~~~~~~~~~~~p~~-- 259 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN--NRDQIIFMVGRGYASPDL-- 259 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHTTCCCCCS--
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC--hHHHHHHHHhcCCCCCCc--
Confidence 4443344456789999999999863 469999999999999999999999974321 111111112111111111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPS 627 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 627 (674)
...+...+..+.+|+.+||+.||++||||.||++.|+.+...+|+
T Consensus 260 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 260 -------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp -------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred -------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 112233445788999999999999999999999999876655554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=439.90 Aligned_cols=273 Identities=27% Similarity=0.405 Sum_probs=221.3
Q ss_pred cccccchhhHHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCC-Cc
Q 005846 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQH-RN 402 (674)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h-~n 402 (674)
+.+.++...+++..++|++.++||+|+||+||+|.+. .++.||||++..... ...+.|.+|+.+|.+++| ||
T Consensus 50 ~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence 3456677788888999999999999999999999853 235799999976443 345679999999999965 89
Q ss_pred eeeEEeEEEeC-CeeEEEEEecCCCcccccccCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 005846 403 LVRLLGFCLEG-EEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (674)
Q Consensus 403 iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 468 (674)
||+++|+|.+. +..+||||||++|+|.++|+.... ...++|.+++.++.|||+||.|||+++ |
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 99999999764 568999999999999999864321 345899999999999999999999988 9
Q ss_pred EEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCC
Q 005846 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547 (674)
Q Consensus 469 iHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~ 547 (674)
|||||||+||||++++.+||+|||+++.+..+..........||+.|||||++.+..|+.++|||||||+||||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 9999999999999999999999999997765544444556789999999999999999999999999999999998 898
Q ss_pred CCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 548 NSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 548 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
|+..... ...+... ...+... ..+...+..+.+++.+||+.||++||||.||+++|++.
T Consensus 287 Pf~~~~~--~~~~~~~----i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 287 PYPGVKI--DEEFCRR----LKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SSTTCCC--SHHHHHH----HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCH--HHHHHHH----HHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 8643221 1112222 2222111 12223345788999999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=427.46 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=208.7
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+.|+..++||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5689999999999999999996 468999999997666566677899999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++|+|.+++. ...+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 9999999884 346999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.. ....+.+..+... ....+
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~~----~~~~~------- 290 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDN----LPPRL------- 290 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHS----SCCCC-------
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHcC----CCCCC-------
Confidence 234457899999999999999999999999999999999999999742 2222232222211 11110
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223457889999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=427.85 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=201.7
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.++||+|+||+||+++. .+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999985 46899999999754 23345779999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
||+||+|.+++.. .+...+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999999853 23456899999999999999999999998 999999999999999999999999999875321
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||.. ....+++. +......+
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~---~i~~~~~~-------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVL---KIISGSFP-------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHH---HHHHTCCC--------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHH---HHHcCCCC--------
Confidence 1123456899999999999999999999999999999999999999743 22222222 22222111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+|+.+||+.||++|||++|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223456889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=426.19 Aligned_cols=253 Identities=25% Similarity=0.304 Sum_probs=205.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.+.|++.++||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35688889999999999999995 4689999999976432 25799999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccccCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGVDQ 501 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~~~~~ 501 (674)
|+||+|.+++. +.+.+++.++..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++.+..+.
T Consensus 132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999994 3457999999999999999999999988 99999999999999987 69999999999875432
Q ss_pred CCC---ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 502 TQG---NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 502 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ..++..+.. ...+.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~---~~~~~---- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR---GPLCLKIAS---EPPPI---- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC---SCCHHHHHH---SCCGG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHc---CCCCc----
Confidence 221 22346799999999999999999999999999999999999999753222 222222211 11110
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++.+||+.||++|||+.||++.|...
T Consensus 276 ----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 ----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp ----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 112233445788999999999999999999999988654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=421.04 Aligned_cols=267 Identities=23% Similarity=0.286 Sum_probs=200.0
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----eeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 420 (674)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 6899999999654322 222345666677899999999999998754 579999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
|||++|+|.++++ ...++|..+++++.|+++||+|||++ ..++|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999994 34699999999999999999999986 23359999999999999999999999999998
Q ss_pred ccCCCCCC--CccccccccCCccCccccccC------CCCccccEEeechhhhHhHhCCCCCCccCCCC--------ccc
Q 005846 496 IFGVDQTQ--GNTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG--------AAD 559 (674)
Q Consensus 496 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~--------~~~ 559 (674)
........ ......+||+.|||||++.+. .++.|+|||||||+||||+||++|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543322 123346899999999998754 47789999999999999999987754322111 011
Q ss_pred hHHHHHhhhcCCCcceecccccCCC-CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 560 LLSYAWKQWRDGTPLQLLDTNLTDS-YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
............. +++.+... .+.+....+.+|+.+||+.||++||||.||+++|+.+
T Consensus 237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111221111111 11111111 1234566788999999999999999999999999764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=418.68 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=209.8
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||+||+++. .+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999985 47899999999753 2345678999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||++||+|.+++. +.+.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999984 4467999999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.........+||+.|||||++.+..|+.++||||+||++|||+||+.||.. .....++..+.. . ..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~---~-~~------- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEGLIFAKIIK---L-EY------- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH---T-CC-------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHc---C-CC-------
Confidence 544555667999999999999999999999999999999999999999742 222223222221 1 11
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl 615 (674)
.++......+.+|+.+||+.||++|||++|++
T Consensus 252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222345688999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=428.84 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=209.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46799999999999999999996 46899999999876666667789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
|+||+|.+++. ...+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999999884 346999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.. ....+.+..+... ....+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~~----~~~~~------ 367 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDN----LPPRL------ 367 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHS----CCCCC------
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHcC----CCCCC------
Confidence 234457899999999999999999999999999999999999999742 2222222222211 11111
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011123356889999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=408.78 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=196.5
Q ss_pred CcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCeeEEEE
Q 005846 348 STDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVY 420 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 420 (674)
+..++||+|+||+||+|.+ .++..||+|++... .....+.|.+|+.++++++|||||++++++.. +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5677899999999999985 46889999998653 33345679999999999999999999999865 34579999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~~~~~ 499 (674)
|||++|+|.+++. +...+++..+..|+.||+.||.|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999994 3467999999999999999999999875 45999999999999984 79999999999986432
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
......+||+.|||||++.+ +|+.++|||||||++|||+||+.||... ..... .......+.....
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~--~~~~~----~~~~i~~~~~~~~--- 250 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQ----IYRRVTSGVKPAS--- 250 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHH----HHHHHTTTCCCGG---
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC--CcHHH----HHHHHHcCCCCCC---
Confidence 23345689999999998864 6999999999999999999999997421 11111 2222222211111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
++......+.+|+.+||+.||++|||+.|+++
T Consensus 251 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122346789999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=400.46 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=189.9
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||+||+++. .+|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999985 468999999996532 334567899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+ +|+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 678877774 3467999999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.. .....+..... .+..
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~---~~~~~~~~~i~----~~~~------ 229 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD---ESIPVLFKNIS----NGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHH----HTCC------
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHH----cCCC------
Confidence 22345689999999999988876 5799999999999999999999742 22222222221 1111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.++......+.+|+.+||+.||++|||++|+++
T Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112223356789999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=408.19 Aligned_cols=247 Identities=26% Similarity=0.293 Sum_probs=196.0
Q ss_pred cCCCcccccccCCcEEEEEeec----CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++|++.+.||+|+||+||+++. ..++.||||++++.. ......+.+|+.+|++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4799999999999999999974 246789999996532 2223467899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||++||+|.+++. +.+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 4567999999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..+++....+ . ..
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~---~-~~----- 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMILK---A-KL----- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH---C-CC-----
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC---cCHHHHHHHHHc---C-CC-----
Confidence 322 233456899999999999999999999999999999999999999742 222223322221 1 10
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
.++......+.+|+.+||+.||++||| ++|+++
T Consensus 244 -----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112223456889999999999999998 466653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=399.87 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=188.7
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--------
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-------- 414 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 414 (674)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999985 4689999999975433 34567899999999999999999999987644
Q ss_pred ----eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 415 ----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 415 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
..++||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965444445677889999999999999999998 99999999999999999999999
Q ss_pred eCCccccCCCCCCC----------ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccch
Q 005846 491 FGMARIFGVDQTQG----------NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADL 560 (674)
Q Consensus 491 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~ 560 (674)
||+++.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ |+.. ..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 99998875432211 2234579999999999999999999999999999999996 4321 1111
Q ss_pred HHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 561 l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.... .......... ........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~-~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTL-TDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1111111111 01122335678999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=390.20 Aligned_cols=285 Identities=35% Similarity=0.613 Sum_probs=245.2
Q ss_pred ccchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
.+++.+++..+++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 44555666788999999999999999999999888999999999877666678899999999999999999999999999
Q ss_pred CeeEEEEEecCCCcccccccCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999864322 235999999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+++...............||+.|+|||.+.+..++.++||||||+++|||++|+.|+.............+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99875433333333445789999999999999999999999999999999999999876555555566666655566666
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+++.+....+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6667777777777788889999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=395.77 Aligned_cols=262 Identities=21% Similarity=0.315 Sum_probs=201.2
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe------CCe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE 415 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~ 415 (674)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999985 479999999997543 2334678899999999999999999998764 357
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+||||||+ |+|.+++. +.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 66878774 4567999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCC--CCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 496 IFGVDQ--TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 496 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.. ....+.+..+........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g---~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG---KNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC---SSHHHHHHHHHHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC---CCHHHHHHHHHHhcCCCC
Confidence 764322 12234457899999999998875 469999999999999999999999743 223333333332222111
Q ss_pred cceecc----------cccC--CCCC-----hhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLD----------TNLT--DSYS-----RNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d----------~~~~--~~~~-----~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...... ..+. ...+ ......+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 100000 0000 0000 112346789999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=387.74 Aligned_cols=198 Identities=22% Similarity=0.353 Sum_probs=170.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeec----CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
...++|++.++||+|+||+||+|+. ..++.||||++.... ...++.+|+++|..+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4567899999999999999999974 246789999986543 345688999999998 699999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC-CCeEEeeeCCcc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAR 495 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~ki~DfGla~ 495 (674)
+|||||+++|+|.+++ +.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999887 24899999999999999999999998 9999999999999877 799999999998
Q ss_pred ccCCCCCC--------------------------CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCC
Q 005846 496 IFGVDQTQ--------------------------GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 496 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
........ ......+||+.|||||++.+. .|+.++||||+||++|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432110 112345799999999999875 589999999999999999999999
Q ss_pred CC
Q 005846 549 SN 550 (674)
Q Consensus 549 ~~ 550 (674)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 63
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=382.72 Aligned_cols=290 Identities=40% Similarity=0.708 Sum_probs=244.4
Q ss_pred ccccchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
...+++.+++...++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345788999999999999999999999999999988899999999875432 2233689999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEe
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~ 489 (674)
...+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 23459999999999999999999999822239999999999999999999999
Q ss_pred eeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC--CCCccchHHHHHhh
Q 005846 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ--TDGAADLLSYAWKQ 567 (674)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~--~~~~~~~l~~~~~~ 567 (674)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.... .........+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987643322 22334569999999999999999999999999999999999999975322 23334455566666
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
........+.+..+...++......+.+++.+||+.||++|||+.||+++|+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 6666667777777777888888999999999999999999999999999998743
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=400.85 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=208.3
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.+.||+|+||+||+++. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999985 46899999999876666677889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC--CCeEEeeeCCccccCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMARIFGVD 500 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~--~~~ki~DfGla~~~~~~ 500 (674)
|+||+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999888843 3456999999999999999999999998 9999999999999854 89999999999986432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.. ....+.+..+.. . .. . ++..
T Consensus 311 ---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~---~~~~~~~~~i~~---~-~~-~-~~~~ 378 (573)
T 3uto_A 311 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKS---C-DW-N-MDDS 378 (573)
T ss_dssp ---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHHHHT---T-CC-C-CCSG
T ss_pred ---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHh---C-CC-C-CCcc
Confidence 223456899999999999999999999999999999999999999742 222222222211 1 10 0 0111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. .......+.+|+.+||+.||++|||+.|+++
T Consensus 379 ~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 A----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp G----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1122346789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=399.58 Aligned_cols=249 Identities=25% Similarity=0.309 Sum_probs=199.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHH---HHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
-++|++.+.||+|+||+||+++. .+|+.||||++.+.. ......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 35799999999999999999995 468999999996531 222233334 45666777999999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+|||||++||+|..++. +.+.+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999984 4567999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
+... .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+...+.. ......
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~---- 410 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMA---- 410 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCC----
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCC----
Confidence 6432 2345689999999999975 579999999999999999999999985432222211111 111111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
..++......+.+|+.+||+.||.+|++ ++||++
T Consensus 411 -------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122233457889999999999999998 677764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.75 Aligned_cols=283 Identities=38% Similarity=0.574 Sum_probs=228.1
Q ss_pred ccccchhhHHHhhcCCCcc------cccccCCcEEEEEeecCCCceeEEEEecccC----ccCHHHHHHHHHHHHhcCCC
Q 005846 332 SLQFDFETIEVATNKFSTD------NKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHR 401 (674)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~ 401 (674)
...|.+.++..++++|... ++||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568889999999999887 8999999999999998 68899999986532 23357789999999999999
Q ss_pred ceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc
Q 005846 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (674)
Q Consensus 402 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~ 481 (674)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999865555567999999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 482 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+......... .
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--L 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--T
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--H
Confidence 999999999999987654333323344678999999998764 5899999999999999999999987643332211 1
Q ss_pred HHHHhhhcC-CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 562 SYAWKQWRD-GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 562 ~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.+....... ......++..+ ...+......+.+++..||+.||.+|||+.+|+++|++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111111 11122222222 2345567778999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=371.39 Aligned_cols=273 Identities=29% Similarity=0.421 Sum_probs=206.6
Q ss_pred chhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 336 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
....+++..++|++.++||+|+||.||+++. +|+.||||++.... ....+++.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344556677899999999999999999987 68899999986543 33346789999999999999999999999999
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
+..++||||+++++|.+++........+++..++.++.||++||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 999999999999999999865433345999999999999999999999875 3499999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.... ..+....... ....
T Consensus 186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~~~~---~~~~ 257 (309)
T 3p86_A 186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGF---KCKR 257 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHHH---SCCC
T ss_pred Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh---cCCC
Confidence 97643221 22334579999999999999999999999999999999999999974321 1111111110 1111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCC
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPS 627 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 627 (674)
...+......+.+++.+||+.||++|||+.+|++.|+.......+
T Consensus 258 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 258 ---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 111223345688999999999999999999999999886554433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.20 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=208.3
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
..++|++.++||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 356899999999999999999984 5789999999977666667889999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999884 236999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+... .....+ ..........
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~---~~~~~~~~~~------- 235 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE---NPLRAL---YLIATNGTPE------- 235 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHH---HHHHHHCSCC-------
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHH---HHHHhCCCCC-------
Confidence 2 233467999999999999999999999999999999999999997422 111111 1111111110
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112233456889999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.78 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=211.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|.+.++||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35788999999999999999996 46889999999776667778899999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999853 2456999999999999999999999998 99999999999999999999999999987643322
Q ss_pred CC------------ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccc--hHHHHHhhh
Q 005846 503 QG------------NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD--LLSYAWKQW 568 (674)
Q Consensus 503 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~--~l~~~~~~~ 568 (674)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+.......... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~---- 239 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF---- 239 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----
Confidence 11 1114579999999999999999999999999999999999998865432221110 00000
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
.+.. .+......+.+++.+||+.||++|||+.++++.|+.....
T Consensus 240 --------~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 --------LDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp --------HHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 1112223577899999999999999999999999875433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=369.25 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=211.9
Q ss_pred hhcCCCcccccccCCcEEEEEeec--------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE 412 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 412 (674)
..++|++.+.||+|+||.||++.+ .++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 457899999999999999999974 235579999997643 33456789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEE
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIl 479 (674)
.+..++||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999986432 1245899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCcc
Q 005846 480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAA 558 (674)
Q Consensus 480 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~ 558 (674)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.|+... ...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~---~~~ 312 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---PVE 312 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CGG
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC---CHH
Confidence 99999999999999987654443334444567889999999999999999999999999999999 88886432 222
Q ss_pred chHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
++........ . ...+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 313 ~~~~~~~~~~----~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 ELFKLLKEGH----R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GHHHHHHTTC----C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCC----C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2322222111 1 111223345788999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=367.32 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=207.4
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----eeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~l 418 (674)
..++|++.++||+|+||.||+|++. ++.||||++..... ....+..|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3468999999999999999999984 79999999965432 2345567999999999999999999998754 4699
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCcEEEeecccccEEEcCCCCeEE
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED----------SRLRIIHRDLKASNILLDAEMNPKI 488 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~~~~iiHrDlkp~NIll~~~~~~ki 488 (674)
||||+++|+|.+++. ...+++..++.++.||++||.|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 999999999999984 34599999999999999999999987 6 999999999999999999999
Q ss_pred eeeCCccccCCCCCCCccccccccCCccCccccccC-----CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHH-
Q 005846 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS- 562 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~- 562 (674)
+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||+||+.|+.............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999887655444444456799999999999763 46678999999999999999999975433221111110
Q ss_pred --------HHHhhhcCCCcceecccccCCC-CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 563 --------YAWKQWRDGTPLQLLDTNLTDS-YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 563 --------~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
........... .+.+... ........+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111111111 1111111 1224456789999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.41 Aligned_cols=261 Identities=27% Similarity=0.375 Sum_probs=212.9
Q ss_pred cccchhhHHHhhcC----------CCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCC
Q 005846 333 LQFDFETIEVATNK----------FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR 401 (674)
Q Consensus 333 ~~~~~~~~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ 401 (674)
..+++++++.+++. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666776666654 677789999999999999965 7999999999877777778899999999999999
Q ss_pred ceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc
Q 005846 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (674)
Q Consensus 402 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~ 481 (674)
||+++++++..++..++||||+++++|.+++. ...+++..++.++.||++||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999884 346999999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 482 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+... ......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~---~~~~~~ 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD---SPVQAM 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHH
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHH
Confidence 999999999999987643322 233467999999999999999999999999999999999999987422 111222
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.... ....... . ........+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~----~~~~~~~-----~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 KRLR----DSPPPKL-----K--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHH----HSSCCCC-----T--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHh----cCCCCCc-----C--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1111110 0 11123346789999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=371.31 Aligned_cols=272 Identities=27% Similarity=0.422 Sum_probs=217.4
Q ss_pred ccccchhhHHHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCce
Q 005846 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNL 403 (674)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~ni 403 (674)
...++...++...++|++.++||+|+||.||++++ .+++.||||++.... ....+.+.+|++++.++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 44567778888899999999999999999999963 356789999997643 33346789999999999 89999
Q ss_pred eeEEeEEEeCCe-eEEEEEecCCCcccccccCCCc---------------------------------------------
Q 005846 404 VRLLGFCLEGEE-KILVYEFVPNKSLDYFLYDPEK--------------------------------------------- 437 (674)
Q Consensus 404 v~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------- 437 (674)
+++++++.+.+. .++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999987654 8999999999999999865332
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 438 ------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 438 ------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 122899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
...........||+.|+|||++.+..++.++||||||+++|||+| |+.|+...... ..+. .....+...
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~---~~~~~~~~~---- 315 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFC---RRLKEGTRM---- 315 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HHHH---HHHHHTCCC----
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---HHHH---HHHHcCCCC----
Confidence 433334445678999999999999999999999999999999999 98886432211 1111 111111111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+++..||+.||++|||+.||+++|+..
T Consensus 316 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 -----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11222335688999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.97 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=199.9
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCce----eEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQE----IAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+++.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357899999999999999999853 4444 588877543 3355678999999999999999999999998755 78
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|+||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 89999999999998854 2456999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.............+|+.|+|||++.+..++.++||||||+++|||+| |+.|+..... ..+....... .
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~----~---- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKG----E---- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTT----C----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHHHcC----C----
Confidence 65544444444567889999999999999999999999999999999 9988753222 2222222111 1
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111223445788999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=358.31 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=207.1
Q ss_pred hcCCCcccccccCCcEEEEEeecC----CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|++.+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999963 3446999999764 33445678999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999853 3356999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+... ...+.........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~---~~~~~~~~~~~~~-------- 271 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM---TNRDVISSVEEGY-------- 271 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS---CHHHHHHHHHTTC--------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC---CHHHHHHHHHcCC--------
Confidence 432222 2223456788999999999999999999999999999999 88886422 1222222221111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
....+......+.+|+..||+.||++|||+.+|+++|+...
T Consensus 272 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 272 -----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112233457889999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=376.33 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=208.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
....++|.+.++||+|+||.||+|.+. +++.||||++..... ...+.|.+|+.++++++||||+++++++..++..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344568899999999999999999975 688999999875432 234568899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999853 2345899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
............+++.|+|||.+.++.++.++||||||+++|||+| |..|+.... ........ ..+..
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~~----~~~~~---- 333 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREFV----EKGGR---- 333 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHHH----HTTCC----
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcCCC----
Confidence 3222111222345778999999999999999999999999999999 888764321 11222211 11111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 334 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 -----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111222345788999999999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.90 Aligned_cols=272 Identities=22% Similarity=0.311 Sum_probs=215.1
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--eeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv 419 (674)
.++|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999964 58999999997543 344677889999999999999999999998765 77999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE----cCCCCeEEeeeCCcc
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAR 495 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~ki~DfGla~ 495 (674)
|||+++++|.+++........+++..++.++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccc--------cCCCCccccEEeechhhhHhHhCCCCCCccCCCC-ccchHHHHHh
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAM--------HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG-AADLLSYAWK 566 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~~~~ 566 (674)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.|+....... ....+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 764332 223457999999999986 5789999999999999999999999975433222 2222222222
Q ss_pred hhcCCCcceec---------cc--ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 567 QWRDGTPLQLL---------DT--NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 567 ~~~~~~~~~~~---------d~--~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
......+..+. .. ......+......+.+++.+||+.||++|||+.|+++..++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 21111111110 00 111234456677889999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.44 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=205.2
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999996 57899999999654 3344567889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++. ..+.+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999884 3456999999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCccccccccCCccCccccccCCCC-ccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.......||+.|+|||++.+..+. .++|||||||++|||++|+.|+... ....+..... ... .
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~---~~~-~------ 231 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVL---RGK-Y------ 231 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH---HCC-C------
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHH---hCC-C------
Confidence 223456799999999999888765 8999999999999999999997432 1222222111 111 0
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+......+.+|+.+||+.||.+|||++|+++.
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122234567899999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.74 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=203.1
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999864 788999999865432 234668899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999984 3456999999999999999999999988 9999999999999999999999999998764433
Q ss_pred CCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.|+....... .....+. .....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~---~~~~~------ 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWK---EKKTY------ 227 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHH---TTCTT------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHh---ccccc------
Confidence 3333445689999999999987775 789999999999999999999975432211 1111111 11100
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..........+.+|+.+||+.||++|||+.|+++.
T Consensus 228 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00011233467789999999999999999998763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.38 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=197.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC----CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
..++|++.+.||+|+||.||+|++. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+++..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999864 5678999999764 3334567999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++++|.+++.. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999853 3446999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 498 GVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+... ...+.........+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~---~~~~~~~~i~~~~~------ 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM---SNQDVIKAVDEGYR------ 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC---CHHHHHHHHHTTEE------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC------
Confidence 5432211 1222345778999999999999999999999999999998 88886422 12222222211111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++..||+.||++||++.+|+++|+..
T Consensus 269 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 -------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111223445788999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=376.48 Aligned_cols=265 Identities=28% Similarity=0.458 Sum_probs=214.9
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
..+++..++|++.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34456677899999999999999999999888999999997643 45788999999999999999999999986 66789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999998532 2236899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
...... ......++..|+|||++..+.++.++|||||||++|||+| |+.|+... ...+++.......+.
T Consensus 335 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~------ 404 (454)
T 1qcf_A 335 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALERGYRM------ 404 (454)
T ss_dssp CCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHHTCCC------
T ss_pred CCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC------
Confidence 432111 1122346788999999999999999999999999999999 88886422 222222222221111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
..+...+..+.+|+.+||+.||++|||+++|+.+|+++....
T Consensus 405 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 112233457889999999999999999999999999876544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=366.63 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=214.4
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec--------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
++..++|.+.++||+|+||.||+++. ..+..||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34557899999999999999999984 233579999997643 33456789999999999 999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
..++..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999864321 245999999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
|||+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+... .
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~---~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---P 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---C
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---C
Confidence 9999999999999999987654443344445567889999999999999999999999999999999 88886422 1
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
..++.... ..+... ..+......+.+++.+||+.||++|||+.||++.|+......
T Consensus 299 ~~~~~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 299 VEELFKLL----KEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHH----HTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHH----HcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 22222222 221111 112223457889999999999999999999999998765443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=364.45 Aligned_cols=267 Identities=25% Similarity=0.394 Sum_probs=206.9
Q ss_pred hhcCCCcccccccCCcEEEEEeec-----CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Ce
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~ 415 (674)
..++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 356899999999999999999973 36889999999877666678899999999999999999999998654 45
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999998542 335999999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCC-CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCC---------CccchHHHHH
Q 005846 496 IFGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD---------GAADLLSYAW 565 (674)
Q Consensus 496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~---------~~~~~l~~~~ 565 (674)
........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76443222 1222345778899999999999999999999999999999999876422100 0000000111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
.....+ .....+...+..+.+++..||+.||++|||+.||++.|+....
T Consensus 243 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 243 ELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111111 1112233344678899999999999999999999999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=375.38 Aligned_cols=269 Identities=29% Similarity=0.455 Sum_probs=212.0
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+++..++|++.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 445567899999999999999999999888889999997643 345789999999999999999999999876 678999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999998531 2346999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... .......++..|+|||.+.++.++.++||||||+++|||+| |+.|+... ...+.+.......+
T Consensus 333 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~--------- 399 (452)
T 1fmk_A 333 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYR--------- 399 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCC---------
T ss_pred Cce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC---------
Confidence 221 12223456789999999999999999999999999999999 88886422 12222222221111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQP 631 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p 631 (674)
...+...+..+.+|+.+||+.||++|||+++|++.|+.+.....+..+|
T Consensus 400 ----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 400 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 1112233457889999999999999999999999999987666554444
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.66 Aligned_cols=263 Identities=28% Similarity=0.374 Sum_probs=202.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..++|++.++||+|+||.||+++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4578999999999999999999988899999999865432 23467889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 66666543 3456999999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee---
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL--- 576 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 576 (674)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+...... +.+...............
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---DQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT---THHHHHHHHHCCCCTTTSGGG
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHHCCCChHHhhhh
Confidence 2 22334578999999999876 56899999999999999999999997543332 223333222222111110
Q ss_pred -------------cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 -------------LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 -------------~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+..............+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000011122346789999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=363.60 Aligned_cols=270 Identities=26% Similarity=0.377 Sum_probs=211.9
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
+++...++|++.+.||+|+||.||++.. .++..||||++.... ....+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455678999999999999999999985 245689999997542 33456789999999999 999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCcC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEE
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQ--------------------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 470 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 470 (674)
...+..++||||+++|+|.+++...... ..+++..++.++.||++||.|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999998653221 34899999999999999999999998 999
Q ss_pred eecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCC
Q 005846 471 RDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNS 549 (674)
Q Consensus 471 rDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~ 549 (674)
|||||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |..|+
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999987654433333344567889999999999999999999999999999998 88886
Q ss_pred CccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCC
Q 005846 550 NFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626 (674)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 626 (674)
...... .... .....+.. ...+......+.+|+.+||+.||.+|||+.+|++.|+......+
T Consensus 276 ~~~~~~--~~~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVD--ANFY----KLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCS--HHHH----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcH--HHHH----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 432211 1111 11111111 11122234578899999999999999999999999988655443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=360.76 Aligned_cols=269 Identities=28% Similarity=0.471 Sum_probs=214.5
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
..++...++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556789999999999999999999863 34789999997643 33456789999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEK---------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 469 (674)
.+++..++||||+++++|.+++..... ...+++.+++.++.||++||.|||+.+ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999864321 256999999999999999999999998 99
Q ss_pred EeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCC
Q 005846 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKN 548 (674)
Q Consensus 470 HrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p 548 (674)
||||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987654333333344568899999999999999999999999999999999 8888
Q ss_pred CCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 549 SNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 549 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
+... ...+.... ...+... ..+......+.+++.+||+.||++||++.+|++.|++.....
T Consensus 277 ~~~~---~~~~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGM---AHEEVIYY----VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTS---CHHHHHHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCC---ChHHHHHH----HhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 6421 11122211 1122111 112233457889999999999999999999999999865443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.59 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=210.6
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
...++|++.+.||+|+||.||++.+.++..||+|++.... ...+++.+|+.++.+++||||+++++++.++...++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3457899999999999999999998888899999997543 345778999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999853 2345999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ......... .+...
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~~------ 224 (268)
T 3sxs_A 159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---NSEVVLKVS----QGHRL------ 224 (268)
T ss_dssp EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHH----TTCCC------
T ss_pred hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC---hHHHHHHHH----cCCCC------
Confidence 21 1223456778999999998899999999999999999999 888864322 111111111 11100
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
..+......+.+++..||+.||++|||+.++++.|+.+..
T Consensus 225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0111223468899999999999999999999999988643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=348.45 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=202.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHh--cCCCceeeEEeEEEeC----Cee
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK--LQHRNLVRLLGFCLEG----EEK 416 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~----~~~ 416 (674)
..++|++.+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999998 7899999998653 33556667777776 7999999999987653 457
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEEeecccccEEEcCCCCeEE
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDAEMNPKI 488 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiHrDlkp~NIll~~~~~~ki 488 (674)
++||||+++|+|.+++. ...+++..++.++.||++||.||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 99999999999999983 346999999999999999999999 665 999999999999999999999
Q ss_pred eeeCCccccCCCCCCC--ccccccccCCccCccccccC------CCCccccEEeechhhhHhHhC----------CCCCC
Q 005846 489 SDFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITG----------KKNSN 550 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwS~Gv~l~elltg----------~~p~~ 550 (674)
+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||+|| +.|+.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998764332221 12334799999999999876 456799999999999999999 66653
Q ss_pred ccCCCCccchHHHHHhhhcC-CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 551 FYQTDGAADLLSYAWKQWRD-GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 551 ~~~~~~~~~~l~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...... ............ .....+. ....+......+.+++.+||+.||++|||+.+|++.|+++
T Consensus 235 ~~~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPND--PSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSS--CCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCC--cchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 222111 111112221111 1111110 1112335667899999999999999999999999999763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=346.90 Aligned_cols=263 Identities=26% Similarity=0.380 Sum_probs=207.5
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
..++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 457899999999999999999985 468899999985433 2334678899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999984 3457999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... ........||+.|+|||.+.+..++.++||||||+++|||+||+.|+.... .............+. . .
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~-~-~ 233 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDSVPN-V-T 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHSSCCCC-H-H
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhccCCC-c-c
Confidence 322 122334579999999999999999999999999999999999999974321 112222222221111 0 1
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHhcCCCC
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-SMATIVLMLNSYSVT 624 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-t~~evl~~L~~~~~~ 624 (674)
. ......+..+.+++.+||+.||++|| +++++.+.|+.....
T Consensus 234 ~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 234 T----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp H----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred h----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1 11223345788999999999999999 999999999875433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.86 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=209.4
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
..++|++.+.||+|+||.||++.+.+++.||+|++.... ...+++.+|+.++++++||||+++++++.++...++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346789999999999999999998888999999997543 3457799999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++++|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999853 3446999999999999999999999998 99999999999999999999999999986543221
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+.........
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~---~~~~~~~~~~~~~------------- 224 (269)
T 4hcu_A 162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGF------------- 224 (269)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTC-------------
T ss_pred -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC---CHHHHHHHHhcCc-------------
Confidence 12223456788999999999999999999999999999999 88886432 1222222221111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+......+.+++..||+.||++||++.++++.|+..
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0111222345688999999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=345.79 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=204.0
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.++||+|+||+||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999964 68899999996543 2334678899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|++++.+..+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 998765555442 3456999999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec---
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL--- 577 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 577 (674)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+. ......+.+................
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 2233457899999999998766 8999999999999999999988742 2233333444333322221111100
Q ss_pred c------------cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 D------------TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d------------~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. ..............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00001111234457789999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.64 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=208.9
Q ss_pred hhcCCCcccccccCCcEEEEEeecC------CCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
..++|++.++||+|+||.||+|++. +++.||||++... ......++.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3568999999999999999999842 4668999999654 33445678899999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCC----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC---CeEE
Q 005846 416 KILVYEFVPNKSLDYFLYDPE----KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKI 488 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~ki 488 (674)
.++||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999986432 2245999999999999999999999998 99999999999999555 5999
Q ss_pred eeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhh
Q 005846 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|+... ...+++.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~---~~~~~~~~i~~- 301 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVTS- 301 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHT-
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHc-
Confidence 99999986543333333445678999999999999999999999999999999998 88886432 22222222211
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
+.. ...+......+.+|+.+||+.||++||++.+|++.|+..
T Consensus 302 ---~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 302 ---GGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ---TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 111223344688999999999999999999999999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=379.99 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=212.9
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCC-CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
++..++|++.++||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+.+..++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3445678999999999999999999754 7899999997643 3467899999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999998542 3356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... .......++..|+|||++.+..++.++|||||||++|||+| |+.|+.... ...+........
T Consensus 371 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~---------- 436 (495)
T 1opk_A 371 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDY---------- 436 (495)
T ss_dssp CCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHHHTTC----------
T ss_pred Cce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCC----------
Confidence 221 12223456789999999999999999999999999999999 888764322 222222222111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
....+......+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 437 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11122233457889999999999999999999999998864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.33 Aligned_cols=266 Identities=26% Similarity=0.410 Sum_probs=195.9
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecCCCc----eeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ----EIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 411 (674)
+++.+..++|++.+.||+|+||.||++.+.... .||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344455678999999999999999999865432 7999998754 3344678999999999999999999999998
Q ss_pred eCCee------EEEEEecCCCcccccccCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC
Q 005846 412 EGEEK------ILVYEFVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 482 (674)
Q Consensus 412 ~~~~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~ 482 (674)
..... ++||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence 87655 99999999999998885322 1225899999999999999999999998 999999999999999
Q ss_pred CCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchH
Q 005846 483 EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLL 561 (674)
Q Consensus 483 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l 561 (674)
++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~ 249 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE---NAEIY 249 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC---hHHHH
Confidence 99999999999987654433333334567889999999999999999999999999999999 888864322 22222
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
...... .. ...+......+.+++.+||+.||++|||+.++++.|++..
T Consensus 250 ~~~~~~----~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 250 NYLIGG----NR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHHTT----CC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcC----CC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222111 11 1112233457889999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=357.70 Aligned_cols=262 Identities=28% Similarity=0.402 Sum_probs=212.1
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
+...++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 44567899999999999999999974 245789999997543 34456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCcccccccCCCc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEee
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEK---------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrD 472 (674)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999864322 234899999999999999999999998 99999
Q ss_pred cccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCc
Q 005846 473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNF 551 (674)
Q Consensus 473 lkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~ 551 (674)
|||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654433333344567889999999999899999999999999999999 8888643
Q ss_pred cCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.. ...+..... .+.. ...+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 256 ~~---~~~~~~~~~----~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IP---PERLFNLLK----TGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CC---GGGHHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---HHHHHHHhh----cCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22 222222221 1111 111223345788999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.11 Aligned_cols=260 Identities=20% Similarity=0.245 Sum_probs=208.5
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999994 5789999999865432 24578999999999 99999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC-----eEEeeeCCccc
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMARI 496 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~ki~DfGla~~ 496 (674)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999988532 457999999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCCCCC-----ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 497 FGVDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 497 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...........+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~- 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA- 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-
Confidence 64332221 124567999999999999999999999999999999999999997654333322222222111100
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+ .+.. ..+ .+.+++..||+.||.+||++.+|++.|++.
T Consensus 239 ~~~~----~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPIE----VLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCHH----HHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCHH----HHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000 0001 122 788999999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=361.28 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=210.9
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecCC------CceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
.++...++|++.+.||+|+||.||++.... ...||+|++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456677899999999999999999998532 2479999997643 23456789999999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCC-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEE
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPE-----------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 479 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIl 479 (674)
.+++..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999885421 1346899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCcc
Q 005846 480 LDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAA 558 (674)
Q Consensus 480 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~ 558 (674)
++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |..|+...... .
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~ 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--S 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--H
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--H
Confidence 99999999999999986644333223334567889999999999999999999999999999999 87776432211 1
Q ss_pred chHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
........... ...+......+.+++..||+.||.+|||+.+|++.|+..
T Consensus 275 ~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 KFYKLVKDGYQ-------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCC-------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111111 011122235688999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=352.29 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=205.4
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||+++.. +|+.||+|++++. .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367899999999999999999864 6899999999753 234567789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999988884 3457999999999999999999999998 99999999999999999999999999985432
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....+..... ... .
T Consensus 158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~---~~~-~------ 222 (337)
T 1o6l_A 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELIL---MEE-I------ 222 (337)
T ss_dssp T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH---HCC-C------
T ss_pred C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHH---cCC-C------
Confidence 2 12334568999999999999999999999999999999999999996421 1222222111 110 0
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
.++......+.+++.+||+.||++|| +++||++.
T Consensus 223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223345788999999999999999 89998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=343.55 Aligned_cols=253 Identities=33% Similarity=0.479 Sum_probs=197.3
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccC----ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|+..+.||+|+||.||++.+ .++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 48899999986532 23357789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC--------CCCeEEeee
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--------EMNPKISDF 491 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~--------~~~~ki~Df 491 (674)
|||+++++|.+++. ...+++..++.++.||++||.|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999883 457999999999999999999999987556999999999999986 778999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+.... . ...........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~---~~~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID---G---LAVAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---H---HHHHHHHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---H---HHHHHhhhcCC
Confidence 9998654322 223578999999999999999999999999999999999999974321 1 11111111111
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.. ...+......+.+++.+||+.||++|||+.|++++|+.
T Consensus 231 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LA---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 11122334578899999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=370.98 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=206.7
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-eeEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILV 419 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv 419 (674)
++..++|++.++||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 34567889999999999999999998 47899999997653 4578999999999999999999999988765 78999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999642 2334799999999999999999999998 99999999999999999999999999985432
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
. .....++..|+|||.+.+..++.++||||||+++|||+| |+.|+..... .+......... .
T Consensus 342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~----~----- 404 (450)
T 1k9a_A 342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY----K----- 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT---TTHHHHHHTTC----C-----
T ss_pred c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC----C-----
Confidence 1 122357889999999999999999999999999999999 9888653322 22222222111 1
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+...+..+.+|+..||+.||++|||+.+|++.|+.+
T Consensus 405 ----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 ----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112223345788999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.93 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=205.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
..++|++.+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999864 689999999975432 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC----CeEEeee
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDF 491 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~ki~Df 491 (674)
.++||||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999984 3457999999999999999999999998 99999999999998877 7999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+... .....+.... ..
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~----~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANIT----AV 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHH----TT
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH----hc
Confidence 9998764322 233457999999999999999999999999999999999999997432 2222222111 11
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. . .+... .......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~-~-~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY-D-FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC-C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC-C-CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 0 00000 1122346789999999999999999999885
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.26 Aligned_cols=265 Identities=27% Similarity=0.407 Sum_probs=212.7
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccCc-cCHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 411 (674)
++...++|++.+.||+|+||.||++.+ .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 345567899999999999999999974 3567899999975433 3457789999999999 9999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCCc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccc
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPEK---------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~ 476 (674)
.++..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999864322 225899999999999999999999998 999999999
Q ss_pred cEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCC
Q 005846 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTD 555 (674)
Q Consensus 477 NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~ 555 (674)
|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.|+......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987654433333334567889999999999999999999999999999999 88886432211
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
............ ...+......+.+++.+||+.||.+|||+.|++++|++..
T Consensus 255 --~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 --SKFYKMIKEGFR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp --HHHHHHHHHTCC-------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hHHHHHhccCCC-------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111111111111 1111223457889999999999999999999999998743
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=350.89 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=207.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+...++|++.+.||+|+||.||++.+.++..||+|++.... ...+++.+|+.++.+++||||+++++++.+++..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 44567899999999999999999999888899999997543 34577899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999854 2346999999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.. .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ............
T Consensus 174 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~----------- 238 (283)
T 3gen_A 174 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGL----------- 238 (283)
T ss_dssp HH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTC-----------
T ss_pred cc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC---hhHHHHHHhccc-----------
Confidence 21 11223456788999999999999999999999999999998 888864322 112221111111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+......+.+++.+||+.||++|||+.++++.|++.
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 --RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111122235688999999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=348.49 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=204.7
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.++|++.+.||+|+||.||++++ .++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 35788899999999999999998 4788999998643 34577899999999999999999999876 4589999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC-eEEeeeCCccccCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMARIFGVDQT 502 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-~ki~DfGla~~~~~~~~ 502 (674)
++++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999965444446899999999999999999999943234999999999999998887 799999999765322
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .....+...... ...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~------- 224 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHNGT-RPP------- 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHTTC-CCC-------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhcCC-CCC-------
Confidence 22346899999999999999999999999999999999999997532211 112222221111 111
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCCCCc
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 632 (674)
........+.+++.+||+.||++|||+.+++++|+......+....|.
T Consensus 225 --~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 225 --LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp --CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred --cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 112233467899999999999999999999999988766665554443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=351.25 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=199.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------- 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 414 (674)
.++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999965 78999999997543 334577899999999999999999999987654
Q ss_pred --------------------------------------------------eeEEEEEecCCCcccccccCCCcCCCCCHH
Q 005846 415 --------------------------------------------------EKILVYEFVPNKSLDYFLYDPEKQGQLDWS 444 (674)
Q Consensus 415 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 444 (674)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999765555567888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC----------CccccccccCC
Q 005846 445 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ----------GNTSRIVGTYG 514 (674)
Q Consensus 445 ~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~----------~~~~~~~gt~~ 514 (674)
.++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999877543211 12234579999
Q ss_pred ccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHH
Q 005846 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCI 594 (674)
Q Consensus 515 y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 594 (674)
|+|||++.+..++.++||||||+++|||++|..|.. +... ........... .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCC---------cccccCChhHH
Confidence 999999999999999999999999999999876521 1111 11111111110 01122334668
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 005846 595 QLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 595 ~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+++.+||+.||++|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.17 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=204.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
.++|++.+.||+|+||.||++... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999964 689999999865332 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC----CeEEeeeC
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 492 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~ki~DfG 492 (674)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999984 3457999999999999999999999988 99999999999999887 89999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+... .....+....... .
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~~~~~~-~-- 234 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVN-Y-- 234 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHTC-C--
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC---CHHHHHHHHHhcC-C--
Confidence 998764322 223457999999999999999999999999999999999999986422 1112222111110 0
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. .. .........+.+++.+||+.||++|||+.|+++
T Consensus 235 --~~-~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 --EF-ED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --CC-CH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --Cc-Cc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00 001122346789999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=346.68 Aligned_cols=264 Identities=28% Similarity=0.455 Sum_probs=197.4
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++..++|++.++||+|+||.||+|++. ..||+|+++... ....+.+.+|+.++++++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3455678999999999999999999874 359999986543 33456789999999999999999999965 556789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999988853 3456999999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCCCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
.............||+.|+|||.+. +..++.++||||||+++|||++|+.|+.... ..................
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~- 247 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMVGRGSLSPDL- 247 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC--CHHHHHHHHHHTSCCCCT-
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc--hHHHHHHHhcccccCcch-
Confidence 4433333344567999999999986 6678999999999999999999999974322 111222222111111100
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.......+..+.+++..||+.||++|||+.+++++|++..
T Consensus 248 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 --------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1112233457889999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.24 Aligned_cols=265 Identities=17% Similarity=0.216 Sum_probs=212.0
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+..+.++ +|+|++++++++.++...++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 456899999999999999999994 5789999999865432 24578899999999 8999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC-----eEEeeeCCcc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMAR 495 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~ki~DfGla~ 495 (674)
||+ +++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999998532 346999999999999999999999988 999999999999987776 9999999998
Q ss_pred ccCCCCCC-----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 496 IFGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 496 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...........+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76543322 1234567999999999999999999999999999999999999998654333333332222211111
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
....+ + ....+..+.+++..||+.||++||++.+|++.|++....
T Consensus 240 ~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 240 TPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp SCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccHHH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 11000 1 112235788999999999999999999999999875443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=378.61 Aligned_cols=269 Identities=28% Similarity=0.447 Sum_probs=216.1
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
..+++..++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++|+||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34455677899999999999999999999888889999997644 346789999999999999999999999866 6789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
|||||+++|+|.+++... ....+++.+++.|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999999998531 2346899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... .......++..|+|||++.++.++.++|||||||++|||++ |+.|+... ...+.+.......+
T Consensus 414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~------- 482 (535)
T 2h8h_A 414 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYR------- 482 (535)
T ss_dssp CCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC---CHHHHHHHHHTTCC-------
T ss_pred CCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC-------
Confidence 42211 11122356788999999999999999999999999999999 88876422 12222222221111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQ 629 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~ 629 (674)
...+......+.+|+.+||+.||++|||+++|+++|+.+.....+..
T Consensus 483 ------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 483 ------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 11122334578899999999999999999999999999876654433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.35 Aligned_cols=249 Identities=25% Similarity=0.308 Sum_probs=195.2
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc--------------------------cCHHHHHHHHHHHH
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--------------------------QGAEEFKNEVVLVA 396 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~ 396 (674)
.++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999985 4688999999865321 12356889999999
Q ss_pred hcCCCceeeEEeEEEe--CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecc
Q 005846 397 KLQHRNLVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 474 (674)
Q Consensus 397 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlk 474 (674)
+++||||+++++++.+ +...++||||+++++|.+++ ....+++..++.++.||++||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56889999999999998876 3457999999999999999999999998 9999999
Q ss_pred cccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCC---CCccccEEeechhhhHhHhCCCCCCc
Q 005846 475 ASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 475 p~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
|+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999998764322 1223457999999999997665 47899999999999999999998642
Q ss_pred cCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. ....+.... . .... .. .........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~---~~~~~~~~~---~-~~~~-~~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 E---RIMCLHSKI---K-SQAL-EF-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S---SHHHHHHHH---H-HCCC-CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c---cHHHHHHHH---h-cccC-CC-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 111111111 1 1110 00 001123346889999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.92 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=200.3
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.++||+|+||.||+++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998789999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++ +|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 985 77777743 2356999999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce------
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ------ 575 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~------ 575 (674)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.|+... ...+.+....+.........
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHHCCCChhhchhhhc
Confidence 122345789999999998764 5899999999999999999999987532 22222333322221111000
Q ss_pred --eccccc-------CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 --LLDTNL-------TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 --~~d~~~-------~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..++.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 01111223457789999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=344.29 Aligned_cols=264 Identities=31% Similarity=0.470 Sum_probs=211.6
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++++..++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3455567899999999999999999998888899999996543 34678999999999999999999999976 456899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999998432 2236999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+......... .
T Consensus 161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~~~----~---- 228 (279)
T 1qpc_A 161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGY----R---- 228 (279)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTC----C----
T ss_pred Cccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc---CHHHHHHHHhccc----C----
Confidence 3321 12223456789999999998899999999999999999999 88776422 1122222221111 0
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
...+......+.+++..||+.||++|||+.++++.|+......
T Consensus 229 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 229 -----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 0112223457889999999999999999999999998765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=358.19 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=201.9
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCce----eEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQE----IAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357899999999999999999853 4444 7778775432 233456788999999999999999999886 56688
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999988542 346899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.............|+..|+|||.+.+..++.++||||||+++|||+| |+.|+..... ......... +....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~~~~- 237 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDLLEK----GERLA- 237 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---THHHHHHHT----TCBCC-
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---HHHHHHHHc----CCCCC-
Confidence 65544444455678889999999999999999999999999999999 9988753322 222222211 11110
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.+......+.+++.+||+.||++||++.++++.|+...
T Consensus 238 --------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 --------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112224668999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.36 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=204.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999854 5788999998653 234467789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+.+|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999884 3456999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCcccccc---CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
. .......||+.|+|||++.. ..++.++|||||||++|||++|+.|+.................. .
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----~---- 236 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----V---- 236 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC----C----
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc----c----
Confidence 2 23345679999999999864 45899999999999999999999997644333322222221110 0
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-MATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-~~evl~ 616 (674)
..++......+.+|+.+||+.||.+||+ +++|+.
T Consensus 237 ------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1122233457889999999999999998 777664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=350.75 Aligned_cols=277 Identities=27% Similarity=0.417 Sum_probs=204.4
Q ss_pred cccccchhhHHHhhcCCCcccccccCCcEEEEEeecC----CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCcee
Q 005846 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLV 404 (674)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv 404 (674)
+.+...+..+....++|.+.+.||+|+||.||+|.+. .+..||+|++... .....+.+.+|+.++++++||||+
T Consensus 20 eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 99 (313)
T 3brb_A 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99 (313)
T ss_dssp ----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCee
Confidence 3445556666677889999999999999999999753 3457999998654 233456789999999999999999
Q ss_pred eEEeEEEeCCe-----eEEEEEecCCCcccccccCC---CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccc
Q 005846 405 RLLGFCLEGEE-----KILVYEFVPNKSLDYFLYDP---EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (674)
Q Consensus 405 ~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~ 476 (674)
++++++.+... .++||||+++++|..++... .....+++..++.++.||++||.|||+.+ |+||||||+
T Consensus 100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~ 176 (313)
T 3brb_A 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAAR 176 (313)
T ss_dssp CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGG
T ss_pred eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcc
Confidence 99999987653 49999999999999887432 23456999999999999999999999988 999999999
Q ss_pred cEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCC
Q 005846 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTD 555 (674)
Q Consensus 477 NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~ 555 (674)
|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 177 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 254 (313)
T 3brb_A 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-- 254 (313)
T ss_dssp GEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC--
Confidence 99999999999999999987654333233334567889999999999999999999999999999999 777754322
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCC
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 626 (674)
............ . ...+......+.+++.+||+.||++|||+.++++.|+.....+|
T Consensus 255 -~~~~~~~~~~~~----~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 255 -NHEMYDYLLHGH----R---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp -GGGHHHHHHTTC----C---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -HHHHHHHHHcCC----C---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 222222222111 1 11122334578899999999999999999999999987654443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.31 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=204.6
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999864 57889999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC--CCCeEEeeeCCccccCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVD 500 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~--~~~~ki~DfGla~~~~~~ 500 (674)
+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 3346999999999999999999999998 999999999999987 789999999999876432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.......||+.|+|||++.+..++.++||||||+++|||++|+.|+... .....+..... .... .+..
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~---~~~~---~~~~ 225 (321)
T 1tki_A 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMN---AEYT---FDEE 225 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH---TCCC---CCHH
T ss_pred ---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHHHc---CCCC---CChh
Confidence 2234467999999999999888999999999999999999999997432 12222222211 1100 0000
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.. ......+.+++.+||+.||++|||+.|+++.
T Consensus 226 ~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 1223468899999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.25 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=210.3
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec--------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
+...++|.+.+.||+|+||.||++.+ .++..||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34467899999999999999999985 246789999997543 33456789999999999 999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
.+.+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999865321 234899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
||++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+... .
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---P 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC---C
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC---C
Confidence 9999999999999999987654333233344567889999999998899999999999999999999 88886432 1
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
..++........ . ...+......+.+++.+||+.||++||++.+|++.|+...
T Consensus 265 ~~~~~~~~~~~~----~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 265 VEELFKLLKEGH----R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHHHHHTC----C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCC----C---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222222221111 1 0112233456889999999999999999999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=358.18 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=197.9
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCeeE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~ 417 (674)
+..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++..+...+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 345679999999999999999999888999999998653 33345778999999999976 99999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||| +.+++|.+++. ....+++.++..++.||++||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 56889998884 3457999999999999999999999998 99999999999997 678999999999876
Q ss_pred CCCCCCCccccccccCCccCcccccc-----------CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.|+... .+.......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-----hhHHHHHHH
Confidence 54443333445679999999999865 67899999999999999999999997421 111111211
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.... .....++......+.+++..||+.||++|||+.|+++.
T Consensus 233 ~~~~---------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 IIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcC---------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 11112222233467899999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.06 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=198.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 418 (674)
.++|++.++||+|+||.||+++.. +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999864 57889999997642 22234578899999887 89999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999988884 3457999999999999999999999998 9999999999999999999999999998532
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCc--cchHHHHHhhhcCCCccee
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA--ADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~--~~~l~~~~~~~~~~~~~~~ 576 (674)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.|+........ ...............
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 21 2234456899999999999999999999999999999999999999854322111 111111111111111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
..++......+.+|+.+||+.||++||++
T Consensus 279 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11222334578899999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.56 Aligned_cols=269 Identities=20% Similarity=0.245 Sum_probs=201.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC----CCceeEEEEecccCcc-----------CHHHHHHHHHHHHhcCCCceeeEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKASGQ-----------GAEEFKNEVVLVAKLQHRNLVRLLG 408 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~~ 408 (674)
.++|++.+.||+|+||.||+|... ++..+|||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5778999998754322 1233567888999999999999999
Q ss_pred EEEe----CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC
Q 005846 409 FCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484 (674)
Q Consensus 409 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~ 484 (674)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77899999999 9999999853 337999999999999999999999998 99999999999999887
Q ss_pred --CeEEeeeCCccccCCCCCC-----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCc
Q 005846 485 --NPKISDFGMARIFGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557 (674)
Q Consensus 485 --~~ki~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~ 557 (674)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-- 266 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-- 266 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--
Confidence 9999999999876433211 1123457999999999999999999999999999999999999997432111
Q ss_pred cchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
..........+....+..+.. ... ....+..+.+++..||+.||++||++.+|++.|+......
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLK-WAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHH-HSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred cHHHHHHHHhhcccccHHHHh-hcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 111112212221111111110 000 0123347889999999999999999999999998865533
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=351.74 Aligned_cols=273 Identities=27% Similarity=0.419 Sum_probs=217.3
Q ss_pred cccccchhhHHHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccCc-cCHHHHHHHHHHHHhc-CCCc
Q 005846 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRN 402 (674)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~n 402 (674)
+.+.+....++...++|++.+.||+|+||.||++.+ .+++.||||++..... ...+.+.+|+.++.++ +|||
T Consensus 13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 345566777788889999999999999999999973 3568899999976433 3346789999999999 7999
Q ss_pred eeeEEeEEEeCC-eeEEEEEecCCCcccccccCCCc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 005846 403 LVRLLGFCLEGE-EKILVYEFVPNKSLDYFLYDPEK-------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (674)
Q Consensus 403 iv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 468 (674)
|+++++++...+ ..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 999999987755 58999999999999999864322 123899999999999999999999998 9
Q ss_pred EEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCC
Q 005846 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 547 (674)
Q Consensus 469 iHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~ 547 (674)
+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654433333344568899999999999999999999999999999998 888
Q ss_pred CCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 548 NSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 548 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
|+...... ...... ...+... ..+......+.+++..||+.||.+|||+.+|++.|+..
T Consensus 250 p~~~~~~~--~~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 250 PYPGVKID--EEFCRR----LKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SSTTCCCS--HHHHHH----HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccchh--HHHHHH----hccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 86432211 111111 1111111 11122345688999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=349.53 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=193.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 418 (674)
..++|++.++||+|+||+||+|+.. +|+.||||++.... ......+..|+..+.++ +|+||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4468999999999999999999965 78999999986532 22233455566666555 99999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+ +++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 6677777743 2456999999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..++... ..+..+..+....
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~--- 271 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPP--- 271 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCH---
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCc---
Confidence 322 2234568999999998875 7999999999999999999997664211 1122222221111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.++......+.+++.+||+.||++|||+.|+++
T Consensus 272 -----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 -----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111223457889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=354.34 Aligned_cols=249 Identities=26% Similarity=0.346 Sum_probs=199.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 417 (674)
..++|++.+.||+|+||.||+++.. +|+.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999854 6889999999753 234456788999999988 7999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++|+|..++. +...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999998884 3456999999999999999999999998 999999999999999999999999999853
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.|+... ...++...... . .
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~---~-~----- 240 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILN---D-E----- 240 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH---C-C-----
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHc---C-C-----
Confidence 222 22334568999999999999889999999999999999999999997432 22222222211 1 1
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCH------HHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM------ATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~------~evl~ 616 (674)
..++......+.+++.+||+.||++||++ .+|++
T Consensus 241 -----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122234567899999999999999998 77764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=357.88 Aligned_cols=270 Identities=18% Similarity=0.196 Sum_probs=204.3
Q ss_pred hhcCCCcccccccCCcEEEEEeecCC------CceeEEEEecccCccCH-----------HHHHHHHHHHHhcCCCceee
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSKASGQGA-----------EEFKNEVVLVAKLQHRNLVR 405 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~ 405 (674)
..++|++.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998654 47899999876542211 12334556677778999999
Q ss_pred EEeEEEeC----CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc
Q 005846 406 LLGFCLEG----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (674)
Q Consensus 406 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~ 481 (674)
+++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998775 4579999999 9999999853 3356999999999999999999999998 99999999999999
Q ss_pred --CCCCeEEeeeCCccccCCCCCCC-----ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCC
Q 005846 482 --AEMNPKISDFGMARIFGVDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554 (674)
Q Consensus 482 --~~~~~ki~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~ 554 (674)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.|+.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764332211 11335699999999999999999999999999999999999999763222
Q ss_pred CCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 555 DGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
. ..........+.. ....+++..+.. ...+..+.+++..||+.||++||++.+|+++|++....
T Consensus 267 ~--~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 D--PKYVRDSKIRYRE-NIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp C--HHHHHHHHHHHHH-CHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred C--HHHHHHHHHHhhh-hHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 1 1222222221111 122222222211 12234678899999999999999999999999765433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=352.02 Aligned_cols=268 Identities=28% Similarity=0.453 Sum_probs=214.2
Q ss_pred chhhHHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEe
Q 005846 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLG 408 (674)
Q Consensus 336 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~ 408 (674)
..+++++..++|++.+.||+|+||.||+|++. .++.||||++..... .....+.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34455667789999999999999999999753 367899999975432 33456889999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCcccccccCCC-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc
Q 005846 409 FCLEGEEKILVYEFVPNKSLDYFLYDPE-------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (674)
Q Consensus 409 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~ 481 (674)
++.+++..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 9999999999999999999999885421 1246799999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccch
Q 005846 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADL 560 (674)
Q Consensus 482 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~ 560 (674)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+.
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQV 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC---CHHHH
Confidence 999999999999986643332223334567889999999999999999999999999999999 77775422 11122
Q ss_pred HHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 561 l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.... ..+... ..+......+.+++.+||+.||++|||+.|+++.|+...
T Consensus 250 ~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 LRFV----MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHH----HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 2211 111111 112233456889999999999999999999999998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.95 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=206.5
Q ss_pred hcCCCcccccccCCcEEEEEee-----cCCCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Ce
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-----LPSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~ 415 (674)
.+.|++.++||+|+||.||+++ ..+++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4568899999999999999998 346889999999753 334567899999999999999999999999876 56
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999843 3356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCC-CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC--------CCCccchHHHHHh
Q 005846 496 IFGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ--------TDGAADLLSYAWK 566 (674)
Q Consensus 496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~--------~~~~~~~l~~~~~ 566 (674)
........ .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.... .............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76543321 12334567888999999999999999999999999999999998742110 0000111111111
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+. ....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111111 1112333446788999999999999999999999999763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.24 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=203.7
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..++|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999864 68999999996542 33456788999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC---CeEEeeeCCccc
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARI 496 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~ki~DfGla~~ 496 (674)
|||+++|+|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999988884 3456999999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.. .....+...... +... .
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~---~~~~~~~~~i~~----~~~~-~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYAQIKA----GAYD-Y 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH----TCCC-C
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHh----CCCC-C
Confidence 64322 22345799999999999999999999999999999999999998642 122222222211 1100 0
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.. .........+.+++.+||+.||++||++.++++.
T Consensus 250 -~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CT----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -Cc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0011223567899999999999999999998854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.57 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=200.8
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|.+.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999995 57899999998643 122345789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+ +|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 677777763 3456999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.|+......... ..+.
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~ 221 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVN 221 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCC
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHH
Confidence 22 2334579999999999988776 68999999999999999999997532211100 0000
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.. ....+......+.+++.+||+.||.+|||+.|+++.
T Consensus 222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 011223334578899999999999999999999853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=352.04 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=206.1
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.+.||+|+||.||++... +|+.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999864 6889999999776555567889999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC--CCCeEEeeeCCccccCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVD 500 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~--~~~~ki~DfGla~~~~~~ 500 (674)
+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999988843 2346999999999999999999999998 999999999999974 577999999999876432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.|+... .....+..... .... .+.
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~i~~---~~~~---~~~- 271 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKR---CDWE---FDE- 271 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHH---CCCC---CCS-
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCCC---CCc-
Confidence 2 223457999999999999999999999999999999999999997432 12222222211 1000 011
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 272 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 ---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111234578899999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.79 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=202.9
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-----CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999985 46899999998542 2234678999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC---eEEeeeCC
Q 005846 418 LVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGM 493 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~ki~DfGl 493 (674)
+||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999987764322 2345899999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+... ...+...... +..
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~----~~~ 249 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIK----GKY 249 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHH----TCC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHc----CCC
Confidence 98765322 2233457999999999999999999999999999999999999997431 1122211111 110
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. ..+.... .....+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000001 12346789999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.63 Aligned_cols=254 Identities=31% Similarity=0.529 Sum_probs=201.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccC-------HHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQG-------AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
.++|++.+.||+|+||.||+++. .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999986 478899999986533221 267899999999999999999999986554
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC-----eEEee
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISD 490 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~ki~D 490 (674)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999887753 3457999999999999999999999875 34999999999999988876 99999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccc--cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM--HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.|+....... ........
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHh
Confidence 999975322 233457899999999984 4567899999999999999999999975432221 11111111
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.... ....+......+.+++.+||+.||++|||+.+|++.|++
T Consensus 244 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGL---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCC---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111 111222334578899999999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.17 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=203.6
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
...++|++.++||+|+||.||++.. .+|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999985 478999999986543 2335678899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc---CCCCeEEeeeCCcc
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMAR 495 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~ki~DfGla~ 495 (674)
||||+++|+|.+.+. ....+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999988884 3456999999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.. .....+...... +.. .
T Consensus 162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~----~~~-~ 231 (444)
T 3soa_A 162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD---EDQHRLYQQIKA----GAY-D 231 (444)
T ss_dssp CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHH----TCC-C
T ss_pred EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHh----CCC-C
Confidence 764322 222346799999999999999999999999999999999999999642 222222222211 111 0
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
... ... ......+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~-~~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPS-PEW----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCT-TTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCc-ccc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 001 1223468899999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.09 Aligned_cols=263 Identities=27% Similarity=0.366 Sum_probs=205.7
Q ss_pred CCcccccccCCcEEEEEeec-----CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEE
Q 005846 347 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 418 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 418 (674)
|++.++||+|+||.||++.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999988753 267889999997653 33456789999999999999999999999884 67899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~----~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHh----hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999984 235999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCC-CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCC--------CccchHHHHHhhhc
Q 005846 499 VDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD--------GAADLLSYAWKQWR 569 (674)
Q Consensus 499 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~--------~~~~~l~~~~~~~~ 569 (674)
..... .......++..|+|||.+.+..++.++||||||+++|||+||+.|+...... ...........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 262 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE--- 262 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH---
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH---
Confidence 43221 1223356788899999999999999999999999999999999886421100 00000000111
Q ss_pred CCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 570 DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 570 ~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
.+........+......+.+|+.+||+.||++|||+.|+++.|+.....+
T Consensus 263 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 ------LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111122223344567889999999999999999999999998754443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=346.17 Aligned_cols=261 Identities=29% Similarity=0.439 Sum_probs=213.0
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++...++|++.+.||+|+||.||++.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 44556778999999999999999999965 47889999997543 34577899999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999998542 3456999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... .............
T Consensus 162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~---~~~~~~~~~~~~~------- 230 (288)
T 3kfa_A 162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYR------- 230 (288)
T ss_dssp CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHHHTTCC-------
T ss_pred cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhccCC-------
Confidence 43322 22233467889999999999999999999999999999999 888764322 2222222211111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++..||+.||.+|||+.++++.|+..
T Consensus 231 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 231 ------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111223345788999999999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.11 Aligned_cols=269 Identities=25% Similarity=0.335 Sum_probs=208.5
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCee
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK 416 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 416 (674)
+..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3457899999999999999999995 5789999999977666667789999999999999999999999873 3477
Q ss_pred EEEEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 417 ILVYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
++||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999998885421 2456999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCCC-------ccccccccCCccCccccccCC---CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 496 IFGVDQTQG-------NTSRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 496 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
......... ......||+.|+|||.+.... ++.++||||||+++|||++|+.|+........ .. ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~-~~~~ 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV-ALAV 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH-HHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh-hHHh
Confidence 643211110 012345799999999987554 78999999999999999999998743211110 11 1111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCC
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPS 627 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~ 627 (674)
. .. ............+.+++.+||+.||.+||++.++++.|+......|.
T Consensus 261 ~---~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 261 Q---NQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp H---CC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred h---cc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 1 10 00011122345788999999999999999999999999987654443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.05 Aligned_cols=268 Identities=27% Similarity=0.365 Sum_probs=211.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-----CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEE--eCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL--EGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~ 416 (674)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36889999999999999999983 468899999998776666778999999999999999999999987 45568
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998532 345999999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCC--------CccchHHHHHhh
Q 005846 497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD--------GAADLLSYAWKQ 567 (674)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~--------~~~~~l~~~~~~ 567 (674)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65433221 223346788899999999999999999999999999999999885421110 000011111111
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
.. .......+......+.+++.+||+.||++|||+.++++.|+......
T Consensus 257 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LE---------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hh---------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11 11112223344567889999999999999999999999998865443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=345.20 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=196.0
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCC----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
++..++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++ .++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence 3445789999999999999999998642 4569999987543 33456789999999999999999999997 4567
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 8999999999999999853 2346999999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... ..+.+..... +...
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~---~~~~~~~i~~----~~~~ 236 (281)
T 1mp8_A 165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIEN----GERL 236 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHT----TCCC
T ss_pred ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC---HHHHHHHHHc----CCCC
Confidence 7643221 12233456789999999999999999999999999999997 888864322 2222222211 1110
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 237 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11223345788999999999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.46 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=199.3
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 419 (674)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999964 58899999997643 23345678899999988 899999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999998884 3456999999999999999999999998 99999999999999999999999999985322
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCcc--chHHHHHhhhcCCCcceec
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA--DLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~ 577 (674)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ...............
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 1 12334568999999999999999999999999999999999999998542221110 111111111111110
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM 611 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~ 611 (674)
.++......+.+++.+||+.||++||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1222334578899999999999999995
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=353.79 Aligned_cols=272 Identities=22% Similarity=0.316 Sum_probs=213.5
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--eeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv 419 (674)
.++|.+.++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999964 58999999997543 344677889999999999999999999998765 77999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE----cCCCCeEEeeeCCcc
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAR 495 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~ki~DfGla~ 495 (674)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966544555999999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCCCCCccccccccCCccCcccccc--------CCCCccccEEeechhhhHhHhCCCCCCccCCCC-ccchHHHHHh
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMH--------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG-AADLLSYAWK 566 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~-~~~~l~~~~~ 566 (674)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....... ..+.+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 764332 2234579999999999865 567889999999999999999999975433222 2222222222
Q ss_pred hhcCCCcceec-----------ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 567 QWRDGTPLQLL-----------DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 567 ~~~~~~~~~~~-----------d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
......+..+. +.......+......+.+++.+||+.||++||++.++++.+++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 11111111100 00111233456677888999999999999999999999988764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.20 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=197.3
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEeccc--CccCHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999999888999999998653 3344577899999999996 59999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899988853 347899999999999999999999988 99999999999995 58999999999987654
Q ss_pred CCCCCccccccccCCccCcccccc-----------CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.... +.........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHh
Confidence 433333345679999999999865 468999999999999999999999974211 1111111111
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
... ....++......+.+|+.+||+.||++|||+.|+++.
T Consensus 282 ~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccc---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 1111122223467899999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.20 Aligned_cols=265 Identities=25% Similarity=0.303 Sum_probs=192.7
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEe----
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLE---- 412 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~---- 412 (674)
.++....+|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 3344566899999999999999999995 478999999997766666778899999999996 9999999999953
Q ss_pred ----CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEE
Q 005846 413 ----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 488 (674)
Q Consensus 413 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki 488 (674)
....++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 345799999996 788777754444567999999999999999999999874 35999999999999999999999
Q ss_pred eeeCCccccCCCCCCC----------ccccccccCCccCcccc---ccCCCCccccEEeechhhhHhHhCCCCCCccCCC
Q 005846 489 SDFGMARIFGVDQTQG----------NTSRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~ 555 (674)
+|||+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765432211 11234689999999998 5667899999999999999999999997422111
Q ss_pred CccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 556 GAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
.. +...............+.+|+.+||+.||++||++.|+++.|+.....
T Consensus 260 ---~~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 ---RI----------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---Hh----------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 000000001111122467899999999999999999999999875433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.74 Aligned_cols=260 Identities=20% Similarity=0.241 Sum_probs=206.6
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 412 (674)
...++...++|++.++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455666789999999999999999999964 5889999998652 12223457899999999999999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
++..++||||+++|+|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999884 346899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCC----CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.|+.. ..............
T Consensus 214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA---DSLVGTYSKIMNHK 289 (410)
T ss_dssp TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHTHH
T ss_pred eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC---CChhhHHHHHHhcc
Confidence 9987643221 1233568999999999997655 88999999999999999999999742 22222222221110
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAE--RPSMATIVLM 617 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPt~~evl~~ 617 (674)
.. .... ........+.+|+.+||+.+|.+ ||+++||++.
T Consensus 290 ~~---~~~p-------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 NS---LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HH---CCCC-------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cc---ccCC-------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 0000 00122346788999999999988 9999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=341.88 Aligned_cols=264 Identities=26% Similarity=0.372 Sum_probs=189.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.++||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999864 68899999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCC---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 422 FVPNKSLDYFLYDPE---KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|++ ++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 57877764321 2245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc---c
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP---L 574 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~---~ 574 (674)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.... ..+.+............ .
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN---DEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCTTTCG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhHhh
Confidence 322 22334578999999999876 468999999999999999999999875322 22223222222111100 0
Q ss_pred ee-----ccccc------------CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 QL-----LDTNL------------TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ~~-----~d~~~------------~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. ..+.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00000 00011123347889999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.67 Aligned_cols=265 Identities=19% Similarity=0.217 Sum_probs=209.3
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
+.+.+++...++|++.++||+|+||+||+++.. +++.||+|++.+.. ....+.+.+|+.++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345566677889999999999999999999965 47889999996521 12233478999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
.+++..++||||+++|+|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999853 2456999999999999999999999988 99999999999999999999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
||+++....... ......+||+.|+|||++. ++.++.++|||||||++|||++|+.|+... ...+......
T Consensus 219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~ 294 (437)
T 4aw2_A 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIM 294 (437)
T ss_dssp CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH
T ss_pred hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhh
Confidence 999987643322 1233467999999999987 567999999999999999999999997432 2222222221
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAE--RPSMATIVLM 617 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPt~~evl~~ 617 (674)
....... + +. ........+.+|+.+||..+|++ ||+++|+++.
T Consensus 295 ~~~~~~~---~--p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKERFQ---F--PT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHHHCC---C--CS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hcccccc---C--Cc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1100000 0 00 01123346788999999888888 9999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.98 Aligned_cols=270 Identities=24% Similarity=0.289 Sum_probs=210.0
Q ss_pred ccccchhhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-----CCceee
Q 005846 332 SLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----HRNLVR 405 (674)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~ 405 (674)
...+++.+.....++|++.++||+|+||.||+++. .+++.||||++... ....+.+..|+.++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 45567777888889999999999999999999996 46889999999643 333456788999999996 999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---
Q 005846 406 LLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--- 482 (674)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~--- 482 (674)
+++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 99998888542 2345999999999999999999999998 999999999999975
Q ss_pred ----------------------CCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhh
Q 005846 483 ----------------------EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 540 (674)
Q Consensus 483 ----------------------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ 540 (674)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 889999999999864321 23457899999999999999999999999999999
Q ss_pred HhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce------------ecc-cccCCCCC--------------------h
Q 005846 541 EIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ------------LLD-TNLTDSYS--------------------R 587 (674)
Q Consensus 541 elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~------------~~d-~~~~~~~~--------------------~ 587 (674)
||++|+.|+.... ..+.+........ ..+.. .++ ......++ .
T Consensus 251 ell~g~~pf~~~~---~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 251 ELYTGSLLFRTHE---HMEHLAMMESIIQ-PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHSSCSCCCSS---HHHHHHHHHHHTC-CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHCCCCCCCCc---HHHHHHHHHHhcC-CCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 9999999975322 1222222211110 00000 000 00000000 0
Q ss_pred hHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 588 NEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 588 ~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.....+.+|+.+||+.||++|||+.|+++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11145779999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=342.73 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=203.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357899999999999999999864 6899999999653 223457788999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999984 3456999999999999999999999988 99999999999999999999999999986532
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....... ...... .
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~---~i~~~~-~------ 220 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYE---KILNAE-L------ 220 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHH---HHHHCC-C------
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHH---HHHhCC-C------
Confidence 223457999999999999999999999999999999999999997421 1111221 111111 0
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
.++......+.+++.+||+.||++|| ++++|++
T Consensus 221 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11222335688999999999999999 8898884
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=350.07 Aligned_cols=248 Identities=25% Similarity=0.292 Sum_probs=196.4
Q ss_pred CcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 348 STDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
...+.||+|+||.||++.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999985 468999999998766566778999999999999999999999999999999999999999
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE--cCCCCeEEeeeCCccccCCCCCCC
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll--~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 99888753 2345899999999999999999999998 9999999999999 567889999999998764332
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+... ...+.+..... .... . ....
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~---~~~~--~-~~~~--- 311 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD---NDAETLNNILA---CRWD--L-EDEE--- 311 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH---TCCC--S-CSGG---
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---ccCC--C-Chhh---
Confidence 223346999999999999889999999999999999999999987432 12222222211 1100 0 0000
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+.+++.+||+.||++|||+.|+++
T Consensus 312 -~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 -FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1122357889999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.39 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=188.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
..++|++.+.||+|+||.||+++.. +++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999965 57889999997543 34568899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeEEeeeCCccccC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMARIFG 498 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ki~DfGla~~~~ 498 (674)
|+++++|.+++. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999998884 3456999999999999999999999998 999999999999975 8899999999998654
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.... .....+.. ....... ..
T Consensus 203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~----i~~~~~~-~~- 271 (349)
T 2w4o_A 203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER--GDQFMFRR----ILNCEYY-FI- 271 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT--CHHHHHHH----HHTTCCC-CC-
T ss_pred cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc--ccHHHHHH----HHhCCCc-cC-
Confidence 22 12234578999999999999999999999999999999999999864221 11111111 1111110 00
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..........+.+|+.+||+.||++|||+.|+++
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111223457889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=344.85 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=203.6
Q ss_pred hcCCCcccccccCCcEEEEEeecCC-C-------ceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS-G-------QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
.++|.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678999999999999999998643 3 4699999987777777889999999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC--------eE
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PK 487 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--------~k 487 (674)
.++||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999853 2334999999999999999999999998 999999999999998887 99
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||++.... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.|+.. ..........
T Consensus 162 l~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~--~~~~~~~~~~--- 230 (289)
T 4fvq_A 162 LSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS--ALDSQRKLQF--- 230 (289)
T ss_dssp ECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT--TSCHHHHHHH---
T ss_pred eccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc--ccchHHHHHH---
Confidence 99999986542 1233568899999999987 6799999999999999999997655321 1111111111
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
...... .+......+.+++.+||+.||++|||+.++++.|++...
T Consensus 231 -~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 -YEDRHQ-----------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HHTTCC-----------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -hhccCC-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111000 011112346789999999999999999999999988644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=348.42 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=195.5
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe---
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE--- 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 415 (674)
..++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999995 5789999999976432 234578899999999999999999999876543
Q ss_pred -eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 416 -KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 416 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999984 3456999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCC-CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.... .....+........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCCCC
Confidence 876433222 22334578999999999999999999999999999999999999974221 11122222222111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHH-HHHhc
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV-LMLNS 620 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl-~~L~~ 620 (674)
.. ... .......+.+++.+||+.||++||++.+++ ..|..
T Consensus 238 ~~---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 238 PP---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CH---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cc---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 10 000 112334688999999999999999665554 44544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=349.96 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=193.9
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.++||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999964 788999999976433 236688999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC--eEEeeeCCccccCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMARIFGVD 500 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--~ki~DfGla~~~~~~ 500 (674)
+++|+|..++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999998884 3456999999999999999999999988 999999999999987776 999999999743222
Q ss_pred CCCCccccccccCCccCccccccCCCCcc-ccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVK-SDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.|+...... ............... ..
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~~~~--~~--- 241 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSVKY--SI--- 241 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHTTCC--CC---
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhcCCC--CC---
Confidence 22334579999999999988887665 89999999999999999997533221 122222222111110 00
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.........+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 ----PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0011123567899999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.60 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=198.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCce----eEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQE----IAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|++.++||+|+||.||+|.+. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999853 4554 477776543 3455788999999999999999999999998765 78
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999998854 2456999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...+........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~~~~~-------- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGE-------- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHTTC--------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHcCC--------
Confidence 54443333344567889999999999999999999999999999999 998875322 222222221111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
....+......+.+++.+||+.||.+||++.|+++.|+...
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112233446889999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.13 Aligned_cols=261 Identities=25% Similarity=0.318 Sum_probs=197.7
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.++||+|+||.||++... +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999964 589999999865432 234667899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|..++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988874 3456999999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC----------
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD---------- 570 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~---------- 570 (674)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+..... .+.+.........
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD---VDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhcccccccccccc
Confidence 12234578999999999876 6789999999999999999999998753322 1222221111111
Q ss_pred -CCc---ceecccccCCC---CChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 -GTP---LQLLDTNLTDS---YSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 -~~~---~~~~d~~~~~~---~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... ..+.++..... ........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000000000 00123446889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.11 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=194.3
Q ss_pred hcCCCcccccccCCcEEEEEeec----CCCceeEEEEecccC----ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
.++|++.+.||+|+||.||+++. .+|+.||+|++.+.. ......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999985 478999999997642 2334567889999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999998884 3456899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+... .....+..... ..
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~---~~---- 237 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKILK---CK---- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHH---TC----
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHh---CC----
Confidence 543221 2233457999999999999999999999999999999999999997432 12222222211 10
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
...+......+.+++.+||+.||++|| ++.++++.
T Consensus 238 -------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 -------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011222345788999999999999999 77787753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.19 Aligned_cols=250 Identities=24% Similarity=0.288 Sum_probs=179.3
Q ss_pred ccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEecCCCc
Q 005846 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKS 427 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 427 (674)
.+.||+|+||.||++... +++.||||++... ....+.+|+.++.++. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6889999999653 3466789999999997 9999999999999999999999999999
Q ss_pred ccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC---CeEEeeeCCccccCCCCCCC
Q 005846 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~ki~DfGla~~~~~~~~~~ 504 (674)
|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 9998843 457999999999999999999999998 99999999999997766 79999999998654322 2
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....................+.... ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Ccc
Confidence 23345789999999999999999999999999999999999999764332211111112222222221100 000
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
........+.+|+..||+.||++|||+.|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 01123457889999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.04 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=208.1
Q ss_pred hcCCCccc-ccccCCcEEEEEeecC---CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|.+.+ .||+|+||.||+|.+. ++..||||++.... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 8999999999999853 57789999997643 34467789999999999999999999999 5667899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999998853 3456999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCC-CccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ..+...... .+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~i~----~~~~--- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIE----QGKR--- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHH----TTCC---
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHh----cCCc---
Confidence 33221 12223456889999999998899999999999999999999 998864322 122222221 1111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
...+......+.+++..||+.||++||++.++++.|+....+.
T Consensus 232 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 232 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1122234457889999999999999999999999998754443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.55 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=203.2
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 415 (674)
....++|.+.+.||+|+||.||+++.. +|+.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999964 68899999997532 34456778899999887 99999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....+...... ...
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~----~~~-- 235 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRM----DNP-- 235 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CCC--
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHh----CCC--
Confidence 543221 2234568999999999999999999999999999999999999997422 22222222211 110
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA-TIV 615 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~-evl 615 (674)
.++......+.+++.+||+.||++||++. +|+
T Consensus 236 --------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11222345688999999999999999997 665
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.77 Aligned_cols=264 Identities=27% Similarity=0.366 Sum_probs=199.2
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-----ccCHHHHHHHHHHHHhcC---CCceeeEEeEEEe
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-----GQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLE 412 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 412 (674)
...++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999995 568899999986432 122345677888877775 9999999999987
Q ss_pred CC-----eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 413 GE-----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 413 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
.. ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 5799999997 5888887542 2334999999999999999999999998 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+... ...+.+......
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~ 234 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN---SEADQLGKIFDL 234 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS---SHHHHHHHHHHH
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHH
Confidence 9999999865422 2234567899999999999999999999999999999999999986432 222333333222
Q ss_pred hcCCCccee------cccccCC-------CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 568 WRDGTPLQL------LDTNLTD-------SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 568 ~~~~~~~~~------~d~~~~~-------~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......... ....+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 211110000 0000000 011123457889999999999999999999885
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=334.78 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=204.3
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357899999999999999999864 68899999986543 3345778999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999884 3456999999999999999999999988 9999999999999999999999999998664333
Q ss_pred CCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.|+....... .. ...+.......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~~~~~~~----- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QE----YSDWKEKKTYL----- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HH----HHHHHTTCTTS-----
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HH----HHHhhhccccc-----
Confidence 2233345678999999999987765 789999999999999999999975432211 11 11111111000
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001123346788999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=335.90 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=208.2
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
.++|++.+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467889999999999999999988888999999976433 4578899999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++++|.+++.. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 99999999853 2346899999999999999999999998 99999999999999999999999999986542211
Q ss_pred CccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+... .......... .+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~i~----~~~~--------- 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDIS----TGFR--------- 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHH----TTCC---------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC---CHHHHHHHHh----cCCc---------
Confidence 11223456788999999998999999999999999999999 78876422 1112222111 1111
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++.+||+.||++||++.++++.|+..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=352.35 Aligned_cols=267 Identities=19% Similarity=0.269 Sum_probs=202.6
Q ss_pred hcCCCcccccccC--CcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDNKLGEG--GFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|++.++||+| +||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999965 68999999996543 3345678889999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998542 2356999999999999999999999998 9999999999999999999999999986542
Q ss_pred CCC-----CCCccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh-hhc-
Q 005846 499 VDQ-----TQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK-QWR- 569 (674)
Q Consensus 499 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~-~~~- 569 (674)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....... .+..... .+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~ 256 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPC 256 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT---HHHHC-------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHhcCCCCc
Confidence 211 1112223478999999999987 579999999999999999999999975322211 1110000 000
Q ss_pred --CC--Ccce---------e----ccc-------------ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 570 --DG--TPLQ---------L----LDT-------------NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 570 --~~--~~~~---------~----~d~-------------~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.. ...+ . ... .....++......+.+|+.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000 0 000 00001122234568899999999999999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.91 Aligned_cols=272 Identities=23% Similarity=0.310 Sum_probs=202.1
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHh--cCCCceeeEEeEEEeC-
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK--LQHRNLVRLLGFCLEG- 413 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~- 413 (674)
....+...++|++.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3444556789999999999999999999984 8999999986432 2344555555554 4999999999999887
Q ss_pred ---CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCcEEEeecccccEEEcCCCC
Q 005846 414 ---EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS-----RLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 414 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiHrDlkp~NIll~~~~~ 485 (674)
...++||||+++|+|.+++. ...+++..++.++.||+.||.|||+.. +.+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 78899999999999999984 346999999999999999999999870 113999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCC--ccccccccCCccCccccccCCCCcc------ccEEeechhhhHhHhC----------CC
Q 005846 486 PKISDFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMHGQFSVK------SDVYSFGVLVLEIITG----------KK 547 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------~DvwS~Gv~l~elltg----------~~ 547 (674)
+||+|||+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||+|| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999998764332221 1224579999999999987766665 9999999999999999 44
Q ss_pred CCCccCCCCccchHHHHHhhhcCCCcceecccccCCC-CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 548 NSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS-YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 548 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
|+....... .............. ..+..... ........+.+++.+||+.||++|||+.+|++.|+...
T Consensus 261 p~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 261 PYHDLVPSD--PSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTTTTSCSS--CCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHhhhcCCC--CchhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 433221111 11111111111111 01111111 12256678999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.93 Aligned_cols=261 Identities=23% Similarity=0.238 Sum_probs=200.8
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-----CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-----SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
+....++|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445678999999999999999999985 46788999998643 334567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCcccccccCCCc-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEK-------------------------------------QGQLDWSRRYKIIGGIARG 456 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~~ 456 (674)
+..++||||+++|+|.+++..... ...+++..++.++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999888742100 1124677888999999999
Q ss_pred HHHHHhcCCCcEEEeecccccEEEcCCC--CeEEeeeCCccccCCCCCC--CccccccccCCccCcccccc--CCCCccc
Q 005846 457 ILYLHEDSRLRIIHRDLKASNILLDAEM--NPKISDFGMARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMH--GQFSVKS 530 (674)
Q Consensus 457 L~~LH~~~~~~iiHrDlkp~NIll~~~~--~~ki~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~k~ 530 (674)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 8999999999876432211 12344679999999999875 6789999
Q ss_pred cEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC
Q 005846 531 DVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610 (674)
Q Consensus 531 DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt 610 (674)
||||||+++|||++|+.|+.... ..+... .......... ..........+.+++.+||+.||++||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~---~~~~~~---~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVN---DADTIS---QVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCC---hHHHHH---HHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999864321 112222 1121111100 0001123456889999999999999999
Q ss_pred HHHHHH
Q 005846 611 MATIVL 616 (674)
Q Consensus 611 ~~evl~ 616 (674)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.98 Aligned_cols=244 Identities=24% Similarity=0.266 Sum_probs=203.4
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999964 6899999998653 2344677899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999884 3356999999999999999999999998 999999999999999999999999999875422
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+... .......... .+..
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~----~~~~------- 255 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIV----SGKV------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH----HCCC-------
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHH----cCCC-------
Confidence 23457999999999999999999999999999999999999997422 1222222111 1110
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
.++......+.+++.+||+.||++||+ +++|++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112223456889999999999999998 888875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.35 Aligned_cols=264 Identities=18% Similarity=0.272 Sum_probs=208.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEE-EeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 421 (674)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... +.+.+|+.+++.++|++++..+.++ ..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56899999999999999999995 57899999998654433 4688999999999988877666655 56778899999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE---cCCCCeEEeeeCCccccC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~ki~DfGla~~~~ 498 (674)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999998853 2346999999999999999999999998 9999999999999 488999999999998765
Q ss_pred CCCCCC-----ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 499 VDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 499 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...........+............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 433211 124467999999999999999999999999999999999999998754433333333322221111000
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
+.+.. ..+..+.+++.+||+.||++|||+.+|++.|+.....
T Consensus 240 -----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 240 -----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 00111 2234688999999999999999999999999875433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.48 Aligned_cols=263 Identities=18% Similarity=0.283 Sum_probs=203.8
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEE-EeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 420 (674)
..++|++.+.||+|+||.||+++. .+++.||||++...... +.+.+|+.+++.++|++++..++.+ ..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 57889999987554322 3578899999999988877776655 6677889999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE---cCCCCeEEeeeCCcccc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIF 497 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~ki~DfGla~~~ 497 (674)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999998853 2346999999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCCCC-----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 498 GVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 498 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...........+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 122346789999999999999999999999999999999999999865444333333332221111100
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
. ..... ..+..+.+++..||+.||++|||+.+|++.|++..
T Consensus 239 -~----~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 -I----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -H----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -h----hhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0 00011 12347889999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.56 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=204.0
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 419 (674)
.++|++.+.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45789999999999999999998 48899999997543 33456789999999999999999999999887 778999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++... ....+++..++.++.||++||.|||+.+ .+|+||||||+|||++.++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 9999999999999642 2336999999999999999999999864 359999999999999999999999999875422
Q ss_pred CCCCCccccccccCCccCccccccCCCCc---cccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSV---KSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.|+.... .... .......+..
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~---~~~~~~~~~~--- 229 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---NMEI---GMKVALEGLR--- 229 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC---HHHH---HHHHHHSCCC---
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC---hHHH---HHHHHhcCCC---
Confidence 12346899999999998765544 8999999999999999999974221 1111 1111111111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
...+......+.+++..||+.||++|||+.++++.|+...
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 ------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122233457889999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=346.35 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=203.1
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
...++|++.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999965 4788999999753 234456788999999987 899999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++|+|..++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999884 3356999999999999999999999998 99999999999999999999999999985
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.. .....+...... . ..
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i~~---~-~~--- 238 (353)
T 2i0e_A 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIME---H-NV--- 238 (353)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH---C-CC---
T ss_pred cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC---CCHHHHHHHHHh---C-CC---
Confidence 4222 1233456899999999999999999999999999999999999999742 222222222211 1 10
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
.++......+.+|+.+||+.||++||+ +++|++
T Consensus 239 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112233457889999999999999995 577664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.98 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=204.1
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999964 78999999996532 23456789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456999999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.|+... ....+..... .+..
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~----~~~~----- 233 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD---HVPTLFKKIC----DGIF----- 233 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS---SSHHHHHHHH----TTCC-----
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC---CHHHHHHHHh----cCCc-----
Confidence 22 2334579999999999988775 68999999999999999999997422 2222222211 1111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+|+.+||+.||++|||+.||++
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011122346789999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=343.88 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=198.3
Q ss_pred hcCCCcc-cccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.+.|++. +.||+|+||.||++.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999985 47899999999877666678899999999985 7999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC---eEEeeeCCcccc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARIF 497 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~ki~DfGla~~~ 497 (674)
||+++++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999853 356999999999999999999999998 999999999999998776 999999999765
Q ss_pred CCCCC-----CCccccccccCCccCcccccc-----CCCCccccEEeechhhhHhHhCCCCCCccCCCCccc--------
Q 005846 498 GVDQT-----QGNTSRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD-------- 559 (674)
Q Consensus 498 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~-------- 559 (674)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223469999999999875 568899999999999999999999976433221000
Q ss_pred hHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 560 LLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...........+.. ..... .. ......+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~-~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDK-DW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHH-HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCc-ccCch-hc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00011111111110 00000 00 112346889999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.52 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=183.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999985 578999999986432 23357789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999998853 2356999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+....... .+. ... .. +.
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~-~~------~~ 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLN---KVV-LA------DY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SS------CC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHH---HHh-hc------cc
Confidence 221 2223578999999999998899999999999999999999999875322211 100 000 00 00
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.||++||++.++++
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 ----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112223457789999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=374.66 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=202.1
Q ss_pred hcCCCccc-ccccCCcEEEEEeecC---CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+.+|++++||||+++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34455555 7999999999999863 45679999997643 3456889999999999999999999999876 56899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999853 3456999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
...... ......+++.|+|||++.+..++.++|||||||++|||+| |+.|+.... ..++..... .+..
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~~~i~----~~~~--- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIE----QGKR--- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---SHHHHHHHH----TTCC---
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH----cCCC---
Confidence 332211 1222345789999999999999999999999999999998 998865322 222222221 1111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
...+......+.+|+..||+.||++||++.+|++.|+...
T Consensus 558 ------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 558 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1122334457889999999999999999999999998743
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.08 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=203.5
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
..++|++.+.||+|+||.||++... ++..||+|++........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999864 467899999987666677889999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE---cCCCCeEEeeeCCccccC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~ki~DfGla~~~~ 498 (674)
|+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999988874 3456999999999999999999999998 9999999999999 888999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.|+.... ..+...... .+.... ..
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~----~~~~~~-~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIR----EGTFTF-PE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HCCCCC-CH
T ss_pred Ccc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHH----hCCCCC-Cc
Confidence 332 2234578999999998865 49999999999999999999999964321 111111111 111000 00
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... ......+.+++.+||+.||++|||+.++++
T Consensus 229 -~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 -KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 012346889999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=346.08 Aligned_cols=271 Identities=24% Similarity=0.305 Sum_probs=197.9
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHH--HHhcCCCceeeEEeEEEe-----CCe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVL--VAKLQHRNLVRLLGFCLE-----GEE 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~-----~~~ 415 (674)
..++|++.+.||+|+||.||+|+. +++.||||++.... .+.+..|.++ +..++|+||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 346899999999999999999987 68999999996543 2344444444 455899999999986543 235
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCcEEEeecccccEEEcCCCCe
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---------SRLRIIHRDLKASNILLDAEMNP 486 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~~~~iiHrDlkp~NIll~~~~~~ 486 (674)
.++||||+++|+|.+++. ....++..++.++.||++||.|||+. + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 689999999999999984 33468999999999999999999988 6 9999999999999999999
Q ss_pred EEeeeCCccccCCCCC------CCccccccccCCccCcccccc-------CCCCccccEEeechhhhHhHhCCCCCCccC
Q 005846 487 KISDFGMARIFGVDQT------QGNTSRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553 (674)
Q Consensus 487 ki~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~ 553 (674)
||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987643221 112234579999999999976 456789999999999999999987643222
Q ss_pred CCC-ccchHH----------HHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 554 TDG-AADLLS----------YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 554 ~~~-~~~~l~----------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
... ...... ..............+.... .........+.+|+.+||+.||++|||+.|+++.|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 111 111111 0000011110000011000 112235667999999999999999999999999998865
Q ss_pred CCCC
Q 005846 623 VTLP 626 (674)
Q Consensus 623 ~~~~ 626 (674)
..+.
T Consensus 318 ~~~~ 321 (336)
T 3g2f_A 318 MIWE 321 (336)
T ss_dssp HCCC
T ss_pred HHHH
Confidence 4443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.83 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=204.3
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe---------
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--------- 412 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 412 (674)
..++|++.+.||+|+||.||++... +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999975 78999999997653 346789999999999999999998864
Q ss_pred -------CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC
Q 005846 413 -------GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 413 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~ 485 (674)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999998542 3457999999999999999999999998 999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.. ....+
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFF 228 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHH
Confidence 9999999998764332 22334689999999999999999999999999999999999987421 01111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
.....+. + +......+.+++.+||+.||++|||+.|+++.|+......
T Consensus 229 ~~~~~~~--------~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 229 TDLRDGI--------I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHTTC--------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHhhccc--------c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1111111 1 1122345778999999999999999999999998765443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.03 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=200.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..++|++.+.||+|+||.||++... +|+.||||++.+.... ..+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999864 6889999999765433 35688888888 7999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC----CCeEEeeeCCccc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISDFGMARI 496 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~----~~~ki~DfGla~~ 496 (674)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999998884 3456999999999999999999999998 9999999999998543 3499999999987
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.........+++.... .+...
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~-- 241 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS-- 241 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC--
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc--
Confidence 64332 22334578999999999988889999999999999999999999976433222222222221 11110
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+...+.......+.+|+.+||+.||++||++.++++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111233457889999999999999999999885
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.17 Aligned_cols=271 Identities=23% Similarity=0.284 Sum_probs=209.3
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHh--cCCCceeeEEeEEEe
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAK--LQHRNLVRLLGFCLE 412 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~ 412 (674)
.++...+...++|.+.+.||+|+||.||+++. +|+.||||++... ..+.+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34445566778999999999999999999998 5899999999643 34567889998888 799999999999988
Q ss_pred CC----eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEEeecccccEEE
Q 005846 413 GE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILL 480 (674)
Q Consensus 413 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiHrDlkp~NIll 480 (674)
.. ..++||||+++|+|.+++. ...+++..++.++.||+.||.||| +.+ |+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 76 7899999999999999984 346999999999999999999999 655 9999999999999
Q ss_pred cCCCCeEEeeeCCccccCCCCCCC--ccccccccCCccCccccccC------CCCccccEEeechhhhHhHhC-------
Q 005846 481 DAEMNPKISDFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITG------- 545 (674)
Q Consensus 481 ~~~~~~ki~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwS~Gv~l~elltg------- 545 (674)
+.++.+||+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999998764332211 22345789999999998765 234789999999999999999
Q ss_pred ---CCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC-CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 546 ---KKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS-YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 546 ---~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
+.|+....... ............... .+.+... ........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 261 ~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 261 EDYQLPYYDLVPSD--PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCTTTTTSCSS--CCHHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCccccCcCc--ccHHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 45543221111 111111221111111 1111111 1235667899999999999999999999999999875
Q ss_pred C
Q 005846 622 S 622 (674)
Q Consensus 622 ~ 622 (674)
.
T Consensus 335 ~ 335 (342)
T 1b6c_B 335 S 335 (342)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.00 Aligned_cols=260 Identities=28% Similarity=0.362 Sum_probs=205.2
Q ss_pred CCCcccccccCCcEEEEEeecCC----CceeEEEEecccCc-cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee-EEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASG-QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK-ILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-~lv 419 (674)
.|...++||+|+||.||+|.+.+ +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999998532 23699999876433 3457789999999999999999999999876655 999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
+||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 3456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CC--CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 500 DQ--TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 500 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.. .........+++.|+|||.+.+..++.++||||||+++|||++|+.|+. ......+...........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~--~~~~~~~~~~~~~~~~~~------- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--RHIDPFDLTHFLAQGRRL------- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT--TTSCGGGHHHHHHTTCCC-------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC--ccCCHHHHHHHhhcCCCC-------
Confidence 22 1122334567899999999999999999999999999999999776632 222222332222211110
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
..+......+.+++..||+.||.+|||+.++++.|++....+
T Consensus 248 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 248 ------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 112223346889999999999999999999999998754443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.73 Aligned_cols=251 Identities=20% Similarity=0.240 Sum_probs=190.1
Q ss_pred cCCCcc-cccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHh-cCCCceeeEEeEEEe----CCeeE
Q 005846 345 NKFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAK-LQHRNLVRLLGFCLE----GEEKI 417 (674)
Q Consensus 345 ~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~----~~~~~ 417 (674)
++|.+. +.||+|+||.||++... +|+.||||++... ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999864 6889999998642 456788888754 589999999999875 56789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeEEeeeCCc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 494 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ki~DfGla 494 (674)
|||||+++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998542 2346999999999999999999999988 999999999999998 789999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCcc-chHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA-DLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~-~~l~~~~~~~~~~~~ 573 (674)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ........ +..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~ 284 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc
Confidence 865422 2233567899999999999999999999999999999999999997543322211 11111111 100
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
....+ . .......+.+|+.+||+.||++|||+.|+++.
T Consensus 285 -~~~~~-~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -EFPNP-E----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCCTT-T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCc-c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0 01233568899999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=338.99 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=204.2
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
.++|++.+.||+|+||.||++... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999964 688999999865432 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC----CeEEeeeC
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 492 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~ki~DfG 492 (674)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 456899999999999999999999998 99999999999999888 79999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+... ...+.+.... ...
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~----~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANIT----SVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHH----TTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHH----hcc
Confidence 998764322 223457899999999999999999999999999999999999986422 1112221111 111
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. . .++.. .......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~-~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y-D-FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C-C-CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c-c-cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0 00000 1122346789999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.88 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=200.1
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
..++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3468999999999999999999854 5778999998543 22335678999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999998884 3356999999999999999999999987 9999999999999999999999999986543
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+... ........... ..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~----~~------ 223 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISR----VE------ 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH----TC------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC---cHHHHHHHHHh----CC------
Confidence 22 223457899999999999999999999999999999999999986422 11111111111 00
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
...+......+.+++.+||+.||++|||+.|+++.
T Consensus 224 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01122234567899999999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.59 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCcEEEEEeecCC----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~ 417 (674)
..+|++.+.||+|+||.||+|.+.+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568889999999999999998532 2358999987533 3345678999999999999999999998754 55789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999853 3456899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCCC--CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 498 GVDQTQ--GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+. ......+...........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~----- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRRL----- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS--TTSCTTTHHHHHHTTCCC-----
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC--ccCCHHHHHHHHhcCCCC-----
Confidence 433211 12233467889999999999999999999999999999999655431 112222222222111100
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTL 625 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 625 (674)
..+......+.+++.+||+.||++|||+.++++.|+......
T Consensus 252 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011122346889999999999999999999999998765443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.40 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=199.8
Q ss_pred hcCCCcccccccCCcEEEEEeecCC-----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.++|...+.||+|+||.||+|.+.. +..||||++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4578888999999999999998642 2359999997543 334557889999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999853 3356999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 498 GVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+... ...++.... ..+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~---~~~~~~~~~----~~~~~-- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKAI----NDGFR-- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHH----HTTCC--
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC---CHHHHHHHH----HCCCc--
Confidence 4332211 1223356788999999999999999999999999999999 98886422 112222221 11111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++.+||+.||++||++.+|+++|+..
T Consensus 269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011223345688999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=355.62 Aligned_cols=264 Identities=20% Similarity=0.212 Sum_probs=206.9
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
+.+.+.+...++|++.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667889999999999999999999964 68999999996532 12234578899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
.+.+..++||||+++|+|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999853 2346999999999999999999999988 99999999999999999999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccc-------cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHH
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~ 563 (674)
||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.|+... ...+....
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~ 281 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGK 281 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHH
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC---CHHHHHHH
Confidence 999987643322 1223457999999999987 356899999999999999999999997432 22222222
Q ss_pred HHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 005846 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER---PSMATIVLM 617 (674)
Q Consensus 564 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R---Pt~~evl~~ 617 (674)
.......... +. ........+.+|+.+||+ +|++| |+++||++.
T Consensus 282 i~~~~~~~~~-----p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKEHLSL-----PL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHHHCCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcccCcCC-----Cc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2111000000 00 011233478899999999 99998 689998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.97 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=202.3
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999854 6889999998653 2334567889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC---eEEeeeCCcccc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMARIF 497 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~ki~DfGla~~~ 497 (674)
||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988774 3456999999999999999999999998 999999999999987665 999999999866
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+... ............ ... ..
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~~~~~~----~~~-~~ 227 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAG----AYD-YP 227 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHT----CCC-CC
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC---chhHHHHHHHhc----ccc-CC
Confidence 4322 223457899999999999999999999999999999999999986421 111222211111 100 00
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. .........+.+++.+||+.||++|||+.|+++
T Consensus 228 ~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 S-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 001122346789999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.64 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=200.0
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
++|.....||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3556667999999999999995 568899999998766666788999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeCCccccCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfGla~~~~~~~~ 502 (674)
++++|.+++........+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999865444456789999999999999999999988 999999999999987 8999999999998754321
Q ss_pred CCccccccccCCccCccccccCC--CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.|+...... .... ...... .
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~-~~~~~~-~---------- 242 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAM-FKVGMF-K---------- 242 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHH-HHHHHH-C----------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHH-Hhhccc-c----------
Confidence 1223457899999999987654 889999999999999999999987432111 1110 110011 0
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.....+......+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001112233457889999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.65 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=207.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-----CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--ee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~ 416 (674)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45788999999999999999983 468899999998776666778999999999999999999999987654 67
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998532 346999999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC--------CCCc-cchHHHHHh
Q 005846 497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ--------TDGA-ADLLSYAWK 566 (674)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~--------~~~~-~~~l~~~~~ 566 (674)
........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+.... .... .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65432211 1223456778999999998899999999999999999999998753210 0000 000001111
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+. ....+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1112233445788999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=340.96 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=203.0
Q ss_pred hhcCCCccc-ccccCCcEEEEEeec---CCCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 343 ATNKFSTDN-KLGEGGFGEVYKGVL---PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 343 ~~~~~~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
..++|.+.+ .||+|+||.||+|.+ ..++.||||++..... ...+++.+|+.++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345778877 999999999999953 3467899999975432 2356789999999999999999999998 66778
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999853 456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+.... ...+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~----~~~~~~~ 239 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAM----LEKGERM 239 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHH----HHTTCCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH----HHcCCCC
Confidence 64433221 1222346788999999998889999999999999999999 998864321 1122211 1111111
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
..+......+.+++..||+.||++||++.+|++.|+++.
T Consensus 240 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112233457889999999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=360.17 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=194.6
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
..++|++.++||+|+||.||++.. .+|+.||||++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999985 46889999999753 33344567889999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
||||+++|+|..++. ....+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999988884 34579999999999999999999998 77 999999999999999999999999999854
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....+...... ...
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~---~~~----- 366 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILM---EEI----- 366 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH---CCC-----
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHHHh---CCC-----
Confidence 322 12234468999999999999999999999999999999999999997422 22222222211 110
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
.++......+.+|+.+||+.||++|| +++|+++
T Consensus 367 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11222345788999999999999999 9999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.87 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=197.9
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe--------C
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--------G 413 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~ 413 (674)
++|++.++||+|+||.||+++. .+|+.||||++.... ......+.+|+.++++++||||+++++++.. +
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5899999999999999999996 578999999986543 2334577899999999999999999999987 3
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
+..++||||+++ +|...+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999986 55555432 2346999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC--CCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 494 ARIFGVDQT--QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 494 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+... .....+.........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCC
Confidence 987653222 122344578999999999876 45899999999999999999999986532 222222222221111
Q ss_pred CC---cceecccccC--------CCCC-hh------HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 GT---PLQLLDTNLT--------DSYS-RN------EVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 ~~---~~~~~d~~~~--------~~~~-~~------~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. .......... .... .. ....+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11 0000000000 0000 00 1235789999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=347.68 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=202.8
Q ss_pred hcCCCcccccccCCcEEEEEeec----CCCceeEEEEecccC----ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGE 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 414 (674)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999986 478999999986532 23345677899999999 6999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++||||+++++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999853 356999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccC--CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+........ ............
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~- 282 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE- 282 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC-
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC-
Confidence 86543222 223346799999999999853 478999999999999999999999754332221 111111111110
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLML 618 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~L 618 (674)
..++......+.+|+.+||+.||++|| ++.|+++..
T Consensus 283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112223345678999999999999999 999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=336.17 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=198.1
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 418 (674)
..++|++.+.||+|+||.||++... +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3568999999999999999999965 78999999987542 33456788999999999 99999999999999999999
Q ss_pred EEEecCCCcccccccCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC--------------
Q 005846 419 VYEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-------------- 483 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-------------- 483 (674)
||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999854221 256999999999999999999999998 9999999999999844
Q ss_pred -----CCeEEeeeCCccccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCc
Q 005846 484 -----MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557 (674)
Q Consensus 484 -----~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~ 557 (674)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------ 233 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN------ 233 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS------
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc------
Confidence 479999999998764322 23589999999999866 667899999999999999999876421
Q ss_pred cchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+. +.....+... ..+......+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~----~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 GDQ----WHEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp SHH----HHHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhH----HHHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 1111121111 112223457889999999999999999999885
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=340.64 Aligned_cols=264 Identities=23% Similarity=0.370 Sum_probs=199.3
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4789999999999999999985 578999999997532 334567889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||+++++|.+++.... ....+++..++.++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999998885322 2456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... ......... ..........
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~~~~~-- 259 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKK-IEQCDYPPLP-- 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHH-HHTTCSCCCC--
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHHH-hhcccCCCCc--
Confidence 22 12234578999999999999999999999999999999999999864221 111111111 1111111100
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 626 (674)
.......+.+++.+||+.||++||++.+|++.|+++....+
T Consensus 260 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 260 ------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11223468899999999999999999999999988654443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.63 Aligned_cols=257 Identities=15% Similarity=0.141 Sum_probs=206.1
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEee------cCCCceeEEEEecccCccCHHHHHHHHHHHHhcC---CCceeeEEeE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGF 409 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~ 409 (674)
+++...++|.+.++||+|+||.||+|. ..+++.||||++... ...++..|+.++.+++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344556789999999999999999994 456889999999754 3456788888888886 9999999999
Q ss_pred EEeCCeeEEEEEecCCCcccccccCCC--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-----
Q 005846 410 CLEGEEKILVYEFVPNKSLDYFLYDPE--KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----- 482 (674)
Q Consensus 410 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~----- 482 (674)
+..++..++||||+++|+|.+++.... ....+++..++.|+.||++||.|||+.+ |+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 999999999999999999999985321 3456999999999999999999999988 999999999999998
Q ss_pred ------CCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCC
Q 005846 483 ------EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556 (674)
Q Consensus 483 ------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~ 556 (674)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.|+.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976543333334455679999999999999999999999999999999999999864221110
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCC-CCHHHHHHHHhcCC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAER-PSMATIVLMLNSYS 622 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R-Pt~~evl~~L~~~~ 622 (674)
..+...+... + ....+.+++..|++.+|.+| |++.++.+.|+...
T Consensus 293 ------------------~~~~~~~~~~-~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 ------------------CKPEGLFRRL-P--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ------------------EEECSCCTTC-S--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ------------------eeechhcccc-C--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0111111111 1 23355678888999999998 58888888887643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.56 Aligned_cols=246 Identities=29% Similarity=0.417 Sum_probs=197.4
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+.|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999985 578999999986543 223467889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+. |+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 566666532 2456999999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.....||+.|+|||++. ++.++.++|||||||++|||++|+.|+.... .............+ ...
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~~-~~~ 274 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP-ALQ 274 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CCC
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCC-CCC
Confidence 22357899999999984 5679999999999999999999999864221 11112222222111 000
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+......+.+++.+||+.||++|||++++++.
T Consensus 275 --------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223467889999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=343.36 Aligned_cols=261 Identities=31% Similarity=0.475 Sum_probs=204.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
...++|++.+.||+|+||.||+|++ .+++.||||++... ......++.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3457899999999999999999984 25678999999654 3344567899999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeE
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPK 487 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~k 487 (674)
..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999864321 245899999999999999999999998 999999999999984 45699
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||+++...............|++.|+|||.+.+..++.++||||||+++|||+| |+.|+... ..........
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---~~~~~~~~~~- 259 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVT- 259 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHH-
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc---CHHHHHHHHh-
Confidence 999999986544333333344578899999999999999999999999999999998 88776422 2222222221
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+... ..+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 260 ---~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 ---SGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111 11222345688999999999999999999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=350.10 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=194.6
Q ss_pred CCCcccccccCCcEEEEEeecC--CC--ceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCeeEEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILV 419 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv 419 (674)
.|+..+.||+|+||.||+|.+. ++ ..||||.+.... ....++|.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999853 22 358999986533 3445789999999999999999999999765 4578999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999853 3456899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCCCC--ccccccccCCccCccccccCCCCccccEEeechhhhHhHhC-CCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 500 DQTQG--NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 500 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... ......+++.|+|||.+.+..++.++||||||+++|||+|| .+|+... ...+........ ...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~---~~~~~~~~~~~~----~~~-- 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQG----RRL-- 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CSSCHHHHHHTT----CCC--
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC---CHHHHHHHHHcC----CCC--
Confidence 22111 22334578899999999999999999999999999999995 5554322 222222222211 110
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 626 (674)
..+......+.+++.+||+.||++||++.++++.|+.....+.
T Consensus 316 -------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0112233468899999999999999999999999987654443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.67 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=192.4
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC--e
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--E 415 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~ 415 (674)
...++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999985 46899999998653 3344567789999999997 999999999997654 6
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 57877773 357999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCC-------------------CCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCC
Q 005846 496 IFGVDQ-------------------TQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTD 555 (674)
Q Consensus 496 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~ 555 (674)
.+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++|+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--- 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS--- 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 753211 1112234579999999999986 67999999999999999999999987532
Q ss_pred CccchHHHHHhhhcCCCccee-----------c----------ccccCCCC------------ChhHHHHHHHHHhhccc
Q 005846 556 GAADLLSYAWKQWRDGTPLQL-----------L----------DTNLTDSY------------SRNEVIRCIQLGLLCVQ 602 (674)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~-----------~----------d~~~~~~~------------~~~~~~~~~~li~~Cl~ 602 (674)
...+.+..............+ + .......+ .......+.+|+.+||+
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 222222222221111110000 0 00000000 00223468899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 005846 603 EDPAERPSMATIVLM 617 (674)
Q Consensus 603 ~dP~~RPt~~evl~~ 617 (674)
.||++|||++|+++.
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=334.61 Aligned_cols=261 Identities=20% Similarity=0.263 Sum_probs=198.7
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc---CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ---GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||++... +++.||+|++...... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999964 6889999999764322 346788999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... .. ............ .
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~---~~~~~~~~~~~~---~- 254 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ----LS---VMGAHINQAIPR---P- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH----HH---HHHHHHHSCCCC---G-
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch----HH---HHHHHhccCCCC---c-
Confidence 221 12234578999999999999999999999999999999999999864321 11 111111111100 0
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHhcCCCCC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERP-SMATIVLMLNSYSVTL 625 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-t~~evl~~L~~~~~~~ 625 (674)
...+......+.+++.+||+.||++|| +++++++.|+......
T Consensus 255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 011122334678899999999999999 9999999998865443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.01 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=192.8
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE 414 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 414 (674)
.......++|++.++||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 33445567899999999999999999984 4788999999965432 23456789999999999999999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE-----cCCCCeEEe
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKIS 489 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll-----~~~~~~ki~ 489 (674)
..++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 107 ~~~lv~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEEEEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEEEEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999999984 8888874 3446999999999999999999999998 9999999999999 455569999
Q ss_pred eeCCccccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+... ...+.+.......
T Consensus 180 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~~~~~~ 254 (329)
T 3gbz_A 180 DFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD---SEIDQLFKIFEVL 254 (329)
T ss_dssp CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHH
T ss_pred cCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC---CHHHHHHHHHHHh
Confidence 999998764332 223345789999999999875 4899999999999999999999986432 2222222222211
Q ss_pred cCCCccee----------------cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 569 RDGTPLQL----------------LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 569 ~~~~~~~~----------------~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
........ ....+...........+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11100000 0000000001113356789999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=359.92 Aligned_cols=255 Identities=29% Similarity=0.375 Sum_probs=206.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
..++|++.+.||+|+||.||+++.. +|+.||||++.+. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999864 6899999999653 23345678899999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|..++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999888542 2345999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.|+...........+........
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--------- 405 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--------- 405 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc---------
Confidence 322 22345899999999999998999999999999999999999999754322211111111111110
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVLM 617 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~~ 617 (674)
..++......+.+|+.+||+.||++|| +++||++.
T Consensus 406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 112223345788999999999999999 78888753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=339.64 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=206.5
Q ss_pred cchhhHHHhhcCCCcc-cccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhc-CCCceeeEEeE
Q 005846 335 FDFETIEVATNKFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKL-QHRNLVRLLGF 409 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~ 409 (674)
..+...+...++|.+. +.||+|+||.||++... +++.||+|++... .......+.+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455566777788887 88999999999999864 6899999998653 334467889999999999 56999999999
Q ss_pred EEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCe
Q 005846 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNP 486 (674)
Q Consensus 410 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ 486 (674)
+.+.+..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999998843 23457999999999999999999999998 999999999999988 7899
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.... ..+.......
T Consensus 174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~ 247 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQ 247 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH
T ss_pred EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHh
Confidence 999999998764322 2234579999999999999999999999999999999999999864321 1111111111
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.. .. ............+.+++.+||+.||++|||++++++.
T Consensus 248 ~~-~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 VN-VD---------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TC-CC---------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cc-cc---------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 10 00 0011112234568899999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=337.30 Aligned_cols=256 Identities=28% Similarity=0.391 Sum_probs=202.2
Q ss_pred hhcCCCcccccccCCcEEEEEeecCC----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
..++|++.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45689999999999999999998532 3359999987653 3345778999999999999999999999764 4578
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999853 3346999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ..+...........
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~---~~~~~~~~~~~~~~------ 233 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE---NKDVIGVLEKGDRL------ 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---GGGHHHHHHHTCCC------
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC---hHHHHHHHhcCCCC------
Confidence 43221 12233456889999999998999999999999999999998 998864322 22222222211110
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+++.+||+.||++||++.++++.|+..
T Consensus 234 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 -------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01122335688999999999999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=374.67 Aligned_cols=248 Identities=29% Similarity=0.434 Sum_probs=197.1
Q ss_pred cccccCCcEEEEEeec---CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVL---PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
++||+|+||.||+|.+ ..++.||||+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999964 346789999997643 334678999999999999999999999986 4568899999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC-C
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ-G 504 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~-~ 504 (674)
|+|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999984 3456999999999999999999999998 999999999999999999999999999877543322 1
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.|+... ...+...... .+.. .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~---~~~~~~~~i~----~~~~---------~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLE----KGER---------M 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHH----TTCC---------C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHH----cCCC---------C
Confidence 2233456789999999999999999999999999999999 99886432 1222222221 1111 1
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+......+.+|+..||+.||++||++.+|++.|+++
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12223345788999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.38 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=200.7
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc--------cCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--------QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
..++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999984 5788999999875421 1234577899999999999999999999999
Q ss_pred CeeEEEEEecCCC-cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 414 EEKILVYEFVPNK-SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 414 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
+..++||||+.+| +|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 8888884 3456999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+...... .
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~--- 237 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V--- 237 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T---
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H---
Confidence 998764332 2334579999999999988877 88999999999999999999997421100 0
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.... ..+......+.+++..||+.||++|||+.++++.
T Consensus 238 ------~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ------EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111223468899999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.39 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=204.9
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35689999999999999999985 468899999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999883 356999999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... .......... ... +.+
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~----~~~-----~~~ 239 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PMKVLFLIPK----NNP-----PTL 239 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH----SCC-----CCC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HHHHHHHhhc----CCC-----CCC
Confidence 12334578999999999999999999999999999999999999864321 1111111111 111 111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+......+.+++..||+.||++|||+.++++.
T Consensus 240 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11223468899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.54 Aligned_cols=259 Identities=25% Similarity=0.308 Sum_probs=194.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------C
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------E 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 414 (674)
.++|++.++||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999984 46889999999754 334456788999999999999999999999654 4
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++||||++++.+ ..+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~l~-~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCCHH-HHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 57999999987644 3431 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.+....+......+.
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~---~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR---DYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCCHH
Confidence 875432 2234568999999999999999999999999999999999999997532 2222222222211111000
Q ss_pred -------------------------eecccccCC---CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 575 -------------------------QLLDTNLTD---SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 575 -------------------------~~~d~~~~~---~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
......+.. .........+.+|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0011125578899999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=344.48 Aligned_cols=261 Identities=28% Similarity=0.366 Sum_probs=197.7
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57999999999999999999964 588999999865432 234567899999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999988763 3446999999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh-----------c
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW-----------R 569 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~-----------~ 569 (674)
.......|++.|+|||++.+. .++.++||||||+++|||++|+.|+..... .+.+....... .
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhhhHhh
Confidence 222345789999999999875 789999999999999999999998753221 11111111110 0
Q ss_pred ------CCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 570 ------DGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 570 ------~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......................+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000000001123457889999999999999999999885
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.23 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=202.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
..++|.+.+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3468999999999999999999864 689999999986655555678999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE---cCCCCeEEeeeCCccccC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~ki~DfGla~~~~ 498 (674)
|+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999988874 3456999999999999999999999998 9999999999999 788999999999987543
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
. .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+... ....+........ . . ..
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~----~-~-~~ 227 (304)
T 2jam_A 161 N----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE---TESKLFEKIKEGY----Y-E-FE 227 (304)
T ss_dssp C----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHCC----C-C-CC
T ss_pred C----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCC----C-C-CC
Confidence 2 1233457899999999999999999999999999999999999986422 1222222221111 0 0 00
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..........+.+++.+||+.||++|||+.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 ----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111223457889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=348.77 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=192.1
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--------ccCHHHHHHHHHHHHhcCCCceeeEEeEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 411 (674)
....++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34568999999999999999999985 467899999986532 112234789999999999999999999974
Q ss_pred eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC---CeEE
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKI 488 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~ki 488 (674)
.+..++||||+++|+|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 566899999999999988884 3457999999999999999999999998 99999999999997544 5999
Q ss_pred eeeCCccccCCCCCCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.|+..... ...+.....
T Consensus 284 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~i~ 358 (419)
T 3i6u_A 284 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 358 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS--SCCHHHHHH
T ss_pred eecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc--hHHHHHHHh
Confidence 999999876432 2233467999999999985 36788999999999999999999999753221 112222211
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. +.... . +.. .......+.+++.+||+.||++|||+.|+++
T Consensus 359 ~----~~~~~-~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 S----GKYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp T----TCCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c----CCCCC-C-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 11100 0 000 0122356889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=340.22 Aligned_cols=264 Identities=25% Similarity=0.313 Sum_probs=197.7
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc-----CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ-----GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
..++|++.+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999964 5899999998653221 124678999999999999999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++ +|..++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 77777643 3346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
+.... .......||+.|+|||++.+. .++.++|||||||++|||++|.+|+.. ....+.+..............
T Consensus 162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~---~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCTTT
T ss_pred ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC---CCHHHHHHHHHHHcCCCChhh
Confidence 64322 223345789999999998764 589999999999999999999987542 222333333333222111111
Q ss_pred ecc------c---ccCCCCC-----hhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 576 LLD------T---NLTDSYS-----RNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 576 ~~d------~---~~~~~~~-----~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+ . ......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0 0000001 2234578899999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.29 Aligned_cols=263 Identities=17% Similarity=0.199 Sum_probs=205.1
Q ss_pred hcCCCcccccccCCcEEEEEeecCC---------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCceee---------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPS---------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR--------- 405 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~--------- 405 (674)
.++|.+.+.||+|+||.||+++... ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999753 789999998754 35789999999999999987
Q ss_pred ------EEeEEEe-CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccE
Q 005846 406 ------LLGFCLE-GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 478 (674)
Q Consensus 406 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NI 478 (674)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999998532 2357999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEeeeCCccccCCCCCC-----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCc
Q 005846 479 LLDAEM--NPKISDFGMARIFGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 479 ll~~~~--~~ki~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876433221 112345799999999999999999999999999999999999999764
Q ss_pred cCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.... ...... ....+... ...+.+.... .......+.+++..||+.||++||++.+|+++|+...
T Consensus 271 ~~~~-~~~~~~-~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPN-TEDIMK-QKQKFVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTC-HHHHHH-HHHHHHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcC-HHHHHH-HHHhccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 3211 111222 11111111 1111111110 0112357889999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.07 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=200.7
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC------ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457899999999999999999965 68999999986532 12467899999999999999999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC----CeEEeeeC
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 492 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~ki~DfG 492 (674)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999984 3456999999999999999999999988 99999999999998877 89999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+... ...+.+.. .....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~----~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE---TKQETLTN----ISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHH----HHTTC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc---chHHHHHH----hHhcc
Confidence 998764322 223456899999999999999999999999999999999999986432 11111111 11111
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. .+.. ........+.+++.+||+.||++||++.++++
T Consensus 228 ~~--~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD--FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC--CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC--Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 0000 01122346789999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=330.37 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=197.1
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|.+.++||+|+||.||++.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46799999999999999999985 468899999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE---cCCCCeEEeeeCCcccc
Q 005846 422 FVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIF 497 (674)
Q Consensus 422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~ki~DfGla~~~ 497 (674)
|+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999998887532 22357999999999999999999999998 9999999999999 55688999999999865
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.... ......||+.|+|||.+. +.++.++||||||+++|||++|+.|+.... ..+...... ...... ..
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~~--~~~~~~-~~- 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKAT--YKEPNY-AV- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH--HCCCCC-CC-
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhhc--cCCccc-cc-
Confidence 4322 233457899999999875 578999999999999999999999974321 111111111 111100 00
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. .......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0012346778999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=331.40 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=202.3
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999864 5778999998643 223456789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999988843 346999999999999999999999988 99999999999999999999999999876532
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+... ... ....
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~---~~~-~~~~------ 229 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHR---RIV-NVDL------ 229 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH---HHH-TTCC------
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHH---HHh-cccc------
Confidence 2 2234578999999999999999999999999999999999999874321 111111 111 1110
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.++......+.+++.+||+.||.+||++.++++
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 112223356789999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.98 Aligned_cols=267 Identities=24% Similarity=0.391 Sum_probs=187.3
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
+.+..++|++.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455689999999999999999999853 68899999886533 334567889999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCC-----CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 418 LVYEFVPNKSLDYFLYDP-----EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
+||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999888531 12456999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCC---CccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh
Q 005846 493 MARIFGVDQTQ---GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568 (674)
Q Consensus 493 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~ 568 (674)
++......... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+..... ...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~ 243 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP---MKVLMLTLQND 243 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHTSS
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch---hhHHHHHhccC
Confidence 99876432211 11234578999999999875 5689999999999999999999999754322 12222121111
Q ss_pred cCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 569 ~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.........+..... .....+.+++.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111111111112 23346789999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.65 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=205.5
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|...+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999964 68999999996532 23456788999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 420 YEFVPNKSLDYFLYDPEK-QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|||+++|+|..++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999988864322 446999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .............
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~------- 409 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA------- 409 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC-------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc-------
Confidence 332 22334589999999999999999999999999999999999999975432211 1111111111110
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM-----ATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~-----~evl~ 616 (674)
..++......+.+++.+||+.||++||++ .+|+.
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 01222334578899999999999999975 56653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.26 Aligned_cols=244 Identities=24% Similarity=0.279 Sum_probs=190.6
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHH-HHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
++|++.+.||+|+||.||+++.. +++.||||++.+... .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57899999999999999999964 578899999976432 233455667666 5678999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|..++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999998884 3456899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.|+... ...++..... ... .
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~---~~~--~----- 256 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNIL---NKP--L----- 256 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHH---HSC--C-----
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHH---hcc--c-----
Confidence 2 22344568999999999999999999999999999999999999997421 2222222221 111 0
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMAT 613 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~e 613 (674)
.++......+.+|+.+||+.||++||++.+
T Consensus 257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 011223346789999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=351.76 Aligned_cols=261 Identities=19% Similarity=0.283 Sum_probs=206.1
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.++||+|+||.||+|+. .+++.||||++...... +++.+|+++++.++| +++..+..++..++..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999995 57899999988654332 357899999999977 566666677788889999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE---cCCCCeEEeeeCCccccC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFG 498 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~ki~DfGla~~~~ 498 (674)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999998853 2456999999999999999999999998 9999999999999 689999999999998765
Q ss_pred CCCCCC-----ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 499 VDQTQG-----NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 499 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 433221 223567999999999999999999999999999999999999998654433333332222211111100
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.. +.. .....+.+|+..||+.||++||++.+|+++|+..
T Consensus 238 ~~-----l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EA-----LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-----HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-----Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 011 1234788999999999999999999999998653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=348.44 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=201.9
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..++|++.++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3568999999999999999999964 68899999987643 334567899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999843 34699999999999999999999985 6 99999999999999999999999999976532
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHH---------HHHhhhcC
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS---------YAWKQWRD 570 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~---------~~~~~~~~ 570 (674)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+............. ..+.....
T Consensus 185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 1 2234578999999999999999999999999999999999999975322111000000 00000000
Q ss_pred CCc--------------ceecc----cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 GTP--------------LQLLD----TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 ~~~--------------~~~~d----~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.. .+.++ ..............+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 00000 00000011123446889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=344.81 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=194.3
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccC-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|.+.++||+|+||.||++... +++.||||++....... ...+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999964 68899999986543221 12345799999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
++ ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 477777643 2446999999999999999999999998 9999999999999999999999999998653222
Q ss_pred CCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc---eecc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL---QLLD 578 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~d 578 (674)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+... ...+.+....+........ ....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS---TVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCChHhchhhhc
Confidence 22334578999999999876 56899999999999999999999987532 2233333333322221111 1100
Q ss_pred cc---------cC----CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TN---------LT----DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~---------~~----~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. .. ..........+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 00 0001122346789999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=335.04 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=197.4
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 421 (674)
..++|++.+.||+|+||.||++.. .|+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346899999999999999999987 58899999987543 457789999999999999999999997655 46899999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|.+++... ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999988432 1223899999999999999999999998 999999999999999999999999999754322
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ..+..... ..+..
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~----~~~~~------- 232 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKGYK------- 232 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHH----TTTCC-------
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----hcCCC-------
Confidence 123357889999999999999999999999999999998 888864322 12222211 11111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+++.+||+.||++||++.++++.|+..
T Consensus 233 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 --MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111223345788999999999999999999999999764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=348.45 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=197.5
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe------eE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------KI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------~~ 417 (674)
..+|++.+.||+|+||.||+++...+..||+|++...... ..+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999877777999988654322 2469999999999999999999965443 78
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeEEeeeCCccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARI 496 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ki~DfGla~~ 496 (674)
+||||++++.+............+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988766544432233567999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC---
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT--- 572 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~--- 572 (674)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.|+... ...+.+....+......
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE---SGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCHHH
Confidence 643322 2345789999999998765 5999999999999999999999987532 22222222222111110
Q ss_pred ------------cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 573 ------------PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 573 ------------~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
........+...++......+.+|+.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000001111122244578899999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.24 Aligned_cols=257 Identities=31% Similarity=0.444 Sum_probs=202.2
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCce--eEEEEeccc-CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQE--IAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 419 (674)
++|++.+.||+|+||.||+++.. ++.. +|+|++... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999864 4554 499988653 233456789999999999 999999999999999999999
Q ss_pred EEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCe
Q 005846 420 YEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 486 (674)
|||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986432 2346999999999999999999999988 9999999999999999999
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHH
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~ 565 (674)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ..++.
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~---- 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELY---- 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH----
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HHHHH----
Confidence 99999999743211 12223456889999999998889999999999999999998 998864221 11111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCC
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSV 623 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~ 623 (674)
.....+.. ...+......+.+++.+||+.||++|||+.++++.|+....
T Consensus 252 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 252 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 11122334578899999999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=351.83 Aligned_cols=196 Identities=22% Similarity=0.417 Sum_probs=154.4
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Ce
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 415 (674)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999854 6899999998653 233456788999999999999999999998543 46
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+ +++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 567877774 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCC-------------------------CccccccccCCccCcccc-ccCCCCccccEEeechhhhHhHhCC
Q 005846 496 IFGVDQTQ-------------------------GNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGK 546 (674)
Q Consensus 496 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwS~Gv~l~elltg~ 546 (674)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76432211 123446789999999986 4667999999999999999999943
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=330.71 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=203.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999965 57889999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998874 3457999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+.. ........
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~~~------ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETY----LRIKKNEY------ 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH----HHHHTTCC------
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHhhccC------
Confidence 222 2334578999999999999899999999999999999999999874321 11111 11111110
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1112233467889999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.68 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=198.8
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEe--CCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLE--GEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 420 (674)
++|++.++||+|+||.||+++. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999984 57899999998643 3467899999999997 9999999999988 66789999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~~~ 499 (674)
||+++++|..++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999988873 3899999999999999999999998 99999999999999777 899999999987643
Q ss_pred CCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhc---------
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWR--------- 569 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~--------- 569 (674)
.. ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+... ....+.+........
T Consensus 184 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~--~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 184 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC--SSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC--CchHHHHHHHHHhcCCchhhhHHH
Confidence 32 2234578999999999877 67999999999999999999999986322 111111111111000
Q ss_pred C--------------CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 570 D--------------GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 570 ~--------------~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. ......................+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000000111111112223567889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.00 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=204.6
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc--------cCHHHHHHHHHHHHhc-CCCceeeEE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG--------QGAEEFKNEVVLVAKL-QHRNLVRLL 407 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~h~niv~l~ 407 (674)
.......++|++.+.||+|+||.||++++. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556678999999999999999999974 799999999865432 1135678899999999 899999999
Q ss_pred eEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 408 GFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 408 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
+++......++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999884 3456999999999999999999999998 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCcccccc------CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
|+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+... .....+
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~ 314 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---RQILML 314 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC---CHHHHH
Confidence 99999998764322 2334679999999999863 35889999999999999999999986421 111222
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..... +... ...+. .. .....+.+++.+||+.||++|||+.++++
T Consensus 315 ~~i~~----~~~~-~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMIME----GQYQ-FSSPE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHH----TCCC-CCHHH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHh----CCCC-CCCcc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 21111 1100 00000 01 12346889999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=338.07 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=203.0
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357889999999999999999964 57889999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998874 3457999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.|+.... ..+..... .....
T Consensus 194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~----~~~~~------ 258 (335)
T 2owb_A 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRI----KKNEY------ 258 (335)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH----HHTCC------
T ss_pred Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHH----hcCCC------
Confidence 22 22334578999999999999999999999999999999999999874321 11111111 11110
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.||++||++.|+++
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122346788999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=341.63 Aligned_cols=271 Identities=21% Similarity=0.244 Sum_probs=199.8
Q ss_pred ccchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCcc-----------CHHHHHHHHHHHHhcCCCc
Q 005846 334 QFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ-----------GAEEFKNEVVLVAKLQHRN 402 (674)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~n 402 (674)
.....++....++|++.+.||+|+||.||++...+|+.||||++...... ..+.+.+|+.++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 34566788889999999999999999999999888999999998643221 1367899999999999999
Q ss_pred eeeEEeEEEeC-----CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 403 LVRLLGFCLEG-----EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 403 iv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
|+++++++... ...++||||++ |+|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 99999998653 35799999998 566666642 3456999999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~ 556 (674)
||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+... .
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~ 238 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS---T 238 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS---S
T ss_pred EEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC---C
Confidence 99999999999999999754322 22334578999999999876 67999999999999999999999987532 1
Q ss_pred ccchHHHHHhhhcCCCcce-----------ec-------ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 557 AADLLSYAWKQWRDGTPLQ-----------LL-------DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~-----------~~-------d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+.+.............. .+ ...............+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 2222222221111111000 00 000000111223456889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.75 Aligned_cols=277 Identities=24% Similarity=0.393 Sum_probs=202.9
Q ss_pred chhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 336 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
....+++..++|++.+.||+|+||.||+|...+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344555667899999999999999999998743 59999986532 23345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
+..++||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999853 2346999999999999999999999998 99999999999998 67999999999
Q ss_pred ccccCCCCC---CCccccccccCCccCcccccc---------CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchH
Q 005846 494 ARIFGVDQT---QGNTSRIVGTYGYMAPEYAMH---------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL 561 (674)
Q Consensus 494 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l 561 (674)
++....... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.|+... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~---~~~~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---PAEAII 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC---CHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHH
Confidence 876532211 122233468999999999864 45789999999999999999999986432 111121
Q ss_pred HHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCCCCceee
Q 005846 562 SYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAFFI 635 (674)
Q Consensus 562 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~ 635 (674)
+... .+....... .. ....+.+++..||+.||++|||+.+++++|+...........|..++
T Consensus 253 ---~~~~-~~~~~~~~~----~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 253 ---WQMG-TGMKPNLSQ----IG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp ---HHHH-TTCCCCCCC----SS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred ---HHhc-cCCCCCCCc----CC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 1111 111111111 11 12357789999999999999999999999998776665555555443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.74 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=194.8
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 414 (674)
.++|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999986 46899999998653 2333567889999999999999999999997653
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++||||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 889988884 256999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|+... ...+.+...........
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~l~~i~~~~g~~~- 246 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS---DHLDQLKEIMKVTGTPP- 246 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCC-
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCC-
Confidence 875422 234578999999999887 68999999999999999999999987532 22222222221111100
Q ss_pred cee-------------------cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 LQL-------------------LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ~~~-------------------~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+. ....+ ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 00000 01112234578899999999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.00 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=201.7
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCeeEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l 418 (674)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368899999999999999999864 68899999986543 3345678999999999999999999998864 568899
Q ss_pred EEEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 419 VYEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999985432 2345999999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... ..++..... .+...
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~----~~~~~- 234 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIR----EGKFR- 234 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HTCCC-
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHh----hcccc-
Confidence 754321 11233578999999999999999999999999999999999999865321 112222111 11111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L 618 (674)
..+......+.+++.+||+.||++||++.||++.+
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred --------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11222345788999999999999999999999755
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.44 Aligned_cols=199 Identities=23% Similarity=0.417 Sum_probs=166.3
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Ce
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 415 (674)
.++|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999985 46788999999753 233456789999999999999999999999776 56
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+. ++|..++. ....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 58888884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCC--------------------CccccccccCCccCcccc-ccCCCCccccEEeechhhhHhHhCCCCC
Q 005846 496 IFGVDQTQ--------------------GNTSRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNS 549 (674)
Q Consensus 496 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwS~Gv~l~elltg~~p~ 549 (674)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76433211 123456899999999986 5567999999999999999999865543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=352.63 Aligned_cols=243 Identities=14% Similarity=0.160 Sum_probs=188.5
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHH---HHHHhcCCCceeeEE-------e
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEV---VLVAKLQHRNLVRLL-------G 408 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~h~niv~l~-------~ 408 (674)
..++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ ..+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356789999999999999999996 46899999999743 334457789999 455556899999998 6
Q ss_pred EEEeCC-----------------eeEEEEEecCCCcccccccCCCc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005846 409 FCLEGE-----------------EKILVYEFVPNKSLDYFLYDPEK----QGQLDWSRRYKIIGGIARGILYLHEDSRLR 467 (674)
Q Consensus 409 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 467 (674)
++...+ ..++||||+ +|+|.+++..... ...+++..++.|+.||++||.|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 655543 278999999 6899988853211 122446888999999999999999998
Q ss_pred EEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccC-----------CCCccccEEeec
Q 005846 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-----------QFSVKSDVYSFG 536 (674)
Q Consensus 468 iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DvwS~G 536 (674)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999985321 2334567 999999999887 899999999999
Q ss_pred hhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 537 VLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 537 v~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
|++|||++|+.|+.......... .+.. . .......+.+|+.+||+.||++|||+.|+++
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~---------------~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSE---------------WIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHSSCCC------CCSG---------------GGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHCCCCCcccccccchh---------------hhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999974322111100 0000 0 0122346889999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=326.88 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=195.9
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
..++|.+.+.||+|+||.||++... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4568999999999999999999965 7899999998653 23345678999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999998843 356899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.|+... ......... ..+..
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~----~~~~~---- 228 (276)
T 2h6d_A 163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE---HVPTLFKKI----RGGVF---- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCCC----
T ss_pred CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHh----hcCcc----
Confidence 322 2234568999999999987765 68999999999999999999986421 111222111 11110
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+......+.+++.+||+.||++|||+.++++.
T Consensus 229 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0112223467889999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=331.94 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=198.6
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
..++|++.+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468999999999999999999975 588999999987776778889999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+++++|..++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999988743 2356999999999999999999999998 9999999999999999999999999975432111
Q ss_pred CCCccccccccCCccCcccc-----ccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 502 TQGNTSRIVGTYGYMAPEYA-----MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.......|++.|+|||++ .+..++.++||||||+++|||++|+.|+.... ... ........... ..
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~---~~~~~~~~~~~-~~ 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---PMR---VLLKIAKSDPP-TL 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC---HHH---HHHHHHHSCCC-CC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC---HHH---HHHHHhccCCc-cc
Confidence 112234689999999998 36678999999999999999999999864321 111 11111111111 10
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.||++|||+.++++
T Consensus 243 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 -------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011223356889999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.07 Aligned_cols=265 Identities=21% Similarity=0.275 Sum_probs=202.4
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC--------CCceeeEEeEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ--------HRNLVRLLGFCL 411 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~ 411 (674)
+...++|++.++||+|+||.||+++. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 34457899999999999999999984 46889999999643 334567889999999996 788999999987
Q ss_pred ----eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCC--
Q 005846 412 ----EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM-- 484 (674)
Q Consensus 412 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~-- 484 (674)
.+...++||||+.++.++.++.. ....+++..++.++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchh
Confidence 45678999999955555554422 235699999999999999999999998 7 99999999999999775
Q ss_pred -----------------------------------------------CeEEeeeCCccccCCCCCCCccccccccCCccC
Q 005846 485 -----------------------------------------------NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517 (674)
Q Consensus 485 -----------------------------------------------~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~a 517 (674)
.+||+|||+++..... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 8999999999875422 233578999999
Q ss_pred ccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCcc---chHHHHHhhhcCC---------Ccceec--------
Q 005846 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA---DLLSYAWKQWRDG---------TPLQLL-------- 577 (674)
Q Consensus 518 PE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~---~~l~~~~~~~~~~---------~~~~~~-------- 577 (674)
||++.+..++.++|||||||++|||++|+.|+......... +.+.......... ......
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99999999999999999999999999999998654433221 1111111111100 000000
Q ss_pred --ccc---------cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 --DTN---------LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 --d~~---------~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.. -....+......+.+|+.+||+.||++|||+.|+++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 001234566778999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=348.82 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=192.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC----C--eeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG----E--EKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----~--~~~ 417 (674)
.+|+..+.||+|+||.||+|++. +|+.||||++..... .+.+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999964 689999999865432 234799999999999999999998642 2 357
Q ss_pred EEEEecCCCcccccccC-CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC-CCeEEeeeCCcc
Q 005846 418 LVYEFVPNKSLDYFLYD-PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAR 495 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~ki~DfGla~ 495 (674)
+||||++++ |...+.. ......+++..++.++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 999999864 4333321 123467999999999999999999999988 9999999999999965 568999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC--
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT-- 572 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~-- 572 (674)
.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||... ...+.+....+......
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~---~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD---SGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCSCCHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCHH
Confidence 764322 12345789999999998765 7999999999999999999999986532 22222222222111110
Q ss_pred --------cceeccccc-----CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 573 --------PLQLLDTNL-----TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 573 --------~~~~~d~~~-----~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+...+.+ ...++......+.+|+.+||+.||++|||+.|+++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000000 001122334678899999999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.07 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=199.2
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEeccc--CccCHHHHHHHHHHHHhcC--CCceeeEEeEE
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQ--HRNLVRLLGFC 410 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~ 410 (674)
+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344455667789999999999999999999888999999998653 2334577899999999997 59999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
..++..++||| +.+++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 668899988843 457899999999999999999999998 999999999999964 8999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCcccccc-----------CCCCccccEEeechhhhHhHhCCCCCCccCCCCccc
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD 559 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~ 559 (674)
||+++...............|++.|+|||.+.+ ..++.++||||||+++|||++|+.|+.... .
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~ 244 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----N 244 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----S
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----H
Confidence 999987654333333344578999999999875 478899999999999999999999874221 1
Q ss_pred hHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 560 LLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
............ ....++......+.+++.+||+.||++||++.|+++.
T Consensus 245 ~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 QISKLHAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111111111 1111122223568899999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.84 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=197.3
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~ 417 (674)
+.|++.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4578888999999999999985 46788999998653 33445678999999999999999999999875 35689
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeEEeeeCCccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARI 496 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ki~DfGla~~ 496 (674)
+||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999984 3356999999999999999999999875 3599999999999997 889999999999975
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
.... ......||+.|+|||.+. +.++.++||||||+++|||++|+.|+.... .... .......+.....
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~----~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQ----IYRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHH----HHHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC--cHHH----HHHHHhccCCccc
Confidence 4322 233457899999999876 569999999999999999999999974321 1111 1122222111111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+......+.+++..||+.||++|||+.++++
T Consensus 251 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 --------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11122346889999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.59 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=203.7
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccC-----------------HHHHHHHHHHHHhcCCCceee
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQG-----------------AEEFKNEVVLVAKLQHRNLVR 405 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~h~niv~ 405 (674)
..++|++.+.||+|+||.||++.. +|+.||||++....... .+.+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 89999999986432111 178999999999999999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCccccc------ccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccE
Q 005846 406 LLGFCLEGEEKILVYEFVPNKSLDYF------LYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNI 478 (674)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NI 478 (674)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 99999999999999999999999998 532 225679999999999999999999998 77 99999999999
Q ss_pred EEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccC-CCCc-cccEEeechhhhHhHhCCCCCCccCCCC
Q 005846 479 LLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSV-KSDVYSFGVLVLEIITGKKNSNFYQTDG 556 (674)
Q Consensus 479 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DvwS~Gv~l~elltg~~p~~~~~~~~ 556 (674)
|++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.|+......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence 9999999999999999875432 23345789999999999877 6666 999999999999999999987532221
Q ss_pred ccchHHHHHhhhcCCCcceecc------cc---cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 557 AADLLSYAWKQWRDGTPLQLLD------TN---LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d------~~---~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.... ...+......+ .. ............+.+++.+||+.||.+|||+.|+++
T Consensus 259 -~~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 -VELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122221 11111100000 00 000001223457889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.15 Aligned_cols=252 Identities=24% Similarity=0.300 Sum_probs=197.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC----ccCHHHHHHHHHHHHhcCCCceeeEEeEEE--eCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS----GQGAEEFKNEVVLVAKLQHRNLVRLLGFCL--EGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~ 416 (674)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999996 468899999996532 234577899999999999999999999985 44578
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||++++ |.+++.. .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 5455432 23457999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCCccCccccccCC--CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
..............|++.|+|||++.+.. ++.++||||||+++|||++|+.|+... ........ ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~----i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFEN----IGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHH----HHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHHH----HhcCCC-
Confidence 65433333334457899999999987644 478999999999999999999986532 11111111 111110
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112233467899999999999999999999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.66 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=196.0
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 413 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 413 (674)
+...++|++.+.||+|+||.||++.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45677999999999999999999985 57899999998654322 24799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHH
Q 005846 414 --------------------------------EEKILVYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYL 460 (674)
Q Consensus 414 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~L 460 (674)
...++||||+++ +|...+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 337899999984 666555421 2345799999999999999999999
Q ss_pred HhcCCCcEEEeecccccEEEc-CCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechh
Q 005846 461 HEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVL 538 (674)
Q Consensus 461 H~~~~~~iiHrDlkp~NIll~-~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~ 538 (674)
|+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9988 99999999999997 68899999999998764332 22345789999999998765 48999999999999
Q ss_pred hhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc---------------eecccccCCCCChhHHHHHHHHHhhcccC
Q 005846 539 VLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL---------------QLLDTNLTDSYSRNEVIRCIQLGLLCVQE 603 (674)
Q Consensus 539 l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---------------~~~d~~~~~~~~~~~~~~~~~li~~Cl~~ 603 (674)
+|||++|+.|+... ...+.+....+........ ......+...++......+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~---~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGE---TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999987532 2222222222211111100 00011111112233445788999999999
Q ss_pred CCCCCCCHHHHHH
Q 005846 604 DPAERPSMATIVL 616 (674)
Q Consensus 604 dP~~RPt~~evl~ 616 (674)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=345.29 Aligned_cols=254 Identities=11% Similarity=0.050 Sum_probs=181.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHHHhc--CCCceeeEE-------eEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKL--QHRNLVRLL-------GFC 410 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~~ 410 (674)
..+|...++||+|+||.||+|++ .+|+.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34588999999999999999995 4789999999977442 3345677886655555 599988755 444
Q ss_pred EeC-----------------CeeEEEEEecCCCcccccccCCCcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 005846 411 LEG-----------------EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRR------YKIIGGIARGILYLHEDSRLR 467 (674)
Q Consensus 411 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 467 (674)
... ...++||||++ ++|.+++... ...+++..+ +.++.||++||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 432 33799999999 8999998542 223455566 788899999999999998
Q ss_pred EEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhC
Q 005846 468 IIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITG 545 (674)
Q Consensus 468 iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg 545 (674)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986532 1213467799999999987 6799999999999999999999
Q ss_pred CCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 546 KKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 546 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.|+......... .+........................+.+|+.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCccccc--------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997643221110 01110000011111111111234557889999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.61 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=196.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
.++|++.++||+|+||.||+++.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999964 68899999987542 334577899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC---CCeEEeeeCCcccc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMARIF 497 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~ki~DfGla~~~ 497 (674)
||+++|+|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988774 3456999999999999999999999998 9999999999999764 45999999999876
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.... ......||+.|+|||++. +.++.++|||||||++|||++|+.|+... ...+++...... ... .
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~----~~~-~- 256 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEILRKVEKG----KYT-F- 256 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHT----CCC-C-
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC----CCC-C-
Confidence 4322 233457999999999876 57999999999999999999999997432 222222222111 100 0
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+.... ......+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00001 122346789999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=326.83 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=198.9
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999864 58999999997643 3467899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998842 3457999999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
. .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.... . ............ ...
T Consensus 179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~---~~~~~~~~~~~~-~~~---- 245 (314)
T 3com_A 179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH---P---MRAIFMIPTNPP-PTF---- 245 (314)
T ss_dssp B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC---H---HHHHHHHHHSCC-CCC----
T ss_pred c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---h---HHHHHHHhcCCC-ccc----
Confidence 2 22234578999999999999999999999999999999999999864221 1 111111111111 000
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+++.+||+.||++|||+.++++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011222356889999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.80 Aligned_cols=252 Identities=27% Similarity=0.358 Sum_probs=201.5
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..++|++.++||+|+||+||++... +++.||||++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4568999999999999999999864 7899999998643 234567889999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc---CCCCeEEeeeCCccc
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARI 496 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~ki~DfGla~~ 496 (674)
|||+++++|.+.+. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999988774 3456999999999999999999999998 99999999999995 566799999999987
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.|+... ...+.+..... .......
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~---~~~~~~~ 243 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVET---GKYAFDL 243 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH---TCCCSCS
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCCCCCC
Confidence 64332 2334579999999999875 6999999999999999999999996422 22222222211 1100000
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.........+.+++.+||+.||.+|||+.++++.
T Consensus 244 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 -------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011233568899999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=364.65 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=204.2
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCee
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 416 (674)
...++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44578999999999999999999964 5788999999753 233456678899999887 799999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+|||||+++|+|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999985 3356999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.. .+..+++..+ ....
T Consensus 492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---~~~~~~~~~i---~~~~----- 558 (674)
T 3pfq_A 492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSI---MEHN----- 558 (674)
T ss_dssp CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHH---HSSC-----
T ss_pred cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC---CCHHHHHHHH---HhCC-----
Confidence 43222 234456899999999999999999999999999999999999999743 2222222222 1111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSM-----ATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~-----~evl~ 616 (674)
..++......+.+|+..||+.||++||++ +||++
T Consensus 559 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11223344578899999999999999997 66664
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.71 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=184.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------C
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------E 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 414 (674)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 56899999999653 233456788999999999999999999998754 5
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++|+|++ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 789988873 356999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+... ...+.+....+.......
T Consensus 180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT---DHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCSCCH
T ss_pred ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCH
Confidence 86532 1234578999999999887 67999999999999999999999987532 222223222222111100
Q ss_pred ceeccc-----------ccC--CCC-----ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 LQLLDT-----------NLT--DSY-----SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ~~~~d~-----------~~~--~~~-----~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
+.+.. .+. ... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 -ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp -HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 000 000 01123467899999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=352.08 Aligned_cols=252 Identities=29% Similarity=0.361 Sum_probs=199.8
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc-------------cCHHHHHHHHHHHHhcCCCceeeEEe
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-------------QGAEEFKNEVVLVAKLQHRNLVRLLG 408 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l~~ 408 (674)
..++|.+.++||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999964 578999999865321 33567899999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC---C
Q 005846 409 FCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---N 485 (674)
Q Consensus 409 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~ 485 (674)
++.++...++||||+++|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999988874 3456999999999999999999999998 99999999999998776 6
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.|+... ...+++....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Confidence 9999999998764332 233457999999999886 57999999999999999999999997532 2222222221
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
. +.... +.... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 261 ~----~~~~~--~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 K----GKYYF--DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp H----CCCCC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c----CCCCC--Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 11100 00000 1123468899999999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.76 Aligned_cols=251 Identities=28% Similarity=0.368 Sum_probs=204.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
..++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999999964 78999999986532 3456789999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE---cCCCCeEEeeeCCcc
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAR 495 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~ki~DfGla~ 495 (674)
||||+.+++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999988874 3456999999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
.+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+... ...+.+..... ......
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~---~~~~~~ 247 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKKVEK---GKYTFE 247 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH---CCCCCC
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHc---CCCCCC
Confidence 764322 2344579999999998865 7999999999999999999999997432 22222222211 110000
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. .........+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~-------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 L-------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp S-------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 001123456889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=334.42 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=186.2
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc--cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
+..++|++.+.||+|+||.||++.. .+|+.||||++..... ...+.+.++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3457899999999999999999995 5789999999975422 222334455556788899999999999999999999
Q ss_pred EEEecCCCcccccccCC-CcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 419 VYEFVPNKSLDYFLYDP-EKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
||||+++ +|.+++... .....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999974 776665331 2345799999999999999999999998 7 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCCccCcccc----ccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
..... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.|+.... .... ..........
T Consensus 160 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~---~~~~~~~~~~ 231 (290)
T 3fme_A 160 LVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG--TPFQ---QLKQVVEEPS 231 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS--CHHH---HHHHHHHSCC
T ss_pred ccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC--chHH---HHHHHhccCC
Confidence 64322 22234689999999996 56678999999999999999999999875321 1111 1111121111
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... ........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQL---------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCc---------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 110 01122346889999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.30 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=200.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Cee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~ 416 (674)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999985 468889999997533 33346788999999999999999999999765 368
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+. ++|..++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 57877773 346999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCC-ccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 497 FGVDQTQG-NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.... ..+.+.............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS---GGGHHHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC---hHHHHHHHHHHhCCCCHH
Confidence 65332222 2344579999999998764 458999999999999999999999875332 223333222211111100
Q ss_pred ee-----------cccc-cCC-----CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 QL-----------LDTN-LTD-----SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ~~-----------~d~~-~~~-----~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+ .... ... .........+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000 000 001122356889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.37 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=195.4
Q ss_pred hhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--------ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
..++|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 456899999999999999999985 457899999986532 12234578999999999999999999998765
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC---eEEee
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISD 490 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~ki~D 490 (674)
. .++||||+++++|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999988884 3457999999999999999999999998 999999999999987665 99999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccc---cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
||+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.|+...... ..+.......
T Consensus 161 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~ 235 (322)
T 2ycf_A 161 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITSG 235 (322)
T ss_dssp CTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHHT
T ss_pred Cccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHhC
Confidence 9999875322 1223457899999999974 567899999999999999999999997532221 1222222111
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... .. +.. .......+.+++.+||+.||++||++.++++
T Consensus 236 ----~~~-~~-~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 ----KYN-FI-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----CCC-CC-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----ccc-cC-chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 100 00 000 0122356889999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=343.80 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=170.2
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhc------CCCceeeEEeEEEeCC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKL------QHRNLVRLLGFCLEGE 414 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~ 414 (674)
....+|++.++||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.+ .|+||+++++++....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 34568999999999999999999854 5889999999653 23345678899988887 5679999999999999
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC--eEEeeeC
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFG 492 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--~ki~DfG 492 (674)
..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999996 5777777432 2345999999999999999999999998 999999999999999987 9999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCc
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 248 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 9976432 22345789999999999999999999999999999999999988653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.64 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=201.8
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC---------ccCHHHHHHHHHHHHhcC-CCceeeEEeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS---------GQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCL 411 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~ 411 (674)
..++|++.+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999964 68899999986543 122456789999999995 999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
.+...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999843 456999999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccc------cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
|++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.|+... ..........
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~ 242 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMIM 242 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc---cHHHHHHHHh
Confidence 9998764322 223457899999999885 456899999999999999999999986432 1111111111
Q ss_pred hhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 566 KQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 566 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. +... . ...........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~----~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 S----GNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H----TCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c----CCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 1100 0 00011223457889999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=330.30 Aligned_cols=258 Identities=29% Similarity=0.405 Sum_probs=196.1
Q ss_pred hcCCCcccccccCCcEEEEEeecC--CCc--eeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
.++|++.+.||+|+||.||+|++. +++ .||||++... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 333 6899988653 2334577899999999999999999999987755 8
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++|+||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999998853 2346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 497 FGVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 497 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+.+... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~---~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKI---DKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH---HTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHHH---HccCCCC
Confidence 64332211 2233457888999999998889999999999999999999 888864321 11222111 1111110
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
..+......+.+++.+||+.||++|||+.++++.|++..
T Consensus 245 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 112233457889999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=335.93 Aligned_cols=259 Identities=25% Similarity=0.302 Sum_probs=190.5
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 414 (674)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999985 46889999999653 2334567889999999999999999999997665
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++||||+++ +|..++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 5666652 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc-
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP- 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~- 573 (674)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ..+.+...........+
T Consensus 175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD---HIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHC-CCCCCHH
T ss_pred cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHH
Confidence 865422 12234578999999999999999999999999999999999999875321 11111111111100000
Q ss_pred ------------------------ceecccccCC---CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 ------------------------LQLLDTNLTD---SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ------------------------~~~~d~~~~~---~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.......... .........+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000 0011235678999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.35 Aligned_cols=262 Identities=21% Similarity=0.332 Sum_probs=194.0
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEE-----------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL----------- 411 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~----------- 411 (674)
.++|++.+.||+|+||.||++... +++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999965 48999999998776666788999999999999999999999873
Q ss_pred ---eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeE
Q 005846 412 ---EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPK 487 (674)
Q Consensus 412 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~k 487 (674)
+....++||||++ |+|.+++. ...+++..++.++.||++||.|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 68888873 356999999999999999999999998 99999999999997 567999
Q ss_pred EeeeCCccccCCCCC-CCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 488 ISDFGMARIFGVDQT-QGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 488 i~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
|+|||+++....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.|+.... ..+.+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH---ELEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHH
Confidence 999999987643221 122334567999999998865 679999999999999999999999875322 112222111
Q ss_pred hhhcCCCc----------ceecccccC------CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 566 KQWRDGTP----------LQLLDTNLT------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 566 ~~~~~~~~----------~~~~d~~~~------~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
........ ...+..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11100000 000000000 0011123457889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.04 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=198.4
Q ss_pred chhhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe-
Q 005846 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE- 412 (674)
Q Consensus 336 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~- 412 (674)
++..+....++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344455678999999999999999999996 478899999986543 3346789999999999 89999999999987
Q ss_pred -----CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeE
Q 005846 413 -----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 487 (674)
Q Consensus 413 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 487 (674)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999998542 3457999999999999999999999998 99999999999999999999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHH
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLS 562 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~ 562 (674)
|+|||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.|+.... ...
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~--- 241 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMR--- 241 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHH---
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHH---
Confidence 99999998654221 1223457899999999987 5678999999999999999999999864221 111
Q ss_pred HHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 563 YAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 563 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
........... .. ........+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~~~~~~-~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ALFLIPRNPAP-RL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHSCCC-CC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhhcCccc-cC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111111 11 01122346889999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=335.18 Aligned_cols=269 Identities=22% Similarity=0.252 Sum_probs=191.4
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe-
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE- 415 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 415 (674)
.......++|++.+.||+|+||.||+|+. .+|+.||||++..... ....+.+|+..++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34556678999999999999999999996 4689999999865432 23456788888999999999999999976433
Q ss_pred ------eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCcEEEeecccccEEEcC-CCCe
Q 005846 416 ------KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH--EDSRLRIIHRDLKASNILLDA-EMNP 486 (674)
Q Consensus 416 ------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~iiHrDlkp~NIll~~-~~~~ 486 (674)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987654433322234567899999999999999999999 777 999999999999997 8999
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHH
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAW 565 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~ 565 (674)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+... .....+....
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD---NSAGQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC---ChHHHHHHHH
Confidence 999999998764332 223457899999999987654 899999999999999999999987532 2222222222
Q ss_pred hhhcCCC------------cceeccc------ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 566 KQWRDGT------------PLQLLDT------NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 566 ~~~~~~~------------~~~~~d~------~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+...... .....+. .............+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2111100 0000000 0011122234668899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=341.61 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=182.3
Q ss_pred cCCCc-ccccccCCcEEEEEeecC---CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCeeEE
Q 005846 345 NKFST-DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKIL 418 (674)
Q Consensus 345 ~~~~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l 418 (674)
+.|++ .++||+|+||.||++++. +++.||||++..... ...+.+|+.++++++||||+++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44665 458999999999999854 578999999975432 3568899999999999999999999965 668899
Q ss_pred EEEecCCCcccccccCC------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE----cCCCCeEE
Q 005846 419 VYEFVPNKSLDYFLYDP------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKI 488 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~ki 488 (674)
||||+.+ +|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 555554321 12235999999999999999999999998 9999999999999 77889999
Q ss_pred eeeCCccccCCCCCC-CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCC------ccch
Q 005846 489 SDFGMARIFGVDQTQ-GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG------AADL 560 (674)
Q Consensus 489 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~------~~~~ 560 (674)
+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+....... ..+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876533211 223456799999999999874 59999999999999999999999985432210 1122
Q ss_pred HHHHHhhhcCCCcceeccc------------ccCCCC------------ChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 561 LSYAWKQWRDGTPLQLLDT------------NLTDSY------------SRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 561 l~~~~~~~~~~~~~~~~d~------------~~~~~~------------~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+......+.........+. .....+ .......+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2222222211111000000 000000 0011346789999999999999999999986
Q ss_pred H
Q 005846 617 M 617 (674)
Q Consensus 617 ~ 617 (674)
.
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.53 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=202.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeec--CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc------eeeEEeEEEe
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN------LVRLLGFCLE 412 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~ 412 (674)
+...++|++.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.+++.++|++ ++++++++..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 34567899999999999999999985 36889999999653 334567889999999987654 9999999999
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC----------
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---------- 482 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---------- 482 (674)
.+..++||||+ +++|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999 88888887532 2346899999999999999999999998 999999999999987
Q ss_pred ---------CCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccC
Q 005846 483 ---------EMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQ 553 (674)
Q Consensus 483 ---------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~ 553 (674)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999864321 234578999999999999999999999999999999999999975432
Q ss_pred CCCccchHHHHHhhhcCCCcceecc-----------------------------ccc--CCCCChhHHHHHHHHHhhccc
Q 005846 554 TDGAADLLSYAWKQWRDGTPLQLLD-----------------------------TNL--TDSYSRNEVIRCIQLGLLCVQ 602 (674)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~d-----------------------------~~~--~~~~~~~~~~~~~~li~~Cl~ 602 (674)
. .+.+........ ..+..... ..+ ...........+.+|+.+||+
T Consensus 239 ~---~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 239 S---KEHLAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp H---HHHHHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred h---HHHHHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 2 122211111110 00000000 000 001123456788999999999
Q ss_pred CCCCCCCCHHHHHH
Q 005846 603 EDPAERPSMATIVL 616 (674)
Q Consensus 603 ~dP~~RPt~~evl~ 616 (674)
.||++|||+.|+++
T Consensus 315 ~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 315 YDPAKRITLREALK 328 (339)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred cCcccccCHHHHhc
Confidence 99999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=328.86 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=199.3
Q ss_pred hhcCCCcccccccCCcEEEEEeec--CCCceeEEEEecccCc--cCHHHHHHHHHHHHhc---CCCceeeEEeEEE----
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKL---QHRNLVRLLGFCL---- 411 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~---- 411 (674)
..++|++.+.||+|+||.||++.. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999986 4678999999864321 2223466777777766 8999999999987
Q ss_pred -eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEee
Q 005846 412 -EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490 (674)
Q Consensus 412 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~D 490 (674)
.....++||||++ |+|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 5888887532 2345899999999999999999999998 99999999999999999999999
Q ss_pred eCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 491 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
||+++...... ......|++.|+|||++.+..++.++||||||+++|||++|+.|+... ...+.+.........
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHHcCC
Confidence 99998654221 233457899999999999999999999999999999999999986432 222222222221111
Q ss_pred CCccee----------cc---cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 GTPLQL----------LD---TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 ~~~~~~----------~d---~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...... .. ..............+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 100000 00 00001112233457889999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=332.49 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=198.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Ce
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 415 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 415 (674)
..++|++.+.||+|+||.||++... +|+.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999964 68899999996533 33356788999999999999999999988764 67
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+. ++|..++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 57877773 346999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCC--------ccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 496 IFGVDQTQG--------NTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 496 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.... ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD---YRHQLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHH
Confidence 764322111 1223578999999998764 679999999999999999999999875322 1122222221
Q ss_pred hhcCCCcce---e---------ccc------ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 567 QWRDGTPLQ---L---------LDT------NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 567 ~~~~~~~~~---~---------~d~------~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
......... . +.. .............+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111110000 0 000 0000001123456789999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=358.13 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=204.1
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecC----CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG 413 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 413 (674)
..++..++|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.++++++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44555678999999999999999999863 24579999987543 334567899999999999999999999984 4
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
+..++||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 568999999999999999853 2346999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..|+... ...+.+...... .
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~---~~~~~~~~i~~~----~ 609 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENG----E 609 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHHT----C
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcC----C
Confidence 987643322 12233457789999999999999999999999999999997 88886422 222222222111 1
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
. ...+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 610 ~---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 R---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 011223345788999999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=324.26 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=192.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE---------- 412 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~---------- 412 (674)
.++|++.+.||+|+||.||+++. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999995 47899999999643 3345678999999999999999999999865
Q ss_pred ---CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEe
Q 005846 413 ---GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (674)
Q Consensus 413 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~ 489 (674)
....++||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3467899999999999999853 2345788999999999999999999998 9999999999999999999999
Q ss_pred eeCCccccCCCCC------------CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCC
Q 005846 490 DFGMARIFGVDQT------------QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556 (674)
Q Consensus 490 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~ 556 (674)
|||+++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----- 230 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----- 230 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-----
Confidence 9999986542211 1122345689999999999764 78999999999999999998 3211
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+.... ........ ..+...++......+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 GMERVNI-LKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHH-HHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhHHHH-HHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0111111 11111111 11112233344557889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.53 Aligned_cols=253 Identities=27% Similarity=0.351 Sum_probs=201.9
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
....++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 445678999999999999999999964 6889999998653 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC---CCeEEeeeCCc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMA 494 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~ki~DfGla 494 (674)
+|+||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999887743 346999999999999999999999998 9999999999999754 46999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
....... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.|+... ...+.+.... .+...
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~----~~~~~ 240 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVE----TGKYA 240 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH----HCCCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHH----cCCCC
Confidence 8764322 2233468999999998865 5899999999999999999999986432 1122222111 11110
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. +... .......+.+++.+||+.||++|||+.++++
T Consensus 241 ~--~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F--DLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C--CSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--Cchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0000 0122346889999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=328.02 Aligned_cols=256 Identities=27% Similarity=0.376 Sum_probs=177.7
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..++|+..+.||+|+||.||++... +|+.||||++.... .....++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578999999999999999999964 68999999997643 223345556665 67778999999999999999999999
Q ss_pred EEecCCCcccccccC--CCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 420 YEFVPNKSLDYFLYD--PEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
|||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999986 66655532 11245799999999999999999999998 7 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccCCccCcccc----ccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
..... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+...... ..... ....+.
T Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~-~~~~~~ 246 (327)
T 3aln_A 176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLT-QVVKGD 246 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C-CCCCSC
T ss_pred ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHH-HHhcCC
Confidence 54322 22234689999999998 4567899999999999999999999997532211 00000 011111
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. .+...........+.+++.+||+.||++||++.+|++
T Consensus 247 ~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 1111111233457889999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.11 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=194.5
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee----
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK---- 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~---- 416 (674)
.++|...+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999985 468999999997542 33356788999999999999999999999877654
Q ss_pred --EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 417 --ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 417 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
++||||+. ++|..++ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 5776666 234999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+... ...+.+...........
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~~~~- 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK---DYLDQLTQILKVTGVPG- 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCC-
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCc-
Confidence 865322 234578999999999887 68999999999999999999999987432 22222222211111100
Q ss_pred ceecc---------------cccCC---CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 LQLLD---------------TNLTD---SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ~~~~d---------------~~~~~---~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+... ..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000 00000 001123457889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.26 Aligned_cols=206 Identities=24% Similarity=0.337 Sum_probs=171.7
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcC-CC-----ceeeEEeE
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HR-----NLVRLLGF 409 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~ 409 (674)
....+...++|++.+.||+|+||.||+|... +++.||||++... ....+++..|+.+++.++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3444556789999999999999999999854 6788999999643 233466788999998885 55 49999999
Q ss_pred EEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc--CCCCeE
Q 005846 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPK 487 (674)
Q Consensus 410 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~k 487 (674)
+...+..++||||+++ +|.+++... ....+++..+..++.||+.||.|||.. ..+|+||||||+||||+ .++.+|
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eccCCceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 9999999999999964 888887542 234599999999999999999999953 12499999999999995 578899
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCc
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.|+..
T Consensus 202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999876422 2345789999999999999999999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=326.89 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=194.9
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe-----
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----- 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 415 (674)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999985 468999999996532 2335678899999999999999999999987654
Q ss_pred -eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 416 -KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 416 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
.++||||+. ++|..++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 57877762 34999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+.... ..+.+....+.......
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC---HHHHHHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCH
Confidence 764322 234578999999999876 678999999999999999999999875322 12222222111110000
Q ss_pred ------------------ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 ------------------LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ------------------~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+ ..........+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 1111234567889999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.56 Aligned_cols=253 Identities=20% Similarity=0.238 Sum_probs=172.7
Q ss_pred hhcCCCccc-ccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCee
Q 005846 343 ATNKFSTDN-KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK 416 (674)
Q Consensus 343 ~~~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 416 (674)
..++|.+.+ .||+|+||.||++... +|+.||||++.... ....+....+..++||||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356888855 6999999999999965 68999999986531 222233344667799999999999876 4458
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeEEeeeCC
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGM 493 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ki~DfGl 493 (674)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998642 2346999999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.......... ..........
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~- 249 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ- 249 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc-
Confidence 9865322 2234578999999999988899999999999999999999999975332211100 0000000000
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..............+.+|+.+||+.||++|||+.|+++
T Consensus 250 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 -----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00001111223457889999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.92 Aligned_cols=262 Identities=20% Similarity=0.287 Sum_probs=199.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-----------CCceeeEEeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----------HRNLVRLLGFCL 411 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~ 411 (674)
.++|++.+.||+|+||.||+++. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999995 57889999999643 234567889999999886 899999999988
Q ss_pred eCC----eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEc-----
Q 005846 412 EGE----EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLD----- 481 (674)
Q Consensus 412 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~----- 481 (674)
... ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 88998888542 234599999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCc---
Q 005846 482 -AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA--- 557 (674)
Q Consensus 482 -~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~--- 557 (674)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4447999999999875422 2334789999999999999999999999999999999999999764332211
Q ss_pred cchHHHHHhhhcCC------------------Ccceeccc----------ccCCCCChhHHHHHHHHHhhcccCCCCCCC
Q 005846 558 ADLLSYAWKQWRDG------------------TPLQLLDT----------NLTDSYSRNEVIRCIQLGLLCVQEDPAERP 609 (674)
Q Consensus 558 ~~~l~~~~~~~~~~------------------~~~~~~d~----------~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 609 (674)
.+.+.......... .....+.. .....++......+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111111111100 00000000 001123456677899999999999999999
Q ss_pred CHHHHHH
Q 005846 610 SMATIVL 616 (674)
Q Consensus 610 t~~evl~ 616 (674)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.62 Aligned_cols=242 Identities=25% Similarity=0.431 Sum_probs=190.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCcc------CHHHHHHHHHHHHhc----CCCceeeEEeEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ------GAEEFKNEVVLVAKL----QHRNLVRLLGFC 410 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~h~niv~l~~~~ 410 (674)
...++|++.+.||+|+||.||+++. .+++.||||++...... ....+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4457899999999999999999985 46889999999654321 223456799999998 899999999999
Q ss_pred EeCCeeEEEEEe-cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeEE
Q 005846 411 LEGEEKILVYEF-VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKI 488 (674)
Q Consensus 411 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ki 488 (674)
...+..++|+|+ +.+++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999843 456999999999999999999999998 99999999999999 8899999
Q ss_pred eeeCCccccCCCCCCCccccccccCCccCccccccCCCC-ccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhh
Q 005846 489 SDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQ 567 (674)
Q Consensus 489 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~ 567 (674)
+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.|+... .. ...
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~----~~~- 247 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QE----ILE- 247 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH----HHH-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HH----Hhh-
Confidence 9999998764322 2345689999999999877764 5999999999999999999986421 00 000
Q ss_pred hcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 568 WRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 568 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. . ..++......+.+++.+||+.||++|||+.|+++
T Consensus 248 --~-~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 --A-E----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --T-C----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --h-c----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 0112223456789999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=327.85 Aligned_cols=245 Identities=24% Similarity=0.405 Sum_probs=197.8
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCcc------CHHHHHHHHHHHHhcC--CCceeeEEeE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ------GAEEFKNEVVLVAKLQ--HRNLVRLLGF 409 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~~~ 409 (674)
+.+...++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445567899999999999999999984 57889999998654221 2245678999999996 5999999999
Q ss_pred EEeCCeeEEEEEecCC-CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeE
Q 005846 410 CLEGEEKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPK 487 (674)
Q Consensus 410 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~k 487 (674)
+...+..++|+|++.+ ++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999986 899888843 457999999999999999999999988 99999999999999 789999
Q ss_pred EeeeCCccccCCCCCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 488 ISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 488 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
|+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.... . .
T Consensus 191 L~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~----~-- 255 (320)
T 3a99_A 191 LIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E----I-- 255 (320)
T ss_dssp ECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H----H--
T ss_pred EeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h----h--
Confidence 9999999876432 2234568999999999987766 688999999999999999999864210 0 0
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..... ..+......+.+++.+||+.||++|||+.+|++
T Consensus 256 -~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 -IRGQV-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HHCCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hcccc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 011122346889999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.29 Aligned_cols=260 Identities=21% Similarity=0.313 Sum_probs=197.9
Q ss_pred HhhcCCCcccccccCCcEEEEEeecC-CC-ceeEEEEecccCccCHHHHHHHHHHHHhcCCCc------eeeEEeEEEeC
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLP-SG-QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN------LVRLLGFCLEG 413 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~ 413 (674)
...++|++.+.||+|+||.||++... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34579999999999999999999853 34 68999999653 334567889999999998766 99999999999
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEE-------------
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL------------- 480 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll------------- 480 (674)
+..++||||+.++.+ +++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~~l~-~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELLGKNTF-EFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECCCCBHH-HHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEeccCCChH-HHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999955444 44432 22346999999999999999999999987 9999999999999
Q ss_pred ------cCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCC
Q 005846 481 ------DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554 (674)
Q Consensus 481 ------~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~ 554 (674)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~- 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE- 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC-
Confidence 67889999999999864322 234578999999999999999999999999999999999999975322
Q ss_pred CCccchHHHHHhhhcCCCcceec----------ccc---------------------cCCCCChhHHHHHHHHHhhcccC
Q 005846 555 DGAADLLSYAWKQWRDGTPLQLL----------DTN---------------------LTDSYSRNEVIRCIQLGLLCVQE 603 (674)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~----------d~~---------------------~~~~~~~~~~~~~~~li~~Cl~~ 603 (674)
..+.+......... .+.... ... ........+...+.+|+.+||+.
T Consensus 244 --~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 --NREHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp --HHHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred --HHHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 12222222111110 000000 000 00011223456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 005846 604 DPAERPSMATIVL 616 (674)
Q Consensus 604 dP~~RPt~~evl~ 616 (674)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=333.85 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=184.7
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+.|...+.||+|+||+||.....+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999997666567999999998653 235678999999886 8999999999999999999999999
Q ss_pred CCCcccccccCCCcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC-------------CCe
Q 005846 424 PNKSLDYFLYDPEKQG----QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-------------MNP 486 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~-------------~~~ 486 (674)
. |+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69998885432111 1133356789999999999999988 9999999999999754 489
Q ss_pred EEeeeCCccccCCCCCCC--ccccccccCCccCcccccc-------CCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 487 KISDFGMARIFGVDQTQG--NTSRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.|+.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-- 245 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-- 245 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--
Confidence 999999998775432221 2234579999999999975 678999999999999999999 8888642111
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
............ +.............+.+++.+||+.||++|||+.+|++
T Consensus 246 --~~~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 --RESNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hHHHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111111100 00111123345678899999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.64 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=179.0
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCcc-C-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQ-G-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
..++|++.+.||+|+||.||++... +|+.||||++...... . .+.+.++..+++.++||||+++++++.+++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467899999999999999999964 6899999999754322 2 23344555678888999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|||+ ++++..+.. .....+++..++.++.||++||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 555554442 1245699999999999999999999985 7 9999999999999999999999999997654
Q ss_pred CCCCCCccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
... ......|++.|+|||.+. ...++.++||||||+++|||++|+.|+.... ...+.+... ......
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~---~~~~~~ 248 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--TDFEVLTKV---LQEEPP 248 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC--SHHHHHHHH---HHSCCC
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccHHHHHHH---hccCCC
Confidence 322 223456899999999984 5568899999999999999999999864321 111222211 111111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... ........+.+++.+||+.||.+||++.++++
T Consensus 249 -~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 -LLP-------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -CCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCC-------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 01122346889999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.17 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=185.4
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+...+|...+.||+|+||+||.....+|+.||||++...... .+.+|+.+++++ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 344578899999999999865444457899999999654332 356899999999 8999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-----CCCeEEeeeCCcc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMAR 495 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~ki~DfGla~ 495 (674)
||+. |+|.+++... ...+.+..++.++.||++||.|||+.+ |+||||||+|||++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 5888887542 233555567889999999999999998 999999999999953 3368899999998
Q ss_pred ccCCCCCC-CccccccccCCccCccccc---cCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcC
Q 005846 496 IFGVDQTQ-GNTSRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
........ .......||+.|+|||++. ...++.++|||||||++|||++ |..|+.... ..... ... .
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~----~~~~~---~~~-~ 243 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----QRQAN---ILL-G 243 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT----THHHH---HHT-T
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh----HHHHH---HHh-c
Confidence 76533211 2234467999999999997 4567889999999999999999 887763211 11111 111 1
Q ss_pred CCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 ~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
....... .........+.+|+.+||+.||++|||+.+|++
T Consensus 244 ~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCcccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111110 112234456789999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=346.13 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=197.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe------CCe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~ 415 (674)
.++|++.++||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999996 46899999998654 33445678999999999999999999998765 667
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC---eEEeeeC
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFG 492 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~ki~DfG 492 (674)
.++||||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999988 999999999999997765 8999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.... ....|.........
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC----
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccc
Confidence 998764332 2234578999999999999999999999999999999999999974311 00110000000000
Q ss_pred c----ceec------cc--ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHH
Q 005846 573 P----LQLL------DT--NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMAT 613 (674)
Q Consensus 573 ~----~~~~------d~--~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~e 613 (674)
. .... .. .............+.+++..||+.||++|||+.+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0 0000 00 0112234456778999999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=345.55 Aligned_cols=240 Identities=22% Similarity=0.339 Sum_probs=191.1
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC--CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe--
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-- 415 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-- 415 (674)
+...++|++.+.||+|+||.||++.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 344579999999999999999999864 58999999986533 3345678899999999999999999999987655
Q ss_pred ---eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 416 ---KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 416 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
.+|||||+++++|.+++. ..+++.+++.|+.||++||.|||+.+ |+||||||+|||++.+ .+||+|||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999988763 26999999999999999999999998 9999999999999986 89999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+++..... ....||+.|+|||++.++. +.++|||||||++|||++|..|+..... ...
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------~~~ 284 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------------DGL 284 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------------SSC
T ss_pred cchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------------ccc
Confidence 99875432 3457999999999987654 8999999999999999999876431100 000
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-HHHHHHHHh
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-MATIVLMLN 619 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-~~evl~~L~ 619 (674)
. ...........+.+++.+||+.||++||+ ++++...|.
T Consensus 285 ~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 P--------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp C--------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred c--------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 00001122346789999999999999995 566665554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.42 Aligned_cols=231 Identities=10% Similarity=0.089 Sum_probs=181.4
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
.++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+..+.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 468999999999999999999964 489999999976533 2346789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++.. + ....++.+|+.||++||.|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 2 456678899999999999999998 9999999999999999999997433
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
|++| ++.++||||||+++|||+||+.|+........... ..+.... .. ..
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~-~~---~~- 224 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAG-QP---IE- 224 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTS-CB---CC-
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhcc-CC---CC-
Confidence 3333 68899999999999999999999754322110000 0000000 00 00
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
...........+.+++.+||+.||++| |+.|+++.|+...
T Consensus 225 --~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 --PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp --HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred --hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 001112234568899999999999999 9999999998743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.50 Aligned_cols=226 Identities=20% Similarity=0.261 Sum_probs=176.6
Q ss_pred cCCCcc-cccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHH-HhcCCCceeeEEeEEEe----CCeeE
Q 005846 345 NKFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLV-AKLQHRNLVRLLGFCLE----GEEKI 417 (674)
Q Consensus 345 ~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~~~ 417 (674)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 7799999999999985 46889999998642 4567888888 55699999999999987 66789
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeEEeeeCCc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 494 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ki~DfGla 494 (674)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998542 2346999999999999999999999998 999999999999998 789999999998
Q ss_pred cccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
.... +..++.++||||||+++|||++|+.|+........ . .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------~----~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------S----PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------h----HHHHH
Confidence 6432 23567899999999999999999999743221110 0 00000
Q ss_pred eecccccCCCCC----hhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 575 QLLDTNLTDSYS----RNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 575 ~~~d~~~~~~~~----~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+.... ...+ ......+.+++.+||+.||++|||+.|+++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 0111 123457889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.32 Aligned_cols=241 Identities=15% Similarity=0.168 Sum_probs=176.8
Q ss_pred hcCCCcccccccCCcEEEEEee-cCCCceeEEEEecccC---ccCHHHHHHHHHHHHhcCC-Cce----------ee---
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQH-RNL----------VR--- 405 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h-~ni----------v~--- 405 (674)
..+|...+.||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|+.+++.++| +|. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4457788999999999999999 4578999999987432 2335778999999999987 221 11
Q ss_pred --------EEeEEEe-----CCeeEEEEEecCCCcccccccC----CCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 005846 406 --------LLGFCLE-----GEEKILVYEFVPNKSLDYFLYD----PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRI 468 (674)
Q Consensus 406 --------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 468 (674)
++.+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||.|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1111111 12346667755 6888877731 122445888999999999999999999998 9
Q ss_pred EEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCcccc----------ccCCCCccccEEeechh
Q 005846 469 IHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA----------MHGQFSVKSDVYSFGVL 538 (674)
Q Consensus 469 iHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DvwS~Gv~ 538 (674)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865322 334567 999999999 55568899999999999
Q ss_pred hhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005846 539 VLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615 (674)
Q Consensus 539 l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl 615 (674)
+|||+||+.|+.......... .++.. ... .+..+.+|+.+||+.||++||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~--~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE---------------WIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG---------------GGGSS--CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhhHH---------------HHHhh--ccc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999975322111100 00110 011 235688999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.07 Aligned_cols=242 Identities=16% Similarity=0.153 Sum_probs=184.1
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--------ccCHHHHHHHHHHHHhcC---------CCceeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--------GQGAEEFKNEVVLVAKLQ---------HRNLVRL 406 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------h~niv~l 406 (674)
.++|++.++||+|+||.||+++. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 78999999997542 234578899999999986 8888888
Q ss_pred EeEEE------------------------------eCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHH
Q 005846 407 LGFCL------------------------------EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456 (674)
Q Consensus 407 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 456 (674)
.+.+. ..+..+|||||+++|++.+.+. ...+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 77653 2678999999999997655552 2568999999999999999
Q ss_pred HHHHH-hcCCCcEEEeecccccEEEcCCC--------------------CeEEeeeCCccccCCCCCCCccccccccCCc
Q 005846 457 ILYLH-EDSRLRIIHRDLKASNILLDAEM--------------------NPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515 (674)
Q Consensus 457 L~~LH-~~~~~~iiHrDlkp~NIll~~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y 515 (674)
|.||| +.+ |+||||||+||||+.++ .+||+|||+++.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 888 99999999999999887 899999999987642 234799999
Q ss_pred cCccccccCCCCccccEEeechh-hhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHH
Q 005846 516 MAPEYAMHGQFSVKSDVYSFGVL-VLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCI 594 (674)
Q Consensus 516 ~aPE~~~~~~~s~k~DvwS~Gv~-l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 594 (674)
+|||++.+.. +.++||||||++ .+++++|..|+... ............... ................+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMT---FKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCC---CSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhc---cCcccchhhhhhcCHHHH
Confidence 9999998665 899999998776 78889998875210 000001001000000 000011112234567889
Q ss_pred HHHhhcccCCCCCCCCHHHHH
Q 005846 595 QLGLLCVQEDPAERPSMATIV 615 (674)
Q Consensus 595 ~li~~Cl~~dP~~RPt~~evl 615 (674)
+|+.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 899887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=281.67 Aligned_cols=185 Identities=18% Similarity=0.183 Sum_probs=131.8
Q ss_pred ccccCCcEEEEEee-cCCCceeEEEEecccC----------ccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEE
Q 005846 352 KLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS----------GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 352 ~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 419 (674)
.++.|++|.+..++ .--|+.+++|++.+.. ....++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666554 2358899999986532 23346799999999999 799999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||++|++|.+.+. ..+.++.. +|+.||+.||.|||++| ||||||||+||||++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999994 34567764 47899999999999998 99999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCC
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
.. ......+||+.|||||++.+ ++..++|+||+|++++++.++..+
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 23445789999999998864 577889999999999998776543
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=204.40 Aligned_cols=106 Identities=19% Similarity=0.499 Sum_probs=95.8
Q ss_pred ccccccccCCCCcccCCCchHHHHHHHHHHhcccccCCCCCCCCCceeeccCC-CCCcEEEEEEccCCCCccchHHHHHH
Q 005846 28 DREYATHVCSTTANFTRNSTYEKNLNLLLSSIPTNASRGNGFSSGFFNATAGQ-DPNRVYGLFLCRGDQTTSDCQDCVTF 106 (674)
Q Consensus 28 ~~~~~~~~C~~~~~~~~~s~~~~nl~~l~~~l~~~~~~~~~~~~~f~~~~~g~-~~~~vygl~~C~~D~~~~~C~~Cl~~ 106 (674)
+..++++.|++ ++|+++++|++||+.||++|+++++ .+..+|++...|. ++++||||+|||||+++++|..||+.
T Consensus 2 ~t~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~---~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~ 77 (108)
T 3a2e_A 2 NTAFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTA---FSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSN 77 (108)
T ss_dssp CCCEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGG---GTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHH
T ss_pred CcceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCc---cccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHH
Confidence 45678899975 7999999999999999999999986 3455677776664 56899999999999999999999999
Q ss_pred HHHHHhhhCCCCcceEEEcceeEEEEcCccc
Q 005846 107 AARDVLQLCPVSKETILWYAECLLRYSDQSI 137 (674)
Q Consensus 107 a~~~~~~~C~~~~~~~~~~~~C~lry~~~~f 137 (674)
|+.++.+.|+++++|+||++.|+||||+++|
T Consensus 78 a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 78 LVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999999999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=258.22 Aligned_cols=184 Identities=16% Similarity=0.231 Sum_probs=144.5
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecccCcc--------CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQ--------GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
...+.||+|+||.||++.. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999966 5788999986442211 134588999999999999999777777788888999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999998 999999999999999 999999999997643
Q ss_pred CCCCC-----ccccccccCCccCcccccc--CCCCccccEEeechhhhHhHhCCCC
Q 005846 500 DQTQG-----NTSRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 500 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
..... ......||+.|||||++.. ..|+.+.|+|+..+-.++-+.++.+
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 22111 1235689999999999976 5688899999988888887776654
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=177.61 Aligned_cols=106 Identities=27% Similarity=0.446 Sum_probs=97.3
Q ss_pred CCCccccccccCCCchhHHHHHHHHHHHHHHHHhhccCCceEEEeeccCCCceeeEEEeecCCCCccchhHHHHHHHhcc
Q 005846 143 TSPTVSLLNTQNVTDQGRLNELVGTQMSQVVTQAVSNTKRFATRKANFTTFQTLYSLAQCTPDLSSSDCNTCLRGAVARL 222 (674)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~fa~~~~~~~~~~~vy~laQC~~dls~~dC~~Cl~~~~~~~ 222 (674)
++.....||..++++.+.|+.+++.||..|+..|+.++.+|+++.....+.++||||+||++|+++.||+.||+.++.++
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 44566789999999999999999999999999998887888888766566789999999999999999999999999999
Q ss_pred CcCCCCCcCcEEEccccccccccCcc
Q 005846 223 PSCCSGKQGGRVLFPSCNVRYELYPF 248 (674)
Q Consensus 223 ~~~c~~~~g~~~~~~~C~lry~~~~f 248 (674)
+++|+++.||+||+++|++|||.++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999987
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-23 Score=211.20 Aligned_cols=150 Identities=19% Similarity=0.120 Sum_probs=120.2
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCc------------------cCHHHHHHHHHHHHhcCCC
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG------------------QGAEEFKNEVVLVAKLQHR 401 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~ 401 (674)
+......|++.+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3334556777899999999999999997799999999864321 12456889999999999
Q ss_pred ceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc
Q 005846 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 481 (674)
Q Consensus 402 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~ 481 (674)
| +++.+++. .+..++||||+++++|.. +.. .....++.||++||.|||+.+ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 66666543 356699999999999987 411 234579999999999999988 99999999999999
Q ss_pred CCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccc
Q 005846 482 AEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522 (674)
Q Consensus 482 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 522 (674)
++.+||+|||+++. +..++|||++.
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999863 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5e-19 Score=178.80 Aligned_cols=136 Identities=17% Similarity=0.182 Sum_probs=105.2
Q ss_pred CCcccccccCCcEEEEEeec-CCCce--eEEEEecccCcc------------------------CHHHHHHHHHHHHhcC
Q 005846 347 FSTDNKLGEGGFGEVYKGVL-PSGQE--IAVKRLSKASGQ------------------------GAEEFKNEVVLVAKLQ 399 (674)
Q Consensus 347 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 399 (674)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999997 68888 999987543111 0135788999999998
Q ss_pred CCce--eeEEeEEEeCCeeEEEEEecCC-C----cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEEEe
Q 005846 400 HRNL--VRLLGFCLEGEEKILVYEFVPN-K----SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH-EDSRLRIIHR 471 (674)
Q Consensus 400 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iiHr 471 (674)
|+++ ..++.+ ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 344432 356899999942 4 44443311 234567889999999999999 887 9999
Q ss_pred ecccccEEEcCCCCeEEeeeCCcccc
Q 005846 472 DLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 472 Dlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
||||+|||++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=5.2e-17 Score=170.70 Aligned_cols=138 Identities=16% Similarity=0.204 Sum_probs=99.5
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccCc--------------cCHHHH--------HHHHHHHHhcCCCce
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG--------------QGAEEF--------KNEVVLVAKLQHRNL 403 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~Ei~~l~~l~h~ni 403 (674)
-|++.+.||+|+||.||+|...+|+.||||+++.... ...... ..|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3899999999999999999998999999998753210 011111 245556666644433
Q ss_pred eeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC
Q 005846 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 483 (674)
Q Consensus 404 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~ 483 (674)
.-..-+.. ...+|||||++++.|..+.. . .....++.||+.+|.+||+.+ ||||||||.|||++++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence 21111111 22379999999998876542 1 124567899999999999988 9999999999999887
Q ss_pred CC----------eEEeeeCCcccc
Q 005846 484 MN----------PKISDFGMARIF 497 (674)
Q Consensus 484 ~~----------~ki~DfGla~~~ 497 (674)
+. +.|+||+-+-..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 73 899999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=8.1e-12 Score=125.92 Aligned_cols=144 Identities=19% Similarity=0.100 Sum_probs=113.8
Q ss_pred hhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 421 (674)
....|+....++.|+.+.||+.... +..+++|+...........+.+|+.+++.+. |..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3457888888999999999999864 6889999986532222345889999999984 6778899999999889999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-------------------------------------- 463 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------- 463 (674)
|++|.+|...+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876531 1122347888999999999981
Q ss_pred ------------------CCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 464 ------------------SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 464 ------------------~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11459999999999999876666799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=5.5e-11 Score=119.32 Aligned_cols=137 Identities=17% Similarity=0.146 Sum_probs=102.3
Q ss_pred CCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEEeEEEeCCeeEEEEEec
Q 005846 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 423 (674)
.+......+.|..+.||+....+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443333456669999998777888999987654 2245788999999986545 456888888777889999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS--------------------------------------- 464 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 464 (674)
+|.+|. ... .+ ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999884 211 12 2357788888888888743
Q ss_pred ----------------CCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 465 ----------------RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 465 ----------------~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.2e-09 Score=115.41 Aligned_cols=142 Identities=18% Similarity=0.276 Sum_probs=107.9
Q ss_pred cccccccCCcEEEEEeecCCCceeEEEEec--ccC-ccCHHHHHHHHHHHHhcC--CCceeeEEeEEEeC---CeeEEEE
Q 005846 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLS--KAS-GQGAEEFKNEVVLVAKLQ--HRNLVRLLGFCLEG---EEKILVY 420 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 420 (674)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4577899999999999875 4678888775 322 122356788999999997 45578888888766 3479999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS------------------------------------ 464 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 464 (674)
||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998885422 124788889999999999999999731
Q ss_pred -------------------CCcEEEeecccccEEEcCCCC--eEEeeeCCccc
Q 005846 465 -------------------RLRIIHRDLKASNILLDAEMN--PKISDFGMARI 496 (674)
Q Consensus 465 -------------------~~~iiHrDlkp~NIll~~~~~--~ki~DfGla~~ 496 (674)
...++|||+++.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.7e-09 Score=111.44 Aligned_cols=186 Identities=20% Similarity=0.228 Sum_probs=122.4
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCc--eeeEEeEEEeCC---eeEEEEEec
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRN--LVRLLGFCLEGE---EKILVYEFV 423 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 423 (674)
.+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 56888886432 33467889999998883 333 344554433333 347899999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---------------------------------------- 463 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 463 (674)
+|..|..... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865331 2467788888999999999999961
Q ss_pred ---------------CCCcEEEeecccccEEEcC--CCCeEEeeeCCccccCCCCCCCccc------------cccccCC
Q 005846 464 ---------------SRLRIIHRDLKASNILLDA--EMNPKISDFGMARIFGVDQTQGNTS------------RIVGTYG 514 (674)
Q Consensus 464 ---------------~~~~iiHrDlkp~NIll~~--~~~~ki~DfGla~~~~~~~~~~~~~------------~~~gt~~ 514 (674)
....++|+|++|.||++++ +..+.|+||+.+............. ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1245899999999999998 4567899999986532110000000 0000111
Q ss_pred ccC-ccccccCCCCccccEEeechhhhHhHhCCCC
Q 005846 515 YMA-PEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 515 y~a-PE~~~~~~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
... |+.... .....+.|++|.++|++.+|..+
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 111 222111 11225789999999999999865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2e-06 Score=88.31 Aligned_cols=136 Identities=22% Similarity=0.174 Sum_probs=97.7
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCC---ceeeEEeEEE-eCCeeEEEEEecCC
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR---NLVRLLGFCL-EGEEKILVYEFVPN 425 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 425 (674)
.+.++.|....||+. |..+++|+-.. ......+.+|..+|+.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999987 56788887532 23346788999999999653 3566676664 34557899999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED------------------------------------------ 463 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 463 (674)
..|..... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 98865321 1245566666666777776666643
Q ss_pred ---------------CCCcEEEeecccccEEEcC---CCCe-EEeeeCCccc
Q 005846 464 ---------------SRLRIIHRDLKASNILLDA---EMNP-KISDFGMARI 496 (674)
Q Consensus 464 ---------------~~~~iiHrDlkp~NIll~~---~~~~-ki~DfGla~~ 496 (674)
....++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.5e-06 Score=85.79 Aligned_cols=135 Identities=19% Similarity=0.186 Sum_probs=96.3
Q ss_pred ccccCCcE-EEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 352 KLGEGGFG-EVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 352 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445555 68987654 4667889976543 3456788999998884 33477888999999999999999999887
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED--------------------------------------------- 463 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------------- 463 (674)
...... .......+..++++.|..||..
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654311 1122345666677777777742
Q ss_pred ----------CCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 464 ----------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 464 ----------~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.7e-06 Score=90.85 Aligned_cols=147 Identities=10% Similarity=0.082 Sum_probs=91.5
Q ss_pred cccc-ccCCcEEEEEeecC-------CCceeEEEEecccC---ccCHHHHHHHHHHHHhcC-C--CceeeEEeEEEeC--
Q 005846 350 DNKL-GEGGFGEVYKGVLP-------SGQEIAVKRLSKAS---GQGAEEFKNEVVLVAKLQ-H--RNLVRLLGFCLEG-- 413 (674)
Q Consensus 350 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~-- 413 (674)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+. + -.+.+++.++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88999999998764 26678888765432 111245678888888884 2 3567788877655
Q ss_pred -CeeEEEEEecCCCcccccccCCCc---CCCCCHHHHHHHHHHHHHHHH-------------------------------
Q 005846 414 -EEKILVYEFVPNKSLDYFLYDPEK---QGQLDWSRRYKIIGGIARGIL------------------------------- 458 (674)
Q Consensus 414 -~~~~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~------------------------------- 458 (674)
...++||||++|..+...+..... ...++..++..++.++++.|.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW 184 (357)
T ss_dssp TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence 346899999999887643200000 001222222223333333333
Q ss_pred -----------------------HHHhc-------CCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 459 -----------------------YLHED-------SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 459 -----------------------~LH~~-------~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+|.+. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 33221 145699999999999999654578999998853
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=4.2e-05 Score=79.40 Aligned_cols=140 Identities=16% Similarity=0.234 Sum_probs=81.3
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCC--CceeeEEe------EEEeCCeeEEEEEe
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH--RNLVRLLG------FCLEGEEKILVYEF 422 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 422 (674)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.++..|.. -.+.+++. +...++..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887554 5889988652 2344455666655531 12333332 22346678999999
Q ss_pred cCCCcccc--------------cccCC-C----c------CCCCCHHHHH------------------------------
Q 005846 423 VPNKSLDY--------------FLYDP-E----K------QGQLDWSRRY------------------------------ 447 (674)
Q Consensus 423 ~~~gsL~~--------------~l~~~-~----~------~~~l~~~~~~------------------------------ 447 (674)
++|..+.. -+|.. . . .....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99976641 01100 0 0 0112332211
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 448 -KIIGGIARGILYLHE----------DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 448 -~i~~~ia~~L~~LH~----------~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+...+.+++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666663 123569999999999999888899999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=4.1e-05 Score=81.52 Aligned_cols=75 Identities=12% Similarity=0.146 Sum_probs=50.4
Q ss_pred ccccccCCcEEEEEeecC-CCceeEEEEecccCc-------cCHHHHHHHHHHHHhcCC--Cc-eeeEEeEEEeCCeeEE
Q 005846 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASG-------QGAEEFKNEVVLVAKLQH--RN-LVRLLGFCLEGEEKIL 418 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--~n-iv~l~~~~~~~~~~~l 418 (674)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999754 467899997643211 223456789998888742 33 4455544 4556789
Q ss_pred EEEecCCC
Q 005846 419 VYEFVPNK 426 (674)
Q Consensus 419 v~e~~~~g 426 (674)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00013 Score=74.83 Aligned_cols=140 Identities=18% Similarity=0.157 Sum_probs=94.2
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCeeEEEEEecC
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
...+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4456799999999999987 5678889987543 3567889999998884 3568888988888888999999999
Q ss_pred CCcccc-----------cccCCCc-------------------CCCCCHHHHH---HHH----------------HHHHH
Q 005846 425 NKSLDY-----------FLYDPEK-------------------QGQLDWSRRY---KII----------------GGIAR 455 (674)
Q Consensus 425 ~gsL~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~~ia~ 455 (674)
+..+.. -||.... .-.-+|.... ++. ..+.+
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 987632 1111110 0012454332 111 11111
Q ss_pred HH-HHHHh-cCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 456 GI-LYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 456 ~L-~~LH~-~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
.+ ..|.. ..++.++|+|+.+.||+++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 12 23321 2356799999999999999887 8888874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=5.9e-05 Score=76.50 Aligned_cols=82 Identities=17% Similarity=0.236 Sum_probs=61.0
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCC---ceeeEEeEEEeCCeeEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHR---NLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~~~~~lv~ 420 (674)
..+....+.+|.|..+.||+.++.+|+.|++|+-..........|..|...|+.|... -+.+++++. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 3456667889999999999999989999999987655444445688899999988421 344555542 347899
Q ss_pred EecCCCccc
Q 005846 421 EFVPNKSLD 429 (674)
Q Consensus 421 e~~~~gsL~ 429 (674)
||++++...
T Consensus 90 e~l~~~~~~ 98 (288)
T 3f7w_A 90 EWVDERPPT 98 (288)
T ss_dssp ECCCCCCCC
T ss_pred EeecccCCC
Confidence 999887653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00027 Score=75.75 Aligned_cols=74 Identities=15% Similarity=0.210 Sum_probs=46.7
Q ss_pred cccccccCCcEEEEEeecCCCceeEEEEeccc------C-c--cCHHHHHHHHHHHHh-cCCCceeeEEeEEEeCCeeEE
Q 005846 349 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA------S-G--QGAEEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~l 418 (674)
..+.||.|..+.||+... ++..++||..... . . .....+..|+..+.. ..+..+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999975 5678999943211 0 1 123334444443322 2234566777664 567799
Q ss_pred EEEec-CC
Q 005846 419 VYEFV-PN 425 (674)
Q Consensus 419 v~e~~-~~ 425 (674)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00053 Score=70.46 Aligned_cols=156 Identities=13% Similarity=0.094 Sum_probs=86.6
Q ss_pred hhhHHHhhcCCCc-----ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEEe-
Q 005846 337 FETIEVATNKFST-----DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLG- 408 (674)
Q Consensus 337 ~~~~~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~- 408 (674)
.+++...-..|.. .+.|+.|....+|+....+| .+++|+..... ..+.+..|+.++..+...+ +.+++.
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 3344444444543 34567788899999887555 68899886521 1234566777777764222 233332
Q ss_pred -----EEEeCCeeEEEEEecCCCccccc--------------ccCCC---cC---CC---CCHHHHHHH-----------
Q 005846 409 -----FCLEGEEKILVYEFVPNKSLDYF--------------LYDPE---KQ---GQ---LDWSRRYKI----------- 449 (674)
Q Consensus 409 -----~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~---~~---~~---l~~~~~~~i----------- 449 (674)
+....+..+++++|++|..+... +|... .. .. ..|...+.-
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 11234567899999998765321 11100 00 00 113221110
Q ss_pred -HHHHHHHHHHHHhc----CCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 450 -IGGIARGILYLHED----SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 450 -~~~ia~~L~~LH~~----~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
...+.+.+..++.. .+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01234455555532 23469999999999999987666899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0016 Score=66.88 Aligned_cols=142 Identities=16% Similarity=0.142 Sum_probs=83.6
Q ss_pred cccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCc--eeeEEeE-----EEeCCeeEEEEEec
Q 005846 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN--LVRLLGF-----CLEGEEKILVYEFV 423 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 423 (674)
..|+ |....||+....+|+.+++|+..... .....+..|..++..+.... +.+++.. ...++..++++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887777789999986331 23456777888888774222 3444432 22345668899999
Q ss_pred CCCccccc--------------ccC----C--CcCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 005846 424 PNKSLDYF--------------LYD----P--EKQGQLDWSRR----YKI---------------IGGIARGILYLHED- 463 (674)
Q Consensus 424 ~~gsL~~~--------------l~~----~--~~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~- 463 (674)
+|..+... +|. . .....+++... ..+ ...+.+.+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 98765420 110 0 00111222211 001 01111222333221
Q ss_pred ---CCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 464 ---SRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 464 ---~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0011 Score=67.49 Aligned_cols=128 Identities=15% Similarity=0.147 Sum_probs=76.8
Q ss_pred ccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCeeEEEEEec-CCCc
Q 005846 350 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFV-PNKS 427 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 427 (674)
.+.|+.|....+|+. ..+++|+........ ....+|+..++.+...++ .+++++ +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 568888876532221 123568877777743333 355544 344457899999 6666
Q ss_pred ccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 005846 428 LDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE--------------------------------------------- 462 (674)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------------------------------------------- 462 (674)
+...... ....++.++++.|+-||+
T Consensus 95 l~~~~~~----------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFK----------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHH----------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHh----------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 5421000 000112222222222222
Q ss_pred -----cCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 463 -----DSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 463 -----~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
.....++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12345899999999999 5667789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00058 Score=73.31 Aligned_cols=74 Identities=16% Similarity=0.272 Sum_probs=51.0
Q ss_pred ccccccCCcEEEEEeecCC--------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCeeEEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY 420 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 420 (674)
.+.|+.|....+|+...++ +..+++|+.... ...+.+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888899999998653 478888887432 122456689999888853344 566665432 3899
Q ss_pred EecCCCccc
Q 005846 421 EFVPNKSLD 429 (674)
Q Consensus 421 e~~~~gsL~ 429 (674)
||++|..|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999876664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0015 Score=68.75 Aligned_cols=142 Identities=20% Similarity=0.226 Sum_probs=85.0
Q ss_pred ccccccCCcEEEEEeecC--------CCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeEEEE
Q 005846 350 DNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 420 (674)
.+.|..|-...+|+...+ +++.+++|+.... ......+.+|..+++.|. +.-..++++.+.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 346777888889998864 2467888886332 234566778999998884 3223566666543 2999
Q ss_pred EecCCCccccc-c----------------cCC--CcCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 005846 421 EFVPNKSLDYF-L----------------YDP--EKQGQLD--WSRRYKIIGGIAR-------------------GILYL 460 (674)
Q Consensus 421 e~~~~gsL~~~-l----------------~~~--~~~~~l~--~~~~~~i~~~ia~-------------------~L~~L 460 (674)
||++|..|..- + |.. .-..... |.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99999777421 1 110 0111222 4555555544422 23333
Q ss_pred H----hc-CCCcEEEeecccccEEEcCC----CCeEEeeeCCccc
Q 005846 461 H----ED-SRLRIIHRDLKASNILLDAE----MNPKISDFGMARI 496 (674)
Q Consensus 461 H----~~-~~~~iiHrDlkp~NIll~~~----~~~ki~DfGla~~ 496 (674)
. .. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 23469999999999999876 7899999998853
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0024 Score=65.84 Aligned_cols=142 Identities=16% Similarity=0.159 Sum_probs=72.0
Q ss_pred ccccccCCcEE-EEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCeeEEEEEecCCC
Q 005846 350 DNKLGEGGFGE-VYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNK 426 (674)
Q Consensus 350 ~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 426 (674)
.+.|+.|.... +|+....+|..+++|....... +.+..|+.++..+.. -.+.+++.+..+. -+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 34565555444 6677654467777776543321 223556676666632 2355666654333 27899999775
Q ss_pred ccccccc---------------------CCCc--CCCCCHHHHH-------HH-------------HHHHHHHHHHHH--
Q 005846 427 SLDYFLY---------------------DPEK--QGQLDWSRRY-------KI-------------IGGIARGILYLH-- 461 (674)
Q Consensus 427 sL~~~l~---------------------~~~~--~~~l~~~~~~-------~i-------------~~~ia~~L~~LH-- 461 (674)
.+..++. .... ...++..... .+ ...+.+.+..|.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 5533221 0000 0112211110 00 011112222221
Q ss_pred -hcCCCcEEEeecccccEEEcCC----CCeEEeeeCCccc
Q 005846 462 -EDSRLRIIHRDLKASNILLDAE----MNPKISDFGMARI 496 (674)
Q Consensus 462 -~~~~~~iiHrDlkp~NIll~~~----~~~ki~DfGla~~ 496 (674)
......++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6799999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0048 Score=66.58 Aligned_cols=75 Identities=13% Similarity=0.074 Sum_probs=49.4
Q ss_pred ccccccCCcEEEEEeecCC-CceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCeeEEEEEecCCCc
Q 005846 350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKS 427 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 427 (674)
.+.|+.|-...+|+....+ +..+++|+......... ...+|..++..|...++ .++++.+. + .+|+||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888899999998754 47788888754322211 12578899998865554 46777652 2 35999999876
Q ss_pred cc
Q 005846 428 LD 429 (674)
Q Consensus 428 L~ 429 (674)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0024 Score=66.98 Aligned_cols=74 Identities=11% Similarity=0.064 Sum_probs=44.7
Q ss_pred ccccccCCcEEEEEeecCC---------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCCeeEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPS---------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILV 419 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv 419 (674)
.+.|+.|....+|+....+ +..+++|+........ .....|..+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567788888999987643 2678888765432221 12367888888775334 34666543 2 3789
Q ss_pred EEecCCCcc
Q 005846 420 YEFVPNKSL 428 (674)
Q Consensus 420 ~e~~~~gsL 428 (674)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998665
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0094 Score=61.64 Aligned_cols=68 Identities=13% Similarity=0.093 Sum_probs=43.9
Q ss_pred ccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC---CCceeeEEeE------EEeCCeeEEEEEecC
Q 005846 354 GEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ---HRNLVRLLGF------CLEGEEKILVYEFVP 424 (674)
Q Consensus 354 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~ 424 (674)
|.|....||+....+| .+++|+...... ..|+.++..|. -+++.+.+.. ...++..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999987667 899998755431 34555665552 1224444432 233567899999999
Q ss_pred CCcc
Q 005846 425 NKSL 428 (674)
Q Consensus 425 ~gsL 428 (674)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 9876
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.41 E-value=0.022 Score=54.01 Aligned_cols=102 Identities=12% Similarity=0.078 Sum_probs=65.1
Q ss_pred cccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCCcc
Q 005846 427 SLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506 (674)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 506 (674)
+|.++|. ..+.+++++++|.++.|.+..|.-+-.... + ..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 5667774 346789999999999999999877622111 1 1233457999999999988763 1110
Q ss_pred ccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCC
Q 005846 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 548 (674)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p 548 (674)
.....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122456888653 3456788899999999998865543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.091 Score=55.82 Aligned_cols=141 Identities=18% Similarity=0.167 Sum_probs=85.1
Q ss_pred ccccccCCcEEEEEeecCC--------CceeEEEEecccCccCHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCCeeEEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 420 (674)
.+.|..|-...+|+....+ +..+++|+........ -...+|..+++.+...+ ..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4567778888999988653 5788888865433221 12367888888874323 34555533 2 27899
Q ss_pred EecCCCccccc-c----------------cC--C-----C---cCCCCCHHHHHHHHHHH-------------------H
Q 005846 421 EFVPNKSLDYF-L----------------YD--P-----E---KQGQLDWSRRYKIIGGI-------------------A 454 (674)
Q Consensus 421 e~~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a 454 (674)
||++|..|..- + |. . . ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99999776321 1 00 0 0 11111244444444322 2
Q ss_pred HHHHHHH---------------------hcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 455 RGILYLH---------------------EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 455 ~~L~~LH---------------------~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
..+..|. ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233332 112346899999999999 8888999999998853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.70 E-value=0.2 Score=52.83 Aligned_cols=30 Identities=27% Similarity=0.388 Sum_probs=25.3
Q ss_pred cEEEeecccccEEE------cCCCCeEEeeeCCccc
Q 005846 467 RIIHRDLKASNILL------DAEMNPKISDFGMARI 496 (674)
Q Consensus 467 ~iiHrDlkp~NIll------~~~~~~ki~DfGla~~ 496 (674)
.++|+|+.+.|||+ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567799999998853
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.60 E-value=0.089 Score=35.89 Aligned_cols=27 Identities=19% Similarity=0.186 Sum_probs=13.9
Q ss_pred EEEehhHHHHHHHHhheeeEEEecccc
Q 005846 287 IAIVAPIAVTAVLFILGFCFLRRKAKK 313 (674)
Q Consensus 287 i~iv~~v~~~~vl~~~~~~~~~r~~~~ 313 (674)
.+++.++++++++++..++++|||+++
T Consensus 15 ~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 15 TGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred eehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 344444555555555555555555544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.00 E-value=0.26 Score=53.06 Aligned_cols=62 Identities=8% Similarity=0.089 Sum_probs=19.1
Q ss_pred CcccccccCCcEEEEEeecCC-CceeEE------EEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 005846 348 STDNKLGEGGFGEVYKGVLPS-GQEIAV------KRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 412 (674)
.+.++|| ||.||+|.+.. ..+||| |..... .......|.+|..++..++|+|+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456676 99999999854 367888 665432 22233567888899999999999999988654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.69 E-value=2.1 Score=40.40 Aligned_cols=86 Identities=7% Similarity=0.009 Sum_probs=62.1
Q ss_pred cCCCceeeEEeEEEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 398 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
..||++++. .+-.+.+...+.|+.-+ +...|- .-..++...+++++..|+....+++. -+|--|.|+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 368988877 45566666666665433 222222 22357889999999999988866653 4788899999
Q ss_pred EEEcCCCCeEEeeeCCcc
Q 005846 478 ILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~ 495 (674)
|+++.++.++|.-.|+-.
T Consensus 110 L~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp EEECTTSCEEESCCEETT
T ss_pred EEEcCCCCEEEEEccCcc
Confidence 999999999998777643
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.42 E-value=0.088 Score=35.82 Aligned_cols=27 Identities=19% Similarity=0.330 Sum_probs=13.5
Q ss_pred EEehhHHHHHHHHhheeeEEEeccccc
Q 005846 288 AIVAPIAVTAVLFILGFCFLRRKAKKK 314 (674)
Q Consensus 288 ~iv~~v~~~~vl~~~~~~~~~r~~~~~ 314 (674)
+++.++++++++++..++++|||++++
T Consensus 15 gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 15 GVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred eehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 334445555555555555555555443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 674 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-80 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-75 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-73 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-72 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-72 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-71 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-71 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-71 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-71 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-70 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-69 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-69 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-69 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-67 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-67 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-67 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-65 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-65 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-64 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-63 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-61 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-50 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-49 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-27 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (649), Expect = 3e-80
Identities = 70/289 (24%), Positives = 133/289 (46%), Gaps = 20/289 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++ + Q + FKNEV ++ K +H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
N++ +G+ + +V ++ SL + L+ + + + + I A+G+ YL
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYL 120
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H S IIHRDLK++NI L ++ KI DFG+A + ++ G+ +MAPE
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 521 AMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
+S +SDVY+FG+++ E++TG+ + + ++ + +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQL--PYSNINNRDQIIFMVGRGYLSPDL---- 231
Query: 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626
N +L C+++ ERP I+ + + +LP
Sbjct: 232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 1e-75
Identities = 82/281 (29%), Positives = 135/281 (48%), Gaps = 22/281 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L + S + F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
+ LVRL + E ++ E++ N SL FL P +L ++ + IA G+ ++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI 125
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
E + IHRDL+A+NIL+ ++ KI+DFG+AR+ ++ + APE
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEA 181
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
+G F++KSDV+SFG+L+ EI+T + Y +++ + +R P +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGR--IPYPGMTNPEVIQNLERGYRMVRPDNCPE-- 237
Query: 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
QL LC +E P +RP+ + +L +
Sbjct: 238 -----------ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 5e-73
Identities = 80/292 (27%), Positives = 133/292 (45%), Gaps = 22/292 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + E F E ++ KL+H
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 71
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L E +V E++ SL FL E L + + IA G+ Y+
Sbjct: 72 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
R+ +HRDL+A+NIL+ + K++DFG+AR+ ++ + APE
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEA 185
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
A++G+F++KSDV+SFG+L+ E+ T + Y ++L + +R P + +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGR--VPYPGMVNREVLDQVERGYRMPCPPECPE-- 241
Query: 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632
L C +++P ERP+ + L Y + QP
Sbjct: 242 -----------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 2e-72
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 22/274 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
++ + ++G G FG V+ G + ++A+K + + E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+L G CLE LV+EF+ + L Y ++G + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
+IHRDL A N L+ K+SDFGM R DQ +++ + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584
++S KSDV+SFGVL+ E+ + K +++ ++ + T
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---------------VEDISTGFRLY 222
Query: 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
R Q+ C +E P +RP+ + ++ L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 7e-72
Identities = 66/291 (22%), Positives = 119/291 (40%), Gaps = 28/291 (9%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCL 411
+G+G FGEV++G G+E+AVK S + + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 412 EGEEKI----LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---- 463
+ LV ++ + SL +L + + K+ A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 464 -SRLRIIHRDLKASNILLDAEMNPKISDFGMARIF--GVDQTQGNTSRIVGTYGYMAPEY 520
+ I HRDLK+ NIL+ I+D G+A D + VGT YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 521 ------AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA----ADLLSYAWKQWRD 570
H + ++D+Y+ G++ EI ++ + ++ R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 571 GTPLQLLDTNLTDSYSRNEVIRCI-QLGLLCVQEDPAERPSMATIVLMLNS 620
Q L N+ + + E +R + ++ C + A R + I L+
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 231 bits (591), Expect = 1e-71
Identities = 77/292 (26%), Positives = 136/292 (46%), Gaps = 22/292 (7%)
Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEF 388
++ +++ E+ + +KLG G +GEVY+GV +AVK L + + + EEF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF 60
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYK 448
E ++ +++H NLV+LLG C ++ EF+ +L +L + +Q ++
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY 119
Query: 449 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR 508
+ I+ + YL + IHRDL A N L+ K++DFG++R+ D +
Sbjct: 120 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG- 175
Query: 509 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568
+ APE + +FS+KSDV++FGVL+ EI T + Y + +
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQV-------- 225
Query: 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
+LL+ + + +L C Q +P++RPS A I +
Sbjct: 226 -----YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 1e-71
Identities = 72/301 (23%), Positives = 129/301 (42%), Gaps = 27/301 (8%)
Query: 340 IEVATNKFS-TDNKLGEGGFGEVYKGVL---PSGQEIAVKRLSKASGQG-AEEFKNEVVL 394
+ + + D +LG G FG V +GV ++A+K L + + + EE E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ +L + +VRL+G C + E +LV E L FL K+ ++ S +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGN-TSRIVGTY 513
G+ YL +HRDL A N+LL KISDFG+++ G D + S
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573
+ APE +FS +SDV+S+GV + E ++ + Y+ +++++ + R P
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFIEQGKRMECP 234
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPAF 633
+ L C +RP T+ + + +L S +
Sbjct: 235 PECPP-------------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
Query: 634 F 634
Sbjct: 282 H 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 232 bits (591), Expect = 1e-71
Identities = 78/314 (24%), Positives = 129/314 (41%), Gaps = 46/314 (14%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSK-ASGQGA 385
L ++E N +GEG FG V++ P +AVK L + AS
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 386 EEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQG------ 439
+F+ E L+A+ + N+V+LLG C G+ L++E++ L+ FL
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 440 ---------------QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 484
L + + I +A G+ YL E + +HRDL N L+ M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 485 NPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 544
KI+DFG++R +M PE + +++ +SDV+++GV++ EI +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 545 GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQED 604
Y +++ RDG L + N + L LC +
Sbjct: 238 YGL--QPYYGMAHEEVI----YYVRDGNILACPE---------NCPLELYNLMRLCWSKL 282
Query: 605 PAERPSMATIVLML 618
PA+RPS +I +L
Sbjct: 283 PADRPSFCSIHRIL 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 3e-71
Identities = 61/274 (22%), Positives = 118/274 (43%), Gaps = 22/274 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
+ +LG G FG V G ++A+K + + S +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
+L G C + ++ E++ N L +L + + + + ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
+ +HRDL A N L++ + K+SDFG++R +D ++ + PE M+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584
+FS KSD+++FGVL+ EI + K ++++ + + + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
+ + C E ERP+ ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 4e-71
Identities = 69/304 (22%), Positives = 120/304 (39%), Gaps = 38/304 (12%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-EEFKNEVVLVAK 397
+E+ + F ++LG G G V+K PSG +A K + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+V G E + E + SLD L K G++ K+ + +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
YL + +I+HRD+K SNIL+++ K+ DFG++ + VGT YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKK------NSNFYQTDGAADLLSYAWKQWRDG 571
PE +SV+SD++S G+ ++E+ G+ G A R
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 572 TPLQLLDTNLTDSYSRNEVIR---------------------CIQLGLLCVQEDPAERPS 610
TP + L + DS + C+ ++PAER
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 611 MATI 614
+ +
Sbjct: 292 LKQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 229 bits (584), Expect = 2e-70
Identities = 75/302 (24%), Positives = 135/302 (44%), Gaps = 37/302 (12%)
Query: 335 FDFETIEVATNKFST---------DNKLGEGGFGEVYKGVLPSGQE----IAVKRLSKA- 380
F FE A +F+ + +G G FGEV G L + +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 381 SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
+ + +F +E ++ + H N++ L G + +++ EF+ N SLD FL + GQ
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQ 124
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
+ ++ GIA G+ YL + +HRDL A NIL+++ + K+SDFG++R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 501 QTQGNTSRIVG---TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557
+ + +G + APE + +F+ SDV+S+G+++ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617
+ + + ++ + + QL L C Q+D RP IV
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 618 LN 619
L+
Sbjct: 287 LD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 2e-69
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 28/279 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH 400
+ + +G+G FG+V G G ++AVK + + + F E ++ +L+H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 59
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
L +HRDL A N+L+ + K+SDFG+ + Q G + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPE 170
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579
+FS KSDV+SFG+L+ EI + + Y D++ K ++ P
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGYKMDAP------ 222
Query: 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
D ++ C D A RPS + L
Sbjct: 223 ---DGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-69
Identities = 73/289 (25%), Positives = 136/289 (47%), Gaps = 27/289 (9%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSKASGQGA-EEFKNEV 392
T E+ + + +G G FGEVYKG+L + +A+K L + +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGG 452
++ + H N++RL G + + +++ E++ N + + EK G+ + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRG 118
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVG 511
IA G+ YL + +HRDL A NIL+++ + K+SDFG++R+ D T S
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571
+ APE + +F+ SDV+SFG+++ E++T + + ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------------- 222
Query: 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
++ ++ + QL + C Q++ A RP A IV +L+
Sbjct: 223 --MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 6e-69
Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 28/278 (10%)
Query: 350 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + +AVK L + A +E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
R++G C E E +LV E L+ +L + + +++ ++ G+ YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTS-RIVGTYGYMAPEYAMH 523
+HRDL A N+LL + KISDFG+++ D+ + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 524 GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583
+FS KSDV+SFGVL+ E + + ++ + +L+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERM 229
Query: 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
L LC D RP A + L L +Y
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-67
Identities = 71/318 (22%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 325 NDLTTLESLQFDFETI-EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL 377
N+ ++ Q ++ E N+ S LG G FG+V + + +AVK L
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 378 SKASGQG-AEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYD- 434
++ E +E+ +++ L H N+V LLG C G +++ E+ L FL
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 435 --------------PEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 480
+ + LD +A+G+ +L IHRDL A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178
Query: 481 DAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 540
KI DFG+AR D +MAPE + ++ +SDV+S+G+ +
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 541 EIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLC 600
E+ + + D +++ + + C
Sbjct: 239 ELFSLGSS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 284
Query: 601 VQEDPAERPSMATIVLML 618
DP +RP+ IV ++
Sbjct: 285 WDADPLKRPTFKQIVQLI 302
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 4e-67
Identities = 72/315 (22%), Positives = 125/315 (39%), Gaps = 31/315 (9%)
Query: 326 DLTTLES-LQFDFETIEVATNKFST--DNKLGEGGFGEVYKGVLP----SGQEIAVKRLS 378
DL+ L L + + + + + +G G FG VY G L AVK L+
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 379 KASGQG-AEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPE 436
+ + G +F E +++ H N++ LLG CL E +V ++ + L F+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 437 KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496
+ + + + + + +HRDL A N +LD + K++DFG+AR
Sbjct: 125 HNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 497 FGVDQTQGNTSR--IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQT 554
+ ++ +MA E +F+ KSDV+SFGVL+ E++T Y
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPD 237
Query: 555 DGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
D+ Y + R P D ++ L C RPS + +
Sbjct: 238 VNTFDITVYLLQGRRLLQPEYCPD-------------PLYEVMLKCWHPKAEMRPSFSEL 284
Query: 615 VLMLNSYSVTLPSPQ 629
V +++ T
Sbjct: 285 VSRISAIFSTFIGEH 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 9e-67
Identities = 70/329 (21%), Positives = 124/329 (37%), Gaps = 46/329 (13%)
Query: 321 SNADNDLTTLESLQFDFETI-EVATNKFSTDNKLGEGGFGEVYKGVLPS------GQEIA 373
++DN+ ++ +++++ E LG G FG+V ++A
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 374 VKRLSKASGQGA-EEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
VK L + + E +E+ ++ +L H N+V LLG C L++E+ L +
Sbjct: 72 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131
Query: 432 LYDPEKQ--------------------GQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471
L ++ L + +A+G+ +L +HR
Sbjct: 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR 188
Query: 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSD 531
DL A N+L+ KI DFG+AR D +MAPE G +++KSD
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248
Query: 532 VYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVI 591
V+S+G+L+ EI + N + A+ +K ++G +
Sbjct: 249 VWSYGILLWEIFSLGVN-PYPGIPVDANF----YKLIQNGFKMD---------QPFYATE 294
Query: 592 RCIQLGLLCVQEDPAERPSMATIVLMLNS 620
+ C D +RPS + L
Sbjct: 295 EIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-65
Identities = 76/318 (23%), Positives = 132/318 (41%), Gaps = 41/318 (12%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQE----IAVKRLSKA-SGQGAEEFKNEVVLVAKLQH 400
F LG G FG VYKG+ +P G++ +A+K L +A S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
++ RLLG CL +++ LDY E + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
R++HRDL A N+L+ + KI+DFG+A++ G ++ + + +MA E
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
+H ++ +SDV+S+GV V E++T + +L+
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKG 229
Query: 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML--------------NSYSVTLP 626
I + + C D RP +++ + LP
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 627 SPQQPAFFIGSRTERDLP 644
SP F+ E D+
Sbjct: 290 SPTDSNFYRALMDEEDMD 307
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-65
Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 23/273 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA-EEFKNEVVLVAKLQHRN 402
+ LGEG +GEV V + + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+ G EG + L E+ L + E + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
+ I HRD+K N+LLD N KISDFG+A +F + + +++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 523 HGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
+F + DV+S G+++ ++ G+ + Q + + W++ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE----YSDWKEKKTYLNPWKKI 232
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+ + L + E+P+ R ++ I
Sbjct: 233 DSA--------PLALLHKILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (550), Expect = 2e-65
Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 34/279 (12%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAE---EFKNEVVLVAKLQ 399
FS ++G G FG VY + + + +A+K++S + Q E + EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H N ++ G L LV E+ + D + L + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
LH +IHRD+KA NILL K+ DFG A I + VGT +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 520 YAM---HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576
+ GQ+ K DV+S G+ +E+ K + + + L L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL-----YHIAQNESPAL 234
Query: 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
+ ++ C+Q+ P +RP+ ++
Sbjct: 235 QSGHWSEY--------FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-64
Identities = 81/293 (27%), Positives = 124/293 (42%), Gaps = 39/293 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSK-ASGQGAEEFKNEVVLVAKL-Q 399
N + +GEG FG+V K + + A+KR+ + AS +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YDPEKQGQLDWSRR 446
H N++ LLG C L E+ P+ +L FL L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
+ARG+ YL + + IHRDL A NIL+ KI+DFG++R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566
+ +MA E + ++ SDV+S+GVL+ EI++ Y A+L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKLPQ 241
Query: 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619
+R PL D L C +E P ERPS A I++ LN
Sbjct: 242 GYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-64
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 31/274 (11%)
Query: 350 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHRNLVRL 406
D ++G G F VYKG+ + E+A L + + FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ +LV E + + +L +L ++ + I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 463 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
+ IIHRDLK NI + + KI D G+A + + ++GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM- 184
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
++ DVY+FG+ +LE+ T + + + AA + +++ G D
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEY--PYSECQNAAQI----YRRVTSGVKPASFDKVA 238
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
++ C++++ ER S+ ++
Sbjct: 239 IPE--------VKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 80/309 (25%), Positives = 135/309 (43%), Gaps = 34/309 (11%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSK-ASGQGAEEFKNEVV 393
EVA K + +LG+G FG VY+GV +A+K +++ AS + EF NE
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------DPEKQGQLDWSRR 446
++ + ++VRLLG +G+ +++ E + L +L + S+
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 447 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT 506
++ G IA G+ YL+ + + +HRDL A N ++ + KI DFGM R
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 507 SRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566
+ + +M+PE G F+ SDV+SFGV++ EI T + YQ +L + +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME 250
Query: 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626
P D +L +C Q +P RPS I+ + P
Sbjct: 251 GGLLDKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSIK--EEMEP 295
Query: 627 SPQQPAFFI 635
++ +F+
Sbjct: 296 GFREVSFYY 304
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-63
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 26/278 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHRN 402
+ +G G +G K G+ + K L S A + +EV L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 403 LVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYDPEKQGQ-LDWSRRYKIIGGIARGILY 459
+VR ++ L V E+ L + K+ Q LD +++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 460 LHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
H D ++HRDLK +N+ LD + N K+ DFG+ARI D + VGT YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
PE ++ KSD++S G L+ E+ + +L + R+G +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELA----GKIREGKFRR-- 233
Query: 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIV 615
+ YS ++ + RPS+ I+
Sbjct: 234 ---IPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-63
Identities = 74/288 (25%), Positives = 111/288 (38%), Gaps = 28/288 (9%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSK---ASGQGAEEFKNE 391
T + KLG+G FG V +G + +AVK L + + ++F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIG 451
V + L HRNL+RL G L K+ V E P SL + QG +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLD--RLRKHQGHFLLGTLSRYAV 118
Query: 452 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-NTSRIV 510
+A G+ YL R IHRDL A N+LL KI DFG+ R +
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 511 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570
+ + APE FS SD + FGV + E+ T + + + +L K ++
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ--EPWIGLNGSQIL---HKIDKE 230
Query: 571 GTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLML 618
G L + + + + C P +RP+ + L
Sbjct: 231 GERLPRPE---------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 3e-63
Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 27/270 (10%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGF 409
+LG+G FG+VYK + A K + S + E++ E+ ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469
++ EF ++D + + + L S+ + + YLH+ +II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKII 132
Query: 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM-----HG 524
HRDLKA NIL + + K++DFG++ +T +GT +MAPE M
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 525 QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584
+ K+DV+S G+ ++E+ + + +L + P L
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL----LKIAKSEPPTLAQ---PSR 240
Query: 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+S N C++++ R + + +
Sbjct: 241 WSSN----FKDFLKKCLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 8e-63
Identities = 69/291 (23%), Positives = 135/291 (46%), Gaps = 25/291 (8%)
Query: 325 NDLTTLESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQ 383
+D LE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 384 GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDW 443
E NE++++ + ++ N+V L L G+E +V E++ SL + + +D
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDE 115
Query: 444 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503
+ + + + +LH ++IHRD+K+ NILL + + K++DFG +Q++
Sbjct: 116 GQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 504 GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSY 563
S +VGT +MAPE + K D++S G++ +E+I G+ + + L
Sbjct: 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENPLRAL--- 225
Query: 564 AWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+ +GTP L+ C+ D +R S +
Sbjct: 226 -YLIATNGTPELQNPEKLSAI--------FRDFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 8e-63
Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 40/281 (14%)
Query: 346 KFSTDN-----KLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGA---EEFKNEVVLVA 396
+++ ++ LG+G FG VY S +A+K L KA + A + + EV + +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
L+H N++RL G+ + L+ E+ P ++ L +K + D R I +A
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANA 118
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYM 516
+ Y H R+IHRD+K N+LL + KI+DFG + + + GT Y+
Sbjct: 119 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYL 171
Query: 517 APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576
PE K D++S GVL E + GK + T +
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-------------------FEANTYQET 212
Query: 577 LDTNLTDSYSRNEVI--RCIQLGLLCVQEDPAERPSMATIV 615
++ + + L ++ +P++RP + ++
Sbjct: 213 YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 3e-61
Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 27/285 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKASGQGA-EEFKNEVVLV 395
E+ + +GEG FG+V++G+ S +A+K + E+F E + +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ H ++V+L+G E ++ E L + ++ LD + ++
Sbjct: 63 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLST 119
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
+ YL R +HRD+ A N+L+ + K+ DFG++R D T S+ +
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 175
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575
MAPE +F+ SDV+ FGV + EI+ + + +G L
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLP 229
Query: 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
+ N + L C DP+ RP + L++
Sbjct: 230 MPP-NCPPT--------LYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-61
Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 39/310 (12%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSKASGQGAE 386
L +D E ++ LG G FG+V + + + +AVK L + +
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 387 E--FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLY---------- 433
+L+ H N+V LLG C + + ++ EF +L +L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 434 ---DPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 490
+ + L +A+G+ +L + IHRDL A NILL + KI D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICD 177
Query: 491 FGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSN 550
FG+AR D +MAPE ++++SDV+SFGVL+ EI +
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----- 232
Query: 551 FYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS 610
+ ++ ++GT ++ D + Q L C +P++RP+
Sbjct: 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPT 283
Query: 611 MATIVLMLNS 620
+ +V L +
Sbjct: 284 FSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-59
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 41/302 (13%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSK-ASGQGAEEFKNE 391
E+ ++ LGEG FG+V ++AVK L A+ + + +E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------DPEK 437
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 438 QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497
+ QL +ARG+ YL + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGA 557
T+ +MAPE ++ +SDV+SFGVL+ EI T + Y
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPV 243
Query: 558 ADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617
+L +K ++G + N + C P++RP+ +V
Sbjct: 244 EEL----FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 618 LN 619
L+
Sbjct: 291 LD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 4e-57
Identities = 63/275 (22%), Positives = 104/275 (37%), Gaps = 31/275 (11%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHR 401
F LGEG F V L + +E A+K L K E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
V+L + E+ + N L ++ K G D + I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
IIHRDLK NILL+ +M+ +I+DFG A++ + Q + VGT Y++PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
SD+++ G ++ +++ G +R G + +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKII 223
Query: 582 TDSYSRNEVI--RCIQLGLLCVQEDPAERPSMATI 614
Y E + L + D +R +
Sbjct: 224 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 194 bits (493), Expect = 1e-56
Identities = 52/273 (19%), Positives = 106/273 (38%), Gaps = 24/273 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
+ + +LG G FG V++ +G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
V L + E +++YEF+ L + D + ++ + + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
+H DLK NI+ + + K+ DFG+ + + GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
+D++S GVL +++G + + + + L D + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL---SPFGGENDDETLRNVKSC--DWNMDDSAFSGI 252
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
++ + DP R ++
Sbjct: 253 SED--------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 186 bits (473), Expect = 7e-54
Identities = 57/273 (20%), Positives = 107/273 (39%), Gaps = 24/273 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
+ + +LG G FG V++ V +G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED 463
+ L + E +L+ EF+ L + + ++ + + G+ ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 464 SRLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
I+H D+K NI+ + + KI DFG+A D+ T + APE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
+D+++ GVL +++G S F D L + W D +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL--SPFAGEDDLETLQNVKRCDWE-------FDEDA 251
Query: 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
S S +Q++P +R ++
Sbjct: 252 FSSVSPE----AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 9e-54
Identities = 66/326 (20%), Positives = 129/326 (39%), Gaps = 23/326 (7%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQG-AEEFKNEVVLVAKLQHR 401
+++ + +GEG +G V + +A+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N++ + + + ++ + LY K L + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT-SRIVGTYGYMAPEY 520
++HRDLK SN+LL+ + KI DFG+AR+ D + V T Y APE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 521 AMHGQFSVKS-DVYSFGVLVLEIITGK-----KNSNFYQTDGAADLLSYAWKQWRDGTPL 574
++ + KS D++S G ++ E+++ + K+ L S + + L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 575 QLLDTNLTDSYSRNEVIR---------CIQLGLLCVQEDPAERPSMATIVLM--LNSYSV 623
+ + L+ + + L + +P +R + + L Y
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 624 TLPSPQQPAFFIGSRTERDLPTKEFE 649
P A F DLP ++ +
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKLK 329
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (464), Expect = 3e-53
Identities = 51/287 (17%), Positives = 105/287 (36%), Gaps = 27/287 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
N++ K+G G FG++Y G + +G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 404 VRLLGFCL-EGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ + +C EG+ ++V E + D F + + + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 463 DSRLRIIHRDLKASNIL---LDAEMNPKISDFGMARIFGVDQTQGN-----TSRIVGTYG 514
IHRD+K N L I DFG+A+ + +T + + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574
Y + + + S + D+ S G +++ G + + + TP+
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISEKKMSTPI 237
Query: 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621
++L E + C ++P + + + +
Sbjct: 238 EVLCKGYPS-----EFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (461), Expect = 5e-53
Identities = 65/282 (23%), Positives = 117/282 (41%), Gaps = 28/282 (9%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---EEFKNEVVLVAKLQ 399
++++ LG GG EV+ L +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 400 HRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
H +V + G +V E+V +L ++ +G + R ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG-NTSRIVGTYG 514
+ + H+ IIHRD+K +NI++ A K+ DFG+AR T+ ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 515 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574
Y++PE A +SDVYS G ++ E++TG+ + D + ++ D P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---PPFTGDSPVSVAYQHVRE--DPIPP 234
Query: 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616
L+ + L + ++P R A +
Sbjct: 235 SARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 180 bits (457), Expect = 2e-51
Identities = 68/276 (24%), Positives = 108/276 (39%), Gaps = 32/276 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVV---LVAK 397
N FS +G GGFGEVY +G+ A+K L K QG NE + LV+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+V + ++ + + + L Y L + G + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
++H +++RDLK +NILLD + +ISD G+A F + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 518 PEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576
PE G + +D +S G ++ +++ G + ++ D L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH---SPFRQHKTKDKHEIDRMTLTMAVELP- 229
Query: 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612
DS+S L +Q D R
Sbjct: 230 ------DSFSPE----LRSLLEGLLQRDVNRRLGCL 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 5e-51
Identities = 64/283 (22%), Positives = 118/283 (41%), Gaps = 27/283 (9%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-FKNEVVL 394
++ E + + + LG G F EV + + +A+K ++K + +G E +NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
+ K++H N+V L G L+ + V L + ++G ++I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVL 117
Query: 455 RGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMARIFGVDQTQGNTSRIVG 511
+ YLH+ I+HRDLK N+L D + ISDFG++++ S G
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACG 171
Query: 512 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571
T GY+APE +S D +S GV+ ++ G + + A L K +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKA--EY 226
Query: 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+++DS +++DP +R +
Sbjct: 227 EFDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 52/272 (19%), Positives = 102/272 (37%), Gaps = 25/272 (9%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV 404
K+ LG G FG V++ V S + K + K G K E+ ++ +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
L EE ++++EF+ + + +L+ + + + +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 465 RLRIIHRDLKASNILLDAEMNP--KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
I H D++ NI+ + KI +FG AR N + Y APE
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 523 HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582
H S +D++S G LV +++G N + + ++ + T + ++
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI---NPFLAETNQQIIENIMNA--EYTFDEEAFKEIS 231
Query: 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+ + ++ R + +
Sbjct: 232 IE--------AMDFVDRLLVKERKSRMTASEA 255
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 174 bits (441), Expect = 4e-50
Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 29/288 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRN 402
K+ K+GEG +G VYK G+ A+K RL K E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+L + +LV+E + +G L+ + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAM 522
R++HRDLK N+L++ E KI+DFG+AR FG+ + + T Y AP+ M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 523 -HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL--------SYAWKQWRDGTP 573
++S D++S G + E++ G + AD L + K W + T
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 574 LQLLDTNLT-------DSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
L D N T +S+ + I L ++ DP +R +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 6e-50
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 39/286 (13%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA---------EEFKNEVVLV 395
+ LG G V + + P+ +E AVK + G E EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 396 AKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIA 454
K+ H N+++L LV++ + L +L ++ L KI+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 455 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
I LH+ L I+HRDLK NILLD +MN K++DFG + + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174
Query: 515 YMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW 568
Y+APE H + + D++S GV++ ++ G F+ L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRMIMSGNY 232
Query: 569 RDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
+ G+P D YS L + P +R +
Sbjct: 233 QFGSPEW-------DDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-49
Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 34/304 (11%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE-----FKNEVVLVAKLQHRNLV 404
+ LGEG F VYK + Q +A+K++ A++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDS 464
LL LV++F+ + L S + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 465 RLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHG 524
I+HRDLK +N+LLD K++DFG+A+ FG + V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA 175
Query: 525 Q-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583
+ + V D+++ G ++ E++ F D D L+ ++ T Q D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 584 SYSRNEVIRCIQLGLL--------------CVQEDPAERPSMATIVLM--LNSYSVTLPS 627
Y + I L + +P R + + M ++ P
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 628 PQQP 631
Q P
Sbjct: 293 CQLP 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 3e-49
Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 34/279 (12%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN----EVVLVAKLQ 399
F LG+G FG+V+ + Q A+K L K ++ + + VL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
H L + E V E++ L Y + + + D SR I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118
Query: 460 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
LH I++RDLK NILLD + + KI+DFGM + + + NT GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579
+ +++ D +SFGVL+ E++ G+ + +L +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ-------------------SPFHGQDEEELFHS 214
Query: 580 NLTDSYSRNEVI--RCIQLGLLCVQEDPAERPSMATIVL 616
D+ + L + +P +R + +
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-49
Identities = 65/295 (22%), Positives = 121/295 (41%), Gaps = 32/295 (10%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSKASGQG--AEEFKNEVVLVAKL 398
A ++ ++GEG +G+V+K + G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 399 ---QHRNLVRLLGFCLEGEEKILVYEFVPNKSLD---YFLYDPEKQGQLDWSRRYKIIGG 452
+H N+VRL C + + +D D + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 453 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGT 512
+ RG+ +LH R++HRDLK NIL+ + K++DFG+ARI+ + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL--------SYA 564
Y APE + ++ D++S G + E+ K ++ D L
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235
Query: 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIR-----CIQLGLLCVQEDPAERPSMATI 614
+ W L + + + + L L C+ +PA+R S +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (435), Expect = 7e-49
Identities = 57/274 (20%), Positives = 102/274 (37%), Gaps = 36/274 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
F LG G FG V+ +G+ A+K L K + E +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
++R+ G + ++ ++ +++ L L ++ + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
II+RDLK NILLD + KI+DFG A+ T + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
++ D +SFG+L+ E++ G + D ++ +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKI 213
Query: 581 LTDSYSRNEVI--RCIQLGLLCVQEDPAERPSMA 612
L L + D ++R
Sbjct: 214 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNL 247
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 77/343 (22%), Positives = 129/343 (37%), Gaps = 48/343 (13%)
Query: 347 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR 405
++ +G G FG VY+ L SG+ +A+K++ + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCLEGEEK------ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILY 459
L F EK LV ++VP + + L + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 460 LHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAP 518
+H I HRD+K N+LLD + K+ DFG A+ + + N S I Y
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192
Query: 519 EYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLL--------SYAWKQWRD 570
++ DV+S G ++ E++ G+ + D D L + +Q R+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 571 GTPL-------QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM-----L 618
P Q+ T + I L ++ P R + L
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 619 NSYSVTLPS-PQQPAFFIGSRTERDLPTKEFECSDKSTSKSIP 660
+V LP+ PA F + T+E + + IP
Sbjct: 310 RDPNVKLPNGRDTPALF-------NFTTQELSSNPPLATILIP 345
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (426), Expect = 6e-48
Identities = 44/288 (15%), Positives = 98/288 (34%), Gaps = 29/288 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN- 402
+ ++GEG FG +++G L + Q++A+K + S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ + F EG +LV + + D + + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 463 DSRLRIIHRDLKASNILLDAEMNP-----KISDFGMARIFGVDQTQGN-----TSRIVGT 512
+++RD+K N L+ + + DFGM + + T+ + + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 513 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572
YM+ + + S + D+ + G + + + G + + + T
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQST 235
Query: 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620
PL+ L + + + P + + +
Sbjct: 236 PLRELCAGFPEEF--------YKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-46
Identities = 72/305 (23%), Positives = 119/305 (39%), Gaps = 33/305 (10%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSKASGQGAEEFKNEVVLVAKLQHRN 402
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+V+LL + LV+EF+ + D + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 463 DSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE-YA 521
R++HRDLK N+L++ E K++DFG+AR FGV V T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
+S D++S G + E++T + + D D L ++ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 582 TDSYSRNEVIR---------------CIQLGLLCVQEDPAERPSMATIVLMLNSY--SVT 624
Y + L + DP +R S + + + VT
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA--LAHPFFQDVT 290
Query: 625 LPSPQ 629
P P
Sbjct: 291 KPVPH 295
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-46
Identities = 59/299 (19%), Positives = 109/299 (36%), Gaps = 45/299 (15%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEE------FKNEVVLVAK 397
+++ LG GGFG VY G+ + +A+K + K E EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
+ ++RLL + + +L+ E + ++G L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRIVGTYG 514
+ + H ++HRD+K NIL+D K+ DFG + + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 515 YMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573
Y PE+ + ++ + V+S G+L+ +++ G +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------IPFEHDEE 215
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632
+ S C L C+ P++RP+ I + + + PQ+ A
Sbjct: 216 IIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEI--QNHPWMQDVLLPQETA 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-46
Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 33/281 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKAS------GQGAEEFKNEVVLVAK 397
+ + T +LG G F V K +G + A K + K G E+ + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+QH N++ L + IL+ E V L FL ++ L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMARIFGVDQTQGNTSRIVGTY 513
++ L+I H DLK NI+L P KI DFG+A I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 514 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573
++APE + +++D++S GV+ +++G + + D + L+
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVSA------- 230
Query: 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
++ D Y N + +DP +R ++
Sbjct: 231 ---VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 59/288 (20%), Positives = 111/288 (38%), Gaps = 27/288 (9%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASG--QGAEEFKNEVVLVAKLQHR 401
K+ K+GEG +G V+K + + +A+KR+ E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLH 461
N+VRL ++ LV+EF YF G LD + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 462 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYA 521
++HRDLK N+L++ K+++FG+AR FG+ ++ +V +
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174
Query: 522 MHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581
+S D++S G + E+ + + + D L ++ T Q
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 582 TDSYSRNEVIR---------------CIQLGLLCVQEDPAERPSMATI 614
Y + L ++ +P +R S
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 54/275 (19%), Positives = 102/275 (37%), Gaps = 30/275 (10%)
Query: 349 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRL 406
T LG G G+V + + ++ A+K L + + EV L + Q ++VR+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70
Query: 407 LGFCLEGEEK----ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE 462
+ ++V E + L + D Q +I+ I I YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 129
Query: 463 DSRLRIIHRDLKASNILLDAEMNP---KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPE 519
+ I HRD+K N+L ++ K++DFG A+ + T Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183
Query: 520 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579
++ D++S GV++ ++ G + ++ + + R G
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIRMGQY--EFPN 238
Query: 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATI 614
S L ++ +P +R ++
Sbjct: 239 PEWSEVSEE----VKMLIRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 62/302 (20%), Positives = 124/302 (41%), Gaps = 41/302 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGA--EEFKNEVVLVAKLQHR 401
+K+ K+G+G FGEV+K +GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 402 NLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
N+V L+ C LV++F + + S +++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQML 126
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNT--SRIVG 511
G L+ R +I+HRD+KA+N+L+ + K++DFG+AR F + + + V
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 512 TYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570
T Y PE + + + D++ G ++ E+ T Q + L+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGS 240
Query: 571 GTPLQLLDTNLTDSYSRNEVIR------------------CIQLGLLCVQEDPAERPSMA 612
TP + + + Y + E+++ + L + DPA+R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 613 TI 614
Sbjct: 301 DA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-42
Identities = 54/277 (19%), Positives = 97/277 (35%), Gaps = 33/277 (11%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAK 397
V N F LG+G FG+V +G+ A+K L K + E ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGI 457
+H L L + V E+ L + L ++ R I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA- 117
Query: 458 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMA 517
L +++RD+K N++LD + + KI+DFG+ + D GT Y+A
Sbjct: 118 --LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 173
Query: 518 PEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577
PE + D + GV++ E++ G+ + + +L
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-------------------FYNQDHERLF 214
Query: 578 DTNLTDSYSRNEVI--RCIQLGLLCVQEDPAERPSMA 612
+ L + + L +++DP +R
Sbjct: 215 ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGG 251
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 3e-40
Identities = 60/272 (22%), Positives = 100/272 (36%), Gaps = 32/272 (11%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK---ASGQGAEEFKNEVVLVAKLQH 400
++F LG G FG V SG A+K L K + E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYL 460
LV+L + +V E+V + L + G+ I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 461 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEY 520
H L +I+RDLK N+L+D + +++DFG A+ + +G T + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 521 AMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580
+ ++ D ++ GVL+ E+ G + D +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY---PPFFADQPIQIYEKIVSGKVR---------- 256
Query: 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612
+S + L +Q D +R
Sbjct: 257 FPSHFSSD----LKDLLRNLLQVDLTKRFGNL 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 76/332 (22%), Positives = 128/332 (38%), Gaps = 44/332 (13%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSK--ASGQGAEEFKNEVVLVAKLQHR 401
+ +G G +G V V +G ++A+K+L + S A+ E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 402 NLVRLLGFCLEGE------EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIAR 455
N++ LL E + LV F+ K +L R ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 456 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGY 515
G+ Y+H IIHRDLK N+ ++ + KI DFG+AR Q + V T Y
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 516 MAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK----------------KNSNFYQTDGAA 558
APE ++ ++ D++S G ++ E+ITGK K + +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM- 617
L S K + G P L+ S N + L + D +R + +
Sbjct: 245 RLQSDEAKNYMKGLP--ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 618 -LNSYSVTLPSPQQPAFFIGSRTERDLPTKEF 648
S T PQ + S + D E+
Sbjct: 303 YFESLHDTEDEPQVQKYDD-SFDDVDRTLDEW 333
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 143 bits (360), Expect = 2e-38
Identities = 57/310 (18%), Positives = 115/310 (37%), Gaps = 45/310 (14%)
Query: 335 FDFETIEVAT---NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKN 390
+D+E+ V + + KLG G + EV++ + + + +++ VK L ++ K
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKR 78
Query: 391 EVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRY 447
E+ ++ L+ N++ L + + LV+E V N L
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132
Query: 448 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNT 506
+ I + + Y H + I+HRD+K N+++D E ++ D+G+A + Q
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 186
Query: 507 SRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK-----KNSNFYQTDGAADL 560
+ V + + PE + + + D++S G ++ +I K + N+ Q A +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 561 LSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIR----------------CIQLGLLCVQED 604
L LD D R+ R + ++ D
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
Query: 605 PAERPSMATI 614
R +
Sbjct: 307 HQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 31/294 (10%)
Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKAS---- 381
L + +V F LG G +G+V+ +G+ A+K L KA+
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 382 GQGAEEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
+ E + E ++ ++ LV L + L+ +++ L L E+
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--- 125
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
+G I + +LH+ L II+RD+K NILLD+ + ++DFG+++ F D
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAA 558
+T+ GT YMAP+ G D +S GVL+ E++TG + + DG
Sbjct: 183 ETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA---SPFTVDGEK 238
Query: 559 DLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612
+ + ++ P S L + +DP +R
Sbjct: 239 NSQAEISRRILKSEP------PYPQEMSAL----AKDLIQRLLMKDPKKRLGCG 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 78/357 (21%), Positives = 135/357 (37%), Gaps = 59/357 (16%)
Query: 336 DFETIEVATNKFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAE 386
F ++EV + F+ + +G G G V + +A+K+LS+ + A+
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYDPEKQGQ 440
E+VL+ + H+N++ LL E ++ LV E + Q +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QME 115
Query: 441 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500
LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+AR G
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-------------- 546
+ V T Y APE + + D++S G ++ E++ K
Sbjct: 173 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 547 -------------KNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRC 593
K + + YA + P L + + + R
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
Query: 594 IQLGLLCVQEDPAERPSMATIVL---MLNSYSVTLPSPQQPAFFIGSRTERDLPTKE 647
+ +L + DPA+R S+ + + Y P + ER+ +E
Sbjct: 290 LLSKMLVI--DPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 78/338 (23%), Positives = 136/338 (40%), Gaps = 42/338 (12%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKA--SGQGAEEFKNEVVL 394
+TI ++ + +G G +G V +G +AVK+LS+ S A+ E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 395 VAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGI 453
+ ++H N++ LL ++ + L + K +L +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 454 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTY 513
RG+ Y+H IIHRDLK SN+ ++ + KI DFG+AR + T +R
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW---- 183
Query: 514 GYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572
Y APE ++ ++ D++S G ++ E++TG+ + D L + GT
Sbjct: 184 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR---TLFPGTDHIDQLKLILR--LVGT 237
Query: 573 PLQLLDTNLTDSYSRNEVIRCIQLG-----------------LL--CVQEDPAERPSMAT 613
P L ++ +RN + Q+ LL + D +R + A
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 614 IVLMLNSYSVTLPSPQQ---PAFFIGSRTERDLPTKEF 648
+ ++Y P + S RDL E+
Sbjct: 298 A--LAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEW 333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (323), Expect = 4e-33
Identities = 38/217 (17%), Positives = 83/217 (38%), Gaps = 18/217 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL 403
++ KLG G F V+ + + +A+K + E ++E+ L+ ++ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKII 450
+ K+L + + + + E + + +I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 451 GGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMARIFGVDQTQGNTSRI 509
+ G+ Y+H R IIH D+K N+L++ + +A + + +
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 510 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 546
+ T Y +PE + + +D++S L+ E+ITG
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 108 bits (270), Expect = 1e-27
Identities = 35/206 (16%), Positives = 66/206 (32%), Gaps = 35/206 (16%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVK--RLSKASGQ--------GAEEFKNEVVLVAKLQH 400
+GEG V+ E VK ++ S + G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 401 RNLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARG 456
R L +L G E ++ E + +++ ++ I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLME--------LIDAKELYRVRVENPDE--VLDMILEE 115
Query: 457 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSR-IVGTYGY 515
+ + I+H DL N+L+ E I DF + G + + R + Y
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171
Query: 516 MAPEYAMHGQFSVKSDVYSFGVLVLE 541
+ Y + D+ S +L+
Sbjct: 172 FSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 674 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.34 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=422.57 Aligned_cols=267 Identities=28% Similarity=0.454 Sum_probs=207.2
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++..++|++.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999874 35999998653 34456789999999999999999999998754 56899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999853 3456999999999999999999999987 9999999999999999999999999998775
Q ss_pred CCCCCCccccccccCCccCcccccc---CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
............||+.|||||++.+ +.++.++|||||||++|||+||+.|+.... ....+.....+.......
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~--~~~~~~~~~~~~~~~p~~-- 231 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDL-- 231 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHHTSCCCCG--
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC--hHHHHHHHHhcCCCCCcc--
Confidence 4444444556789999999999864 358999999999999999999999964221 111122222222211111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLP 626 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 626 (674)
...+...+..+.+|+.+||+.||++||||+||++.|+.....+|
T Consensus 232 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 -------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11122334578899999999999999999999999987655544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=411.34 Aligned_cols=255 Identities=28% Similarity=0.450 Sum_probs=201.4
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578889999999999999999988889999999764 3446789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 9999998853 3456899999999999999999999988 99999999999999999999999999987643322 2
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDS 584 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~ 584 (674)
......||+.|||||++.+..++.++|||||||++|||+|++.|+. ......+++.......+. .
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~--~~~~~~~~~~~i~~~~~~-------------~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDISTGFRL-------------Y 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT--CSCCHHHHHHHHHHTCCC-------------C
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC--CCCCHHHHHHHHHhcCCC-------------C
Confidence 2334578999999999999999999999999999999999665532 122222333332222111 1
Q ss_pred CChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 585 YSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 585 ~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+.....++.+|+.+||+.||++||||+||+++|+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1222345788999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=414.14 Aligned_cols=261 Identities=31% Similarity=0.469 Sum_probs=211.6
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++++..++|++.++||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3445567899999999999999999999888899999997543 446789999999999999999999998754 56789
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|.+++... ....+++..+++|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+++...
T Consensus 85 v~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 99999999998877432 3346999999999999999999999987 9999999999999999999999999999875
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.... .......||+.|||||++.++.++.++|||||||++|||+||+.|+.. .....+++.... .+..
T Consensus 161 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~--~~~~~~~~~~i~----~~~~----- 228 (272)
T d1qpca_ 161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPEVIQNLE----RGYR----- 228 (272)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHH----TTCC-----
T ss_pred CCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC--CCCHHHHHHHHH----hcCC-----
Confidence 3322 223345789999999999999999999999999999999997766421 222222222222 1111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+...+..+.+|+.+||+.||++||||++|+++|+++
T Consensus 229 ----~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 111223345688999999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-50 Score=415.24 Aligned_cols=265 Identities=28% Similarity=0.416 Sum_probs=216.7
Q ss_pred hhhHHHhhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCe
Q 005846 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 415 (674)
Q Consensus 337 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 415 (674)
++++++..++|++.++||+|+||+||+|++. +|+.||||+++... ...++|.+|+.+|++++|||||++++++.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3445566778999999999999999999864 58899999997543 456789999999999999999999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+++|+|..++... ....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999988542 3457999999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
....+.. .......|++.|||||++.++.++.|+|||||||++|||++|+.|+. .......+.... ..+.
T Consensus 164 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~--~~~~~~~~~~~i----~~~~--- 233 (287)
T d1opja_ 164 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDLSQVYELL----EKDY--- 233 (287)
T ss_dssp TCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS--TTCCHHHHHHHH----HTTC---
T ss_pred ecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC--CcchHHHHHHHH----hcCC---
Confidence 7654322 22334568999999999999999999999999999999999877642 122222222222 2211
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
....+...+..+.+|+.+||+.||++|||+.||++.|+...
T Consensus 234 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122333457889999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=409.70 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=203.5
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999996 468999999986543 23346789999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++|+|.+++. ....+++.++..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 3457999999999999999999999998 99999999999999999999999999998754443
Q ss_pred CCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.......+||+.|||||++.+..+ +.++|||||||++|||+||+.|+....... ... .. +.......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~-~~---~~~~~~~~------ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEY-SD---WKEKKTYL------ 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHH-HH---HHTTCTTS------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHH-HH---HhcCCCCC------
Confidence 344456789999999999988876 578999999999999999999975332211 111 11 11111100
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.........+.+|+.+||+.||++|||++|+++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122346778999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=411.80 Aligned_cols=270 Identities=28% Similarity=0.430 Sum_probs=213.1
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++..++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. .+..++||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 3445789999999999999999999988889999999654 345678999999999999999999999985 45688999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++... ....++|.+++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++.....
T Consensus 91 Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 91 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999998887542 3456999999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.. .......||+.|+|||++.++.++.++|||||||++|||+||+.|+.. .....+.+....... .
T Consensus 167 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i~~~~----~------- 232 (285)
T d1fmka3 167 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGY----R------- 232 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHTTC----C-------
T ss_pred Cc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC--CCCHHHHHHHHHhcC----C-------
Confidence 22 233345789999999999999999999999999999999998776432 222223333322211 1
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCCCCCCCCCc
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVTLPSPQQPA 632 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~ 632 (674)
...+......+.+++.+||+.||++||+|++|+.+|+......+++.+|.
T Consensus 233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred --CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence 11222334578899999999999999999999999999877766555553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=404.54 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=208.5
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999985 46899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++|+|.+++. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998773 346999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccccC
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLT 582 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 582 (674)
......+||+.|||||++.+..++.++|||||||++|||+||+.||.. ....+.+ ......+.+.
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~---~~~~~~~~~~-------- 235 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---ENPLRAL---YLIATNGTPE-------- 235 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHH---HHHHHHCSCC--------
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC---CCHHHHH---HHHHhCCCCC--------
Confidence 233456899999999999999999999999999999999999999742 1111222 2211111110
Q ss_pred CCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 583 DSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 583 ~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...+......+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112233457889999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=403.05 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=211.6
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecC
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 424 (674)
++|++.++||+|+||+||+|++++++.||||++++.. ...++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5889999999999999999999888899999997643 346789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC
Q 005846 425 NKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG 504 (674)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 504 (674)
+|+|..++.. ....+++..+++++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence 9999988753 3456899999999999999999999988 99999999999999999999999999987654332 2
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......||+.|+|||++.+..++.|+|||||||++|||+| |+.|+.... ..++...... +.. .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i~~----~~~---------~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQ----GLR---------L 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHT----TCC---------C
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHHHHHh----CCC---------C
Confidence 3334578999999999999999999999999999999998 787764322 2222222221 111 1
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
..+......+.+|+.+||+.||++|||+++|++.|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1122334578899999999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=409.71 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=197.1
Q ss_pred cCCCcccccccCCcEEEEEeecCC-C---ceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS-G---QEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
++|++.++||+|+||+||+|++.. + ..||||++... .....++|.+|+.+|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467778999999999999998642 3 25889988654 344456799999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|.+++.. ....++|.+++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 3456999999999999999999999987 99999999999999999999999999987754
Q ss_pred CCCCCc---cccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 500 DQTQGN---TSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 500 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... .....||+.|||||.+.++.++.++|||||||++|||+| |+.|+... ...+++.......+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~---~~~~~~~~i~~~~~------ 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYR------ 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCC------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC------
Confidence 332221 222457899999999999999999999999999999998 78886422 22233322222111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+.+.+..+.+|+.+||+.||++||||.||++.|+..
T Consensus 252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112233445788999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=416.69 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=208.6
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecCC-C-----ceeEEEEeccc-CccCHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPS-G-----QEIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 411 (674)
+++..++|++.++||+|+||+||+|++.. + ..||+|++... .......+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34556789999999999999999998532 2 36899998653 333456789999999998 8999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCCc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEe
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPEK--------------------QGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 471 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHr 471 (674)
+.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999864321 235899999999999999999999988 9999
Q ss_pred ecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCC
Q 005846 472 DLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSN 550 (674)
Q Consensus 472 Dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~ 550 (674)
||||+|||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.|+.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654444333445678999999999999999999999999999999998 788864
Q ss_pred ccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 005846 551 FYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLN 619 (674)
Q Consensus 551 ~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~ 619 (674)
..... ..+. +....+.. ...+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~--~~~~----~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVD--ANFY----KLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCS--HHHH----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHH--HHHH----HHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 32211 1111 11222111 1122333457889999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=397.76 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=205.2
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||+||+++.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999964 6889999998642 2344677899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++. +...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 9999999999884 3457999999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.......||+.|||||++.+..++.++|||||||++|||++|+.|+.. ....+++.... ....
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~----~~~~------- 221 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRIS----RVEF------- 221 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHH----TTCC-------
T ss_pred ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC---CCHHHHHHHHH----cCCC-------
Confidence 223456799999999999999999999999999999999999999742 22222222211 1111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.++......+.+|+.+||+.||++|||++|+++
T Consensus 222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112223457889999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=405.37 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=206.4
Q ss_pred hcCCCccc-ccccCCcEEEEEeecC---CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 344 TNKFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 344 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
.++|.+.+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35666666 4999999999999753 34579999997643 3345789999999999999999999999864 56899
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 3457999999999999999999999988 9999999999999999999999999999875
Q ss_pred CCCCC-CccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 499 VDQTQ-GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 499 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
..... .......||+.|||||++.++.++.++|||||||++|||+| |+.|+.... ..++.... ..+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i----~~~~~~-- 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFI----EQGKRM-- 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHH----HTTCCC--
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcCCCC--
Confidence 43322 22334568999999999999999999999999999999998 888865322 22222222 222211
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+...+..+.+|+.+||+.||++||||.+|++.|+..
T Consensus 232 -------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12223345788999999999999999999999999763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=403.07 Aligned_cols=258 Identities=29% Similarity=0.480 Sum_probs=200.9
Q ss_pred hcCCCcccccccCCcEEEEEeecCCC-----ceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSG-----QEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
.+.|++.+.||+|+||+||+|.++.+ ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999986532 369999996543 334557899999999999999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+.+++|.+++.. ....++|.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999887743 3456999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
....... ......||+.|||||++.++.++.++|||||||++|||++|+.|+.. .....+++... ..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~--~~~~~~~~~~i----~~~~---- 230 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAI----NDGF---- 230 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHHHHHHH----HTTC----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc--cCCHHHHHHHH----hccC----
Confidence 5433222 23345689999999999999999999999999999999997766432 11222222222 1211
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+...+..+.+|+.+||+.||++||||.||+++|+..
T Consensus 231 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 231 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1122333445788999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=399.89 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=194.1
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv 419 (674)
++|++.+.||+|+||+||+++. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ +...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999985 468999999986543 3345678999999999999999999999875 3457999
Q ss_pred EEecCCCcccccccCCC-cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 420 YEFVPNKSLDYFLYDPE-KQGQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885432 3457999999999999999999999865 23599999999999999999999999999998
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
+.... .......||+.|||||++.+..++.++|||||||++|||+||+.|+... ...++..... .+....
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~~i~----~~~~~~- 233 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIR----EGKFRR- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHH----HTCCCC-
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHHHHHH----cCCCCC-
Confidence 65332 2234568999999999999999999999999999999999999997432 2222222221 111111
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 234 --------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12223346889999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=401.15 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=205.8
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
+.|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688999999999999999996 468899999998776666788999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++|+|..++.. ....+++.++..++.||++||.|||+++ |+||||||+|||++.++++||+|||+++..... .
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 99999988743 3456999999999999999999999998 999999999999999999999999999764321 1
Q ss_pred CccccccccCCccCccccc-----cCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecc
Q 005846 504 GNTSRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLD 578 (674)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d 578 (674)
.......||+.|||||++. +..|+.++|||||||++|||+||+.|+... ...+.+..... .. ...+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~---~~~~~~~~i~~---~~-~~~~-- 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAK---SE-PPTL-- 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS---CGGGHHHHHHH---SC-CCCC--
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHHc---CC-CCCC--
Confidence 1233467999999999984 456899999999999999999999996432 22223222221 11 1111
Q ss_pred cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 579 TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 579 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233457889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=402.68 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=198.0
Q ss_pred cccccCCcEEEEEeecC---CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEecCC
Q 005846 351 NKLGEGGFGEVYKGVLP---SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 425 (674)
Q Consensus 351 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 425 (674)
++||+|+||+||+|.+. .++.||||+++... ....++|.+|+.+|++++|||||+++|++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999853 34679999996533 2335679999999999999999999999854 567899999999
Q ss_pred CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCCC-
Q 005846 426 KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQG- 504 (674)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 504 (674)
|+|.+++. ....+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999884 3456999999999999999999999988 9999999999999999999999999998765433222
Q ss_pred ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceecccccCC
Q 005846 505 NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTD 583 (674)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~ 583 (674)
......||+.|||||.+.+..++.++|||||||++|||+| |+.|+... ...++..... .+...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~---~~~~~~~~i~----~~~~~--------- 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLE----KGERM--------- 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHH----TTCCC---------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC---CHHHHHHHHH----cCCCC---------
Confidence 2334578999999999999999999999999999999998 88886432 2222222222 22111
Q ss_pred CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 584 SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 584 ~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+...+..+.+|+.+||+.||++|||+++|+.+|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11223345788999999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=412.43 Aligned_cols=200 Identities=28% Similarity=0.404 Sum_probs=177.0
Q ss_pred HhhcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
+..++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467899999999999999999995 468999999997643 33356789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
|||+++|+|.+++. +.+.+++..+..++.||++||.|||+. + |+||||||+||||+.++++||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999985 345699999999999999999999974 6 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCc
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNF 551 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~ 551 (674)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 22346899999999999999999999999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=403.80 Aligned_cols=265 Identities=28% Similarity=0.463 Sum_probs=213.9
Q ss_pred hhHHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccCcc-CHHHHHHHHHHHHhcCCCceeeEEeEE
Q 005846 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKASGQ-GAEEFKNEVVLVAKLQHRNLVRLLGFC 410 (674)
Q Consensus 338 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~ 410 (674)
.+++..+++|++.++||+|+||+||+|++. +++.||||+++..... ..++|.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445666789999999999999999999853 4578999999764433 356799999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCC---------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPE---------------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRII 469 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 469 (674)
......++||||+++|+|.++++... ....+++..++.|+.||+.||+|||+.+ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999885321 2235899999999999999999999988 99
Q ss_pred EeecccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCC-
Q 005846 470 HRDLKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN- 548 (674)
Q Consensus 470 HrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p- 548 (674)
||||||+||||+.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|..|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999999877544444444556789999999999999999999999999999999999754
Q ss_pred CCccCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 549 SNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 549 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
+.. ....+++..+ ..+.... .+...+..+.+|+.+||+.||++||||.||+++|+++
T Consensus 243 ~~~---~~~~e~~~~v----~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYG---MAHEEVIYYV----RDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTT---SCHHHHHHHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCC---CCHHHHHHHH----HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 322 2222333222 2222111 1223345788999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=402.82 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=203.7
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999986 46899999998653 2345678999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999988874 4467999999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.........+||+.|||||++.+..++.++|||||||++|||+||+.||... ....++... . ....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i---~-~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKI---I-KLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---H-TTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHH---H-cCCC-------
Confidence 4444455568999999999999999999999999999999999999997522 222222211 1 1111
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.++......+.+|+.+||+.||++|||++|++.
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112233456889999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=389.26 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=195.9
Q ss_pred CcccccccCCcEEEEEeecC-CCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCeeEEEE
Q 005846 348 STDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVY 420 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 420 (674)
+..++||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999964 6889999998653 33445678999999999999999999999865 34579999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc-CCCCeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ki~DfGla~~~~~ 499 (674)
||+++|+|.+++. +...+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999984 3457999999999999999999999875 4599999999999996 578999999999986432
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
......+||+.|||||++.+ +++.++|||||||++|||++|+.||... ..... ..+....+.....
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~--~~~~~----~~~~i~~~~~~~~--- 233 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQ----IYRRVTSGVKPAS--- 233 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHH----HHHHHTTTCCCGG---
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc--ccHHH----HHHHHHcCCCCcc---
Confidence 22345689999999998865 6999999999999999999999997421 11111 2222222211111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+......+.+|+.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11122346789999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.7e-47 Score=399.05 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=208.6
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
-++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999985 46899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc--CCCCeEEeeeCCccccCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~ki~DfGla~~~~~~ 500 (674)
+++|+|.+++.. ..+.+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999888843 3456999999999999999999999998 99999999999996 4678999999999876432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.......||+.|||||++.+..++.++|||||||++|||++|+.|+.. ....+.+...... ... .+
T Consensus 180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~~---~~~---~~-- 245 (350)
T d1koaa2 180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKSC---DWN---MD-- 245 (350)
T ss_dssp ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHT---CCC---SC--
T ss_pred ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC---CCHHHHHHHHHhC---CCC---CC--
Confidence 223456899999999999999999999999999999999999999742 2222333222211 100 00
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
..........+.+|+.+||+.||++|||++|+++.
T Consensus 246 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111233467899999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-48 Score=397.89 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=190.3
Q ss_pred hhcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 343 ATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 343 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
..+.|++.+.||+|+||+||+++.. +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999864 68899999997543 233456789999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc---CCCCeEEeeeCCcccc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARIF 497 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~ki~DfGla~~~ 497 (674)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999984 3457999999999999999999999998 99999999999994 5789999999999865
Q ss_pred CCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.. ....++..... .....
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~i~---~~~~~---- 227 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQIL---KAEYE---- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHH---TTCCC----
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC---CCHHHHHHHHh---ccCCC----
Confidence 4322 23346799999999999999999999999999999999999999742 11222222221 11110
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
............+.+|+.+||+.||++|||++|+++
T Consensus 228 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 ---FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011112233457889999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=396.29 Aligned_cols=269 Identities=26% Similarity=0.387 Sum_probs=204.4
Q ss_pred cchhhHHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeE
Q 005846 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRL 406 (674)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l 406 (674)
++...+++..++|++.++||+|+||.||+|++. +++.||||+++... ....+.+.+|+..+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 345566677789999999999999999999842 34689999997543 33456678888888777 78999999
Q ss_pred EeEEEeC-CeeEEEEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEee
Q 005846 407 LGFCLEG-EEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 472 (674)
Q Consensus 407 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrD 472 (674)
++++.+. ...++||||+++|+|.+++.... ....+++.+++.++.||++||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9998765 46899999999999999986432 1345899999999999999999999988 99999
Q ss_pred cccccEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCC-CCCc
Q 005846 473 LKASNILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSNF 551 (674)
Q Consensus 473 lkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~-p~~~ 551 (674)
|||+||||++++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+||.. |+..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987765554445556789999999999999999999999999999999999865 4432
Q ss_pred cCCCCccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 552 YQTDGAADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
. .....+ ......+... ..+......+.+++.+||+.||++|||+.||+++|+++
T Consensus 240 ~---~~~~~~---~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 240 V---KIDEEF---CRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp C---CCSHHH---HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CHHHHH---HHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111111 1111222111 11222345688999999999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=400.54 Aligned_cols=255 Identities=28% Similarity=0.460 Sum_probs=200.7
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCc----eeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 418 (674)
++|++.++||+|+||+||+|.+. +|+ +||+|+++.. .....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999863 444 5889988653 445577899999999999999999999999865 5677
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccC
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFG 498 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~ 498 (674)
++||+.+|+|.+++.. ....+++..+++++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8899999999887753 3557999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 499 VDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
............||+.|||||++.++.++.++|||||||++|||+| |+.|+... ...++........+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~---~~~~~~~~i~~~~~-------- 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILEKGER-------- 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS---CGGGHHHHHHHTCC--------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHcCCC--------
Confidence 5554444555678999999999999999999999999999999999 66665432 22223322222111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 112223345788999999999999999999999988653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=394.84 Aligned_cols=245 Identities=29% Similarity=0.421 Sum_probs=200.1
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
+.|+..++||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3589999999999999999985 5688999999976432 23456889999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++. ....+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999976663 3457999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCccccccccCCccCcccccc---CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceec
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLL 577 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (674)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.|+... ...+. .........+ .+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~~~---~~~i~~~~~~-~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSA---LYHIAQNESP-ALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHH---HHHHHHSCCC-CCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC---CHHHH---HHHHHhCCCC-CCC
Confidence 234579999999999863 56899999999999999999999986421 11111 2222222111 111
Q ss_pred ccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 578 DTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 578 d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
+......+.+|+.+||+.||++|||++|+++
T Consensus 236 --------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122346889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.1e-47 Score=396.72 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=208.0
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEec
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 423 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 423 (674)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999995 479999999998766556677899999999999999999999999999999999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc--CCCCeEEeeeCCccccCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~ki~DfGla~~~~~~~ 501 (674)
++|+|.+++.. ....+++.+++.|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999877632 3456999999999999999999999998 99999999999998 67899999999998765332
Q ss_pred CCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
......||+.|||||++.+..++.++|||||||++|||+||+.||.. ....+++..... .... .
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~---~~~~-------~ 247 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKR---CDWE-------F 247 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHHHHH---CCCC-------C
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHh---CCCC-------C
Confidence 23446799999999999999999999999999999999999999742 222222222221 1100 0
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
...........+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112234568899999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=387.98 Aligned_cols=251 Identities=26% Similarity=0.359 Sum_probs=204.9
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC------ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS------GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
.++|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 478999999986432 23467899999999999999999999999999999
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC----CeEEeeeC
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 492 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~ki~DfG 492 (674)
+|||||+++|+|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999984 3457999999999999999999999998 99999999999998776 49999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGT 572 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 572 (674)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.. ....+.+.... ...
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~i~----~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVS----AVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHH----TTC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC---CCHHHHHHHHH----hcC
Confidence 998764332 23345789999999999999999999999999999999999999742 22222222211 111
Q ss_pred cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 573 PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 573 ~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.. ............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000011123346789999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=388.61 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=196.8
Q ss_pred HhhcCCCcccccccCCcEEEEEeecCC----CceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCee
Q 005846 342 VATNKFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 416 (674)
Q Consensus 342 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 416 (674)
+..++|++.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|+.++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 445789999999999999999998642 3468899886543 334567999999999999999999999985 4678
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
++||||+++|+|..++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999888743 3456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 497 FGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
+..... .......||+.|+|||++.++.++.++|||||||++|||+| |.+|+... ...+++..... +...
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~---~~~~~~~~i~~----~~~~- 228 (273)
T d1mp8a_ 158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIEN----GERL- 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC---CGGGHHHHHHT----TCCC-
T ss_pred ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC---CHHHHHHHHHc----CCCC-
Confidence 653322 23344678999999999999999999999999999999998 77776432 22333333322 1111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
..+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223345788999999999999999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=390.23 Aligned_cols=250 Identities=28% Similarity=0.380 Sum_probs=197.9
Q ss_pred hcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 422 (674)
-++|++.++||+|+||.||+|++ .|+.||||+++.. ...+.|.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45788899999999999999998 5789999999654 3457899999999999999999999999764 567999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+++|+|.+++... ....++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999998532 2335899999999999999999999987 999999999999999999999999999865322
Q ss_pred CCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
.....++..|+|||++.++.++.++|||||||++|||+| |+.|+.. ....++...... +..
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~---~~~~~~~~~i~~----~~~-------- 218 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEK----GYK-------- 218 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT---SCGGGHHHHHTT----TCC--------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHc----CCC--------
Confidence 223467899999999999999999999999999999999 5665432 222333333221 111
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...+......+.+|+.+||+.||++||||.+|+++|+..
T Consensus 219 -~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 -MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112223345788999999999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=395.52 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=213.4
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeec------CCCceeEEEEecccC-ccCHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKL-QHRNLVRLLGFCL 411 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 411 (674)
+++..++|++.++||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 455668999999999999999999974 346789999997643 33456789999999999 6999999999999
Q ss_pred eCCeeEEEEEecCCCcccccccCCC---------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccc
Q 005846 412 EGEEKILVYEFVPNKSLDYFLYDPE---------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 476 (674)
Q Consensus 412 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~ 476 (674)
+++..++||||+++|+|.++++... ....+++..+..++.||++||.|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999886432 2336899999999999999999999998 999999999
Q ss_pred cEEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCC
Q 005846 477 NILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDG 556 (674)
Q Consensus 477 NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~ 556 (674)
|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.... .
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~--~ 252 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--P 252 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--C
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC--C
Confidence 99999999999999999998765444444455789999999999999999999999999999999999655532211 1
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
....+. +....+. ....+...+..+.+|+.+||+.||++||||++|+++|++.
T Consensus 253 ~~~~~~---~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 253 VDSKFY---KMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp SSHHHH---HHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH---HHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111111 1111111 1112223345788999999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=392.09 Aligned_cols=263 Identities=29% Similarity=0.455 Sum_probs=213.9
Q ss_pred HHHhhcCCCcccccccCCcEEEEEeecC------CCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 005846 340 IEVATNKFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE 412 (674)
Q Consensus 340 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 412 (674)
+++..++|++.++||+|+||+||+|.+. +++.||||+++... ......|.+|+.++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3455678899999999999999999863 35789999997543 3344568999999999999999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCC-------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCC
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDP-------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 485 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~ 485 (674)
++..++||||+++|+|.+++... .....+++..+.+++.||++||.|||+++ |+||||||+||||+++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999887532 12235799999999999999999999987 999999999999999999
Q ss_pred eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCC-CCCccCCCCccchHHHH
Q 005846 486 PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSNFYQTDGAADLLSYA 564 (674)
Q Consensus 486 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~-p~~~~~~~~~~~~l~~~ 564 (674)
+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||+. |+. .....+.+..+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~---~~~~~~~~~~i 248 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFV 248 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT---TSCHHHHHHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC---CCCHHHHHHHH
Confidence 99999999987765544444555679999999999999999999999999999999999964 432 22222233222
Q ss_pred HhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 565 WKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 565 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
. .+.... .+...+..+.+|+.+||+.||++||||++|+++|++.
T Consensus 249 ~----~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 M----EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp H----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H----hCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2 221111 1222335788999999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=389.17 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=206.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 419 (674)
-++|++.+.||+|+||.||+++. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999995 57899999999753 234567789999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|..++. +...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999998884 4567999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.|+... +...+...... +..
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~----~~~------ 222 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILM----EEI------ 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH----CCC------
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc---CHHHHHHHHhc----CCC------
Confidence 22 2344578999999999999999999999999999999999999986432 22222222211 111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
.++......+.+|+.+||+.||++||+ ++|+++
T Consensus 223 ----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112233456789999999999999995 788875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=384.43 Aligned_cols=255 Identities=29% Similarity=0.402 Sum_probs=195.7
Q ss_pred cCCCcccccccCCcEEEEEeecC--CC--ceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
++|++.+.||+|+||.||+|++. ++ ..||||++.+. .....++|.+|+.+|++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999853 22 36899998653 33445789999999999999999999999965 4678
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999887753 3446999999999999999999999988 999999999999999999999999999987
Q ss_pred CCCCCCC-ccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 498 GVDQTQG-NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.|+.. ....+.+.. ..+.+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~---~~~~~~~~~---i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---LNGSQILHK---IDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHH---HHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC---cCHHHHHHH---HHhCCCCCC
Confidence 5443322 2234567889999999999999999999999999999998 7888642 222222222 222221111
Q ss_pred ecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 005846 576 LLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNS 620 (674)
Q Consensus 576 ~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~ 620 (674)
.+...+..+.+|+.+||+.||++||||.||+++|++
T Consensus 236 ---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 122233568899999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=387.99 Aligned_cols=262 Identities=27% Similarity=0.395 Sum_probs=208.6
Q ss_pred HHhhcCCCcccccccCCcEEEEEeecC--------CCceeEEEEecccCc-cCHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 005846 341 EVATNKFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSKASG-QGAEEFKNEVVLVAKL-QHRNLVRLLGFC 410 (674)
Q Consensus 341 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 410 (674)
++..++|++.+.||+|+||.||+|+.. ++..||||+++.... ....++.+|...+.++ +|||||+++++|
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 345678999999999999999999842 234799999976543 3457788899999888 899999999999
Q ss_pred EeCCeeEEEEEecCCCcccccccCCC-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeeccccc
Q 005846 411 LEGEEKILVYEFVPNKSLDYFLYDPE-------------KQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 477 (674)
Q Consensus 411 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~N 477 (674)
.+++..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 99999999999999999999986432 1246899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHh-CCCCCCccCCCC
Q 005846 478 ILLDAEMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSNFYQTDG 556 (674)
Q Consensus 478 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~ellt-g~~p~~~~~~~~ 556 (674)
||++.++.+||+|||+++...............|++.|+|||.+.++.++.++|||||||++|||++ |.+|+.. ..
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~---~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---VP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT---CC
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC---CC
Confidence 9999999999999999998765555555566789999999999999999999999999999999998 5666432 12
Q ss_pred ccchHHHHHhhhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 557 AADLLSYAWKQWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
... .+..+..+.... .+...+..+.+|+.+||+.||++|||+.||+++|+++
T Consensus 243 ~~~----~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 VEE----LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHH----HHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HHHHHHcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 222 222222222211 1222345788999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=389.47 Aligned_cols=257 Identities=31% Similarity=0.427 Sum_probs=203.5
Q ss_pred cCCCcccccccCCcEEEEEeecCC-Cc--eeEEEEeccc-CccCHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPS-GQ--EIAVKRLSKA-SGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 419 (674)
++|++.++||+|+||+||+|++.+ |. .||||++... .....+.|.+|+++|+++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999999753 33 4788887543 334556799999999999 799999999999999999999
Q ss_pred EEecCCCcccccccCC-------------CcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCe
Q 005846 420 YEFVPNKSLDYFLYDP-------------EKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 486 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 486 (674)
|||+++|+|.++++.. .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999988 9999999999999999999
Q ss_pred EEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 487 KISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 487 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|..|+. ......++...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~--~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLP- 240 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHHHHHHGG-
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC--CCCCHHHHHHHHH-
Confidence 999999998654222 2234568999999999999999999999999999999999876421 1222222222221
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCC
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYS 622 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~ 622 (674)
.+. ....+...+..+.+|+.+||+.||++||||+||++.|++..
T Consensus 241 ---~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 241 ---QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp ---GTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111 11122233457889999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=384.88 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=203.1
Q ss_pred ccccccCCcEEEEEeecCCC----ceeEEEEeccc-CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CeeEEEEEec
Q 005846 350 DNKLGEGGFGEVYKGVLPSG----QEIAVKRLSKA-SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEFV 423 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 423 (674)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999986432 25899999753 444567899999999999999999999998764 5889999999
Q ss_pred CCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCCC
Q 005846 424 PNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQTQ 503 (674)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 503 (674)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998853 3456889999999999999999999988 999999999999999999999999999876543322
Q ss_pred C--ccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccccc
Q 005846 504 G--NTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTNL 581 (674)
Q Consensus 504 ~--~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 581 (674)
. ......||+.|+|||.+.++.++.++||||||+++|||+||+.|+... ....+.........+. .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~--~~~~~~~~~i~~g~~~----~------ 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--VNTFDITVYLLQGRRL----L------ 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCC----C------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC--CCHHHHHHHHHcCCCC----C------
Confidence 2 223457899999999999999999999999999999999988875422 1222333333222111 1
Q ss_pred CCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcCCCC
Q 005846 582 TDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSYSVT 624 (674)
Q Consensus 582 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~~~~ 624 (674)
.+......+.+|+.+||+.||++||+|.||++.|++...+
T Consensus 255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122334688999999999999999999999999876433
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=385.56 Aligned_cols=267 Identities=23% Similarity=0.286 Sum_probs=198.7
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----eeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 420 (674)
++|...++||+|+||.||+|++ +|+.||||+++..... ...++.|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677788999999999999997 6899999999654221 122334555566789999999999998654 579999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
||+++|+|.+++.. ..++|..+++++.|++.||.|||+. +..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999943 4699999999999999999999974 12359999999999999999999999999998
Q ss_pred ccCCCCCC--CccccccccCCccCccccccCC------CCccccEEeechhhhHhHhCCCCCCccCCCC--------ccc
Q 005846 496 IFGVDQTQ--GNTSRIVGTYGYMAPEYAMHGQ------FSVKSDVYSFGVLVLEIITGKKNSNFYQTDG--------AAD 559 (674)
Q Consensus 496 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~--------~~~ 559 (674)
........ .......||+.|||||++.+.. ++.|+|||||||+||||+||..|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77443222 2234568999999999987542 6789999999999999999987754322111 001
Q ss_pred hHHHHHhhhcCCCcceecccccCCCC-ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 560 LLSYAWKQWRDGTPLQLLDTNLTDSY-SRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
...........+. .++.+.... +.+....+.+|+.+||+.||++|||+.||+++|++.
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111222111111 111111111 234556788999999999999999999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-45 Score=382.29 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=203.6
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.++||+|+||+||+++. .+|+.||||++++. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4689999999999999999996 46899999999653 2345678999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988874 4556899999999999999999999988 999999999999999999999999999876422
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....||+.|||||++.+..++.++|||||||++|||+||+.|+.. ....++.... .... .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i---~~~~-~------- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKI---LNAE-L------- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHH---HHCC-C-------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC---cCHHHHHHHH---HcCC-C-------
Confidence 2346899999999999999999999999999999999999999742 2222222211 1111 0
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
.++......+.+++.+||+.||.+|| |++++++
T Consensus 219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11222334678999999999999996 8999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-46 Score=377.94 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=200.4
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc---cCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----e
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG---QGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----E 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~ 415 (674)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46899999999999999999985 5789999999976433 33457899999999999999999999987644 3
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+|||||+++++|..++. ..+.+++.+++.++.||++||.|||+.+ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998874 4457999999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCCC-CCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 496 IFGVDQT-QGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 496 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
....... .......+||+.|||||++.+..++.++|||||||++|||+||+.||... .. .....+........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~---~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SP---VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SH---HHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc---CH---HHHHHHHHhcCCCC
Confidence 6543322 22334568999999999999999999999999999999999999997421 11 22222222222111
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHhc
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-SMATIVLMLNS 620 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-t~~evl~~L~~ 620 (674)
. ... ....+..+.+++.+||+.||++|| |+++++..|.+
T Consensus 234 ~---~~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 P---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp G---GGT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C---chh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 011 112335788999999999999999 89999888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=380.26 Aligned_cols=257 Identities=25% Similarity=0.278 Sum_probs=196.7
Q ss_pred cccccccCCcEEEEEeec-CCCceeEEEEecccCcc-----CHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 349 TDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ-----GAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 349 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.+++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 457899999999999996 46899999998654322 124688999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+.++++..+. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9998887665 24456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc--
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT-- 579 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~-- 579 (674)
......+||+.|+|||++... .++.++|||||||++|||+||+.|+.. ....+.+....+...........+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~---~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC---CCHHHHHHHHHHhcCCCChhhccchhc
Confidence 223345799999999998755 579999999999999999999988643 2233333333332211111100000
Q ss_pred ----ccC---CCCC-----hhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 580 ----NLT---DSYS-----RNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 580 ----~~~---~~~~-----~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... ...+ ......+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 0001 122357889999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-45 Score=383.53 Aligned_cols=244 Identities=24% Similarity=0.266 Sum_probs=204.3
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc---CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA---SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 420 (674)
++|++.++||+|+||.||+++. .+|+.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4799999999999999999986 47999999998643 2344677899999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVD 500 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~ 500 (674)
||+.+|+|..++. +.+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999988884 3457999999999999999999999998 999999999999999999999999999876422
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.. .....++..... .. .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i~~---~~-~------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVS---GK-V------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH---CC-C-------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC---cCHHHHHHHHhc---CC-C-------
Confidence 2346899999999999999999999999999999999999999742 222222222211 11 0
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
..+......+.+++.+||+.||.+|+ |++++++
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01122334688999999999999994 8999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-45 Score=371.65 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=202.9
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCcc---------CHHHHHHHHHHHHhcC-CCceeeEEeEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQ---------GAEEFKNEVVLVAKLQ-HRNLVRLLGFCLE 412 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~ 412 (674)
.++|++.+.||+|+||+||+++. .+|+.||||++.+.... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999985 57899999998654321 1245789999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeC
Q 005846 413 GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 492 (674)
Q Consensus 413 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfG 492 (674)
++..+|||||+++|+|.+++. ..+.+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999995 3457999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCCCccccccccCCccCcccccc------CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK 566 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~ 566 (674)
+++.+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.|+... .........
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~---~~~~~~~~i-- 227 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMI-- 227 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH--
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC---CHHHHHHHH--
Confidence 998765432 2334679999999999853 35788999999999999999999997532 222222211
Q ss_pred hhcCCCcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 567 QWRDGTPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 567 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...... . ...........+.+|+.+||+.||++|||++||++
T Consensus 228 -~~~~~~--~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 -MSGNYQ--F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HHTCCC--C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HhCCCC--C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111110 0 01111223457889999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-45 Score=387.32 Aligned_cols=248 Identities=25% Similarity=0.308 Sum_probs=197.9
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC---ccCHHHHHH---HHHHHHhcCCCceeeEEeEEEeCCeeE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS---GQGAEEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---Ei~~l~~l~h~niv~l~~~~~~~~~~~ 417 (674)
++|++.+.||+|+||.||+|+. .+|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999996 468999999986421 222333444 466677778999999999999999999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
+||||+++|+|..++. +...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999984 3567899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL 576 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (674)
... ......||+.|||||++.. ..++.++|||||||++|||+||+.||...... +........... .
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~~~~--~--- 225 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMTLTM--A--- 225 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---CHHHHHHHSSSC--C---
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccC--C---
Confidence 432 2334579999999999975 46899999999999999999999997543222 222111111111 0
Q ss_pred cccccCCCCChhHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005846 577 LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPS-----MATIVL 616 (674)
Q Consensus 577 ~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt-----~~evl~ 616 (674)
...+......+.+|+.+||+.||++||| ++|+++
T Consensus 226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0112223356889999999999999999 688874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=373.49 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=201.1
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999995 578999999996543 2335678999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
|+.++++..... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998766554432 23456999999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc---eec
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL---QLL 577 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~ 577 (674)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.|+... ...+.+............. ...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD---SEIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC---CHHHHHHHHHHhcCCCchhhccccc
Confidence 2333457999999999887665 578999999999999999999997532 2222222222211111100 000
Q ss_pred -ccccCCCC-----------ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 578 -DTNLTDSY-----------SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 578 -d~~~~~~~-----------~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+...... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 01223567899999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=377.69 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=203.8
Q ss_pred hcCCCcccccccCCcEEEEEeecC-CCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
.++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+.+|++++||||+++++++.+++..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999964 688999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCC--CCeEEeeeCCccccCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMARIFGVD 500 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~--~~~ki~DfGla~~~~~~ 500 (674)
+++|+|.+++.. ....+++.++..++.||++||.|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 3346999999999999999999999988 9999999999999854 48999999999875432
Q ss_pred CCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceecccc
Q 005846 501 QTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDTN 580 (674)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~~ 580 (674)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ...+.+..... .... .+..
T Consensus 158 ---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~---~~~~---~~~~ 225 (321)
T d1tkia_ 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMN---AEYT---FDEE 225 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH---TCCC---CCHH
T ss_pred ---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh---CCCC---CChh
Confidence 2234467899999999999999999999999999999999999997432 22222222211 1100 0000
Q ss_pred cCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 581 LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 581 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
... .....+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001 12346789999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=380.22 Aligned_cols=252 Identities=20% Similarity=0.240 Sum_probs=196.6
Q ss_pred hcCCCccc-ccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhc-CCCceeeEEeEEEe----CCee
Q 005846 344 TNKFSTDN-KLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKL-QHRNLVRLLGFCLE----GEEK 416 (674)
Q Consensus 344 ~~~~~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~~ 416 (674)
.++|++.. .||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788875 599999999999985 57899999998643 4678899987655 89999999999875 3568
Q ss_pred EEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC---CCCeEEeeeCC
Q 005846 417 ILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGM 493 (674)
Q Consensus 417 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ki~DfGl 493 (674)
++|||||+||+|.+++... ....+++.++..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999998542 2346999999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 494 ARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
++...... ......||+.|||||++.+..|+.++|||||||++|||+||+.||....... ...........+..
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKTRIRMGQY 234 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH---HHHHHHHHHhcCCC
Confidence 98765332 2344679999999999999999999999999999999999999975322211 11111111111100
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.+...........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000111123457889999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=379.79 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=202.1
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEeccc---CccCHHHHHHHHHHHH-hcCCCceeeEEeEEEeCCeeEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKA---SGQGAEEFKNEVVLVA-KLQHRNLVRLLGFCLEGEEKILV 419 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~lv 419 (674)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+..|+.++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999964 6899999999653 2344566677777665 68999999999999999999999
Q ss_pred EEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCC
Q 005846 420 YEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGV 499 (674)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~ 499 (674)
|||+++|+|..++. ....+++.++..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcceeccc
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQLLDT 579 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~d~ 579 (674)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||.. .....+..... .+.+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~----~~~~------ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIR----MDNP------ 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHH----HCCC------
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC---CCHHHHHHHHH----cCCC------
Confidence 22 233446899999999999999999999999999999999999999742 22222222221 1111
Q ss_pred ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHH-HHHH
Q 005846 580 NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA-TIVL 616 (674)
Q Consensus 580 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~-evl~ 616 (674)
.++......+.+|+.+||+.||++||++. ++++
T Consensus 221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11222345688999999999999999995 6753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.9e-45 Score=371.88 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=202.5
Q ss_pred cCCCcccccccCCcEEEEEeecCCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 422 (674)
++|++.++||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999899999999996543 33357899999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQT 502 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 502 (674)
+.++++..+.. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 99888877763 4567999999999999999999999987 9999999999999999999999999998765332
Q ss_pred CCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCccee-----
Q 005846 503 QGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQL----- 576 (674)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~----- 576 (674)
.......|++.|+|||.+.+. .++.++|||||||++|||++|+.||... ...+.+...............
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC---CHHHHHHHHHHhhCCCChhhccchhh
Confidence 223345689999999998754 5689999999999999999999997432 222233222221111100000
Q ss_pred ----------cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 577 ----------LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 577 ----------~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
................+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001112223457889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=367.64 Aligned_cols=240 Identities=24% Similarity=0.412 Sum_probs=194.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCc------cCHHHHHHHHHHHHhcC--CCceeeEEeEEEeCC
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASG------QGAEEFKNEVVLVAKLQ--HRNLVRLLGFCLEGE 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~ 414 (674)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999995 4789999999865321 11234678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-CCCeEEeeeC
Q 005846 415 EKILVYEFVPN-KSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFG 492 (674)
Q Consensus 415 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~ki~DfG 492 (674)
..++||||+.+ +++.+++. ....+++.++..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 56666663 3457999999999999999999999998 999999999999985 4799999999
Q ss_pred CccccCCCCCCCccccccccCCccCccccccCCC-CccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 493 MARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+++..... ......||+.|||||++.+..+ +.++|||||||++|||+||+.|+.... . . .+..
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~----i---~~~~ 220 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E----I---IRGQ 220 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H----H---HHCC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H----H---hhcc
Confidence 99865322 2334679999999999987765 577999999999999999999974211 0 1 1110
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. . ++...+..+.+|+.+||+.||++|||++|+++
T Consensus 221 ~-------~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V-------F----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C-------C----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-------C----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0 11122356889999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=365.63 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=197.3
Q ss_pred hcCCCcccccccCCcEEEEEeec-CC-CceeEEEEecccC--ccCHHHHHHHHHHHHhc---CCCceeeEEeEEEe----
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PS-GQEIAVKRLSKAS--GQGAEEFKNEVVLVAKL---QHRNLVRLLGFCLE---- 412 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~---- 412 (674)
.++|++.++||+|+||+||+++. .+ ++.||||+++... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999985 34 5679999986432 22233456777777666 79999999999863
Q ss_pred -CCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeee
Q 005846 413 -GEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 491 (674)
Q Consensus 413 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~Df 491 (674)
....++++||+.++++..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 246789999999988765543 34556899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 492 GMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
|+++..... .......||+.|||||++.+..++.++||||+||++|||++|+.||... ...+.+..........
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC---CHHHHHHHHHHhhCCC
Confidence 999765322 2334568999999999999999999999999999999999999997532 2223333222211111
Q ss_pred Ccce----------ecc---cccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 572 TPLQ----------LLD---TNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 572 ~~~~----------~~d---~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.... ... ......+.......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000 00001112223456788999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=369.36 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=194.8
Q ss_pred CCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CeeEE
Q 005846 346 KFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG------EEKIL 418 (674)
Q Consensus 346 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~~l 418 (674)
+|+..++||+|+||+||+|+. .+|+.||||++...... +.+|+.+|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999996 46899999999765432 35799999999999999999998643 24689
Q ss_pred EEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCcccc
Q 005846 419 VYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIF 497 (674)
Q Consensus 419 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~ 497 (674)
||||++++++..+.........+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999988766555433334567999999999999999999999988 99999999999999775 8999999999876
Q ss_pred CCCCCCCccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh----------
Q 005846 498 GVDQTQGNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK---------- 566 (674)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~---------- 566 (674)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.... ..+.+....+
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~---~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC---HHHHHHHHHHHhCCChHHhh
Confidence 4332 2234579999999998875 568999999999999999999999875322 2222222111
Q ss_pred -hhcCCC----cceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 567 -QWRDGT----PLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 567 -~~~~~~----~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
...... ....................+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 00000000111112233456889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=363.76 Aligned_cols=263 Identities=23% Similarity=0.344 Sum_probs=196.7
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC--------
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 413 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------- 413 (674)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999995 57899999998543 333456789999999999999999999998653
Q ss_pred CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCC
Q 005846 414 EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 493 (674)
Q Consensus 414 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGl 493 (674)
...++||||+.++++..+. .....++...+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999988877655 34456899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCC--CccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcC
Q 005846 494 ARIFGVDQTQ--GNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRD 570 (674)
Q Consensus 494 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 570 (674)
++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.|+.. ......+....+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~---~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC---CCHHHHHHHHHHhcCC
Confidence 9876543222 122335799999999998765 689999999999999999999998642 2222222222222211
Q ss_pred CCcc---ee--------cccccCCCCChh-------HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 571 GTPL---QL--------LDTNLTDSYSRN-------EVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 571 ~~~~---~~--------~d~~~~~~~~~~-------~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.... .. +........... ....+++|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1100 00 000000000111 1235678999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-43 Score=359.07 Aligned_cols=260 Identities=17% Similarity=0.234 Sum_probs=195.9
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCceee-EEeEEEeCCeeEEEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLVR-LLGFCLEGEEKILVYEF 422 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~ 422 (674)
++|++.++||+|+||+||+|++ .+|+.||||++...... +++..|++++++++|+|++. +.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999985 56899999998654332 35788999999998776554 55566778889999999
Q ss_pred cCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEc---CCCCeEEeeeCCccccCC
Q 005846 423 VPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMARIFGV 499 (674)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~ki~DfGla~~~~~ 499 (674)
+.++.+ ..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+..
T Consensus 85 ~~~~l~-~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGPSLE-DLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCCBHH-HHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCCchh-hhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 955444 4432 23457999999999999999999999998 99999999999975 456799999999998754
Q ss_pred CCCC-----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcc
Q 005846 500 DQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPL 574 (674)
Q Consensus 500 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (674)
.... .......||+.|||||.+.+..++.++|||||||++|||+||+.|+.......................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence 3322 123456899999999999999999999999999999999999999764433322222111111100000
Q ss_pred eecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 575 QLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 575 ~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.+.+.. ..+..+.+++..||+.+|++||+++++.+.|+..
T Consensus 237 ---~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 ---IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 001111 2234678899999999999999999999888763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=368.00 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=196.3
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC-ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----eeE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS-GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKI 417 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~ 417 (674)
+.+|+++++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999984 579999999997543 334567899999999999999999999987653 335
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcccc
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIF 497 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~ 497 (674)
++++++.+|+|.+++. ...+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5566778999999884 346999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCC-CccccccccCCccCcccccc-CCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce
Q 005846 498 GVDQTQ-GNTSRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ 575 (674)
Q Consensus 498 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (674)
...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC---HHHHHHHHhhhccCCChhh
Confidence 443222 22345679999999999854 567899999999999999999999974322 1112111111111110000
Q ss_pred e------------cccccCCCC-----ChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 576 L------------LDTNLTDSY-----SRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 576 ~------------~d~~~~~~~-----~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
. ......... ......++.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000000 01122367899999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=363.02 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=192.1
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEeccc--CccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKA--SGQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 414 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 414 (674)
.++|++.++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 56899999999999999999995 46999999999753 2333567889999999999999999999998655
Q ss_pred eeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCc
Q 005846 415 EKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 494 (674)
Q Consensus 415 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla 494 (674)
..++||||+ +.+|..++ +...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 569999999 56666665 3457999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 495 RIFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
+..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.|+.... ..+.+............
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC---hHHHHHHHHhccCCCcH
Confidence 875432 2345799999999998764 57899999999999999999999874321 11222111111100000
Q ss_pred ------------------ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 574 ------------------LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 574 ------------------~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
.+.....+ ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 01111223467899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-42 Score=353.94 Aligned_cols=261 Identities=17% Similarity=0.235 Sum_probs=205.0
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCeeEEEEE
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 421 (674)
.++|++.++||+|+||+||+|+. .+|+.||||++..... .+.+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57899999999999999999995 4688999999865432 2356789999999965 899999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcC-----CCCeEEeeeCCccc
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMARI 496 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~ki~DfGla~~ 496 (674)
|+ +++|.+++.. ....+++.++..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6788777743 3456999999999999999999999998 999999999999974 57899999999998
Q ss_pred cCCCCCC-----CccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCC
Q 005846 497 FGVDQTQ-----GNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDG 571 (674)
Q Consensus 497 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 571 (674)
+...... .......||+.|||||.+.+..++.++|||||||++|||+||+.|+......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6543221 12345679999999999999999999999999999999999999986443333222222211111100
Q ss_pred CcceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcC
Q 005846 572 TPLQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLMLNSY 621 (674)
Q Consensus 572 ~~~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~L~~~ 621 (674)
.. ..+.... +..+.+++..|++.+|++||+++.+.+.|++.
T Consensus 236 ~~-----~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PL-----RELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CH-----HHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Ch-----HHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00 0111122 24678889999999999999999998888664
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-42 Score=351.76 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=205.1
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeCCeeEEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 421 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 421 (674)
++|+++++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 578899999986543 2346788999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCccccCCCC
Q 005846 422 FVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARIFGVDQ 501 (674)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~~~~~~~ 501 (674)
++.+++|..++. ..+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988774 3467899999999999999999999988 9999999999999999999999999998765433
Q ss_pred CCCccccccccCCccCccccccCC-CCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCcce-----
Q 005846 502 TQGNTSRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTPLQ----- 575 (674)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~----- 575 (674)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.|+. ...+..+.+..............
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC--CCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 223345788999999987665 6899999999999999999999852 22233333333322221111000
Q ss_pred -e--------ccc-ccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 576 -L--------LDT-NLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 576 -~--------~d~-~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
. ... .............+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 0001112233456788999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=356.73 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=201.0
Q ss_pred cCCCcccccccCCcEEEEEeec----CCCceeEEEEeccc----CccCHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSKA----SGQGAEEFKNEVVLVAKLQH-RNLVRLLGFCLEGEE 415 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~ 415 (674)
++|++.++||+|+||+||+++. .+|+.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999974 25789999998643 22345668899999999976 899999999999999
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+++|||+.+|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999998884 3456788999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCccCccccccC--CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP 573 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 573 (674)
.+..... .......|++.|++||.+.+. .++.++|||||||+||||++|+.||....... ......+......
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~~- 252 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSE- 252 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHCC-
T ss_pred hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcccCC-
Confidence 7643322 223446799999999999765 47889999999999999999999975433322 2222222211111
Q ss_pred ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005846 574 LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERP-----SMATIVL 616 (674)
Q Consensus 574 ~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----t~~evl~ 616 (674)
..++......+.+++.+||+.||++|| |++|+++
T Consensus 253 ---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112233456788999999999999999 4788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-41 Score=352.80 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=195.5
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeC--CeeEEEE
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVY 420 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 420 (674)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 57899999999653 3467899999999995 99999999998754 4689999
Q ss_pred EecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCC-CeEEeeeCCccccCC
Q 005846 421 EFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMARIFGV 499 (674)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~ki~DfGla~~~~~ 499 (674)
||+.+++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997664 35999999999999999999999998 99999999999998655 589999999987643
Q ss_pred CCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHh------------
Q 005846 500 DQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWK------------ 566 (674)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~------------ 566 (674)
.. ......||+.|+|||.+.+. .++.++||||+||+++||++|+.|+..... ..+.......
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~--~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHH
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch--hHHHHHHHHHHHCCchhhhhhh
Confidence 32 23345789999999998765 479999999999999999999998653222 1111111100
Q ss_pred hhcCCCccee-----------cccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 567 QWRDGTPLQL-----------LDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 567 ~~~~~~~~~~-----------~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......... ................+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0000111111223456889999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=351.70 Aligned_cols=258 Identities=26% Similarity=0.315 Sum_probs=189.5
Q ss_pred cCCCcccccccCCcEEEEEeecC-CCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEe------CCe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE 415 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~ 415 (674)
++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999964 69999999997543 3334568899999999999999999999964 367
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.++||||+.++++..+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999877665442 35899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhh-------
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQW------- 568 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~------- 568 (674)
..... .......||+.|+|||++.+..++.++||||+||+++||++|+.||.... ............
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~---~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHH
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC---HHHHHHHHHHhccCCCHHH
Confidence 65432 23345578999999999999999999999999999999999999874321 111111111000
Q ss_pred -c----------CCCc-------ceecccccCC---CCChhHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005846 569 -R----------DGTP-------LQLLDTNLTD---SYSRNEVIRCIQLGLLCVQEDPAERPSMATIVLM 617 (674)
Q Consensus 569 -~----------~~~~-------~~~~d~~~~~---~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~~ 617 (674)
. .... .......... .........+.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000 0000001101 1122345678899999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=350.23 Aligned_cols=257 Identities=24% Similarity=0.319 Sum_probs=193.3
Q ss_pred hcCCCcccccccCCcEEEEEeec-CCCceeEEEEecccC--ccCHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Ce
Q 005846 344 TNKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKAS--GQGAEEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 415 (674)
Q Consensus 344 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 415 (674)
.++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999985 579999999997543 23346788999999999999999999998643 34
Q ss_pred eEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 416 KILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 416 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.+++++|+.+|+|.+++. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 467778889999999883 346999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCCccCccccccC-CCCccccEEeechhhhHhHhCCCCCCccCCCCccchHHHHHhhhcCCCc-
Q 005846 496 IFGVDQTQGNTSRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAADLLSYAWKQWRDGTP- 573 (674)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~- 573 (674)
.... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.... .................
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~---~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCChH
Confidence 5432 23345789999999987765 46899999999999999999999974321 11222211111110000
Q ss_pred -----------------ceecccccCCCCChhHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005846 574 -----------------LQLLDTNLTDSYSRNEVIRCIQLGLLCVQEDPAERPSMATIVL 616 (674)
Q Consensus 574 -----------------~~~~d~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~evl~ 616 (674)
.......+. .........+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000 000122346789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-36 Score=318.18 Aligned_cols=263 Identities=19% Similarity=0.239 Sum_probs=191.1
Q ss_pred cCCCcccccccCCcEEEEEeec-CCCceeEEEEecccCccCHHHHHHHHHHHHhcC-----------CCceeeEEeEEEe
Q 005846 345 NKFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-----------HRNLVRLLGFCLE 412 (674)
Q Consensus 345 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~~ 412 (674)
.+|++.++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999985 579999999997543 23456788999988875 5789999998764
Q ss_pred C--CeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcCCCC----
Q 005846 413 G--EEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMN---- 485 (674)
Q Consensus 413 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~---- 485 (674)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4567777776665543333333455678999999999999999999997 55 999999999999987654
Q ss_pred --eEEeeeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechhhhHhHhCCCCCCccCCCCccc---h
Q 005846 486 --PKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSNFYQTDGAAD---L 560 (674)
Q Consensus 486 --~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~l~elltg~~p~~~~~~~~~~~---~ 560 (674)
++|+|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||.......... .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999976532 2234579999999999999999999999999999999999999975433221111 1
Q ss_pred HHHHHhhhcC------------------CCcceecccc----------cCCCCChhHHHHHHHHHhhcccCCCCCCCCHH
Q 005846 561 LSYAWKQWRD------------------GTPLQLLDTN----------LTDSYSRNEVIRCIQLGLLCVQEDPAERPSMA 612 (674)
Q Consensus 561 l~~~~~~~~~------------------~~~~~~~d~~----------~~~~~~~~~~~~~~~li~~Cl~~dP~~RPt~~ 612 (674)
+......... ......+... ............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111100 0000000000 01123445677899999999999999999999
Q ss_pred HHHH
Q 005846 613 TIVL 616 (674)
Q Consensus 613 evl~ 616 (674)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=4.5e-23 Score=196.37 Aligned_cols=168 Identities=19% Similarity=0.177 Sum_probs=119.4
Q ss_pred CcccccccCCcEEEEEeecCCCceeEEEEecccCc------------------cCHHHHHHHHHHHHhcCCCceeeEEeE
Q 005846 348 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASG------------------QGAEEFKNEVVLVAKLQHRNLVRLLGF 409 (674)
Q Consensus 348 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~niv~l~~~ 409 (674)
.+.++||+|+||+||+|+..+|+.||||+++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988899999998753110 001234568889999999999988865
Q ss_pred EEeCCeeEEEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEEeecccccEEEcCCCCeEEe
Q 005846 410 CLEGEEKILVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 489 (674)
Q Consensus 410 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~ki~ 489 (674)
. ..+++|||++++.+.. ++......++.|++++|.|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2379999998876543 233445678999999999999998 99999999999999654 8999
Q ss_pred eeCCccccCCCCCCCccccccccCCccCccccccCCCCccccEEeechh
Q 005846 490 DFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 538 (674)
Q Consensus 490 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwS~Gv~ 538 (674)
|||++.....+.......+-+. . -.|. ....|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHH
Confidence 9999976542221100000000 0 0011 23567889999996533
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=2.4e-07 Score=90.43 Aligned_cols=148 Identities=18% Similarity=0.104 Sum_probs=102.9
Q ss_pred hHHHhhcCCCcccccccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCeeE
Q 005846 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKI 417 (674)
Q Consensus 339 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~ 417 (674)
++...-.+|+..+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3344445777666655555678999875 56678889887655444456788888888774 434677888888888999
Q ss_pred EEEEecCCCcccccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 005846 418 LVYEFVPNKSLDYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHED---------------------------------- 463 (674)
Q Consensus 418 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------- 463 (674)
+||++++|..+...... ......++.++++.|+.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999887544311 111233455666666666642
Q ss_pred ----------------------CCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 464 ----------------------SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 464 ----------------------~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
....++|+|+.|.|||+++++..-|.||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11237999999999999987767799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=2.5e-05 Score=75.07 Aligned_cols=130 Identities=18% Similarity=0.150 Sum_probs=87.7
Q ss_pred ccccCCc-EEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCeeEEEEEecCCCcc
Q 005846 352 KLGEGGF-GEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSL 428 (674)
Q Consensus 352 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 428 (674)
.+..|.. +.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 679999887788888998655432 245778888877743 3356778888888889999999998877
Q ss_pred cccccCCCcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 005846 429 DYFLYDPEKQGQLDWSRRYKIIGGIARGILYLHE---------------------------------------------- 462 (674)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------------------------- 462 (674)
.... +... .++.++++.|.-||+
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 5422 1111 122233344444442
Q ss_pred -----c----CCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 463 -----D----SRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 463 -----~----~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
. .++.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12238999999999999988777899999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00021 Score=73.27 Aligned_cols=77 Identities=13% Similarity=0.162 Sum_probs=49.8
Q ss_pred ccccccCCcEEEEEeecCC-CceeEEEEecc-------cCccCHHHHHHHHHHHHhcC-C--CceeeEEeEEEeCCeeEE
Q 005846 350 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSK-------ASGQGAEEFKNEVVLVAKLQ-H--RNLVRLLGFCLEGEEKIL 418 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~-------~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~l 418 (674)
.+.||.|....||+....+ ++.++||.-.. ......++...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 67889996432 11223344566888887662 2 345556654 5566789
Q ss_pred EEEecCCCcc
Q 005846 419 VYEFVPNKSL 428 (674)
Q Consensus 419 v~e~~~~gsL 428 (674)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0021 Score=63.69 Aligned_cols=136 Identities=16% Similarity=0.090 Sum_probs=80.4
Q ss_pred cEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCcee--eEE-----eEEEeCCeeEEEEEecCCCcccc
Q 005846 358 FGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNLV--RLL-----GFCLEGEEKILVYEFVPNKSLDY 430 (674)
Q Consensus 358 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv--~l~-----~~~~~~~~~~lv~e~~~~gsL~~ 430 (674)
--.||+...++|+.+++|+.... ....+++..|+..+..|...++. ..+ .....++..+.++++++|..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999989999999987643 23456788899988887533221 111 12344567789999998866532
Q ss_pred ccc--------------------CCCcCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhcCCCc
Q 005846 431 FLY--------------------DPEKQGQLDWS----------------------RRYKIIGGIARGILYL-HEDSRLR 467 (674)
Q Consensus 431 ~l~--------------------~~~~~~~l~~~----------------------~~~~i~~~ia~~L~~L-H~~~~~~ 467 (674)
.-. .......+++. .....+..+...+.-+ .+..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 100 00001112211 1122223333322222 1222346
Q ss_pred EEEeecccccEEEcCCCCeEEeeeCCccc
Q 005846 468 IIHRDLKASNILLDAEMNPKISDFGMARI 496 (674)
Q Consensus 468 iiHrDlkp~NIll~~~~~~ki~DfGla~~ 496 (674)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.58 E-value=0.0028 Score=64.61 Aligned_cols=74 Identities=15% Similarity=0.222 Sum_probs=49.5
Q ss_pred ccccccCCcEEEEEeecCCC--------ceeEEEEecccCccCHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCCeeEEEE
Q 005846 350 DNKLGEGGFGEVYKGVLPSG--------QEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVY 420 (674)
Q Consensus 350 ~~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 420 (674)
++.|+.|-.-.+|+...+++ +.|.+++.. .. .......+|..+++.+.-.+ ..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35788888899999876432 456666554 22 23345678999988884334 4477777643 6899
Q ss_pred EecCCCccc
Q 005846 421 EFVPNKSLD 429 (674)
Q Consensus 421 e~~~~gsL~ 429 (674)
||++|..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999886664
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.34 E-value=0.064 Score=52.00 Aligned_cols=157 Identities=12% Similarity=0.039 Sum_probs=82.2
Q ss_pred chhhHHHhhcCCCcccc-----cccCCcEEEEEeecCCCceeEEEEecccCccCHHHHHHHHHHHHhcCCCce-----ee
Q 005846 336 DFETIEVATNKFSTDNK-----LGEGGFGEVYKGVLPSGQEIAVKRLSKASGQGAEEFKNEVVLVAKLQHRNL-----VR 405 (674)
Q Consensus 336 ~~~~~~~~~~~~~~~~~-----lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~ 405 (674)
+.++++....+|.+.+. |..|---+.|+.+..+| .+++|+...... .+++..|+.++..|...++ +.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 44556666667766433 44566678899887555 589998865322 2344556667776643221 11
Q ss_pred EE---eEEEeCCeeEEEEEecCCCcccccccC--------------------CCcCCCCC------------------HH
Q 005846 406 LL---GFCLEGEEKILVYEFVPNKSLDYFLYD--------------------PEKQGQLD------------------WS 444 (674)
Q Consensus 406 l~---~~~~~~~~~~lv~e~~~~gsL~~~l~~--------------------~~~~~~l~------------------~~ 444 (674)
.. .+.........++.++.+......... ........ ..
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 012234556777777777554321100 00000000 00
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCcEEEeecccccEEEcCCCCeEEeeeCCcc
Q 005846 445 RRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAR 495 (674)
Q Consensus 445 ~~~~i~~~ia~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~ki~DfGla~ 495 (674)
.....+..+...+.-.+. .-+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222222222222222 123459999999999999988877899999885
|